Citrus Sinensis ID: 025893
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | 2.2.26 [Sep-21-2011] | |||||||
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.995 | 0.692 | 0.804 | 1e-116 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 1.0 | 0.673 | 0.78 | 1e-111 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.967 | 0.659 | 0.653 | 3e-86 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.971 | 0.585 | 0.624 | 4e-84 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.796 | 0.535 | 0.737 | 4e-83 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.975 | 0.657 | 0.58 | 1e-80 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.739 | 0.252 | 0.492 | 9e-44 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.747 | 0.247 | 0.448 | 2e-42 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.739 | 0.253 | 0.486 | 4e-42 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.898 | 0.311 | 0.421 | 6e-42 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 198/246 (80%), Positives = 220/246 (89%), Gaps = 1/246 (0%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CC++DDMH+A DNG +M +SAG +G A+E+A + Q V +QPI VP+I+VD
Sbjct: 1 MSCFSCCDDDDMHRATDNG-PFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELK+IT+NFG+ ALIGEGSYGRVY+G+LKSG AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 60 ELKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLK 119
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
EN V+LLGYCVDG RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRVKIAVGA
Sbjct: 120 DENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGA 179
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKA PHIIHRDIKSSN+L+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 180 AKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 239
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 240 GYHAPE 245
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1026), Expect = e-111, Method: Compositional matrix adjust.
Identities = 195/250 (78%), Positives = 216/250 (86%), Gaps = 4/250 (1%)
Query: 1 MSCFGCC-EEDDMHKAADNGNAYMVKS--SAGTDGAYH-ASEAAPKGAQAVKVQPIEVPA 56
MSCFGCC E+DDMHK AD G + G D +H ASE A KG VK+QPIEVP
Sbjct: 1 MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARHHQASETAQKGPPVVKLQPIEVPI 60
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
I ELKE T++FG+N+LIGEGSYGRVYYG+L + +AIKKLD++KQPD EFLAQVSMV
Sbjct: 61 IPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNKQPDNEFLAQVSMV 120
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SRLKH+NFVQLLGYCVDG SR+L+YEFA+NGSLHDILHGRKGVKGAQPGPVLSW QRVKI
Sbjct: 121 SRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQRVKI 180
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
AVGAA+GLEYLHEKA+PHIIHRDIKSSNVL+F+DDVAKIADFDLSNQAPDMAARLHSTRV
Sbjct: 181 AVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHSTRV 240
Query: 237 LGTFGYHAPE 246
LGTFGYHAPE
Sbjct: 241 LGTFGYHAPE 250
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 162/248 (65%), Positives = 186/248 (75%), Gaps = 10/248 (4%)
Query: 3 CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQ--PIEVPAISVD 60
C C ED N + S +D + S+ AP VK + PIEVP +S+D
Sbjct: 6 CCTCQIEDS------NEEQQLKSSQQQSDANHKNSKPAPVAKHEVKKEALPIEVPPLSLD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSR 118
E+KE TENFG+ ALIGEGSYGRVYY L G A A+KKLD + + D EFL+QVSMVSR
Sbjct: 60 EVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVSMVSR 119
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
LKHEN +QLLG+CVDG RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RVKIAV
Sbjct: 120 LKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRVKIAV 179
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
AA+GLEYLHEK+ P +IHRDI+SSNVL+F+D AKIADF+LSNQAPD AARLHSTRVLG
Sbjct: 180 EAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHSTRVLG 239
Query: 239 TFGYHAPE 246
TFGYHAPE
Sbjct: 240 TFGYHAPE 247
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 156/250 (62%), Positives = 189/250 (75%), Gaps = 11/250 (4%)
Query: 3 CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGA---QAVKVQP-IEVPAIS 58
C C E+ H + N ++ D +H + P+ A A+K P I+VPA+S
Sbjct: 48 CCACHVEEPYHSSE---NEHLRSPKHHNDFGHHTRK--PQAAVKPDALKEPPSIDVPALS 102
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMV 116
+DELKE T+NFG+ +LIGEGSYGR YY LK G A A+KKLD + +P+ EFL QVS V
Sbjct: 103 LDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRV 162
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
S+LKH+NFV+L GYCV+G R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+I
Sbjct: 163 SKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRI 222
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
AV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AKIADF+LSNQ+PDMAARLHSTRV
Sbjct: 223 AVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRV 282
Query: 237 LGTFGYHAPE 246
LGTFGYHAPE
Sbjct: 283 LGTFGYHAPE 292
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 4e-83, Method: Compositional matrix adjust.
Identities = 146/198 (73%), Positives = 166/198 (83%), Gaps = 2/198 (1%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEE 108
PIEVP +SVDE+KE T+NFG+ +LIGEGSYGRVYY L G A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
FL QVSMVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
W RVKIAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AK+ADF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 229 ARLHSTRVLGTFGYHAPE 246
ARLHSTRVLGTFGYHAPE
Sbjct: 233 ARLHSTRVLGTFGYHAPE 250
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (766), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 145/250 (58%), Positives = 184/250 (73%), Gaps = 10/250 (4%)
Query: 6 CCEEDDMHKAADNGNAYMVKSS-------AGTDGAYHASEAAPKGAQAVKVQPIEVPAIS 58
CC D A N Y + G + + AP+ KV PIE+P+++
Sbjct: 3 CCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPSVA 62
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQPDEEFLAQVSMV 116
+DEL + NFG ALIGEGSYGRV+ G K G A AIKKLDAS ++PD +F +Q+S+V
Sbjct: 63 LDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLSVV 121
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SRLKH++FV+LLGYC++ +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRVKI
Sbjct: 122 SRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRVKI 181
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A GAAKGLE+LHEK P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHSTRV
Sbjct: 182 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHSTRV 241
Query: 237 LGTFGYHAPE 246
LGTFGYHAPE
Sbjct: 242 LGTFGYHAPE 251
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 9e-44, Method: Compositional matrix adjust.
Identities = 94/191 (49%), Positives = 126/191 (65%), Gaps = 9/191 (4%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSM 115
S +EL EIT+ F ++GEG +G VY G L+ G A+K+L A S Q D EF A+V +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+SR+ H + V L+GYC+ R+L YE+ SN +L LHG KG+ PVL W +RV+
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG-KGL------PVLEWSKRVR 471
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
IA+G+AKGL YLHE P IIHRDIKS+N+L+ D+ A++ADF L+ + D STR
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVSTR 530
Query: 236 VLGTFGYHAPE 246
V+GTFGY APE
Sbjct: 531 VMGTFGYLAPE 541
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (436), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 88/196 (44%), Positives = 126/196 (64%), Gaps = 12/196 (6%)
Query: 52 IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFL 110
+ V ++ EL++ T+ F ++GEG +GRVY G ++ G A+K L Q D EF+
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFI 391
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
A+V M+SRL H N V+L+G C++G +R L YE NGS+ LH +G L W
Sbjct: 392 AEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-----EG-----TLDW 441
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
R+KIA+GAA+GL YLHE ++P +IHRD K+SNVL+ DD K++DF L+ +A + +
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 501
Query: 231 LHSTRVLGTFGYHAPE 246
+ STRV+GTFGY APE
Sbjct: 502 I-STRVMGTFGYVAPE 516
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 171 bits (433), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 93/191 (48%), Positives = 123/191 (64%), Gaps = 9/191 (4%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSM 115
+ +EL +ITE F + ++GEG +G VY GIL G AIK+L + S + EF A+V +
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+SR+ H + V L+GYC+ R L YEF N +L LHG+ PVL W +RV+
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-------PVLEWSRRVR 470
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
IA+GAAKGL YLHE P IIHRDIKSSN+L+ D+ A++ADF L+ + D A STR
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQSHISTR 529
Query: 236 VLGTFGYHAPE 246
V+GTFGY APE
Sbjct: 530 VMGTFGYLAPE 540
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 6e-42, Method: Compositional matrix adjust.
Identities = 100/237 (42%), Positives = 142/237 (59%), Gaps = 16/237 (6%)
Query: 11 DMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFG 70
+ + +++GN++ + G Y S +AP A Q + +EL +ITE F
Sbjct: 302 NSQQQSNSGNSFGSQRGGG---GYTRSGSAPDSAVMGSGQT----HFTYEELTDITEGFS 354
Query: 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLD-ASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
+ ++GEG +G VY G L G A+K+L S Q D EF A+V ++SR+ H + V L+G
Sbjct: 355 KHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVG 414
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
YC+ + R+L YE+ N +L LHG KG PVL W +RV+IA+G+AKGL YLHE
Sbjct: 415 YCIADSERLLIYEYVPNQTLEHHLHG----KGR---PVLEWARRVRIAIGSAKGLAYLHE 467
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
P IIHRDIKS+N+L+ D+ A++ADF L+ + D STRV+GTFGY APE
Sbjct: 468 DCHPKIIHRDIKSANILLDDEFEAQVADFGLA-KLNDSTQTHVSTRVMGTFGYLAPE 523
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | ||||||
| 255548287 | 362 | Serine/threonine-protein kinase PBS1, pu | 1.0 | 0.679 | 0.926 | 1e-132 | |
| 224130874 | 362 | predicted protein [Populus trichocarpa] | 1.0 | 0.679 | 0.902 | 1e-127 | |
| 118485120 | 324 | unknown [Populus trichocarpa] | 1.0 | 0.759 | 0.902 | 1e-127 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 1.0 | 0.516 | 0.869 | 1e-126 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 1.0 | 0.681 | 0.869 | 1e-126 | |
| 224064746 | 362 | predicted protein [Populus trichocarpa] | 1.0 | 0.679 | 0.882 | 1e-125 | |
| 359811321 | 361 | pto-interacting protein 1-like [Glycine | 1.0 | 0.681 | 0.865 | 1e-124 | |
| 351725893 | 361 | serine/threonine protein kinase [Glycine | 1.0 | 0.681 | 0.849 | 1e-122 | |
| 225437716 | 362 | PREDICTED: pto-interacting protein 1 [Vi | 1.0 | 0.679 | 0.837 | 1e-121 | |
| 356505673 | 361 | PREDICTED: pto-interacting protein 1-lik | 1.0 | 0.681 | 0.837 | 1e-119 |
| >gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1227), Expect = e-132, Method: Compositional matrix adjust.
Identities = 228/246 (92%), Positives = 236/246 (95%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEEDDMHKAAD+G Y VKSSAG G YHASE AP+GAQAVK+QPIEVP+ISVD
Sbjct: 1 MSCFGCCEEDDMHKAADSGGPYPVKSSAGNVGGYHASETAPRGAQAVKIQPIEVPSISVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG N+LIGEGSYGRVYYGILKSG AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGINSLIGEGSYGRVYYGILKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130874|ref|XP_002320946.1| predicted protein [Populus trichocarpa] gi|222861719|gb|EEE99261.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1186), Expect = e-127, Method: Compositional matrix adjust.
Identities = 222/246 (90%), Positives = 231/246 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEEDD+ KAADNG Y VKSSAG G YHASE AP+G QAVK+QPIEVPAISVD
Sbjct: 1 MSCFGCCEEDDVQKAADNGGPYAVKSSAGHVGNYHASETAPRGPQAVKIQPIEVPAISVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T NFGT++LIGEGSYGRVYYG+LKS AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTVNFGTDSLIGEGSYGRVYYGVLKSEQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKADP IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPRIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118485120|gb|ABK94423.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1186), Expect = e-127, Method: Compositional matrix adjust.
Identities = 222/246 (90%), Positives = 231/246 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEEDD+ KAADNG Y VKSSAG G YHASE AP+G QAVK+QPIEVPAISVD
Sbjct: 1 MSCFGCCEEDDVQKAADNGGPYAVKSSAGHVGNYHASETAPRGPQAVKIQPIEVPAISVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T NFGT++LIGEGSYGRVYYG+LKS AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTVNFGTDSLIGEGSYGRVYYGVLKSEQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKADP IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPRIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-126, Method: Compositional matrix adjust.
Identities = 214/246 (86%), Positives = 230/246 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEED+ HKAA++G Y+VK+ AG DG YHAS+ A +GAQ VKVQPIEVP I D
Sbjct: 116 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 175
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 176 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 235
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 236 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 295
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 296 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 355
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 356 GYHAPE 361
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 455 bits (1170), Expect = e-126, Method: Compositional matrix adjust.
Identities = 214/246 (86%), Positives = 230/246 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEED+ HKAA++G Y+VK+ AG DG YHAS+ A +GAQ VKVQPIEVP I D
Sbjct: 1 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064746|ref|XP_002301545.1| predicted protein [Populus trichocarpa] gi|222843271|gb|EEE80818.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1168), Expect = e-125, Method: Compositional matrix adjust.
Identities = 217/246 (88%), Positives = 229/246 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CCEEDD+HKAAD G Y VKSSAG G YHASE APKGAQA K+QPIEVP IS D
Sbjct: 1 MSCFCCCEEDDIHKAADYGGQYTVKSSAGNLGNYHASETAPKGAQAFKIQPIEVPEISGD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFGT++LIGEGSYGRVYYG+LKSG A+IKKLDASKQPD+EFL+QVSMVSRLK
Sbjct: 61 ELKEVTDNFGTSSLIGEGSYGRVYYGVLKSGQDASIKKLDASKQPDDEFLSQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYCVDG SRVL YEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLIYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKADPHI+HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIVHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1153), Expect = e-124, Method: Compositional matrix adjust.
Identities = 213/246 (86%), Positives = 228/246 (92%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CCEEDD+HKAA++G Y+VK+ AG DG Y ASE A +G Q VK QPIEVP IS D
Sbjct: 1 MSCFSCCEEDDLHKAAESGGPYVVKNPAGNDGNYLASETAKQGTQPVKPQPIEVPNISAD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG +ALIGEGSYGRVYYG+LKS AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDALIGEGSYGRVYYGVLKSELAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYC+DG+SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725893|ref|NP_001237620.1| serine/threonine protein kinase [Glycine max] gi|223452365|gb|ACM89510.1| serine/threonine protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-122, Method: Compositional matrix adjust.
Identities = 209/246 (84%), Positives = 226/246 (91%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEEDD K A++G ++VK+S G DG ASE A +G QAVK+QPIEVP + VD
Sbjct: 1 MSCFGCCEEDDYQKTAESGGQHVVKNSTGNDGNSRASETAKQGTQAVKIQPIEVPELQVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKEIT+ FG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDGFGESSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437716|ref|XP_002280340.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297744052|emb|CBI37022.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1135), Expect = e-121, Method: Compositional matrix adjust.
Identities = 206/246 (83%), Positives = 226/246 (91%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCE+DD+H A ++GN + K+ AG DG Y ++ APKG QAVKVQPI VP I D
Sbjct: 1 MSCFGCCEDDDIHTAPESGNPFAAKNPAGNDGGYRHTDPAPKGTQAVKVQPIAVPPIPFD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKEIT+NFGT+ALIGEGSYGRVYYG+LK+G AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61 ELKEITDNFGTSALIGEGSYGRVYYGLLKNGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFV+L+GYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGP+LSW QRVKIAVGA
Sbjct: 121 HDNFVELIGYCVDGGSRILAYEFASNGSLHDILHGRKGVKGAQPGPILSWAQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GL+YLHEKA PHIIHRDIKSSNVL+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLDYLHEKASPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505673|ref|XP_003521614.1| PREDICTED: pto-interacting protein 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1115), Expect = e-119, Method: Compositional matrix adjust.
Identities = 206/246 (83%), Positives = 224/246 (91%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CCEEDD KA+++G ++VK+S G G ASE A +G QAVK+QPIEVP + VD
Sbjct: 1 MSCFSCCEEDDYQKASESGGQHVVKNSTGNHGNGRASETAKQGTQAVKIQPIEVPELPVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKEIT+ FG ++LIGEGSYGRVYYG+LKS AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDGFGESSLIGEGSYGRVYYGVLKSRQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | ||||||
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 1.0 | 0.681 | 0.788 | 2e-102 | |
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.995 | 0.673 | 0.740 | 1.4e-96 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.995 | 0.674 | 0.691 | 1.2e-90 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.995 | 0.673 | 0.615 | 2e-79 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.934 | 0.637 | 0.685 | 3.3e-79 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.975 | 0.588 | 0.630 | 3.8e-78 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.849 | 0.571 | 0.701 | 3.5e-75 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.975 | 0.657 | 0.592 | 9.3e-75 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.825 | 0.600 | 0.682 | 1.8e-71 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.930 | 0.318 | 0.423 | 2.3e-42 |
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 194/246 (78%), Positives = 214/246 (86%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCC EDD+ A D G M K S G DG + SE A KGAQ+VKVQPIEV AI D
Sbjct: 1 MSCFGCCREDDLPGANDYGGHNMTKQSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILAD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
EL E T +FGTN+LIGEGSY RVY+G+LK+G AAIKKLD++KQP+EEFLAQVSMVSRLK
Sbjct: 61 ELIEATNDFGTNSLIGEGSYARVYHGVLKNGQRAAIKKLDSNKQPNEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H NFV+LLGY VDG SR+L +EFA NGSLHDILHGRKGVKGA+PGP+LSW QRVKIAVGA
Sbjct: 121 HVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKA+PH+IHRDIKSSNVLIFD+DVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 241 GYHAPE 246
|
|
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
Identities = 183/247 (74%), Positives = 209/247 (84%)
Query: 1 MSCFGCCEE-DDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISV 59
M CFGCC +D + ++ G V ++ G +G +H PK +++QPI V AI
Sbjct: 1 MGCFGCCGGGEDFRRVSETGPK-PVHNTGGYNGGHHQRADPPKNLPVIQMQPISVAAIPA 59
Query: 60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
DEL++IT+N+G+ +LIGEGSYGRV+YGILKSG AAAIKKLD+SKQPD+EFLAQVSMVSRL
Sbjct: 60 DELRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSKQPDQEFLAQVSMVSRL 119
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+ EN V LLGYCVDG RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRVKIAVG
Sbjct: 120 RQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVG 179
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
AA+GLEYLHEKA+PH+IHRDIKSSNVL+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGT
Sbjct: 180 AARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
Query: 240 FGYHAPE 246
FGYHAPE
Sbjct: 240 FGYHAPE 246
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 1.2e-90, P = 1.2e-90
Identities = 170/246 (69%), Positives = 198/246 (80%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFG C +D A D G + AG +G ++ P + +QPI VPAI VD
Sbjct: 1 MSCFGWCGSEDFRNATDTGPR-PAHNPAGYNGGHYQRADPPMNQPVIPMQPISVPAIPVD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
EL++IT+N+G+ LIGEGSYGRV+YG+LKSG AAAIKKLD+SKQPD+EFL+Q+SMVSRL+
Sbjct: 60 ELRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSKQPDQEFLSQISMVSRLR 119
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+N L+GYCVDG RVLAYEFA GSLHD LHG+KG KGA GPV++WQQRVKIAVGA
Sbjct: 120 HDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRVKIAVGA 179
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEK P +IHRDIKSSNVL+FDDDVAKI DFDLS+QAPDMAARLHSTRVLGTF
Sbjct: 180 ARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHSTRVLGTF 239
Query: 241 GYHAPE 246
GYHAPE
Sbjct: 240 GYHAPE 245
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 152/247 (61%), Positives = 189/247 (76%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFG C +D+ AD G + +S G +G +H P V +QPI VPAI VD
Sbjct: 1 MSCFGWCGSEDVRNPADTGPS-QAHNSIGYNGRHHQRADPPMNQPVVNMQPIAVPAIPVD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
EL++ITENF + L+G+GSYGRV+YG+LKSG AAIKKL +KQPD+EFL+QVSMVSRL
Sbjct: 60 ELEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTKQPDQEFLSQVSMVSRLH 119
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HEN V L+ YCVDG RVLAYEFA+ G+LHD+LHG+ GV GA GPV++WQ+RVKIA+GA
Sbjct: 120 HENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRVKIALGA 179
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV-LGT 239
A+GLEYLH+K +P +IHRDIK+SN+L+FDDD+AKI DFDL +QAP+MA RLHS R+ LG
Sbjct: 180 ARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSCRMALGA 239
Query: 240 FGYHAPE 246
H PE
Sbjct: 240 SRSHCPE 246
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 3.3e-79, P = 3.3e-79
Identities = 161/235 (68%), Positives = 184/235 (78%)
Query: 17 DNGNAYMVKSSAGTDGAYHA-SEAAPKGAQAVKVQ--PIEVPAISVDELKEITENFGTNA 73
D+ +KSS A H S+ AP VK + PIEVP +S+DE+KE TENFG+ A
Sbjct: 13 DSNEEQQLKSSQQQSDANHKNSKPAPVAKHEVKKEALPIEVPPLSLDEVKEKTENFGSKA 72
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYC 131
LIGEGSYGRVYY L G A A+KKLD + + D EFL+QVSMVSRLKHEN +QLLG+C
Sbjct: 73 LIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFC 132
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
VDG RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RVKIAV AA+GLEYLHEK+
Sbjct: 133 VDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKS 192
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
P +IHRDI+SSNVL+F+D AKIADF+LSNQAPD AARLHSTRVLGTFGYHAPE
Sbjct: 193 QPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHSTRVLGTFGYHAPE 247
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 786 (281.7 bits), Expect = 3.8e-78, P = 3.8e-78
Identities = 157/249 (63%), Positives = 189/249 (75%)
Query: 3 CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHAS--EAAPKGAQAVKVQP-IEVPAISV 59
C C E+ H + N ++ D +H +AA K A+K P I+VPA+S+
Sbjct: 48 CCACHVEEPYHSSE---NEHLRSPKHHNDFGHHTRKPQAAVK-PDALKEPPSIDVPALSL 103
Query: 60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVS 117
DELKE T+NFG+ +LIGEGSYGR YY LK G A A+KKLD + +P+ EFL QVS VS
Sbjct: 104 DELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVS 163
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+LKH+NFV+L GYCV+G R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+IA
Sbjct: 164 KLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIA 223
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
V AA+GLEYLHEK P +IHRDI+SSNVL+F+D AKIADF+LSNQ+PDMAARLHSTRVL
Sbjct: 224 VDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVL 283
Query: 238 GTFGYHAPE 246
GTFGYHAPE
Sbjct: 284 GTFGYHAPE 292
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 758 (271.9 bits), Expect = 3.5e-75, P = 3.5e-75
Identities = 148/211 (70%), Positives = 170/211 (80%)
Query: 38 EAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIK 97
+A K + PIEVP +SVDE+KE T+NFG+ +LIGEGSYGRVYY L G A A+K
Sbjct: 40 QAVVKPEAQKEALPIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALK 99
Query: 98 KLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
KLD + + + EFL QVSMVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHG
Sbjct: 100 KLDVAPEAETNTEFLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHG 159
Query: 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215
RKGV+GAQPGP L W RVKIAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AK+
Sbjct: 160 RKGVQGAQPGPTLDWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKV 219
Query: 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
ADF+LSNQAPD AARLHSTRVLGTFGYHAPE
Sbjct: 220 ADFNLSNQAPDNAARLHSTRVLGTFGYHAPE 250
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
Identities = 148/250 (59%), Positives = 186/250 (74%)
Query: 6 CCEEDDMHKAADNGNAYMVK-SSAGTD--GAYHASEA----APKGAQAVKVQPIEVPAIS 58
CC D A N Y + AG G + E AP+ KV PIE+P+++
Sbjct: 3 CCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPSVA 62
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQPDEEFLAQVSMV 116
+DEL + NFG ALIGEGSYGRV+ G K G A AIKKLDAS ++PD +F +Q+S+V
Sbjct: 63 LDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLSVV 121
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SRLKH++FV+LLGYC++ +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRVKI
Sbjct: 122 SRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRVKI 181
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A GAAKGLE+LHEK P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHSTRV
Sbjct: 182 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHSTRV 241
Query: 237 LGTFGYHAPE 246
LGTFGYHAPE
Sbjct: 242 LGTFGYHAPE 251
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 1.8e-71, P = 1.8e-71
Identities = 140/205 (68%), Positives = 167/205 (81%)
Query: 44 AQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK 103
A+ ++ PI VP++SVDE+ E T+NFG N+LIGEGSYGRVYY L G A A+KKLD +
Sbjct: 22 AKPKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALKKLDLAP 81
Query: 104 QPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG 161
+ + EFL+QVSMVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHGRKGV+
Sbjct: 82 EDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQD 141
Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A PGP L W RVKIAV AA+GLEYLHEK P +IHRDI+SSN+L+FDD AKIADF+LS
Sbjct: 142 ALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNLS 201
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPE 246
NQ+PD AARL STRVLG+FGY++PE
Sbjct: 202 NQSPDNAARLQSTRVLGSFGYYSPE 226
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 453 (164.5 bits), Expect = 2.3e-42, P = 2.3e-42
Identities = 103/243 (42%), Positives = 142/243 (58%)
Query: 5 GCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKE 64
G + + + GN+Y +AG G Y + G + S +EL E
Sbjct: 312 GSMYNNSQQQQSSMGNSY---GTAG--GGYPHHQMQSSGTPDSAILGSGQTHFSYEELAE 366
Query: 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHEN 123
IT+ F ++GEG +G VY G L+ G A+K+L A S Q D EF A+V ++SR+ H +
Sbjct: 367 ITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRH 426
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V L+GYC+ R+L YE+ SN +L LHG KG+ PVL W +RV+IA+G+AKG
Sbjct: 427 LVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG-KGL------PVLEWSKRVRIAIGSAKG 479
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
L YLHE P IIHRDIKS+N+L+ D+ A++ADF L+ + D STRV+GTFGY
Sbjct: 480 LAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVSTRVMGTFGYL 538
Query: 244 APE 246
APE
Sbjct: 539 APE 541
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.8048 | 0.9959 | 0.6920 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 246 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.002 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-42
Identities = 60/176 (34%), Positives = 85/176 (48%), Gaps = 17/176 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
+GEG +G VY K+G AIK + EE L ++ ++ +L H N V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
D L E+ GSL D+L +G LS + ++I + +GLEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN- 111
Query: 192 DPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+K N+L+ D+ K+ADF LS + L + GT Y APE
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-40
Identities = 55/154 (35%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G VY G LK A+K L DAS+Q EEFL + ++ +L H N V+L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C + + E+ G L L + P LS + A+ A+G+EYL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR--------PKLSLSDLLSFALQIARGMEYL 118
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K + IHRD+ + N L+ ++ V KI+DF LS
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-39
Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 17/154 (11%)
Query: 75 IGEGSYGRVYYGILKSGHA-----AAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G VY G LK A+K L DAS+Q EEFL + ++ +L H N V+L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C + ++ E+ G L D L + LS + A+ A+G+EYL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-------PKELSLSDLLSFALQIARGMEYL 119
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K + IHRD+ + N L+ ++ V KI+DF LS
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-39
Identities = 55/153 (35%), Positives = 82/153 (53%), Gaps = 9/153 (5%)
Query: 75 IGEGSYGRVYYGILKSG----HAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+GEG++G VY G LK A+K L DAS++ ++FL + ++ +L H N V+LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C + L E+ G L D L + V + LS + + A+ AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K +HRD+ + N L+ +D V KI+DF LS
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 55/154 (35%), Positives = 84/154 (54%), Gaps = 18/154 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G VY G LK A+K L AS++ EEFL + S++ +L H N V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C G + E+ G L D L + G L+ + +++A+ AKG+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K + +HRD+ + N L+ ++ V KI+DF LS
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-35
Identities = 59/176 (33%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
+G GS+G VY K G A+K L + D+ ++ ++ RL H N V+L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
D L E+ G L D L LS + KIA+ +GLEYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+K N+L+ ++ V KIADF L+ + ++ +T V GT Y APE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-35
Identities = 59/176 (33%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGY 130
+GEGS+G+VY K+G AIK + K E L ++ ++ +LKH N V+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
D L E+ G L D+L R LS + LEYLH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRD+K N+L+ +D K+ADF L+ Q +T V GT Y APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-32
Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
IG+G +G VY ++G AIK + + +E + + ++ + KH N V+ G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ EF S GSL D+L L+ Q + KGLEYLH
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN-- 117
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRDIK++N+L+ D K+ DF LS Q ++ ++GT + APE
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 4e-31
Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 20/180 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
L+G GS+G VY + K +G A+K ++ S +EE ++ ++S L+H N V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 130 YCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEY 186
D L E+ S GSL +L + P PV+ ++ + I +GL Y
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVI--RKYTRQI----LEGLAY 116
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH I+HRDIK +N+L+ D V K+ADF + + D+ + V GT + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-30
Identities = 55/152 (36%), Positives = 86/152 (56%), Gaps = 11/152 (7%)
Query: 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
A IG+G +G V G + G A+K L + FLA+ S+++ L+H N VQLLG +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D L R G V++ Q++ A+ +G+EYL EK
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSR----GRA---VITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
+ +HRD+ + NVL+ +D VAK++DF L+ +A
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 62/184 (33%), Positives = 94/184 (51%), Gaps = 32/184 (17%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE---EFLAQVSMVSRLKHENFVQLLG 129
LIG G++G VY G+ L++G AIK++ K +E + ++ ++ LKH N V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDIL--HGRKG-----VKGAQPGPVLSWQQRVKIAVGAAK 182
S + E+A NGSL I+ G V Q VL +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ---VL-------------Q 110
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL YLHE+ +IHRDIK++N+L D V K+ADF ++ + D++ S V+GT +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165
Query: 243 HAPE 246
APE
Sbjct: 166 MAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 75 IGEGSYGRVYYGILKSG------HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
+GEG++G+V+ G A+K L + D ++F + +++ +HEN V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV---LSWQQRVKIAVGAA 181
G C +G ++ +E+ +G L+ L HG P L+ Q ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
G+ YL A H +HRD+ + N L+ D V KI DF +S
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (248), Expect = 1e-24
Identities = 60/183 (32%), Positives = 82/183 (44%), Gaps = 21/183 (11%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHE-NFVQLL 128
+GEGS+G VY + A+K L + E FL ++ +++ L H N V+L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ D S L E+ GSL D+L LS + + I LEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKI------GRKGPLSESEALFILAQILSALEYLH 118
Query: 189 EKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTR----VLGTFGYH 243
K IIHRDIK N+L+ D V K+ DF L+ PD + +GT GY
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 244 APE 246
APE
Sbjct: 176 APE 178
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-23
Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIK--KLDASKQPDEEFLAQ----VSMVSRLKHENFVQ 126
L+G GS+G VY G+ L G A+K L Q +E + Q ++++S+L+H N VQ
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LG + + + E GSL +L G+ P PV+ R + GLEY
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL-----LGLEY 117
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
LH++ + +HRDIK +N+L+ + V K+ADF ++ Q
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-22
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G+ + A+K L ++FLA+ ++ +L+H +QL C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E GSL + L G G L Q + +A A G+ YL + +
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ---N 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD+ + NVL+ ++++ K+ADF L+
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-22
Identities = 57/181 (31%), Positives = 90/181 (49%), Gaps = 15/181 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
E F +GEGSYG VY I ++G AIK + ++ +E + ++S++ + V
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIV 61
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ G T + E+ GS+ DI+ L+ ++ I KGLE
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLE 113
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH IHRDIK+ N+L+ ++ AK+ADF +S Q D A+ ++ V+GT + AP
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAP 168
Query: 246 E 246
E
Sbjct: 169 E 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 4e-22
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 74 LIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
IG+GS+G+VY G +K++D S ++E L +V ++ +L H N ++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ + E+A G L + +K + G +Q + V L+YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQK-----KEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGYHA 244
+ I+HRDIK N+ + + + K+ DF +S L ST V+GT Y +
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKTVVGTPYYLS 171
Query: 245 PE 246
PE
Sbjct: 172 PE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-21
Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 75 IGEGSYGRVYYGIL------KSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
+GEG++G+VY G L S + AIK L + +P +EF + ++S L+H N V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKIAVG 179
LLG C + +E+ ++G LH+ L L + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A G+EYL + H +HRD+ + N L+ + KI+DF LS
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-21
Identities = 59/184 (32%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
+ ++G+GS G VY K +G A+KK+ + ++ L ++ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 124 FVQLLG-YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
V+ G + +G + E+ GSL D+L + P PVL+ IA K
Sbjct: 61 VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQILK 110
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL+YLH K HIIHRDIK SN+LI KIADF +S + + +T V GT Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVTY 166
Query: 243 HAPE 246
+PE
Sbjct: 167 MSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 3e-21
Identities = 56/181 (30%), Positives = 86/181 (47%), Gaps = 25/181 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
IGEG+YG+VY K+G A+KK+ + E F + ++ ++ +L+H N V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 130 YCVD--GTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
S + +E+ HD+ L VK + Q +GL+
Sbjct: 66 IVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVK-------FTESQIKCYMKQLLEGLQ 114
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH I+HRDIK SN+LI +D V K+ADF L+ + ++ RV+ T Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 246 E 246
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-21
Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G YG VY G+ K A+K L EEFL + +++ +KH N VQLLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ EF + G+L D L R+ + VL + +A + +EYL +K
Sbjct: 74 EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 123
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ IHRD+ + N L+ ++ + K+ADF LS
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 5e-21
Identities = 60/174 (34%), Positives = 81/174 (46%), Gaps = 15/174 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
IG G+YG VY + +G AIK + D E + Q +SM+ +H N V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ E+ GSL DI GP LS Q + KGL YLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIAYVCRETLKGLAYLHET-- 120
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IHRDIK +N+L+ +D K+ADF +S Q A+ S +GT + APE
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 8e-21
Identities = 57/175 (32%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 75 IGEGSYGRVY-YGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+ G V +G A+K +L+ ++ ++ L ++ ++ + V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ + E+ GSL IL K V+G P +L KIAV KGL YLHEK
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHEKH 120
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+K SN+L+ K+ DF +S Q + A+ T V GT Y APE
Sbjct: 121 --KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-20
Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G A+K L E FL + ++ +L+H+ VQL C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ S GSL D L +G K L Q V +A A+G+ YL + +
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR---N 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD+ + N+L+ ++ V KIADF L+
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-20
Identities = 59/185 (31%), Positives = 80/185 (43%), Gaps = 36/185 (19%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+GEG+YG VY K+G A+KK LD +E L ++S++ LKH N V+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L L +E+ L L R G P + S ++ +GL Y
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL------LRGLAYC 114
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTFG 241
H I+HRD+K N+LI D V K+ADF L AR T + T
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTLW 163
Query: 242 YHAPE 246
Y APE
Sbjct: 164 YRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-20
Identities = 48/155 (30%), Positives = 83/155 (53%), Gaps = 13/155 (8%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG+G++G VY G+LK A+K ++ PD +FL + ++ + H N V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
V + E GSL L +K L+ ++ +++++ AA G+EYL K
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK- 112
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
+ IHRD+ + N L+ +++V KI+DF +S +
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEG 145
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 61/179 (34%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLG-YCV 132
IGEG+ G VY +G AIKK+ KQ E + ++ ++ KH N V Y V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
V E+ GSL DI+ Q ++ Q + +GLEYLH +
Sbjct: 87 GDELWV-VMEYMDGGSLTDII--------TQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---HSTR--VLGTFGYHAPE 246
++IHRDIKS N+L+ D K+ADF AA+L S R V+GT + APE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGF-------AAQLTKEKSKRNSVVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-20
Identities = 54/187 (28%), Positives = 93/187 (49%), Gaps = 28/187 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKL---------DASKQPD--EEFLAQVSMVSRLKH 121
LIG+G+YGRVY + + +G A+K++ S+Q D + +++ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVG 179
N VQ LG+ + E+ GS+ L +GR + V + ++V
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV----- 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
+GL YLH K I+HRD+K+ N+L+ D + KI+DF +S ++ D+ + + G+
Sbjct: 118 -LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 240 FGYHAPE 246
+ APE
Sbjct: 174 VFWMAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 4e-20
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 75 IGEGSYGRVYY-GILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
IGEG++G V+ ++G A+KK+ + + L ++ + +H V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
G+ VL E+ L ++L + +P L Q KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE-----RP---LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRD+K +N+LI D V KIADF L+ + RL+S +V T Y APE
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-20
Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 16/176 (9%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
IG+GS+G V+ + K+ A+K++D +++ EE + + ++++L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+D + E+A NG LH +L Q G L Q + + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK-------MQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRDIKS N+ + D KI D ++ D + ++GT Y +PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 5e-20
Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 75 IGEGSYGRVYYGI--LKSGH--AAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G++G V G+ +KSG A+K L + +EFL + S++++L H V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C G +L E A G L L R+ + + + +V A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K H +HRD+ + NVL+ + AKI+DF +S
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-20
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 19/164 (11%)
Query: 74 LIGEGSYGRV----YYGILKSGH--AAAIKKL--DASKQPDEEFLAQVSMVSRL-KHENF 124
+GEG++G+V G+ A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIA 177
+ LLG C + E+A++G+L D L R P L+ + V A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G+E+L K IHRD+ + NVL+ +D V KIADF L+
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-20
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G + AIK + +++F+ + ++ +L H N VQL G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ +NG L + L RKG G + + + + +EYL
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKGKLGT--------EWLLDMCSDVCEAMEYLESNG--- 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD+ + N L+ +D+V K++DF L+
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-19
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 75 IGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
+G G++G VY G+ + A+K L S+Q + +FL + ++S+ H+N V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
L+G + R + E + G L L R + +P L+ + + A AKG +
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRP--RPERPSS-LTMKDLLFCARDVAKGCK 130
Query: 186 YLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLS 221
YL E H IHRDI + N L+ VAKIADF ++
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-19
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL- 119
L + T F +IGEG+YG+VY K+G AIK +D + +EE + +++ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 120 KHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
H N G + L E GS+ D++ G + +++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
I +GL YLHE +IHRDIK N+L+ + K+ DF +S Q R ++
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 234 TRVLGTFGYHAPE 246
+GT + APE
Sbjct: 173 --FIGTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-19
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 74 LIGEGSYGRVYYG----ILKSGHA---AAIKKLD--ASKQPDEEFLAQVSMVSRLKHENF 124
+G G++G VY G IL G A+K L A+ Q +EFL + ++S H N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
V+LLG C+ + + E G L L R P+L+ ++ + I + AKG
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFDLS 221
YL H IHRD+ + N L+ + V KI DF L+
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-19
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
I EL + E IG G +G V+ G AIK + +E+F+ + ++
Sbjct: 1 IHPSELTLVQE-------IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVM 53
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
+L H VQL G C + + L +EF +G L D L ++G S + + +
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGM 105
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ +G+ YL +IHRD+ + N L+ ++ V K++DF ++
Sbjct: 106 CLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-19
Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 75 IGEGSYGRVYYGILKSGH-------------------AAAIKKLDASKQPDEEFLAQVSM 115
+GEG +G V+ + + A I + DA+K +FL +V +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL----------HGRKGVKGAQPG 165
+SRLK N ++LLG CVD + E+ NG L+ L +G V A
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
P +S+ + +A+ A G++YL + + +HRD+ + N L+ ++ KIADF +S
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-19
Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IG G+YGRVY K+G AIKK K+ +++++ LKHEN V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 128 LGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPV---LSWQQRVKIAVGAAK 182
+ ++ + L +++A + I R+ + + P + L WQ
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------ILN 119
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN--QAPDMAARLHSTRV 236
G+ YLH ++HRD+K +N+L+ + V KI D L+ AP + V
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPLADLDPV 175
Query: 237 LGTFGYHAPE 246
+ T Y APE
Sbjct: 176 VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-19
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 24/168 (14%)
Query: 75 IGEGSYGRVYY----GILKSGH----AAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
IG+G++GRV+ G+L A + K +AS +F + ++++ H N V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR-------------KGVKGAQPGPVLSWQQR 173
LLG C G L +E+ + G L++ L R K LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ IA A G+ YL E+ +HRD+ + N L+ ++ V KIADF LS
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-19
Identities = 53/153 (34%), Positives = 85/153 (55%), Gaps = 17/153 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG+G +G V G + G+ A+K K DA+ Q FLA+ S++++L+H N VQLLG V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 133 -DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ + E+ + GSL D L R VL +K ++ + +EYL
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEAN- 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
+ +HRD+ + NVL+ +D+VAK++DF L+ +A
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-19
Identities = 52/159 (32%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 74 LIGEGSYGRVYYGILKS--GH--AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
+G+GS+G V G + G A+K L + K D ++FL + +++ L HEN ++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + ++ E A GSL D L RK G L V+IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRL--RKDALGHFLISTL-CDYAVQIA----NGMRYL 113
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
K IHRD+ + N+L+ DD KI DF L P
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 7e-19
Identities = 60/177 (33%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG G+ VY I L + AIK++D K +E +V +S+ H N V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
V G L + S GSL DI +K + P L + KGLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR--VLGTFGYHAPE 246
IHRDIK+ N+L+ +D KIADF +S D R R +GT + APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-18
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 72 NALIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
+IG G +G V G L K AIK L A + +FL + S++ + H N +
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+L G ++ E+ NGSL L G + Q V + G A G++
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGMK 120
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL ++ + +HRD+ + N+L+ + V K++DF LS
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 54/176 (30%), Positives = 87/176 (49%), Gaps = 18/176 (10%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE-EFLAQ-VSMVSRLKHENFVQLLGY 130
IG+GS+G VY I ++ AIK +D + DE E + Q + +S+ + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ G+ + E+ GS D+L +PG L I GLEYLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL---------KPGK-LDETYIAFILREVLLGLEYLHEE 117
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IHRDIK++N+L+ ++ K+ADF +S Q ++ ++ +GT + APE
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPE 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-18
Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V YG + + AIK + ++EF+ + ++ +L HE VQL G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ SNG L + L R+ K QP Q +++ +G+ YL K
Sbjct: 72 RPIYIVTEYMSNGCLLNYL--REHGKRFQP------SQLLEMCKDVCEGMAYLESK---Q 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD+ + N L+ D K++DF LS
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-18
Identities = 55/168 (32%), Positives = 87/168 (51%), Gaps = 16/168 (9%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRL-K 120
E+ +IGEG++G+V ++K AAIK L AS+ +F ++ ++ +L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQR 173
H N + LLG C + +A E+A G+L D L + + K L+ QQ
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
++ A A G++YL EK IHRD+ + NVL+ ++ +KIADF LS
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-18
Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 68 NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHEN 123
+F +G+GSYG VY L A+K++D E+ + ++ +++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
+ +DG + E+A G L + K + ++ Q+ +I + +G
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLS-----KAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
L+ LHE+ I+HRD+KS+N+L+ +D+ KI D +S A+ +GT Y
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPHYM 168
Query: 244 APE 246
APE
Sbjct: 169 APE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-18
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 75 IGEGSYGRVYYGILK---SGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
+G+GS+G VY G+ K G AIK ++ + E EFL + S++ + V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
LLG G ++ E + G L L R + + Q+ +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL K +HRD+ + N ++ +D KI DF ++
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-18
Identities = 57/161 (35%), Positives = 87/161 (54%), Gaps = 16/161 (9%)
Query: 74 LIGEGSYGRVYYG-ILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRL-KHENFVQL 127
+IGEG++G+V I K G AAIK++ ASK +F ++ ++ +L H N + L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGA 180
LG C LA E+A +G+L D L + ++ LS QQ + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-18
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
L+G+G++G V+ G LK A+K K D ++ +FL++ ++ + H N V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ E G L +K L +Q VK A+ AA G+ YL K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
+ IHRD+ + N L+ +++V KI+DF +S Q D
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-18
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G +G V+ G+ K+ AIK L + ++F +V + RL+H++ + L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
G + E GSL L + G VL + +A A+G+ YL E+
Sbjct: 74 GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ IHRD+ + N+L+ +D V K+ADF L+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-18
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
+GEG +G+V +G A+K L+ S + +F ++ ++ L HEN V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C G S L E+ +GSL D L + ++ ++ + + KG++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMD 123
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
YL + IHRD+ + N+L+ +D+ KI+DF L+ P
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-17
Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 14/158 (8%)
Query: 75 IGEGSYGRVY----YGILKSGHA--AAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ Y + A+K L DAS ++F + +++ L+HE+ V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV--LSWQQRVKIAVGAAKG 183
G CV+G ++ +E+ +G L+ L HG V A+ L+ Q + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ YL A H +HRD+ + N L+ ++ + KI DF +S
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-17
Identities = 58/179 (32%), Positives = 87/179 (48%), Gaps = 21/179 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
+GEG+ G V LK +G A+K + PD ++ L ++ + K V+ G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 132 VDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--KIAVGAAKGLEYL 187
+D +S + A E+ GSL D ++ + +G + G ++V KIA KGL YL
Sbjct: 69 LDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGKIAESVLKGLSYL 121
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H + IIHRDIK SN+L+ K+ DF +S + + A T GT Y APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT-GTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 57/177 (32%), Positives = 93/177 (52%), Gaps = 33/177 (18%)
Query: 75 IGEGSYGRVY----YGILKS--GHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V YGI KS A+K L +A+ + + ++++ ++ + KH+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 124 FVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP------------VLSW 170
+ LLG C +G V+ E+A+ G+L + L R+ PGP LS+
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSF 133
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
+ V A A+G+EYL + IHRD+ + NVL+ +D+V KIADF L+ D+
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-17
Identities = 56/183 (30%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENF 124
IGEGS G V KS G A+KK+D KQ E L +V ++ +H N
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V++ + G + EF G+L DI+ H R ++ +Q + + K
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLAVLKA 127
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
L +LH + +IHRDIKS ++L+ D K++DF Q R S ++GT +
Sbjct: 128 LSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWM 182
Query: 244 APE 246
APE
Sbjct: 183 APE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-17
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G+G +G V+ G AIK L E FL + ++ +L+HE VQL Y V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 71
Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ + E+ S GSL D L G + G L Q V +A A G+ Y+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERM--- 121
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
+ +HRD++++N+L+ ++ V K+ADF L+ D
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 31/191 (16%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAA-----AIKKLDASKQPDEEF----LAQVSMVS 117
+ ++GEG+YG V LK + A AIKK S+ DE+ L +V ++
Sbjct: 1 NKYEVLGVVGEGAYGVV----LKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLR 55
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV--LSWQQRVK 175
+L+HEN V L L +E+ +L ++L G G P V WQ
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG--GLPPDAVRSYIWQ---- 108
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
+ + Y H +IIHRDIK N+L+ + V K+ DF + A T
Sbjct: 109 ----LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTD 160
Query: 236 VLGTFGYHAPE 246
+ T Y APE
Sbjct: 161 YVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-17
Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 23/184 (12%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKL-------DASKQPDEEFLAQVSMVSRLKHENFVQ 126
++G+G+YG VY G+ G A+K++ A+++ E+ +V ++ LKH N VQ
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LG C+D + + EF GS+ IL+ G P PV K G+ Y
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL----GTFGY 242
LH ++HRDIK +NV++ + + K+ DF + + + + +L GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 243 HAPE 246
APE
Sbjct: 175 MAPE 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-17
Identities = 63/184 (34%), Positives = 88/184 (47%), Gaps = 20/184 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA---QVSMVSRLKHE 122
E+F IG G+YG VY + +G AAIK + +P E+F ++ M+ KH
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHS 66
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
N V G + + EF GSL DI H GP LS Q ++ +
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQ 117
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL YLH K +HRDIK +N+L+ D+ K+ADF +S Q A+ S +GT +
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYW 172
Query: 243 HAPE 246
APE
Sbjct: 173 MAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-17
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSM 115
+ ++ L + T+ + IG+G+YG+VY K G AA+K LD DEE A+ ++
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI 71
Query: 116 VSRL-KHENFVQLLG--YCVD---GTSRVLAYEFASNGSLHDILHG--RKGVKGAQPGPV 167
+ L H N V+ G Y D G L E + GS+ +++ G G + + +
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA--M 129
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
+S+ I GA GL++LH IIHRD+K +N+L+ + K+ DF +S Q
Sbjct: 130 ISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--T 179
Query: 228 AARLHSTRVLGTFGYHAPE 246
+ RL +GT + APE
Sbjct: 180 STRLRRNTSVGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-17
Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 19/156 (12%)
Query: 73 ALIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
+IGEG +G V G +G A+K K D + Q FL + +++++L H+N V+LLG
Sbjct: 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67
Query: 131 CV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ +G V+ E S G+L + L R + Q ++ ++ A+G+EYL
Sbjct: 68 ILHNGLYIVM--ELMSKGNLVNFLRTRG--RALVSVI-----QLLQFSLDVAEGMEYLES 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
K ++HRD+ + N+L+ +D VAK++DF L+
Sbjct: 119 K---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-17
Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 21/157 (13%)
Query: 73 ALIGEGSYGRVYYGIL-----KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFV 125
++G G++G VY G+ K AIK L + S + ++E L + +++ + H + V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
+LLG C+ +S+V L + G L D + K G+Q +L+W V AKG+
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNW------CVQIAKGM 122
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL EK ++HRD+ + NVL+ KI DF L+
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-17
Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 18/161 (11%)
Query: 75 IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ + A+K L +AS+ ++F + +++ L+H++ V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGR-----KGVKGAQPGPVLSWQQRVKIAVGA 180
G C +G ++ +E+ +G L+ L HG G + PG L+ Q + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQI 131
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A G+ YL A H +HRD+ + N L+ V KI DF +S
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-17
Identities = 57/162 (35%), Positives = 86/162 (53%), Gaps = 18/162 (11%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
+IGEG++G+V +K AAIK++ ASK +F ++ ++ +L H N + L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG--------PVLSWQQRVKIAVG 179
LG C LA E+A +G+L D L + V P LS QQ + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-17
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 75 IGEGSYGRVYYGILKSGHA-AAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG G++G V+ G L++ + A+K + PD +FL + ++ + H N V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ E G L GP L ++ +++ AA G+EYL K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESK- 113
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
H IHRD+ + N L+ + +V KI+DF +S + D
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-17
Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDEE--FLAQVSMVSRLKHENFVQLLG 129
IG G +G+V G G + A +K+L AS PDE+ FL +V L H N +Q LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C++ +L EF G L + L +G+ + QR +A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MACEVASGLLWLHQ 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
IH D+ N + D KI D+ L+
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 9e-17
Identities = 61/181 (33%), Positives = 83/181 (45%), Gaps = 26/181 (14%)
Query: 75 IGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDE---EFLAQVSMVSRLKHENFVQLLGY 130
IGEG+YG VY SG A+KK+ + D L +++++ L+H N V+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 131 CVDG--TSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLE 185
V S L E+ SL D + P P Q VK + + +GL+
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNM----------PTPFSESQ--VKCLMLQLLRGLQ 122
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLHE IIHRD+K SN+L+ D KIADF L+ A T + T Y AP
Sbjct: 123 YLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAP 177
Query: 246 E 246
E
Sbjct: 178 E 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 38/190 (20%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIK-------KLDASKQPDEEFLAQVSMVSRLKHENF 124
IG G++G+VY + L +G A+K K+ +E + ++ LKH N
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE----MKVLELLKHPNL 61
Query: 125 VQLLGYCVDGTSRVLAY-EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA-- 181
V+ G V +V + E+ S G+L ++L G +L + V I V
Sbjct: 62 VKYYGVEVH-REKVYIFMEYCSGGTLEELLEH---------GRIL--DEHV-IRVYTLQL 108
Query: 182 -KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD----LSNQAPDMAARLHSTRV 236
+GL YLH I+HRDIK +N+ + + V K+ DF L N M + S
Sbjct: 109 LEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA- 164
Query: 237 LGTFGYHAPE 246
GT Y APE
Sbjct: 165 -GTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-16
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 75 IGEGSYGRVYY----GILK---------SGHA--AAIKKL--DASKQPDEEFLAQVSMVS 117
+GEG +G V+ G+ + G A+K L D +K +FL ++ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK---GVKGAQPGPVLSWQQRV 174
RLK+ N ++LLG CV + E+ NG L+ L R+ A P +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+AV A G++YL A + +HRD+ + N L+ + KIADF +S
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-16
Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 27/189 (14%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKL---------DASKQPDEEFLA-QVSMVSRLKH 121
ALIG GS+G VY G+ SG A+K++ K+ + LA +++++ L+H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
EN VQ LG +D + E+ GS+ +L+ GA ++ R +
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQIL----- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP----DMAARLHSTRVL 237
KGL YLH + IIHRDIK +N+L+ + KI+DF +S + +
Sbjct: 117 KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 238 GTFGYHAPE 246
G+ + APE
Sbjct: 174 GSVFWMAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-16
Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G A+K L E FL + ++ +L+H+ VQL Y V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVS 71
Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ + E+ S GSL D L + G G L V +A A G+ Y+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KDG-----EGRALKLPNLVDMAAQVAAGMAYIERM--- 121
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
+ IHRD++S+N+L+ D V KIADF L+ D
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-16
Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 21/165 (12%)
Query: 75 IGEGSYGRVYY----GILKSGHA----AAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V GI K A+K L DA+ + + ++++ M+ + KH+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ G+ + P L+++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A A+G+EYL A IHRD+ + NVL+ +D+V KIADF L+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-16
Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G AIK L E FLA+ +++ +L+H V+L V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVTQ 72
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ NGSL D L +G+K L+ + + +A A+G+ ++ K +
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERK---N 122
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD++++N+L+ + KIADF L+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-16
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G ++ AIK ++ +E+F+ + ++ +L H VQL G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ EF NG L + L R+G +LS Q V +G+EYL +
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV------CEGMEYLERNS--- 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD+ + N L+ V K++DF ++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 53/165 (32%), Positives = 88/165 (53%), Gaps = 21/165 (12%)
Query: 75 IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V G+ K + A + K DA+++ + ++++ M+ + KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVK-----GAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ G++ P LS++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-15
Identities = 54/175 (30%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSR-LKHENFVQLLGYCV 132
IG+G+ G VY I + +G AIK+++ +QP +E + +V R KH N V L +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ +G Q + + LE+LH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 134
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS N+L+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-15
Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 43 GAQAVKVQPIEVPAISVDELKEITEN---FGTNALIGEGSYGRVY----YGILKSGHA-- 93
G + V + P ++P D E N FG +G G++G+V YG+ KS
Sbjct: 13 GNEYVYIDPTQLP---YDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMK 67
Query: 94 AAIKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150
A+K L + E ++++ ++S L HEN V LLG C G ++ E+ G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
+ L RK +LS+ +V AKG+ +L K + IHRD+ + NVL+
Sbjct: 128 NFLR-RKRESFLTLEDLLSFSYQV------AKGMAFLASK---NCIHRDLAARNVLLTHG 177
Query: 211 DVAKIADFDLS 221
+ KI DF L+
Sbjct: 178 KIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
IGEGS G V +KS G A+KK+D KQ E L +V ++ +HEN V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
G + EF G+L DI+ H R ++ +Q + + K L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLKALSVLHAQG 136
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS ++L+ D K++DF Q R S ++GT + APE
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-15
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSM 115
I + L++ F ++G G+YG+VY G +K+G AAIK +D ++ +EE +++M
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 116 VSRLKHE-NFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
+ + H N G + + L EF GS+ D++ KG L
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NAL 118
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
I +GL +LH +IHRDIK NVL+ ++ K+ DF +S Q
Sbjct: 119 KEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 229 ARLHSTRVLGTFGYHAPE 246
R ++ +GT + APE
Sbjct: 176 GRRNT--FIGTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF 109
P+ I D + ++ + IG+G+YG+V+ + K +G AA+K LD DEE
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61
Query: 110 LAQVSMVSRLK-HENFVQLLGY-----CVDGTSRVLAYEFASNGSLHDILHG--RKGVKG 161
A+ +++ L H N V+ G +G L E + GS+ D++ G ++G +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+P ++++ I A GL++LH IHRD+K +N+L+ + K+ DF +S
Sbjct: 122 EEP--IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPE 246
Q + RL +GT + APE
Sbjct: 172 AQL--TSTRLRRNTSVGTPFWMAPE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-15
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 28/164 (17%)
Query: 75 IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENF 124
+GEG +G+V L +G A+K L + +Q + +++++ L HEN
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 125 VQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
V+ G C + + L E+ GSL D L P L+ Q + A +
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICE 118
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
G+ YLH + H IHRD+ + NVL+ +D + KI DF L+ P+
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 25/153 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ +++ AIKK+ S KQ +E++ + +V + +L+H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 130 YCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLE 185
+ + L E+ GS DIL +K + Q V+IA GA +GL
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHKKPL------------QEVEIAAICHGALQGLA 129
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
YLH IHRDIK+ N+L+ + K+ADF
Sbjct: 130 YLHSHE---RIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-15
Identities = 52/182 (28%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF------LAQVSMVSRLKHENFVQL 127
IGEG+YG VY +G AIKK+ K E L ++ ++ L H N ++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L L +EF I ++G+ + L +Q +GL +
Sbjct: 64 LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-YQ--------LLQGLAFC 114
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLH--STRVLGTFGYHA 244
H I+HRD+K N+LI + V K+ADF L+ + H TR Y A
Sbjct: 115 HSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRA 166
Query: 245 PE 246
PE
Sbjct: 167 PE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-15
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIK------KLDASKQPD-EEFLAQVSMVSRLKHENFVQ 126
++GEG +G V G L + +K KLD + EEFL++ + + H N ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 127 LLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
L+G C + +S ++ F +G LH L + + P+ Q +K V
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QTLLKFMVDI 122
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A G+EYL + + IHRD+ + N ++ +D +ADF LS
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-15
Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
+G G+YG VY L +G AA+K + D + Q + MV KH N V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ E+ GSL DI H GP LS Q + +GL YLH K
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+HRDIK +N+L+ D+ K+ADF ++ + A+ S +GT + APE
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 6e-15
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYC 131
L+G G+YG+VY G +K+G AAIK +D + +EE +++M+ + H N G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 132 VDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ L EF GS+ D++ KG L + I +GL
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLS 125
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+LH+ +IHRDIK NVL+ ++ K+ DF +S Q R ++ +GT + AP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 180
Query: 246 E 246
E
Sbjct: 181 E 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-15
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
E+ + +G+G +G V+ G AIK L E FL + ++ +L+H+ V
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
L Y V + + EF GSL D L ++G G L Q V +A A G+
Sbjct: 66 L--YAVVSEEPIYIVTEFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMA 116
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
Y+ + IHRD++++N+L+ D+ V KIADF L+ D
Sbjct: 117 YIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-15
Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 25/191 (13%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKL----DASKQPDEEFLAQVSMVSR 118
E EN G ++G+G+YG VY S AIK++ QP E ++++ S
Sbjct: 6 EYDEN-GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSY 61
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
LKH N VQ LG + + E GSL +L + G ++ + +++
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLH--STR 235
+GL+YLH+ I+HRDIK NVL+ V KI+DF S + A ++ +
Sbjct: 118 --LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR----LAGINPCTET 168
Query: 236 VLGTFGYHAPE 246
GT Y APE
Sbjct: 169 FTGTLQYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-15
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 75 IGEGSYGRVY----YGI--LKSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ Y + K A+K L D + ++F + +++ L+HE+ V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGV-----KGAQPGPVLSWQQRVKIAVGA 180
G C DG ++ +E+ +G L+ L HG + + Q L Q + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A G+ YL A H +HRD+ + N L+ + + KI DF +S
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 19/175 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
IGEGS G V K +G A+KK+D KQ E L +V ++ HEN V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
G + EF G+L DI+ H R ++ +Q + + + L YLH +
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLSVLRALSYLHNQG 138
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS ++L+ D K++DF Q + S ++GT + APE
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 18/156 (11%)
Query: 72 NALIGEGSYGRVYYGILKSGH----AAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFV 125
IGEG +G VY G+ S A A+K K S E+FL + ++ + H + V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+L+G + ++ E A G L L K L + + + L
Sbjct: 71 KLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL K +HRDI + NVL+ D K+ DF LS
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 56/181 (30%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDE--EFLA--QVSMVSRLKHENFV 125
+GEG+Y VY ++G AIKK L K+ + F A ++ ++ LKH N +
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
LL ++ L +EF L ++ + V P + S+ +GLE
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM------TLRGLE 116
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH I+HRD+K +N+LI D V K+ADF L+ R + +V+ T Y AP
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAP 171
Query: 246 E 246
E
Sbjct: 172 E 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 74 LIGEGSYGRVYYGILKSG----HAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
+IG G +G V G LK AIK L + +++ +FL++ S++ + H N + L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ EF NG+L L G Q + Q V + G A G++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVI----QLVGMLRGIAAGMKYL 122
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
++ + +HRD+ + N+L+ + V K++DF LS D + T LG
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 75 IGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G VY GI ++ AIK +D + DE + +++++S+ + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ GT + E+ GS D+L +PGP L I KGL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSER 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 75 IGEGSYGRVYY----GILK-------------SGHAAAIKKL--DASKQPDEEFLAQVSM 115
+GEG +G V+ G+ K A+K L DA+K +FL ++ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 173
+SRLK N ++LL C+ + E+ NG L+ L H + +S+
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ +A A G++YL + + +HRD+ + N L+ + KIADF +S
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 59/188 (31%), Positives = 83/188 (44%), Gaps = 23/188 (12%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL---DASKQPDEEFLAQVSMVSRL 119
E EN G L+GEGSYG V K +G AIKK + K + + ++ M+ +L
Sbjct: 1 EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+HEN V L+ L +EF + L D+ G L + K
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESRVRKYLFQ 108
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-TRVLG 238
+G+E+ H +IIHRDIK N+L+ V K+ DF A +AA T +
Sbjct: 109 ILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF---ARTLAAPGEVYTDYVA 162
Query: 239 TFGYHAPE 246
T Y APE
Sbjct: 163 TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 21/165 (12%)
Query: 75 IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V GI K A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P ++++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G+EYL A IHRD+ + NVL+ +++V KIADF L+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 74 LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
+IG G +G V+ GILK A AIK L +++ ++FL++ S++ + H N ++L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ E+ NG+L L G S Q V + G A G++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL 123
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+D + +HRD+ + N+L+ + K++DF LS
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKLDASKQPDE----EFLA 111
L+EIT +G G +G V+ K +K L K DE EF
Sbjct: 7 LQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRR 57
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++ M +L H+N V+LLG C + + E+ G L L K P LS +
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
Q+V + A G+++L ++ +HRD+ + N L+ K++ LS
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-14
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G + A+K L + FL + +++ L+H+ V+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ + GSL D L +G K P + + + A+G+ Y+ K +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK---N 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
IHRD++++NVL+ + + KIADF L+ D
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-14
Identities = 38/176 (21%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 75 IGEGSYGR-VYYGILKSGHAAAIKKLDASK-QPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
+G+G++G Y + K+++ ++ E A + ++S L+H N + +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+D + ++ E+A+ G+L+D + +KG + + + + Y+H+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRDIK+ N+ + + K+ DF +S + V+GT Y +PE
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 8e-14
Identities = 54/175 (30%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G V+ GI ++ AIK +D + DE + +++++S+ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ T + E+ GS D+L +PGP L Q I KGL+YLH +
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-14
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 31/184 (16%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKH---ENFVQL 127
LIG G+YG VY G + +G A+K ++ D+ + +V+++S+L+ N +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + G + E+A GS+ ++ + GP+ V I L+Y+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKYISV-IIREVLVALKYI 117
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGY 242
H+ +IHRDIK++N+L+ + K+ DF + AA L+ +GT +
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGV-------AALLNQNSSKRSTFVGTPYW 167
Query: 243 HAPE 246
APE
Sbjct: 168 MAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-13
Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 74 LIGEGSYGRVYYGILKSGH----AAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
+IG G +G V G LK AIK L A +++ +FL++ S++ + H N + L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ E+ NGSL L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
+D +HRD+ + N+L+ + V K++DF LS D ++TR
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 1e-13
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 39/187 (20%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G+GS+G+V K +G A+K L ++ E L + +++SR+ H V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 130 YCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK----- 182
+ L E+A G L L + + + A+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL-----------------SKEGRFSEERARFYAAE 101
Query: 183 ---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
LEYLH II+RD+K N+L+ D K+ DF L+ + +R ++ GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 240 FGYHAPE 246
Y APE
Sbjct: 157 PEYLAPE 163
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 52/191 (27%), Positives = 72/191 (37%), Gaps = 39/191 (20%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---------NF 124
I +G+YGRV+ KS G AIK + + + + + V ++ E +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD------MIRKNQVDQVLTERDILSQAQSPY 54
Query: 125 VQLLGYCVDGTSRV-LAYEFASNGSLHDILH--GRKGVKGAQPGPVLSWQQRVKIAVGAA 181
V L Y G + L E+ G L +L G L
Sbjct: 55 VVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-----------SLDEDVARIYIAEIV 103
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------NQAPDMAARLHSTR 235
LEYLH IIHRD+K N+LI + K+ DF LS Q R
Sbjct: 104 LALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 236 VLGTFGYHAPE 246
++GT Y APE
Sbjct: 161 IVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 57/184 (30%), Positives = 97/184 (52%), Gaps = 17/184 (9%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDEEFLA---QVSMVSRLKHEN 123
+ IGEGS+G++Y KS IK++D +K P +E A +V +++++KH N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V + + E+ G L ++ ++GV ++ +LSW V+I++G
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSW--FVQISLG---- 113
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L+++H D I+HRDIKS N+ + + VAK+ DF ++ Q D + L T +GT Y
Sbjct: 114 LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYT-CVGTPYY 168
Query: 243 HAPE 246
+PE
Sbjct: 169 LSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-13
Identities = 45/159 (28%), Positives = 64/159 (40%), Gaps = 18/159 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM----VSRLK-HENFVQL 127
+IGEGS+ V K + AIK LD + E+ + V + ++RL H ++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
D + E+A NG L + L + A LEYL
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---------LDEKCTRFYAAEILLALEYL 118
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
H K IIHRD+K N+L+ D KI DF +
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 19/155 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAA----AIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126
++G G++G VY GI + G AIK L+ + P + EF+ + +++ + H + V+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C+ T + L + +G L D +H K G+Q +L+W V AKG+ Y
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL--LLNW------CVQIAKGMMY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L E+ ++HRD+ + NVL+ + KI DF L+
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-13
Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDEE--FLAQVSMVSRLKHENFVQLLG 129
IG G +G+V G + SG+ A +K+L S E+ FL + L+H N +Q LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + T +L EF G L L + + P P + Q+ +A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP-TTLQR---MACEIALGLLHLHK 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
+ IH D+ N L+ D KI D+ LS+
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSH 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL-GYC 131
+G+G++G+VY K +G AA K + + + E+F+ ++ ++S KH N V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ +L EF G+L I L +G+ Q V + L +LH
Sbjct: 73 YENKLWIL-IEFCDGGALDSIMLELERGLTEPQIRYVCRQ---------MLEALNFLHSH 122
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+IHRD+K+ N+L+ D K+ADF +S + + + +GT + APE
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-13
Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 74 LIGEGSYGRVYYGILKSG-----HAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
L+ EG++GR++YGIL +K + AS+ L + ++ L H+N +
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 127 LLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+L C+ DG + Y + + G+L L + A LS QQ V +A+ A G+
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG-EANNPQALSTQQLVHMAIQIACGMS 131
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YLH++ +IH+DI + N +I ++ KI D LS
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALS 164
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-13
Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 28/166 (16%)
Query: 75 IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQP-DEEFLAQVSMVSRLKHENFVQ 126
+GE +G+VY G L + A AIK L D ++ P EEF + M SRL+H N V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR------------KGVKGAQPGPVLSWQQRV 174
LLG + + + S+ LH+ L R K VK V
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-----V 127
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
I A G+E+L + H++H+D+ + NVL+FD KI+D L
Sbjct: 128 HIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-13
Identities = 61/199 (30%), Positives = 86/199 (43%), Gaps = 52/199 (26%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK---HEN 123
A IGEG+YG VY L +G A+KK+ EE L +++++ +L+ H N
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 124 FVQLLGYCV-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG--PV----LSWQQ 172
V+LL C L +E L L K +PG P L Q
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-----KCPKPGLPPETIKDLMRQ- 115
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
+G+++LH I+HRD+K N+L+ D KIADF L AR++
Sbjct: 116 -------LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL--------ARIY 157
Query: 233 S-----TRVLGTFGYHAPE 246
S T V+ T Y APE
Sbjct: 158 SFEMALTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-13
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 17/187 (9%)
Query: 66 TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD----ASKQPDEEFLAQVSMVSRLK 120
NF IG+G + VY I L G A+KK+ + ++ L ++ ++ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H N ++ L ++ + E A G L I H +K K P + W+ V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYFVQLC-- 116
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
LE++H K I+HRDIK +NV I V K+ D L HS ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 240 FGYHAPE 246
Y +PE
Sbjct: 170 PYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-13
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 46/198 (23%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
A IG+G++G V+ K+ A+KK+ + E F L ++ ++ LKHEN V L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 128 LGYC---VDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+ C +R L +EF HD L G L + VK +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCE----HD-LAG------------LLSNKNVKFTLS 119
Query: 180 AAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMA 228
K GL Y+H I+HRD+K++N+LI D + K+ADF L+ + + +
Sbjct: 120 EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 229 ARLHSTRVLGTFGYHAPE 246
++ RV+ T Y PE
Sbjct: 177 PNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-13
Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G V+ GI ++ AIK +D + DE + +++++S+ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ GT + E+ GS D+L + GP +Q + KGL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------RAGPFDEFQIATMLK-EILKGLDYLHSEK 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 6e-13
Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 19/175 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA-QVSMVSRLKHENFVQLLGYCV 132
IG+G+ G V+ I + +G AIK+++ KQP +E + ++ ++ LK+ N V L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ + Q + + LE+LH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV----------TETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS NVL+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-13
Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
IG+G+ G VY I + +G AIK+++ +QP +E + +V R K+ N V L +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ +G Q + + L++LH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALDFLHSN-- 134
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS N+L+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-13
Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
IG+G+ G VY + + +G AI++++ +QP +E + +V R K+ N V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ +G Q + + LE+LH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS N+L+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-13
Identities = 60/194 (30%), Positives = 89/194 (45%), Gaps = 51/194 (26%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQ---- 126
+G+GSYG V ++ G IKKL+ AS++ + + ++S+LKH N V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 127 ----------LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
++G+C G D+ H K Q G +L Q V+
Sbjct: 68 WEGEDGLLYIVMGFCEGG----------------DLYHKLK----EQKGKLLPENQVVEW 107
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD----LSNQAPDMAARLH 232
V A L+YLHEK HI+HRD+K+ NV + ++ K+ D L NQ DMA+ L
Sbjct: 108 FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL- 162
Query: 233 STRVLGTFGYHAPE 246
+GT Y +PE
Sbjct: 163 ----IGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 55/199 (27%), Positives = 82/199 (41%), Gaps = 45/199 (22%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
+GEG++G VY +K+G A+KK+ + D F L ++ ++ +LKH N V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLID 74
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV-----LSWQQRVKIAVGAAK-- 182
+A E R V P L VK+ K
Sbjct: 75 ---------MAVERPDK-----SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 183 ------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPDM 227
G+ YLHE HI+HRDIK++N+LI + + KIADF L + +
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 228 AARLHSTRVLGTFGYHAPE 246
T ++ T Y PE
Sbjct: 178 GGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 18/164 (10%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
+GE ++G++Y G L AIK L P + EF + S+++ L H N V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL-----HGRKGVKGAQPGPV---LSWQQRVKIAVG 179
LG + +E+ + G LH+ L H G + G V L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
A G+EYL + +H+D+ + N+LI + KI+D LS +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 24/171 (14%)
Query: 75 IGEGSYGRVYY-------GILKSGHAA----------AIKKL--DASKQPDEEFLAQVSM 115
+GEG +G V+ + A A+K L DAS E+FL +V +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--GPVLSWQQR 173
+SRL N +LLG C + E+ NG L+ L LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
+ +A A G+ YL + +HRD+ + N L+ + KIADF +S
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK---SGHA---AAIKKLDASKQPD 106
EV + L+E+ G+GS+G VY G + G A A+K ++ S
Sbjct: 2 EVSREKITLLREL----------GQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 51
Query: 107 E--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
E EFL + S++ + V+LLG G ++ E ++G L L + P
Sbjct: 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 111
Query: 165 G-PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
G P + Q+ +++A A G+ YL+ K +HRD+ + N ++ D KI DF ++
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 19/175 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
IGEGS G V K SG A+K +D KQ E L +V ++ +H+N V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + EF G+L DI+ + L+ +Q + + L YLH +
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG- 137
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS ++L+ D K++DF Q + D+ R ++GT + APE
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-12
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 75 IGEGSYGRVYYGILKSGHA---AAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+GEG +G V G L + A+K + ++ E+FL++ + H N ++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 129 GYCVDGTSR------VLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
G C+ V+ F +G LH +L+ R G P L Q VK A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR---LGDCP-QYLPTQMLVKFMTDIA 122
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
G+EYL K IHRD+ + N ++ ++ +ADF LS +
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK 161
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-12
Identities = 52/192 (27%), Positives = 92/192 (47%), Gaps = 37/192 (19%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKL-----DASKQPD--EEFLAQVSMVSRLKHENF 124
+G G++ Y +K+G A+K++ +S+Q + E ++ +++RL H +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV--GAAK 182
+++LG + + L E+ + GS+ +L + G +++ V I +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS--------KYGA---FKEAVIINYTEQLLR 114
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHST----- 234
GL YLHE IIHRD+K +N+LI D +IADF A +AA+
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLI--DSTGQRLRIADF---GAAARLAAKGTGAGEFQG 166
Query: 235 RVLGTFGYHAPE 246
++LGT + APE
Sbjct: 167 QLLGTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-12
Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRLK 120
N+ L+G+G++GRVY + +G A+K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HE VQ G D + + E+ GS+ D L G + R K
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR-KYTRQI 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST---RVL 237
+G+EYLH I+HRDIK +N+L K+ DF S + T V
Sbjct: 114 LEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVT 168
Query: 238 GTFGYHAPE 246
GT + +PE
Sbjct: 169 GTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 29/196 (14%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDE--EFLAQV 113
+++L+ + E IG G+ G+VY K+GH A+K++ + +E L +
Sbjct: 12 ADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL 64
Query: 114 SMVSRLKHE--NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+V H+ V+ GY + + + E S + D L K ++G P +L
Sbjct: 65 DVVL-KSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKL--LKRIQGPIPEDILG-- 117
Query: 172 QRVKIAVGAAKGLEYLHEKADPH-IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
K+ V K L YL EK H +IHRD+K SN+L+ K+ DF +S + D A+
Sbjct: 118 ---KMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171
Query: 231 LHSTRVLGTFGYHAPE 246
TR G Y APE
Sbjct: 172 ---TRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-12
Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 32/184 (17%)
Query: 75 IGEGSYGRVYYGIL----KSGHAAAIKKLDASK-QPDE--EFLAQVSMVSRLKHENFVQL 127
IGEGS+G+ IL + G IK+++ SK P E E +V+++S +KH N VQ
Sbjct: 8 IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+ + + ++ G L+ ++ ++GV +L W ++ +A L+++
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLA------LKHV 117
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-----GTFGY 242
H D I+HRDIKS N+ + D K+ DF + A L+ST L GT Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYY 167
Query: 243 HAPE 246
+PE
Sbjct: 168 LSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-12
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 35/199 (17%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQ 112
SVDE +++ I EG+YG VY K+G A+KKL K+ E F L +
Sbjct: 3 SVDEYEKLNR-------IEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLRE 54
Query: 113 VSMVSRLKHENFVQL----LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
++++ +L+H N V + +G +D V+ Y + H K + P L
Sbjct: 55 INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY----------VEHDLKSLMETMKQPFL 104
Query: 169 SWQQRVK-IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
Q VK + + G+ +LH+ I+HRD+K+SN+L+ + + KI DF L+ +
Sbjct: 105 --QSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
Query: 228 AARLHSTRVLGTFGYHAPE 246
T+++ T Y APE
Sbjct: 160 LKPY--TQLVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 6e-12
Identities = 59/180 (32%), Positives = 94/180 (52%), Gaps = 29/180 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ +++ AIKK+ S KQ +E++ + +V + R+KH N ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
+ + L E+ GS D+L K P+ Q V+IA GA +GL Y
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAITHGALQGLAY 140
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH ++IHRDIK+ N+L+ + K+ADF + +A+ +S +GT + APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFG----SASIASPANS--FVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-12
Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 29/180 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ + A+KK+ S KQ +E++ + +V + +LKH N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
+ + L E+ GS D+L K P+ Q V+IA GA +GL Y
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAITHGALQGLAY 136
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH +IHRDIK+ N+L+ + K+ADF ++++ + +GT + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-12
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 38/186 (20%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF-----LAQVSMVSRLKHENFVQLL 128
IGEGSYG V+ + +G AIKK S+ D+ L ++ M+ +LKH N V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 129 GYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
V R L +E+ + L+++ +GV KI + + +
Sbjct: 67 E--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE---------HLIKKIIWQTLQAVNF 115
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTF 240
H+ + IHRD+K N+LI K+ DF AR+ + T + T
Sbjct: 116 CHKH---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATR 164
Query: 241 GYHAPE 246
Y APE
Sbjct: 165 WYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ +++ AIKK+ S KQ +E++ + +V + +L+H N +Q G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ + L E+ GS D+L K +P L + + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP---LQEVEIAAVTHGALQGLAYLHS 133
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHSTRVLGTFGYHAPE 246
++IHRD+K+ N+L+ + + K+ DF S AP + +GT + APE
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 51/167 (30%), Positives = 86/167 (51%), Gaps = 21/167 (12%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYGI-LKSGH----AAAIKKLDASKQP--DEEFLAQVS 114
LKE TE F ++G G++G VY G+ + G AIK+L + P ++E L +
Sbjct: 4 LKE-TE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+++ + + + +LLG C+ T +++ + G L D + K G+Q +L+W
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW---- 114
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
V AKG+ YL E+ ++HRD+ + NVL+ KI DF L+
Sbjct: 115 --CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-11
Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLA--QVSMVSRLK-HENFVQLLGY 130
+G+G++G VY K G AIKK+ EE + +V + +L H N V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ +E+ G+L+ ++ RKG + S ++ +GL ++H+
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQI------LQGLAHIHKH 118
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
HRD+K N+L+ +V KIADF L A ++ +R T + T Y APE
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ A+K + E FLA+ +++ L+H+ V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
++ EF + GSL D L +G K QP P L + + A+G+ ++ ++ +
Sbjct: 74 PIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR---N 122
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD++++N+L+ V KIADF L+
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGY 130
IG+GS+G V KS G K++D + ++ +++V+++ LKH N V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 131 CVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+D +++ L Y E+ G L ++ K + + W+ ++ + L
Sbjct: 68 IIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLA----LYEC 121
Query: 188 HEKADPH--IIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGY 242
H ++DP ++HRD+K +N+ + ++ K+ DF L+ A T V GT Y
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA----KTYV-GTPYY 176
Query: 243 HAPE 246
+PE
Sbjct: 177 MSPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 20/178 (11%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLKHENFVQLL 128
IGEG+YG VY G K+G A+KK+ + +EE + ++S++ L+H N V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL--ESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + L +EF S L L + V S+ ++ +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCH 118
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ ++HRD+K N+LI + V K+ADF L+ +A + R+++ V+ T Y APE
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 37/187 (19%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+GEG+Y VY G + +G A+K LDA + + ++S++ LKHEN V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 132 VDGTSRVLAYEFASNG--SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+L +E+ D HG +G P V S+ ++ KG+ + HE
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDT-HGVRG--ALDPNTVKSFTYQL------LKGIAFCHE 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDL-----------SNQ-------APD--MAA 229
++HRD+K N+LI K+ADF L SN+ APD + +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 230 RLHSTRV 236
R +ST +
Sbjct: 176 RTYSTSI 182
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-11
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 75 IGEGSYGRVYYGILKS------GHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
+G+GS+G VY GI K AIK ++ + E EFL + S++ + V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL-SWQQRVKIAVGAAKGLE 185
LLG G ++ E + G L L + P S ++ +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL+ +HRD+ + N ++ +D KI DF ++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-11
Identities = 35/83 (42%), Positives = 42/83 (50%), Gaps = 10/83 (12%)
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
P +L KIAV K LEYLH K +IHRD+K SNVLI + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 224 APDMAARLHSTRVLGTFGYHAPE 246
D A+ T G Y APE
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 74 LIGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQL 127
+G+G++G V Y L+ +G A+KKL S +F ++ ++ L+H+N V+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 128 LGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C R L E+ GSL D L + + + + Q KG+E
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGME 122
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
YL K +HRD+ + N+L+ ++ KI DF L+ P
Sbjct: 123 YLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 30/84 (35%), Positives = 40/84 (47%), Gaps = 14/84 (16%)
Query: 171 QQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
Q+VK + K LEYLH K IIHRDIK N+L+ + I DF+++
Sbjct: 92 SQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT 148
Query: 223 QAPDMAARLHSTRVLGTFGYHAPE 246
+ +T GT GY APE
Sbjct: 149 KVTP---DTLTTSTSGTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 19/150 (12%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF--LAQVSMVSRLK-HENFVQLLGY 130
IGEG++ V K+G AIK + + E+ L ++ + RL H N ++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 131 CVDGTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYLH 188
D + LA F + +L++++ GRK +P P ++RVK K L+++H
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRK-----RPLP----EKRVKSYMYQLLKSLDHMH 117
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
I HRDIK N+LI DD+ K+ADF
Sbjct: 118 RNG---IFHRDIKPENILI-KDDILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 29/189 (15%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQ--PDEEFLAQVSMVSRLKHE 122
NF IGEG+YG VY +G A+KK LD + P + ++S++ L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP-----VLSWQQRVKIA 177
N V+LL L +EF LH L +K + + + S+ ++
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSGIPLPLIKSYLFQL--- 109
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
+GL + H ++HRD+K N+LI + K+ADF L+ +A + R ++ V+
Sbjct: 110 ---LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV 162
Query: 238 GTFGYHAPE 246
T Y APE
Sbjct: 163 -TLWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 74 LIGEGSYGRVYYGILK----SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQ 126
++G+G +G V LK S A+K L A S EEFL + + + H N ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 127 LLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
L+G + ++ ++ F +G LH L + G +P L Q V+ +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVRFMIDI 122
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
A G+EYL K + IHRD+ + N ++ ++ +ADF LS +
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 52/183 (28%), Positives = 79/183 (43%), Gaps = 31/183 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IGEG+YG VY +G A+KK L+ DE + ++S++ L H N V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE---TEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL----SWQQRVKIAVGAAKG 183
L L +EF D+ P L +Q +G
Sbjct: 64 LDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQG 111
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
+ Y H ++HRD+K N+LI + K+ADF L+ +A + R ++ V+ T Y
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYR 166
Query: 244 APE 246
APE
Sbjct: 167 APE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 41/203 (20%)
Query: 72 NALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF---------------LAQVSM 115
A +GEG+YG+V +G AIKK+ + ++ L ++ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
++ +KHEN + L+ V+G L + + L ++ + L+ Q
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKC 123
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQ 223
I + GL LH+ + +HRD+ +N+ I + KIADF L+ ++
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 224 APDMAARLHSTRVLGTFGYHAPE 246
M R T + T Y APE
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPE 203
|
Length = 335 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 32/173 (18%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAA-AIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
+GEG +G+V ++G+ A+K L + E + L++ +++ ++ H + ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR------------- 173
L G C +L E+A GSL L + V P + S R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKV---GPSYLGSDGNRNSSYLDNPDERAL 124
Query: 174 -----VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ A ++G++YL E ++HRD+ + NVL+ + KI+DF LS
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKH 121
F IGEG+YG+VY K +G A+KK LD K E F + ++ ++ +L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNH 65
Query: 122 ENFVQLLGYCVDGTSRV----------LAYEFASNGSLHDILHGRKGVKGAQPGPV-LSW 170
N V L D + L +E+ HD++ G+ + G V S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLM----GL--LESGLVHFSE 115
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
+GL Y H+K + +HRDIK SN+L+ + K+ADF L+ +R
Sbjct: 116 DHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 231 LHSTRVLGTFGYHAPE 246
++ +V+ T Y PE
Sbjct: 173 PYTNKVI-TLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 19/156 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGHA----AAIKKLD--ASKQPDEEFLAQVSMVSRLKHENFVQ 126
L+G G +G V+ GI + G + AIK + + +Q +E + + L H V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C G S L + + GSL D + + P +L+W V AKG+ Y
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNW------CVQIAKGMYY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
L E ++HR++ + N+L+ D + +IADF +++
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-10
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 75 IGEGSYGRVYYGILKSGHA---AAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ K AIK K + K +E + + ++ +L + V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + + +L E AS G L+ L G+K ++ V++ + G++YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K + +HRD+ + NVL+ + AKI+DF LS
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 45/189 (23%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEGSY VY GI + +G A+K + + F A + S++ LKH N V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIA 177
HDI+H ++ + PG + + R+
Sbjct: 69 ------------------HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FM 109
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
+GL Y+H + HI+HRD+K N+LI K+ADF L+ +A + ++ +S+ V+
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV 165
Query: 238 GTFGYHAPE 246
T Y P+
Sbjct: 166 -TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-10
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 75 IGEGSYGRV---YYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G++G V Y + KS A+K L + +E L + +++ +L + V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C + S +L E A G L+ L K V + ++ + G++YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE---------KNITELVHQVSMGMKYLE 112
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
E + +HRD+ + NVL+ AKI+DF LS
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 16/147 (10%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
+ +I + +I G G Y G +K+G +K+++ +A + +L+
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG---KLQ 741
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H N V+L+G C L +E+ +L ++L LSW++R KIA+G
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIAIGI 789
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLI 207
AK L +LH + P ++ ++ ++I
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIII 816
|
Length = 968 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 27/164 (16%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF------LAQVSMVSRLKHENFVQ 126
L+G+G GRV+ LK +G A+K LD K+ + L + +++ L H
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLD--KKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 127 LLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQ-RVKIA-VGAAK 182
L Y T L ++ G L +L QPG LS + R A V A
Sbjct: 66 L--YASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVARFYAAEVLLA- 115
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
LEYLH I++RD+K N+L+ + ++DFDLS Q+
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-10
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 20/156 (12%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
+GEG +G+V +G A+K L + + ++ ++ L HEN V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C + G L EF +GSL + L K ++ +Q++K AV KG++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--------INLKQQLKYAVQICKGMD 123
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL + +HRD+ + NVL+ + KI DF L+
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-10
Identities = 54/176 (30%), Positives = 90/176 (51%), Gaps = 19/176 (10%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG-YC 131
+G+G++G+VY K A A K+ +K +E +++ ++ +++ H V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
DG ++ EF G++ I L +G+ +P Q +V I + L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLT--EP------QIQV-ICRQMLEALQYLHSM 129
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+K+ NVL+ D K+ADF +S + R S +GT + APE
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-10
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 19/155 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGH----AAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
++G G++G VY GI + G AIK L + S + ++E L + +++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C+ T + L + G L D + K G+Q +L+W V AKG+ Y
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNW------CVQIAKGMSY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L E ++HRD+ + NVL+ + KI DF L+
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-10
Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 15/174 (8%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
+G+G++G+VY K +G AA K +D + + E+++ ++ +++ H N V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ + EF + G++ ++ + P+ Q RV + + L YLHE
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER-------PLTEPQIRV-VCKQTLEALNYLHEN-- 122
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+K+ N+L D K+ADF +S + R S +GT + APE
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEGSY VY G K +G A+K + ++ F A + S++ LKH N V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ L +E+ L + G G P V + ++ +GL Y+H++
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYMDKHPG--GLHPENVKLFLFQL------LRGLSYIHQR- 122
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+I+HRD+K N+LI D K+ADF L+ +A + + +S V+ T Y P+
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-09
Identities = 32/72 (44%), Positives = 40/72 (55%), Gaps = 5/72 (6%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
KIAV K L YL K + IIHRD+K SN+L+ + K+ DF +S Q D A+ T
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---T 165
Query: 235 RVLGTFGYHAPE 246
R G Y APE
Sbjct: 166 RDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 69 FGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDE---EFLAQVSMVSRLKHENF 124
F ++GEG+YG V K AIKK S++ +E L ++ M+ LK EN
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
V+L L +E+ L + + G P V S+ ++ K +
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL------IKAI 113
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+ H+ I+HRDIK N+LI +DV K+ DF + + + + T + T Y +
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRS 169
Query: 245 PE 246
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 21/129 (16%)
Query: 97 KKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHG 155
K L + + F S++S+L H++ V+L G CV D V E+ G L LH
Sbjct: 36 KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHR 93
Query: 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--- 212
K L W ++ +A A L YL +K ++H ++ N+L+ +
Sbjct: 94 EKN------NVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEG 142
Query: 213 ----AKIAD 217
K++D
Sbjct: 143 YVPFIKLSD 151
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 37/190 (19%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVSRLKHENFVQL 127
IG G+YG V + ++G AIKK+ S D+ A+ + ++ L+HEN + L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGPVLSWQQRVKIA 177
L +L S +D+ LH K +K QP L+
Sbjct: 65 L--------DILRPP--SPEDFNDVYIVTELMETDLH--KVIKSPQP---LTDDHIQYFL 109
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRV 236
+GL+YLH ++IHRD+K SN+L+ + KI DF L+ PD + T
Sbjct: 110 YQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 237 LGTFGYHAPE 246
+ T Y APE
Sbjct: 167 VVTRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 58/191 (30%), Positives = 83/191 (43%), Gaps = 36/191 (18%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK------HENFV 125
A IG G+YG VY SGH A+K + D L+ V V+ LK H N V
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 126 QLLGYC----VDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
+L+ C D ++V L +E D+ + P P L + +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVD----QDL----RTYLDKVPPPGLPAETIKDLMRQF 117
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TR 235
+GL++LH I+HRD+K N+L+ K+ADF L AR++S T
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTP 166
Query: 236 VLGTFGYHAPE 246
V+ T Y APE
Sbjct: 167 VVVTLWYRAPE 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG 129
IG G +G+V + + A +K+L A+ E EFL Q L+H N +Q LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
CV+ +L +E+ G L L + + +L Q ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN--SQLLLLQ---RMACEIAAGVTHMHK 117
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADF 218
+ +H D+ N + D K+ D+
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDY 143
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 38/165 (23%)
Query: 74 LIGEGSYGRVYYGIL-----KSGHAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHENFVQ 126
+IG+G +G VY+G L + H A +K L+ + E+FL + ++ H N +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCA-VKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDIL----HG--RKGVKGAQPGPVLSWQQRVKIAVG- 179
LLG C+ S GS +L HG R ++ P VK +G
Sbjct: 61 LLGICLP-----------SEGSPLVVLPYMKHGDLRNFIRSETHNPT------VKDLIGF 103
Query: 180 ---AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
AKG+EYL K +HRD+ + N ++ + K+ADF L+
Sbjct: 104 GLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-09
Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 25/170 (14%)
Query: 90 SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA-YEFA 144
+GH AIK L +E F + ++ +RL H N V LL + A +E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
+L ++L A G L + ++ + L H + I+HRD+K N
Sbjct: 62 PGRTLREVL--------AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQN 109
Query: 205 VLIFDDDV---AKIADFDLSNQAPDM--AARLHSTR---VLGTFGYHAPE 246
+++ V AK+ DF + P + A TR VLGT Y APE
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-09
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE----NFVQLLG 129
+G+G+YG VY + + +G A+K++ DE Q+ M + H+ V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ + E+ GSL D L+ P VL +I KGL++L
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL-- 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
K + +IIHRD+K +NVL+ + K+ DF +S + A L T + G Y APE
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-09
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 40/198 (20%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA-----QVSMVS 117
E+ E + + +G G+YG V I ++G AIKKL S+ E A +++++
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLK 69
Query: 118 RLKHENFVQLLGYCVDGTS--------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
++HEN + LL S V+ Y L I+ G LS
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIM-----------GHPLS 115
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMA 228
+ + GL+Y+H IIHRD+K N+ + +D KI DF L+ A +M
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM- 171
Query: 229 ARLHSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 172 -----TGYVVTRWYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 37/105 (35%), Positives = 51/105 (48%), Gaps = 15/105 (14%)
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
E GSL +L +K G P +L KI++ +GL YL EK I+HRD+K
Sbjct: 79 EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLREKHK--IMHRDVK 127
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
SN+L+ K+ DF +S Q D A +GT Y +PE
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 19/186 (10%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK------LDASKQPDEEFLAQVSMVSRLK 120
NF IG G + VY L G A+KK +DA + D + ++ ++ +L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLN 60
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H N ++ ++ + E A G L ++ K K P + W+ V++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLC--- 116
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
LE++H + ++HRDIK +NV I V K+ D L HS ++GT
Sbjct: 117 -SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 241 GYHAPE 246
Y +PE
Sbjct: 171 YYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 15/184 (8%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHE 122
NF IG G + VY L A+KK+ + D ++ + ++ ++ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
N ++ L ++ + E A G L ++ K K P + W+ V++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLC----S 117
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
+E++H + ++HRDIK +NV I V K+ D L HS ++GT Y
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 243 HAPE 246
+PE
Sbjct: 173 MSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEG+Y V+ G K + + A+K++ + A +VS++ LKH N V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEK 190
L +E+ + + + G ++S VKI + +GL Y H++
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNC---------GNLMS-MHNVKIFMFQLLRGLSYCHKR 122
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRD+K N+LI + K+ADF L+ +A + + +S V+ T Y P+
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 23/175 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+ G VY L + A+K LD + + ++ ++++ ++ + + G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ EF GSL V P VL +IAV KGL YL
Sbjct: 69 FVENRISICTEFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL- 114
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRD+K SN+L+ K+ DF +S Q + A+ + +GT Y APE
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 51/184 (27%), Positives = 73/184 (39%), Gaps = 33/184 (17%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL----KHENFVQLLG 129
+G G+YG+V +G AIKKL Q + RL HEN + LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 130 -YCVDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
+ + L L++I+ +K LS + +G
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRG 130
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGY 242
L+Y+H IIHRD+K SN+ + +D KI DF L+ D M T + T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWY 181
Query: 243 HAPE 246
APE
Sbjct: 182 RAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 22/150 (14%)
Query: 75 IGEGSYGRVYYGI---LKSGHAA-----AIKKLDAS-KQPDEEFLAQVSMVSRLKHENFV 125
+G+G++ +++ GI + +K LD S + E F SM+S+L H++ V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G CV G ++ E+ GSL L K + SW+ V AK L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SWKLEV------AKQLA 110
Query: 186 Y-LHEKADPHIIHRDIKSSNVLIFDDDVAK 214
+ LH D + H ++ + NVL+ ++ K
Sbjct: 111 WALHFLEDKGLTHGNVCAKNVLLIREEDRK 140
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 74 LIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
++G G +G + G L K AI L A + FLA+ + + H N V+L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G G + ++ E+ SNG+L L +G L Q + + G A G++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYL 123
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
E +H+ + + VL+ D V KI+ F
Sbjct: 124 SEMG---YVHKGLAAHKVLVNSDLVCKISGF 151
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 44/178 (24%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQ--VSMVSRLKHENFVQLLG 129
++G G++G V+ K+ I K +Q DE AQ ++ L H N ++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
++ + ++ E+A G+L + + R +L + ++ +A L ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLA------LHHVHT 119
Query: 190 KADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
K I+HRD+K+ N+L+ V KI DF +S ++++ + V+GT Y +PE
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 31/199 (15%)
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKL-DASKQPD--EEFLAQVS 114
V + EN IG G+YG V I +SG AIKK+ A P + L ++
Sbjct: 3 VGSRYKPIEN------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 115 MVSRLKHENFVQLLGYCV----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
++ KH+N + + D + + + LH I+H QP L+
Sbjct: 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD------QP---LTE 106
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDM 227
+ +GL+Y+H A+ +IHRD+K SN+L+ +D +I DF ++ +P
Sbjct: 107 EHIRYFLYQLLRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 228 AARLHSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 164 HKY-FMTEYVATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 18/176 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
IGEG+YG V+ + + A+K++ D + L ++ ++ LKH+N V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
L +E+ L G + +Q KGL + H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+++HRD+K N+LI + K+ADF L+ +A + R +S V+ T Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPD 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 36 ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAA 94
+S ++ + A P ++S EL+ + IG G+ G VY I + +G
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLS--ELERVNR-------IGSGAGGTVYKVIHRPTGRLY 102
Query: 95 AIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLG-YCVDGTSRVLAYEFASNGSLHD 151
A+K + + + + ++ ++ + H N V+ + +G +VL EF GSL
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL-LEFMDGGSLE- 160
Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
G + Q +A G+ YLH + HI+HRDIK SN+LI
Sbjct: 161 ---GTH---------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAK 205
Query: 212 VAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPE 246
KIADF +S Q D +GT Y +PE
Sbjct: 206 NVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 61/197 (30%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE--EFLA--QVSMVSRLKHENFVQLLG 129
+GEGSY VY G K +G A+K++ + +E F A + S++ LKH N V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLKHANIV---- 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGV-------------------KGAQPGPVLSW 170
+LHDI+H +K + G
Sbjct: 67 ------------------TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSM------ 102
Query: 171 QQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
V++ + +GL Y H++ ++HRD+K N+LI + K+ADF L+ +A + +
Sbjct: 103 -HNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPS 157
Query: 230 RLHSTRVLGTFGYHAPE 246
+ +S V+ T Y P+
Sbjct: 158 KTYSNEVV-TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-08
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 29/188 (15%)
Query: 73 ALIGEGSYGRVYYG--ILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK------HENF 124
A IGEG+YG+V+ + G A+K++ + L+ + V+ L+ H N
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 125 VQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V+L C V T R D+ V P P + + + +G
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRG 122
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TRVLG 238
L++LH ++HRD+K N+L+ K+ADF L AR++S T V+
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSVVV 171
Query: 239 TFGYHAPE 246
T Y APE
Sbjct: 172 TLWYRAPE 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-08
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 21/165 (12%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRLK 120
N+ L+G+G++GRVY +G A+K++ S + +E A ++ ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 121 HENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
HE VQ G D R L+ E GS+ D L GA L+ K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY----GA-----LTENVTRKYTR 113
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
+G+ YLH I+HRDIK +N+L K+ DF S +
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 20/185 (10%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHE 122
+F ++G+GS+G+V K +A I K D Q D E + + +++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 123 NFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
F+ L C R+ E+ + G L + H ++ K +P Q V A +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------QAVFYAAEIS 111
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
GL +LH + II+RD+K NV++ + KIADF + + M + + GT
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPD 166
Query: 242 YHAPE 246
Y APE
Sbjct: 167 YIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-08
Identities = 54/179 (30%), Positives = 73/179 (40%), Gaps = 26/179 (14%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKHENFVQLL 128
+G GS+GRV K +G AIK L KQ + S++ L H V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSHPFIVNMM 84
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS-WQQRVKIAVGAAKGLEYL 187
D EF G L H RK G P V + + +A EYL
Sbjct: 85 CSFQDENRVYFLLEFVVGGEL--FTHLRKA--GRFPNDVAKFYHAELVLA------FEYL 134
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H K II+RD+K N+L+ + K+ DF + + PD L GT Y APE
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQ-------PDEEFLAQV--SMVSRLKHENFV 125
+G+GS+G VY ++K A A ++L K+ P+E A ++S+L H V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ ++ + + E+ L L K G LS Q + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVH 120
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
Y+H++ I+HRD+K+ N+ + +++ KI DF +S M + +T GT Y +P
Sbjct: 121 YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSP 174
Query: 246 E 246
E
Sbjct: 175 E 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 31/188 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLKHENF-VQL 127
IGEG+YG+VY +G A+KK + DEE L ++S++ L + V+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK--TRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 128 LGYCVDGT-------SRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
L V+ S L +E+ S+ +GR + + S+ ++
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL----- 119
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLG 238
KG+ + H+ ++HRD+K N+L+ + KIAD L +A + + ++ ++
Sbjct: 120 -LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIPVKSYTHEIV- 173
Query: 239 TFGYHAPE 246
T Y APE
Sbjct: 174 TLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 39/111 (35%), Positives = 53/111 (47%), Gaps = 19/111 (17%)
Query: 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--KIAVGAAKGLEYLHEKADPHI 195
+ EF GSL I +KG GP+ + KIAV +GL YL+ I
Sbjct: 79 CMCMEFMDCGSLDRIY--KKG------GPI---PVEILGKIAVAVVEGLTYLYNVH--RI 125
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+HRDIK SN+L+ K+ DF +S + + A T V GT Y +PE
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 27/192 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
E+ E + + +G G+YG V K+G A+KKL Q + ++ ++ +
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
KHEN + LL S ++ + H + GA ++ Q+ V
Sbjct: 74 KHENVIGLLDVFTPARS------LEEFNDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 123
Query: 180 -----AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
+GL+Y+H AD IIHRD+K SN+ + +D KI DF L+ D T
Sbjct: 124 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 175
Query: 235 RVLGTFGYHAPE 246
+ T Y APE
Sbjct: 176 GYVATRWYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 28/66 (42%), Positives = 38/66 (57%), Gaps = 6/66 (9%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLHSTRVLGTF 240
+GL+YLH I+HRDIK N+L+ + V KI DF L+ + PD H T+ + T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQ 168
Query: 241 GYHAPE 246
Y APE
Sbjct: 169 YYRAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-07
Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 68 NFGTNALIGEGSYGRVY--YGILKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRL 119
N+ L+G+G++GRVY Y + +G A K++ S + +E A ++ ++ L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 120 KHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+HE VQ G D + L E+ GS+ D L GA V R +
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQIL- 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-V 236
+G+ YLH I+HRDIK +N+L K+ DF S + + R V
Sbjct: 117 ----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169
Query: 237 LGTFGYHAPE 246
GT + +PE
Sbjct: 170 TGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 54/194 (27%), Positives = 81/194 (41%), Gaps = 36/194 (18%)
Query: 64 EITENFGTNALIGEGSYGRV--YYGILKSGHAAAIKKL-------DASKQPDEEFLAQVS 114
EIT + +G G++G V L +G AIKK+ +K+ E +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRE----LK 61
Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
++ L+HEN + L + + E LH +L R L Q
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP----------LEKQFI 110
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLH 232
+GL+Y+H ++HRD+K SN+LI ++ KI DF L+ Q P M +
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV- 166
Query: 233 STRVLGTFGYHAPE 246
STR Y APE
Sbjct: 167 STRY-----YRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 4e-07
Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 25/161 (15%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
++F +G GS+GRV K SG A+K L KQ E L + ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H V L G D ++ L E+ G L L RK G P PV A
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RK--SGRFPEPV--------ARFYA 107
Query: 181 AK---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
A+ LEYLH I++RD+K N+L+ D KI DF
Sbjct: 108 AQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 60/200 (30%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKL-DA-SKQPDEEFLAQ-----VSMVSRLK-HENFV 125
+G+G+YG V+ I ++ A+KK+ DA D AQ + + L H N V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIV 70
Query: 126 QLLG----------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+LL Y L +E+ LH ++ R + L +
Sbjct: 71 KLLNVIKAENDKDIY--------LVFEYMET-DLHAVI--RANI--------LEDVHKRY 111
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPD 226
I K L+Y+H ++IHRD+K SN+L+ D K+ADF L + + P
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 227 MAARLHSTRVLGTFGYHAPE 246
+ T + T Y APE
Sbjct: 169 L------TDYVATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-07
Identities = 53/192 (27%), Positives = 80/192 (41%), Gaps = 27/192 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
E+ E + +G G+YG V + A+KKL Q ++ ++ +
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71
Query: 120 KHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
KHEN + LL TS V L++I+ +K LS +
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----------LSDEHVQ 121
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
+ +GL+Y+H IIHRD+K SNV + +D +I DF L+ QA D T
Sbjct: 122 FLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMT 173
Query: 235 RVLGTFGYHAPE 246
+ T Y APE
Sbjct: 174 GYVATRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 22/180 (12%)
Query: 74 LIGEGSYGRVYYGILKSGH---AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLL 128
++G+GS+G+V LK A + K D Q D E + + ++S ++ F+ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 129 GYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGLEY 186
C R+ EF + G L + H +K + + R + A L +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA--------RARFYAAEITSALMF 111
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH+K II+RD+K NVL+ + K+ADF + + + ++ GT Y APE
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 33/187 (17%)
Query: 73 ALIGEGSYGRV----------YYGI--LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
A++G G +G+V Y I LK G A ++++ F + +
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----ANSER 60
Query: 121 HENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H V L C V E+A+ G L ++H V S + V A
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV--------FSEPRAVFYAAC 109
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
GL+YLHE I++RD+K N+L+ + KIADF L + M ++ GT
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTSTFCGT 164
Query: 240 FGYHAPE 246
+ APE
Sbjct: 165 PEFLAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 31/183 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
+G G+YG V + ++G AIKKL Q + + ++ ++ +KHEN + LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 131 CVDGTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQ----RVKIAV-GAAKG 183
F + SL + G G ++ ++ R++ V KG
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
L+Y+H IIHRD+K N+ + +D KI DF L+ Q TR Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182
Query: 244 APE 246
APE
Sbjct: 183 APE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-07
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 21/166 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRL 119
N+ L+G G++G VY +G A+K++ S++ +E A ++ ++ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 120 KHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+H+ VQ G D + L+ E+ GS+ D L GA V R +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQIL- 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
+G+ YLH I+HRDIK +N+L K+ DF S +
Sbjct: 117 ----QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-07
Identities = 35/105 (33%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
E GSL +L K + P +L K+++ +GL YL EK I+HRD+K
Sbjct: 83 EHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAVLRGLAYLREKH--QIMHRDVK 131
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
SN+L+ K+ DF +S Q D A +GT Y +PE
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 27/191 (14%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDAS-----KQPDEEFLAQVSMVSR 118
NF ++G G+YG+V+ GH A A+K L + + E + ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
++ F+ L Y +++ L ++ + G L L+ R+ + V++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----------ESEVRVY 110
Query: 178 VGA-AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
+ L++LH+ II+RDIK N+L+ + + DF LS + + R +S
Sbjct: 111 IAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165
Query: 236 VLGTFGYHAPE 246
GT Y APE
Sbjct: 166 FCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 21/177 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEG+Y V+ G K + + A+K++ + A +VS++ LKH N V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--GPVLSWQQRVKIAVGAAKGLEYLHE 189
S L +E+ K +K G ++S +GL Y H
Sbjct: 74 HTDKSLTLVFEYLD-----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ ++HRD+K N+LI + K+ADF L+ +A + + +S V+ T Y P+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
K+++ KGL YL EK I+HRD+K SN+L+ K+ DF +S Q D A
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160
Query: 235 RVLGTFGYHAPE 246
+GT Y +PE
Sbjct: 161 SFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 45/188 (23%), Positives = 81/188 (43%), Gaps = 26/188 (13%)
Query: 74 LIGEGSYGRVYYGILKSGHAA--AIKKLD--------ASKQPDEEFLAQVSMVS----RL 119
+G G++G VY K+ A+K+++ ++ D+ VS V+ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-KIAV 178
+H N V+ ++ + + L + + K K ++R+ I V
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT------EERIWNIFV 120
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
L YLH+ + I+HRD+ +N+++ +DD I DF L+ Q + T V+G
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVG 175
Query: 239 TFGYHAPE 246
T Y PE
Sbjct: 176 TILYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 20/176 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
I +G++G VY + +G AIK L K+ D QV+ V + +Q
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL---KKSDMIAKNQVTNVKAERAIMMIQGES---P 57
Query: 134 GTSRVLAYEFASNGSLH---DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
++ L Y F S L+ + L+G + L + G+E LH++
Sbjct: 58 YVAK-LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRDIK N+LI K+ DF LS L + + +GT Y APE
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 43/188 (22%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEG+Y VY G K + + A+K++ + A +VS++ LKH N V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGA-------------QPGPVLSWQQRVKIAV 178
+LHDI+H K + G ++
Sbjct: 68 ----------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF 111
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
+GL Y H + ++HRD+K N+LI + K+ADF L+ +A + + +S V+
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV- 166
Query: 239 TFGYHAPE 246
T Y P+
Sbjct: 167 TLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 24/180 (13%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G+G +G V +K +G A KKLD ++ ++ L + ++ ++ F+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 130 YCVDGTSRV-LAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
Y + + L + G L + G P + + A GLE+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGE---------PGFPEARAIFYAAQIICGLEH 110
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH++ I++RD+K NVL+ D +I+D L A ++ GT GY APE
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKGRAGTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 43/186 (23%), Positives = 72/186 (38%), Gaps = 24/186 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLK 120
++ +G G++GRV+ + S H A+K + KQ ++ + ++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H ++L D + E+ G L L S + A
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEI 110
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
LEYLH K I++RD+K N+L+ + K+ DF + + D L GT
Sbjct: 111 VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTP 162
Query: 241 GYHAPE 246
Y APE
Sbjct: 163 EYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV-- 125
NF ++G G+YG+V+ SGH D+ K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-------DSGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 126 --QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR-----VKIA 177
Q+L + V L Y F ++ LH IL + G + LS ++R V+I
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIY 110
Query: 178 VGA-AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
G LE+LH+ II+RDIK N+L+ + + DF LS + D R +S
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165
Query: 236 VLGTFGYHAPE 246
GT Y AP+
Sbjct: 166 FCGTIEYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 31/190 (16%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGH--AAAIKKLDASK-----QPDEEFLAQVSMVSRL 119
E+F +G GS+GRV K+ AIK+ + SK Q D F ++ +++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYI 88
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H V L G D + L EF G L K P V + + +
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF----PNDVGCFYAAQIVLI- 143
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR---V 236
EYL +I++RD+K N+L+ D K+ DF A++ TR +
Sbjct: 144 ----FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTL 188
Query: 237 LGTFGYHAPE 246
GT Y APE
Sbjct: 189 CGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSR----LKH 121
E F I G++G+VY G K + A+K + + ++ + QV R L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQV-QAERDALALSK 62
Query: 122 ENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
F+ L Y + + V L E+ G + +LH + G + VK
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEM-----AVKYISEV 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A L+YLH IIHRD+K N+LI ++ K+ DF LS
Sbjct: 114 ALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 57/209 (27%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE------FLAQVSMV 116
++ + + IGEG+YG V K +G AIKK+ P E L ++ ++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKIL 57
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGP 166
R KHEN + +L R ++E S +D+ L+ K +K Q
Sbjct: 58 RRFKHENIIGILD-----IIRPPSFE-----SFNDVYIVQELMETDLY--KLIK-TQH-- 102
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
LS +GL+Y+H A+ ++HRD+K SN+L+ + KI DF L
Sbjct: 103 -LSNDHIQYFLYQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGL------ 152
Query: 227 MAARLHS---------TRVLGTFGYHAPE 246
AR+ T + T Y APE
Sbjct: 153 --ARIADPEHDHTGFLTEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 14/181 (7%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
+G GS G V+ + A+KK+ + Q + L ++ ++ RL H+N V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGV-----KGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
S L + S L+ + ++ + + GP+ R+ +GL+Y+
Sbjct: 73 PSGSD-LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKYI 130
Query: 188 HEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN-QAPDMAARLHSTRVLGTFGYHAP 245
H +++HRD+K +NV I +D V KI DF L+ P + + + + L T Y +P
Sbjct: 131 HSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 246 E 246
Sbjct: 188 R 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 32/186 (17%)
Query: 73 ALIGEGSYGRVYYGILK-SGHAAAIK--KLDASKQPDE--------EFLAQVSMVSRLKH 121
++G+GS+G+V LK + A+K K D Q D+ LA KH
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KH 55
Query: 122 ENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
QL C R+ E+ + G L + H ++ + +P + A
Sbjct: 56 PFLTQLHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEP-------RARFYAAEI 105
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
GL++LHE+ II+RD+K NVL+ + KIADF + + + + ++ GT
Sbjct: 106 VLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTFCGTP 160
Query: 241 GYHAPE 246
Y APE
Sbjct: 161 DYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 42/190 (22%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKL--------DASKQPDEEFLAQVSMVSRLKHENFV 125
IG G+YG V ++ AIKK+ DA + L ++ ++ L HEN +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-----LREIKLLRHLDHENVI 67
Query: 126 QLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+ + R + YE LH I ++ +Q LS
Sbjct: 68 AIKD-IMPPPHREAFNDVYIVYELMDT-DLHQI------IRSSQT---LSDDHCQYFLYQ 116
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---SNQAPDMAARLHSTRV 236
+GL+Y+H +++HRD+K SN+L+ + KI DF L +++ D TR
Sbjct: 117 LLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR- 172
Query: 237 LGTFGYHAPE 246
Y APE
Sbjct: 173 ----WYRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 26/138 (18%), Positives = 54/138 (39%), Gaps = 23/138 (16%)
Query: 89 KSGHAAAIKKLDASKQPDEEFL---AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145
+ A+KK++ E+ ++ +L+H N + + + + + +
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 146 NGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEYLHEKADPHIIHRDI 200
GS D+L H +G+ + IA L+Y+H K IHR +
Sbjct: 83 YGSCEDLLKTHFPEGLP------------ELAIAFILKDVLNALDYIHSK---GFIHRSV 127
Query: 201 KSSNVLIFDDDVAKIADF 218
K+S++L+ D ++
Sbjct: 128 KASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 35/111 (31%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 139 LAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA-AKGLEYLHEKADPHI 195
L Y F + G L+ IL +G + V+ ++ VK + A L++LH I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---I 119
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+RD+K N+L+ ++ K+ DF LS ++ D + +S GT Y APE
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 30/184 (16%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQVSMVSR------LKHENF 124
++G+GS+G+V+ LK + AIK L D D+ + +MV + +H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLSLAWEHPFL 58
Query: 125 VQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
L YC T L + E+ + G L + H + K P A
Sbjct: 59 THL--YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATF-------YAAEIIC 107
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL++LH K I++RD+K N+L+ D KIADF + + +M + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDY 162
Query: 243 HAPE 246
APE
Sbjct: 163 IAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 74 LIGEGSYGR---VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLL-G 129
++GEGS+GR V + +A +L S E+ + +++++KH N V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ DG ++ E+ G L + ++G K +L W ++ + V +++HE
Sbjct: 67 FEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGV------QHIHE 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADF 218
K ++HRDIKS N+ + + K+ DF
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDF 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 48/192 (25%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
IGEG+YG VY + + A+KK+ +Q DE + ++S++ ++H N V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRL-- 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGV------------KGAQPGPVLSWQQR-VKI 176
D++H K + K P + R +K
Sbjct: 67 --------------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 177 AV-GAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHST 234
+ +G+ Y H ++HRD+K N+LI + K+ADF L+ +A + R +
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGIPVRTFTH 162
Query: 235 RVLGTFGYHAPE 246
V+ T Y APE
Sbjct: 163 EVV-TLWYRAPE 173
|
Length = 294 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 48/191 (25%), Positives = 79/191 (41%), Gaps = 25/191 (13%)
Query: 60 DELKEITENFGTNAL--IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVS 117
+ +E+ + G + + GS GRV+ K G + L ++ L + ++
Sbjct: 57 QKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVV-LKIGQKGTT--LIEAMLLQ 112
Query: 118 RLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+ H + +++ V G T VL + + L+ L R L Q +
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPH---YSSDLYTYLTKRSRP--------LPIDQALI 161
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
I +GL YLH + IIHRD+K+ N+ I D D I D + Q P +A
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG-- 215
Query: 236 VLGTFGYHAPE 246
+ GT +APE
Sbjct: 216 LAGTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 17/178 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
+G+G +G V ++ +G A KKL+ + + E + + +++++ H F+ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
Y + + NG D+ + V PG + GLE+LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGG--DLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQ 115
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPE 246
+ II+RD+K NVL+ +D +I+D L A ++ T+ GT G+ APE
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-05
Identities = 24/64 (37%), Positives = 36/64 (56%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE LH + + ++RD+K N+L+ D +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167
Query: 243 HAPE 246
APE
Sbjct: 168 MAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 38/187 (20%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDAS----KQPDEEFLAQVS-MVSRLKHENFVQLL 128
IG+GS+G+V K+ G A+K L K+ + +A+ + ++ +KH V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---------IAVG 179
Y F + L+ +L G G + QR + A
Sbjct: 62 -----------HYSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAE 104
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
A L YLH +II+RD+K N+L+ + DF L + + ++ GT
Sbjct: 105 IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
Query: 240 FGYHAPE 246
Y APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 54/209 (25%), Positives = 80/209 (38%), Gaps = 52/209 (24%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKL--DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
LIG+G G VY A+KK+ D S+ P + FL + + + L H V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-------KIAVGA- 180
C DG + +L +L K V WQ+ K +VGA
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLL---KSV----------WQKESLSKELAEKTSVGAF 115
Query: 181 -------AKGLEYLHEKADPHIIHRDIKSSNVL--------IFDDDVAKIADF---DLSN 222
+EY+H K ++HRD+K N+L I D A DL +
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 223 QAPDMAARLHST-----RVLGTFGYHAPE 246
D +S+ +++GT Y APE
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 21/56 (37%), Positives = 32/56 (57%), Gaps = 3/56 (5%)
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
P LS+ V + A G+E+L K + +HRD+ + NVLI + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLA 286
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 25/64 (39%), Positives = 37/64 (57%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE LH++ I++RD+K N+L+ D +I+D L+ P+ + RV GT GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167
Query: 243 HAPE 246
APE
Sbjct: 168 MAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE LH + I++RD+K N+L+ D +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 243 HAPE 246
APE
Sbjct: 168 MAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 20/178 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGY 130
+G+G +G V +K +G A KKLD K+ E+ + + F+ L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 131 CVDG-TSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ T L + G L + I + G +G + V+ + ++ G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQI------TCGILHLH 112
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I++RD+K NVL+ D +++D L+ + D T+ GT GY APE
Sbjct: 113 SMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 38/188 (20%)
Query: 74 LIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHEN--FV 125
+IG G +G VY G K +G A+K LD KQ + L + M+S + + F+
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+ Y ++ + + G LH L HG V S + A
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLG 238
GLE++H + +++RD+K +N+L+ + +I+D D S + P H++ +G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VG 157
Query: 239 TFGYHAPE 246
T GY APE
Sbjct: 158 THGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 25/147 (17%)
Query: 75 IGEGSYGRVYYGILK---------SGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK 120
+G G+ ++Y GIL + IK + P F SM+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H++ V L G CV ++ EF G L D+ RK VL+ + K+A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRK-------SDVLTTPWKFKVAKQL 114
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLI 207
A L YL +K ++H ++ + N+L+
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 45/178 (25%), Positives = 70/178 (39%), Gaps = 22/178 (12%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G +GRV +KS A+K + + Q E ++ ++ H V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
D + E+ G L IL R G + R IA EYLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR--------GLFDEYTARFYIA-CVVLAFEYLH 110
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ II+RD+K N+L+ + K+ DF + + + + GT Y APE
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWT--FCGTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLL 128
++G+GS+G+V K +A I K D Q D E + + +++ F+ L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
C R+ E+ + G L + H ++ K +P V A A GL +L
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------HAVFYAAEIAIGLFFL 117
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--SNQAPDMAARLHSTRVLGTFGYHAP 245
H K II+RD+K NV++ + KIADF + N R GT Y AP
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCGTPDYIAP 170
Query: 246 E 246
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 1e-04
Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 21/185 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+YG VY K G A+K+++ + +++++ LKH N + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVF 67
Query: 132 VDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYLH 188
+ + R L +++A + H I R A P+ + VK + G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHR--ASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 189 EKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
++HRD+K +N+L+ + KIAD + N A L V+ TF
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFW 180
Query: 242 YHAPE 246
Y APE
Sbjct: 181 YRAPE 185
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 35/124 (28%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 43 GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
G + + V P+++P S E+ +N +G G++GRV +G+ S A+
Sbjct: 15 GHEYIYVDPMQLPYDSAWEMPR--DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAV 72
Query: 97 KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
K L ++ + E+ ++++ ++S L H N V LLG C G + E+ G L D L
Sbjct: 73 KMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
Query: 154 HGRK 157
H K
Sbjct: 133 HRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 46/191 (24%), Positives = 82/191 (42%), Gaps = 27/191 (14%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDAS-----KQPDEEFLAQVSMVSR 118
NF ++G G+YG+V+ +GH A+K L + + E + +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
++ F+ L Y +++ L ++ S G + L+ R + V+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE----------VRFY 110
Query: 178 VGAA-KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
G LE+LH+ I++RDIK N+L+ + + DF LS + + R +S
Sbjct: 111 SGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-- 165
Query: 236 VLGTFGYHAPE 246
GT Y APE
Sbjct: 166 FCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 25/66 (37%), Positives = 33/66 (50%), Gaps = 10/66 (15%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTF 240
G+++LH IIHRD+K SN+++ D KI DF L+ A M TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 241 GYHAPE 246
Y APE
Sbjct: 183 -YRAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 35/192 (18%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+YG VY K G A+K+++ + +++++ LKH N + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 67
Query: 132 VDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK------- 182
+ R L +++A + H I R +P V++ G K
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP---------VQLPRGMVKSLLYQIL 118
Query: 183 -GLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLS---NQAPDMAARLHST 234
G+ YLH ++HRD+K +N+L+ + KIAD + N A L
Sbjct: 119 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP- 174
Query: 235 RVLGTFGYHAPE 246
V+ TF Y APE
Sbjct: 175 -VVVTFWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 26/64 (40%), Positives = 37/64 (57%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL++LH+K II+RD+K NVL+ D KIADF + + +M ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162
Query: 243 HAPE 246
APE
Sbjct: 163 IAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 34/186 (18%)
Query: 74 LIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHEN--FV 125
+IG G +G VY G K +G A+K LD KQ + L + M+S + + F+
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
+ Y ++ + + G LH L +Q G V S ++ A GL
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHL--------SQHG-VFSEKEMRFYATEIILGL 110
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLGTF 240
E++H + +++RD+K +N+L+ + +I+D D S + P H++ +GT
Sbjct: 111 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VGTH 159
Query: 241 GYHAPE 246
GY APE
Sbjct: 160 GYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 56/185 (30%), Positives = 82/185 (44%), Gaps = 32/185 (17%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQVSMVSR----LKHEN-FV 125
++G+GS+G+V LK G A+K L D D+ + +MV + L EN F+
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTMVEKRVLALAWENPFL 58
Query: 126 QLLGYCVDGTSRVLAY--EFASNGSL--HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
L YC T L + EF + G L H GR + A
Sbjct: 59 THL-YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-----------FDLYRATFYAAEIV 106
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
GL++LH K II+RD+K NV++ D KIADF + + ++ ++ GT
Sbjct: 107 CGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPD 161
Query: 242 YHAPE 246
Y APE
Sbjct: 162 YIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 8/64 (12%)
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG----Y 242
+H H+IHRDIKS+N+L+ + + K+ DF S M A S V TF Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAATVSDDVGRTFCGTPYY 211
Query: 243 HAPE 246
APE
Sbjct: 212 VAPE 215
|
Length = 496 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 46/213 (21%), Positives = 78/213 (36%), Gaps = 73/213 (34%)
Query: 75 IGEGSYGRVY----YGILKSG--HAAAIKKLDASKQPDEEFLAQVSMVSRLK-------H 121
+G G++G+V +GI KS A+K L E ++++ LK H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE----YKALMTELKILIHIGHH 70
Query: 122 ENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGR---------KGVKGAQPGPVLSWQ 171
N V LLG C G ++ E+ G+L + L + K + + +
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 172 QR-------------------------------------------VKIAVGAAKGLEYLH 188
QR + + A+G+E+L
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL- 189
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A IHRD+ + N+L+ +++V KI DF L+
Sbjct: 190 --ASRKCIHRDLAARNILLSENNVVKICDFGLA 220
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 19/41 (46%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G+++L K + IHRD+ + NVL+ D VAKI DF L+
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLA 259
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 9/88 (10%)
Query: 75 IGEGSYGRVY----YGILKSGHA--AAIKKLDASKQPDEE--FLAQVSMVSRL-KHENFV 125
+G G++G+V +G+ K + A+K L AS DE ++++ ++S L +H+N V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDIL 153
LLG C G ++ E+ G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 52/182 (28%), Positives = 77/182 (42%), Gaps = 32/182 (17%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDE--EFLAQVSMVSRLKHENFVQLLG 129
+G+G YG+V+ K +G A+K++ S + +E L + +++ K E V+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-----AVGAAKGL 184
D LA E+ G +L+ G + R + AV A
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNL--------GVLSEDHARFYMAEMFEAVDA---- 116
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
LHE IHRD+K N LI K+ DF LS A +S V+G+ Y A
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA---NS--VVGSPDYMA 166
Query: 245 PE 246
PE
Sbjct: 167 PE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 25/64 (39%), Positives = 35/64 (54%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE L + I++RD+K N+L+ D +I+D L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRV-GTVGY 167
Query: 243 HAPE 246
APE
Sbjct: 168 MAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 24/114 (21%), Positives = 55/114 (48%), Gaps = 17/114 (14%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGY---CVDGTSRV-LAYEFASNGSLHDILHGRKGVKGA 162
+ ++ + R+ N +++ G+ VD R+ L E+ + G L ++L K
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---- 118
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKAD-PHIIHRDIKSSNVLIFDDDVAKI 215
LS++ ++ +A+ KGL L++ + P ++++ S + L+ ++ KI
Sbjct: 119 -----LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKI 164
|
Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 26/188 (13%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDEEFLAQVSMVSRL----- 119
+F ++G+GS+G+V K +A I K D Q D+ + +MV +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---VECTMVEKRVLALS 57
Query: 120 KHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
F+ L C R+ E+ + G L + ++ + +P V A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVF-------YAA 108
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
A GL +LH K II+RD+K NV++ + KIADF + + +M + + G
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCG 163
Query: 239 TFGYHAPE 246
T Y APE
Sbjct: 164 TPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
AKG+E+L A IHRD+ + N+L+ +++V KI DF L+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 226
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 9e-04
Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 33/188 (17%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKL--------DASKQPDEEFLAQVSMVSRLKHENF 124
+IG+GSYG V I +G AIKK+ DA++ L ++ ++ L+H +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDI 61
Query: 125 VQLLGYCVDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
V++ + + R + +E + LH ++ + + +Q
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT-PEHHQFFLYQ-------- 111
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLG 238
+ L+Y+H ++ HRD+K N+L D KI DF L+ A D + T +
Sbjct: 112 LLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 239 TFGYHAPE 246
T Y APE
Sbjct: 169 TRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 17/41 (41%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G+E+L A IHRD+ + N+L+ +++V KI DF L+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 20/179 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
L+G+G++G+V K +G A+K L +K L + ++ +H F+ L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTAL 60
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
Y R+ E+A+ G L L + V S + L+YL
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYL 111
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H ++ ++++RD+K N+++ D KI DF L + A + + GT Y APE
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 48/181 (26%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLL 128
L+G+G++G+V K+ +A I K + DE L + ++ +H F+ L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP-FLTAL 60
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA--AKGLE 185
Y R+ E+A+ G L H + V S + R + GA L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL--FFHLSRE-------RVFS-EDRARF-YGAEIVSALG 109
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH +++RD+K N+++ D KI DF L + A + + GT Y AP
Sbjct: 110 YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164
Query: 246 E 246
E
Sbjct: 165 E 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 26/182 (14%)
Query: 74 LIGEGSYGRVYYGILKSG-HAAAIKKLDASKQPDEEFLAQVSMVSRLKH-------ENFV 125
+IG GSY +V LK A+K + D+E + V KH F+
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---DIDWVQTEKHVFEQASSNPFL 58
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
L C TSR+ L E+ + G L + H ++ K L + A L
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYAAEICIAL 109
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+LHE+ II+RD+K NVL+ D K+ D+ + + + ++ GT Y A
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIA 164
Query: 245 PE 246
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 7/67 (10%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
GL+Y+H A+ ++HRD+K N+L+ D KI DF L+ ++ P A T + T
Sbjct: 117 GLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVAT 172
Query: 240 FGYHAPE 246
Y APE
Sbjct: 173 RWYRAPE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188
Query: 243 HAPE 246
APE
Sbjct: 189 RAPE 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 55/200 (27%), Positives = 80/200 (40%), Gaps = 34/200 (17%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDAS----KQPDEEFLAQVSMVSRLKH 121
E+F T LI G+YG VY K A+KK++ + ++ + +++ ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 122 ENFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
V + +C T R L E+ G +L K PV + V
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETVL 112
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHS----- 233
A LEYLH I+HRD+K N+LI K+ DF LS + L+
Sbjct: 113 A---LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 234 -TR------VLGTFGYHAPE 246
TR V GT Y APE
Sbjct: 167 DTREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 243 HAPE 246
APE
Sbjct: 185 RAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL----KHENFVQLL 128
L+G+G++G+V K +G A+K L ++ +A SR+ +H F+ L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTAL 60
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
Y R+ E+A+ G L L + V + ++ LEYL
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYL 111
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H + +++RDIK N+++ D KI DF L + A + + GT Y APE
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 5/63 (7%)
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
LE+LH+ I++RD+K N+L+ + DF LS ++ + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 244 APE 246
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 18/52 (34%), Positives = 29/52 (55%)
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
++HRD+KS+N+ + + K+ DF S Q D + ++ GT Y APE
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPE 246
APE
Sbjct: 192 RAPE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.83 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.75 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.38 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.33 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.33 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.27 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.92 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.9 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.66 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.51 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.5 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.26 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.18 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.03 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.86 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.82 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.67 | |
| PLN02236 | 344 | choline kinase | 97.24 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.13 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.01 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.65 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.55 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.45 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.41 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.33 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.2 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 95.83 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.46 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.39 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 95.18 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.12 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.05 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.55 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.45 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.17 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=291.21 Aligned_cols=166 Identities=33% Similarity=0.469 Sum_probs=148.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
..+|...+.||.|+|++||+|+++ ++..||||.+.+... ..+.+..|+.+|+.++|||||++++++..++++||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 458888888999999999999987 788999999976642 3456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC------CceEE
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD------DVAKI 215 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~------~~~kl 215 (246)
|||.||+|.+||+.++ .+++..++.++.|++.||++||+++ ||||||||+|||++.. -.+||
T Consensus 89 EyC~gGDLs~yi~~~~---------~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---------RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred EeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEe
Confidence 9999999999998875 4899999999999999999999996 9999999999999864 46899
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+|+.+..... ..++||||.|||||
T Consensus 157 ADFGfAR~L~~~~~---a~tlcGSplYMAPE 184 (429)
T KOG0595|consen 157 ADFGFARFLQPGSM---AETLCGSPLYMAPE 184 (429)
T ss_pred cccchhhhCCchhH---HHHhhCCccccCHH
Confidence 99999999875443 36789999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=290.32 Aligned_cols=185 Identities=50% Similarity=0.905 Sum_probs=164.1
Q ss_pred cccccCHHHHHHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEE
Q 025893 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYC 131 (246)
Q Consensus 53 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~ 131 (246)
....+++++++..+++|...+.||+|+||.||+|...++..||||++...... ..+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999998899999988766554 66799999999999999999999999
Q ss_pred EeCC-eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 132 VDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 132 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
.+.+ ..+||+||+++|+|.++|...... .++|..+++|+.++|.||.|||....|+|+|||||++|||+|++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 9988 599999999999999999875421 48999999999999999999999888899999999999999999
Q ss_pred CceEEccccCCCCCCccccccccccc-cccccccCCC
Q 025893 211 DVAKIADFDLSNQAPDMAARLHSTRV-LGTFGYHAPE 246 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~~~~~~~~~~~~-~gt~~y~aPE 246 (246)
+.+||+|||+|+..+.... ...+. .||.+|+|||
T Consensus 214 ~~aKlsDFGLa~~~~~~~~--~~~~~~~gt~gY~~PE 248 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDT--SVSTTVMGTFGYLAPE 248 (361)
T ss_pred CCEEccCccCcccCCcccc--ceeeecCCCCccCChh
Confidence 9999999999987654111 11222 7999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=276.85 Aligned_cols=168 Identities=27% Similarity=0.440 Sum_probs=145.7
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--------HHHHHHHHHHHhcCCCCCccceEeEEEeC
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--------DEEFLAQVSMVSRLKHENFVQLLGYCVDG 134 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 134 (246)
.+.+.|.+.+.||+|+||.|-+|..+ +|+.||||.+.+.+.. .....+|+++|++|+|||||++++++..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 35677888999999999999999955 8999999999654321 23456899999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---C
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---D 211 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~---~ 211 (246)
...|+||||++||+|.+.+-..+ .+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ .
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk---------~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK---------YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc---------ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 99999999999999999987654 3667777889999999999999998 9999999999999865 6
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+|+.... .....++||||.|.|||
T Consensus 317 llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPE 348 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPE 348 (475)
T ss_pred EEEecccchhhcccc---ceehhhhcCCccccChh
Confidence 899999999998642 22347899999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=271.99 Aligned_cols=167 Identities=28% Similarity=0.371 Sum_probs=148.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.++||+|+||+||+++.+ +++.+|+|.+++... ..+....|..+|.+++||+||+++-.|++...+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 358999999999999999999976 789999999976543 345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+||+.||+|...|+..+ .+++..+..++.+|+.||.|||+++ ||||||||+|||+|.+|+++|+||||
T Consensus 104 ld~~~GGeLf~hL~~eg---------~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---------RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred EeccCCccHHHHHHhcC---------CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999999997654 4888999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+..-... ..+.++|||+.|||||
T Consensus 172 ~k~~~~~~--~~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 172 CKEDLKDG--DATRTFCGTPEYMAPE 195 (357)
T ss_pred chhcccCC--CccccccCCccccChH
Confidence 98643322 2346789999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=277.62 Aligned_cols=166 Identities=30% Similarity=0.483 Sum_probs=150.9
Q ss_pred hcCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCC----CCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
..|...+.||+|+|.+||.++. .+|+.||+|.+.+ .....+.+.+||++.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999997 6899999999976 3445678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|+|+.++|..+++.++ .+++.+++.++.||+.||.|||+++ |+|||||..|++++++.++||+|||||
T Consensus 98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence 9999999999998554 4899999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..+...... ..+.||||.|+|||
T Consensus 166 t~le~~~Er--k~TlCGTPNYIAPE 188 (592)
T KOG0575|consen 166 TQLEYDGER--KKTLCGTPNYIAPE 188 (592)
T ss_pred eeecCcccc--cceecCCCcccChh
Confidence 887644332 36789999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=256.58 Aligned_cols=164 Identities=30% Similarity=0.391 Sum_probs=147.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|+..+.||.|+||+|.+++.+ +|..+|+|.+.+.+.. .+...+|..+|+.+.||+++++.+.+.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 468999999999999999999987 7889999999766532 34567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||++||.|..+++..+ .+++..++.++.||+.||+|||+.+ |++|||||+|||+|++|.+||+|||+
T Consensus 123 meyv~GGElFS~Lrk~~---------rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---------RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred EeccCCccHHHHHHhcC---------CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccc
Confidence 99999999999998765 3888899999999999999999996 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+..... ..+.||||.|+|||
T Consensus 191 AK~v~~r-----T~TlCGTPeYLAPE 211 (355)
T KOG0616|consen 191 AKRVSGR-----TWTLCGTPEYLAPE 211 (355)
T ss_pred eEEecCc-----EEEecCCccccChH
Confidence 9876432 36789999999998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=262.31 Aligned_cols=163 Identities=29% Similarity=0.429 Sum_probs=144.3
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe-eEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-RVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~E~ 143 (246)
+.+..+.||+|..|+||+++++ ++..+|+|.+.... ....++.+|++++++.+||+||+++|.|..+.. ++|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455678999999999999988 78899999995433 235788999999999999999999999999984 9999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|.+|+|.+++...+ .+++...-.++.+|++||.|||. + .||||||||+|||++..|.+||+|||.++
T Consensus 160 MDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred cCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccH
Confidence 99999999997653 38889999999999999999996 5 49999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+... ...+++||..|||||
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPE 247 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPE 247 (364)
T ss_pred Hhhhh----hcccccccccccChh
Confidence 87554 347899999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=259.55 Aligned_cols=173 Identities=25% Similarity=0.410 Sum_probs=146.9
Q ss_pred HhcCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEe-EEEeCCe-eEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLG-YCVDGTS-RVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~-~~~~~~~-~~l 139 (246)
..+|++.+.||+|+||+||++.. .+|..+|.|.+.-...+ ..+...|+.+|++|+|||||++++ .+.+++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35788888999999999999985 48999999999754443 457889999999999999999998 4555555 789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeCCCCCCCeEecCCCceEEcc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH--IIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
|||||.+|+|.+.++..+. ....+++..+.+++.|++.||..||++ .++ |+||||||.||+++.+|.+||+|
T Consensus 98 vmE~c~~GDLsqmIk~~K~-----qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKK-----QKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred HHHhhcccCHHHHHHHHHh-----ccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence 9999999999999875442 124589999999999999999999994 345 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++.+....+ ...+.+|||+||+||
T Consensus 172 fGL~r~l~s~~t--fA~S~VGTPyYMSPE 198 (375)
T KOG0591|consen 172 FGLGRFLSSKTT--FAHSLVGTPYYMSPE 198 (375)
T ss_pred chhHhHhcchhH--HHHhhcCCCcccCHH
Confidence 999998765433 345789999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=260.88 Aligned_cols=164 Identities=37% Similarity=0.602 Sum_probs=139.4
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCC-eeEEEEecCCCC
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT-SRVLAYEFASNG 147 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~E~~~~g 147 (246)
...||+|+||+||+|.++....||+|.+...... .+.|.+|+.+|.+|+|||||+++|++.++. ...|||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3459999999999999984444999999755433 458999999999999999999999999887 789999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEccccCCCCCCc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPD 226 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Dfgls~~~~~ 226 (246)
+|.+++.... ...+++..++.++.+|+.||.|||+++ +||||||||+|||++.++ ++||+|||+++....
T Consensus 126 sL~~~l~~~~-------~~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 126 SLSVLLHKKR-------KRKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred cHHHHHhhcc-------cCCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999997631 124899999999999999999999985 299999999999999997 999999999987543
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.. ...+...||+.|||||
T Consensus 197 ~~--~~~~~~~GT~~wMAPE 214 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPE 214 (362)
T ss_pred cc--ccccCCCCCccccChh
Confidence 21 1223468999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=258.75 Aligned_cols=168 Identities=30% Similarity=0.445 Sum_probs=143.4
Q ss_pred HhcCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 139 (246)
.+.|+....||+|.||.||+|+. .+|..||+|++..+... ..-..+||.||++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45788888999999999999995 58999999999766532 34556899999999999999999998876 68999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
|+|||+. ||.-++.... ..|++.++..++.|++.||.|||+++ |+|||||.+|||||.+|.+||+|||
T Consensus 196 VFeYMdh-DL~GLl~~p~--------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG--------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EEecccc-hhhhhhcCCC--------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccc
Confidence 9999986 8988886532 24899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+......... .+..+-|.+|.|||
T Consensus 264 LAr~y~~~~~~~-~T~rVvTLWYRpPE 289 (560)
T KOG0600|consen 264 LARFYTPSGSAP-YTSRVVTLWYRPPE 289 (560)
T ss_pred ceeeccCCCCcc-cccceEEeeccChH
Confidence 999765443332 24455699999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.67 Aligned_cols=168 Identities=29% Similarity=0.454 Sum_probs=147.0
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CC--CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~--~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 136 (246)
..+.|.+.+.||+|+||+|++|.+. ++..||+|.+... .. ..+.+.+|+.+++++. ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3568999999999999999999865 7899999977553 11 2345668999999999 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CceEE
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKI 215 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-~~~kl 215 (246)
+|+||||+.||+|.+++.... .+.+..+..++.|++.|+.|||+++ |+||||||+|||++.+ +.+||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEE
Confidence 999999999999999998743 3888999999999999999999997 9999999999999998 99999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++.... .......+.+||+.|+|||
T Consensus 163 ~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPE 191 (370)
T KOG0583|consen 163 SDFGLSAISP--GEDGLLKTFCGSPAYAAPE 191 (370)
T ss_pred eccccccccC--CCCCcccCCCCCcccCCHH
Confidence 9999998763 1222347889999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=247.17 Aligned_cols=165 Identities=29% Similarity=0.409 Sum_probs=140.9
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.|+....+|+|+||.||+|+.+ +|+.||||++..+..+ .+-.++|+.+|++|+|||+|.++++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4677788999999999999987 8999999999765543 24567999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
|+. ++.+.|.... ..++...+..++.|++.|+.|||+++ ++||||||+||||..+|.+||+|||+|+.
T Consensus 83 ~dh-TvL~eLe~~p--------~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 83 CDH-TVLHELERYP--------NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFART 150 (396)
T ss_pred cch-HHHHHHHhcc--------CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHh
Confidence 987 4545554332 13788899999999999999999997 99999999999999999999999999998
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... .-+..+.|.+|.|||
T Consensus 151 L~~pgd--~YTDYVATRWYRaPE 171 (396)
T KOG0593|consen 151 LSAPGD--NYTDYVATRWYRAPE 171 (396)
T ss_pred hcCCcc--hhhhhhhhhhccChh
Confidence 764322 225678899999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=257.22 Aligned_cols=172 Identities=30% Similarity=0.400 Sum_probs=149.2
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
+...++|...+.||+|+|++|++|+.+ ++..+|||++.+.. ...+....|-.+|.+| .||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344579999999999999999999965 89999999987543 2334566788889999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
+|+|+||+++|+|.++|+..+ .|.+...+.++.+|+.||+|||++| ||||||||+|||+|.++++||+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---------sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---------SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---------cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence 999999999999999998765 4888899999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccc---------cc--cccccccccccCCC
Q 025893 217 DFDLSNQAPDMAAR---------LH--STRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~---------~~--~~~~~gt~~y~aPE 246 (246)
|||.|+.+...... .. ..+++||..|.+||
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE 257 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE 257 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHH
Confidence 99999987643221 11 25699999999998
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=253.27 Aligned_cols=167 Identities=29% Similarity=0.464 Sum_probs=149.8
Q ss_pred HHhcCCCCceeccCCceEEEEEE-ECCCCEEEEEEcCCCCCCH----HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vaik~~~~~~~~~----~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
....|++.+.||+|.||+|-+|+ +..|+.||||.+++++... -.+.+|++||+.|+||||+.++++|++.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34578888999999999999998 4689999999998776443 357789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||..+|+|++|+..++ .|++..+..+++||..|+.|||.++ ++|||||.+|||+|+++.+||+|||
T Consensus 131 vMEYaS~GeLYDYiSer~---------~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG---------SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEecCCccHHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 999999999999998765 4899999999999999999999986 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+..+.. .....++||+|-|.+||
T Consensus 199 LSNly~~---~kfLqTFCGSPLYASPE 222 (668)
T KOG0611|consen 199 LSNLYAD---KKFLQTFCGSPLYASPE 222 (668)
T ss_pred hhhhhcc---ccHHHHhcCCcccCCcc
Confidence 9977543 23347899999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=260.42 Aligned_cols=168 Identities=28% Similarity=0.414 Sum_probs=147.0
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCee
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR 137 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 137 (246)
...++|.+.++||+|+||+|+++..+ +++.+|||.+++.. .+.+..+.|-+|+.-.. ||+++.++..|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34579999999999999999999987 78899999998764 34567788888877665 99999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
|+||||+.||++..+++.. .+++.++..|+.+|+.||.|||+++ ||+||||.+|||+|.+|.+||+|
T Consensus 445 ~fvmey~~Ggdm~~~~~~~----------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD----------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred EEEEEecCCCcEEEEEecc----------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecc
Confidence 9999999999965555433 3899999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+++....... .+.++||||.|||||
T Consensus 512 FGlcKe~m~~g~--~TsTfCGTpey~aPE 538 (694)
T KOG0694|consen 512 FGLCKEGMGQGD--RTSTFCGTPEFLAPE 538 (694)
T ss_pred cccccccCCCCC--ccccccCChhhcChh
Confidence 999998653332 457899999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=256.68 Aligned_cols=165 Identities=33% Similarity=0.474 Sum_probs=146.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+..... +.+.+|++++++|+|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788889999999999999976 78999999998765544 567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+.| +|..+|.... .++++.+..++.+++.||.|||+.+ |+|||+||+|||++..+++|++|||+|+
T Consensus 82 ~a~g-~L~~il~~d~---------~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---------KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred hhhh-hHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence 9987 9999997654 3899999999999999999999986 9999999999999999999999999999
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ..+.+.|||.|||||
T Consensus 149 ~m~~~t~--vltsikGtPlYmAPE 170 (808)
T KOG0597|consen 149 AMSTNTS--VLTSIKGTPLYMAPE 170 (808)
T ss_pred hcccCce--eeeeccCcccccCHH
Confidence 8654222 235678999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=250.80 Aligned_cols=146 Identities=26% Similarity=0.346 Sum_probs=133.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|+++++||+|+||.||+|+-+ +|..+|+|++.++.. ..+.++.|-.+|...++|+||+++-.|++..++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 468999999999999999999966 899999999987654 345677888999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||++||++..+|.... .|++..+..++.+++.|+..+|..| +|||||||+|+|||..|++||+||||
T Consensus 220 MEylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EEecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence 99999999999997654 5899999999999999999999998 99999999999999999999999999
Q ss_pred CCC
Q 025893 221 SNQ 223 (246)
Q Consensus 221 s~~ 223 (246)
|+.
T Consensus 288 s~g 290 (550)
T KOG0605|consen 288 STG 290 (550)
T ss_pred cch
Confidence 854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=253.63 Aligned_cols=167 Identities=30% Similarity=0.461 Sum_probs=147.1
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHH--HHHHHHHHhcCC-CCCccceEeEEEeCC-eeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE--FLAQVSMVSRLK-HENFVQLLGYCVDGT-SRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~--~~~e~~~l~~l~-hp~iv~~~~~~~~~~-~~~l 139 (246)
+-++|.+.+.||.|+||.||+|..+ ++..||||++++....-++ -++|+..|++|. |||||++++++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568888999999999999999955 7999999999876655554 357999999999 999999999999887 9999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
|||||+ .+|+++++.+. ..|++..+..|+.||++||.|+|.+| +.|||+||+|||+.....+||+|||
T Consensus 88 VfE~Md-~NLYqLmK~R~--------r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRN--------RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred eHHhhh-hhHHHHHhhcC--------CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccc
Confidence 999996 59999998764 25999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|+...... .-+..+.|.+|.|||
T Consensus 156 LARev~Skp---PYTeYVSTRWYRAPE 179 (538)
T KOG0661|consen 156 LAREVRSKP---PYTEYVSTRWYRAPE 179 (538)
T ss_pred cccccccCC---CcchhhhcccccchH
Confidence 999864332 336678999999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=232.99 Aligned_cols=167 Identities=32% Similarity=0.451 Sum_probs=147.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|.||.||+|+.+ ++..||+|++.+++. ...++.+|+++.+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 568999999999999999999965 788899999976542 346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+||..+|++...|+..... .+++.....++.|++.||.|||.++ |+||||||+|+|++..+.+||+|||.
T Consensus 101 lEya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred EEecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999854432 3777778899999999999999986 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+...+.. ...++|||.-|.+||
T Consensus 171 sV~~p~~----kR~tlcgt~dyl~pE 192 (281)
T KOG0580|consen 171 SVHAPSN----KRKTLCGTLDYLPPE 192 (281)
T ss_pred eeecCCC----CceeeecccccCCHh
Confidence 8775422 236889999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=240.04 Aligned_cols=169 Identities=33% Similarity=0.516 Sum_probs=142.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeCC--eeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~E 142 (246)
.+|...+.||+|+||.||++... +|...|+|.+...... .+.+.+|+.+|++|+|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35677789999999999999965 6899999998655322 466889999999999999999999744444 6889999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls 221 (246)
|+++|+|.+++....+ .|++..++.+.+||++||.|||+++ ||||||||+|||++. ++.+||+|||++
T Consensus 97 y~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred ccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccc
Confidence 9999999999987643 3899999999999999999999997 999999999999999 799999999999
Q ss_pred CCCCccc-cccccccccccccccCCC
Q 025893 222 NQAPDMA-ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~-~~~~~~~~~gt~~y~aPE 246 (246)
+...... .......+.||+.|||||
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPE 191 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPE 191 (313)
T ss_pred cccccccccccccccccCCccccCch
Confidence 8755311 111224578999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.56 Aligned_cols=167 Identities=31% Similarity=0.508 Sum_probs=142.7
Q ss_pred CCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCC
Q 025893 69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
+.+.+.||+|.||.||+|.++....||+|.+.......++|.+|+++|++|+|+|||+++++|..+..+||||||++.|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 34456799999999999999977799999998888888999999999999999999999999999889999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccc
Q 025893 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (246)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~ 228 (246)
|.++|+...+ ..+...+.+.++.||++||+||++++ +|||||..+|||++++..+||+|||||+......
T Consensus 288 Ll~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 288 LLDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred HHHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999987332 24777888999999999999999996 9999999999999999999999999999543332
Q ss_pred cccccccccccccccCCC
Q 025893 229 ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE 246 (246)
.. .....-=...|.|||
T Consensus 358 Y~-~~~~~kfPIkWtAPE 374 (468)
T KOG0197|consen 358 YT-ASEGGKFPIKWTAPE 374 (468)
T ss_pred ee-ecCCCCCCceecCHH
Confidence 21 111112245799998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=230.17 Aligned_cols=165 Identities=31% Similarity=0.456 Sum_probs=143.2
Q ss_pred cCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.|...+.||+|.||.||+|+. ++|+.||||++...+.. .....+|+..|+.++|+||+.+.++|...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 567778899999999999995 48999999999766543 45678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
++. +|...++... ..++..++..++.+++.||+|||++. |+||||||.|+|++.+|.+||+|||+++.
T Consensus 83 m~t-dLe~vIkd~~--------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKN--------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred ccc-cHHHHhcccc--------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence 975 9999997654 24888999999999999999999996 99999999999999999999999999998
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ..-+-|.+|.|||
T Consensus 151 f~~p~~~~--~~~V~TRWYRAPE 171 (318)
T KOG0659|consen 151 FGSPNRIQ--THQVVTRWYRAPE 171 (318)
T ss_pred cCCCCccc--ccceeeeeccChH
Confidence 76443221 1225689999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=246.50 Aligned_cols=172 Identities=34% Similarity=0.476 Sum_probs=141.0
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------------CHHHHHHHHHHHhcCCCCCccc
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------------PDEEFLAQVSMVSRLKHENFVQ 126 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---------------~~~~~~~e~~~l~~l~hp~iv~ 126 (246)
....++|.+.+.||+|.||+|-+|+.. +++.||||++.+... ..+...+||.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999966 799999999864321 1257889999999999999999
Q ss_pred eEeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 025893 127 LLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (246)
Q Consensus 127 ~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~N 204 (246)
|+++..++ +.+|||+|||..|.+...-. ..+-+++.+++.|+++++.||+|||.++ |+||||||+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---------d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---------DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN 240 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---------CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence 99998764 68899999999988753211 1123889999999999999999999998 9999999999
Q ss_pred eEecCCCceEEccccCCCCCCcccc---ccccccccccccccCCC
Q 025893 205 VLIFDDDVAKIADFDLSNQAPDMAA---RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 205 il~~~~~~~kl~Dfgls~~~~~~~~---~~~~~~~~gt~~y~aPE 246 (246)
+|++++|++||+|||.+...+.... .......+|||.|||||
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE 285 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPE 285 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchH
Confidence 9999999999999999876532211 11113367999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=252.26 Aligned_cols=165 Identities=32% Similarity=0.512 Sum_probs=147.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH-HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~-~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
..|.....||+|.-|.||.++.. +++.||||++....... +-+.+|+.+|+.++|+|||++++.|...+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 35777788999999999999954 78899999998777665 45679999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+||+|.+.+.... +++.++..|++++++||.|||.++ |+|||||.+|||++.+|.+||+|||||..+
T Consensus 353 ~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred CCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 9999999987653 889999999999999999999998 999999999999999999999999999887
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ...+.+|||+|||||
T Consensus 420 ~~~~~--KR~TmVGTPYWMAPE 439 (550)
T KOG0578|consen 420 SEEQS--KRSTMVGTPYWMAPE 439 (550)
T ss_pred ccccC--ccccccCCCCccchh
Confidence 65432 346789999999998
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=232.08 Aligned_cols=169 Identities=28% Similarity=0.434 Sum_probs=147.9
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-----C----HHHHHHHHHHHhcCC-CCCccceEeEE
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-----P----DEEFLAQVSMVSRLK-HENFVQLLGYC 131 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-----~----~~~~~~e~~~l~~l~-hp~iv~~~~~~ 131 (246)
+.+-+.|.-.+.||+|..+.|.++.++ +|..+|+|++..... . .+.-..|+.+|+++. ||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 455678888899999999999999876 788999998853211 1 244567999999986 99999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 132 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
+.+...++|+|.|+.|.|.|+|.+.- .+++....+|++|+.+|+.|||..+ ||||||||+|||++++.
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNM 160 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecccc
Confidence 99999999999999999999997653 5899999999999999999999996 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||++..+...... ..+||||+|+|||
T Consensus 161 ~i~isDFGFa~~l~~GekL---relCGTPgYLAPE 192 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEKL---RELCGTPGYLAPE 192 (411)
T ss_pred ceEEeccceeeccCCchhH---HHhcCCCcccChh
Confidence 9999999999988765543 5789999999998
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=232.11 Aligned_cols=168 Identities=29% Similarity=0.412 Sum_probs=140.8
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCC-ccceEeEEEeCC------e
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGT------S 136 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~------~ 136 (246)
.|...+.||+|+||+||+|+.+ +|+.||+|++..... ......+|+.++++|+|+| |+++++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4555667999999999999966 899999999976544 3456789999999999999 999999999877 7
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.++|+||+.. +|.+++....... ..++...+..+++||+.||.|||+++ |+||||||+|||++..|.+||+
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeee
Confidence 8999999964 9999998654211 23666788999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+|+........ .+..++|.+|.|||
T Consensus 163 DFGlAra~~ip~~~--yt~evvTlWYRaPE 190 (323)
T KOG0594|consen 163 DFGLARAFSIPMRT--YTPEVVTLWYRAPE 190 (323)
T ss_pred ccchHHHhcCCccc--ccccEEEeeccCHH
Confidence 99999865432221 24567899999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=230.92 Aligned_cols=168 Identities=27% Similarity=0.402 Sum_probs=141.9
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRV 138 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 138 (246)
..++|+.++.|++|+||.||+|+.+ +++.||+|+++..+.. .-.-++||.+|.+.+|||||.+..+... -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3467888889999999999999976 8899999999755422 2345789999999999999999988764 36789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+|||||+. +|..++.... ..+...++..++.|++.|++|||... |+|||||++|+|+...|.+||+||
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 99999986 9999887654 24788889999999999999999986 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|+....... ..+..+-|.+|.|||
T Consensus 222 GLAR~ygsp~k--~~T~lVVTLWYRaPE 247 (419)
T KOG0663|consen 222 GLAREYGSPLK--PYTPLVVTLWYRAPE 247 (419)
T ss_pred chhhhhcCCcc--cCcceEEEeeecCHH
Confidence 99998765432 224556799999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=240.09 Aligned_cols=146 Identities=24% Similarity=0.357 Sum_probs=130.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|+..+.||+|+||+||++..+ +++.+|+|.+.... .....+..|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999876 78899999986432 12346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred cCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence 9999999999986543 3788999999999999999999997 999999999999999999999999998
Q ss_pred CCC
Q 025893 222 NQA 224 (246)
Q Consensus 222 ~~~ 224 (246)
+..
T Consensus 149 ~~~ 151 (363)
T cd05628 149 TGL 151 (363)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=241.56 Aligned_cols=167 Identities=22% Similarity=0.326 Sum_probs=143.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||.||++..+ +++.+|+|.+.+.. .....+.+|+.+++.++||||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999976 68899999885422 2234577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 122 ~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 122 MEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999986532 778888999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......+||+.|+|||
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE 213 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPE 213 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHH
Confidence 876532211 1224567999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=246.02 Aligned_cols=165 Identities=24% Similarity=0.328 Sum_probs=145.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC-CC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~-~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.-|.+.+.||.|+-|.|.+|++. +|+.+|||.+.+. +. ....+.+|+.+|+-+.|||+++++++|.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45778889999999999999975 8999999999755 22 2356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|.|++++..++ .+++.++..+++||+.|+.|||..+ |+||||||+|+|+|....+||+|||+|
T Consensus 92 Eyv~gGELFdylv~kG---------~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---------PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred EecCCchhHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecccee
Confidence 9999999999997765 3888999999999999999999986 999999999999999888999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..-.... ...+-||+|.|.|||
T Consensus 160 sLe~~gk---lLeTSCGSPHYA~PE 181 (786)
T KOG0588|consen 160 SLEVPGK---LLETSCGSPHYAAPE 181 (786)
T ss_pred ecccCCc---cccccCCCcccCCch
Confidence 7644322 235679999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=231.54 Aligned_cols=171 Identities=29% Similarity=0.377 Sum_probs=149.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|++...||.|.-+.||+|+.. .+..||||++...+ .+.+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 468999999999999999999955 78999999997544 335788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
||.+|++.++++..... .+.+..+..|.++++.||.|||.+| -||||||+.||||+.+|.|||+|||.+.
T Consensus 105 fMa~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred hhcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence 99999999999865422 3888899999999999999999998 8999999999999999999999999987
Q ss_pred CCCcccccc-cc-ccccccccccCCC
Q 025893 223 QAPDMAARL-HS-TRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~-~~-~~~~gt~~y~aPE 246 (246)
.+.....+. .. ++++|||.|||||
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPE 200 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPE 200 (516)
T ss_pred eecccCceeeEeeccccCcccccChH
Confidence 654433211 12 6789999999998
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=237.43 Aligned_cols=167 Identities=29% Similarity=0.428 Sum_probs=147.3
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCee
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR 137 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 137 (246)
.+...|.+.+.||+|.||.||++..+ +|+.+|+|.+.+... ..+.+.+|+.+|++|+ |||||.+++++.+...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34568888999999999999999977 699999999976543 3468899999999999 99999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC----Cce
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVA 213 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~----~~~ 213 (246)
++|||+|.||+|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence 9999999999999999764 1789999999999999999999997 9999999999999743 479
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|++|||++..... .......+|||.|+|||
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APE 208 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPE 208 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCch
Confidence 9999999988654 22236789999999998
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=236.25 Aligned_cols=164 Identities=28% Similarity=0.399 Sum_probs=142.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|..+ +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357888999999999999999976 78899999986432 2345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred EcCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999987543 3778888889999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++..... ....+||+.|+|||
T Consensus 165 ~~~~~~~-----~~~~~gt~~y~aPE 185 (329)
T PTZ00263 165 AKKVPDR-----TFTLCGTPEYLAPE 185 (329)
T ss_pred ceEcCCC-----cceecCChhhcCHH
Confidence 8765322 13457999999998
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=239.08 Aligned_cols=144 Identities=22% Similarity=0.271 Sum_probs=128.2
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.|...+.||+|+||+||+|+.. ++..+|+|.+..... ....+..|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999965 788999999865321 23567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 999999999986543 3778888889999999999999997 9999999999999999999999999976
Q ss_pred C
Q 025893 223 Q 223 (246)
Q Consensus 223 ~ 223 (246)
.
T Consensus 150 ~ 150 (381)
T cd05626 150 G 150 (381)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=238.66 Aligned_cols=146 Identities=24% Similarity=0.358 Sum_probs=130.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||.||+++.. +++.||+|.+.... .....+..|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999976 78999999986432 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence 9999999999986543 3788999999999999999999997 999999999999999999999999998
Q ss_pred CCC
Q 025893 222 NQA 224 (246)
Q Consensus 222 ~~~ 224 (246)
+..
T Consensus 149 ~~~ 151 (364)
T cd05599 149 TGL 151 (364)
T ss_pred eec
Confidence 754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=238.30 Aligned_cols=145 Identities=28% Similarity=0.330 Sum_probs=128.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||++..+ +++.+|+|.+.... .....+.+|+.++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999865 78899999985432 12346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999986533 3778888899999999999999997 999999999999999999999999998
Q ss_pred CC
Q 025893 222 NQ 223 (246)
Q Consensus 222 ~~ 223 (246)
+.
T Consensus 149 ~~ 150 (377)
T cd05629 149 TG 150 (377)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=237.37 Aligned_cols=144 Identities=22% Similarity=0.284 Sum_probs=128.4
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
+|.+.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999965 78899999986432 234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 82 YIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999986543 3778888889999999999999997 9999999999999999999999999975
Q ss_pred C
Q 025893 223 Q 223 (246)
Q Consensus 223 ~ 223 (246)
.
T Consensus 150 ~ 150 (376)
T cd05598 150 G 150 (376)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=232.29 Aligned_cols=163 Identities=25% Similarity=0.364 Sum_probs=141.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||.||++..+ +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999976 78899999986432 12356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 81 EYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence 9999999999987543 3788888999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... ....+||+.|+|||
T Consensus 149 ~~~~~~-----~~~~~gt~~y~aPE 168 (291)
T cd05612 149 KKLRDR-----TWTLCGTPEYLAPE 168 (291)
T ss_pred hhccCC-----cccccCChhhcCHH
Confidence 765321 13457999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=231.62 Aligned_cols=160 Identities=26% Similarity=0.335 Sum_probs=136.7
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
+.||+|+||.||++..+ +++.+|+|.+.... .....+..|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 78899999986432 22346778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~ 227 (246)
+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 9999886543 3788999999999999999999997 999999999999999999999999998753221
Q ss_pred ccccccccccccccccCCC
Q 025893 228 AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE 246 (246)
.. .....+||+.|+|||
T Consensus 149 ~~--~~~~~~gt~~y~aPE 165 (323)
T cd05571 149 GA--TMKTFCGTPEYLAPE 165 (323)
T ss_pred CC--cccceecCccccChh
Confidence 11 123567999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=237.87 Aligned_cols=144 Identities=22% Similarity=0.273 Sum_probs=127.9
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.|...+.||+|+||.||+|+.. +++.+|+|.+..... ....+.+|+.++++++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999975 788999999865322 23467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 999999999986542 3778888899999999999999997 9999999999999999999999999975
Q ss_pred C
Q 025893 223 Q 223 (246)
Q Consensus 223 ~ 223 (246)
.
T Consensus 150 ~ 150 (382)
T cd05625 150 G 150 (382)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=232.77 Aligned_cols=163 Identities=29% Similarity=0.429 Sum_probs=142.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 68899999986432 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 9999999999996543 3788889999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....+||+.|+|||
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE 168 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPE 168 (333)
T ss_pred ccccc-----ccCCcccCccccChh
Confidence 76533 224567999999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=233.97 Aligned_cols=164 Identities=27% Similarity=0.387 Sum_probs=141.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-C-CCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~-~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||.||+|..+ + +..+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457999999999999999999865 3 357999988543 2234567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 109 v~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence 999999999999997543 3788889999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++..... ....+||+.|+|||
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE 198 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPE 198 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHH
Confidence 98764321 23467999999998
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=236.41 Aligned_cols=168 Identities=21% Similarity=0.300 Sum_probs=143.3
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
..++|.+.+.||+|+||.||++..+ +++.+|+|.+.... .....+.+|+.+++.++||||+++++.+.+....++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3579999999999999999999976 78899999885422 223457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 121 v~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 121 VMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999986532 677888889999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++....... ......+||+.|+|||
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE 213 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPE 213 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHH
Confidence 9876532211 1224567999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=228.21 Aligned_cols=178 Identities=28% Similarity=0.410 Sum_probs=142.1
Q ss_pred HhcCCCCceeccCCceEEEEEEECC-----------------CCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccc
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS-----------------GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQ 126 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~ 126 (246)
.++|.+.+.||+|+||.||+|.+++ +..+|+|.+..... ...++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997532 23699998865432 2357889999999999999999
Q ss_pred eEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 025893 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 196 (246)
Q Consensus 127 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iv 196 (246)
+++++.+.+..+++|||+++|+|.+++........ ......+++.....++.||+.||.|||+++ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999865321110 111234788889999999999999999997 99
Q ss_pred eCCCCCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 197 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 197 Hrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||||||+|||++.++.+||+|||+++...............+++.|+|||
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence 99999999999999999999999987653322211223345678999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=235.78 Aligned_cols=167 Identities=23% Similarity=0.324 Sum_probs=142.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||.||++..+ ++..+|+|.+.... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 468999999999999999999976 78899999985422 2234577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 122 ~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999999986532 677888889999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......+||+.|+|||
T Consensus 189 ~~~~~~~~~-~~~~~~~gt~~y~aPE 213 (370)
T cd05596 189 CMKMDANGM-VRCDTAVGTPDYISPE 213 (370)
T ss_pred eeeccCCCc-ccCCCCCCCcCeECHH
Confidence 876432211 1223567999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=226.04 Aligned_cols=166 Identities=25% Similarity=0.369 Sum_probs=140.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.|+..+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999965 789999998864321 23457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 9999999888754321 13788999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....||+.|+|||
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE 171 (285)
T cd05631 151 QIPEGET---VRGRVGTVGYMAPE 171 (285)
T ss_pred EcCCCCe---ecCCCCCCCccCHh
Confidence 6432211 13457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=236.79 Aligned_cols=168 Identities=33% Similarity=0.510 Sum_probs=138.5
Q ss_pred HhcCCCCceeccCCceEEEEEEECC--C--CE-EEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS--G--HA-AAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~--~--~~-vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
.++-.+.+.||+|.||.||+|.++. + .. ||+|....+. ....++.+|+++|++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455556899999999999999652 2 23 8999886422 224678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
++||||+|.||+|.++|+.... .++..+.+.++.+++.||+|||+++ ++||||-.+|||++..+.+||+
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 9999999999999999987642 3888999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++.......... ...-...|+|||
T Consensus 305 DFGLs~~~~~~~~~~~--~~klPirWLAPE 332 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKF--LKKLPIRWLAPE 332 (474)
T ss_pred ccccccCCcceeeccc--cccCcceecChh
Confidence 9999987542221110 111346899998
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=236.30 Aligned_cols=166 Identities=27% Similarity=0.365 Sum_probs=148.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
...|.+.+.||+|.|++|.++++. ++..||||.+.++.... ..+.+|+.+|+.|.|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 468899999999999999999976 89999999998776543 45789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+.+|.+++++..... ..+..+..++.|+..|++|||+++ |||||||.+|||++.+..+||+|||++
T Consensus 135 eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccc
Confidence 99999999999987653 445777889999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..+.... ...+.||++.|.|||
T Consensus 203 ~~~~~~~---~lqt~cgsppyAaPE 224 (596)
T KOG0586|consen 203 TFFDYGL---MLQTFCGSPPYAAPE 224 (596)
T ss_pred eeecccc---cccccCCCCCccChH
Confidence 8876433 236789999999998
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=228.69 Aligned_cols=160 Identities=27% Similarity=0.349 Sum_probs=136.7
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
+.||+|+||.||++..+ ++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 78999999986432 23356788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~ 227 (246)
+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 9998886533 3788999999999999999999997 999999999999999999999999998753221
Q ss_pred ccccccccccccccccCCC
Q 025893 228 AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE 246 (246)
.. .....+||+.|+|||
T Consensus 149 ~~--~~~~~~gt~~y~aPE 165 (328)
T cd05593 149 AA--TMKTFCGTPEYLAPE 165 (328)
T ss_pred cc--ccccccCCcCccChh
Confidence 11 123467999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=236.79 Aligned_cols=168 Identities=24% Similarity=0.431 Sum_probs=147.8
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCe-eEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-RVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~ 141 (246)
++|...+++|+|+||.+++.+++ ++..+++|++...... +....+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999987 6788999999755433 3467889999999999999999999998888 89999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
+||+||++.+.|...++ ..++++.+..++.|++.|+.|||+.. |+|||||+.||++..++.|||+|||+|
T Consensus 84 ~Y~eGg~l~~~i~~~k~-------~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGla 153 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-------VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLA 153 (426)
T ss_pred eecCCCCHHHHHHHHhh-------ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhh
Confidence 99999999999987653 24889999999999999999999774 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.+..... ...+++|||.||+||
T Consensus 154 K~l~~~~~--~a~tvvGTp~YmcPE 176 (426)
T KOG0589|consen 154 KILNPEDS--LASTVVGTPYYMCPE 176 (426)
T ss_pred hhcCCchh--hhheecCCCcccCHH
Confidence 98765432 236789999999998
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=232.81 Aligned_cols=146 Identities=25% Similarity=0.362 Sum_probs=129.8
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|+..+.||+|+||.||++..+ +++.+|+|.+... ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 7889999998642 223456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred eCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence 9999999999986543 3788899999999999999999997 999999999999999999999999998
Q ss_pred CCC
Q 025893 222 NQA 224 (246)
Q Consensus 222 ~~~ 224 (246)
+..
T Consensus 149 ~~~ 151 (360)
T cd05627 149 TGL 151 (360)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=242.13 Aligned_cols=162 Identities=32% Similarity=0.510 Sum_probs=139.8
Q ss_pred hcCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCCC-H---HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQP-D---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~~-~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+-|..++.||.|+||.||.|+. ++.+.||||++..+-.. . .+++.|+..|++|.|||+|.+.|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466677899999999999995 48889999999755332 2 46789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|||- |+..|++.-.+. .+.+-.+..|+.+.+.||.|||+.+ .||||||..|||+.+.|.|||+|||.+
T Consensus 106 EYCl-GSAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred HHHh-ccHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccch
Confidence 9996 588888865442 3777788899999999999999997 999999999999999999999999987
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ..++++|||+|||||
T Consensus 174 si~~------PAnsFvGTPywMAPE 192 (948)
T KOG0577|consen 174 SIMA------PANSFVGTPYWMAPE 192 (948)
T ss_pred hhcC------chhcccCCccccchh
Confidence 6532 236899999999998
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=228.83 Aligned_cols=160 Identities=26% Similarity=0.352 Sum_probs=136.1
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
+.||+|+||.||++..+ ++..||+|.+.... .....+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999975 78999999986432 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~ 227 (246)
+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 9998886432 3788999999999999999999997 999999999999999999999999998753221
Q ss_pred ccccccccccccccccCCC
Q 025893 228 AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE 246 (246)
.. ......||+.|+|||
T Consensus 149 ~~--~~~~~~gt~~y~aPE 165 (323)
T cd05595 149 GA--TMKTFCGTPEYLAPE 165 (323)
T ss_pred CC--ccccccCCcCcCCcc
Confidence 11 123467999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=230.60 Aligned_cols=178 Identities=22% Similarity=0.428 Sum_probs=139.6
Q ss_pred HhcCCCCceeccCCceEEEEEEE------CCCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeCC-
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGT- 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~- 135 (246)
.++|++.+.||+|+||.||+|.+ .++..||+|.+...... ...+..|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46889999999999999999974 13567999998654322 35688999999999 8999999999887654
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCC-----------------------------------------------------C
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKG-----------------------------------------------------A 162 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~-----------------------------------------------------~ 162 (246)
..+++|||+++|+|.+++........ .
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999875321000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccccccccccccccc
Q 025893 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242 (246)
Q Consensus 163 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y 242 (246)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............+|+.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 00124778888999999999999999987 999999999999999999999999999765332222122334567899
Q ss_pred cCCC
Q 025893 243 HAPE 246 (246)
Q Consensus 243 ~aPE 246 (246)
+|||
T Consensus 243 ~aPE 246 (338)
T cd05102 243 MAPE 246 (338)
T ss_pred cCcH
Confidence 9998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=237.51 Aligned_cols=174 Identities=29% Similarity=0.493 Sum_probs=146.8
Q ss_pred HHHHHHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCC
Q 025893 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135 (246)
Q Consensus 59 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 135 (246)
.++++...+.+.+...||+|+||+||+|+|. ..||||.+...... .+.|++|+..+++-+|.||+-++|+|..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3455555667777889999999999999986 47999999766544 467999999999999999999999999888
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
. .||+-+|+|-+|+.+|+-.+. .|...+.+.|+.||++|+.|||.++ |||||||..||++.++++|||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred e-eeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEE
Confidence 7 899999999999999976542 3888899999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||||+................|...|||||
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPE 560 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPE 560 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHH
Confidence 9999987654433322234456888999998
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=225.75 Aligned_cols=147 Identities=27% Similarity=0.356 Sum_probs=130.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||.|.-|+||+++.+ ++..+|+|++.+.... ..+...|-+||+.++||++++++..+..+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 46777889999999999999987 6688999999765432 345667889999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|||+||+|..+.+.+. ...+++..++.++.+|+.||+|||-.| ||.|||||+||||.++|++.|+||.|+
T Consensus 157 eyCpGGdL~~LrqkQp-------~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-------GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred ecCCCccHHHHHhhCC-------CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccc
Confidence 9999999999887654 346999999999999999999999998 999999999999999999999999987
Q ss_pred CC
Q 025893 222 NQ 223 (246)
Q Consensus 222 ~~ 223 (246)
..
T Consensus 227 ~~ 228 (459)
T KOG0610|consen 227 LR 228 (459)
T ss_pred cc
Confidence 54
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=230.05 Aligned_cols=168 Identities=25% Similarity=0.290 Sum_probs=143.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||++..+ +++.+|+|.+..... ....+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999976 788999999865422 2345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence 99999999999975421 3788899999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
......... ......||+.|+|||
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE 173 (330)
T cd05601 150 ARLTANKMV-NSKLPVGTPDYIAPE 173 (330)
T ss_pred eECCCCCce-eeecccCCccccCHH
Confidence 765432221 223457999999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=227.37 Aligned_cols=158 Identities=23% Similarity=0.282 Sum_probs=135.4
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
||+|+||.||++... ++..+|+|.+... ......+..|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 6889999998643 22345677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~ 229 (246)
.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 81 FHHLQREG---------RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 99986532 3788899999999999999999997 99999999999999999999999999875432211
Q ss_pred ccccccccccccccCCC
Q 025893 230 RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ~~~~~~~~gt~~y~aPE 246 (246)
.....+||+.|+|||
T Consensus 149 --~~~~~~gt~~y~aPE 163 (312)
T cd05585 149 --KTNTFCGTPEYLAPE 163 (312)
T ss_pred --ccccccCCcccCCHH
Confidence 124567999999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=226.62 Aligned_cols=160 Identities=26% Similarity=0.352 Sum_probs=135.3
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
+.||+|+||.||++..+ ++..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999965 78899999986432 22356678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
+|.+++.... .+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9998886433 37889999999999999999997 55 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... ......||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (325)
T cd05594 149 DGA--TMKTFCGTPEYLAPE 166 (325)
T ss_pred CCc--ccccccCCcccCCHH
Confidence 111 123457999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=229.19 Aligned_cols=168 Identities=22% Similarity=0.285 Sum_probs=141.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||.||+++.+ +++.+|+|.+.+.. ...+.+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999976 68899999986421 22345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred ecCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence 9999999999986532 13788889999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
......... ......||+.|+|||
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE 173 (331)
T cd05597 150 LRLLADGTV-QSNVAVGTPDYISPE 173 (331)
T ss_pred eecCCCCCc-cccceeccccccCHH
Confidence 654322211 112346999999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=240.17 Aligned_cols=166 Identities=28% Similarity=0.494 Sum_probs=140.9
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC--CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEE
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------SRVL 139 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------~~~l 139 (246)
|.....||+|+||.||+++++ +|+.||||.+... ....+.+.+|+++|++|+|||||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445567999999999999965 8999999998653 345688899999999999999999998755433 4579
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCC--ceEE
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDD--VAKI 215 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~--~~~--~~kl 215 (246)
|||||.||+|...|+...+.. .|++..++.++.++..||.|||.++ |+||||||.||++. .+| .-||
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred EEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEee
Confidence 999999999999998765433 4999999999999999999999987 99999999999985 334 4799
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||.|+.+.... ...+++||+.|++||
T Consensus 166 tDfG~Arel~d~s---~~~S~vGT~~YLhPe 193 (732)
T KOG4250|consen 166 TDFGAARELDDNS---LFTSLVGTEEYLHPE 193 (732)
T ss_pred ecccccccCCCCC---eeeeecCchhhcChH
Confidence 9999999887654 346789999999997
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-34 Score=227.76 Aligned_cols=165 Identities=36% Similarity=0.551 Sum_probs=147.7
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
-|.+...||+|+||.||++.++ +|+.+|||++... .+..++..|+.+|++.+.|++|+++|.+.....+|+|||||-.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 4556678999999999999987 7999999998544 4667889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|++.++++.+. ..|++..+..++...+.||+|||... -+|||||..|||++.+|.+||+|||.+.++..
T Consensus 113 GSiSDI~R~R~--------K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 113 GSISDIMRARR--------KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred CcHHHHHHHhc--------CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 99999998765 25899999999999999999999985 89999999999999999999999999998765
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... .++++|||.|||||
T Consensus 182 TMAK--RNTVIGTPFWMAPE 199 (502)
T KOG0574|consen 182 TMAK--RNTVIGTPFWMAPE 199 (502)
T ss_pred hHHh--hCccccCcccccHH
Confidence 4433 46789999999998
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=230.62 Aligned_cols=159 Identities=25% Similarity=0.413 Sum_probs=136.3
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
++||.|.||+||-|.++ +|+.||||.+.+.. .....+++|+.||+++.||.||.+...|+..+.+++|||.+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 68999999999999976 89999999997643 3356788999999999999999999999999999999999965 5
Q ss_pred HHHHh-ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CceEEccccCCCCC
Q 025893 149 LHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIADFDLSNQA 224 (246)
Q Consensus 149 L~~~l-~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~---~~~kl~Dfgls~~~ 224 (246)
..+.| .+.+ ..|++.....++.||+.||.|||.++ |+|.||||+|+|+.+. ..+||+|||+|+..
T Consensus 649 MLEMILSsEk--------gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 649 MLEMILSSEK--------GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred HHHHHHHhhc--------ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec
Confidence 55554 3332 24888888899999999999999997 9999999999999753 48999999999987
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ...+++|||.|+|||
T Consensus 718 gEks---FRrsVVGTPAYLaPE 736 (888)
T KOG4236|consen 718 GEKS---FRRSVVGTPAYLAPE 736 (888)
T ss_pred chhh---hhhhhcCCccccCHH
Confidence 6433 346789999999998
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=228.81 Aligned_cols=168 Identities=21% Similarity=0.257 Sum_probs=141.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||+++.+ +++.+|+|.+.... .....+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999976 78889999886422 12345778899999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~gg~L~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred eCCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence 9999999999997532 13788888999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ .....+||+.|+|||
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE 173 (331)
T cd05624 150 LKMNQDGTV-QSSVAVGTPDYISPE 173 (331)
T ss_pred eeccCCCce-eeccccCCcccCCHH
Confidence 765332211 123457999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=221.95 Aligned_cols=166 Identities=26% Similarity=0.420 Sum_probs=139.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|.+.+.||+|+||.||+|..+ ++..||+|.+..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 47888999999999999999976 788999999864432 245677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~-~l~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 85 LDS-DLKQYLDNCG--------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred CCc-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceee
Confidence 975 9998886432 13678888999999999999999997 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE 173 (288)
T cd07871 153 KSVPTK--TYSNEVVTLWYRPPD 173 (288)
T ss_pred ccCCCc--cccCceecccccChH
Confidence 432111 123456899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=226.05 Aligned_cols=163 Identities=29% Similarity=0.458 Sum_probs=136.0
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHH---hcCCCCCccceEeEEEeCCeeEEE
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMV---SRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l---~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
|.+.+.||+|+||.||++..+ +++.+|+|.+.... ...+.+..|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999976 78999999986432 2234566666554 577899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|..++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence 9999999999887542 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... .....+||+.|+|||
T Consensus 148 ~~~~~~~~~--~~~~~~g~~~y~aPE 171 (324)
T cd05589 148 CKEGMGFGD--RTSTFCGTPEFLAPE 171 (324)
T ss_pred CccCCCCCC--cccccccCccccCHh
Confidence 875332211 124567999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=239.23 Aligned_cols=161 Identities=27% Similarity=0.442 Sum_probs=137.8
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEcCC-----CCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe--eEEEEec
Q 025893 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDA-----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS--RVLAYEF 143 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--~~lv~E~ 143 (246)
..+||+|.|-+||+|... +|-.||+-.++. +....+.|..|+.+|+.|+|||||+++.+|.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999975 788888765532 22234789999999999999999999999998766 6688999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls~ 222 (246)
+..|+|..|++..+. +.......+++||+.||.|||++ .|||+|||||.+||+|+. .|.|||+|+|||+
T Consensus 125 ~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred ccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence 999999999987763 66788889999999999999999 789999999999999985 6899999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ...++|||.|||||
T Consensus 195 l~r~s~----aksvIGTPEFMAPE 214 (632)
T KOG0584|consen 195 LLRKSH----AKSVIGTPEFMAPE 214 (632)
T ss_pred Hhhccc----cceeccCccccChH
Confidence 754332 35689999999998
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=224.52 Aligned_cols=164 Identities=28% Similarity=0.400 Sum_probs=130.2
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~ 141 (246)
.|...+++|.|+||.||+|... +++.+|||+.-.+.. .--+|+++|++++|||||++.-+|.... ...+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 5666789999999999999965 678999999854443 2236899999999999999998876432 334899
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgl 220 (246)
||++. +|.++++.... ....++...+.-++.||..||.|||+.+ |+||||||+|+|+|. .|.+||+|||.
T Consensus 102 eymP~-tL~~~~r~~~~-----~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTR-----ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HhchH-HHHHHHHHHhh-----cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCc
Confidence 99975 99999874211 0123566667789999999999999987 999999999999995 59999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+.+...... .+..-|..|.|||
T Consensus 173 AK~L~~~epn---iSYicSRyYRaPE 195 (364)
T KOG0658|consen 173 AKVLVKGEPN---ISYICSRYYRAPE 195 (364)
T ss_pred ceeeccCCCc---eeEEEeccccCHH
Confidence 9987654432 3445688999998
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=221.65 Aligned_cols=167 Identities=27% Similarity=0.425 Sum_probs=140.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|++.+.||+|+||.||+|..+ +++.+|+|.+..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 788999999864432 23467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+. ++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred CCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcce
Confidence 995 688888764321 3778888999999999999999997 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......||+.|+|||
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE 173 (303)
T cd07869 152 AKSVPSH--TYSNEVVTLWYRPPD 173 (303)
T ss_pred eccCCCc--cCCCCcccCCCCChH
Confidence 5432111 123456899999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=229.96 Aligned_cols=168 Identities=27% Similarity=0.391 Sum_probs=143.8
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999976 78999999986432 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence 9999999999987542 3788899999999999999999987 999999999999999999999999998
Q ss_pred CCCCccc---------------------------cccccccccccccccCCC
Q 025893 222 NQAPDMA---------------------------ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE 246 (246)
....... .........||+.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 7654322 001123457999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=236.65 Aligned_cols=171 Identities=18% Similarity=0.240 Sum_probs=141.5
Q ss_pred cCCCCceeccCCceEEEEEEEC-C-CCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~-~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.|.+.+.||+|+||.||+|... + +..+|+|.+...... ...+..|+.+++.++||||+++++++...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999865 4 677888876544322 345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 148 ~gg~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 148 SGGDLNKQIKQRLK-----EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred CCCCHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999988754321 1123788888999999999999999987 999999999999999999999999999865
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
............+||+.|+|||
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE 241 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPE 241 (478)
T ss_pred CCccccccccccCCCccccCHh
Confidence 4332222234567999999998
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=226.16 Aligned_cols=166 Identities=25% Similarity=0.320 Sum_probs=139.4
Q ss_pred cCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCee
Q 025893 68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR 137 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 137 (246)
+|.+.+.||+|+||.||+++.. ++..+|+|.+.... ...+.+..|+.+++.++ ||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999752 57889999885421 22356778999999995 99999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 99999999999999986543 3788899999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+++........ .....+||+.|+|||
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE 176 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPE 176 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHH
Confidence 9998764322211 123467999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=224.92 Aligned_cols=160 Identities=24% Similarity=0.329 Sum_probs=135.5
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++||+|+||.||++..+ ++..+|+|.+..... ....+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999976 788999999865322 234577899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 99998886432 3889999999999999999999997 99999999999999999999999999875321
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (329)
T cd05588 149 PGD--TTSTFCGTPNYIAPE 166 (329)
T ss_pred CCC--ccccccCCccccCHH
Confidence 111 124567999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=226.06 Aligned_cols=168 Identities=22% Similarity=0.281 Sum_probs=141.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||+++.+ ++..+|+|.+.+.. .....+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999976 67889999885321 12345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ey~~~g~L~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred eccCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence 9999999999997532 13788888999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......+||+.|+|||
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE 173 (332)
T cd05623 150 LKLMEDGT-VQSSVAVGTPDYISPE 173 (332)
T ss_pred eecccCCc-ceecccccCccccCHH
Confidence 75432211 1123457999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=224.18 Aligned_cols=160 Identities=26% Similarity=0.375 Sum_probs=134.6
Q ss_pred ceeccCCceEEEEEEEC----CCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 73 ALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+.||+|+||.||+++.. +++.+|+|.+.... .....+..|+.+++.++||||+++++.+..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999852 57889999886432 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... .+.+..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999986543 3677888889999999999999997 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE 170 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPE 170 (323)
T ss_pred cccCCC--cccccCCCccccChh
Confidence 322211 123457999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-34 Score=222.73 Aligned_cols=167 Identities=24% Similarity=0.406 Sum_probs=142.3
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC---CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
+.++|++...||+|.|+.|+++.++ +|+.+|+|.+... ....+++.+|+.|.+.|+||||+++++.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888889999999999999876 7999999987543 34567888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CceEEcc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIAD 217 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~---~~~kl~D 217 (246)
+|++.|++|..-|-.+. .+++..+..+++||+++|.|||.++ |||||+||+|+|+.+. .-+||+|
T Consensus 89 Fe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred EecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecc
Confidence 99999999986665442 3678888899999999999999997 9999999999999743 4699999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++..+.... ....++|||+|||||
T Consensus 157 FGvAi~l~~g~---~~~G~~GtP~fmaPE 182 (355)
T KOG0033|consen 157 FGLAIEVNDGE---AWHGFAGTPGYLSPE 182 (355)
T ss_pred cceEEEeCCcc---ccccccCCCcccCHH
Confidence 99998776222 234678999999998
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=222.95 Aligned_cols=166 Identities=27% Similarity=0.394 Sum_probs=143.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|++.+.||+|+||.||++..+ ++..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999976 788899998865432 23568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ .|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 84 HMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 999999999986543 3788889999999999999999853 39999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....||+.|+|||
T Consensus 153 ~~~~~~----~~~~~g~~~y~aPE 172 (331)
T cd06649 153 QLIDSM----ANSFVGTRSYMSPE 172 (331)
T ss_pred cccccc----cccCCCCcCcCCHh
Confidence 653221 23457999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=223.77 Aligned_cols=165 Identities=26% Similarity=0.303 Sum_probs=138.2
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCC-CccceEeEEEeCCeeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHE-NFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~ 141 (246)
+|.+.+.||+|+||.||+|..+ +++.+|+|.+.+.. ...+.+..|+.++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999976 67889999986432 2345677899999999865 5888999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 9999999999886543 3788899999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .....+||+.|+|||
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE 171 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPE 171 (324)
T ss_pred eecCCCCC--ceeeecCCccccChh
Confidence 65321111 123467999999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=242.85 Aligned_cols=178 Identities=28% Similarity=0.487 Sum_probs=146.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
+.+....+.||+|.||+||+|+.. +...||||.++.... ...+|.+|++++..|+|||||+++|+|..++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345555678999999999999843 245699999975543 357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCC-C----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQ-P----GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~-~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
++|+|||..|||.++|+......... . .+.|+..+.+.|+.|||.||.||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999998665432211 1 234889999999999999999999984 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+|||+++...............=...||+||
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE 675 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE 675 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence 9999999999876555443331223357899998
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=222.65 Aligned_cols=160 Identities=27% Similarity=0.355 Sum_probs=132.7
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhc-CCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSR-LKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|... +++.||+|.+.... ...+.+..|..++.. ++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 68889999886432 223445566666654 4799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 99999886542 3788888999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.. ......+||+.|+|||
T Consensus 149 ~~--~~~~~~~gt~~y~aPE 166 (316)
T cd05592 149 GE--GKASTFCGTPDYIAPE 166 (316)
T ss_pred CC--CccccccCCccccCHH
Confidence 22 1224567999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-33 Score=230.55 Aligned_cols=165 Identities=32% Similarity=0.494 Sum_probs=144.8
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.|.....||+|+||.||+|... +++.||+|.+..... ..+++.+|+.++.+++++||.++++.+..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 5666678999999999999954 899999999976543 4578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
.||++.+.++... .+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++.++
T Consensus 94 ~gGsv~~lL~~~~---------~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN---------ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred cCcchhhhhccCC---------CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence 9999999987543 3466666778999999999999997 999999999999999999999999999887
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ..+++|||.|||||
T Consensus 162 ~~~~~r--r~tfvGTPfwMAPE 181 (467)
T KOG0201|consen 162 TNTVKR--RKTFVGTPFWMAPE 181 (467)
T ss_pred echhhc--cccccccccccchh
Confidence 654433 37899999999998
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=222.79 Aligned_cols=166 Identities=28% Similarity=0.422 Sum_probs=142.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|++.+.||+|+||.||++..+ ++..+|+|.+...... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999976 7888999987654322 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++.... .+++..+..++.+++.||.|||+.. .|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 84 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 999999999986543 3778888899999999999999752 39999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....||+.|+|||
T Consensus 153 ~~~~~~----~~~~~~~~~y~aPE 172 (333)
T cd06650 153 QLIDSM----ANSFVGTRSYMSPE 172 (333)
T ss_pred hhhhhc----cccCCCCccccCHH
Confidence 543211 23457999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=223.39 Aligned_cols=160 Identities=24% Similarity=0.333 Sum_probs=134.5
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||++..+ +++.+|+|.+.+... ....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 788999999865321 234567788888776 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|..++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 99998886432 3788999999999999999999997 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (329)
T cd05618 149 PGD--TTSTFCGTPNYIAPE 166 (329)
T ss_pred CCC--ccccccCCccccCHH
Confidence 111 124567999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=226.83 Aligned_cols=162 Identities=28% Similarity=0.415 Sum_probs=136.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|+..+.||+|+||.||++... +++.||+|.+...... ...+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 46677788999999999999976 7899999998644322 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+.+++|.+.. .+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 154 ~~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 154 MDGGSLEGTH-------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217 (353)
T ss_pred CCCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccccee
Confidence 9999986432 2456777889999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 218 ~~~~~~--~~~~~~gt~~y~aPE 238 (353)
T PLN00034 218 LAQTMD--PCNSSVGTIAYMSPE 238 (353)
T ss_pred cccccc--cccccccCccccCcc
Confidence 532211 123457999999998
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=222.69 Aligned_cols=160 Identities=24% Similarity=0.336 Sum_probs=134.4
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|..+ +++.+|+|.+.... ...+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 68899999986432 2234567788888765 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|..++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 99998886543 3788889999999999999999997 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... ......||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (321)
T cd05591 149 NGV--TTTTFCGTPDYIAPE 166 (321)
T ss_pred CCc--cccccccCccccCHH
Confidence 211 124567999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=222.53 Aligned_cols=165 Identities=26% Similarity=0.306 Sum_probs=137.8
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+|.+.+.||+|+||.||+|+.+ ++..+|+|.+.+.. .....+..|..++..+. ||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5778899999999999999976 67899999986432 12344667777877774 899999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence 9999999999886543 3788899999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+...... ......+||+.|+|||
T Consensus 149 ~~~~~~~--~~~~~~~gt~~y~aPE 171 (323)
T cd05616 149 KENMWDG--VTTKTFCGTPDYIAPE 171 (323)
T ss_pred eecCCCC--CccccCCCChhhcCHH
Confidence 7533211 1224567999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=227.74 Aligned_cols=170 Identities=28% Similarity=0.414 Sum_probs=143.6
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+...+.+.||+|.||.|.++....+..||+|.++.... .+.+|..|+.+|.+|+|||||+++|+|..++.+++++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 44556778999999999999988789999999986543 3578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++...... .+.-...++|+.||+.||+||.+.+ +|||||.++|||++.++++||+|||+++.+
T Consensus 618 EnGDLnqFl~aheap-------t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-------TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hcCcHHHHHHhccCc-------ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 999999999876422 1334455679999999999999986 999999999999999999999999999976
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........-..++-...|||||
T Consensus 688 ysg~yy~vqgr~vlpiRwmawE 709 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWE 709 (807)
T ss_pred ccCCceeeecceeeeeeehhHH
Confidence 6544433223445567899987
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=221.37 Aligned_cols=160 Identities=26% Similarity=0.383 Sum_probs=132.7
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||+||+|..+ +++.+|+|.+.... .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999976 78999999986432 12234455544 56889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 99999886533 3788888999999999999999997 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.. ......+||+.|+|||
T Consensus 149 ~~--~~~~~~~gt~~y~aPE 166 (323)
T cd05575 149 HS--KTTSTFCGTPEYLAPE 166 (323)
T ss_pred CC--CccccccCChhhcChh
Confidence 11 1224567999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=222.26 Aligned_cols=160 Identities=28% Similarity=0.370 Sum_probs=134.5
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|+.+ +++.+|+|.+.... ...+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 68899999986432 2335667788888776 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQKSR---------RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 99999886543 3788899999999999999999997 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... ......||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (320)
T cd05590 149 NGK--TTSTFCGTPDYIAPE 166 (320)
T ss_pred CCC--cccccccCccccCHH
Confidence 111 124467999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=226.11 Aligned_cols=178 Identities=24% Similarity=0.419 Sum_probs=140.9
Q ss_pred HhcCCCCceeccCCceEEEEEEE------CCCCEEEEEEcCCCCC--CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+|.+ .++..||+|.+..... ..+.+.+|+.++..+ +||||+++++++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999963 2356799999865432 345688999999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCC-------------------------------------------------------
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKG------------------------------------------------------- 161 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~------------------------------------------------------- 161 (246)
.++||||+++|+|.+++........
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999865321000
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccc
Q 025893 162 -----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (246)
Q Consensus 162 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~ 230 (246)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 001124788899999999999999999987 999999999999999999999999998765432221
Q ss_pred cccccccccccccCCC
Q 025893 231 LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 231 ~~~~~~~gt~~y~aPE 246 (246)
.......+++.|+|||
T Consensus 271 ~~~~~~~~~~~y~aPE 286 (375)
T cd05104 271 VVKGNARLPVKWMAPE 286 (375)
T ss_pred cccCCCCCCcceeChh
Confidence 1112234567899998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=218.41 Aligned_cols=166 Identities=25% Similarity=0.372 Sum_probs=140.3
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
+|+..+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778889999999999999965 788999999865322 12456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999988754321 13788999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....||+.|+|||
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE 171 (285)
T cd05605 151 EIPEGET---IRGRVGTVGYMAPE 171 (285)
T ss_pred ecCCCCc---cccccCCCCccCcH
Confidence 6432221 13457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=226.71 Aligned_cols=161 Identities=22% Similarity=0.274 Sum_probs=137.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
..|.+.+.||+|+||.||++... +++.||+|... ...+.+|+.++++|+||||+++++++......++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 57999999999999999999965 78899999653 2356789999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 167 -~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 167 -TDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred -CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 68988886543 3788899999999999999999997 9999999999999999999999999986532
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......+||+.|+|||
T Consensus 234 ~~~~-~~~~~~~gt~~y~aPE 253 (391)
T PHA03212 234 DINA-NKYYGWAGTIATNAPE 253 (391)
T ss_pred cccc-cccccccCccCCCChh
Confidence 2111 1123467999999998
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=221.35 Aligned_cols=160 Identities=25% Similarity=0.351 Sum_probs=135.9
Q ss_pred ceeccCCceEEEEEEE----CCCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 73 ALIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~----~~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+.||+|+||.||+++. .+++.+|+|.+..... ....+..|+.++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 2578999999864322 23456789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 999999986432 3789999999999999999999997 9999999999999999999999999987643
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......||+.|+|||
T Consensus 150 ~~~~--~~~~~~g~~~y~aPE 168 (318)
T cd05582 150 DHEK--KAYSFCGTVEYMAPE 168 (318)
T ss_pred CCCC--ceecccCChhhcCHH
Confidence 3211 123467999999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=222.28 Aligned_cols=165 Identities=25% Similarity=0.311 Sum_probs=138.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+|+..+.||+|+||.||+|..+ +++.||+|.+.... ...+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999976 78899999986432 22345777888888886 577888999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence 9999999999986543 3889999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ......||+.|+|||
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE 171 (323)
T cd05615 149 KEHMVDGV--TTRTFCGTPDYIAPE 171 (323)
T ss_pred cccCCCCc--cccCccCCccccCHH
Confidence 75432211 123467999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=221.76 Aligned_cols=160 Identities=26% Similarity=0.384 Sum_probs=132.7
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||++..+ +++.+|+|.+.... .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999975 78999999986432 12234555554 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 99998886533 3788999999999999999999997 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (325)
T cd05604 149 QSD--TTTTFCGTPEYLAPE 166 (325)
T ss_pred CCC--CcccccCChhhCCHH
Confidence 111 124567999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=220.95 Aligned_cols=160 Identities=26% Similarity=0.353 Sum_probs=133.5
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhc-CCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSR-LKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|..+ ++..+|+|.+.... .....+..|..++.. ++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999976 78899999986432 233456677777765 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 99999886532 3788889999999999999999997 99999999999999999999999999874321
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.. ......+||+.|+|||
T Consensus 149 ~~--~~~~~~~gt~~y~aPE 166 (316)
T cd05620 149 GD--NRASTFCGTPDYIAPE 166 (316)
T ss_pred CC--CceeccCCCcCccCHH
Confidence 11 1224567999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=221.14 Aligned_cols=160 Identities=26% Similarity=0.384 Sum_probs=132.0
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|+.. +++.+|+|.+.+.. .....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 68899999986432 12234555554 67889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|...+.... .+.+..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 99998886432 3778888889999999999999987 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (321)
T cd05603 149 PEE--TTSTFCGTPEYLAPE 166 (321)
T ss_pred CCC--ccccccCCcccCCHH
Confidence 111 224567999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=218.06 Aligned_cols=167 Identities=28% Similarity=0.391 Sum_probs=139.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|.+.+.||+|+||.||+++.+ +++.+|+|++..... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999986 688899999865432 24567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|++++.+..+..... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 999877665543221 3788889999999999999999987 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......||+.|+|||
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE 171 (287)
T cd07848 149 NLSEGSNA-NYTEYVATRWYRSPE 171 (287)
T ss_pred cccccccc-cccccccccccCCcH
Confidence 75432211 123457999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=227.63 Aligned_cols=168 Identities=26% Similarity=0.400 Sum_probs=149.0
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
+..-|.+.+.||+|.|..|-+|++- +|..||||++.+.+.+ ...+.+|+..|+-++|||||+++++...+..+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4567888999999999999999965 8999999999877654 35788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCceEEcccc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFD 219 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~-~~~~~kl~Dfg 219 (246)
+|.-.+|+|++||-.+.. .+.+....+++.||+.|+.|||.. ++|||||||+|+.+. ..|.+||.|||
T Consensus 96 LELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 999999999999976542 488999999999999999999987 599999999999887 57999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+..+..... ..+.||+..|-|||
T Consensus 165 FSNkf~PG~k---L~TsCGSLAYSAPE 188 (864)
T KOG4717|consen 165 FSNKFQPGKK---LTTSCGSLAYSAPE 188 (864)
T ss_pred ccccCCCcch---hhcccchhhccCch
Confidence 9987765443 36789999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=226.54 Aligned_cols=178 Identities=27% Similarity=0.457 Sum_probs=140.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|++.+.||+|+||.||++... ++..||+|.+...... .+.+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 458889999999999999998742 2357999998654332 35678899999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCC---------------------------------------------------------
Q 025893 137 RVLAYEFASNGSLHDILHGRKGV--------------------------------------------------------- 159 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~--------------------------------------------------------- 159 (246)
.++||||+++|+|.+++......
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998643210
Q ss_pred ----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccccccccc
Q 025893 160 ----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235 (246)
Q Consensus 160 ----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~ 235 (246)
........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 00001124788889999999999999999997 99999999999999999999999999876543222111122
Q ss_pred ccccccccCCC
Q 025893 236 VLGTFGYHAPE 246 (246)
Q Consensus 236 ~~gt~~y~aPE 246 (246)
..+++.|||||
T Consensus 274 ~~~~~~y~aPE 284 (374)
T cd05106 274 ARLPVKWMAPE 284 (374)
T ss_pred CCCccceeCHH
Confidence 34567899998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=220.01 Aligned_cols=167 Identities=26% Similarity=0.345 Sum_probs=144.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
-++|+.+++||+|.||+|.+++-+ +++.+|+|++++.-. ....-+.|-++|+.-+||++..+.-.|+..+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 468889999999999999999976 899999999876432 234456788999999999999999899999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||..||.|.-.|...+ .+++...+.+-.+|+.||.|||+++ ||.||||.+|+|+|.+|++||.|||+
T Consensus 247 MeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred EEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeeccc
Confidence 99999999988886544 4788888889999999999999986 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++..-... ....++||||.|+|||
T Consensus 315 CKE~I~~g--~t~kTFCGTPEYLAPE 338 (516)
T KOG0690|consen 315 CKEEIKYG--DTTKTFCGTPEYLAPE 338 (516)
T ss_pred chhccccc--ceeccccCChhhcCch
Confidence 98643322 2347899999999998
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=221.43 Aligned_cols=160 Identities=24% Similarity=0.361 Sum_probs=131.4
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+++.+ +++.+|+|.+.... .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 67889999986432 12234444443 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 99999986543 3677888889999999999999997 99999999999999999999999999875422
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (325)
T cd05602 149 HNG--TTSTFCGTPEYLAPE 166 (325)
T ss_pred CCC--CcccccCCccccCHH
Confidence 111 224567999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=211.46 Aligned_cols=168 Identities=27% Similarity=0.476 Sum_probs=143.0
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|.+.+.||+|+||.||++.++++..+|+|.+.......+.+..|+.++++++||||+++++++......+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46778889999999999999988778899999876666677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.+||+|||+++....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999865321 3788889999999999999999987 99999999999999999999999999876532
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......++..|+|||
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE 171 (256)
T cd05114 153 DEYT-SSSGAKFPVKWSPPE 171 (256)
T ss_pred Ccee-ccCCCCCchhhCChh
Confidence 2211 112233567899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=220.33 Aligned_cols=160 Identities=27% Similarity=0.374 Sum_probs=133.5
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhc-CCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSR-LKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||+||+|... +++.+|+|.+.... .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 67899999986432 233456667777775 5899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 99999986532 3788888999999999999999997 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... ......||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (316)
T cd05619 149 GDA--KTCTFCGTPDYIAPE 166 (316)
T ss_pred CCC--ceeeecCCccccCHH
Confidence 111 123567999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=226.02 Aligned_cols=163 Identities=25% Similarity=0.274 Sum_probs=137.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
..|.+.+.||+|+||.||++.+. +++.||+|... ...+.+|+.++++|+|||||++++++......++|||++.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 46888999999999999999976 67889999632 2345689999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 244 -~~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 244 -SDLYTYLGARL--------RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred -CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 68988886432 13889999999999999999999997 9999999999999999999999999987653
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
............||+.|+|||
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE 332 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPE 332 (461)
T ss_pred cccccccccccCCCcCCcCHH
Confidence 322111123457999999998
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=221.38 Aligned_cols=166 Identities=26% Similarity=0.422 Sum_probs=136.4
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 138 (246)
.|.+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778889999999999999965 78999999986432 22346788999999999999999999886432 479
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+||||+. ++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence 9999995 68998886432 3788999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCcccc-ccccccccccccccCCC
Q 025893 219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
|+++....... ........||+.|+|||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE 176 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPE 176 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHH
Confidence 99875432211 11123457999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=233.11 Aligned_cols=174 Identities=21% Similarity=0.296 Sum_probs=142.8
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCC-----
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT----- 135 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 135 (246)
..++|.+.+.||+|+||.||+++.. +++.||+|.+...... ...+.+|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3568999999999999999999865 7899999998655433 345778999999999999999988765432
Q ss_pred ---eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 136 ---SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 136 ---~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
.+++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~-----~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAK-----TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 36799999999999999865431 1124888899999999999999999986 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++..............+||+.|+|||
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE 215 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHH
Confidence 9999999997654332222234568999999998
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=215.59 Aligned_cols=162 Identities=25% Similarity=0.358 Sum_probs=135.2
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
||+|+||+||++..+ +++.+|+|.+..... ..+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 788999999864332 124567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~ 229 (246)
.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 81 RYHIYNVDE-----ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 888753221 1124889999999999999999999997 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCCC
Q 025893 230 RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ~~~~~~~~gt~~y~aPE 246 (246)
......||+.|+|||
T Consensus 153 --~~~~~~g~~~y~aPE 167 (280)
T cd05608 153 --KTKGYAGTPGFMAPE 167 (280)
T ss_pred --cccccCCCcCccCHH
Confidence 123457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=220.40 Aligned_cols=160 Identities=24% Similarity=0.326 Sum_probs=135.0
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||++..+ +++.+|+|.+..... ....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 678999999865422 234577888888888 599999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 99998886432 3889999999999999999999997 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (327)
T cd05617 149 PGD--TTSTFCGTPNYIAPE 166 (327)
T ss_pred CCC--ceecccCCcccCCHH
Confidence 111 124567999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=224.02 Aligned_cols=178 Identities=23% Similarity=0.402 Sum_probs=141.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCC-CCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 136 (246)
.+.|.+.+.||+|+||.||+|... .+..||+|.+...... .+.+.+|+.+++++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999853 1346999998654332 457889999999996 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCC-------------------------------------------------------
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKG------------------------------------------------------- 161 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~------------------------------------------------------- 161 (246)
.|+|||||++|+|.+++........
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864321000
Q ss_pred --------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 025893 162 --------------------------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 162 --------------------------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~ 209 (246)
......+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 000124788888999999999999999986 999999999999999
Q ss_pred CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||+++...............+++.|+|||
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 9999999999987653322221223345778999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=216.81 Aligned_cols=168 Identities=27% Similarity=0.456 Sum_probs=137.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC----EEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+|+..+.||+|+||.||+|.+. ++. .+|+|.+..... ...++..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57899999999999999999864 444 389999864432 246788999999999999999999999764 5678
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
++||+++|+|.+++..... .+++...+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred eeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccc
Confidence 9999999999999875431 3778888999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...............++..|+|||
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE 181 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALE 181 (316)
T ss_pred ccccccCCCcceeccCCccceeecChH
Confidence 998764332221112233567899998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=215.86 Aligned_cols=168 Identities=29% Similarity=0.407 Sum_probs=141.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC---CCCHHHHHHHHHHHhcCCCCCccceEeEEEe-----CCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-----GTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 136 (246)
...|...+.||+|.||.|..+..+ +|..||||++... ....++..+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666788999999999999976 8999999999632 2345778899999999999999999998875 356
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
+|+|+|+|+ -+|.+.++... .|+...+..++.|++.||+|+|+.+ |+||||||.|+|++.+..+||+
T Consensus 101 vYiV~elMe-tDL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence 799999994 59999998654 3888999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+|+...........+..+.|.+|.|||
T Consensus 168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPE 197 (359)
T KOG0660|consen 168 DFGLARYLDKFFEDGFMTEYVATRWYRAPE 197 (359)
T ss_pred cccceeeccccCcccchhcceeeeeecCHH
Confidence 999999875331222235567899999998
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=219.07 Aligned_cols=158 Identities=25% Similarity=0.284 Sum_probs=130.9
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcC---CCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL---KHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
||+|+||+||+|+.+ ++..+|+|.+..... ....+..|..++..+ .||||+++++.+......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 789999999864321 123345566666655 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 99998886533 3788999999999999999999997 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (330)
T cd05586 149 DNK--TTNTFCGTTEYLAPE 166 (330)
T ss_pred CCC--CccCccCCccccCHH
Confidence 211 124567999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=235.96 Aligned_cols=167 Identities=26% Similarity=0.432 Sum_probs=142.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCC-CCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+.|.+...||.|.||+||+|..+ ++-..|.|.+.. +....++++.||.||...+||+||++++.|..++.+|+..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34555667999999999999977 455667787753 3445688999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
.||....++-... ..|.+.++..++.|++.||.|||++. |||||||..|||+..+|.++|+|||.+...
T Consensus 112 ~GGAVDaimlEL~--------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred CCchHhHHHHHhc--------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 9999988776543 24899999999999999999999996 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ....+++|||+|||||
T Consensus 181 ~~t~--qkRDsFIGTPYWMAPE 200 (1187)
T KOG0579|consen 181 KSTR--QKRDSFIGTPYWMAPE 200 (1187)
T ss_pred hhHH--hhhccccCCcccccch
Confidence 4322 2345789999999998
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=217.84 Aligned_cols=160 Identities=27% Similarity=0.361 Sum_probs=134.7
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||+||++..+ ++..+|+|.+.+.. .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 68899999986432 2335567788888877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|..++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 99998886542 3889999999999999999999997 99999999999999999999999999865322
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~g~~~y~aPE 166 (318)
T cd05570 149 GGV--TTSTFCGTPDYIAPE 166 (318)
T ss_pred CCC--cccceecCccccCHH
Confidence 111 123457999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=209.99 Aligned_cols=168 Identities=27% Similarity=0.416 Sum_probs=138.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|++.+.||+|+||.||+|.++ .+..+|+|.+...... ...+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 57888899999999999999753 3567999998754322 35688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+|++|||.
T Consensus 85 ~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EEeCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence 99999999999986532 13789999999999999999999987 99999999999999999999999998
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+......... ......+++.|+|||
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE 178 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPE 178 (266)
T ss_pred cccccccchh-cccCCCCceeecCHH
Confidence 7653221111 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=209.81 Aligned_cols=170 Identities=25% Similarity=0.452 Sum_probs=144.2
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|++.+.||+|+||.||+|...++..+|+|.+.......+.+..|+.++++++||||+++++.+...+..++++||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35788899999999999999998778889999987655556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 85 ~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 85 KGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence 9999999865422 23778888999999999999999986 9999999999999999999999999997654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|+|||
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE 174 (261)
T cd05072 155 DNEYT-AREGAKFPIKWTAPE 174 (261)
T ss_pred CCcee-ccCCCccceecCCHH
Confidence 32211 112234667899998
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=208.24 Aligned_cols=170 Identities=26% Similarity=0.476 Sum_probs=143.6
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|++.+.||+|+||.||+|...++..+|+|.+.......+++.+|+.++++++||||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45788899999999999999998777889999987766667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 85 YGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999865431 23789999999999999999999987 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .......+..|+|||
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE 174 (261)
T cd05068 155 EDIYE-AREGAKFPIKWTAPE 174 (261)
T ss_pred CCccc-ccCCCcCceeccCcc
Confidence 22111 011112345799998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=211.24 Aligned_cols=179 Identities=25% Similarity=0.415 Sum_probs=142.2
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
..++|++.+.||+|+||.||+|..+ ++..+|+|.+..... ...++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568999999999999999998753 245799998854332 23468899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
.++||||+++++|.+++....... .......+.+..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986543211 1111234678888999999999999999986 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++...............+++.|+|||
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 9999987654322221122335678899998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=243.97 Aligned_cols=172 Identities=26% Similarity=0.289 Sum_probs=150.7
Q ss_pred HHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 62 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
++.-.++|.+.++||+|+||.|.+++++ +++.+|+|++.+. .....-|+.|-.+|..-+.+.|+.++-+|.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3334679999999999999999999987 7889999998752 2345678889999999899999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
+|+||||++||+|..++.... .+++..++.|+..|+.||.-+|+.| +|||||||+|||+|..|++||+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence 999999999999999997643 3889999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||.|-.+...+. ..+...+|||-|++||
T Consensus 218 DFGsClkm~~dG~-V~s~~aVGTPDYISPE 246 (1317)
T KOG0612|consen 218 DFGSCLKMDADGT-VRSSVAVGTPDYISPE 246 (1317)
T ss_pred cchhHHhcCCCCc-EEeccccCCCCccCHH
Confidence 9999877654433 3456778999999998
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=211.73 Aligned_cols=165 Identities=24% Similarity=0.359 Sum_probs=139.1
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
|+..+.||+|+||+||++... +++.+|+|.+..... ....+..|+.++++++|+||+.+.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999975 788999999865432 124567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+|||++..
T Consensus 82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 82 MNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred ccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCccee
Confidence 999999988854321 13889999999999999999999997 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....|++.|+|||
T Consensus 152 ~~~~~~---~~~~~g~~~~~aPE 171 (285)
T cd05632 152 IPEGES---IRGRVGTVGYMAPE 171 (285)
T ss_pred cCCCCc---ccCCCCCcCccChH
Confidence 432211 13457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=207.65 Aligned_cols=167 Identities=27% Similarity=0.467 Sum_probs=141.0
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
+|++.+.||+|+||.||++.++++..+|+|.+.........+..|+.++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 57788899999999999999877778999998766566678889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~ 227 (246)
+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 85 CLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999865431 3789999999999999999999997 999999999999999999999999998764322
Q ss_pred ccccccccccccccccCCC
Q 025893 228 AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE 246 (246)
... ......++..|+|||
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe 171 (256)
T cd05059 154 QYT-SSQGTKFPVKWAPPE 171 (256)
T ss_pred ccc-ccCCCCCCccccCHH
Confidence 111 111122345799997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=213.44 Aligned_cols=166 Identities=25% Similarity=0.418 Sum_probs=139.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|.+.+.||+|+||.||+|..+ ++..+|+|.+..... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999976 788899999864432 235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 86 LDK-DLKQYMDDCG--------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred CCC-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccccee
Confidence 975 8888875432 13778888899999999999999997 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+|+.|+|||
T Consensus 154 ~~~~~~--~~~~~~~~~~y~aPE 174 (309)
T cd07872 154 KSVPTK--TYSNEVVTLWYRPPD 174 (309)
T ss_pred cCCCcc--ccccccccccccCCH
Confidence 432211 112346899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=211.99 Aligned_cols=166 Identities=28% Similarity=0.456 Sum_probs=133.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC--CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcC---CCCCccceEeEEE-----e
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL---KHENFVQLLGYCV-----D 133 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~--~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l---~hp~iv~~~~~~~-----~ 133 (246)
++|++.+.||+|+||.||+|... .+..+|+|.+..... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 467899998864322 234566777776665 6999999999885 2
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
....++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence 456889999996 699998865321 23788999999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||+++..... .......||+.|+|||
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE 179 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPE 179 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChH
Confidence 99999998764322 1224557999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=211.79 Aligned_cols=165 Identities=25% Similarity=0.359 Sum_probs=139.0
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
|+..+.||+|+||.||++... +++.+|+|.+...... ...+..|+.++++++|++|+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999976 7889999988654322 23567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 82 ~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 82 MNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred cCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 999999998854321 13788899999999999999999986 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....||+.|+|||
T Consensus 152 ~~~~~~---~~~~~g~~~y~aPE 171 (285)
T cd05630 152 VPEGQT---IKGRVGTVGYMAPE 171 (285)
T ss_pred cCCCcc---ccCCCCCccccChH
Confidence 432221 13347999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=209.98 Aligned_cols=159 Identities=26% Similarity=0.349 Sum_probs=133.3
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
||+|+||.||++..+ +++.+|+|.+..... ....+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999975 789999999864321 233456799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~ 229 (246)
.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 81 KYHIYNVGE-------RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred HHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence 988754321 13778888899999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCCC
Q 025893 230 RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ~~~~~~~~gt~~y~aPE 246 (246)
.....||+.|+|||
T Consensus 151 ---~~~~~~~~~y~aPE 164 (277)
T cd05607 151 ---ITQRAGTNGYMAPE 164 (277)
T ss_pred ---eeccCCCCCccCHH
Confidence 13356899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=206.94 Aligned_cols=168 Identities=27% Similarity=0.456 Sum_probs=141.9
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|.+.+.||+|+||.||++.+..+..+|+|.+.......+.+.+|+.++++++||||+++++++......+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46778889999999999999887667799999876666677899999999999999999999999988999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..... .+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999865321 3788999999999999999999987 99999999999999999999999999875433
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......++..|+|||
T Consensus 153 ~~~~-~~~~~~~~~~y~~pe 171 (256)
T cd05113 153 DEYT-SSVGSKFPVRWSPPE 171 (256)
T ss_pred Ccee-ecCCCccChhhCCHH
Confidence 2211 111223567799997
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=211.74 Aligned_cols=165 Identities=27% Similarity=0.413 Sum_probs=140.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+|++++++++||||+++++.+..++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999976 6888899987644222 35678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... .+++..+..++.|++.||.|||++. .++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 81 MDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 99999999996542 3788889999999999999999742 399999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....|++.|+|||
T Consensus 150 ~~~~~----~~~~~~~~~~~aPE 168 (308)
T cd06615 150 LIDSM----ANSFVGTRSYMSPE 168 (308)
T ss_pred ccccc----cccCCCCcCccChh
Confidence 43221 23467899999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=215.55 Aligned_cols=169 Identities=28% Similarity=0.472 Sum_probs=141.0
Q ss_pred HHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHh--cCCCCCccceEeEEEeC----CeeE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVS--RLKHENFVQLLGYCVDG----TSRV 138 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~--~l~hp~iv~~~~~~~~~----~~~~ 138 (246)
+..+..+.+.||+|.||+||+|+++ |+.||||.+. ..+++.+.+|.++.+ .|+|+||+.+.+.-..+ .++|
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~--srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS--SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEec--ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 4556777889999999999999998 8899999984 334567888887775 56899999999886544 3679
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeeeCCCCCCCeEecCCCce
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-----KADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-----~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
||++|.+.|+|+|||... +++....++++..++.||.+||- +|.|.|.|||||..|||+..++..
T Consensus 286 LvTdYHe~GSL~DyL~r~----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred EeeecccCCcHHHHHhhc----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 999999999999999764 48889999999999999999994 678899999999999999999999
Q ss_pred EEccccCCCCCCcc--ccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDM--AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~--~~~~~~~~~~gt~~y~aPE 246 (246)
-|+|+|||...... ......+..+||-.|||||
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPE 390 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPE 390 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChH
Confidence 99999998653322 1122335678999999998
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=234.30 Aligned_cols=177 Identities=23% Similarity=0.336 Sum_probs=142.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||.||+|... +++.||+|++...... .+++.+|+.++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999976 7899999998654222 356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 142 EFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||++|++|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864321110 001123567778899999999999999997 9999999999999999999999999
Q ss_pred CCCCCCcccc----------------ccccccccccccccCCC
Q 025893 220 LSNQAPDMAA----------------RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~----------------~~~~~~~~gt~~y~aPE 246 (246)
+++....... .......+||+.|||||
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE 201 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence 9976521100 00112357999999998
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=208.56 Aligned_cols=166 Identities=28% Similarity=0.429 Sum_probs=131.8
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCC
Q 025893 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 2346888877544322 3467889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccc
Q 025893 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (246)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~ 228 (246)
|.+++....... ...+.+...+.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 82 LKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred HHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 999997644211 122467778899999999999999997 9999999999999999999999999986543222
Q ss_pred cccccccccccccccCCC
Q 025893 229 ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE 246 (246)
.........+++.|+|||
T Consensus 155 ~~~~~~~~~~~~~y~aPE 172 (269)
T cd05042 155 YYITKDCHAVPLRWLAPE 172 (269)
T ss_pred heeccCCCCCcccccCHH
Confidence 111122334677899997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=224.46 Aligned_cols=166 Identities=25% Similarity=0.339 Sum_probs=132.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeC--------Ce
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--------TS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--------~~ 136 (246)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 457999999999999999999975 78899999885432 2345699999999999999999887532 24
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEE
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKI 215 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl 215 (246)
+++||||+++ +|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYAR-----NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceee
Confidence 6789999975 77776643211 1124888899999999999999999997 99999999999999654 7999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++....... .....||+.|+|||
T Consensus 213 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE 240 (440)
T PTZ00036 213 CDFGSAKNLLAGQR---SVSYICSRFYRAPE 240 (440)
T ss_pred eccccchhccCCCC---cccCCCCcCccCHH
Confidence 99999986543221 23457899999998
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=208.86 Aligned_cols=177 Identities=29% Similarity=0.488 Sum_probs=141.5
Q ss_pred hcCCCCceeccCCceEEEEEEECC-C-----CEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS-G-----HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
++|++.+.||+|+||.||+|.... + ..+++|.+...... ...+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478888999999999999998642 2 46899988644322 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGA-------QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
+++||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999754321110 01134788889999999999999999997 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+++...............+++.|+|||
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPE 196 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHH
Confidence 99999999987543222111223345788999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=220.64 Aligned_cols=166 Identities=36% Similarity=0.520 Sum_probs=138.1
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHh--cCCCCCccceEeEEEeCC----eeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVS--RLKHENFVQLLGYCVDGT----SRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~--~l~hp~iv~~~~~~~~~~----~~~lv~ 141 (246)
..++..+||+|.||.||+|.+. ++.||||++... ..+.|.+|-+|.+ .++|+||++++++-.... .++||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3445567999999999999987 489999998533 2456777766655 567999999999877655 889999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCCeeeCCCCCCCeEecCCCceEE
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK------ADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
||.+.|+|.++|... .++|....+++..++.||+|||+- -.|+|+|||||..|||+..+.+.-|
T Consensus 288 ~fh~kGsL~dyL~~n----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred eeccCCcHHHHHHhc----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 999999999999875 389999999999999999999973 2357999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||||..+...........-+||..|||||
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPE 388 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPE 388 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHH
Confidence 9999998776544433334468999999998
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=214.70 Aligned_cols=161 Identities=24% Similarity=0.326 Sum_probs=136.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
..+|.+.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++......++|+|++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 357999999999999999999976 6778999975432 2346899999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
. ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~-~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 140 S-SDLYTYLTKRS--------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred C-CcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 5 68888886432 13789999999999999999999997 999999999999999999999999998753
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......||+.|+|||
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE 226 (357)
T PHA03209 208 VVAP---AFLGLAGTVETNAPE 226 (357)
T ss_pred ccCc---ccccccccccccCCe
Confidence 2211 123457999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=238.33 Aligned_cols=174 Identities=29% Similarity=0.493 Sum_probs=142.4
Q ss_pred cCCCCceeccCCceEEEEEEEC--CCC----EEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK--SGH----AAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~--~~~----~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
+-.+.+.||+|.||.||.|... .+. .||+|.+.... ....+|.+|..+|++++|||||+++|.+.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3445678999999999999865 343 38999997654 345789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
++|||++|+|..+|++.+..... ...++..+.+.++.+||.|+.||+++. +|||||..+|+|++....+||+|||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999876533222 345889999999999999999999995 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|+...............=...|||||
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PE 874 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPE 874 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHH
Confidence 999544333322222212246899998
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=212.51 Aligned_cols=170 Identities=24% Similarity=0.393 Sum_probs=131.9
Q ss_pred CceeccCCceEEEEEEEC---CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCC
Q 025893 72 NALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAYEFASN 146 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~E~~~~ 146 (246)
.+.||+|+||.||+|..+ ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 357999999999999864 46789999986443 23457789999999999999999998864 456789999985
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec----CCCceEEccccCCC
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSN 222 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~----~~~~~kl~Dfgls~ 222 (246)
++|.+++..............+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 588888764332111111224788889999999999999999997 99999999999994 56789999999997
Q ss_pred CCCcccc-ccccccccccccccCCC
Q 025893 223 QAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
....... ........||+.|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred ccCCCCccccccCCccccccccCCH
Confidence 6543211 11123467899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=207.02 Aligned_cols=166 Identities=27% Similarity=0.388 Sum_probs=134.2
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCC
Q 025893 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
.||+|+||.||+|... ++..+++|.+...... ...+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999854 3456899988654432 3468889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccc
Q 025893 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (246)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~ 228 (246)
|.+++....... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 82 LKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred HHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 999987543211 123567778889999999999999987 9999999999999999999999999987543322
Q ss_pred cccccccccccccccCCC
Q 025893 229 ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE 246 (246)
.........|++.|+|||
T Consensus 155 ~~~~~~~~~~~~~y~aPE 172 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPE 172 (269)
T ss_pred eeecCCCcCCcccccCHh
Confidence 222223456788999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=218.55 Aligned_cols=165 Identities=28% Similarity=0.402 Sum_probs=137.4
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 138 (246)
+|+..+.||+|+||.||++... +++.||+|++..... ....+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999965 789999999864322 2356788999999999999999999998776 789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence 9999996 58888775432 3788999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++........ ......+|+.|+|||
T Consensus 148 g~a~~~~~~~~~-~~~~~~~~~~y~aPE 174 (372)
T cd07853 148 GLARVEEPDESK-HMTQEVVTQYYRAPE 174 (372)
T ss_pred cceeecccCccc-cCCCCCcCCCcCCHH
Confidence 998754322111 123346899999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=210.01 Aligned_cols=157 Identities=19% Similarity=0.321 Sum_probs=133.2
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecC
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAYEFA 144 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~E~~ 144 (246)
..||+|+++.||+|.+ +++.||+|.+...... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 5889999998765443 2567799999999999999999999877 35678999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++.... .+++...+.++.+++.||.|||+.. .++||||||+|||+++++.+||+|||+++..
T Consensus 105 ~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 105 TRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred CCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 9999999997543 3788889999999999999999842 2789999999999999999999999998764
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ....||+.|+|||
T Consensus 174 ~~~~-----~~~~~~~~y~aPE 190 (283)
T PHA02988 174 SSPP-----FKNVNFMVYFSYK 190 (283)
T ss_pred cccc-----ccccCcccccCHH
Confidence 3221 2346899999998
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=216.83 Aligned_cols=164 Identities=27% Similarity=0.346 Sum_probs=135.8
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----- 135 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 135 (246)
..++|.+.+.||+|+||.||++... ++..+|+|.+..... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999975 788999999864322 2456778999999999999999999986543
Q ss_pred -eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 136 -SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 136 -~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
..|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence 46899999965 67666532 2677888899999999999999997 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++...... ......||+.|+|||
T Consensus 164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE 192 (359)
T cd07876 164 ILDFGLARTACTNF---MMTPYVVTRYYRAPE 192 (359)
T ss_pred EecCCCccccccCc---cCCCCcccCCCCCch
Confidence 99999987543211 123457899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=208.68 Aligned_cols=177 Identities=27% Similarity=0.414 Sum_probs=140.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|++.+.||+|+||.||+|... .+..+++|.+...... ...+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46788889999999999999842 4567999998643322 2467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 140 AYEFASNGSLHDILHGRKGVK--------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~--------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
+|||+++++|.+++....... .......+++...+.++.|++.||.|||+++ ++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985432100 0001234788889999999999999999997 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+++...............++..|+|||
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChH
Confidence 99999999997653322211223345677899998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=225.36 Aligned_cols=153 Identities=34% Similarity=0.574 Sum_probs=132.6
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHH
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 151 (246)
++-||.|+-|.||+|+++ ++.||||++...+ ..+|.-|++|+||||+.+.|+|.....++||||||..|.|..
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 345899999999999987 6789999874221 246778999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccccc
Q 025893 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231 (246)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~ 231 (246)
+|+..+ .+..........+||.||.|||.+. |||||||.-||||..+..+||+|||.++......+
T Consensus 202 VLka~~---------~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-- 267 (904)
T KOG4721|consen 202 VLKAGR---------PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-- 267 (904)
T ss_pred HHhccC---------ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--
Confidence 998765 3666777788999999999999986 99999999999999999999999999987655432
Q ss_pred ccccccccccccCCC
Q 025893 232 HSTRVLGTFGYHAPE 246 (246)
Q Consensus 232 ~~~~~~gt~~y~aPE 246 (246)
.-.|+||..|||||
T Consensus 268 -kMSFaGTVaWMAPE 281 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPE 281 (904)
T ss_pred -hhhhhhhHhhhCHH
Confidence 24689999999998
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=208.52 Aligned_cols=177 Identities=25% Similarity=0.471 Sum_probs=143.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
++|.+.+.||+|+||.||+|... ++..+|+|.+...... .+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46888889999999999999864 2467999998654433 467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 139 LAYEFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
++|||+++++|.+++........ ......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999975432110 111234788899999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++................+++.|+|||
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE 194 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChh
Confidence 999999987543222211123345678999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-29 Score=205.38 Aligned_cols=169 Identities=30% Similarity=0.479 Sum_probs=140.2
Q ss_pred hcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|...+.||+|+||.||+|.++. ...+|+|.+...... ...+..|+.++++++||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999998752 347899988654332 35688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++..... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence 999999999999865331 3789999999999999999999986 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+................+++.|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe 178 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPE 178 (266)
T ss_pred hhcccccccceeccCCCCCccccChh
Confidence 98764222111112233567899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=206.28 Aligned_cols=169 Identities=30% Similarity=0.463 Sum_probs=142.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.+|.+.+.||+|+||.||+|..+ ++..+|+|.+.........+.+|+.++++++||||+++++++......+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 46778889999999999999965 68889999987665556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 ~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 86 YGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred CCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999865331 23788889999999999999999987 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......+++.|+|||
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE 175 (263)
T cd05052 156 GDTYT-AHAGAKFPIKWTAPE 175 (263)
T ss_pred cceee-ccCCCCCccccCCHH
Confidence 32211 111223467899998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=211.82 Aligned_cols=178 Identities=30% Similarity=0.459 Sum_probs=145.0
Q ss_pred HHHHHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEE----
Q 025893 59 VDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV---- 132 (246)
Q Consensus 59 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~---- 132 (246)
.+.+....++|++.+.||+|+||.||++... +++.+|+|.+.........+..|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3444556789999999999999999999975 688999998865544456788899999999 6999999999874
Q ss_pred -eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 133 -DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 133 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
..+..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~ 161 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLK-----RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG 161 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhc-----cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence 34568999999999999998764221 1124788888999999999999999986 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||++........ ......|++.|+|||
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 194 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPE 194 (286)
T ss_pred CEEEccCCceeecccCCC--ccccccCCCcccChh
Confidence 999999999876532211 123456999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=208.63 Aligned_cols=169 Identities=32% Similarity=0.518 Sum_probs=142.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeC------Cee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG------TSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~------~~~ 137 (246)
.+.|...+.||+|+||.||+|... +++.+|+|.+.........+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 457888889999999999999965 688899999876666667888999999998 699999999998753 457
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
|++|||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.+||+|
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEcc
Confidence 899999999999999875331 23788999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++........ ......|++.|+|||
T Consensus 155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE 181 (272)
T cd06637 155 FGVSAQLDRTVG--RRNTFIGTPYWMAPE 181 (272)
T ss_pred CCCceecccccc--cCCcccccccccCHh
Confidence 999876432211 224567999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=208.11 Aligned_cols=178 Identities=25% Similarity=0.417 Sum_probs=141.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|++.+.||+|+||.||+|..+ .+..+|+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 468999999999999999999753 2447999987644322 34577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKG-AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
++||||+++|+|.+++........ ....+.+.+..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975432111 111234567788899999999999999987 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...............++..|+|||
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE 191 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHH
Confidence 999987653322221222334677899998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=206.02 Aligned_cols=167 Identities=31% Similarity=0.444 Sum_probs=142.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|++.+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 458999999999999999999965 788899998864432 345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++..
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99999999886432 3788899999999999999999986 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 156 ~~~~~~--~~~~~~~~~~y~~PE 176 (267)
T cd06646 156 ITATIA--KRKSFIGTPYWMAPE 176 (267)
T ss_pred eccccc--ccCccccCccccCHh
Confidence 532211 113456899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=215.25 Aligned_cols=163 Identities=30% Similarity=0.431 Sum_probs=137.4
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeC------
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG------ 134 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 134 (246)
+.++|...+.||+|+||.||+|... ++..||+|.+..... ....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999965 788999999865432 234577899999999999999999887543
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
...++++|++ +++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEE
Confidence 3468999988 78998887543 2888999999999999999999997 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++..... .....||+.|+|||
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE 185 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPE 185 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCch
Confidence 9999998765321 23457999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=217.95 Aligned_cols=178 Identities=29% Similarity=0.479 Sum_probs=142.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCC-CCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+|+++ .+..||+|.+...... ...+..|+.++.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 457888899999999999999853 3457999999754332 346889999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCC--------------------------------------------------------
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVK-------------------------------------------------------- 160 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~-------------------------------------------------------- 160 (246)
.++||||+++|+|.+++.......
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996532100
Q ss_pred ---------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 161 ---------------------------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 161 ---------------------------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
.....+.+++...+.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 0011245788888999999999999999986 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+.+||+|||+++...............+++.|+|||
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 999999999999987643222111122345788999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=219.53 Aligned_cols=167 Identities=26% Similarity=0.383 Sum_probs=144.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.|..-++||+|+||.||-+..+ +|..+|.|++.+.. ....-.++|-.+|.+++.++||.+--+|.+.+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46777889999999999999866 89999999986432 22344667889999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
..|.||+|.-.|.+... +.+++.+++.++.+|+.||++||... ||.|||||+|||+|+.|+++|+|+|||
T Consensus 265 tlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred EeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceE
Confidence 99999999988876653 45899999999999999999999986 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..++..... ...+||.+|||||
T Consensus 335 vei~~g~~~---~~rvGT~GYMAPE 356 (591)
T KOG0986|consen 335 VEIPEGKPI---RGRVGTVGYMAPE 356 (591)
T ss_pred EecCCCCcc---ccccCcccccCHH
Confidence 877654432 3448999999998
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=205.47 Aligned_cols=169 Identities=30% Similarity=0.493 Sum_probs=140.9
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|.+.+.||+|+||.||+|.......+|+|.+.......+.+..|+.++++++||||+++++.+. ....++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3578899999999999999998776667999999876666778999999999999999999998874 566899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+|+|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 84 KGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 9999999975321 23788899999999999999999986 9999999999999999999999999987653
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|+|||
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE 173 (262)
T cd05071 154 DNEYT-ARQGAKFPIKWTAPE 173 (262)
T ss_pred ccccc-cccCCcccceecCHh
Confidence 32211 112234677899998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=217.02 Aligned_cols=164 Identities=18% Similarity=0.272 Sum_probs=138.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC---CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
..+|.+.+.||+|+||.||++... .+..+++|.+... ....+|+.++++++||||+++++++......+++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999753 3567899987543 245679999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
++. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 167 ~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 167 KYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred hcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 995 68988884332 3889999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...............||+.|+|||
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE 257 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPE 257 (392)
T ss_pred ccCcccccccccccccccCccCHh
Confidence 654332222223467999999998
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-29 Score=206.59 Aligned_cols=160 Identities=25% Similarity=0.390 Sum_probs=137.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|+..+.||+|+||.||+|... +++.+|+|.+...... ...+..|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36778889999999999999965 7889999988654322 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 81 MDGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CCCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 9999996542 2677888899999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....||+.|+|||
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE 163 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPE 163 (279)
T ss_pred ccccc----ccCCCCChhhcCce
Confidence 53221 23457999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=193.99 Aligned_cols=165 Identities=24% Similarity=0.404 Sum_probs=138.2
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|...+.||+|.||+||+|+.+ +++.||+|.++.+..+ .....+|+-+++.|+|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3445567999999999999955 7889999998755433 46788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
|. .+|..+..+..+ .+..+....++.|++.||.|||+++ ++||||||+|+||+.+|.+|+.|||+++.
T Consensus 83 cd-qdlkkyfdslng--------~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred hh-HHHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence 95 589888876543 3778888999999999999999996 99999999999999999999999999987
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... +..+-|.+|.+|.
T Consensus 151 fgipvrcy--saevvtlwyrppd 171 (292)
T KOG0662|consen 151 FGIPVRCY--SAEVVTLWYRPPD 171 (292)
T ss_pred cCCceEee--eceeeeeeccCcc
Confidence 75443221 2234578888774
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=203.15 Aligned_cols=162 Identities=28% Similarity=0.494 Sum_probs=132.9
Q ss_pred eeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHH
Q 025893 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~ 150 (246)
.||+|+||.||+|..+ +++.+|+|.+..... ....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999975 788999998764332 2356889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccc
Q 025893 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (246)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~ 230 (246)
+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 82 TFLRTEG--------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred HHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 9986432 13788899999999999999999987 999999999999999999999999998764321111
Q ss_pred cccccccccccccCCC
Q 025893 231 LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 231 ~~~~~~~gt~~y~aPE 246 (246)
.......++..|+|||
T Consensus 151 ~~~~~~~~~~~y~aPE 166 (252)
T cd05084 151 STGGMKQIPVKWTAPE 166 (252)
T ss_pred ccCCCCCCceeecCch
Confidence 0011112345799998
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=208.77 Aligned_cols=163 Identities=30% Similarity=0.424 Sum_probs=142.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++......+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999976 68899999886432 22456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 81 EYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999986543 3788889999999999999999987 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....|++.|+|||
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE 168 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPE 168 (290)
T ss_pred cccCCC-----CCCCCCCccccChh
Confidence 875432 23457899999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=207.34 Aligned_cols=169 Identities=30% Similarity=0.514 Sum_probs=144.0
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
..+|.+.+.||+|+||.||+|..+.+..+++|.+..... ....+..|+.+++.++||||+++++++......+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 457888899999999999999988788999999876544 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++...
T Consensus 85 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 85 EKGSLLAFLRSPEG-------QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred ccCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999975432 23788999999999999999999987 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....+++.|+|||
T Consensus 155 ~~~~~~--~~~~~~~~~~~~PE 174 (261)
T cd05148 155 KEDVYL--SSDKKIPYKWTAPE 174 (261)
T ss_pred CCcccc--ccCCCCceEecCHH
Confidence 432211 11234567899997
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=230.27 Aligned_cols=172 Identities=23% Similarity=0.366 Sum_probs=137.2
Q ss_pred hcCCCCceeccCCceEEEEEEECC-CCEEEEEEcCC-CCCCHHHHHHHHHHHhcCC-CCCccceEeE-EEe---C---Ce
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDA-SKQPDEEFLAQVSMVSRLK-HENFVQLLGY-CVD---G---TS 136 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vaik~~~~-~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~-~~~---~---~~ 136 (246)
.+..+.+.|-+|||+.||+|.... +..+|+|++-. +......+.+||++|++|+ |+|||.+++. ... . -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 356677899999999999999764 48999998753 3444577889999999998 9999999993 221 1 24
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
++|.||||.||.|-+++..+.. ..|++.++++|+.++++|+.+||.. .|+|||||||.+||||+.++..|||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq-------~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ-------TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh-------ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 5788999999999999986542 2389999999999999999999998 6789999999999999999999999
Q ss_pred cccCCCCCCccccccc-------cccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLH-------STRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~-------~~~~~gt~~y~aPE 246 (246)
|||.+........... .-....|+.|.|||
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPE 225 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPE 225 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChH
Confidence 9998864322211000 01124789999998
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=208.54 Aligned_cols=177 Identities=28% Similarity=0.407 Sum_probs=140.3
Q ss_pred hcCCCCceeccCCceEEEEEEECC---------------CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS---------------GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLG 129 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~---------------~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~ 129 (246)
++|++.+.||+|+||.||+++... ...+|+|.+...... ...+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987532 224899988654322 356889999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCCHHHHhccCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeE
Q 025893 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVK---GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206 (246)
Q Consensus 130 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil 206 (246)
++......++||||+++++|.+++....... .......+++..++.++.|++.||.|||+++ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999986432111 0111234788899999999999999999997 999999999999
Q ss_pred ecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 207 ~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.++.+||+|||++................+++.|+|||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 9999999999999987653322211122334577899998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=204.04 Aligned_cols=169 Identities=30% Similarity=0.482 Sum_probs=141.7
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|++.+.||+|+||.||+|....+..+|+|.+.......+.+.+|+.++++++||||+++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4578889999999999999999887888999999776666778999999999999999999999875 566889999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 84 KGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 9999999865321 23788999999999999999999987 9999999999999999999999999987653
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|+|||
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE 173 (260)
T cd05070 154 DNEYT-ARQGAKFPIKWTAPE 173 (260)
T ss_pred Ccccc-cccCCCCCccccChH
Confidence 32211 111233567899998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=207.17 Aligned_cols=178 Identities=24% Similarity=0.437 Sum_probs=142.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
.++|.+.+.||+|+||.||++... ++..+|+|.+..... ....+..|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999742 245688998865432 3457889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 139 LAYEFASNGSLHDILHGRKGVKG----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
+++||+++++|.+++........ ......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975432110 011124889999999999999999999987 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++...............+++.|+|||
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 192 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHH
Confidence 99999987653322211123344678899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=206.29 Aligned_cols=178 Identities=26% Similarity=0.416 Sum_probs=143.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||++..+ ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 468888999999999999999864 2367999998644322 34678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGA-QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
++||||+++++|.+++......... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754322110 11234788899999999999999999986 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...............+|..|+|||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHH
Confidence 999987654332221223445788999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=215.56 Aligned_cols=165 Identities=26% Similarity=0.330 Sum_probs=136.7
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC-----
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG----- 134 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----- 134 (246)
...++|+..+.||+|+||.||++... +++.+|+|.+...... ...+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35679999999999999999999865 7889999998654322 35677899999999999999999988643
Q ss_pred -CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 135 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 346899999965 67776643 2678888899999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||+++...... ......||+.|+|||
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE 188 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPE 188 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHH
Confidence 999999997643321 123457999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=206.59 Aligned_cols=167 Identities=34% Similarity=0.463 Sum_probs=142.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|...+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 347777888999999999999865 788999998865432 235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 88 CGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999986543 3788999999999999999999997 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .......||+.|+|||
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE 176 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPE 176 (267)
T ss_pred ccCcc--cccccccCcccccChh
Confidence 43211 1123457999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=204.61 Aligned_cols=169 Identities=28% Similarity=0.463 Sum_probs=142.8
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|++.+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.++++++||||+++++++ .....+++|||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 568899999999999999999988889999999987777778899999999999999999999886 4567899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 84 NGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999865332 23788889999999999999999987 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|+|||
T Consensus 154 ~~~~~-~~~~~~~~~~y~~pe 173 (260)
T cd05067 154 DNEYT-AREGAKFPIKWTAPE 173 (260)
T ss_pred CCCcc-cccCCcccccccCHH
Confidence 22111 112234567899997
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=225.25 Aligned_cols=175 Identities=19% Similarity=0.260 Sum_probs=132.0
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEECC--CCEEEEE------------------EcCCCCCCHHHHHHHHHHHhcCCCC
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILKS--GHAAAIK------------------KLDASKQPDEEFLAQVSMVSRLKHE 122 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vaik------------------~~~~~~~~~~~~~~e~~~l~~l~hp 122 (246)
..+.++|.+.+.||+|+||+||++..+. +...+.| .+.........+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456799999999999999999987542 2222222 1111111234577899999999999
Q ss_pred CccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 123 ~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
||+++++++...+..|+++|++. ++|.+++...... ............++.||+.||.|||+++ |+||||||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP 295 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD----WKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKL 295 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc----ccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 99999999999999999999985 5787776533210 0011335567789999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++.++.+||+|||+++........ .....+||+.|+|||
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE 338 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPE 338 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCch
Confidence 9999999999999999999765432211 123467999999998
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=203.93 Aligned_cols=170 Identities=30% Similarity=0.508 Sum_probs=145.0
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|.+.+.||+|+||.||++..+++..+|+|.+.......+++..|+.++++++||||+++++++......+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46889999999999999999998777889999998776777889999999999999999999999998899999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.+||+|||++....
T Consensus 85 ~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 85 KGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred CCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999975431 23788999999999999999999986 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|+|||
T Consensus 155 ~~~~~-~~~~~~~~~~y~~PE 174 (261)
T cd05034 155 DDEYT-AREGAKFPIKWTAPE 174 (261)
T ss_pred chhhh-hhhccCCCccccCHH
Confidence 32111 111223456799997
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=220.76 Aligned_cols=165 Identities=19% Similarity=0.318 Sum_probs=131.6
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC------CCccceEeEEEeC-C
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH------ENFVQLLGYCVDG-T 135 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h------p~iv~~~~~~~~~-~ 135 (246)
...++|.+.+.||+|+||+||+|... +++.||||++.........+..|+.+++.++| ++++++++++... .
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 34578999999999999999999975 68889999986543334455667777776654 4588888888764 5
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCC---
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDD--- 211 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nil~~~~~--- 211 (246)
+.++|||++ +++|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++..+
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 788999988 778988886543 37888999999999999999997 45 99999999999998665
Q ss_pred -------------ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 -------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 -------------~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||++..... .....+||+.|+|||
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE 315 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPE 315 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcH
Confidence 499999998764321 124568999999998
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=202.76 Aligned_cols=168 Identities=28% Similarity=0.443 Sum_probs=141.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|.+.+.||+|+||.||++... ++..+++|.+..... ....+.+|+.++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47889999999999999999865 788999998864322 12467789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
++||+++++|.+++.... .+++.....++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||
T Consensus 82 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999986543 3778888999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccc-cccccccccccCCC
Q 025893 220 LSNQAPDMAARLH-STRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~-~~~~~gt~~y~aPE 246 (246)
+++.......... .....|++.|+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPE 177 (263)
T ss_pred cceeccccccccccccCCCcCccccCcc
Confidence 9875432211111 12356889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=206.31 Aligned_cols=178 Identities=26% Similarity=0.371 Sum_probs=142.7
Q ss_pred HhcCCCCceeccCCceEEEEEEECC-----------------CCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccc
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS-----------------GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQ 126 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~ 126 (246)
.++|++.+.||+|+||.||++.... +..+|+|.+..... ..+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999987542 23579998865432 2457889999999999999999
Q ss_pred eEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 025893 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA--QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (246)
Q Consensus 127 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~N 204 (246)
+++++......++++||+++++|.+++......... .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999998654321110 11224789999999999999999999987 9999999999
Q ss_pred eEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 205 il~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++.++.++|+|||+++...............+|+.|+|||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE 202 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence 999999999999999987653322222223445778999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=204.78 Aligned_cols=168 Identities=27% Similarity=0.429 Sum_probs=135.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC----EEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|+..+.||+|+||.||+|.+. ++. .+++|.+..... ...++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 47788899999999999999875 454 377777753322 2356777888899999999999999875 455788
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
++||+++|+|.+++..... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 86 i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCc
Confidence 9999999999999965331 3788999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...............++..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE 181 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALE 181 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHH
Confidence 997654322222223445778899998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=223.12 Aligned_cols=162 Identities=30% Similarity=0.447 Sum_probs=137.6
Q ss_pred eeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHH
Q 025893 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 151 (246)
+||+|.||+||-|+.. +...+|||.+.... ....-+..|+.+.+.|+|.|||+++|.+-..++.-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999976 55678999996543 345567889999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccCCCCCCccccc
Q 025893 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAAR 230 (246)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls~~~~~~~~~ 230 (246)
+|+...+.-. =.+.+.-.+..||++||.|||++. |||||||-+|+|++. .|.+||+|||.++.+... .
T Consensus 662 LLrskWGPlK------DNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--n 730 (1226)
T KOG4279|consen 662 LLRSKWGPLK------DNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--N 730 (1226)
T ss_pred HHHhccCCCc------cchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--C
Confidence 9998765310 146677789999999999999985 999999999999986 789999999999876432 2
Q ss_pred cccccccccccccCCC
Q 025893 231 LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 231 ~~~~~~~gt~~y~aPE 246 (246)
.-..++.||..|||||
T Consensus 731 P~TETFTGTLQYMAPE 746 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPE 746 (1226)
T ss_pred ccccccccchhhhChH
Confidence 2346788999999998
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=207.47 Aligned_cols=178 Identities=27% Similarity=0.471 Sum_probs=141.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--------CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 568888999999999999999741 23468999886432 2245788999999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
...+++|||+++|+|.+++........ ..+...+++..++.++.|++.||.|||+++ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999976432110 011234788889999999999999999997 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............+++.|+|||
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 209 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE 209 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence 999999999999998654322221222334677899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=203.33 Aligned_cols=165 Identities=23% Similarity=0.352 Sum_probs=131.2
Q ss_pred eeccCCceEEEEEEECCC---CEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCC
Q 025893 74 LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~---~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
.||+|+||.||++...++ ..+++|.+..... ..+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 3466776654432 34678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccc
Q 025893 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (246)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~ 228 (246)
|.+++...... ...+++.....++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch
Confidence 99999754311 113566777889999999999999986 9999999999999999999999999976432211
Q ss_pred cccccccccccccccCCC
Q 025893 229 ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE 246 (246)
.........|++.|+|||
T Consensus 154 ~~~~~~~~~~~~~y~aPE 171 (268)
T cd05086 154 YIETEDDKCVPLRWLAPE 171 (268)
T ss_pred hhhcccCCcCcccccCch
Confidence 111123456889999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=228.37 Aligned_cols=166 Identities=27% Similarity=0.359 Sum_probs=142.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+..|+.++..++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999976 7889999998654322 256778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+.+++|.+++.... .+.+..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++
T Consensus 84 Ey~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 9999999999986532 3778888999999999999999987 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ......+|+.|++||
T Consensus 152 ~~~~~~~~--~~~~~~~t~~~~~pe 174 (669)
T cd05610 152 KVTLNREL--NMMDILTTPSMAKPK 174 (669)
T ss_pred ccccCCcc--cccccccCccccCcc
Confidence 86543221 223467899999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=224.16 Aligned_cols=172 Identities=32% Similarity=0.503 Sum_probs=150.8
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEe-----CC
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVD-----GT 135 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~-----~~ 135 (246)
.+-++-|++..+||.|.+|+||+++.+ +++..|+|++.......+++..|.++++.+. |||++.+++++.. ++
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 334567888899999999999999954 8899999999888777888889999999886 9999999999873 57
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
++|||||||.+|+..|++++..+ ..+.|..+..|++.++.|+.+||... ++|||+|-.|||+..++.|||
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g-------~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKG-------NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcc-------cchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 89999999999999999987652 35899999999999999999999874 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.|||++.++.. +.....+.+|||.|||||
T Consensus 165 vDFGvSaQlds--T~grRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPE 193 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCCcccccce
Confidence 99999987654 333457889999999998
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=208.14 Aligned_cols=178 Identities=30% Similarity=0.474 Sum_probs=140.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--------CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
.++|.+.+.||+|+||.||++... +...+|+|.+..... ....+..|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999753 234699998875432 235678899999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
...|+||||+++|+|.+++....... .......+++..++.++.|++.||.|||+++ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997643211 0112234889999999999999999999987 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............+++.|+|||
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 212 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 212 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence 999999999999987654322111112223457899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=211.57 Aligned_cols=178 Identities=22% Similarity=0.403 Sum_probs=138.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC-C
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG-T 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~-~ 135 (246)
.++|++.+.||+|+||.||+|... +++.||+|.+...... .+.+..|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357889999999999999999632 3468999988644322 34577899999999 799999999988754 5
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCC----------------------------------------------------CC
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKG----------------------------------------------------AQ 163 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~----------------------------------------------------~~ 163 (246)
..++++||+++++|.+++........ ..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864321100 00
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccccccccccccccccc
Q 025893 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243 (246)
Q Consensus 164 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~ 243 (246)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0124789999999999999999999986 9999999999999999999999999998654322222223345678899
Q ss_pred CCC
Q 025893 244 APE 246 (246)
Q Consensus 244 aPE 246 (246)
|||
T Consensus 243 aPE 245 (337)
T cd05054 243 APE 245 (337)
T ss_pred CcH
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=206.04 Aligned_cols=165 Identities=32% Similarity=0.477 Sum_probs=132.7
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcC---CCCCccceEeEEEe-----CC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL---KHENFVQLLGYCVD-----GT 135 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~-----~~ 135 (246)
+|+..+.||+|+||.||+|..+ +++.+|+|.+..... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999976 788999998864322 223556677776655 69999999998764 34
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++++||+. ++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 5789999997 489888864321 23788999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++....... .....||+.|+|||
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 177 (288)
T cd07863 150 ADFGLARIYSCQMA---LTPVVVTLWYRAPE 177 (288)
T ss_pred CccCccccccCccc---CCCccccccccCch
Confidence 99999876542221 23456899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=206.54 Aligned_cols=179 Identities=28% Similarity=0.468 Sum_probs=142.4
Q ss_pred HHhcCCCCceeccCCceEEEEEEECC------CCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeCC
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGT 135 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 135 (246)
..++|++.+.||+|+||.||++.... ...+|+|.+...... ...+.+|+.+++++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 35678889999999999999998642 357899988654332 24678899999999 7999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 208 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~ 208 (246)
..+++|||+++|+|.+++........ ......+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 99999999999999999875421100 012345889999999999999999999986 99999999999999
Q ss_pred CCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 209 ~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.++.+||+|||+++...............+++.|+|||
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 204 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE 204 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence 99999999999998754332221122233567899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=211.53 Aligned_cols=178 Identities=24% Similarity=0.413 Sum_probs=138.1
Q ss_pred HhcCCCCceeccCCceEEEEEEE------CCCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC-C
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG-T 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~-~ 135 (246)
.++|++.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45799999999999999999973 24678999998654332 34678899999999 589999999988654 4
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCC------------------------------------------------------
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKG------------------------------------------------------ 161 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~------------------------------------------------------ 161 (246)
..+++|||+++|+|.+++........
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999865321000
Q ss_pred ----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccccccccccc
Q 025893 162 ----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237 (246)
Q Consensus 162 ----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~ 237 (246)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 000124678888999999999999999997 9999999999999999999999999987643222111112234
Q ss_pred ccccccCCC
Q 025893 238 GTFGYHAPE 246 (246)
Q Consensus 238 gt~~y~aPE 246 (246)
+++.|+|||
T Consensus 243 ~~~~y~aPE 251 (343)
T cd05103 243 LPLKWMAPE 251 (343)
T ss_pred CCcceECcH
Confidence 567899998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=206.54 Aligned_cols=164 Identities=34% Similarity=0.536 Sum_probs=138.6
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHH---HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE---EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~---~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
|++.+.||+|+||+||++... +++.+|+|.+........ ....|+.++++++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999977 567899999976654332 3355999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
.+++|.+++.... .+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccc---------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999997322 3889999999999999999999997 999999999999999999999999998642
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.. .........+|+.|+|||
T Consensus 149 ~~--~~~~~~~~~~~~~y~aPE 168 (260)
T PF00069_consen 149 SE--NNENFNPFVGTPEYMAPE 168 (260)
T ss_dssp TS--TTSEBSSSSSSGGGSCHH
T ss_pred cc--cccccccccccccccccc
Confidence 11 111224567899999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=213.99 Aligned_cols=164 Identities=25% Similarity=0.319 Sum_probs=136.3
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeC------
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------ 134 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 134 (246)
..++|.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999965 78899999986532 2235678899999999999999999987543
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
...|+||||+.+ +|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 357999999965 77777642 2678888899999999999999997 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++...... ......||+.|+|||
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE 195 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPE 195 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHH
Confidence 99999997653221 123457899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=205.59 Aligned_cols=176 Identities=29% Similarity=0.407 Sum_probs=139.4
Q ss_pred cCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
+|.+.+.||+|+||.||+|... .+..+|+|.+...... .+.+..|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666778999999999999853 2467999998654332 3567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 140 AYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
++||+.+++|.+++....... .......+++..+..++.|++.||.|||+++ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985332110 0011234788888999999999999999997 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++...............+++.|+|||
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPE 196 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHH
Confidence 9999999988654322221123345678999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=206.15 Aligned_cols=166 Identities=27% Similarity=0.448 Sum_probs=142.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
..+|...+.||+|+||.||++... +++.+++|.+..... ..+.+..|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888899999999999999965 788999998875443 346788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 99 ~~~~~L~~~~~~~----------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 99 LAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred cCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 9999999998643 2778889999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 166 ~~~~~~--~~~~~~~~~~y~aPE 186 (296)
T cd06654 166 ITPEQS--KRSTMVGTPYWMAPE 186 (296)
T ss_pred cccccc--ccCcccCCccccCHH
Confidence 432211 113356899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=201.08 Aligned_cols=167 Identities=30% Similarity=0.449 Sum_probs=142.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|...+.||+|+||.||++..+ ++..+++|.+.... .....+..|+.++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999976 78899999886433 2346788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence 999999999875421 24788889999999999999999986 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....|++.|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE 171 (256)
T cd08529 151 LSDNTNF--ANTIVGTPYYLSPE 171 (256)
T ss_pred ccCccch--hhccccCccccCHH
Confidence 5432221 23456899999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=203.12 Aligned_cols=170 Identities=24% Similarity=0.400 Sum_probs=141.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||+|+.+ +++.+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999965 789999998754221 2346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++...... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999888542211 123778888999999999999999987 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
......... .....|++.|+|||
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~aPE 176 (267)
T cd08228 154 RFFSSKTTA--AHSLVGTPYYMSPE 176 (267)
T ss_pred eeccchhHH--HhcCCCCccccChh
Confidence 765432211 13456889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=206.16 Aligned_cols=171 Identities=26% Similarity=0.466 Sum_probs=140.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||++... ++..+|+|.+...... .+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 468999999999999999999741 3457899988654332 35688999999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.+++|||+.+|+|.+++..... ..+++.++..++.|++.||.|||+++ |+|+||||+|||++.++.+||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEEC
Confidence 9999999999999999865331 12789999999999999999999986 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...............+++.|+|||
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 213 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPE 213 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHh
Confidence 999998654322211112334678899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=200.76 Aligned_cols=168 Identities=30% Similarity=0.486 Sum_probs=139.5
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|.+...||+|+||.||++....+..+|+|.+.......+.+.+|+.++++++|||++++++++. ....+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 468888899999999999999876678999988766666678899999999999999999998874 5668899999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 85 GSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999965331 23788899999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......++..|+|||
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe 173 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPE 173 (260)
T ss_pred Cccc-ccCCCccchhhCCHH
Confidence 2111 112234667899997
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=206.04 Aligned_cols=166 Identities=26% Similarity=0.404 Sum_probs=139.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|...+.||+|+||.||+|..+ ++..||+|.+.... .....+.+|+.++++++||||+++++++..+...++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999976 78899999886443 2345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~-~~l~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 86 LD-KDLKQYLDDCG--------NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred cc-cCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 97 58988886432 13778889999999999999999987 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+++.|+|||
T Consensus 154 ~~~~~~--~~~~~~~~~~y~~PE 174 (301)
T cd07873 154 KSIPTK--TYSNEVVTLWYRPPD 174 (301)
T ss_pred cCCCCC--cccccceeecccCcH
Confidence 432211 112345789999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=204.68 Aligned_cols=176 Identities=24% Similarity=0.401 Sum_probs=138.8
Q ss_pred cCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
+|++.+.||+|+||.||+|... ....+++|.+..... ....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 124688888754432 23568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 025893 140 AYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~N 204 (246)
++||+.+++|.+++........ ......+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999865321100 011234788999999999999999999987 9999999999
Q ss_pred eEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 205 il~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|++++++.+||+|||+++...............++..|+|||
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE 199 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE 199 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHH
Confidence 999999999999999987643322211123345677899997
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=200.13 Aligned_cols=167 Identities=24% Similarity=0.386 Sum_probs=141.0
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+|++.+.||+|+||.||++... ++..+|+|.+.... ...+.+..|+.+++.++||||+++++.+...+..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778889999999999999976 78899999875432 23467788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|.+++..... ..+++.....++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 81 DGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence 99999998864321 13778889999999999999999987 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......|++.|+|||
T Consensus 151 ~~~~~--~~~~~~~~~~~~aPE 170 (255)
T cd08219 151 TSPGA--YACTYVGTPYYVPPE 170 (255)
T ss_pred ccccc--ccccccCCccccCHH
Confidence 33221 123456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=231.77 Aligned_cols=175 Identities=23% Similarity=0.346 Sum_probs=140.7
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC--Cee
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 137 (246)
...++|.+.+.||+|+||.||++... ++..+|+|.+...... ...+..|+.++++|+|||||+++++|... ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999976 6778999988654322 35688999999999999999999988653 568
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeeeCCCCCCCeEecC----
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD----PHIIHRDIKSSNVLIFD---- 209 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~----~~ivHrdlkp~Nil~~~---- 209 (246)
||||||+++|+|.++|...... ...+++..++.|+.||+.||.|||+.+. .+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 9999999999999998653211 1248899999999999999999998532 24999999999999964
Q ss_pred -------------CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 -------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 -------------~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+.+||+|||++....... ......||+.|+|||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPE 211 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPE 211 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHH
Confidence 2358999999997653221 123457999999998
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=203.21 Aligned_cols=169 Identities=27% Similarity=0.429 Sum_probs=136.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCC----EEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....+.+|+.+++.+.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888899999999999999864 454 479998864432 24567889999999999999999999875 4567
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+||
T Consensus 85 l~~~~~~~g~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCC
Confidence 8999999999999986532 13788999999999999999999986 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++...............+++.|+|||
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALE 181 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHH
Confidence 9988654322211112223567899998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=205.84 Aligned_cols=167 Identities=24% Similarity=0.413 Sum_probs=140.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 6788889999999999999976 7899999988643222 357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|..++..... ...+++..+..++.+++.||.|||+.. .|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 82 DAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred CCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999988865321 113789999999999999999999741 3999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... .....|++.|+|||
T Consensus 154 ~~~~----~~~~~~~~~y~aPE 171 (286)
T cd06622 154 VASL----AKTNIGCQSYMAPE 171 (286)
T ss_pred cCCc----cccCCCccCccCcc
Confidence 3221 23456889999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=202.38 Aligned_cols=176 Identities=26% Similarity=0.440 Sum_probs=141.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
++|+....||+|+||.||+|+.+ +...+++|.+...... ...+..|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 2356899987654433 467889999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+||||+++++|.+++..............+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975442111111124889999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++....... .......+++.|+|||
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE 188 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPE 188 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChh
Confidence 99875432211 1123345678899998
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=204.60 Aligned_cols=177 Identities=24% Similarity=0.379 Sum_probs=140.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-----------------CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccce
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-----------------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQL 127 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~ 127 (246)
++|++.+.||+|+||.||++... +...+|+|.+..... ....+..|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57889999999999999998632 234689998865432 23578899999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 025893 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (246)
Q Consensus 128 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Ni 205 (246)
++++......+++|||+++++|.+++........ ......+++..+..++.|++.||.|||+++ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999876432211 112234788899999999999999999997 99999999999
Q ss_pred EecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 206 l~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++.++.++|+|||+++...............+++.|+|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 202 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE 202 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence 99999999999999987653222111112234567899986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=206.68 Aligned_cols=169 Identities=24% Similarity=0.386 Sum_probs=130.9
Q ss_pred ceeccCCceEEEEEEEC---CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCC
Q 025893 73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAYEFASNG 147 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~E~~~~g 147 (246)
..||+|+||.||+|..+ ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++++||+. +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 57999999999999865 45679999886443 23467789999999999999999998854 467789999986 5
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCceEEccccCCCC
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSNQ 223 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~----~~~~~~kl~Dfgls~~ 223 (246)
+|.+++..............+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 88887754322111111224788889999999999999999997 9999999999999 4567899999999976
Q ss_pred CCccccc-cccccccccccccCCC
Q 025893 224 APDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
....... .......||+.|+|||
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred cCCCcccccccCcceecccccCcH
Confidence 5432211 1123457899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=201.19 Aligned_cols=169 Identities=29% Similarity=0.466 Sum_probs=138.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CC---CEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.+|++.+.||+|+||.||+|... ++ ..+|+|.+...... .+.+..|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 47888899999999999999864 32 36899988654322 35788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... ..+++.+...++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999999996542 13788889999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccc-cccccccccccCCC
Q 025893 221 SNQAPDMAARLH-STRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~-~~~~~gt~~y~aPE 246 (246)
+........... .....++..|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe 179 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPE 179 (267)
T ss_pred ccccccccceeeecCCCccceeecCHh
Confidence 987543222111 11223456899997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=205.24 Aligned_cols=166 Identities=28% Similarity=0.450 Sum_probs=142.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|...+.||+|+||.||++... +++.+|+|.+..... ..+.+..|+.+++.++||||+++++++......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 468999999999999999999964 789999999865443 345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 98 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 98 LAGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred cCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 9999999998643 2778889999999999999999987 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE 185 (297)
T cd06656 165 ITPEQS--KRSTMVGTPYWMAPE 185 (297)
T ss_pred ccCCcc--CcCcccCCccccCHH
Confidence 432211 123456889999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=200.54 Aligned_cols=162 Identities=28% Similarity=0.460 Sum_probs=138.4
Q ss_pred ceeccCCceEEEEEE-ECCCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~-~~~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
..||+|.|+.|-.+. ..++..+|||++.+.. ..+.+..+|++++..-+ |+||+.++++|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 479999999999998 5689999999998764 45678899999998876 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---ceEEccccCCCCCCc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPD 226 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~---~~kl~Dfgls~~~~~ 226 (246)
...|..+. .+.+..+.+++.+|+.||.|||.++ |.||||||+|||..+.. -+||+||.|......
T Consensus 164 LshI~~~~---------~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 164 LSHIQKRK---------HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred HHHHHHhh---------hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99998776 3788999999999999999999998 99999999999997643 589999988654321
Q ss_pred c-----ccccccccccccccccCCC
Q 025893 227 M-----AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~-----~~~~~~~~~~gt~~y~aPE 246 (246)
. .......+.+|+..|||||
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPE 256 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPE 256 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchh
Confidence 1 1122234678999999998
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=205.21 Aligned_cols=168 Identities=27% Similarity=0.421 Sum_probs=142.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|++.+.||+|+||.||++... ++..+|+|.+..... ..+.+..|+.++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888889999999999999975 688999998864432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 84 CDGGALDSIMLELE--------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred cCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 99999999986532 13888999999999999999999997 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~PE 173 (280)
T cd06611 153 NKSTLQ--KRDTFIGTPYWMAPE 173 (280)
T ss_pred hccccc--ccceeecchhhcCHH
Confidence 432211 123456899999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=202.59 Aligned_cols=167 Identities=29% Similarity=0.424 Sum_probs=138.8
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|.+.+.||+|+||.||+|..+ ++..+|+|.+..... ....+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999976 788999998864322 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
++ ++|.+++..... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 97 689888864321 124788999999999999999999987 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+++.|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE 171 (285)
T cd07861 151 FGIPVR--VYTHEVVTLWYRAPE 171 (285)
T ss_pred cCCCcc--cccCCcccccccChH
Confidence 432211 112345789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=201.82 Aligned_cols=171 Identities=27% Similarity=0.392 Sum_probs=132.8
Q ss_pred CCCceeccCCceEEEEEEECC-CC--EEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeC------Cee
Q 025893 70 GTNALIGEGSYGRVYYGILKS-GH--AAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSR 137 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~~-~~--~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~~ 137 (246)
.+.+.||+|+||.||+|.... +. .+|+|.+..... ..+.+..|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999763 33 589998865432 245688899999999999999999987532 246
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++++||+++|+|.+++....... ....+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECC
Confidence 89999999999998874322110 1124789999999999999999999986 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+++...............+++.|+|||
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHH
Confidence 99998754322211122334677899987
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=203.42 Aligned_cols=168 Identities=29% Similarity=0.426 Sum_probs=141.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.+.|++.+.||+|+||.||+|... ++..+++|.+..... ..+.+..|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 357888999999999999999976 688999999865432 245688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|..++.... ..+++..+..++.|++.+|.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 91 CPGGAVDAIMLELD--------RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 99999988775432 13788999999999999999999986 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+++.|+|||
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE 180 (292)
T cd06644 160 NVKTLQ--RRDSFIGTPYWMAPE 180 (292)
T ss_pred cccccc--ccceecCCccccCce
Confidence 332211 123456889999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=200.37 Aligned_cols=168 Identities=27% Similarity=0.419 Sum_probs=137.8
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CC---HHHHHHHHHHHhcCCCCCccceEeEEEeC--Cee
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 137 (246)
.+|.+.+.||+|+||.||++... ++..+|+|.+.... .. ...+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999975 68899999875322 11 24677899999999999999999988764 467
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
+++|||+++++|.+++.... .+++...+.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence 89999999999999986542 2678888899999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025893 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
||++......... .......|+..|+|||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPE 179 (265)
T ss_pred CccccccccccccccccccCCCCccccChh
Confidence 9998764321111 1123356899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=200.00 Aligned_cols=155 Identities=25% Similarity=0.481 Sum_probs=130.4
Q ss_pred eeccCCceEEEEEEECC-C----------CEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 74 LIGEGSYGRVYYGILKS-G----------HAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~-~----------~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.||+|+||.||+|.... + ..+++|.+.........+.+|+.++++++||||+++++++.. ...++|+|
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence 68999999999999763 3 247778765554446788899999999999999999999988 77899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-------ceEE
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-------VAKI 215 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-------~~kl 215 (246)
|+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||
T Consensus 81 ~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 81 YVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred cCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEe
Confidence 9999999999875431 3788889999999999999999986 99999999999999877 7999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++..... .....++..|+|||
T Consensus 150 ~Dfg~a~~~~~------~~~~~~~~~y~aPE 174 (259)
T cd05037 150 SDPGIPITVLS------REERVERIPWIAPE 174 (259)
T ss_pred CCCCccccccc------ccccccCCCccChh
Confidence 99999876433 12345678899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=203.13 Aligned_cols=177 Identities=24% Similarity=0.426 Sum_probs=141.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+|.+.+.||+|+||.||++... ++..+++|.+...... ...+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788889999999999999742 3446888887544332 3568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 140 AYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
||||+++++|.+++....... .......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997543110 0011234789999999999999999999997 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||++................+++.|+|||
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 195 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence 9999999987654322222223445788999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=201.88 Aligned_cols=166 Identities=23% Similarity=0.322 Sum_probs=136.8
Q ss_pred HHHhcCCCC-ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEe----CCe
Q 025893 64 EITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD----GTS 136 (246)
Q Consensus 64 ~~~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~----~~~ 136 (246)
.++++|.+. ++||-|-.|+|..+.++ +++.+|+|.+..+ ...++|+++.-.. .|||||.+++++.+ ...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 356788765 67999999999999976 8899999988433 4556777776555 49999999998764 345
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCce
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVA 213 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~ 213 (246)
+.+|||.++||+|+..++.++.. .+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcce
Confidence 67899999999999999876632 4899999999999999999999997 999999999999974 4579
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||||+...... ...+.|=||+|.|||
T Consensus 204 KLtDfGFAK~t~~~~---~L~TPc~TPyYvaPe 233 (400)
T KOG0604|consen 204 KLTDFGFAKETQEPG---DLMTPCFTPYYVAPE 233 (400)
T ss_pred EecccccccccCCCc---cccCCcccccccCHH
Confidence 999999998754322 235678899999998
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=202.48 Aligned_cols=165 Identities=28% Similarity=0.449 Sum_probs=139.2
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
|++.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|+.+++.++||||+++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566778999999999999976 67788999886443 2345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|..++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 87 GAVDAVMLELE--------RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred CcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 99988875422 13788999999999999999999997 99999999999999999999999999876432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... ......||+.|+|||
T Consensus 156 ~~~--~~~~~~~~~~y~aPE 173 (282)
T cd06643 156 TIQ--RRDSFIGTPYWMAPE 173 (282)
T ss_pred ccc--ccccccccccccCHh
Confidence 211 123457899999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=205.01 Aligned_cols=175 Identities=32% Similarity=0.495 Sum_probs=137.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCC--EEEEEEcCCCC--CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vaik~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+.... .....+.+|+.++.++ +||||+++++++...+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999975 454 35777765322 2235678899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 140 AYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
||||+++++|.+++........ ......+++..++.++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975431110 011235789999999999999999999987 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||++....... ......++..|+|||
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE 193 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE 193 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHH
Confidence 9999999986432111 112223466799997
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=198.23 Aligned_cols=171 Identities=33% Similarity=0.514 Sum_probs=140.8
Q ss_pred ceeccCCceEEEEEEEC-C---CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~---~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|... . +..+++|.+...... .+.+..|+.+++.++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36999999999999965 3 778999998765443 56788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..............+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976521100011234899999999999999999999986 99999999999999999999999999987654
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
...........+++.|+|||
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE 177 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPE 177 (262)
T ss_pred ccccccccCCCcCccccCHH
Confidence 32112223456789999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=201.24 Aligned_cols=169 Identities=25% Similarity=0.446 Sum_probs=141.1
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|++.+.||+|+||.||++....+..+++|.+.......+.+.+|+.++++++|+||+++++.+.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46788999999999999999987777789999887655556788899999999999999999999877 77899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 84 KGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CCcHHHHHHhCCc-------cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999975432 23678888999999999999999986 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|+|||
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE 173 (260)
T cd05073 154 DNEYT-AREGAKFPIKWTAPE 173 (260)
T ss_pred CCCcc-cccCCcccccccCHh
Confidence 32211 112234567799998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=197.18 Aligned_cols=161 Identities=32% Similarity=0.524 Sum_probs=134.0
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHH
Q 025893 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 151 (246)
+||+|+||.||+|...++..+|+|.+...... ...+.+|+.++++++||||+++++++......++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999999878889999988654322 3468889999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccccc
Q 025893 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231 (246)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~ 231 (246)
++.... ..+.+..+..++.+++.+|.|+|+++ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 149 (250)
T cd05085 82 FLRKKK--------DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS- 149 (250)
T ss_pred HHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-
Confidence 886432 13788999999999999999999987 999999999999999999999999998654322111
Q ss_pred ccccccccccccCCC
Q 025893 232 HSTRVLGTFGYHAPE 246 (246)
Q Consensus 232 ~~~~~~gt~~y~aPE 246 (246)
......+++.|+|||
T Consensus 150 ~~~~~~~~~~y~aPE 164 (250)
T cd05085 150 SSGLKQIPIKWTAPE 164 (250)
T ss_pred cCCCCCCcccccCHH
Confidence 111223467799998
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=201.36 Aligned_cols=167 Identities=29% Similarity=0.483 Sum_probs=139.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---C--------HHHHHHHHHHHhcCCCCCccceEeEEEeCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---P--------DEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~--------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 135 (246)
+|...+.||+|+||.||+|... +++.+|+|.+..... . .+.+..|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 788999998753211 1 135678999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence 9999999999999999986542 3788888899999999999999986 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++................|+..|+|||
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 180 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180 (272)
T ss_pred eeccccccccccccccccccccCCccccCHH
Confidence 9999987654322221223456889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=201.94 Aligned_cols=169 Identities=27% Similarity=0.437 Sum_probs=138.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-----CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeC--Cee
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 137 (246)
..|++.+.||+|+||.||++.+. ++..+|+|.+..... ....+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35678889999999999999742 577899999864432 235788999999999999999999998875 567
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence 89999999999999986432 13788999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025893 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
||+++........ .......|+..|+|||
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE 182 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHH
Confidence 9998865432211 1112345777899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=200.78 Aligned_cols=168 Identities=29% Similarity=0.470 Sum_probs=137.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC----EEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+|++.+.||+|+||.||+|..+ ++. .+|+|.+...... ...+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 57788899999999999999865 343 5889987655432 3578889999999999999999999987 78899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
++||+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 86 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred EEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCc
Confidence 9999999999999875431 3789999999999999999999986 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...............++..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALE 181 (279)
T ss_pred ccccccCcccceecCCCcccccccCHH
Confidence 998754322211111122456799998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=199.82 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=135.6
Q ss_pred CCCCceeccCCceEEEEEEEC-C---CCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCe-----
Q 025893 69 FGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----- 136 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~---~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----- 136 (246)
|.+.+.||+|+||.||+|... + +..+|+|.+...... ...+..|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567788999999999999864 2 367999998754332 3568899999999999999999998876554
Q ss_pred -eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 137 -RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 137 -~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
.++++||+++|+|..++....... ....+++.....++.|++.||.|||+++ ++||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence 789999999999999885433111 1124888999999999999999999986 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++...............++..|+|||
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHh
Confidence 9999987654322211112233567899997
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=199.69 Aligned_cols=167 Identities=29% Similarity=0.516 Sum_probs=139.8
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC-------HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~-------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
+|...+.||+|+||.||+|...+++.+|+|.+...... ...+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788899999999999998878899999988644321 13577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 81 MEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 99999999999986532 2678888899999999999999987 99999999999999999999999999
Q ss_pred CCCCCcccc----ccccccccccccccCCC
Q 025893 221 SNQAPDMAA----RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~----~~~~~~~~gt~~y~aPE 246 (246)
+........ ........|++.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe 178 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChh
Confidence 875432111 11123356899999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=198.83 Aligned_cols=167 Identities=22% Similarity=0.401 Sum_probs=142.0
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|+..+.||+|+||.||.++.. ++..+++|.+.... .....+.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999855 78899999876443 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 999999999875421 23788999999999999999999987 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~ape 171 (256)
T cd08221 151 LGSEYS--MAETVVGTPYYMSPE 171 (256)
T ss_pred cccccc--cccccCCCccccCHh
Confidence 533221 123457899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=198.57 Aligned_cols=165 Identities=35% Similarity=0.588 Sum_probs=141.6
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|++.+.||+|+||.||++... ++.+|+|.+.........+.+|+.++++++|+||+++++++.+....++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 357888999999999999999876 7889999987655456788899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSRGR-------AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999875431 13789999999999999999999997 9999999999999999999999999998753
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
... ....++..|+|||
T Consensus 154 ~~~-----~~~~~~~~~~ape 169 (256)
T cd05039 154 QGQ-----DSGKLPVKWTAPE 169 (256)
T ss_pred ccc-----ccCCCcccccCch
Confidence 221 1223456799997
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=203.99 Aligned_cols=176 Identities=31% Similarity=0.509 Sum_probs=144.4
Q ss_pred HHHHHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEe---
Q 025893 59 VDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD--- 133 (246)
Q Consensus 59 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--- 133 (246)
+.++....+.|++.+.||+|+||.||+|... +++.+|+|.+.........+..|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 3344445678889999999999999999975 788999998866555556788899999998 69999999999853
Q ss_pred ---CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 134 ---GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 134 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
....+++|||+.+|+|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~ 157 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTEN 157 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence 4578999999999999999875432 13778888899999999999999997 9999999999999999
Q ss_pred CceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++|+|||++........ ......|++.|+|||
T Consensus 158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 191 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPE 191 (282)
T ss_pred CCEEEeeCcchhhhhcccc--CCCcccccccccCHh
Confidence 9999999999875432211 123457899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=205.05 Aligned_cols=178 Identities=28% Similarity=0.474 Sum_probs=140.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
.++|.+.+.||+|+||.||++... ....+|+|.+...... ...+..|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999742 2346899987644322 34678899999999 599999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
...+++|||+++|+|.+++........ ......+++...+.++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999976432100 011234889999999999999999999987 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............+++.|+|||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE 206 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence 999999999999998654322211112223456899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=203.63 Aligned_cols=165 Identities=35% Similarity=0.604 Sum_probs=132.3
Q ss_pred CceeccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 72 NALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~-----~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.+.||.|.||.||+|.+. .+..|+||.+...... .+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 2457999999554332 478999999999999999999999999888899999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.++|..... ..+++..+..++.||+.||.|||+++ ++|++|+++||++++++.+||+|||++...
T Consensus 84 ~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 84 PGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccc-------cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 99999999987621 23889999999999999999999986 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.............+...|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE 175 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPE 175 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HH
T ss_pred cccccccccccccccccccccc
Confidence 2211111223345678899997
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=202.07 Aligned_cols=165 Identities=28% Similarity=0.429 Sum_probs=134.8
Q ss_pred CCCCceeccCCceEEEEEEE-----CCCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEE
Q 025893 69 FGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL 139 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~-----~~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 139 (246)
|...+.||+|+||+||++.. .++..+|+|.+..... ..+.+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37888999999999988653 2577899999865433 346788999999999999999999988653 45789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
+|||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 86 v~e~~~~~~l~~~~~~~----------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EecCCCCCCHHHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecc
Confidence 99999999999998653 2889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCcccccc-ccccccccccccCCC
Q 025893 220 LSNQAPDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
+++......... ......++..|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE 180 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVE 180 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHh
Confidence 988654322111 112234567799998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=203.06 Aligned_cols=178 Identities=28% Similarity=0.434 Sum_probs=141.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|+..+.||+|+||.||++... ++..+|+|.+...... ...+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 4678999988654322 35688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCC-------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKG-------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~N 204 (246)
++++||+++++|.+++........ ......+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999974332110 011234788889999999999999999987 9999999999
Q ss_pred eEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 205 il~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++.++.+||+|||++................+++.|+|||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE 202 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHH
Confidence 999999999999999987543222111112234567799997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=200.58 Aligned_cols=176 Identities=27% Similarity=0.453 Sum_probs=139.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|.+. .+..+++|.+...... ...+..|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467889999999999999999865 3567899987644332 35688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---ceE
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAK 214 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~---~~k 214 (246)
+++|||+++++|.+++........ ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++ .+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 999999999999999976532111 1124889999999999999999999997 99999999999998654 699
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++................++.|+|||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHH
Confidence 99999998653222111112223456899998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=200.99 Aligned_cols=169 Identities=30% Similarity=0.487 Sum_probs=136.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CC---CEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.+|++.+.||+|+||.||+|..+ ++ ..+|+|.+..... ....+..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46778899999999999999865 33 3599999865422 245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence 999999999999865431 3788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCccccccc-ccccc--ccccccCCC
Q 025893 221 SNQAPDMAARLH-STRVL--GTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~-~~~~~--gt~~y~aPE 246 (246)
+........... ..... .+..|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHh
Confidence 876533221111 01111 245799998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=197.99 Aligned_cols=168 Identities=27% Similarity=0.516 Sum_probs=141.6
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
.+|++.+.||+|+||.||++.+..+..+|+|.+.........+..|++++++++||||+++++++......++++||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 36777889999999999999887778899999876666677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..... .+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999865331 3778888999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......++..|+|||
T Consensus 153 ~~~~-~~~~~~~~~~~~aPe 171 (256)
T cd05112 153 DQYT-SSTGTKFPVKWSSPE 171 (256)
T ss_pred Cccc-ccCCCccchhhcCHh
Confidence 2111 112233567899998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=203.93 Aligned_cols=168 Identities=26% Similarity=0.362 Sum_probs=139.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|+..+.||+|+||.||++..+ +++.|++|.+..... ....+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999976 678999998865432 2346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 81 EYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred ecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCc
Confidence 9999999999996543 3788888899999999999999986 999999999999999999999999998
Q ss_pred CCCCccc-------------cccccccccccccccCCC
Q 025893 222 NQAPDMA-------------ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~-------------~~~~~~~~~gt~~y~aPE 246 (246)
+...... .........|++.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 186 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCch
Confidence 6421000 000112346788999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=202.05 Aligned_cols=177 Identities=23% Similarity=0.416 Sum_probs=140.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+|...+.||+|+||.||++... ++..+++|.+..... ....+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 57778889999999999999632 355788898764432 34678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 140 AYEFASNGSLHDILHGRKGVK------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
++||+++++|.+++....... .......+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 999999999999987543210 0011134788999999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++................+++.|+|||
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 194 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHH
Confidence 999999987543222111122334678899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=201.33 Aligned_cols=169 Identities=27% Similarity=0.449 Sum_probs=136.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-----CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 138 (246)
++|++.+.||+|+||.||++..+ ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888899999999999999742 577899999865432 245788999999999999999999987543 4678
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence 9999999999999986432 13788999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccc-cccccccccccCCC
Q 025893 219 DLSNQAPDMAARLH-STRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~-~~~~~gt~~y~aPE 246 (246)
|++........... .....++..|+|||
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 181 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPE 181 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHH
Confidence 99986543221110 11122345689997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=198.74 Aligned_cols=167 Identities=31% Similarity=0.501 Sum_probs=139.0
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----------HHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
.|.+...||+|+||.||+|... ++..+|+|.+...... .+.+..|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999865 6888999988643221 1357789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.++++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence 999999999999999996543 3778888899999999999999987 9999999999999999999999
Q ss_pred cccCCCCCCccccc----cccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAAR----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~----~~~~~~~gt~~y~aPE 246 (246)
|||+++........ .......|++.|+|||
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe 182 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChh
Confidence 99998765421111 0112346889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=197.99 Aligned_cols=163 Identities=32% Similarity=0.545 Sum_probs=136.5
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEE-eCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~E~~~ 145 (246)
++|.+.+.||+|+||.||++..+ +..+++|.+... ...+.+..|+.++++++|+|++++++++. ..+..++++||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 47888899999999999999765 778999987543 33567889999999999999999999765 4567899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 84 KGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence 9999999875432 23788899999999999999999987 9999999999999999999999999987543
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
... ....++..|+|||
T Consensus 154 ~~~-----~~~~~~~~y~aPE 169 (256)
T cd05082 154 STQ-----DTGKLPVKWTAPE 169 (256)
T ss_pred ccC-----CCCccceeecCHH
Confidence 221 2334567899997
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=204.25 Aligned_cols=173 Identities=28% Similarity=0.430 Sum_probs=141.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-C----CCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEe-CCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~ 136 (246)
...|+....||+|.||.||+|..+ + ...+|||+++..+. ......+|+.+++.|+|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457889999999999999999643 2 23689999865532 24567789999999999999999998887 788
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC----Cc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DV 212 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~----~~ 212 (246)
+|+++||.+. +|..+|+.++..+. ..++...+..|+.||+.|+.|||++- |+||||||.|||+-.+ |.
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 9999999986 99999987664432 24788889999999999999999985 9999999999999866 89
Q ss_pred eEEccccCCCCCCcccccc-ccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
+||+|||+++.+....... ....++-|.+|.|||
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence 9999999998865443222 234566799999998
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=204.20 Aligned_cols=148 Identities=30% Similarity=0.444 Sum_probs=130.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|+..+.||+|+||.||++... ++..+|+|.+...... ...+..|+++++.++||||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999976 6899999998755432 346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+.+++|.+++..... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred EecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence 99999999999864321 24888899999999999999999987 999999999999999999999999998
Q ss_pred CCC
Q 025893 222 NQA 224 (246)
Q Consensus 222 ~~~ 224 (246)
...
T Consensus 151 ~~~ 153 (316)
T cd05574 151 KQS 153 (316)
T ss_pred hcc
Confidence 654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=202.67 Aligned_cols=165 Identities=30% Similarity=0.482 Sum_probs=142.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.+|+..+.||.|+||.||++... +++.+++|.+..... ..+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999864 788999998865433 3467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|..++... .+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.+||+|||++...
T Consensus 99 ~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 99 AGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred CCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 999999988643 2788999999999999999999997 999999999999999999999999998764
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......|++.|+|||
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE 185 (296)
T cd06655 166 TPEQS--KRSTMVGTPYWMAPE 185 (296)
T ss_pred ccccc--cCCCcCCCccccCcc
Confidence 33221 123356899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=204.98 Aligned_cols=166 Identities=18% Similarity=0.249 Sum_probs=134.0
Q ss_pred CCceeccC--CceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 71 TNALIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 71 ~~~~lG~G--~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+..+||+| +|++||++..+ +++.||+|.+...... .+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 78899999875 7899999998654332 245667999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++++||+.....
T Consensus 82 ~~~~l~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFM-------DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999999865321 13788999999999999999999997 999999999999999999999999865432
Q ss_pred Cccccc-----cccccccccccccCCC
Q 025893 225 PDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
...... .......++..|+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPE 178 (327)
T ss_pred ccccccccccccccccccceecccChH
Confidence 211110 0112235778899998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=206.38 Aligned_cols=178 Identities=29% Similarity=0.469 Sum_probs=140.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
..+|.+.+.||+|+||.||++... ....+|+|.+...... ...+..|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 457889999999999999999742 1236899987643322 35788999999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
...++++||+++|+|.+++....... .......+++..++.++.|++.||.|||+++ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999997543110 0112334788899999999999999999987 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............++..|+|||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE 206 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence 999999999999987654322111112233457899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=200.76 Aligned_cols=166 Identities=28% Similarity=0.413 Sum_probs=139.8
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|+..+.||+|+||.||++..+ +++.+|+|++..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999976 688999998854322 23567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|++++.|..++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence 999988877764332 3789999999999999999999986 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......++..|+|||
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE 170 (286)
T cd07847 149 ILTGPGD--DYTDYVATRWYRAPE 170 (286)
T ss_pred ecCCCcc--cccCcccccccCCHH
Confidence 6543221 112345788999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=198.38 Aligned_cols=156 Identities=26% Similarity=0.472 Sum_probs=128.3
Q ss_pred eeccCCceEEEEEEECC-------------CCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 74 LIGEGSYGRVYYGILKS-------------GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~-------------~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.||+|+||.||+|.... ...+++|.+...... ...+..|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 124788887654332 3467888999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-------
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV------- 212 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~------- 212 (246)
+|||+++++|..++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 82 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS--------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred EEecccCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCce
Confidence 999999999988886432 13788889999999999999999987 999999999999986653
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|++|||++...... ....|+..|+|||
T Consensus 151 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE 178 (262)
T cd05077 151 IKLSDPGIPITVLSR------QECVERIPWIAPE 178 (262)
T ss_pred eEeCCCCCCccccCc------ccccccccccChh
Confidence 899999998654321 2346888999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=201.52 Aligned_cols=166 Identities=27% Similarity=0.440 Sum_probs=138.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|+..+.||+|+||.||+|..+ +++.+|+|.+..... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999976 788999999864332 234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+.+ +|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 85 LDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred CCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccc
Confidence 975 99988864321 3788889999999999999999997 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+++.|+|||
T Consensus 153 ~~~~~~--~~~~~~~~~~~~aPE 173 (291)
T cd07844 153 KSVPSK--TYSNEVVTLWYRPPD 173 (291)
T ss_pred cCCCCc--cccccccccccCCcH
Confidence 422111 112335688999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=203.30 Aligned_cols=175 Identities=33% Similarity=0.469 Sum_probs=143.9
Q ss_pred HHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeC-----
Q 025893 62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG----- 134 (246)
Q Consensus 62 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~----- 134 (246)
+....++|.+...||+|+||.||++... +++.+|+|.+.........+..|+.+++++ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 3445678999999999999999999975 788999999876555556788899999999 799999999998754
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
...++|+||+++++|.++++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLI-----CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 357999999999999998864221 1123788899999999999999999986 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||++......... .....|++.|+|||
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 198 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPE 198 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChh
Confidence 9999998765432211 23456889999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=201.65 Aligned_cols=156 Identities=25% Similarity=0.422 Sum_probs=126.7
Q ss_pred eeccCCceEEEEEEEC-C------------------------CCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccce
Q 025893 74 LIGEGSYGRVYYGILK-S------------------------GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQL 127 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~-~------------------------~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~ 127 (246)
.||+|+||.||+|.+. + ...+++|.+...... ...+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999742 1 124788887644322 3567889999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 128 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
++++.+....++||||+++|+|..++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill 150 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence 999999999999999999999999886432 13788889999999999999999986 9999999999999
Q ss_pred cCCC-------ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDD-------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~-------~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..+ .+|++|||++...... ....+++.|+|||
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe 190 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPE 190 (274)
T ss_pred eccCcccCccceeeecCCccccccccc------cccccCCcccCch
Confidence 7543 4899999987643221 2235788899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=196.55 Aligned_cols=167 Identities=34% Similarity=0.470 Sum_probs=143.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
++|+..+.||+|+||.||++... ++..+++|.+..... ....+..|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999975 678899998865433 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++...
T Consensus 83 ~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 83 GGGSLQDIYQVTR--------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred CCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence 9999999886542 13788899999999999999999986 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......|+..|+|||
T Consensus 152 ~~~~~--~~~~~~~~~~y~~Pe 171 (262)
T cd06613 152 TATIA--KRKSFIGTPYWMAPE 171 (262)
T ss_pred hhhhh--ccccccCCccccCch
Confidence 43221 123457889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=213.77 Aligned_cols=164 Identities=26% Similarity=0.405 Sum_probs=139.8
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHH---------HHHHHHHHHhcCC---CCCccceEeEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE---------EFLAQVSMVSRLK---HENFVQLLGYCVD 133 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~---------~~~~e~~~l~~l~---hp~iv~~~~~~~~ 133 (246)
.+|...+.+|+|+||.|++|.++ +...|+||.+.+...-.. ..-.|++||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 36889999999999999999987 566789998866543222 2346999999998 9999999999999
Q ss_pred CCeeEEEEecC-CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 134 GTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 134 ~~~~~lv~E~~-~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
++++||+||-. ++-+|+++|.... .+.+..+..|+.||+.|+++||+++ |||||||-+|++++.+|-
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---------~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---------RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF 708 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---------ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence 99999999976 5779999997654 4888899999999999999999998 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||.+...... .-..++||..|.|||
T Consensus 709 ~klidfgsaa~~ksg----pfd~f~gtv~~aape 738 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSG----PFDVFVGTVDYAAPE 738 (772)
T ss_pred EEEeeccchhhhcCC----Ccceeeeeccccchh
Confidence 999999987653321 225688999999998
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=202.09 Aligned_cols=165 Identities=32% Similarity=0.475 Sum_probs=139.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC------HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
+|+..+.||+|+||.||+|... +++.+++|.+...... ...+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999976 7889999998654332 24567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||+|+||+++.++.+||+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence 9999 899999986532 13889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......+++.|+|||
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE 172 (298)
T cd07841 149 ARSFGSPNR--KMTHQVVTRWYRAPE 172 (298)
T ss_pred eeeccCCCc--cccccccceeeeCHH
Confidence 876543221 112335688899997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=200.79 Aligned_cols=167 Identities=25% Similarity=0.361 Sum_probs=137.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||+|..+ ++..+++|.+..... ....+.+|+.+++.++|+||+++++++......++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 357889999999999999999865 788999999865432 23467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+. ++|.+++.... ..+.+..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 84 YMH-TDLAQYMIQHP--------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred ccc-CCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence 995 67777764322 12667788889999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......+++.|+|||
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE 173 (291)
T cd07870 152 AKSIPSQ--TYSSEVVTLWYRPPD 173 (291)
T ss_pred ccCCCCC--CCCCccccccccCCc
Confidence 5432211 113345789999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=196.74 Aligned_cols=161 Identities=28% Similarity=0.486 Sum_probs=129.5
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCC
Q 025893 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
.||+|+||.||+|.++ .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 345689998865432 2356889999999999999999999885 457889999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccc
Q 025893 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (246)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~ 228 (246)
|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 999986432 13789999999999999999999987 9999999999999999999999999987543322
Q ss_pred cccc-cccccccccccCCC
Q 025893 229 ARLH-STRVLGTFGYHAPE 246 (246)
Q Consensus 229 ~~~~-~~~~~gt~~y~aPE 246 (246)
.... .....+++.|+|||
T Consensus 150 ~~~~~~~~~~~~~~y~aPE 168 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPE 168 (257)
T ss_pred cceeccCCCCCCcccCCHH
Confidence 1111 11122357899997
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=200.89 Aligned_cols=170 Identities=24% Similarity=0.408 Sum_probs=141.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||++... ++..+++|.+..... ...++.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788889999999999999964 789999998764322 2356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-----QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCCHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 99999999998864221 1124788999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
......... .....|++.|+|||
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~ape 176 (267)
T cd08229 154 RFFSSKTTA--AHSLVGTPYYMSPE 176 (267)
T ss_pred hccccCCcc--cccccCCcCccCHH
Confidence 765432211 12346889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=197.52 Aligned_cols=170 Identities=27% Similarity=0.439 Sum_probs=142.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 88999999885322 22457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++..... ....+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-----QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred ecCCCCCHHHHHHHhcc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 99999999998864321 1124788999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......|++.|+|||
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~apE 176 (267)
T cd08224 154 RFFSSKTT--AAHSLVGTPYYMSPE 176 (267)
T ss_pred eeccCCCc--ccceecCCccccCHH
Confidence 76432211 113356889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=198.11 Aligned_cols=177 Identities=27% Similarity=0.421 Sum_probs=140.8
Q ss_pred HhcCCCCceeccCCceEEEEEEECC-----CCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEe-CCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 137 (246)
.++|.+.+.||+|+||.||+|.... +..+++|.+..... ....+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4688889999999999999999764 67789998764332 23567889999999999999999998776 4678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++++||+++++|.+++....... ......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGE-ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999986543211 011234889999999999999999999986 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+++...............++..|+|||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE 189 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALE 189 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHH
Confidence 99998653322211112334677899998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=196.18 Aligned_cols=167 Identities=28% Similarity=0.435 Sum_probs=137.5
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC------CHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRV 138 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 138 (246)
+|...+.||+|+||.||++... ++..+++|.+..... ....+.+|+.++++++||||+++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 7888999999999999999865 688999998754321 12457789999999999999999998875 35678
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+++||+++++|.+++.... .+++.....++.|++.||.|||+++ |+|+||+|+||+++.++.+||+||
T Consensus 83 l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~df 150 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 150 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 9999999999999986532 3778888899999999999999986 999999999999999999999999
Q ss_pred cCCCCCCcccc-ccccccccccccccCCC
Q 025893 219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
|+++....... ........|+..|+|||
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (266)
T cd06651 151 GASKRLQTICMSGTGIRSVTGTPYWMSPE 179 (266)
T ss_pred CCccccccccccCCccccCCccccccCHH
Confidence 99876532111 11112356889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=216.39 Aligned_cols=145 Identities=22% Similarity=0.283 Sum_probs=126.6
Q ss_pred CCCCceeccCCceEEEEEE-ECCCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 69 FGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~-~~~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
|..++.||-|.||+|.+++ ..+...+|+|.+++... .......|-.||..-+.+.||+|+-.|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5556789999999999998 44677899998876532 224566788899999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
++||++..+|-... .|.+..++.++.++..|+++.|.+| +|||||||+|||||.+|++||.|||||.-
T Consensus 711 IPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred cCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999999886554 4788888999999999999999998 99999999999999999999999999976
Q ss_pred CC
Q 025893 224 AP 225 (246)
Q Consensus 224 ~~ 225 (246)
+.
T Consensus 779 fR 780 (1034)
T KOG0608|consen 779 FR 780 (1034)
T ss_pred ce
Confidence 54
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=199.89 Aligned_cols=168 Identities=29% Similarity=0.383 Sum_probs=136.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHH-HhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|++.+.||+|+||.||++..+ ++..||+|.+..... ....+..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 789999999865432 23455566664 667789999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|++ |+|.+++...... ...+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred hhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 996 6888887643211 12488999999999999999999986 5 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ .....|+..|+|||
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~aPE 173 (283)
T cd06617 152 GYLVDSVA---KTIDAGCKPYMAPE 173 (283)
T ss_pred cccccccc---cccccCCccccChh
Confidence 76532211 12356889999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=204.02 Aligned_cols=164 Identities=31% Similarity=0.488 Sum_probs=137.8
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.|.....||+|+||.||++... ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444457999999999999865 688999999865433 24568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 103 ~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 103 GGALTDIVTHT----------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 99999988542 2788899999999999999999997 9999999999999999999999999987543
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......|++.|+|||
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE 188 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPE 188 (292)
T ss_pred cccc--cCceeecCccccCHH
Confidence 2211 123456899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=195.47 Aligned_cols=160 Identities=28% Similarity=0.471 Sum_probs=130.6
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
.||+|+||.||+|.++ ++..+|+|.+...... .+.+..|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5778999988644332 357889999999999999999999875 45678999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~ 227 (246)
+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999986532 3788999999999999999999997 999999999999999999999999998765432
Q ss_pred cccc-ccccccccccccCCC
Q 025893 228 AARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~~-~~~~~~gt~~y~aPE 246 (246)
.... ......+++.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE 168 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPE 168 (257)
T ss_pred CCeeeecCCCCCCccccCHh
Confidence 2111 112223467899998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-28 Score=199.38 Aligned_cols=166 Identities=29% Similarity=0.416 Sum_probs=141.5
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|++.+.||+|+||.||+|... ++..+++|.+..... ....+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999975 788999999865432 246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+ +++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~-~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9 999999986533 23888999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .......|+..|+|||
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE 170 (286)
T cd07832 149 FSEEEP-RLYSHQVATRWYRAPE 170 (286)
T ss_pred ccCCCC-CccccccCcccccCce
Confidence 543221 1123456899999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=196.32 Aligned_cols=164 Identities=29% Similarity=0.482 Sum_probs=140.0
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
+|+..+.||+|+||.||+|... ++..+++|.+..... ..+.+..|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677789999999999999976 789999998754331 235688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999986532 3778888899999999999999987 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ......|++.|+|||
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~~pe 171 (258)
T cd06632 149 AKQVVEFS---FAKSFKGSPYWMAPE 171 (258)
T ss_pred ceeccccc---cccccCCCcceeCHH
Confidence 87643322 123456899999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=201.99 Aligned_cols=165 Identities=23% Similarity=0.379 Sum_probs=137.8
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|...+.||+|+||.||+|... +|..+|+|.+..... ....+.+|+.++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999976 788999999864322 235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+. ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CD-QDLKKYFDSCN--------GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 97 58888775432 13789999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+++.|+|||
T Consensus 149 ~~~~~~--~~~~~~~~~~y~aPE 169 (284)
T cd07839 149 FGIPVR--CYSAEVVTLWYRPPD 169 (284)
T ss_pred cCCCCC--CcCCCccccCCcChH
Confidence 432211 112346789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=200.83 Aligned_cols=165 Identities=27% Similarity=0.384 Sum_probs=140.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|++.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|+++++.++||||+++++++...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56778889999999999999965 68889999875432 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... .+++.....++.+++.+|.|||+.. .++||||+|+||+++.++.++|+|||++..
T Consensus 85 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 85 MDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred CCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 99999999886532 3788899999999999999999731 399999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....||..|+|||
T Consensus 154 ~~~~~----~~~~~~~~~~~aPE 172 (284)
T cd06620 154 LINSI----ADTFVGTSTYMSPE 172 (284)
T ss_pred hhhhc----cCccccCcccCCHH
Confidence 42221 13457899999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=198.16 Aligned_cols=167 Identities=26% Similarity=0.445 Sum_probs=139.4
Q ss_pred cCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCC-------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 68 NFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... ....+..|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 4788999998864331 13567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADF 218 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Df 218 (246)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .+||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 999999999999986532 3788889999999999999999997 99999999999998765 6999999
Q ss_pred cCCCCCCcccccc--ccccccccccccCCC
Q 025893 219 DLSNQAPDMAARL--HSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~--~~~~~~gt~~y~aPE 246 (246)
|++.......... ......||..|+|||
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE 178 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178 (268)
T ss_pred ccccccccccccCCccccccccccceeCHh
Confidence 9987664332111 112346889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-28 Score=195.88 Aligned_cols=167 Identities=29% Similarity=0.436 Sum_probs=138.9
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~E 142 (246)
+|++.+.||+|++|.||++..+ +++.+++|.+..... ..+.+..|+.++++++|||++++++.+.. ....++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999966 678899999865432 23567889999999999999999988764 446789999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++..... ..+++.++..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 9999999999875321 23788999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......|++.|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE 172 (257)
T cd08223 151 VLENQCD--MASTLIGTPYYMSPE 172 (257)
T ss_pred EecccCC--ccccccCCcCccChh
Confidence 6532211 223456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=201.44 Aligned_cols=168 Identities=29% Similarity=0.495 Sum_probs=135.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC----EEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|+..+.||+|+||.||+|... ++. .+|+|.+...... ...+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 57788889999999999999864 454 4688887654332 24678899999999999999999998754 4678
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
++||+++|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 86 v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred eehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccc
Confidence 9999999999999865431 3788889999999999999999986 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...............++..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALE 181 (303)
T ss_pred ccccccCcccccccCCCccccccCCHH
Confidence 998654322221122334577899997
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=199.95 Aligned_cols=174 Identities=32% Similarity=0.486 Sum_probs=136.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC--EEEEEEcCCCCC--CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vaik~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|++.+.||+|+||.||+|..+ ++. .+++|.+..... ..+.+..|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999875 343 468887753222 235688899999999 699999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 141 YEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
+||+++++|.+++........ ......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965432110 011234888999999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++........ ......+..|+|||
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 188 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIE 188 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCch
Confidence 9999999864322111 11122345799998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=197.40 Aligned_cols=170 Identities=29% Similarity=0.498 Sum_probs=138.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCC---EEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~---~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|+..+.||+|+||.||+|..+ ++. .+++|.+...... .+.+..|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999865 333 6899988654322 4568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCc
Confidence 9999999999999865321 3788899999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCccccccc-cccccccccccCCC
Q 025893 220 LSNQAPDMAARLH-STRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~-~~~~~gt~~y~aPE 246 (246)
++........... ......++.|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE 180 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPE 180 (268)
T ss_pred cceecccccccceeccCCCcCceecCHH
Confidence 9876543221111 11122345799997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=213.35 Aligned_cols=163 Identities=28% Similarity=0.372 Sum_probs=139.7
Q ss_pred cCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-C-----CCccceEeEEEeCCeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H-----ENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-h-----p~iv~~~~~~~~~~~~~lv 140 (246)
.|.+.++||+|+||.|.+|.. ++++.||||+++..+....+-..|+.+|..|+ | -|+|+++++|...++.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 567788999999999999995 48999999999888777777788999999887 3 4899999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCceEEccc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADF 218 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~--~~~~kl~Df 218 (246)
+|.+. -+|.++|+.... ..|+...++.++.||+.||.+||..+ |||+||||+|||+.+ ...+||+||
T Consensus 267 fELL~-~NLYellK~n~f-------~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKF-------RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ehhhh-hhHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 99985 599999987542 24888999999999999999999987 999999999999985 458999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|.|....... -+.+-+..|.|||
T Consensus 336 GSSc~~~q~v-----ytYiQSRfYRAPE 358 (586)
T KOG0667|consen 336 GSSCFESQRV-----YTYIQSRFYRAPE 358 (586)
T ss_pred ccccccCCcc-----eeeeeccccccch
Confidence 9987643221 2456788999998
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=197.64 Aligned_cols=171 Identities=32% Similarity=0.506 Sum_probs=143.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCC------ee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGT------SR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~------~~ 137 (246)
.++|++.+.||+|+||.||+|..+ +++.+++|.+.......+.+..|+.+++++ +||||+++++++.... ..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 578999999999999999999976 678899999876665667889999999999 6999999999997654 48
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECC
Confidence 9999999999999988643210 124788899999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++........ ......|++.|+|||
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE 183 (275)
T cd06608 157 FGVSAQLDSTLG--RRNTFIGTPYWMAPE 183 (275)
T ss_pred Cccceecccchh--hhcCccccccccCHh
Confidence 999875433221 123456899999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=195.85 Aligned_cols=166 Identities=35% Similarity=0.532 Sum_probs=143.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
++|+..+.||+|+||.||++..+ ++..+++|.+..... .+.+.+|+.++++++||||+++++.+......|+++||+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57888899999999999999977 578999999865433 6788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 82 AGSVSDIMKITN--------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred CCcHHHHHHhCc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 999999986433 24789999999999999999999986 9999999999999999999999999988654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......|+..|+|||
T Consensus 151 ~~~~--~~~~~~~~~~y~~PE 169 (256)
T cd06612 151 DTMA--KRNTVIGTPFWMAPE 169 (256)
T ss_pred cCcc--ccccccCCccccCHH
Confidence 3221 123456889999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=200.95 Aligned_cols=164 Identities=32% Similarity=0.462 Sum_probs=138.8
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.|+..+.||+|+||.||+|... ++..+|+|.+..... ..+.+..|+.++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4555677999999999999865 678899998864432 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|.+++... .+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 85 GGGSALDLLKPG----------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence 999999988542 2788889999999999999999986 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......|+..|+|||
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE 171 (277)
T cd06642 152 TDTQI--KRNTFVGTPFWMAPE 171 (277)
T ss_pred cCcch--hhhcccCcccccCHH
Confidence 43221 123356889999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=198.54 Aligned_cols=165 Identities=32% Similarity=0.460 Sum_probs=142.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|+..+.||.|+||.||+|... +++.+++|.+..... ....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999976 788999999865432 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 81 CGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999998653 2788999999999999999999987 99999999999999999999999999877
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 148 ~~~~~~--~~~~~~~~~~y~~PE 168 (274)
T cd06609 148 LTSTMS--KRNTFVGTPFWMAPE 168 (274)
T ss_pred eccccc--ccccccCCccccChh
Confidence 543221 223457899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=197.38 Aligned_cols=170 Identities=31% Similarity=0.431 Sum_probs=138.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++++.....||+|+||.||+|... ++..+++|.+..... ..+.+.+|+.++++++|+||+++++++...+..++++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 455656678999999999999965 677899998865433 345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls~ 222 (246)
+++++|.+++...... ....+..+..++.|++.||.|||+++ |+||||||+||+++. .+.+||+|||++.
T Consensus 87 ~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 87 VPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred CCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999998754211 01267778889999999999999987 999999999999986 6799999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......|++.|+|||
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE 179 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPE 179 (268)
T ss_pred ecccCCC--ccccCCCCccccChh
Confidence 5432111 122345889999998
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=201.80 Aligned_cols=166 Identities=31% Similarity=0.457 Sum_probs=140.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|+..+.||+|+||.||+|..+ +++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999976 688999998864332 24567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|++++.|..+..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 999988887765322 3789999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......++..|+|||
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~aPE 170 (286)
T cd07846 149 TLAAPGE--VYTDYVATRWYRAPE 170 (286)
T ss_pred eccCCcc--ccCcccceeeccCcH
Confidence 6533221 123356889999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=232.56 Aligned_cols=168 Identities=26% Similarity=0.417 Sum_probs=141.8
Q ss_pred hcCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
-+|+....||.|.||.||.|.. .+|...|+|.+.... ...+.+.+|..++..|+|||+|+++|+-...+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3567778899999999999984 589999999875332 233567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
||++|+|.+.+...+ ..++.....+..|++.|+.|||.+| ||||||||+||+++.+|.+|++|||.|.
T Consensus 1315 yC~~GsLa~ll~~gr---------i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR---------IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HhccCcHHHHHHhcc---------hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 999999999997654 3566667778999999999999998 9999999999999999999999999997
Q ss_pred CCCccccc--cccccccccccccCCC
Q 025893 223 QAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
........ ...+...|||.|||||
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPE 1408 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPE 1408 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCch
Confidence 65543211 1224568999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=219.91 Aligned_cols=166 Identities=31% Similarity=0.525 Sum_probs=139.6
Q ss_pred CCCCceeccCCceEEEEEEEC-CC---CEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~---~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
..+.++||.|.||+|++|+++ .| ..||||.++.... ...+|+.|+.||.+++||||++|.|+......+.||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 356689999999999999976 33 4699999976543 45789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
||++|+|..+|+...+ -+.+.+...+.+.|+.||+||-+++ +|||||..+|||++.+-.+||+|||+++
T Consensus 711 yMENGsLDsFLR~~DG--------qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred hhhCCcHHHHHhhcCC--------ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccccee
Confidence 9999999999987653 2888899999999999999999997 9999999999999999999999999999
Q ss_pred CCCccccccccccccc--cccccCCC
Q 025893 223 QAPDMAARLHSTRVLG--TFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~g--t~~y~aPE 246 (246)
.+.+.... ..++.-| ...|.|||
T Consensus 780 vledd~~~-~ytt~GGKIPiRWTAPE 804 (996)
T KOG0196|consen 780 VLEDDPEA-AYTTLGGKIPIRWTAPE 804 (996)
T ss_pred ecccCCCc-cccccCCccceeecChh
Confidence 76443211 1111111 25799998
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-28 Score=200.03 Aligned_cols=166 Identities=28% Similarity=0.456 Sum_probs=142.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|.+.+.||+|+||.||++... ++..+++|.+.... ...+.+..|+.++++++||||+++++.+...+..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368888999999999999999865 68889999986443 2346788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++..
T Consensus 98 ~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 98 LAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred CCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 9999999998653 2778888999999999999999997 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE 185 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPE 185 (293)
T ss_pred cccccc--ccccccCChhhcCch
Confidence 543221 123346889999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=206.07 Aligned_cols=161 Identities=19% Similarity=0.207 Sum_probs=124.2
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC--CCCEEEEEEcCCCC----C--CHHHHHHHHHHHhcCCCCCccceEeEEEeCC
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASK----Q--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vaik~~~~~~----~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 135 (246)
.+.+.|.+.+.||+|+||+||+|.++ +++.+|||++.... . ..+.+.+|+.+|++|+|+||+..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999865 56778999865321 1 23568899999999999999853322 24
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCC-CCCCeEecCCCceE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI-KSSNVLIFDDDVAK 214 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdl-kp~Nil~~~~~~~k 214 (246)
..|+||||++|++|... .. .. ...++.+++.+|.|||+++ |+|||| ||+|||++.++.+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 57999999999999632 10 11 1357789999999999997 999999 99999999899999
Q ss_pred EccccCCCCCCcccccc------ccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARL------HSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~------~~~~~~gt~~y~aPE 246 (246)
|+|||+|+......... ......+++.|+|||
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence 99999998654332111 113567888999998
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=209.53 Aligned_cols=167 Identities=26% Similarity=0.304 Sum_probs=139.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l 139 (246)
..+|..+.+||+|+||+|.++..+ +.+.+|||+++++- .+.+--+.|-++|.-.. -|.++.++..|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 458899999999999999999976 67789999997652 22333445656665543 7899999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+.||+|.-.++.... +.+..+..++.+|+.||-|||+++ |+.||||.+|||++.+|++||.|||
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred EEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecc
Confidence 9999999999988876653 556677889999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++..... .....++||||-|+|||
T Consensus 496 mcKEni~~--~~TTkTFCGTPdYiAPE 520 (683)
T KOG0696|consen 496 MCKENIFD--GVTTKTFCGTPDYIAPE 520 (683)
T ss_pred cccccccC--CcceeeecCCCcccccc
Confidence 99874332 23457899999999998
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=197.85 Aligned_cols=164 Identities=26% Similarity=0.455 Sum_probs=140.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.|+..+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|+.++++++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677788999999999999965 78899999886542 23457888999999886 999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++... .+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 82 EYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred ecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence 999999999998643 2788999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......|++.|+|||
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE 171 (277)
T cd06917 149 ALLNQNSS--KRSTFVGTPYWMAPE 171 (277)
T ss_pred eecCCCcc--ccccccCCcceeCHH
Confidence 76543321 123456899999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=199.38 Aligned_cols=164 Identities=29% Similarity=0.398 Sum_probs=141.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
+|++.+.||.|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 78899999986433 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999986542 3788899999999999999999987 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|+..|+|||
T Consensus 149 ~~~~~~---~~~~~~~~~~y~~PE 169 (258)
T cd05578 149 KVTPDT---LTTSTSGTPGYMAPE 169 (258)
T ss_pred ccCCCc---cccccCCChhhcCHH
Confidence 654322 123456888999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=193.78 Aligned_cols=163 Identities=31% Similarity=0.552 Sum_probs=134.8
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHH
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~ 150 (246)
+.||+|+||.||++....++.+++|.+...... ...+.+|+.++++++||||+++++++......++|+||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999766899999988654433 457889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccc
Q 025893 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (246)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~ 230 (246)
+++..... .+++..++.++.+++.||.|||+++ ++||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 99865321 3778888999999999999999987 999999999999999999999999998764321111
Q ss_pred cccccccccccccCCC
Q 025893 231 LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 231 ~~~~~~~gt~~y~aPE 246 (246)
.......++..|+|||
T Consensus 150 ~~~~~~~~~~~y~~PE 165 (251)
T cd05041 150 VSDGLKQIPIKWTAPE 165 (251)
T ss_pred eccccCcceeccCChH
Confidence 1111223456799997
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=198.93 Aligned_cols=166 Identities=26% Similarity=0.348 Sum_probs=138.4
Q ss_pred cCCCCceeccCCceEEEEEEE----CCCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCee
Q 025893 68 NFGTNALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 137 (246)
+|++.+.||+|+||.||++.. .+|..+|+|.+.... ...+.+..|+.+++++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999985 268889999886432 2235678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 99999999999999986543 3778888889999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++......... ......|+..|+|||
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE 176 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPD 176 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChh
Confidence 9998765332111 123456899999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=196.61 Aligned_cols=165 Identities=32% Similarity=0.457 Sum_probs=140.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+-|+..+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++||||+++++++......++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45677888999999999999865 788999998764432 235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++... .+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 84 LGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 9999999998643 2788999999999999999999987 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|+..|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE 171 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPE 171 (277)
T ss_pred cccchh--hhccccCCccccChh
Confidence 533211 123456889999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=196.38 Aligned_cols=169 Identities=28% Similarity=0.486 Sum_probs=138.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEe--CCee
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR 137 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 137 (246)
++|...+.||+|+||.||++.+. ++..+|+|.+...... .+.+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 36777789999999999999853 3678999998766553 5678999999999999999999999887 5678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
+++|||+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999975431 3888999999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
||++.......... ......++..|+|||
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe 182 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcH
Confidence 99998764221111 111223456688987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=195.71 Aligned_cols=168 Identities=26% Similarity=0.418 Sum_probs=138.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC------CCHHHHHHHHHHHhcCCCCCccceEeEEEeC--Cee
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~------~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 137 (246)
.+|.+.+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 37888999999999999999965 78899999874321 1224678899999999999999999998764 467
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++++||+++++|.+++.... .+++.....++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence 89999999999999986532 2678888999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCcccc-ccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
||+++....... ........|+..|+|||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPE 179 (264)
T ss_pred cccccccccccccCccccccCCcccccCHh
Confidence 999976532111 11113456899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=202.45 Aligned_cols=163 Identities=31% Similarity=0.450 Sum_probs=137.8
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
|.....||+|+||.||++... ++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999865 78899999986433 3346688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|..++... .+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVSQT----------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9999887543 2788999999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... ......|++.|+|||
T Consensus 170 ~~~--~~~~~~~~~~y~aPE 187 (297)
T cd06659 170 DVP--KRKSLVGTPYWMAPE 187 (297)
T ss_pred ccc--cccceecCccccCHH
Confidence 211 123457899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=193.65 Aligned_cols=166 Identities=23% Similarity=0.381 Sum_probs=139.9
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|+..+.||+|+||.||++... +++.+|+|.+..... ....+..|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999999865 788899999865432 245788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-~~~kl~Dfgls~ 222 (246)
+++++|.+++..... ..+++..+..++.+++.+|.|||+++ ++|+||+|+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 999999999975432 23788899999999999999999987 9999999999999854 568999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....|++.|+|||
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE 171 (256)
T cd08220 151 ILSSKSK---AYTVVGTPCYISPE 171 (256)
T ss_pred ecCCCcc---ccccccCCcccCch
Confidence 6543221 23456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=194.85 Aligned_cols=171 Identities=33% Similarity=0.431 Sum_probs=144.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|++.+.||+|+||.||+|... ++..+++|.+..... ....+.+|+.+++.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999965 678899999865433 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ...+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 999999999875321 123788999999999999999999997 99999999999999999999999999876
Q ss_pred CCcccccc--ccccccccccccCCC
Q 025893 224 APDMAARL--HSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE 246 (246)
........ ......|++.|+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe 176 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPE 176 (267)
T ss_pred hccCccccccccccccCChhhcChH
Confidence 54332211 123456899999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=196.41 Aligned_cols=165 Identities=31% Similarity=0.463 Sum_probs=140.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
..|+..+.||+|+||.||+|..+ ++..+|+|.+..... ....+..|+.++++++||||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45677788999999999999976 688899998865432 235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 84 LGGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 9999999998643 2778888899999999999999986 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......++..|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE 171 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPE 171 (277)
T ss_pred ccCCcc--ccccccCcccccCHh
Confidence 543221 123356888999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=199.45 Aligned_cols=170 Identities=29% Similarity=0.450 Sum_probs=137.7
Q ss_pred CCCCceeccCCceEEEEEEEC---CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEE
Q 025893 69 FGTNALIGEGSYGRVYYGILK---SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL 139 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 139 (246)
|++.+.||+|+||.||+|..+ ++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 677889999999999999965 47889999987532 2246678899999999999999999999988 88999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC----CCceEE
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD----DDVAKI 215 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~----~~~~kl 215 (246)
||||+++ +|.+++....... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEE
Confidence 9999975 7777765332111 124788889999999999999999997 999999999999999 899999
Q ss_pred ccccCCCCCCcccc-ccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
+|||++........ ........+|+.|+|||
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 185 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHH
Confidence 99999886543222 11223456889999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=199.02 Aligned_cols=166 Identities=27% Similarity=0.409 Sum_probs=139.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 140 (246)
++|+..+.||+|+||.||+|..+ ++..+++|.+..... ....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999976 688999999864432 234567899999999999999999999877 889999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+||+. ++|.+++..... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 85 ~e~~~-~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred ehhcC-cCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCc
Confidence 99997 499888865331 3789999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......+++.|+|||
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE 176 (293)
T cd07843 153 AREYGSPLK--PYTQLVVTLWYRAPE 176 (293)
T ss_pred eeeccCCcc--ccccccccccccCch
Confidence 876543221 113345789999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=214.79 Aligned_cols=176 Identities=30% Similarity=0.458 Sum_probs=146.3
Q ss_pred HHHHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 60 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
++++....+......||-|.||.||.|.|+ ..-.||||.++.+....++|+.|+.+|+.++|||+|+++|+|..+...|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 445444556666778999999999999987 5778999999999999999999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
||+|||.+|+|.+||+..... .++.-..+.++.||..||.||..++ +|||||..+|+|+.++..+||+||
T Consensus 340 IiTEfM~yGNLLdYLRecnr~-------ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS-------EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred EEEecccCccHHHHHHHhchh-------hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence 999999999999999864321 2555566788999999999999986 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++.+.......+.. ..=...|.|||
T Consensus 410 GLsRlMtgDTYTAHAG-AKFPIKWTAPE 436 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAG-AKFPIKWTAPE 436 (1157)
T ss_pred chhhhhcCCceecccC-ccCcccccCcc
Confidence 9999865432221111 11135688887
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=192.93 Aligned_cols=167 Identities=33% Similarity=0.518 Sum_probs=139.2
Q ss_pred CCCCceeccCCceEEEEEEEC-CC----CEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SG----HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~----~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
|.+.+.||+|+||.||++... .+ ..+|+|.+..... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 345678999999999999975 33 7899999876554 3567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence 999999999998754311 1788999999999999999999996 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........... ....+++.|+|||
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~y~~Pe 174 (258)
T smart00219 151 RDLYDDDYYKK-KGGKLPIRWMAPE 174 (258)
T ss_pred eeccccccccc-ccCCCcccccChH
Confidence 76543322111 1123678999997
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=197.81 Aligned_cols=166 Identities=28% Similarity=0.424 Sum_probs=138.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|+..+.||+|+||.||+|..+ ++..+|+|.+..... ....+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999976 788999998864432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+. ++|..++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 81 LH-QDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred cc-cCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 96 689888864321 24788999999999999999999987 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+++.|+|||
T Consensus 150 ~~~~~~--~~~~~~~~~~y~aPE 170 (284)
T cd07860 150 FGVPVR--TYTHEVVTLWYRAPE 170 (284)
T ss_pred cccCcc--ccccccccccccCCe
Confidence 432211 112335788999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=196.92 Aligned_cols=157 Identities=27% Similarity=0.355 Sum_probs=128.0
Q ss_pred eeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHH---HhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSM---VSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~---l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.||+|+||.||++... +++.+|+|.+...... ...+..|..+ +....||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 6889999988654321 2233444433 334579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999886543 3889999999999999999999997 9999999999999999999999999986543
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....||+.|+|||
T Consensus 149 ~~~----~~~~~~~~~y~aPE 165 (279)
T cd05633 149 KKK----PHASVGTHGYMAPE 165 (279)
T ss_pred ccC----ccCcCCCcCccCHH
Confidence 221 12346899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=195.70 Aligned_cols=157 Identities=27% Similarity=0.353 Sum_probs=128.6
Q ss_pred eeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHH---HHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQV---SMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~---~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+||+|+||.||++... +++.+|+|.+...... ...+..|. ..++...||+|+++++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 6889999988654221 12233333 34555679999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999998886432 3889999999999999999999987 9999999999999999999999999987543
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....|++.|+|||
T Consensus 149 ~~~----~~~~~~~~~y~aPE 165 (278)
T cd05606 149 KKK----PHASVGTHGYMAPE 165 (278)
T ss_pred ccC----CcCcCCCcCCcCcH
Confidence 221 13457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=194.36 Aligned_cols=167 Identities=34% Similarity=0.523 Sum_probs=131.6
Q ss_pred eeccCCceEEEEEEEC-CCC--EEEEEEcCCCC--CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 74 LIGEGSYGRVYYGILK-SGH--AAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~-~~~--~vaik~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
+||+|+||.||+|..+ ++. .+++|.+.... ...+.+..|+.++.++ +||||+++++++...+..+++|||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 6899999999999975 444 46888776432 2235788999999999 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 148 SLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 148 ~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+|.+++........ ......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 99999875432110 011234789999999999999999999986 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .......++.|+|||
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE 181 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIE 181 (270)
T ss_pred ccccchhh---hccCCCCccccCChH
Confidence 86432111 111223456799998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=197.40 Aligned_cols=156 Identities=27% Similarity=0.491 Sum_probs=129.1
Q ss_pred eeccCCceEEEEEEEC-CC-------CEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 74 LIGEGSYGRVYYGILK-SG-------HAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~-~~-------~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.||+|+||.||+|..+ .+ ..+++|.+..... ..+.+..|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5899999999999864 22 2377777654432 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--------eEEc
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--------AKIA 216 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~--------~kl~ 216 (246)
++|+|.+++..... .+++...+.++.||+.||.|||+++ |+||||||+||+++.++. ++++
T Consensus 82 ~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 82 KFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred CCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEec
Confidence 99999999975431 3788889999999999999999997 999999999999987654 6999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++..... .....+++.|+|||
T Consensus 151 d~g~~~~~~~------~~~~~~~~~y~aPE 174 (258)
T cd05078 151 DPGISITVLP------KEILLERIPWVPPE 174 (258)
T ss_pred ccccccccCC------chhccccCCccCch
Confidence 9999865432 13356889999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=193.57 Aligned_cols=162 Identities=30% Similarity=0.553 Sum_probs=134.5
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|.+.+.||+|+||.||++.. ++..+|+|.+... .....+.+|+.++++++||||+++++++... ..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 5788899999999999999874 5778999988543 2346788999999999999999999998654 47899999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 83 GNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred CCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 999999975432 13788889999999999999999986 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.. .....+..|+|||
T Consensus 153 ~~-----~~~~~~~~y~~pe 167 (254)
T cd05083 153 GV-----DNSKLPVKWTAPE 167 (254)
T ss_pred cC-----CCCCCCceecCHH
Confidence 11 1223456799997
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=196.06 Aligned_cols=167 Identities=29% Similarity=0.442 Sum_probs=135.3
Q ss_pred hcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|.+.+.||+|+||.||+|...+ ...+++|....... ..+.+.+|+.++++++||||+++++++.+ ...+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 467888999999999999998642 24588898754432 24578899999999999999999998865 557899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++..+.+||+|||+
T Consensus 85 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 85 MELAPLGELRSYLQVNK--------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred EEcCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCce
Confidence 99999999999996532 13788999999999999999999986 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++........ ......+++.|+|||
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE 178 (270)
T cd05056 154 SRYLEDESYY-KASKGKLPIKWMAPE 178 (270)
T ss_pred eeecccccce-ecCCCCccccccChh
Confidence 8765433211 112233557899998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=193.83 Aligned_cols=163 Identities=31% Similarity=0.494 Sum_probs=134.6
Q ss_pred ceeccCCceEEEEEEECC--CC--EEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILKS--GH--AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~--~~--~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|++|.||+|.+.. +. .+|+|.+..... ..+.+..|+.++++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998642 32 589999876554 24578899999999999999999999988 889999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999876431 13789999999999999999999987 99999999999999999999999999987643
Q ss_pred cccc-cccccccccccccCCC
Q 025893 227 MAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~-~~~~~~~gt~~y~aPE 246 (246)
.... .......++..|+|||
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE 170 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPE 170 (257)
T ss_pred cccceecccCCCCCceecCHH
Confidence 2211 1112345778899998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=226.25 Aligned_cols=172 Identities=27% Similarity=0.408 Sum_probs=131.5
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeC------
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------ 134 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 134 (246)
+...+|+...+||+|+||.||+++.+ +|+.+|||++.... ..-..+.+|+.++.+|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45678888899999999999999988 99999999997654 2235678899999999999999986533211
Q ss_pred --------------------------------------------------------------------------------
Q 025893 135 -------------------------------------------------------------------------------- 134 (246)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (246)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 025893 135 ---------------------------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181 (246)
Q Consensus 135 ---------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~ 181 (246)
..+||-||||+.-.+.++++..... -......+++++|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREIL 707 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHH
Confidence 1235666777766666665433210 02455668999999
Q ss_pred HHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC----c------------cccccccccccccccccCC
Q 025893 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP----D------------MAARLHSTRVLGTFGYHAP 245 (246)
Q Consensus 182 ~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~----~------------~~~~~~~~~~~gt~~y~aP 245 (246)
+||.|+|+++ ||||||||.||+++.++.|||+|||++.... . .......+..+||.-|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999998 9999999999999999999999999997621 0 0111123567899999999
Q ss_pred C
Q 025893 246 E 246 (246)
Q Consensus 246 E 246 (246)
|
T Consensus 785 E 785 (1351)
T KOG1035|consen 785 E 785 (1351)
T ss_pred H
Confidence 8
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=197.51 Aligned_cols=166 Identities=28% Similarity=0.379 Sum_probs=140.0
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|++.+.||+|+||.||+|..+ +++.+++|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888899999999999999976 68899999886432 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
++++.+..+..... .+++..+..++.||+.||.|||.++ ++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 82 VERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred CCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 99877766554322 3788899999999999999999987 99999999999999999999999999877
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .......++..|+|||
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~~PE 171 (288)
T cd07833 150 LRARPA-SPLTDYVATRWYRAPE 171 (288)
T ss_pred cCCCcc-ccccCcccccCCcCCc
Confidence 544322 1223456889999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=193.39 Aligned_cols=167 Identities=27% Similarity=0.478 Sum_probs=141.3
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|...+.||+|+||.||++... ++..+++|.+..... ....+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999865 788999999865544 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 81 CSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 99999999986532 3678888899999999999999987 99999999999999999999999999876
Q ss_pred CCccccccc--cccccccccccCCC
Q 025893 224 APDMAARLH--STRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~--~~~~~gt~~y~aPE 246 (246)
......... .....+++.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE 173 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPE 173 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChh
Confidence 543222110 11346788999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=192.99 Aligned_cols=161 Identities=30% Similarity=0.483 Sum_probs=130.8
Q ss_pred ceeccCCceEEEEEEEC-CC---CEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~---~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|.+. .+ ..+|+|.+..... ..+.+..|+.++++++||||+++++++. ....+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999854 22 6799999876554 3467889999999999999999999876 4567999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 99999997543 3788999999999999999999986 99999999999999999999999999876533
Q ss_pred cccccc-cccccccccccCCC
Q 025893 227 MAARLH-STRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~-~~~~~gt~~y~aPE 246 (246)
...... .....++..|+|||
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE 168 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPE 168 (257)
T ss_pred CCcccccccCccccccccCHH
Confidence 221110 11122356799998
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=196.05 Aligned_cols=167 Identities=26% Similarity=0.419 Sum_probs=139.5
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+|+..+.||+|++|.||+|... ++..+|+|.+..... ..+.+..|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999976 688999999865432 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++ +|.+++..... ...+++..+..++.|++.||.|||+++ ++||||+|+||++++++.+||+|||++...
T Consensus 81 ~~-~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 81 DK-DLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred Cc-cHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 85 88888865331 123889999999999999999999987 999999999999999999999999998754
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......+|+.|++||
T Consensus 151 ~~~~~--~~~~~~~~~~y~~PE 170 (284)
T cd07836 151 GIPVN--TFSNEVVTLWYRAPD 170 (284)
T ss_pred cCCcc--ccccccccccccChH
Confidence 32211 112345788999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-30 Score=216.03 Aligned_cols=165 Identities=25% Similarity=0.332 Sum_probs=143.0
Q ss_pred hcCCCCceeccCCceEEEEEEECC-CCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.+++....||-|+||+|-++.... ...+|+|.+++.. ...+....|-++|...+.|+||+++-.|.++.++|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 355566789999999999998763 3358888886543 23456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|-|-||.|+..|+.+. .+...+...++..+++|+.|||+++ ||.|||||+|++++.+|.+||.|||+|
T Consensus 500 EaClGGElWTiLrdRg---------~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---------SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred HhhcCchhhhhhhhcC---------CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhH
Confidence 9999999999998776 3777788889999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.+.... .+.++||||.|.|||
T Consensus 568 Kki~~g~---KTwTFcGTpEYVAPE 589 (732)
T KOG0614|consen 568 KKIGSGR---KTWTFCGTPEYVAPE 589 (732)
T ss_pred HHhccCC---ceeeecCCcccccch
Confidence 9875443 347899999999998
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=202.88 Aligned_cols=167 Identities=28% Similarity=0.401 Sum_probs=137.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeC-----Cee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~ 137 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 78999999986432 2235678899999999999999999887654 357
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++++||+. ++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred EEEehhcc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECc
Confidence 89999996 4888887543 3888999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
||++.......... ......||+.|+|||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPE 179 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChH
Confidence 99987643322111 112356899999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=193.79 Aligned_cols=167 Identities=27% Similarity=0.435 Sum_probs=140.7
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|+..+.||+|+||.||++... +++.+++|.+.... ....++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778889999999999999865 78899999886432 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 81 CEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 999999998865321 13788889999999999999999986 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~~~~pe 171 (256)
T cd08218 151 LNSTVE--LARTCIGTPYYLSPE 171 (256)
T ss_pred cCcchh--hhhhccCCccccCHH
Confidence 543221 123456889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=208.66 Aligned_cols=166 Identities=31% Similarity=0.497 Sum_probs=137.9
Q ss_pred cCCCCceeccCCceEEEEEEEC---CCC--EEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK---SGH--AAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~---~~~--~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
...+.++||.|.||.||+|.+. .|. .||||.-+.+. .+.+.|+.|..+|++++|||||++.|.|.+ ...|||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3345578999999999999854 233 47888765433 346789999999999999999999999964 568999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||.++.|.|..||+..+. .|+......++.||..||.|||+.. +|||||..+|||+.+...+||+|||+
T Consensus 469 mEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred EecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 999999999999987653 4888888899999999999999985 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+........ +...-...|||||
T Consensus 538 SR~~ed~~yYka-S~~kLPIKWmaPE 562 (974)
T KOG4257|consen 538 SRYLEDDAYYKA-SRGKLPIKWMAPE 562 (974)
T ss_pred hhhccccchhhc-cccccceeecCcc
Confidence 998876554432 2333456899998
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=192.29 Aligned_cols=163 Identities=26% Similarity=0.443 Sum_probs=128.7
Q ss_pred ceeccCCceEEEEEEEC----CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEE-eCCeeEEEEecCC
Q 025893 73 ALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFAS 145 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~E~~~ 145 (246)
+.||+|+||.||+|... ....+|+|.+..... ..+.+..|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 234689998754322 2457788999999999999999999876 4556789999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... .+.+...+.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999865321 2567778889999999999999986 9999999999999999999999999987543
Q ss_pred cccc--ccccccccccccccCCC
Q 025893 226 DMAA--RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~--~~~~~~~~gt~~y~aPE 246 (246)
.... ........+++.|+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE 172 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALE 172 (262)
T ss_pred CCcceeecccccCcCCccccChh
Confidence 2111 01112334677899998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=197.00 Aligned_cols=164 Identities=29% Similarity=0.440 Sum_probs=140.7
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+|+..+.||+|+||.||++..+ +++.+++|.+..... ....+.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777788999999999999976 788999998865532 3456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
++++|.+++.... ..+++.....++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 82 DGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred CCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchh
Confidence 9999999987542 137888888999999999999999 76 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ....|+..|+|||
T Consensus 151 ~~~~~~----~~~~~~~~y~~PE 169 (265)
T cd06605 151 LVNSLA----KTFVGTSSYMAPE 169 (265)
T ss_pred hHHHHh----hcccCChhccCHH
Confidence 532211 2267889999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=195.79 Aligned_cols=168 Identities=29% Similarity=0.489 Sum_probs=133.9
Q ss_pred eeccCCceEEEEEEECC-------CCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 74 LIGEGSYGRVYYGILKS-------GHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~-------~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.||+|+||.||+|...+ +..+++|.+.... .....+.+|+.+++.++||||+++++++......+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998642 2468889875443 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-----ceEEcccc
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFD 219 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-----~~kl~Dfg 219 (246)
++++|.+++....... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||
T Consensus 82 ~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 82 EGGDLLSYLRDARVER--FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred CCCcHHHHHHHhhhcc--cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999997543211 01234788999999999999999999986 99999999999999877 89999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...............++..|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 183 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPE 183 (269)
T ss_pred cccccccccccccCcccCCCccccCHH
Confidence 987653322211112334678899998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=192.55 Aligned_cols=166 Identities=30% Similarity=0.436 Sum_probs=143.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|++.+.||+|++|.||++... ++..+++|++..... ....+..|+..+.+++||||+++++++......++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 689999999876543 356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
+++++|.+++.... .+++.....++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999997542 37889999999999999999999 86 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ .....++..|+|||
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~~pE 170 (264)
T cd06623 149 VLENTLDQ--CNTFVGTVTYMSPE 170 (264)
T ss_pred ecccCCCc--ccceeecccccCHh
Confidence 65432221 12446889999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=195.43 Aligned_cols=167 Identities=24% Similarity=0.365 Sum_probs=136.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|+..+.||+|++|.||+|..+ +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 788999998865432 23567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls 221 (246)
|++ ++|.+++..... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++
T Consensus 82 ~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-------FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred ccc-ccHHHHHHhCCC-------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 996 588887754332 12567778889999999999999986 999999999999985 567999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......|++.|+|||
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~PE 173 (294)
T PLN00009 151 RAFGIPVR--TFTHEVVTLWYRAPE 173 (294)
T ss_pred cccCCCcc--ccccCceeecccCHH
Confidence 75432211 112345788999997
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=196.49 Aligned_cols=169 Identities=28% Similarity=0.445 Sum_probs=136.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe-----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----- 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----- 136 (246)
.++|...+.||+|+||.||+|..+ +++.+|+|.+.... .....+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 458999999999999999999976 78899999885432 223456689999999999999999999876543
Q ss_pred ---eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 137 ---RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 137 ---~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
.++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--------VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL 158 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence 499999996 48888875432 13789999999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCccccc--cccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
||+|||++......... .......++..|+|||
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 193 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcH
Confidence 99999998765432211 1112345788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=193.01 Aligned_cols=157 Identities=25% Similarity=0.366 Sum_probs=135.5
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
||.|+||.||++... ++..+++|.+..... ..+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 688999999865432 235688899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~ 229 (246)
.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 81 WTILRDRG---------LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred HHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 99996543 2788888999999999999999986 9999999999999999999999999988764322
Q ss_pred ccccccccccccccCCC
Q 025893 230 RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ~~~~~~~~gt~~y~aPE 246 (246)
......|++.|++||
T Consensus 148 --~~~~~~~~~~~~~PE 162 (262)
T cd05572 148 --KTWTFCGTPEYVAPE 162 (262)
T ss_pred --ccccccCCcCccChh
Confidence 123457899999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=201.92 Aligned_cols=164 Identities=27% Similarity=0.358 Sum_probs=136.3
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeC------
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG------ 134 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 134 (246)
+.+.|+..+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4678999999999999999999965 789999999864322 234677899999999999999999988644
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
...|+||||+. ++|.+.+... +++..+..++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 35699999996 5888877431 677888899999999999999997 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++....... .....||+.|+|||
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE 187 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPE 187 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHH
Confidence 999999976533211 23456889999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=195.42 Aligned_cols=170 Identities=26% Similarity=0.369 Sum_probs=136.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCe-----
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS----- 136 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~----- 136 (246)
++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++++. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999976 788999998764432 2356788999999996 6999999999887665
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEE
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKI 215 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl 215 (246)
.|++|||+++ +|.+++...... ....+++..+..++.||+.||.|||+++ |+||||+|+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence 7999999985 898887643321 1124789999999999999999999997 999999999999998 889999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++........ ......+++.|+|||
T Consensus 153 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE 181 (295)
T cd07837 153 ADLGLGRAFSIPVK--SYTHEIVTLWYRAPE 181 (295)
T ss_pred eecccceecCCCcc--ccCCcccccCCCChH
Confidence 99999875432211 112235788999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=201.56 Aligned_cols=168 Identities=27% Similarity=0.441 Sum_probs=138.2
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcC-CCCCccceEeEEEeC--Cee
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG--TSR 137 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~ 137 (246)
+.++|.+.+.||+|+||.||+|... ++..+|+|++.... .....+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 5678899999999999999999976 68889999885432 2234567899999999 999999999998653 467
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+. ++|..++... .+.+.....++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred EEEecccc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence 99999997 5999888643 2778888899999999999999986 99999999999999999999999
Q ss_pred ccCCCCCCccccc---cccccccccccccCCC
Q 025893 218 FDLSNQAPDMAAR---LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~---~~~~~~~gt~~y~aPE 246 (246)
||++......... .......||+.|+|||
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 182 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPE 182 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCce
Confidence 9998765432211 1123456899999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=194.97 Aligned_cols=159 Identities=26% Similarity=0.360 Sum_probs=133.7
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
||+|+||+||++... +++.+|+|.+.... .....+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 78899999886432 1234567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~ 229 (246)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 149 (277)
T cd05577 81 KYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK- 149 (277)
T ss_pred HHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-
Confidence 999865432 23788999999999999999999997 9999999999999999999999999987643211
Q ss_pred ccccccccccccccCCC
Q 025893 230 RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ~~~~~~~~gt~~y~aPE 246 (246)
......++..|+|||
T Consensus 150 --~~~~~~~~~~y~~PE 164 (277)
T cd05577 150 --KIKGRAGTPGYMAPE 164 (277)
T ss_pred --ccccccCCCCcCCHH
Confidence 113346788999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=204.46 Aligned_cols=169 Identities=27% Similarity=0.390 Sum_probs=137.8
Q ss_pred cCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCC--CH------HHHHHHHHHHhcCCCCCccceEeEEE-eCCee
Q 025893 68 NFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQ--PD------EEFLAQVSMVSRLKHENFVQLLGYCV-DGTSR 137 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~--~~------~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~ 137 (246)
.|-++.+||+|+|+.||+|.. ...+.||+|+-...+. +. +...+|..|.+.|+||.||++++++. +....
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 466667899999999999984 4677889987543332 21 23457899999999999999999986 45566
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceE
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK 214 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~k 214 (246)
+-|+|||+|.+|..||+..+ .+++..++.|+.||+.||.||... .|+|||=||||.|||+.+ -|.+|
T Consensus 544 CTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 78999999999999998765 478999999999999999999998 678999999999999964 47899
Q ss_pred EccccCCCCCCccccc-----cccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
|.||||++.+...... ...+...||.+|++||
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPE 650 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPE 650 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcc
Confidence 9999999986543221 1234568999999998
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=196.05 Aligned_cols=162 Identities=32% Similarity=0.484 Sum_probs=137.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-C---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-P---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.|...+.||+|+||.||+|... +++.+|+|.+..... . ...+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46888899999999999999975 788999998854322 2 246788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+. |++.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.+||+|||++
T Consensus 95 e~~~-g~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 95 EYCL-GSASDILEVHK--------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred HhhC-CCHHHHHHHcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence 9997 57777765322 13788999999999999999999987 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ....|++.|+|||
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE 181 (307)
T cd06607 163 SLVSPA------NSFVGTPYWMAPE 181 (307)
T ss_pred eecCCC------CCccCCccccCce
Confidence 754321 3456889999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=201.04 Aligned_cols=163 Identities=29% Similarity=0.419 Sum_probs=136.8
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----- 135 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 135 (246)
+.++|++.+.||+|+||.||++... ++..||+|++..... ....+..|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999865 789999998854322 2346788999999999999999999987654
Q ss_pred -eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 136 -SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 136 -~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
..++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 348999998 77998887542 2788999999999999999999987 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||++...... .....+++.|+|||
T Consensus 159 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE 185 (343)
T cd07880 159 ILDFGLARQTDSE-----MTGYVVTRWYRAPE 185 (343)
T ss_pred EeecccccccccC-----ccccccCCcccCHH
Confidence 9999998764321 12346789999997
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=190.96 Aligned_cols=169 Identities=22% Similarity=0.377 Sum_probs=138.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 141 (246)
+|++.+.||.|+||.||++... ++..+|+|.+...... .+.+..|+.++++++||||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778889999999999999865 7888999988644332 3467789999999999999999998764 45678999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-----EKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-----~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
||+++++|.+++..... ....+++..+..++.|++.||.||| +.+ ++|+||+|+||+++.++.+||+
T Consensus 81 e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-----ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred hhccCCCHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence 99999999999865421 1124888999999999999999999 664 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++........ ......|++.|+|||
T Consensus 153 d~g~~~~~~~~~~--~~~~~~~~~~~~~pE 180 (265)
T cd08217 153 DFGLAKILGHDSS--FAKTYVGTPYYMSPE 180 (265)
T ss_pred cccccccccCCcc--cccccccCCCccChh
Confidence 9999887543221 123456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=195.18 Aligned_cols=170 Identities=29% Similarity=0.432 Sum_probs=138.9
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC----
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT---- 135 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~---- 135 (246)
...++|++.+.||+|+||.||+|..+ +++.+|+|.+.... .....+..|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999976 68899999986432 23356778999999999999999999987654
Q ss_pred ------eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 025893 136 ------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 136 ------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~ 209 (246)
..++++||+++ ++.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~ 151 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNN 151 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 78999999976 7777775432 13789999999999999999999997 999999999999999
Q ss_pred CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||++......... ......+++.|+|||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE 187 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPE 187 (302)
T ss_pred CCcEEeCcccccccccCCccc-ccccceeccCccChH
Confidence 999999999998765432211 112234678899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=196.60 Aligned_cols=167 Identities=34% Similarity=0.455 Sum_probs=137.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 139 (246)
.++|+..+.||+|+||.||+|..+ +++.||+|.+...... ...+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999975 7899999988643221 23566899999999999999999998765 56899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 86 v~e~~~-~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEecCC-CCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccc
Confidence 999996 48888876432 13789999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++......... .....+++.|+|||
T Consensus 154 ~~~~~~~~~~~--~~~~~~~~~y~aPE 178 (309)
T cd07845 154 LARTYGLPAKP--MTPKVVTLWYRAPE 178 (309)
T ss_pred eeeecCCccCC--CCcccccccccChh
Confidence 98765432211 12234678899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=193.15 Aligned_cols=164 Identities=30% Similarity=0.478 Sum_probs=138.3
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.|..-+.||+|++|.||++... ++..+++|.+..... ..+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4445578999999999999965 788999998864432 34567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++... .+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||++....
T Consensus 100 ~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 100 GGALTDIVTHT----------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 99999998652 2788889999999999999999997 9999999999999999999999999876543
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......|++.|+|||
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE 185 (285)
T cd06648 167 KEVP--RRKSLVGTPYWMAPE 185 (285)
T ss_pred cCCc--ccccccCCccccCHH
Confidence 2211 123356899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=194.48 Aligned_cols=167 Identities=32% Similarity=0.426 Sum_probs=137.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~E 142 (246)
+|...+.||.|++|.||++... +++.+|+|.+..... ....+.+|++++++++||||+++++++... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999975 688899998865433 346788999999999999999999988654 46899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 82 YCEGGSLDSIYKKVKK-----RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred ecCCCCHHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccc
Confidence 9999999988754221 1123788889999999999999999987 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ....++..|+|||
T Consensus 154 ~~~~~~~----~~~~~~~~y~~pE 173 (287)
T cd06621 154 ELVNSLA----GTFTGTSFYMAPE 173 (287)
T ss_pred ccccccc----ccccCCccccCHH
Confidence 5432211 2345788999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=199.22 Aligned_cols=167 Identities=29% Similarity=0.435 Sum_probs=138.2
Q ss_pred HHHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeC--
Q 025893 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG-- 134 (246)
Q Consensus 61 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-- 134 (246)
++..+.++|...+.||+|+||.||++... ++..||+|++..... ..+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 34456689999999999999999999864 788999999865432 235677899999999999999999987643
Q ss_pred ----CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 135 ----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 135 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 3467888876 78998887643 2788999999999999999999997 9999999999999999
Q ss_pred CceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.+||+|||++...... .....||+.|+|||
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE 187 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPE 187 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHH
Confidence 99999999998764321 13456889999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=188.67 Aligned_cols=165 Identities=33% Similarity=0.546 Sum_probs=142.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|.+.+.||+|++|.||++... ++..+++|.+..... ..+.+.+|++++++++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999866 678999999876543 345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 99999999986542 3789999999999999999999987 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....|+..|+|||
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe 169 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPE 169 (254)
T ss_pred cCCCccc--ccccccchhhcCHh
Confidence 5432221 23456889999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=193.53 Aligned_cols=169 Identities=33% Similarity=0.474 Sum_probs=145.1
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
..+.|...+.||+|+||.||++... ++..+++|.+.......+.+..|+.+++.++|+||+++++.+......++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3567888889999999999999976 788999999876544566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 97 ~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 97 MDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred cCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 99999999997643 13888999999999999999999986 99999999999999999999999998765
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+++.|++||
T Consensus 166 ~~~~~~--~~~~~~~~~~y~~PE 186 (286)
T cd06614 166 LTKEKS--KRNSVVGTPYWMAPE 186 (286)
T ss_pred hccchh--hhccccCCcccCCHh
Confidence 433221 123446888999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-27 Score=192.25 Aligned_cols=162 Identities=29% Similarity=0.418 Sum_probs=133.8
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCC-CCCccceEeEEEeC--CeeEEEEe
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDG--TSRVLAYE 142 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~~~lv~E 142 (246)
|.+.+.||+|+||.||++..+ ++..+|+|.+..... .......|+.++.++. ||||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999965 788999998865432 2234457888899886 99999999999987 88999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++.
T Consensus 81 ~~~-~~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 81 LMD-MNLYELIKGRK--------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cCC-ccHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence 997 58888876532 13789999999999999999999997 999999999999999 999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....+++.|+|||
T Consensus 148 ~~~~~~~---~~~~~~~~~y~aPE 168 (282)
T cd07831 148 GIYSKPP---YTEYISTRWYRAPE 168 (282)
T ss_pred ccccCCC---cCCCCCCcccCChh
Confidence 6543221 13346889999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=190.05 Aligned_cols=172 Identities=27% Similarity=0.377 Sum_probs=133.4
Q ss_pred CCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 69 FGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
|.+.+.||+|+||.||+|..+ ++..+|+|.+...... .+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556778999999999999854 3678999988654322 356788999999999999999999886542
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++++||+.+|+|.+++....... ....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence 2468899999999998875322110 1123788889999999999999999986 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++...............+++.|++||
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHh
Confidence 9999988654322211122334567888887
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=195.13 Aligned_cols=168 Identities=29% Similarity=0.391 Sum_probs=142.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 140 (246)
++|...+.||+|+||.||++..+ ++..+++|.+.... .....+..|+.++++++ ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999976 78999999886532 22356778999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence 99999999999997543 3889999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCccccc------------------cccccccccccccCCC
Q 025893 221 SNQAPDMAAR------------------LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~------------------~~~~~~~gt~~y~aPE 246 (246)
+......... .......|+..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe 192 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHH
Confidence 8765432210 1123456889999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=191.29 Aligned_cols=167 Identities=29% Similarity=0.500 Sum_probs=139.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|...+.||+|+||.||++..+ ++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999976 68889999986432 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Dfgls~ 222 (246)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .+||+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence 999999999865331 13788999999999999999999986 99999999999999875 57999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......|++.|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~ape 172 (257)
T cd08225 151 QLNDSME--LAYTCVGTPYYLSPE 172 (257)
T ss_pred hccCCcc--cccccCCCccccCHH
Confidence 6543221 112346899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=194.47 Aligned_cols=159 Identities=33% Similarity=0.499 Sum_probs=135.5
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHH
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~ 150 (246)
..||+|+||.||++..+ ++..+|+|++..... ....+.+|+.+++.++||||+++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999875 788999998864332 3456888999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccc
Q 025893 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (246)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~ 230 (246)
+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 106 ~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 106 DIVTHT----------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 987543 2788889999999999999999997 99999999999999999999999999875432211
Q ss_pred cccccccccccccCCC
Q 025893 231 LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 231 ~~~~~~~gt~~y~aPE 246 (246)
......|++.|+|||
T Consensus 172 -~~~~~~~~~~y~~pE 186 (292)
T cd06657 172 -RRKSLVGTPYWMAPE 186 (292)
T ss_pred -cccccccCccccCHH
Confidence 123456899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=191.68 Aligned_cols=160 Identities=29% Similarity=0.421 Sum_probs=135.2
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
||.|+||.||++... +++.+++|.+..... ..+.+.+|+.++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 689999999865433 345688899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~ 229 (246)
.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 99987543 3788999999999999999999987 99999999999999999999999999875432211
Q ss_pred ------ccccccccccccccCCC
Q 025893 230 ------RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ------~~~~~~~~gt~~y~aPE 246 (246)
........+++.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe 171 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPE 171 (265)
T ss_pred cccccccccccCcccCccccCHH
Confidence 00123456888999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=191.25 Aligned_cols=165 Identities=28% Similarity=0.395 Sum_probs=137.9
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
|+..+.||+|++|.||+|... ++..+|+|++..... ....+.+|+.++++++||||+++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567788999999999999975 789999998865432 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
. ++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 5 689998865431 13789999999999999999999986 999999999999999999999999998764
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....+++.|+|||
T Consensus 150 ~~~~~~--~~~~~~~~~~~aPE 169 (283)
T cd07835 150 GVPVRT--YTHEVVTLWYRAPE 169 (283)
T ss_pred CCCccc--cCccccccCCCCCc
Confidence 322111 12235688999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-26 Score=193.52 Aligned_cols=162 Identities=33% Similarity=0.500 Sum_probs=136.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
..|...+.||+|+||.||++... ++..+|+|.+...... ...+..|+.++++++|||++++++++.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777888999999999999965 7889999998644322 246788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+. |+|.+++.... ..+++..+..++.+++.||.|||+++ |+||||+|+||+++.++.+||+|||++
T Consensus 105 e~~~-g~l~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 105 EYCL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred eCCC-CCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 9997 48877775432 13788999999999999999999987 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....|++.|+|||
T Consensus 173 ~~~~~------~~~~~~~~~y~aPE 191 (317)
T cd06635 173 SIASP------ANSFVGTPYWMAPE 191 (317)
T ss_pred cccCC------cccccCCccccChh
Confidence 65432 13456889999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=204.80 Aligned_cols=167 Identities=22% Similarity=0.382 Sum_probs=141.0
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E 142 (246)
..|++.+.||+||.++||++...+.+.+|+|++.... .....|.+|+..|.+|+ |.+||++++|-..++++|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4688889999999999999998877888888875433 33567999999999997 9999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|- ..+|..+|+...... ..| .+..+..|++.++.++|.++ |||.||||.|+|+. .|.+||+|||+|.
T Consensus 441 ~G-d~DL~kiL~k~~~~~-------~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSID-------PDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred cc-cccHHHHHHhccCCC-------chH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhc
Confidence 86 469999998765321 223 66788999999999999997 99999999999985 5789999999999
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
......+.....+-+||+.||+||
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPE 531 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPE 531 (677)
T ss_pred ccCccccceeeccccCcccccCHH
Confidence 877655554455668999999998
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=187.69 Aligned_cols=175 Identities=30% Similarity=0.402 Sum_probs=144.0
Q ss_pred HhcCCCCceeccCCceEEEEEE-ECCCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeE
Q 025893 66 TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 138 (246)
.++|.+.+.||+|||+.||++. ..++..+|+|++.... .+.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3589999999999999999998 4588999999987555 55678889999999999999999988876544 489
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
|++.|...|+|.+.+..... .+..+++.+.+.++.+|+.||++||+. .|++.||||||.|||+.+.+.++|.||
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~-----kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI-----KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred EEeehhccccHHHHHHHHhh-----cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 99999999999999976542 223589999999999999999999998 567999999999999999999999999
Q ss_pred cCCCCCCccccccc-------cccccccccccCCC
Q 025893 219 DLSNQAPDMAARLH-------STRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~-------~~~~~gt~~y~aPE 246 (246)
|.+...+....... ...---|..|.|||
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPE 208 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPE 208 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCch
Confidence 99887653221100 01112478899998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=195.59 Aligned_cols=167 Identities=22% Similarity=0.308 Sum_probs=141.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+..+||+|+|.+|.+++++ +.+.+|+|.+++.-. +..-...|-.+..+. +||++|-++.+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999975 788999998865422 223344555555544 59999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
|.||++||+|...++..+ .|+++.++.+..+|..||.|||++| |+.||||.+|+|+|..|++||.|+|
T Consensus 329 vieyv~ggdlmfhmqrqr---------klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred EEEEecCcceeeehhhhh---------cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccc
Confidence 999999999988776554 3899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++..-... ...+++||||.|+|||
T Consensus 397 mcke~l~~g--d~tstfcgtpnyiape 421 (593)
T KOG0695|consen 397 MCKEGLGPG--DTTSTFCGTPNYIAPE 421 (593)
T ss_pred hhhcCCCCC--cccccccCCCcccchh
Confidence 998643322 2347899999999998
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=196.75 Aligned_cols=165 Identities=28% Similarity=0.389 Sum_probs=137.9
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEe-CCee
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSR 137 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 137 (246)
..+.++|+..+.||+|+||.||++... ++..+|+|++.... ...+.+..|+.++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345778999999999999999999866 78999999875432 234677889999999999999999999875 5678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++++||+ +++|.+++... .+++.....++.|++.||.|||+++ |+||||+|+||+++.++.+||+|
T Consensus 86 ~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR----------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EEEeehh-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence 8999998 56898888643 2677888889999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++...... .....+++.|+|||
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE 175 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPE 175 (328)
T ss_pred cccccccCCC-----cCCCcccccccCce
Confidence 9998753221 12346788999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=198.33 Aligned_cols=168 Identities=26% Similarity=0.407 Sum_probs=137.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEe----CCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~ 137 (246)
.++|++.+.||+|+||.||++... ++..+|+|++.... .....+..|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999965 78999999986542 234567789999999999999999988763 3567
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++|+||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 99999995 68988886432 3788999999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCcccccc--ccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARL--HSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~--~~~~~~gt~~y~aPE 246 (246)
||++.......... ......|+..|+|||
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChH
Confidence 99987643221111 112347899999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=196.38 Aligned_cols=168 Identities=29% Similarity=0.420 Sum_probs=136.0
Q ss_pred HhcCC-CCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---------------HHHHHHHHHHhcCCCCCccceE
Q 025893 66 TENFG-TNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---------------EEFLAQVSMVSRLKHENFVQLL 128 (246)
Q Consensus 66 ~~~~~-~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---------------~~~~~e~~~l~~l~hp~iv~~~ 128 (246)
.++|. +.+.||+|+||.||+|..+ +++.+|+|.+....... ..+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34564 3567999999999999965 78899999885432211 2467899999999999999999
Q ss_pred eEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 025893 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 208 (246)
Q Consensus 129 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~ 208 (246)
+++...+..+++|||+. ++|.+++.... .+++.....++.|++.||.|||+.+ |+|+||+|+||+++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~ 153 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN 153 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence 99999999999999996 69999886532 3788899999999999999999987 99999999999999
Q ss_pred CCCceEEccccCCCCCCccc------------cccccccccccccccCCC
Q 025893 209 DDDVAKIADFDLSNQAPDMA------------ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 209 ~~~~~kl~Dfgls~~~~~~~------------~~~~~~~~~gt~~y~aPE 246 (246)
.++.+||+|||++....... .........+++.|+|||
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 203 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPE 203 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCCh
Confidence 99999999999987643110 001112335788999998
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=187.79 Aligned_cols=164 Identities=25% Similarity=0.296 Sum_probs=132.5
Q ss_pred HHHHHHhcCCCCcee--ccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 61 ELKEITENFGTNALI--GEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 61 ~~~~~~~~~~~~~~l--G~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++.+...+.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 344455677777666 99999999999965 788899998865432221 22222212 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEE
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKI 215 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl 215 (246)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEE
Confidence 999999999999999997543 3889999999999999999999997 99999999999999888 9999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++...... ....|++.|+|||
T Consensus 152 ~dfg~~~~~~~~------~~~~~~~~y~aPE 176 (267)
T PHA03390 152 CDYGLCKIIGTP------SCYDGTLDYFSPE 176 (267)
T ss_pred ecCccceecCCC------ccCCCCCcccChh
Confidence 999998754321 2346899999998
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=186.45 Aligned_cols=169 Identities=28% Similarity=0.475 Sum_probs=143.3
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|.+.+.||+|+||.||++... ++..+++|.+..... ....+..|+++++.++|||++++.+.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999975 788999999865433 345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ....+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 999999999876431 1124889999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......|++.|+|||
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~pe 173 (258)
T cd08215 153 LSSTVD--LAKTVVGTPYYLSPE 173 (258)
T ss_pred cccCcc--eecceeeeecccChh
Confidence 543321 123457899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=185.24 Aligned_cols=165 Identities=35% Similarity=0.553 Sum_probs=143.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+|...+.||+|++|.||++... ++..+++|.+..... ....+.+|+.++++++||||+++.+.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999976 788899999865543 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++.... ..+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 81 GGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred CCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 999999987542 13889999999999999999999986 9999999999999999999999999987754
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... .....|+..|++||
T Consensus 150 ~~~~---~~~~~~~~~~~~PE 167 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPE 167 (253)
T ss_pred cccc---ccceecCCcccCHH
Confidence 3321 23456889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=197.70 Aligned_cols=166 Identities=27% Similarity=0.400 Sum_probs=137.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeC-----Ce
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 136 (246)
.+.|.+.+.||+|+||.||++... ++..||+|.+.... .....+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999965 78999999986432 2345677899999999999999999987644 34
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 799999995 68988886432 3888999999999999999999986 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++........ ......+|..|+|||
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 178 (337)
T cd07858 151 DFGLARTTSEKGD--FMTEYVVTRWYRAPE 178 (337)
T ss_pred cCccccccCCCcc--cccccccccCccChH
Confidence 9999876543221 123456889999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=186.71 Aligned_cols=167 Identities=32% Similarity=0.483 Sum_probs=142.5
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 141 (246)
+|...+.||+|++|.||+|... ++..+++|.+..... ..+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999976 788999999865542 356788999999999999999999999988 8899999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999987543 3889999999999999999999986 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
................++..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE 173 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPE 173 (260)
T ss_pred EecccccccccccCCCCCccccCHh
Confidence 7654432211123456889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=189.55 Aligned_cols=169 Identities=24% Similarity=0.430 Sum_probs=135.5
Q ss_pred cCCCCceeccCCceEEEEEEECC--CCEEEEEEcCCCC-----------CCHHHHHHHHHHHhc-CCCCCccceEeEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILKS--GHAAAIKKLDASK-----------QPDEEFLAQVSMVSR-LKHENFVQLLGYCVD 133 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~--~~~vaik~~~~~~-----------~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~ 133 (246)
+|++.+.||+|+||.||++..+. +..+|+|.+.... ....++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 6789999874321 112456678887765 789999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
.+..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.. .++|+||+|+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-----KKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcE
Confidence 9999999999999999988754221 1124788899999999999999999632 39999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++....... ......|+..|+|||
T Consensus 154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe 183 (269)
T cd08528 154 TITDFGLAKQKQPES---KLTSVVGTILYSCPE 183 (269)
T ss_pred EEecccceeeccccc---ccccccCcccCcChh
Confidence 999999987654322 123456889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=191.54 Aligned_cols=164 Identities=29% Similarity=0.458 Sum_probs=137.3
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
|++.+.||+|+||.||+|... +++.+++|++..... ......+|+..+++++ ||||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999976 678899999865433 2234557899999999 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+++|.+++..... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence 7899988865431 23789999999999999999999987 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....|+..|+|||
T Consensus 150 ~~~~~---~~~~~~~~~~~aPE 168 (283)
T cd07830 150 RSRPP---YTDYVSTRWYRAPE 168 (283)
T ss_pred cCCCC---cCCCCCcccccCce
Confidence 33221 13346888999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=190.17 Aligned_cols=165 Identities=31% Similarity=0.472 Sum_probs=137.6
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEe
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAYE 142 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~E 142 (246)
|++.+.||+|+||.||+|... ++..+|+|.+.... .....+..|+.++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999976 68899999987553 2345688899999999999999999999888 88999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++ +|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 81 YMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cccc-cHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9974 8988886532 13788999999999999999999987 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......++..|+|||
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~PE 171 (287)
T cd07840 149 PYTKRNSA-DYTNRVITLWYRPPE 171 (287)
T ss_pred eccCCCcc-cccccccccccCCce
Confidence 65433211 112345788899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-28 Score=213.05 Aligned_cols=167 Identities=32% Similarity=0.472 Sum_probs=147.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|.+...+|.|+||.||+++.+ +++..|+|.++....+ ...+..|+-+++.-+|||||.+++.+......|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468999999999999999999965 8899999998765433 45566789999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
|.+|+|++.-.... .+++.++..++++.+.||+|||+++ -+|||||-.|||+.+.|.+|+.|||.+..
T Consensus 94 cgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred cCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh
Confidence 99999998776543 4888999999999999999999997 89999999999999999999999999987
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... ....+.|||+|||||
T Consensus 162 itati~--KrksfiGtpywmapE 182 (829)
T KOG0576|consen 162 ITATIA--KRKSFIGTPYWMAPE 182 (829)
T ss_pred hhhhhh--hhhcccCCccccchh
Confidence 654433 346789999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=218.15 Aligned_cols=162 Identities=25% Similarity=0.492 Sum_probs=133.9
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
..+...|...+.||+|+||.||+|..+ ++..||+|++....... ..|+.++++++|||||++++++.+....++||
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 344567888889999999999999975 78899999986443222 24588899999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.++++. ++|..+..++.|++.||.|||....++|+||||||+||+++.++..++. ||..
T Consensus 763 Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 763 EYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred eCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 99999999999852 7889999999999999999996655569999999999999998887775 6654
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....||+.|||||
T Consensus 830 ~~~~~------~~~~~~t~~y~aPE 848 (968)
T PLN00113 830 GLLCT------DTKCFISSAYVAPE 848 (968)
T ss_pred ccccc------CCCccccccccCcc
Confidence 43211 12346899999998
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=187.28 Aligned_cols=156 Identities=27% Similarity=0.356 Sum_probs=129.1
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHH-HhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|... +++.+|+|.+...... ...+..|..+ ...++||||+++++++...+..|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 6889999998654321 1233445444 4456899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 99999986543 3788889999999999999999986 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.....|++.|+|||
T Consensus 150 ------~~~~~~~~~y~~pe 163 (260)
T cd05611 150 ------NKKFVGTPDYLAPE 163 (260)
T ss_pred ------cccCCCCcCccChh
Confidence 23456889999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=194.26 Aligned_cols=166 Identities=25% Similarity=0.328 Sum_probs=133.3
Q ss_pred cCCCCceeccCCceEEEEEEEC-C--CCEEEEEEcCCCC---CCHHHHHHHHHHHhcC-CCCCccceEeEEEeC----Ce
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-S--GHAAAIKKLDASK---QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG----TS 136 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~--~~~vaik~~~~~~---~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~----~~ 136 (246)
+|.+.+.||+|+||.||++... + +..+|+|.+.... .....+..|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999975 4 7789999886432 1245678899999999 499999999875432 45
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.++++||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence 688899885 68998886432 3788999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccc--cccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
|||+++........ .......||+.|+|||
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE 179 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPE 179 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcH
Confidence 99999765432211 1123457899999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=191.39 Aligned_cols=166 Identities=25% Similarity=0.330 Sum_probs=137.1
Q ss_pred cCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCee
Q 025893 68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 137 (246)
+|++.+.||+|+||.||++... ++..+|+|.+.... ...+.+..|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677889999999999998742 56789999886432 1235677899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 99999999999999886432 3788888899999999999999986 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+++........ ......|++.|+|||
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE 176 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPE 176 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHH
Confidence 9998765432211 112356889999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=189.03 Aligned_cols=161 Identities=32% Similarity=0.504 Sum_probs=135.3
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.|...+.||+|+||.||+|... ++..+++|.+...... ...+..|+.+++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3666678999999999999965 7889999998643321 2467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+. +++.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++.
T Consensus 102 ~~~-~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 102 YCL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred cCC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 996 57877775432 13788899999999999999999997 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... .....|+..|+|||
T Consensus 170 ~~~~------~~~~~~~~~y~aPE 187 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPE 187 (313)
T ss_pred ccCC------CCCccccccccChh
Confidence 4321 13457899999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=191.44 Aligned_cols=168 Identities=30% Similarity=0.394 Sum_probs=132.2
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|.....||+|+||.||++... ++..+|+|.+..... ....+..|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999976 788999999865432 2356788999999996 99999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
+. +++.++...... .....+++..+..++.+++.||.|||+. + |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~-~~l~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 85 MD-ISLDKFYKYVYE----VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred cc-CCHHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhH
Confidence 86 455544321100 0012488899999999999999999974 5 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....|++.|+|||
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE 177 (288)
T cd06616 157 QLVDSIA---KTRDAGCRPYMAPE 177 (288)
T ss_pred HhccCCc---cccccCccCccCHH
Confidence 5432221 13346889999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=192.07 Aligned_cols=169 Identities=28% Similarity=0.436 Sum_probs=135.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
.++|.+.+.||+|+||.||+|..+ +++.+|+|.+..... ....+.+|+.++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999976 788999998854322 2346778999999999999999998875443
Q ss_pred --eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 136 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
..++++||+.+ +|...+.... ..+++..+..++.|++.||.|||+++ |+|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 45899999965 7777665322 23889999999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCccccc---------cccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAAR---------LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~---------~~~~~~~gt~~y~aPE 246 (246)
||+|||++......... .......|++.|+|||
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChH
Confidence 99999998764322111 0112346788999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=193.06 Aligned_cols=161 Identities=30% Similarity=0.420 Sum_probs=133.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
.++|...+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468989999999999999999965 78999999986432 22356788999999999999999999987543
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++|+||+. .+|..++.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEecccc-cCHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 4589999996 477766531 2788889999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++..... .....+|+.|+|||
T Consensus 159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE 184 (342)
T cd07879 159 LDFGLARHADAE-----MTGYVVTRWYRAPE 184 (342)
T ss_pred eeCCCCcCCCCC-----CCCceeeecccChh
Confidence 999998764321 13346789999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=186.66 Aligned_cols=167 Identities=29% Similarity=0.476 Sum_probs=140.5
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+|++.+.||+|+||.||++..+ ++..+++|.+..... ....+..|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999865 788999999865432 234677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 81 APFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred cCCCCHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 999999998865321 1124788899999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....|++.|++||
T Consensus 153 ~~~~~----~~~~~~~~~~~~Pe 171 (256)
T cd08530 153 LKKNM----AKTQIGTPHYMAPE 171 (256)
T ss_pred hccCC----cccccCCccccCHH
Confidence 54331 12345888999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=190.46 Aligned_cols=162 Identities=30% Similarity=0.492 Sum_probs=135.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.|...+.||+|+||.||+|..+ ++..+++|.+..... ...++..|+.+++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666778999999999999976 678899998864321 1246778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+. |++.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 95 e~~~-~~l~~~~~~~~--------~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 95 EYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred EccC-CCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence 9996 58887775332 13778889999999999999999986 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....|++.|+|||
T Consensus 163 ~~~~~------~~~~~~~~~y~aPE 181 (308)
T cd06634 163 SIMAP------ANXFVGTPYWMAPE 181 (308)
T ss_pred eeecC------cccccCCccccCHH
Confidence 65432 13456889999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=191.37 Aligned_cols=163 Identities=21% Similarity=0.292 Sum_probs=129.8
Q ss_pred eeccC--CceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 74 LIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 74 ~lG~G--~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
.||+| +||+||++.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++......++++||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999975 7999999998654433 256788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcc
Q 025893 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (246)
Q Consensus 148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~ 227 (246)
+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+|++||+.+......
T Consensus 85 ~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 85 SANSLLKTYFP-------EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred CHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 99999875431 13788888899999999999999986 999999999999999999999999754322111
Q ss_pred ccc-----cccccccccccccCCC
Q 025893 228 AAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~-----~~~~~~~gt~~y~aPE 246 (246)
... .......++..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE 178 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPE 178 (328)
T ss_pred CccccccccccccccCccCccChh
Confidence 100 0011123566799998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=179.23 Aligned_cols=165 Identities=30% Similarity=0.381 Sum_probs=132.4
Q ss_pred CCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHH-hcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 71 TNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMV-SRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
....||+|++|.|-+-++. +|...|+|.+...- ...++.++|+.+. +...+|++|+++|...+...+|+.||.|.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 3446999999999888876 79999999986543 3345677888765 45579999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
-+|..+-+.... .+..+++...=+|+..|..||.|||++- .++|||+||+||||+.+|.+|++|||++..+..
T Consensus 129 tSldkfy~~v~~-----~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 129 TSLDKFYRKVLK-----KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred hhHHHHHHHHHh-----cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 477665543211 1234777777789999999999999975 699999999999999999999999999988765
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
+... +.-.|.-.|||||
T Consensus 202 SiAk---t~daGCkpYmaPE 218 (282)
T KOG0984|consen 202 SIAK---TMDAGCKPYMAPE 218 (282)
T ss_pred hhHH---HHhcCCCccCChh
Confidence 5432 3356889999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=200.29 Aligned_cols=177 Identities=24% Similarity=0.385 Sum_probs=129.0
Q ss_pred HhcCCCCceeccCCceEEEEEEE-----------------CCCCEEEEEEcCCCCCC-HHH--------------HHHHH
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-----------------KSGHAAAIKKLDASKQP-DEE--------------FLAQV 113 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~vaik~~~~~~~~-~~~--------------~~~e~ 113 (246)
.++|.+.++||+|+||.||+|.. ..++.||||++...... .++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 13467999998643221 122 33466
Q ss_pred HHHhcCCCCCc-----cceEeEEEe--------CCeeEEEEecCCCCCHHHHhccCCCCC---------------CCCCC
Q 025893 114 SMVSRLKHENF-----VQLLGYCVD--------GTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPG 165 (246)
Q Consensus 114 ~~l~~l~hp~i-----v~~~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~~~---------------~~~~~ 165 (246)
.++.+++|.++ ++++++|.. ....|||+||+++++|.+++....... .....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766554 667777653 356799999999999999987532110 01112
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCC
Q 025893 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245 (246)
Q Consensus 166 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aP 245 (246)
..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... ......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 33567888899999999999999986 999999999999999999999999998754322111 11122358999999
Q ss_pred C
Q 025893 246 E 246 (246)
Q Consensus 246 E 246 (246)
|
T Consensus 380 E 380 (507)
T PLN03224 380 E 380 (507)
T ss_pred h
Confidence 8
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=184.06 Aligned_cols=163 Identities=30% Similarity=0.469 Sum_probs=130.1
Q ss_pred CCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCC
Q 025893 70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+....||.|+-|.|++++++ +|...|||.+..... ..++++..+.++.+- ++|.||+.+|+|.....+++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34456999999999999987 688999999975533 335677777766544 58999999999999999999999884
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
..+..+++.-.. .+++...=++...++.||.||-.+- .|+|||+||+|||+|+.|.+|++|||++..+.
T Consensus 175 -~C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 175 -TCAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred -HHHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 345555543321 3666666678888999999998764 59999999999999999999999999998876
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+... +.-.|.+.|||||
T Consensus 244 dSkAh---trsAGC~~YMaPE 261 (391)
T KOG0983|consen 244 DSKAH---TRSAGCAAYMAPE 261 (391)
T ss_pred ccccc---ccccCCccccCcc
Confidence 65543 4457999999998
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=203.78 Aligned_cols=165 Identities=30% Similarity=0.482 Sum_probs=135.7
Q ss_pred CCceeccCCceEEEEEEEC--CCC--EEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 71 TNALIGEGSYGRVYYGILK--SGH--AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~--~~~--~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+.++||+|+||.|++|.|. .|. .||||.+..... ...+|++|+.+|.+|+|||++++||...+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3457999999999999986 344 489999976543 46799999999999999999999999987 6778999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+.|+|.+.|+... ...|.......++.||+.||.||.++. +|||||..+|+|+.....+||+||||.+.+
T Consensus 193 plGSLldrLrka~-------~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK-------KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred ccchHHHHHhhcc-------ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 9999999998622 134777888899999999999999996 999999999999999999999999999987
Q ss_pred Ccccccc-ccccccccccccCCC
Q 025893 225 PDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
....... ......-...|+|||
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPE 285 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPE 285 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHh
Confidence 6544321 111112245799998
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=187.39 Aligned_cols=164 Identities=30% Similarity=0.436 Sum_probs=137.6
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
|...+.||+|++|.||++... +++.+++|.+...... ...+..|+.++++++||||+++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999975 7888999988654332 457788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~-~l~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 81 DT-DLYKLIKDRQ--------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CC-CHHHHHHhhc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 75 8888876532 13788999999999999999999997 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|+|||
T Consensus 149 ~~~~~--~~~~~~~~~~~~~PE 168 (283)
T cd05118 149 GSPVR--PYTHYVVTRWYRAPE 168 (283)
T ss_pred CCCcc--cccCccCcccccCcH
Confidence 43321 112345788999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-28 Score=189.87 Aligned_cols=162 Identities=28% Similarity=0.388 Sum_probs=128.1
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHH-hcCCCCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMV-SRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
...||.|.||+|++-.++ +|+..|||+++.... +..+++.|.+.. +.-+.||||+++|++..++..|+.||.|. -
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 346999999999999987 799999999975543 456778887654 55569999999999999999999999995 4
Q ss_pred CHHHHhc---cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 148 SLHDILH---GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 148 ~L~~~l~---~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+|..+.+ .... ..+++...-.|....+.||.||-..- .|+|||+||+|||++..|.+||+|||++..+
T Consensus 148 SlDklYk~vy~vq~-------~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQK-------SRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred hHHHHHHHHHHHHh-------ccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 6644322 1111 12666666667777889999998753 6999999999999999999999999999887
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..+... +.-+|...|||||
T Consensus 219 v~SiAk---T~daGCrpYmAPE 237 (361)
T KOG1006|consen 219 VDSIAK---TVDAGCRPYMAPE 237 (361)
T ss_pred HHHHHh---hhccCCccccChh
Confidence 654433 4457999999998
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=192.44 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=138.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 138 (246)
+|.+.+.||+|+||.||+|... ++..+++|.+.... ...+.+..|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778889999999999999976 68899999886543 23467889999999999999999999988775 789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
++|||+. ++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+||
T Consensus 81 lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 9999997 58988886532 3888999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025893 219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
|++......... .......+|+.|+|||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 176 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPE 176 (330)
T ss_pred CceEeecccccccccccccccccCcCCce
Confidence 998765433210 1123456889999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=184.80 Aligned_cols=164 Identities=32% Similarity=0.468 Sum_probs=132.9
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcC---CCCCccceEeEEEeCCe-----
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRL---KHENFVQLLGYCVDGTS----- 136 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~----- 136 (246)
|++.+.||+|+||.||++..+ ++..+|+|.+...... ...+..|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999987 5889999998643222 24566777776655 59999999999988776
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-------PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence 899999997 489888865321 13789999999999999999999986 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++........ .....+++.|+|||
T Consensus 150 dfg~~~~~~~~~~---~~~~~~~~~~~~PE 176 (287)
T cd07838 150 DFGLARIYSFEMA---LTSVVVTLWYRAPE 176 (287)
T ss_pred ccCcceeccCCcc---cccccccccccChH
Confidence 9999876543221 12345788999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=187.13 Aligned_cols=168 Identities=21% Similarity=0.258 Sum_probs=121.2
Q ss_pred HhcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCCC--HH----------HHHHHHHHHhcCCCCCccceEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DE----------EFLAQVSMVSRLKHENFVQLLG 129 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~~--~~----------~~~~e~~~l~~l~hp~iv~~~~ 129 (246)
.+.|.+.+.||+|+||.||+|.... +..+++|........ .+ ....+...+..++|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3589999999999999999999763 345666654322211 11 1223344566788999999998
Q ss_pred EEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 025893 130 YCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (246)
Q Consensus 130 ~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Ni 205 (246)
.+.... ..++++|++. .++.+.+.... ..++..+..++.|++.||.|||+++ |+||||||+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 765443 3467888774 46666664322 1457778899999999999999986 99999999999
Q ss_pred EecCCCceEEccccCCCCCCcccc-----ccccccccccccccCCC
Q 025893 206 LIFDDDVAKIADFDLSNQAPDMAA-----RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 206 l~~~~~~~kl~Dfgls~~~~~~~~-----~~~~~~~~gt~~y~aPE 246 (246)
|++.++.++|+|||+|+....... ........||+.|+|||
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape 203 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD 203 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence 999999999999999976532111 01113356999999997
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=187.06 Aligned_cols=167 Identities=30% Similarity=0.485 Sum_probs=134.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.++|.+.+.||+|+||.||+|.+. ++..+|+|.+..... ....+..|+.++.++. ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 467888999999999999999987 588999999865432 2345666777666665 999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+. +++.+++..... .+++..+..++.|++.||.|||+.. .|+||||+|+||+++.++.+||+|||++
T Consensus 94 e~~~-~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred eccC-cCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccc
Confidence 9985 477777654321 3788888999999999999999741 3999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
......... ....+++.|+|||
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE 184 (296)
T cd06618 163 GRLVDSKAK---TRSAGCAAYMAPE 184 (296)
T ss_pred hhccCCCcc---cCCCCCccccCHh
Confidence 765332211 2335788999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=195.03 Aligned_cols=163 Identities=29% Similarity=0.456 Sum_probs=137.5
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCe----
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS---- 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~---- 136 (246)
+.++|.....||+|+||.||+|+.. ++..+|+|.+..... ....+.+|+.++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999976 688999998864322 23557789999999999999999988766554
Q ss_pred --eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 137 --RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 137 --~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
.++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELK 158 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEE
Confidence 89999998 67999988642 3888999999999999999999997 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||++...... .....+|+.|+|||
T Consensus 159 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE 185 (343)
T cd07851 159 ILDFGLARHTDDE-----MTGYVATRWYRAPE 185 (343)
T ss_pred Ecccccccccccc-----ccCCcccccccCHH
Confidence 9999998765322 23456888999997
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=189.72 Aligned_cols=158 Identities=18% Similarity=0.227 Sum_probs=126.2
Q ss_pred CceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhc
Q 025893 79 SYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154 (246)
Q Consensus 79 ~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~ 154 (246)
+++.||.++.. ++..+|+|++.... .....+..|+.+++.++||||+++++++......+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 34445555543 68999999986542 234578899999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc-----
Q 025893 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA----- 229 (246)
Q Consensus 155 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~----- 229 (246)
.... ..+++.....++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 92 ~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 92 THFP-------EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred Hhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 5432 13778888999999999999999996 99999999999999999999999998865432111
Q ss_pred ccccccccccccccCCC
Q 025893 230 RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ~~~~~~~~gt~~y~aPE 246 (246)
........++..|+|||
T Consensus 162 ~~~~~~~~~~~~y~aPE 178 (314)
T cd08216 162 HDFPKSSVKNLPWLSPE 178 (314)
T ss_pred ccccccccccccccCHH
Confidence 00112345788899998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=181.54 Aligned_cols=158 Identities=31% Similarity=0.410 Sum_probs=135.0
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
||+|+||.||++... +++.+++|.+..... ....+..|+.++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 688999999865432 235788899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~ 229 (246)
.+++.... .+++.....++.|++.||.|+|+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 99986543 3788999999999999999999986 99999999999999999999999999876533211
Q ss_pred ccccccccccccccCCC
Q 025893 230 RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 230 ~~~~~~~~gt~~y~aPE 246 (246)
......|+..|++||
T Consensus 149 --~~~~~~~~~~~~~Pe 163 (250)
T cd05123 149 --RTNTFCGTPEYLAPE 163 (250)
T ss_pred --cccCCcCCccccChH
Confidence 123456888999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=185.21 Aligned_cols=164 Identities=33% Similarity=0.445 Sum_probs=137.8
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
|+..+.||+|+||.||+|... +++.+++|.+.... ...+.+..|+.++++++||||+++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 68999999987542 23467788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
. ++|.+++.... ..+++..+..++.+++.||.|||+++ |+|+||+|+||++++++.+||+|||++...
T Consensus 81 ~-~~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 81 D-MDLKKYLDKRP--------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred C-cCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence 7 59999997542 13888999999999999999999997 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....++..|+|||
T Consensus 149 ~~~~~~--~~~~~~~~~~~aPE 168 (282)
T cd07829 149 GIPLRT--YTHEVVTLWYRAPE 168 (282)
T ss_pred CCCccc--cCccccCcCcCChH
Confidence 432211 12335678899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=191.56 Aligned_cols=167 Identities=25% Similarity=0.349 Sum_probs=134.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeC---------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--------- 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--------- 134 (246)
..+|.+.+.||.|+||.||+|..+ ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 357888999999999999999975 788999998865433 346688899999999999999998776543
Q ss_pred -----CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 025893 135 -----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 135 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~ 209 (246)
...++++||+. ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 35789999997 5898887542 2788899999999999999999997 999999999999984
Q ss_pred -CCceEEccccCCCCCCccccc-cccccccccccccCCC
Q 025893 210 -DDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 -~~~~kl~Dfgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||++......... .......|+..|+|||
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 188 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHH
Confidence 567899999998754321111 0112235788999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=183.43 Aligned_cols=168 Identities=24% Similarity=0.369 Sum_probs=132.2
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCC---C---CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---S---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~---~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.|.+.+.||+|+||.||++... .+..+++|.+.. . ......+..|+.++++++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3777889999999999999865 444455554432 1 12234566789999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||+
T Consensus 81 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-----TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-----cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence 999999999988864221 1124889999999999999999999987 999999999999975 5699999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......|++.|+|||
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~~~pe 175 (260)
T cd08222 152 SRLLMGSCD--LATTFTGTPYYMSPE 175 (260)
T ss_pred eeecCCCcc--cccCCCCCcCccCHH
Confidence 876533221 123456889999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=179.41 Aligned_cols=148 Identities=22% Similarity=0.225 Sum_probs=122.9
Q ss_pred CCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhccC
Q 025893 78 GSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR 156 (246)
Q Consensus 78 G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~ 156 (246)
|.||+||+++.+ +++.+|+|.+.... .+..|...+....||||+++++++.+....+++|||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 789999999975 78899999986543 2233444555567999999999999999999999999999999998654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccccccccc
Q 025893 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236 (246)
Q Consensus 157 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~ 236 (246)
. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++++|||++...... ....
T Consensus 80 ~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~ 142 (237)
T cd05576 80 L---------NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGE 142 (237)
T ss_pred c---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccC
Confidence 2 3788999999999999999999987 999999999999999999999999987654321 1234
Q ss_pred cccccccCCC
Q 025893 237 LGTFGYHAPE 246 (246)
Q Consensus 237 ~gt~~y~aPE 246 (246)
.++..|+|||
T Consensus 143 ~~~~~y~aPE 152 (237)
T cd05576 143 AVENMYCAPE 152 (237)
T ss_pred CcCccccCCc
Confidence 5677899998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-28 Score=187.74 Aligned_cols=168 Identities=32% Similarity=0.511 Sum_probs=133.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCC---CCCCHHHHHHHHHHHhcCCCCCccceEeEEEe--------C
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--------G 134 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~---~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--------~ 134 (246)
..|.....||+|.||.||+|+.+ +++.||+|++-. .........+|+.+|..|+|+|++.+.+.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999976 678889887632 22334667889999999999999999877653 2
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
...|+|+.+|+. +|.-+|.... ..++...+.+++.++..||.|+|+.. |+|||+|++|+||+.++.+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK 164 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence 347899999976 8988886543 24788889999999999999999985 99999999999999999999
Q ss_pred EccccCCCCCCccccccc--cccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLH--STRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~--~~~~~gt~~y~aPE 246 (246)
|+|||+++.+........ .+..+-|.+|.+||
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppE 198 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE 198 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHH
Confidence 999999987654432211 12234589999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-27 Score=184.48 Aligned_cols=165 Identities=28% Similarity=0.415 Sum_probs=133.7
Q ss_pred cCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeE
Q 025893 68 NFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 138 (246)
+.+-.+.||-|.||.||-+.. ++|+.||+|++..-.. ..+.+.+|+.+|..++|.|++..++...... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445567899999999999885 4899999999864433 3467889999999999999999988766443 357
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+++|.+.. +|.+++-+.. .++...+..++.||+.||+|||+.+ |+||||||.|+|++++..+||+||
T Consensus 134 V~TELmQS-DLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHHh-hhhheeccCC---------CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccc
Confidence 88898864 8988886543 3777788889999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++........ +.+..+-|-+|.|||
T Consensus 201 GLARvee~d~~~-hMTqEVVTQYYRAPE 227 (449)
T KOG0664|consen 201 GLARTWDQRDRL-NMTHEVVTQYYRAPE 227 (449)
T ss_pred ccccccchhhhh-hhHHHHHHHHhccHH
Confidence 999875543333 233345688999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=198.18 Aligned_cols=174 Identities=20% Similarity=0.242 Sum_probs=119.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-C----CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeE------EEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY------CVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~------~~~~ 134 (246)
.++|.+.+.||+|+||.||+|.+. + +..+|+|++.... ..+.+..+ .+....+.+++.+... ....
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 468999999999999999999976 5 6889999875332 12222221 1222222233222211 2355
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVK-----------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~-----------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~ 203 (246)
...++|+||+.+++|.+++....... ............+..++.|++.||.|||+++ |+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence 67899999999999999986532100 0000011123345678999999999999987 999999999
Q ss_pred CeEecC-CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 204 NVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 204 Nil~~~-~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++. ++.+||+|||+++........ .....+||+.|||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE 327 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPE 327 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChH
Confidence 999986 579999999999865432221 224568999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=176.80 Aligned_cols=164 Identities=23% Similarity=0.418 Sum_probs=133.4
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeE-EEeCCeeEEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGY-CVDGTSRVLAY 141 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~-~~~~~~~~lv~ 141 (246)
+.+.|.+.+.||+|.||++.+++++ +.+.+++|.+........+|.+|..---.|. |.||+.-++. |+..+.+.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4578888999999999999999988 6778999999888888899999988766666 8999987654 66778888999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCceEEcccc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFD 219 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~--~~~~kl~Dfg 219 (246)
||++.|+|..-+... .+.+.....++.|+++|+.|+|+++ +||||||.+||||.. ...+||+|||
T Consensus 102 E~aP~gdL~snv~~~----------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA----------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred ccCccchhhhhcCcc----------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 999999998877543 3777888899999999999999996 999999999999964 4589999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++....... .+--+..|.+||
T Consensus 169 ~t~k~g~tV~-----~~~~~~~y~~pe 190 (378)
T KOG1345|consen 169 LTRKVGTTVK-----YLEYVNNYHAPE 190 (378)
T ss_pred cccccCceeh-----hhhhhcccCCcH
Confidence 9876432211 122345566765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=199.37 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=128.7
Q ss_pred CCCceeccCCceEEEEEEEC-CCC----EEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 70 GTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~-~~~----~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
...++||.|.||+||+|.+- .|+ +||+|++..... ...+++.|+-+|.+|+|||++|++++|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999863 443 589998865543 3678999999999999999999999998766 788999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|++.|.|.++++..+. .+..+..+.+..||++||.|||.+. +|||||..+|+|+.+...+||.|||+++
T Consensus 778 ~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred hcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 9999999999988664 3777888999999999999999995 9999999999999999999999999999
Q ss_pred CCCcccc
Q 025893 223 QAPDMAA 229 (246)
Q Consensus 223 ~~~~~~~ 229 (246)
.+.....
T Consensus 847 ll~~d~~ 853 (1177)
T KOG1025|consen 847 LLAPDEK 853 (1177)
T ss_pred ccCcccc
Confidence 8765543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=170.70 Aligned_cols=138 Identities=20% Similarity=0.189 Sum_probs=105.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCC---C-------HHH-----------------HHHHHHHHhcCCCCCc
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---P-------DEE-----------------FLAQVSMVSRLKHENF 124 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~---~-------~~~-----------------~~~e~~~l~~l~hp~i 124 (246)
...||+|+||.||+|...+|+.||+|.+..... . ... ...|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999987899999999865421 1 011 2348899999988877
Q ss_pred cceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeeCCCCCC
Q 025893 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADPHIIHRDIKSS 203 (246)
Q Consensus 125 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~ivHrdlkp~ 203 (246)
........ ...+|||||++++++...+.... .++...+..++.|++.+|.|+ |+.+ |+||||||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY 147 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 54433322 22389999999877654432111 377888999999999999999 6876 999999999
Q ss_pred CeEecCCCceEEccccCCCCC
Q 025893 204 NVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 204 Nil~~~~~~~kl~Dfgls~~~ 224 (246)
|||++ ++.++|+|||+|...
T Consensus 148 NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HEEEE-CCcEEEEEccccccC
Confidence 99998 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=196.43 Aligned_cols=167 Identities=28% Similarity=0.402 Sum_probs=129.3
Q ss_pred cCCCCceeccCCceE-EEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCC
Q 025893 68 NFGTNALIGEGSYGR-VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~-V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
-|...+++|.|+-|+ ||+|.+. ++.||||++..... .-..+|+..|+.-+ ||||||+++.-.++.+.||..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 345556789998887 7999886 78999998753321 23457999888776 9999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CC--ceEEccccC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DD--VAKIADFDL 220 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~--~~kl~Dfgl 220 (246)
.+|.+++.... ..... ......+.++.|++.||.+||+.+ ||||||||.||||+. ++ .++|+|||+
T Consensus 587 -~sL~dlie~~~-~d~~~----~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 587 -CSLQDLIESSG-LDVEM----QSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred -hhHHHHHhccc-cchhh----cccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 59999998741 11000 111344578899999999999986 999999999999986 33 689999999
Q ss_pred CCCCCcccccc-ccccccccccccCCC
Q 025893 221 SNQAPDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
++.+....... ......||-+|+|||
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHH
Confidence 99876543322 235677999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=173.69 Aligned_cols=161 Identities=21% Similarity=0.354 Sum_probs=132.9
Q ss_pred HhcCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeC--CeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDG--TSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~~~lv~ 141 (246)
.++|++.+.+|+|.|++||.|.. .+.+.++||.+++- ..+.+.+|+.+|..|. ||||+++++...++ ..+.|++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 46888899999999999999984 47788999988533 3467889999999998 99999999998765 4567999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgl 220 (246)
||+.+.+...+.. .|+..++..++.+++.||.|||++| |+|||+||.|++||. ...++|+|+|+
T Consensus 115 E~v~n~Dfk~ly~------------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP------------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred hhhccccHHHHhh------------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecch
Confidence 9999888766553 4777888999999999999999998 999999999999995 67899999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|...-..... +..+.+..|..||
T Consensus 180 AEFYHp~~eY---nVRVASRyfKGPE 202 (338)
T KOG0668|consen 180 AEFYHPGKEY---NVRVASRYFKGPE 202 (338)
T ss_pred HhhcCCCcee---eeeeehhhcCCch
Confidence 9876543332 3345667777776
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=165.16 Aligned_cols=139 Identities=18% Similarity=0.172 Sum_probs=109.3
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---------------------------HHHHHHHHHHHhcCCCCCc
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------DEEFLAQVSMVSRLKHENF 124 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---------------------------~~~~~~e~~~l~~l~hp~i 124 (246)
...||+|+||.||+|...+|+.||+|.+...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999999778999999998654211 1123568899999999988
Q ss_pred cceEeEEEeCCeeEEEEecCCCCCHHHH-hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCC
Q 025893 125 VQLLGYCVDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKS 202 (246)
Q Consensus 125 v~~~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp 202 (246)
.....+... ..+|||||++|+++... +... .++......++.|++.++.++|+ ++ |+||||||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP 146 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSE 146 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCh
Confidence 655544433 24899999998755432 3221 26677888999999999999999 87 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCc
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
+||+++ ++.++|+|||++.....
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhEEEE-CCCEEEEEcccceecCC
Confidence 999998 88999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=189.39 Aligned_cols=178 Identities=28% Similarity=0.451 Sum_probs=139.8
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC----C----CCEEEEEEcCCCCC--CHHHHHHHHHHHhcCC-CCCccceEeEEEe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK----S----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVD 133 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~----~----~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~ 133 (246)
..++..+.+.||+|.||.|++|... . ...||||.+..... ..+.+..|+.+|+.+. ||||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3445556669999999999999743 1 34589999875443 3568899999999996 9999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhccCC-CCCCCCC----C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeE
Q 025893 134 GTSRVLAYEFASNGSLHDILHGRK-GVKGAQP----G--PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~----~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil 206 (246)
.+..++|+||+..|+|.++++..+ ....... . ..++..+.+.++.||+.|++||++.. +|||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999998776 1110111 1 24888999999999999999999985 999999999999
Q ss_pred ecCCCceEEccccCCCCCCccccccccccccc--cccccCCC
Q 025893 207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLG--TFGYHAPE 246 (246)
Q Consensus 207 ~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~g--t~~y~aPE 246 (246)
+..+..+||+|||+++.......... ..-.| ...|||||
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApE 491 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPE 491 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHH
Confidence 99999999999999986443332211 11112 24599998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=163.40 Aligned_cols=166 Identities=36% Similarity=0.519 Sum_probs=139.9
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
|...+.||+|++|.||++... ++..+++|.+..... ..+.+.+|+..+++++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456678999999999999976 588999999876544 35678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... .+++.....++.+++.++.|||.++ ++|+||+|.||+++.++.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 81 GGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 9999999875431 1678888899999999999999986 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......++..|++||
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe 169 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPE 169 (225)
T ss_pred Ccccc-cccceeccCCcCCHh
Confidence 33200 113456788899997
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=173.04 Aligned_cols=167 Identities=19% Similarity=0.328 Sum_probs=137.7
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-C-C----CccceEeEEEeCCe
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H-E----NFVQLLGYCVDGTS 136 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-h-p----~iv~~~~~~~~~~~ 136 (246)
.+.+.|.+...+|+|.||+|-.+..+ ++..||+|+++.-..-.+..+-|+++++++. + | -+|.+.++|.-.++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 34778999999999999999999865 6788999999766666677788999999984 2 2 35677788888999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC------
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD------ 210 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~------ 210 (246)
.+||+|.+ |.++.++|..... ..++...++.++.|+++++.|||+.. ++|-||||+|||+.+.
T Consensus 166 iCivfell-G~S~~dFlk~N~y-------~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY-------IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc-------cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence 99999988 6799999976442 24888999999999999999999986 9999999999998432
Q ss_pred --------------CceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 211 --------------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 --------------~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..+||+|||.|+..... .++++.|..|.|||
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPE 279 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPE 279 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCch
Confidence 24799999998764322 25678899999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=182.41 Aligned_cols=161 Identities=22% Similarity=0.372 Sum_probs=131.9
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
+.+.|.....+|.|+|+.|..+.+. +++..++|++.... .+..+|+.++... +||||+++++.+.+....|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3567888888999999999999866 78889999997662 2233455454444 69999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe-cCCCceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~-~~~~~~kl~Dfgls 221 (246)
++.|+.+.+.+..... +. ..+..++.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||++
T Consensus 397 ~l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred hccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 9999999888765431 22 566679999999999999997 9999999999999 58899999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... ..+.+=|..|.|||
T Consensus 464 ~~~~~~-----~~tp~~t~~y~APE 483 (612)
T KOG0603|consen 464 SELERS-----CDTPALTLQYVAPE 483 (612)
T ss_pred hhCchh-----hcccchhhcccChh
Confidence 876543 23445688999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-22 Score=155.91 Aligned_cols=159 Identities=36% Similarity=0.583 Sum_probs=134.4
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHH
Q 025893 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (246)
Q Consensus 75 lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 151 (246)
||+|.+|.||++... +++.+++|.+...... .+.+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999976 5889999998765543 5678899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccCCCCCCccccc
Q 025893 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAAR 230 (246)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls~~~~~~~~~ 230 (246)
++.... ..+++..+..++.+++.++.+||+.+ ++|+||+|.||+++. .+.++|+|||.+........
T Consensus 81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 987542 13788899999999999999999997 999999999999999 89999999999875543211
Q ss_pred cccccccccccccCCC
Q 025893 231 LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 231 ~~~~~~~gt~~y~aPE 246 (246)
......+...|++||
T Consensus 149 -~~~~~~~~~~~~~pe 163 (215)
T cd00180 149 -LLKTIVGTPAYMAPE 163 (215)
T ss_pred -hhhcccCCCCccChh
Confidence 112345778888887
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=158.86 Aligned_cols=135 Identities=16% Similarity=0.186 Sum_probs=103.7
Q ss_pred CCceeccCCceEEEEEEECCCCEEEEEEcCCCC-CCHHHHHHHHHHHhcC-----CCCCccceEeEEEeCC---eeE-EE
Q 025893 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRL-----KHENFVQLLGYCVDGT---SRV-LA 140 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~---~~~-lv 140 (246)
....||+|+||.||. +......+||++.... ...+.+.+|+.+++.+ +||||+++++++.++. .++ +|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 356899999999996 5433334788876542 2456789999999999 6799999999999874 334 78
Q ss_pred Eec--CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeeCCCCCCCeEecC----CCce
Q 025893 141 YEF--ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL-EYLHEKADPHIIHRDIKSSNVLIFD----DDVA 213 (246)
Q Consensus 141 ~E~--~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~~ivHrdlkp~Nil~~~----~~~~ 213 (246)
+|| +.+++|.+++.... +++. ..++.+++.++ .|||+++ |+||||||+|||++. .+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred ecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcE
Confidence 999 56799999996532 4444 35677888777 8999997 999999999999974 3479
Q ss_pred EEccccCCC
Q 025893 214 KIADFDLSN 222 (246)
Q Consensus 214 kl~Dfgls~ 222 (246)
+|+||+.++
T Consensus 149 ~LiDg~G~~ 157 (210)
T PRK10345 149 VVCDNIGES 157 (210)
T ss_pred EEEECCCCc
Confidence 999954443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=160.49 Aligned_cols=153 Identities=37% Similarity=0.529 Sum_probs=131.8
Q ss_pred CceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhcc
Q 025893 79 SYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155 (246)
Q Consensus 79 ~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 155 (246)
+||.||+|... +++.+++|.+...... .+.+..|+..+++++|+||+++++.+......++++||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 5899999998755432 57889999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccccccccc
Q 025893 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235 (246)
Q Consensus 156 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~ 235 (246)
.. .+++.....++.+++.++.|||..+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 145 (244)
T smart00220 81 RG---------RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT 145 (244)
T ss_pred cc---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence 32 2778889999999999999999986 9999999999999999999999999987654332 1234
Q ss_pred ccccccccCCC
Q 025893 236 VLGTFGYHAPE 246 (246)
Q Consensus 236 ~~gt~~y~aPE 246 (246)
..+++.|++||
T Consensus 146 ~~~~~~~~~pE 156 (244)
T smart00220 146 FVGTPEYMAPE 156 (244)
T ss_pred ccCCcCCCCHH
Confidence 56888999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=157.52 Aligned_cols=166 Identities=27% Similarity=0.384 Sum_probs=133.6
Q ss_pred HhcCCCCceeccCCceEEEEEEE-CCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
...|.+.+.||.|+||.+|+|.. .+|..||||.-. +...-..+.-|..+.+.|+ ...|..+..+..+..+-.+||+.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es-~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES-SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeec-ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 56899999999999999999995 589999999753 2233345667888888888 47888888888888999999998
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEEccccC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDL 220 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl~Dfgl 220 (246)
+ |.+|.+++.-.. ..++..+++-++-|++.-++|+|.++ ++||||||+|+|+.- ...+-++|||+
T Consensus 93 L-GPsLEdLfnfC~--------R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCS--------RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred c-CccHHHHHHHHh--------hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccc
Confidence 7 889998875322 24888999999999999999999997 999999999999974 34688999999
Q ss_pred CCCCCccccccc-----cccccccccccC
Q 025893 221 SNQAPDMAARLH-----STRVLGTFGYHA 244 (246)
Q Consensus 221 s~~~~~~~~~~~-----~~~~~gt~~y~a 244 (246)
|+......+..+ .....||..|.+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehh
Confidence 988765443322 245678888854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=162.49 Aligned_cols=164 Identities=27% Similarity=0.385 Sum_probs=136.1
Q ss_pred cCCCCceeccCCceEEEEEE-ECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCC
Q 025893 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+|.+.+.||+|+||.++.|. .-+++.||||.- ..+....++..|....+.|. .++|..++-+...+.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 79999999999999999998 458999999953 44455667888888888876 789999988888888889999987
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-----CceEEccccC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-----DVAKIADFDL 220 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-----~~~kl~Dfgl 220 (246)
|.+|.|+..-.. ..++..+++-++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+
T Consensus 107 GPSLEDLFD~Cg--------R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 107 GPSLEDLFDLCG--------RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred CcCHHHHHHHhc--------CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 889998875332 35899999999999999999999996 9999999999999854 3688999999
Q ss_pred CCCCCccccccc-----cccccccccccC
Q 025893 221 SNQAPDMAARLH-----STRVLGTFGYHA 244 (246)
Q Consensus 221 s~~~~~~~~~~~-----~~~~~gt~~y~a 244 (246)
|+......+..+ ..++.||..||+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeE
Confidence 998766554322 346789999996
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=152.03 Aligned_cols=139 Identities=14% Similarity=0.180 Sum_probs=113.6
Q ss_pred HHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHH----------HHHHHHHHhcCCCCCccceEeEEEe
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE----------FLAQVSMVSRLKHENFVQLLGYCVD 133 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~----------~~~e~~~l~~l~hp~iv~~~~~~~~ 133 (246)
.+.++|...++||.|+||.||+... ++..+|+|.+.......+. +.+|+..+.++.||+|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3567899999999999999999655 5778999998654433322 5789999999999999999888664
Q ss_pred C--------CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 025893 134 G--------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (246)
Q Consensus 134 ~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Ni 205 (246)
. ...+|+|||++|.+|.++.. ++. ....+++.+|..+|..+ ++|||++|.||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Ni 166 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNF 166 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHE
Confidence 3 35789999999999988732 222 24568999999999997 99999999999
Q ss_pred EecCCCceEEccccCCCCC
Q 025893 206 LIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 206 l~~~~~~~kl~Dfgls~~~ 224 (246)
+++.++ ++|+|||..+..
T Consensus 167 li~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred EEeCCC-EEEEECCCcccc
Confidence 999888 999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=146.64 Aligned_cols=131 Identities=18% Similarity=0.205 Sum_probs=103.9
Q ss_pred CCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHH-----HHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecC
Q 025893 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE-----EFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~-----~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
....|++|+||+||++.. .+..++.+.+.....-.. .+.+|+++|++|. |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 345799999999997765 567777777765543222 4678999999996 5889999886 4468999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCC-CCCCeEecCCCceEEccccCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI-KSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdl-kp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.|.+|.+.+.. ....++.|++.+|.++|+++ |+|||| ||+|||++.++.++|+|||++..
T Consensus 81 ~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 81 AGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred cCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 99998654311 11346788999999999997 999999 79999999999999999999975
Q ss_pred CC
Q 025893 224 AP 225 (246)
Q Consensus 224 ~~ 225 (246)
..
T Consensus 142 ~~ 143 (218)
T PRK12274 142 GN 143 (218)
T ss_pred cC
Confidence 43
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=148.24 Aligned_cols=134 Identities=22% Similarity=0.338 Sum_probs=112.1
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---------HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+.||+|++|.||+|.+ .+..+++|........ ...+.+|+.++..+.|++|.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 5678888876432211 13567899999999999998888787778888999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
++|++|.+++... .+ ....++.+++.+|.++|+.+ ++|+|++|.|||++ .+.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988542 12 66788999999999999997 99999999999999 78899999999876
Q ss_pred C
Q 025893 224 A 224 (246)
Q Consensus 224 ~ 224 (246)
.
T Consensus 144 ~ 144 (211)
T PRK14879 144 S 144 (211)
T ss_pred C
Confidence 4
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=160.32 Aligned_cols=144 Identities=25% Similarity=0.370 Sum_probs=124.7
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCee
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR 137 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 137 (246)
..+.+.|.....||+|+|+.||++... ..+.||+|.+..... ...+..|+++|..+. +.||+++.+++..++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 345678899999999999999999843 466799999865433 355889999999997 89999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIA 216 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~ 216 (246)
.+|+||++.-+..++... ++...+..+++.++.||.++|.+| ||||||||.|+|.+. .+.-.|.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred EEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEE
Confidence 999999999888888864 667788889999999999999998 999999999999984 5677899
Q ss_pred cccCCC
Q 025893 217 DFDLSN 222 (246)
Q Consensus 217 Dfgls~ 222 (246)
|||++.
T Consensus 176 DFgLA~ 181 (418)
T KOG1167|consen 176 DFGLAQ 181 (418)
T ss_pred echhHH
Confidence 999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=157.22 Aligned_cols=161 Identities=26% Similarity=0.333 Sum_probs=128.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC------e
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------S 136 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------~ 136 (246)
.+|.-.+.+|.|.- .|--+... .++.||+|++.... ...++..+|..++..+.|+||++++.++.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666677888776 45555543 68899999875332 23456778999999999999999999987543 4
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.|+|||++. .+|...+... ++-.+...+..|++.|++|||+.+ |+||||||+||++..++.+||.
T Consensus 96 ~y~v~e~m~-~nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred HHHHHHhhh-hHHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence 589999995 5898887632 666788899999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++..... ...+..+.|..|.|||
T Consensus 161 dfg~ar~e~~~---~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 161 DFGLARTEDTD---FMMTPYVVTRYYRAPE 187 (369)
T ss_pred cchhhcccCcc---cccCchhheeeccCch
Confidence 99999864332 1224567889999998
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=159.17 Aligned_cols=167 Identities=24% Similarity=0.314 Sum_probs=129.0
Q ss_pred cCCCCceeccCCceEEEEEEECCC--CEEEEEEcCCCCC-CHHHHHHHHHHHhcCCC----CCccceEeEE-EeCCeeEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSG--HAAAIKKLDASKQ-PDEEFLAQVSMVSRLKH----ENFVQLLGYC-VDGTSRVL 139 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~--~~vaik~~~~~~~-~~~~~~~e~~~l~~l~h----p~iv~~~~~~-~~~~~~~l 139 (246)
.|.+.+.||+|+||.||++..... ..+|+|....... ....+..|+.++..+.. +++.++++.. ....+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996643 4678887654322 22267788888888873 6899999888 47778899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-----CceE
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-----DVAK 214 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-----~~~k 214 (246)
||+.+ |.+|.++..... ...++..+++.++.|++.+|+++|+.| ++||||||+|+++... ..+.
T Consensus 99 VM~l~-G~sL~dl~~~~~-------~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-------PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred EEecc-CccHHHHHHhCC-------CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence 99987 889999875433 124888999999999999999999998 9999999999999854 4699
Q ss_pred EccccCCCCCC--cccc------ccccccccccccccCC
Q 025893 215 IADFDLSNQAP--DMAA------RLHSTRVLGTFGYHAP 245 (246)
Q Consensus 215 l~Dfgls~~~~--~~~~------~~~~~~~~gt~~y~aP 245 (246)
|.|||+++... .... ......+.||..|+++
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence 99999998322 1111 0111235699999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=152.09 Aligned_cols=143 Identities=17% Similarity=0.175 Sum_probs=108.6
Q ss_pred cCCCCceeccCCceEEEEEE--ECCCCEEEEEEcCCCCCC-------------------------HHHHHHHHHHHhcCC
Q 025893 68 NFGTNALIGEGSYGRVYYGI--LKSGHAAAIKKLDASKQP-------------------------DEEFLAQVSMVSRLK 120 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~--~~~~~~vaik~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 120 (246)
.|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ...+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 458999999988643210 012457999999997
Q ss_pred CCC--ccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeC
Q 025893 121 HEN--FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198 (246)
Q Consensus 121 hp~--iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHr 198 (246)
+.. +.+++++ ...++||||+.+.+|...+.... .+.......++.|++.++.+||.++ .|+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 533 3444432 23589999999988866542211 2445566789999999999999985 49999
Q ss_pred CCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 199 DIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 199 dlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
||||+||+++ ++.++|+|||++.....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999999 88999999999875443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=166.19 Aligned_cols=138 Identities=22% Similarity=0.330 Sum_probs=111.0
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEE-cCCCCC--------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKK-LDASKQ--------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~-~~~~~~--------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
...|...+.||+|+||.||++.+.... +++|+ +.+... ..+.+.+|+.++++++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567789999999999999876433 33333 222111 12457889999999999999988888887788
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.++||||+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ .++.++|+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 899999999999998874 23568899999999999997 9999999999999 67889999
Q ss_pred cccCCCCCC
Q 025893 217 DFDLSNQAP 225 (246)
Q Consensus 217 Dfgls~~~~ 225 (246)
|||+++...
T Consensus 470 DFGla~~~~ 478 (535)
T PRK09605 470 DFGLGKYSD 478 (535)
T ss_pred eCcccccCC
Confidence 999998643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-21 Score=162.33 Aligned_cols=170 Identities=20% Similarity=0.271 Sum_probs=136.2
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC------CCCccceEeEEEeCC
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK------HENFVQLLGYCVDGT 135 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~------hp~iv~~~~~~~~~~ 135 (246)
+.+...|.+....|+|-|++|.+|... .|..||||+|.....--+.=+.|+++|++|. --|+++++-.|...+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 344567888888999999999999965 6889999999876544444567999999996 348899999999999
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAK 214 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~k 214 (246)
+++||+|.+ ..+|.++|+..+.. ..|....+..++.|+..||..|-.++ |+|.||||+|||+++ ...+|
T Consensus 508 HLClVFE~L-slNLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999988 46999999865432 23677888899999999999999887 999999999999996 56799
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||||.|........ +-..-+..|.|||
T Consensus 578 LCDfGSA~~~~enei----tPYLVSRFYRaPE 605 (752)
T KOG0670|consen 578 LCDFGSASFASENEI----TPYLVSRFYRAPE 605 (752)
T ss_pred eccCccccccccccc----cHHHHHHhccCcc
Confidence 999999877654332 1122345688887
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-20 Score=143.64 Aligned_cols=131 Identities=24% Similarity=0.395 Sum_probs=106.3
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEcCCCC--CC-------HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASK--QP-------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~~~vaik~~~~~~--~~-------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.||+|+||.||++.+ ++..+++|...... .. .+.+.+|+.++..++|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 46788888854322 11 145668999999999887766666666777789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+|++|.+++.... ..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998874321 067889999999999997 99999999999999 889999999998764
Q ss_pred C
Q 025893 225 P 225 (246)
Q Consensus 225 ~ 225 (246)
.
T Consensus 140 ~ 140 (199)
T TIGR03724 140 D 140 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=144.67 Aligned_cols=136 Identities=16% Similarity=0.167 Sum_probs=106.6
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC-----------------------HHHHHHHHHHHhcCCCCC-
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-----------------------DEEFLAQVSMVSRLKHEN- 123 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~-----------------------~~~~~~e~~~l~~l~hp~- 123 (246)
.|.+.+.||+|+||.||++..++|+.+|+|.+...... ......|+.++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 37778899999999999999888999999986543210 112567888888888774
Q ss_pred -ccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 124 -FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 124 -iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
++..++ ....+++|||++|++|.+.... .....++.+++.++.++|..+ |+||||+|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 444443 3456899999999998765321 123467889999999999987 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+||+++.++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-20 Score=154.27 Aligned_cols=134 Identities=22% Similarity=0.358 Sum_probs=114.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-----C---CCccceEeEEEe----
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----H---ENFVQLLGYCVD---- 133 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-----h---p~iv~~~~~~~~---- 133 (246)
.+|.+.++||.|.|++||+|... ..+.||+|+.+..+...+..+.||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 57888899999999999999976 6778999999877777888899999999874 2 479999999874
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
+.++++|+|++ |-+|..+|..... ..++...+..|+.||+.||.|||..+ .|||-||||+|||+-..
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~Y-------rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNY-------RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCC-------CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 56889999998 7789888865432 34888999999999999999999976 79999999999999644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-19 Score=148.25 Aligned_cols=167 Identities=36% Similarity=0.537 Sum_probs=137.0
Q ss_pred CCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCC-CccceEeEEEeCCeeEEEEec
Q 025893 69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHE-NFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~E~ 143 (246)
|.....||.|+|+.||++... ..+++|.+..... ....+.+|+.++..+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999876 7788998865432 256788999999999988 799999999877778999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEccccCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN 222 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Dfgls~ 222 (246)
+.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++.|||+++
T Consensus 80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 9999999777654210 13778889999999999999999997 99999999999999888 79999999987
Q ss_pred CCCcccccc----ccccccccccccCCC
Q 025893 223 QAPDMAARL----HSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~----~~~~~~gt~~y~aPE 246 (246)
......... ......||..|+|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe 178 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPE 178 (384)
T ss_pred ecCCCCccccccccccccccccccCCHH
Confidence 544332211 235668999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=127.19 Aligned_cols=136 Identities=21% Similarity=0.241 Sum_probs=112.2
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC--CCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
.+.||+|.++.||++.... ..+++|....... ...+..|+..++.+++ +++++++.+....+..++++||+.++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 4679999999999999764 6789998765443 5678899999999986 5899999888888889999999988766
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
..+ +......++.+++.++.++|......++|+|++|+||+++..+.++++|||++....
T Consensus 81 ~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 81 DEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 532 234556778899999999998643459999999999999998999999999987643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=133.68 Aligned_cols=135 Identities=18% Similarity=0.237 Sum_probs=95.5
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCH---HH----------------------HHHHHHHHhcCCCCC--c
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EE----------------------FLAQVSMVSRLKHEN--F 124 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~---~~----------------------~~~e~~~l~~l~hp~--i 124 (246)
.+.||+|+||+||+|...+++.||+|.+....... .. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999876432211 11 124555555554332 3
Q ss_pred cceEeEEEeCCeeEEEEecCCCCCHHH-HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCC
Q 025893 125 VQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKS 202 (246)
Q Consensus 125 v~~~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp 202 (246)
.+.++. ...+++|||++++.+.. .+.... .. .....++.+++.++.++|. ++ |+|+||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p 143 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSE 143 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence 444432 34589999999854321 111100 11 4567889999999999999 76 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+||+++ ++.++|+|||.+....
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhEEEE-CCcEEEEECccccccc
Confidence 999999 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-17 Score=133.22 Aligned_cols=135 Identities=15% Similarity=0.199 Sum_probs=103.0
Q ss_pred ceec-cCCceEEEEEEECCCCEEEEEEcCCCC--------------CCHHHHHHHHHHHhcCCCCCc--cceEeEEEeCC
Q 025893 73 ALIG-EGSYGRVYYGILKSGHAAAIKKLDASK--------------QPDEEFLAQVSMVSRLKHENF--VQLLGYCVDGT 135 (246)
Q Consensus 73 ~~lG-~G~fg~V~~~~~~~~~~vaik~~~~~~--------------~~~~~~~~e~~~l~~l~hp~i--v~~~~~~~~~~ 135 (246)
..|| .|+.|+||.+... +..+++|.+.... .....+.+|+.++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 7889999988765 6778888764211 122457789999999998875 66776644322
Q ss_pred ----eeEEEEecCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 136 ----SRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 136 ----~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
..++|||+++| .+|.+++.... ++.. .+.+++.+|.+||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~ 178 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD 178 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence 22599999997 68988875421 3433 3568899999999998 9999999999999988
Q ss_pred CceEEccccCCCCCC
Q 025893 211 DVAKIADFDLSNQAP 225 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~ 225 (246)
+.++|+|||.+....
T Consensus 179 ~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 179 GKFWLIDFDRGELRT 193 (239)
T ss_pred CCEEEEECCCcccCC
Confidence 899999999987643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=141.56 Aligned_cols=182 Identities=22% Similarity=0.296 Sum_probs=134.5
Q ss_pred HHHHHHhcCCCCceeccCCceEEEEEEECCC------CEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEE
Q 025893 61 ELKEITENFGTNALIGEGSYGRVYYGILKSG------HAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCV 132 (246)
Q Consensus 61 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~------~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 132 (246)
++.....++++..++-+|.||+||+|.+++. +.|-+|.+.... .....++.|.-++..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3344456788888899999999999987632 234455443222 23346778888888899999999999876
Q ss_pred e-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 133 D-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 133 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
+ ...+++.+.++.-|+|..+|...++.+...+ ..++-.+...++.|++.|+.|||.++ |||.||..+|++||+.-
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~a-qtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYA-QTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccc-cchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 5 4667788888888999999985554433222 34677778889999999999999997 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|=.+++.+-.....-.....-....||+||
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE 468 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE 468 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence 99999999998765433221111112345788886
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-18 Score=159.46 Aligned_cols=117 Identities=19% Similarity=0.232 Sum_probs=83.3
Q ss_pred cCCC-CCccceEeEE-------EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 025893 118 RLKH-ENFVQLLGYC-------VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189 (246)
Q Consensus 118 ~l~h-p~iv~~~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 189 (246)
.++| +||.+++++| ......++++|++ +++|.++|.... ..+++..++.++.||+.||.|||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHS 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHh
Confidence 3455 5777777776 2334566778887 569999996432 238889999999999999999999
Q ss_pred CCCCCeeeCCCCCCCeEecC-------------------CCceEEccccCCCCCCcccc--------------ccccccc
Q 025893 190 KADPHIIHRDIKSSNVLIFD-------------------DDVAKIADFDLSNQAPDMAA--------------RLHSTRV 236 (246)
Q Consensus 190 ~~~~~ivHrdlkp~Nil~~~-------------------~~~~kl~Dfgls~~~~~~~~--------------~~~~~~~ 236 (246)
++ |+||||||+|||++. ++.+|++|||+++....... .......
T Consensus 99 ~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 99 QG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred CC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 97 999999999999954 44567777777654211000 0001124
Q ss_pred cccccccCCC
Q 025893 237 LGTFGYHAPE 246 (246)
Q Consensus 237 ~gt~~y~aPE 246 (246)
+||+.|||||
T Consensus 176 ~gt~~Y~APE 185 (793)
T PLN00181 176 MEMSWYTSPE 185 (793)
T ss_pred CCCcceEChh
Confidence 6899999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-18 Score=151.57 Aligned_cols=164 Identities=21% Similarity=0.330 Sum_probs=121.8
Q ss_pred CCCceeccCCceEEEEEEEC-CCCEEEEEEcC----CCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~----~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
....++|.|.+|.|+..... .....+.|... ..... ...+..|+.+-..|.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34568999999977766543 33333444332 11111 112556777788899999988777666655555559
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|||++ +|..++.... .+...++..++.|++.|+.|+|++| |.|||+|++|+++...+.+||+|||.+
T Consensus 401 E~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred hcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcc
Confidence 99999 9999987642 2667778889999999999999998 999999999999999999999999998
Q ss_pred CCCCccccc--cccccccccccccCCC
Q 025893 222 NQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
......... .....++|+..|+|||
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE 494 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPE 494 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcc
Confidence 765433222 3345678999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-17 Score=152.11 Aligned_cols=145 Identities=28% Similarity=0.378 Sum_probs=112.3
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.+.|.+.+.||+|+||.||+|...+|+.||+|.-....... |.-=.+++.+|+ -+.|..+..++.-.+..+||+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 34677778899999999999998779999999865443321 111123344444 3456666666667788899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-------CCceEE
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-------DDVAKI 215 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-------~~~~kl 215 (246)
|.+.|+|.+++...+ ...|..+..+..|++.-++.||.++ |||+||||+|+||.. ...++|
T Consensus 775 y~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 775 YSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 999999999998443 3778888899999999999999997 999999999999942 236999
Q ss_pred ccccCCCCC
Q 025893 216 ADFDLSNQA 224 (246)
Q Consensus 216 ~Dfgls~~~ 224 (246)
+|||-+-.+
T Consensus 843 IDfG~siDm 851 (974)
T KOG1166|consen 843 IDFGRSIDM 851 (974)
T ss_pred Eecccceee
Confidence 999987543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-17 Score=145.79 Aligned_cols=155 Identities=26% Similarity=0.340 Sum_probs=126.2
Q ss_pred eeccCCceEEEEEEE----CCCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCC
Q 025893 74 LIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~----~~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
++|+|.||.|++++- ..+..+|+|.+.+... .......|-.++...+ ||.+|+++-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998752 3467788888754321 1123445667777777 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+|+|...+.... .+.+.....+...++.++.++|..+ |+|||+|++||+++.+|++++.|||+++..-
T Consensus 81 gg~lft~l~~~~---------~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---------MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccCC---------chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence 999988776543 3667777788889999999999997 9999999999999999999999999998754
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
... ..|||..|||||
T Consensus 149 ~~~------~~cgt~eymApE 163 (612)
T KOG0603|consen 149 KEK------IACGTYEYRAPE 163 (612)
T ss_pred hhh------hcccchhhhhhH
Confidence 322 228999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-15 Score=129.13 Aligned_cols=141 Identities=21% Similarity=0.261 Sum_probs=96.2
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---------------------------HH--------------HHH
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------DE--------------EFL 110 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---------------------------~~--------------~~~ 110 (246)
.+.||.|++|.||+|+.++|+.||||+....-.. .. ++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998543110 00 133
Q ss_pred HHHHHHhcC----CCCCccceEeEE-EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH-HH
Q 025893 111 AQVSMVSRL----KHENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK-GL 184 (246)
Q Consensus 111 ~e~~~l~~l----~hp~iv~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~-~l 184 (246)
.|+..+.++ ++.+-+.+-..+ ......+|||||++|++|.++...... ... ...++..++. .+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--------~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--------GLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--------CCC---HHHHHHHHHHHHH
Confidence 344444333 333333333332 223456899999999999887643210 011 2345555554 46
Q ss_pred HHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 185 ~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
..+|..+ ++|+|++|.||+++.++.++++|||++..+..
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7788886 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.6e-14 Score=106.83 Aligned_cols=131 Identities=16% Similarity=0.100 Sum_probs=95.9
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecCCCCCHHH
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHD 151 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~E~~~~g~L~~ 151 (246)
+.|+.|.++.||++... +..+++|...........+..|+.+++.+.+.++ .+++.+. ....++||||++|.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999998865 6789999875543333456778888888865443 4555443 334579999999987753
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
.. .. ...++.+++.+|..||..+ ...++|+|++|.||+++ ++.++++||+.+...
T Consensus 81 ~~--------------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 81 ED--------------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc--------------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 20 00 1235678899999999975 12359999999999998 678999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-14 Score=126.27 Aligned_cols=144 Identities=15% Similarity=0.210 Sum_probs=92.0
Q ss_pred hcCCCCceeccCCceEEEEEEECC-CCEEEEEEcCCCCC---------------------------CH--------H---
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQ---------------------------PD--------E--- 107 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vaik~~~~~~~---------------------------~~--------~--- 107 (246)
.+|+. +.||.|++|.||+|++++ |+.||||++.+.-. .. +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999886 99999999864310 00 1
Q ss_pred ---HHHHHHHHHhcC----CCCCccceEeEEEe-CCeeEEEEecCCCCCHHHHh--ccCCCCCCCCCCCCCCHHHHHHHH
Q 025893 108 ---EFLAQVSMVSRL----KHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIA 177 (246)
Q Consensus 108 ---~~~~e~~~l~~l----~hp~iv~~~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~~~~~~~~~~~~~l~~~~~~~i~ 177 (246)
++.+|+.-+.++ .+.+.+.+-..+.+ ....+|||||+.|+++.++- ..... ....+....+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-----d~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-----DMKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-----CHHHHHHHHHHHHH
Confidence 123333333333 24444444444332 45667999999999998753 22110 00012222233333
Q ss_pred HHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----ceEEccccCCCCCCc
Q 025893 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPD 226 (246)
Q Consensus 178 ~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~----~~kl~Dfgls~~~~~ 226 (246)
.|+ ...| ++|+|++|.||+++.++ .+++.|||++..+..
T Consensus 274 ~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 343 3455 99999999999999887 999999999877643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.7e-15 Score=116.90 Aligned_cols=156 Identities=26% Similarity=0.420 Sum_probs=120.1
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
..|.+...|+.|+|++. |..+++|++.... ....+|..|.-.|+.+.||||+.+++.|..+..+.++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 35778889999999987 4555667664333 3346888999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc--cccCCCCCCcc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA--DFDLSNQAPDM 227 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~--Dfgls~~~~~~ 227 (246)
+..|....+. .+.-.++.+++.+++.|+.|||+.. |-|.---|....++||++-+++|+ |--++-+.
T Consensus 275 ynvlhe~t~v-------vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 275 YNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred HHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 9999876542 2556778899999999999999974 334445689999999999887765 32222110
Q ss_pred ccccccccccccccccCCC
Q 025893 228 AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE 246 (246)
....-.|.||+||
T Consensus 344 ------~gr~y~pawmspe 356 (448)
T KOG0195|consen 344 ------VGRAYSPAWMSPE 356 (448)
T ss_pred ------cccccCcccCCHH
Confidence 1123468899997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.1e-14 Score=128.68 Aligned_cols=168 Identities=26% Similarity=0.372 Sum_probs=129.6
Q ss_pred cCCCCceeccCCceEEEEEEEC--CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~--~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.|.+.+.||+|.|+.|-..... ....+|.|.+..... ..+....|..+-+.+. |+|++++++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 5666677999999999877643 334566666543322 2334455777777777 999999999999999999999
Q ss_pred ecCCCCCHHHHh-ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeeCCCCCCCeEecCCC-ceEEccc
Q 025893 142 EFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKADPHIIHRDIKSSNVLIFDDD-VAKIADF 218 (246)
Q Consensus 142 E~~~~g~L~~~l-~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Df 218 (246)
||..++++.+.+ .... ...+......+..|+..++.|+| ..+ +.|||+||+|.+++..+ .+|++||
T Consensus 101 ~~s~g~~~f~~i~~~~~--------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS--------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccccccccCCc--------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence 999999998877 3221 12334455678899999999999 776 99999999999999999 9999999
Q ss_pred cCCCCCCc-cccccccccccc-cccccCCC
Q 025893 219 DLSNQAPD-MAARLHSTRVLG-TFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~-~~~~~~~~~~~g-t~~y~aPE 246 (246)
|+|..... ..........+| ++.|+|||
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E 199 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPE 199 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcc
Confidence 99988766 444434456678 99999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.1e-13 Score=125.44 Aligned_cols=133 Identities=30% Similarity=0.422 Sum_probs=91.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
..+|+.+++|-.|+||.||..+++ +.+.+|+ ++.+.+.-.+. ++.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn------ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN------ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc------cccccCCccee-------------------
Confidence 468999999999999999999987 5677888 44333211110 33333444443
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
|+-...++.-. .++. +.+.+++|+|+-+ |+|||+||+|.+|..-|++|+.|||+++..
T Consensus 136 --gDc~tllk~~g---------~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --GDCATLLKNIG---------PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --chhhhhcccCC---------CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 44444444322 1222 1267899999987 999999999999999999999999998642
Q ss_pred Cccc-------------cccccccccccccccCCC
Q 025893 225 PDMA-------------ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~-------------~~~~~~~~~gt~~y~aPE 246 (246)
-... .......++|||.|+|||
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 1110 011235679999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.8e-12 Score=97.19 Aligned_cols=134 Identities=16% Similarity=0.153 Sum_probs=93.8
Q ss_pred ceeccCCceEEEEEEECC-------CCEEEEEEcCCCCC----------------------C-HHHH----HHHHHHHhc
Q 025893 73 ALIGEGSYGRVYYGILKS-------GHAAAIKKLDASKQ----------------------P-DEEF----LAQVSMVSR 118 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~-------~~~vaik~~~~~~~----------------------~-~~~~----~~e~~~l~~ 118 (246)
..||.|--+.||.|...+ +..+|+|..+.+.. . ...+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998542 47899997632110 0 1112 268888888
Q ss_pred CCC--CCccceEeEEEeCCeeEEEEecCCCCCHH-HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCC
Q 025893 119 LKH--ENFVQLLGYCVDGTSRVLAYEFASNGSLH-DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADPH 194 (246)
Q Consensus 119 l~h--p~iv~~~~~~~~~~~~~lv~E~~~~g~L~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~ 194 (246)
+.. -++.+++.+ ..-+|||||+.+..+. ..++.. .++......+..+++.+|..+ |..+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g--- 145 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN--- 145 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 763 455666643 4567899999764442 122211 144455667788999999988 7776
Q ss_pred eeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 195 ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
|+|+||++.|||+. ++.+.|+|||.+...
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999999996 467999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.1e-12 Score=99.25 Aligned_cols=142 Identities=20% Similarity=0.270 Sum_probs=102.9
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCC--CCccceEeEEEeC---CeeEEEEecCC
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKH--ENFVQLLGYCVDG---TSRVLAYEFAS 145 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~---~~~~lv~E~~~ 145 (246)
+.|+.|..+.||++...+|..+++|....... ....+..|+.+++.+.+ .++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999877667899998765433 34577889999999875 4467777776553 25689999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA---------------------------------- 191 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------- 191 (246)
|.++.+.+... .++..+...++.+++..|..||+..
T Consensus 84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 88776544210 1444555556666666666666421
Q ss_pred -------------------CCCeeeCCCCCCCeEecC--CCceEEccccCCCCC
Q 025893 192 -------------------DPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQA 224 (246)
Q Consensus 192 -------------------~~~ivHrdlkp~Nil~~~--~~~~kl~Dfgls~~~ 224 (246)
...++|+|+.+.||+++. .+.+.|+||+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 134799999999999998 567899999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.3e-13 Score=127.24 Aligned_cols=141 Identities=21% Similarity=0.214 Sum_probs=111.7
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCC--CCHHHHHH---HHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK--QPDEEFLA---QVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~--~~~~~~~~---e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
+|...+.||++.|=+|.+|+++.|. |++|++-+.. ...+.+.+ |++ ....++||.+.+--+.......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666778999999999999988776 7888874432 33444444 444 455679999988777666777788888
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|.. .+|+|.|..+. .|...+..-|+.|++.||.-||..+ |+|+|||.+||||.+-.-+.|+||..-+
T Consensus 102 yvk-hnLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHh-hhhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 885 49999987653 4666667779999999999999997 9999999999999998889999997655
Q ss_pred C
Q 025893 223 Q 223 (246)
Q Consensus 223 ~ 223 (246)
.
T Consensus 169 P 169 (1431)
T KOG1240|consen 169 P 169 (1431)
T ss_pred C
Confidence 4
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.2e-11 Score=91.68 Aligned_cols=130 Identities=20% Similarity=0.327 Sum_probs=97.5
Q ss_pred eeccCCceEEEEEEECCCCEEEEEE-cCCCCCC--------HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 74 LIGEGSYGRVYYGILKSGHAAAIKK-LDASKQP--------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~~~vaik~-~~~~~~~--------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.+.+|+-+.+|.+.+. |..+.+|. +++.... .+...+|+.++.++.--.|....-+..++....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5788999999999775 33455553 3332221 134567999998887555555555667788888999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+|..|.+.+... ...++..|-.-+.-||..+ |+|+||.++||++...+ +-++||||+...
T Consensus 82 ~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 998888888542 1356777778888999997 99999999999998766 889999998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.6e-12 Score=107.44 Aligned_cols=113 Identities=26% Similarity=0.352 Sum_probs=81.1
Q ss_pred CCCCccceEeEEEeC---------------------------CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHH
Q 025893 120 KHENFVQLLGYCVDG---------------------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172 (246)
Q Consensus 120 ~hp~iv~~~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~ 172 (246)
+|||||+++++|.++ ..+|+||...+ .+|..++..+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----------CchHH
Confidence 599999998776532 24588887774 48999987543 55566
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCC--ceEEccccCCCCCCccccc----cccccccccccccC
Q 025893 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDD--VAKIADFDLSNQAPDMAAR----LHSTRVLGTFGYHA 244 (246)
Q Consensus 173 ~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~--~~~--~~kl~Dfgls~~~~~~~~~----~~~~~~~gt~~y~a 244 (246)
...++.|+++|+.|||.++ |.|||+|.+|||+. +++ .+.|+|||.+-......-. ...-..-|....||
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 7778999999999999998 99999999999995 333 5789999987543221110 01112336666788
Q ss_pred CC
Q 025893 245 PE 246 (246)
Q Consensus 245 PE 246 (246)
||
T Consensus 420 PE 421 (598)
T KOG4158|consen 420 PE 421 (598)
T ss_pred hh
Confidence 87
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.5e-12 Score=112.03 Aligned_cols=100 Identities=33% Similarity=0.504 Sum_probs=88.3
Q ss_pred HhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 025893 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195 (246)
Q Consensus 116 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 195 (246)
|+.+.|.|+.++.|.+.++...++|.+||..|+|.+.+.... ..+++.....++++|+.||.|+|... -.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--------~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~ 70 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--------IKLDYFFILSFIRDISKGLAYLHNSP--IG 70 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--------cCccHHHHHHHHHHHHHHHHHHhcCc--ce
Confidence 467899999999999999999999999999999999997632 23788888889999999999999852 23
Q ss_pred eeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 196 vHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
.|+.|+..|++++..+.+||+|||+.....
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhccccc
Confidence 999999999999999999999999987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.3e-12 Score=102.50 Aligned_cols=149 Identities=21% Similarity=0.282 Sum_probs=88.3
Q ss_pred CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCC----------CCccceEeEE--
Q 025893 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKH----------ENFVQLLGYC-- 131 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~h----------p~iv~~~~~~-- 131 (246)
......||.|+|+.||.+.+. +++.+|+|....... ..+++.+|.-....+.+ -.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345578999999999999976 799999998743222 23455555533333221 1122222221
Q ss_pred -------EeC---Ce-----eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 025893 132 -------VDG---TS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 196 (246)
Q Consensus 132 -------~~~---~~-----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iv 196 (246)
... .. .+++|.-+ .++|.+++......... ...+....++.+..|++..+++||+.| +|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 111 11 24566666 45888775421110000 111334445566789999999999998 99
Q ss_pred eCCCCCCCeEecCCCceEEccccCCCC
Q 025893 197 HRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 197 Hrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
|+||+|+|++++.+|.+.|+||+....
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r 194 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVR 194 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEE
T ss_pred ecccceeeEEEcCCCCEEEcChHHHee
Confidence 999999999999999999999986544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-10 Score=88.65 Aligned_cols=143 Identities=21% Similarity=0.274 Sum_probs=103.3
Q ss_pred CCceeccCCceEEEEEEECCCCEEEEEEc-CCCCC--------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 71 TNALIGEGSYGRVYYGILKSGHAAAIKKL-DASKQ--------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~~~~~vaik~~-~~~~~--------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
...+|-+|.-++|+++.+. |+...||.- .+... ...+..+|+..+.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999876 677677753 22211 1245678999988876555555455666777778899
Q ss_pred ecCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---ceEEcc
Q 025893 142 EFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIAD 217 (246)
Q Consensus 142 E~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~---~~kl~D 217 (246)
||++| .++.+++....... ........++..|-+.+.-||... |+|+||..+||++..++ .+-++|
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence 99976 47788886554221 222233578888999999999986 99999999999997654 458999
Q ss_pred ccCCCCC
Q 025893 218 FDLSNQA 224 (246)
Q Consensus 218 fgls~~~ 224 (246)
||++...
T Consensus 160 fgls~~s 166 (229)
T KOG3087|consen 160 FGLSSVS 166 (229)
T ss_pred ecchhcc
Confidence 9998653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=1e-11 Score=95.57 Aligned_cols=74 Identities=27% Similarity=0.231 Sum_probs=61.6
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... ..+++..+..++.|++.||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRG--------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 68899987533 13899999999999999999999873 999999999999999 999875432
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
....||+.|||||
T Consensus 62 -------~~~~g~~~y~aPE 74 (176)
T smart00750 62 -------EQSRVDPYFMAPE 74 (176)
T ss_pred -------ccCCCcccccChH
Confidence 1226899999998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=106.14 Aligned_cols=99 Identities=32% Similarity=0.440 Sum_probs=78.5
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
++||.|++|...+|.++|..++... ..++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e------~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGE------ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCccc------ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence 5789999999999999997554221 25566778899999999999 55 899999999999999999999
Q ss_pred ccccCCCCCCccc----cccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMA----ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~----~~~~~~~~~gt~~y~aPE 246 (246)
.|||+........ .....+.-+||..||+||
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE 432 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPE 432 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHH
Confidence 9999987654433 111123457999999998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.7e-09 Score=85.67 Aligned_cols=139 Identities=15% Similarity=0.060 Sum_probs=93.8
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEcCCCC------------CCHHHHHHHHHHHhcCCCCCc--cceEeEEEe-----C
Q 025893 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASK------------QPDEEFLAQVSMVSRLKHENF--VQLLGYCVD-----G 134 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~~~vaik~~~~~~------------~~~~~~~~e~~~l~~l~hp~i--v~~~~~~~~-----~ 134 (246)
.+-.-....|.+..+ .|+.+.||...... .....+.+|...+.+|..-+| +...++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333444666554 46788888653221 112246788888877753333 344445443 2
Q ss_pred CeeEEEEecCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC----
Q 025893 135 TSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---- 209 (246)
Q Consensus 135 ~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---- 209 (246)
...+||||++++. +|.+++..... ..........++.+++..+.-||..| |+|+|+++.|||++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-------~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-------NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 3468999999875 78888753211 01344566688999999999999998 999999999999975
Q ss_pred ---CCceEEccccCCCC
Q 025893 210 ---DDVAKIADFDLSNQ 223 (246)
Q Consensus 210 ---~~~~kl~Dfgls~~ 223 (246)
+..+.++||+.+..
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 46789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.6e-09 Score=84.14 Aligned_cols=123 Identities=21% Similarity=0.246 Sum_probs=77.8
Q ss_pred EEEEEEECCCCEEEEEEcCCCCC-----------------------C----HHHHHHHHHHHhcCCCC--CccceEeEEE
Q 025893 82 RVYYGILKSGHAAAIKKLDASKQ-----------------------P----DEEFLAQVSMVSRLKHE--NFVQLLGYCV 132 (246)
Q Consensus 82 ~V~~~~~~~~~~vaik~~~~~~~-----------------------~----~~~~~~e~~~l~~l~hp--~iv~~~~~~~ 132 (246)
.||.|...++..+|+|....... . .....+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988889999997643210 0 02345799999999855 466666442
Q ss_pred eCCeeEEEEecCC--CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeeeCCCCCCCeEecC
Q 025893 133 DGTSRVLAYEFAS--NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY-LHEKADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 133 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~~~~~ivHrdlkp~Nil~~~ 209 (246)
.-.|||||++ |..+..+.... +.......++.+++..+.. +|..+ |+|+||.+.|||++.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD 142 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence 3469999998 65554433221 1122334567777775555 56776 999999999999987
Q ss_pred CCceEEccccCCCC
Q 025893 210 DDVAKIADFDLSNQ 223 (246)
Q Consensus 210 ~~~~kl~Dfgls~~ 223 (246)
+ .+.|+|||.+..
T Consensus 143 ~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 143 G-KVYIIDFGQAVD 155 (188)
T ss_dssp T-CEEE--GTTEEE
T ss_pred c-eEEEEecCccee
Confidence 7 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.2e-10 Score=99.31 Aligned_cols=169 Identities=25% Similarity=0.247 Sum_probs=124.9
Q ss_pred HhcCCCCceecc--CCceEEEEEEE--C-CCCEEEEEEcCC--C-CCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGE--GSYGRVYYGIL--K-SGHAAAIKKLDA--S-KQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~--G~fg~V~~~~~--~-~~~~vaik~~~~--~-~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 136 (246)
.+.|.+...+|. |.+|.||.+.. + ++..+|+|+-.. . ......-.+|+....+++ |+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 456777888999 99999999876 4 677888887322 1 122233445666666775 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeeeCCCCCCCeEecCC-C
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK----GLEYLHEKADPHIIHRDIKSSNVLIFDD-D 211 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~~ivHrdlkp~Nil~~~~-~ 211 (246)
.++-+|+|. .+|..+...... .++.........+... ||.++|+.. ++|-|+||+||++..+ .
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWT 260 (524)
T ss_pred ceeeecccc-chhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccc
Confidence 999999984 688887765432 2455555666777777 999999986 9999999999999998 7
Q ss_pred ceEEccccCCCCCCcccccc---ccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARL---HSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~---~~~~~~gt~~y~aPE 246 (246)
..+++|||+...+....-.. ......|..-|++||
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke 298 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE 298 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChh
Confidence 88999999877654432111 112235777899887
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.3e-09 Score=92.58 Aligned_cols=118 Identities=16% Similarity=0.238 Sum_probs=95.7
Q ss_pred CCCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCC
Q 025893 90 SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168 (246)
Q Consensus 90 ~~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l 168 (246)
++..|.+...+.+... .+...+.+..|+.|+||||++++..+......|||+|.+. .|..+++. +
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------------l 101 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------------L 101 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------------h
Confidence 5777777777655442 2345667888999999999999999999999999999984 67777764 3
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 169 ~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
....+.--+.||+.||.|||..+ .++|++|.-+.++++..|.-||++|.++..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~ 154 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSK 154 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence 34455567899999999999765 599999999999999999999999987643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-09 Score=89.93 Aligned_cols=97 Identities=28% Similarity=0.419 Sum_probs=79.4
Q ss_pred HHHhcCCCCCccceEeEEEeCC-----eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 025893 114 SMVSRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188 (246)
Q Consensus 114 ~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH 188 (246)
.-+-++.|.|||+++.+|.+.. ...+++||+..|++.++|+.... ....+......+++-||+.||.|||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-----~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-----NQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-----hhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 3455667999999999987643 46788999999999999975432 1224666667789999999999999
Q ss_pred hCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 189 EKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 189 ~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
+. .|+|+|.++..+-|++..++.+|+.
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEec
Confidence 97 7889999999999999999998875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.6e-09 Score=95.03 Aligned_cols=146 Identities=23% Similarity=0.269 Sum_probs=113.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--CCCEEEEEEcCCCCC-CHHH--HHHHHHHHhcCC-CCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ-PDEE--FLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vaik~~~~~~~-~~~~--~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l 139 (246)
..+|..+..||.|.|+.|+....+ ++..+++|.+.+... ...+ -..|+-+...+. |.+++++...|......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 347888889999999999987744 577889988754432 2222 234555555554 8999999888888888889
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CceEEccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADF 218 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-~~~kl~Df 218 (246)
-.|||+++++...+.... .+.+...+++..|++.++.++|++. ++|+|++|+||++..+ +..++.||
T Consensus 344 p~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred chhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence 999999998876553221 3566777889999999999999886 9999999999999886 77889999
Q ss_pred cCCCC
Q 025893 219 DLSNQ 223 (246)
Q Consensus 219 gls~~ 223 (246)
|....
T Consensus 412 ~~~t~ 416 (524)
T KOG0601|consen 412 GCWTR 416 (524)
T ss_pred ccccc
Confidence 98754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.1e-07 Score=73.15 Aligned_cols=137 Identities=12% Similarity=0.096 Sum_probs=97.3
Q ss_pred eccCCceEEEEEEECCCCEEEEEEcCCC-------CCCHHHHHHHHHHHhcCCCCC--ccceEeEEE-e--C--CeeEEE
Q 025893 75 IGEGSYGRVYYGILKSGHAAAIKKLDAS-------KQPDEEFLAQVSMVSRLKHEN--FVQLLGYCV-D--G--TSRVLA 140 (246)
Q Consensus 75 lG~G~fg~V~~~~~~~~~~vaik~~~~~-------~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~-~--~--~~~~lv 140 (246)
-|+||.+-|++-.+. |..+-+|+-... ......|.+|+..+.+|..-+ +.+.. ++. . . -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888889987665 446778875411 224578999999888876322 44444 222 1 1 235799
Q ss_pred EecCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--eEEcc
Q 025893 141 YEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIAD 217 (246)
Q Consensus 141 ~E~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~--~kl~D 217 (246)
+|-+.+ -+|.+++..... ...+......+..+++..+.-||+.+ +.|+|+.+.||+++.++. ++++|
T Consensus 104 Te~L~g~~~L~~~l~~~~~-------~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-------SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-------CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 997753 588888754321 12455666788999999999999997 999999999999986666 99999
Q ss_pred ccCCCC
Q 025893 218 FDLSNQ 223 (246)
Q Consensus 218 fgls~~ 223 (246)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 986654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.3e-08 Score=78.13 Aligned_cols=133 Identities=17% Similarity=0.200 Sum_probs=91.7
Q ss_pred CCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC-----------------------CHHHHHHHHHHHhcCCCC--C
Q 025893 69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-----------------------PDEEFLAQVSMVSRLKHE--N 123 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~-----------------------~~~~~~~e~~~l~~l~hp--~ 123 (246)
..+...||-|--+.||.|....|..+|+|.-+.... ......+|...|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999998899999995422100 012345788899988744 5
Q ss_pred ccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 025893 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (246)
Q Consensus 124 iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~ 203 (246)
+.+.++ -+.-.+||||++|-.|...- +.....-.++..|+.-+.-+-..| +||+|+.+=
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSef 231 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEF 231 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence 555543 35567999999987765432 111222334444444444333455 999999999
Q ss_pred CeEecCCCceEEccccCCC
Q 025893 204 NVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 204 Nil~~~~~~~kl~Dfgls~ 222 (246)
||+++++|.+.++||--+.
T Consensus 232 NIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred eEEEecCCCEEEEeCcccc
Confidence 9999999999999996544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-07 Score=75.22 Aligned_cols=108 Identities=23% Similarity=0.270 Sum_probs=80.2
Q ss_pred HHHHHHHHHHHhcCCCC--CccceEeEEEeCC----eeEEEEecCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHH
Q 025893 106 DEEFLAQVSMVSRLKHE--NFVQLLGYCVDGT----SRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178 (246)
Q Consensus 106 ~~~~~~e~~~l~~l~hp--~iv~~~~~~~~~~----~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ 178 (246)
.....+|...+..|..- .+++.+++..... ..+||+|++++. +|.+++..... ++......++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~ 125 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLR 125 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHH
Confidence 34566777777666533 3455666655432 347999999874 78888865321 33455667899
Q ss_pred HHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---ceEEccccCCCCCC
Q 025893 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAP 225 (246)
Q Consensus 179 ~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~---~~kl~Dfgls~~~~ 225 (246)
+++..+.-||..+ |+|+|+++.|||++.++ .+.++||+-++...
T Consensus 126 ~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 126 ALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999999998 99999999999999876 88999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.2e-07 Score=80.84 Aligned_cols=141 Identities=14% Similarity=0.170 Sum_probs=102.7
Q ss_pred ceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCC-CCHHHH
Q 025893 80 YGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAYEFASN-GSLHDI 152 (246)
Q Consensus 80 fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~E~~~~-g~L~~~ 152 (246)
-.+.|++... +|..+++|++..... .......-++.++++.|+|||.+.+++.. ...+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3457888865 899999999832221 11122234678899999999999998873 4567899999875 677765
Q ss_pred hccCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 153 LHGRKGVK------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 153 l~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
--...... ........++.....++.|+..||.++|+.| +.=+-|.+.+||++.+.+++|+.-|+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceee
Confidence 43221111 1122345778888999999999999999997 88899999999999998999988777544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.3e-07 Score=84.05 Aligned_cols=141 Identities=21% Similarity=0.237 Sum_probs=87.9
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---------------------------HH--------------HHHH
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------DE--------------EFLA 111 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---------------------------~~--------------~~~~ 111 (246)
..|+.++-|.||+|++++|+.||||+..+.-.. .. ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 578999999999999999999999998653111 00 1223
Q ss_pred HHHHHhcC----C-CCCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 025893 112 QVSMVSRL----K-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186 (246)
Q Consensus 112 e~~~l~~l----~-hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 186 (246)
|..-+.++ . .|++.--.-++.-.+.-.|+|||+.|-.+.+....... ..+.........++..-.-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--------g~d~k~ia~~~~~~f~~q~- 281 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--------GIDRKELAELLVRAFLRQL- 281 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--------CCCHHHHHHHHHHHHHHHH-
Confidence 33333332 2 33332222233345667899999999888877422110 1332222222222111111
Q ss_pred HhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 187 lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++ .+ ++|.|..|.||++..++.+-+.|||+...+..
T Consensus 282 ~~-dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LR-DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred Hh-cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22 34 99999999999999999999999999877653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-06 Score=70.64 Aligned_cols=141 Identities=16% Similarity=0.168 Sum_probs=84.9
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCC--CccceEeEEEeCCeeEEEEecCCCCC-H
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGYCVDGTSRVLAYEFASNGS-L 149 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~~~~~~~lv~E~~~~g~-L 149 (246)
..||+|..+.||+. .+..+++|.... ........+|.++++.+..- .+.+.+.+....+...++||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999974 244567777654 33445678899999887633 35677888877778889999998853 1
Q ss_pred HHH---------------------hccCCCCCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHhhC-CCCCee
Q 025893 150 HDI---------------------LHGRKGVKGAQPGPVLSWQQRVKIAV----------GAAK-GLEYLHEK-ADPHII 196 (246)
Q Consensus 150 ~~~---------------------l~~~~~~~~~~~~~~l~~~~~~~i~~----------~i~~-~l~~lH~~-~~~~iv 196 (246)
... ++... .....+.... ..+.. .+.. ...+|... ..+.++
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~-----~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTK-----CDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCC-----CCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 111 11100 0000111000 00000 0111 11222211 123578
Q ss_pred eCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 197 HRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 197 Hrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
|+|+.|.||++++++ +.|+||+.+...
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999999878 999999987653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=2e-06 Score=67.99 Aligned_cols=137 Identities=15% Similarity=0.184 Sum_probs=85.1
Q ss_pred HHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHH----------HHHHHHHHhcC---CCCCccceEeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE----------FLAQVSMVSRL---KHENFVQLLGYC 131 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~----------~~~e~~~l~~l---~hp~iv~~~~~~ 131 (246)
+..+|...+++-......|.+-.. ++..+.+|.........++ ..+.+..+.++ .--....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346777777777766666665544 4678888876543322221 12233333333 222333333332
Q ss_pred E-----eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeE
Q 025893 132 V-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206 (246)
Q Consensus 132 ~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil 206 (246)
. -....+++|||++|..|.+... +.+ .+...+.+++.-+|..| ++|+|+.|.|++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFl 167 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFL 167 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEE
Confidence 2 1234468999999988876532 222 24455677899999998 999999999999
Q ss_pred ecCCCceEEccccCCCC
Q 025893 207 IFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 207 ~~~~~~~kl~Dfgls~~ 223 (246)
+..++ ++++||+-.+.
T Consensus 168 v~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EECCc-EEEEECccccc
Confidence 98544 89999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.8e-06 Score=68.95 Aligned_cols=74 Identities=15% Similarity=0.069 Sum_probs=50.3
Q ss_pred eccCCc-eEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCCHHH
Q 025893 75 IGEGSY-GRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (246)
Q Consensus 75 lG~G~f-g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 151 (246)
|-.|.. ..||+.... +..+.+|...... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 333443 678988654 4667778764432 345667888887774 3446677887776667899999999877653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.2e-06 Score=75.20 Aligned_cols=136 Identities=20% Similarity=0.224 Sum_probs=87.0
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCH--------------------------------H------HHHHHHH
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD--------------------------------E------EFLAQVS 114 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~--------------------------------~------~~~~e~~ 114 (246)
+.|+.-+.|.||+|+.++|+.||||+-.+.-... + +|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999875431110 0 1223332
Q ss_pred ----HHhcCCCCC------ccceEeEEEeCCeeEEEEecCCCCCHHH--HhccCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 025893 115 ----MVSRLKHEN------FVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182 (246)
Q Consensus 115 ----~l~~l~hp~------iv~~~~~~~~~~~~~lv~E~~~~g~L~~--~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 182 (246)
..+.+.|-+ |.+++ +.-.....|+||||+|..+.| .|.... ++...+..-+.+...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYL 314 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHH
Confidence 223334544 33332 222345689999999987754 444433 444444444444333
Q ss_pred HHHHHhhCCCCCeeeCCCCCCCeEecC----CCceEEccccCCCCCC
Q 025893 183 GLEYLHEKADPHIIHRDIKSSNVLIFD----DDVAKIADFDLSNQAP 225 (246)
Q Consensus 183 ~l~~lH~~~~~~ivHrdlkp~Nil~~~----~~~~kl~Dfgls~~~~ 225 (246)
-+-+.| | ++|.|-.|.||++.. ++.+.+-|||+...++
T Consensus 315 ~qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 315 EQIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 233333 3 899999999999984 5689999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.4e-06 Score=67.95 Aligned_cols=102 Identities=28% Similarity=0.324 Sum_probs=77.1
Q ss_pred HHHHHHhcCCC-CCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 025893 111 AQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189 (246)
Q Consensus 111 ~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 189 (246)
.|.-+++.+++ +++++++|+|- .++++||...+++....... ......+|..+.+|+.++++.+.+++.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l------~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL------SQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc------ccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 47778888886 69999999992 35678999876654210000 000126799999999999999999988
Q ss_pred CCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 190 ~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
.-...+.-.|++++|+-+++++.+|++|..-..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 533357779999999999999999999997654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.5e-05 Score=62.50 Aligned_cols=133 Identities=16% Similarity=0.212 Sum_probs=88.2
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCC-----------------CCHHHHHHHHHHHhcCC------CCCccceE
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------------QPDEEFLAQVSMVSRLK------HENFVQLL 128 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~-----------------~~~~~~~~e~~~l~~l~------hp~iv~~~ 128 (246)
...||+|+.-.||. +......+||++.... ....+..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999998885 3445566778775544 11244556665544444 88999999
Q ss_pred eEEEeCCeeEEEEecCCC------CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 129 GYCVDGTSRVLAYEFASN------GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 129 ~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
|+..++...-+|+|.+.. .+|.+++.... ++. .....+. +-..||-+.. |+.+|++|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~ 146 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQALD---EFKRYLLDHH---IVIRDLNP 146 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHHHH---HHHHHHHHcC---CeecCCCc
Confidence 999999999999987642 46777775432 443 2333333 3345666554 99999999
Q ss_pred CCeEecCC--C--ceEEcc-ccCCCC
Q 025893 203 SNVLIFDD--D--VAKIAD-FDLSNQ 223 (246)
Q Consensus 203 ~Nil~~~~--~--~~kl~D-fgls~~ 223 (246)
.||++... + .+.|+| ||-...
T Consensus 147 ~NIv~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ccEEEEecCCCceEEEEEeCCCCccc
Confidence 99999743 2 466666 565444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.36 E-value=1e-05 Score=76.81 Aligned_cols=77 Identities=14% Similarity=0.254 Sum_probs=56.1
Q ss_pred CceeccCCceEEEEEEECCC---CEEEEEEcCCCC--CCHHHHHHHHHHHhcCC-CCCc--cceEeEEEeC---CeeEEE
Q 025893 72 NALIGEGSYGRVYYGILKSG---HAAAIKKLDASK--QPDEEFLAQVSMVSRLK-HENF--VQLLGYCVDG---TSRVLA 140 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~---~~vaik~~~~~~--~~~~~~~~e~~~l~~l~-hp~i--v~~~~~~~~~---~~~~lv 140 (246)
...|+.|.++.+|+.....+ ..+++|+..... .....+.+|+.+++.|. |+++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999998876543 357777765432 23456889999999996 6655 7788877664 467899
Q ss_pred EecCCCCC
Q 025893 141 YEFASNGS 148 (246)
Q Consensus 141 ~E~~~~g~ 148 (246)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.2e-06 Score=66.82 Aligned_cols=77 Identities=16% Similarity=0.213 Sum_probs=54.3
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCC--CccceEeEEEe---CCeeEEEEecCCCC
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGYCVD---GTSRVLAYEFASNG 147 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~~---~~~~~lv~E~~~~g 147 (246)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.|... .+.+++..... ....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468999999999999876 58899986544 3345677888888777532 35677764432 34568999999987
Q ss_pred CHHH
Q 025893 148 SLHD 151 (246)
Q Consensus 148 ~L~~ 151 (246)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.5e-05 Score=60.70 Aligned_cols=128 Identities=17% Similarity=0.262 Sum_probs=85.1
Q ss_pred CCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCcc-ceEeEEEeCCeeEEEEecCCCCCH
Q 025893 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV-QLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv-~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
..+.|++|.+|.||++.++ +..+|+|.- ........+..|+++|..++..++. +++.+. ..++.|||+.|..|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvr-r~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVR-RRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEe-cCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 3457999999999999988 457788764 3445677889999999988865553 344332 22355999999888
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC-CCCeEecCCCceEEccccCCCC
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK-SSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk-p~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.+.-... .-.. ...+++.-.-|-..| |-|..|. |...++..++.+-|+||..|+.
T Consensus 100 ~~~~~~~------------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG------------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc------------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7765321 1122 223334433344444 7888774 5556666666999999998874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.2e-05 Score=63.47 Aligned_cols=76 Identities=16% Similarity=0.039 Sum_probs=54.9
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC---CCccceEeEEEe---CCeeEEEEecCC
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH---ENFVQLLGYCVD---GTSRVLAYEFAS 145 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h---p~iv~~~~~~~~---~~~~~lv~E~~~ 145 (246)
.+.||.|..+.||+....++ .+.+|.. +.......+..|...++.|.- ..+.++++++.. .+..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 45799999999998865545 3555653 332244678889999988853 467888887754 366899999999
Q ss_pred CCCH
Q 025893 146 NGSL 149 (246)
Q Consensus 146 ~g~L 149 (246)
+.++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.18 E-value=4e-05 Score=61.70 Aligned_cols=73 Identities=14% Similarity=0.065 Sum_probs=45.7
Q ss_pred ceeccCCceEEEEEEECC--CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC-CCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 73 ALIGEGSYGRVYYGILKS--GHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~--~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
+.|..|-...+|+....+ +..+++|..........+...|+.+++.+.. .-.+++++... + .++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 457778888999887653 5678888765432222233467777777743 23445554432 2 379999988654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.4e-05 Score=62.76 Aligned_cols=150 Identities=17% Similarity=0.184 Sum_probs=92.1
Q ss_pred CHHHHHHHHhcCCCCc---eeccCCceEEEEEEECCCCEEEEEEcCCCCCCH--------------------H-----HH
Q 025893 58 SVDELKEITENFGTNA---LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD--------------------E-----EF 109 (246)
Q Consensus 58 ~~~~~~~~~~~~~~~~---~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~--------------------~-----~~ 109 (246)
+...+..+.....+.. .|.+|.-..||+|...++..+|+|+........ . ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3344444444444443 456777788999998888999999885432211 1 12
Q ss_pred HHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 025893 110 LAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186 (246)
Q Consensus 110 ~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 186 (246)
.+|+.-|+++. +-.+.+-+.+. .-.|||||+... .-.-.|+. ..+.......+..++++.+.-
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----------v~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----------VPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----------CCcCchhHHHHHHHHHHHHHH
Confidence 34666666654 23333333332 236899998542 11111111 112233456677778888876
Q ss_pred HhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 187 lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
|-... .+||.||..=|||+. ++.+.|+|||-|...
T Consensus 182 l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 182 LYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHhc--CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 66522 499999999999999 889999999977543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.3e-07 Score=79.93 Aligned_cols=150 Identities=17% Similarity=0.120 Sum_probs=102.0
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC-ccceEeEEEeCCeeEEEEecCCCC-CHHH
Q 025893 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEFASNG-SLHD 151 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~E~~~~g-~L~~ 151 (246)
-+++++++++++.+....+....+.+... .....++++|.+++||| .++.++.+..+...+++++++.++ +...
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 36888999999887432222223433222 44556788999999999 888888888889999999999876 2221
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCcccccc
Q 025893 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231 (246)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~ 231 (246)
..... .-.+...+...+.+.-..+++++|+-. -+||| ||+..+ +..|..||+....+....
T Consensus 325 ~~~~s--------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 325 EMTVS--------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred cCChh--------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 11100 001333344456666778899999863 48998 666554 678999999987765433
Q ss_pred ccccccccccccCCC
Q 025893 232 HSTRVLGTFGYHAPE 246 (246)
Q Consensus 232 ~~~~~~gt~~y~aPE 246 (246)
..+++.+|+.++|||
T Consensus 386 ~~~t~~~~~~~~~pe 400 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPE 400 (829)
T ss_pred ccccCCCCCCCCCch
Confidence 236778999999997
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.5e-05 Score=61.05 Aligned_cols=71 Identities=13% Similarity=0.132 Sum_probs=43.1
Q ss_pred eeccCCce-EEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCC---CccceEeEEEeC---CeeEEEEecCCC
Q 025893 74 LIGEGSYG-RVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---NFVQLLGYCVDG---TSRVLAYEFASN 146 (246)
Q Consensus 74 ~lG~G~fg-~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp---~iv~~~~~~~~~---~~~~lv~E~~~~ 146 (246)
.|+.|+.. .||+. +..+++|.... ......+..|..++..|... .+.++++..... ...+++||+++|
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 46666655 48865 23466665433 33455788899888877532 344555443332 235889999988
Q ss_pred CCH
Q 025893 147 GSL 149 (246)
Q Consensus 147 g~L 149 (246)
.++
T Consensus 79 ~~l 81 (235)
T cd05155 79 ETA 81 (235)
T ss_pred CCC
Confidence 655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=9e-07 Score=82.68 Aligned_cols=142 Identities=20% Similarity=0.216 Sum_probs=95.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.|.+.+.+-+|.++.++.+.-. +|...+++...... ...+....+-.++-...+|.+++..-.+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 35556667788899998877643 45444444432221 11122222222333334677776655555567789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
+|..+++|...|+.... .+..-...+...+.++++|||... ++|||++|.|+++..++..++.|||.
T Consensus 884 ~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred HHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 99999999998876542 222223345556778999999874 89999999999999999999999984
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00024 Score=61.62 Aligned_cols=74 Identities=15% Similarity=0.117 Sum_probs=52.9
Q ss_pred ceeccCCceEEEEEEECCC-CEEEEEEcCC------C--CCCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEE
Q 025893 73 ALIGEGSYGRVYYGILKSG-HAAAIKKLDA------S--KQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~-~~vaik~~~~------~--~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv 140 (246)
+.||.|.+..||++...+| +.+.||.-.. . ....+....|.+.|..+. ..++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998766 4788997431 1 124466777888877753 3467777766 44667899
Q ss_pred EecCCCCC
Q 025893 141 YEFASNGS 148 (246)
Q Consensus 141 ~E~~~~g~ 148 (246)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=57.09 Aligned_cols=124 Identities=25% Similarity=0.379 Sum_probs=84.5
Q ss_pred hcCCCCceeccCCc-eEEEEEEECCCCEEEEEEcC---CCC-------------------CCHHHHHHHHHHHhcCC---
Q 025893 67 ENFGTNALIGEGSY-GRVYYGILKSGHAAAIKKLD---ASK-------------------QPDEEFLAQVSMVSRLK--- 120 (246)
Q Consensus 67 ~~~~~~~~lG~G~f-g~V~~~~~~~~~~vaik~~~---~~~-------------------~~~~~~~~e~~~l~~l~--- 120 (246)
.+++..+.||.|.- |.||+++.. |..+|+|... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57888889999999 999999876 6799999831 100 00124667776666554
Q ss_pred CCCc--cceEeEEEeCC------------------eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHH
Q 025893 121 HENF--VQLLGYCVDGT------------------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180 (246)
Q Consensus 121 hp~i--v~~~~~~~~~~------------------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i 180 (246)
+.++ |+++|+..-.. ...||.||.+... .+.. .-+.++
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~----~~~~~~ 173 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQI----RDIPQM 173 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccch----hHHHHH
Confidence 5566 89999874221 1235666665432 0222 234566
Q ss_pred HHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 181 ~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
..-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 77788999987 999999999985 3478899853
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0002 Score=58.54 Aligned_cols=141 Identities=11% Similarity=0.092 Sum_probs=74.3
Q ss_pred eccCCceEEEEEEECCCCEEEEEEcCCCCCCH-HHHHHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecCCCCCHHH-
Q 025893 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHD- 151 (246)
Q Consensus 75 lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~-~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~E~~~~g~L~~- 151 (246)
+..|-.+.+|+... ++..+++|......... -+...|..+++.+....+ .+++... . -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45577778898763 45677788654332211 234678888887763323 3444433 2 368999998865431
Q ss_pred -------------HhccCCCCCCCCCCCCCCHH-HHHHHHHH---------HHHHHHHHhhC-----CCCCeeeCCCCCC
Q 025893 152 -------------ILHGRKGVKGAQPGPVLSWQ-QRVKIAVG---------AAKGLEYLHEK-----ADPHIIHRDIKSS 203 (246)
Q Consensus 152 -------------~l~~~~~~~~~~~~~~l~~~-~~~~i~~~---------i~~~l~~lH~~-----~~~~ivHrdlkp~ 203 (246)
.+...-... .....+... ....+..+ +..-+..+-.. ..+.++|+|+.|.
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQP--RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 111000000 001111111 11111111 11112222111 1124899999999
Q ss_pred CeEecCCCceEEccccCCCC
Q 025893 204 NVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 204 Nil~~~~~~~kl~Dfgls~~ 223 (246)
||+++.++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0011 Score=55.89 Aligned_cols=164 Identities=17% Similarity=0.217 Sum_probs=84.2
Q ss_pred cCHHHHHHHHhcCCC-----CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC--CCccceEe
Q 025893 57 ISVDELKEITENFGT-----NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129 (246)
Q Consensus 57 ~~~~~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~ 129 (246)
++.+++......|.+ .+.|..|....+|+....+| .+++|... ....+....|+.++..|.. -.+.+++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 455566666667755 24466677778998876544 67888765 2233444445555555431 12333332
Q ss_pred ------EEEeCCeeEEEEecCCCCCHH-----------HHh---ccC-CCCCCCCC-CCCCCH-HHHHH-----------
Q 025893 130 ------YCVDGTSRVLAYEFASNGSLH-----------DIL---HGR-KGVKGAQP-GPVLSW-QQRVK----------- 175 (246)
Q Consensus 130 ------~~~~~~~~~lv~E~~~~g~L~-----------~~l---~~~-~~~~~~~~-~~~l~~-~~~~~----------- 175 (246)
+....+..++++||++|..+. ..+ +.. ........ ...+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 112345678999999886321 111 111 11100000 001111 11111
Q ss_pred -HHHH-HHHHHHHHhhC----CCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 176 -IAVG-AAKGLEYLHEK----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 176 -i~~~-i~~~l~~lH~~----~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.+.+ +...+..+... -...++|+|+.|.||+++.+...-|+||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11112222210 122499999999999998766668999998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00071 Score=56.41 Aligned_cols=161 Identities=17% Similarity=0.198 Sum_probs=88.0
Q ss_pred HHHHHHhcCCC-----CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCC--CccceEeE---
Q 025893 61 ELKEITENFGT-----NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGY--- 130 (246)
Q Consensus 61 ~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~--- 130 (246)
++..+.+.|.+ .+.|..|....+|+....+ ..+++|.... ........|+.++..|.+- .+.+++..
T Consensus 3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g 79 (296)
T cd05153 3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDG 79 (296)
T ss_pred HHHHHHHHcCCCchhheecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCC
Confidence 44555555553 3456677778899876543 4678887654 3445666777777776432 24444331
Q ss_pred ---EEeCCeeEEEEecCCCCCHHH-----------H---hccCC-CCCCC-CCCCCCCHHHHH----------HHHHHHH
Q 025893 131 ---CVDGTSRVLAYEFASNGSLHD-----------I---LHGRK-GVKGA-QPGPVLSWQQRV----------KIAVGAA 181 (246)
Q Consensus 131 ---~~~~~~~~lv~E~~~~g~L~~-----------~---l~~~~-~~~~~-~~~~~l~~~~~~----------~i~~~i~ 181 (246)
....+..++++++++|..+.. . ++... ..... .......|.... .....+.
T Consensus 80 ~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 159 (296)
T cd05153 80 EYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLA 159 (296)
T ss_pred cEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHH
Confidence 123456688999998865421 0 11100 00000 000111221110 0111123
Q ss_pred HHHHHHhh----CCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 182 KGLEYLHE----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 182 ~~l~~lH~----~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
..+.++.. .....++|+|+.|.|+|++.++.+.|+||+.+...
T Consensus 160 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 160 DELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred HHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 34444443 11224899999999999998877789999887653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0021 Score=54.03 Aligned_cols=165 Identities=18% Similarity=0.241 Sum_probs=88.7
Q ss_pred cCHHHHHHHHhcCCCC-----ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCC--CccceEe
Q 025893 57 ISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLG 129 (246)
Q Consensus 57 ~~~~~~~~~~~~~~~~-----~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~ 129 (246)
.+.+++....+.|.+. +.++.|.-..+|+....++ .+++|..... ...+....|+.++..|... .+.+++.
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 3456666666677553 4566776778998875544 5677876432 1234555667777666422 2344433
Q ss_pred E------EEeCCeeEEEEecCCCCCHH-----------HH---hccC-CCCCCCCCC--CCCCHHHHH------------
Q 025893 130 Y------CVDGTSRVLAYEFASNGSLH-----------DI---LHGR-KGVKGAQPG--PVLSWQQRV------------ 174 (246)
Q Consensus 130 ~------~~~~~~~~lv~E~~~~g~L~-----------~~---l~~~-~~~~~~~~~--~~l~~~~~~------------ 174 (246)
. ....+..++++||++|..+. .. ++.. .+....... ..-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 2 11245678999999874421 11 1110 010000000 001111110
Q ss_pred HHHHHHHHHHHHHhh----CCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 175 KIAVGAAKGLEYLHE----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 175 ~i~~~i~~~l~~lH~----~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.....+...+.++.. .....++|+|+.+.|++++.++.+.|+||+.+..
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 001122334444432 1123599999999999999887778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00064 Score=56.92 Aligned_cols=73 Identities=19% Similarity=0.137 Sum_probs=45.1
Q ss_pred eeccCCceEEEEEEECC-------CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC-ccceEeEEEeCCeeEEEEecCC
Q 025893 74 LIGEGSYGRVYYGILKS-------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~-------~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.|..|--..+|+....+ +..+++|..........+...|..++..+.... ..++++++. + .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeC
Confidence 45566667889887554 467888886554333345567777777765322 345555553 1 35789988
Q ss_pred CCCHH
Q 025893 146 NGSLH 150 (246)
Q Consensus 146 ~g~L~ 150 (246)
|..+.
T Consensus 81 G~~l~ 85 (302)
T cd05156 81 SRTLT 85 (302)
T ss_pred CCcCC
Confidence 76553
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0056 Score=52.39 Aligned_cols=144 Identities=15% Similarity=0.202 Sum_probs=75.7
Q ss_pred eeccCCceEEEEEEECC-----CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecCCCC
Q 025893 74 LIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~E~~~~g 147 (246)
.|-.|--..+|+....+ +..+++|.........-+-..|..+++.+..-++ .++++.+... .|.||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45457777899886532 3568888765433222223567777776653222 3555655322 478888775
Q ss_pred CHHHH-----------------hccCCCCCCCCCCCCCCHHHHHHHHHH-----------------HHHHHHH----Hhh
Q 025893 148 SLHDI-----------------LHGRKGVKGAQPGPVLSWQQRVKIAVG-----------------AAKGLEY----LHE 189 (246)
Q Consensus 148 ~L~~~-----------------l~~~~~~~~~~~~~~l~~~~~~~i~~~-----------------i~~~l~~----lH~ 189 (246)
++... ++.... . .......+.+...+..+ +...+.. +..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~-~--~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDM-P--GPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCC-C--CCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 55311 111110 0 00001112222222211 1111111 222
Q ss_pred -CCCCCeeeCCCCCCCeEecC-CCceEEccccCCCCC
Q 025893 190 -KADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQA 224 (246)
Q Consensus 190 -~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls~~~ 224 (246)
.....++|+|+++.|||+++ ++.+.++||..+...
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 11234899999999999986 468999999887654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0037 Score=54.10 Aligned_cols=162 Identities=16% Similarity=0.145 Sum_probs=91.6
Q ss_pred CCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCH-HHHHHHHHHHhcCCCCCccceEeEEE-------eCC-eeEEEE
Q 025893 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV-------DGT-SRVLAY 141 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~-~~~~~e~~~l~~l~hp~iv~~~~~~~-------~~~-~~~lv~ 141 (246)
....||+|+-+.+|..-.- +.. +.|+........ .+...| +.+--.||-+-. .-.|. +.. ..-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk~a~--la~~p~~p~~~~-rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQKVAE--LAATPDAPLLNY-RVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchHHHHHHHH--hccCCCCcchhh-hhcccHHHhhCCCccceeEEec
Confidence 3457999999999854211 122 335443322221 122221 222223554332 11111 112 244566
Q ss_pred ecCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 142 EFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
..+++. .+..++.-. +..+..+...|...+++++.++.+..-||..| -+-+|++++|+|+++++.+.|.|=..
T Consensus 90 P~v~g~~pI~~~y~p~---tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 90 PKVSGKEPIHMIYSPA---TRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred ccCCCccchhhhcCch---hhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence 666553 223333211 11233456889999999999999999999998 77799999999999999999887432
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
-.... .... ..-.+|.+.|.+||
T Consensus 164 fqi~~-ng~~--~~cpVg~~eftPPE 186 (637)
T COG4248 164 FQINA-NGTL--HLCPVGVSEFTPPE 186 (637)
T ss_pred eeecc-CCce--EecccCccccCCHH
Confidence 11110 1111 12246888899987
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0026 Score=52.95 Aligned_cols=73 Identities=14% Similarity=0.145 Sum_probs=45.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecCCCC
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNG 147 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~E~~~~g 147 (246)
.+.++.|....+|+.. .+++.+.+|.-. ......|..|..-|+.|. --.+.+++++....+..+|++||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3568889999999876 557788888765 223346777887777763 456778888888777889999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.11 Score=44.05 Aligned_cols=95 Identities=16% Similarity=0.138 Sum_probs=56.2
Q ss_pred ccccCHHHHHHHHhcCCCC---c-eeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCC--Cccce
Q 025893 54 VPAISVDELKEITENFGTN---A-LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQL 127 (246)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~---~-~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~ 127 (246)
.+.++++.+......+.+. . ..-.+.-..||+....++..+++|...........+..|+..+..|... .++..
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4556677666665555332 1 1122345679998877778899998765555666777787777665421 12221
Q ss_pred ---Ee--EEEeCCeeEEEEecCCCCC
Q 025893 128 ---LG--YCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 128 ---~~--~~~~~~~~~lv~E~~~~g~ 148 (246)
-| ....++..+.++++++|..
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 11 1223456778889887753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.015 Score=48.99 Aligned_cols=32 Identities=22% Similarity=0.481 Sum_probs=28.4
Q ss_pred CCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 193 ~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+.++|+|+.+.|++++..+.+=|.||+++...
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 46999999999999998888889999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.032 Score=48.63 Aligned_cols=72 Identities=11% Similarity=0.161 Sum_probs=47.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcC-----CCC---CCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEE
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLD-----ASK---QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~-----~~~---~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv 140 (246)
.+.||.|....||+.... +..++||.-. .+. ....+-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456899999999998764 4568888754 111 13334444566665543 347888888775 446788
Q ss_pred EecCCC
Q 025893 141 YEFASN 146 (246)
Q Consensus 141 ~E~~~~ 146 (246)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.019 Score=48.85 Aligned_cols=30 Identities=20% Similarity=0.393 Sum_probs=25.8
Q ss_pred CeeeCCCCCCCeEecC-CCceEEccccCCCC
Q 025893 194 HIIHRDIKSSNVLIFD-DDVAKIADFDLSNQ 223 (246)
Q Consensus 194 ~ivHrdlkp~Nil~~~-~~~~kl~Dfgls~~ 223 (246)
-+.|+|+.+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3789999999999975 57899999988764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.056 Score=46.34 Aligned_cols=71 Identities=20% Similarity=0.166 Sum_probs=46.5
Q ss_pred eeccCCceEEEEEEECCC-CEEEEEEcC----C---C-CCCHHHHHHHHHHHhcCC--CC-CccceEeEEEeCCeeEEEE
Q 025893 74 LIGEGSYGRVYYGILKSG-HAAAIKKLD----A---S-KQPDEEFLAQVSMVSRLK--HE-NFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~-~~vaik~~~----~---~-~~~~~~~~~e~~~l~~l~--hp-~iv~~~~~~~~~~~~~lv~ 141 (246)
.||.|....||++....+ +.++||.-. . + ..+.++..-|...|+... -| .+++++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997644 578888632 1 1 223455566777776654 23 45555543 456667899
Q ss_pred ecCCC
Q 025893 142 EFASN 146 (246)
Q Consensus 142 E~~~~ 146 (246)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.025 Score=46.81 Aligned_cols=32 Identities=19% Similarity=0.404 Sum_probs=26.0
Q ss_pred CCeeeCCCCCCCeEecCCCc-eEEccccCCCCC
Q 025893 193 PHIIHRDIKSSNVLIFDDDV-AKIADFDLSNQA 224 (246)
Q Consensus 193 ~~ivHrdlkp~Nil~~~~~~-~kl~Dfgls~~~ 224 (246)
+.++|+|+.+.|||++.++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997554 469999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.14 Score=42.93 Aligned_cols=30 Identities=27% Similarity=0.417 Sum_probs=25.5
Q ss_pred CCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 193 ~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 35899999999999987 6688999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.018 Score=49.26 Aligned_cols=137 Identities=22% Similarity=0.245 Sum_probs=85.1
Q ss_pred CCceeccCCceEEEEEEECCCCEEEEEEcCCCC---C--------------------CHH--H--HHHHHHHHhcCCCCC
Q 025893 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---Q--------------------PDE--E--FLAQVSMVSRLKHEN 123 (246)
Q Consensus 71 ~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~---~--------------------~~~--~--~~~e~~~l~~l~hp~ 123 (246)
+..+|..|--..||.+.-.+|..+|||+.+.+- . +++ . ...|+.-|++|..-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445788899999999998889999999874321 0 011 1 124666667665444
Q ss_pred ccceEeEEEeCCeeEEEEecCCCCCH--HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC
Q 025893 124 FVQLLGYCVDGTSRVLAYEFASNGSL--HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (246)
Q Consensus 124 iv~~~~~~~~~~~~~lv~E~~~~g~L--~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk 201 (246)
|.-.--... ..-.|||+|+.+ +- ...|+. ..++...+..+-.+++.-+.-|-..+ ++||-||.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd----------~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLS 292 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKD----------ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLS 292 (520)
T ss_pred CCCCCceee--ecceEeeeeccC-CCCcCccccc----------ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchh
Confidence 432211111 123589999842 22 122221 12555556666666766676666554 69999999
Q ss_pred CCCeEecCCCceEEccccCCCC
Q 025893 202 SSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 202 p~Nil~~~~~~~kl~Dfgls~~ 223 (246)
-=|+|+ .+|.+.|+|.+-+..
T Consensus 293 EfN~Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 293 EFNLLY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred hhhheE-ECCEEEEEEcccccc
Confidence 999887 567788889876543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.025 Score=45.15 Aligned_cols=99 Identities=15% Similarity=0.177 Sum_probs=61.7
Q ss_pred EEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHH
Q 025893 95 AIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172 (246)
Q Consensus 95 aik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~ 172 (246)
.+|++....- ...-+..+.+++.++. .|+++..- +.-.+-++.|+|-..... ..
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------------~~-- 144 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------------FS-- 144 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------------hh--
Confidence 4455543322 3455677788877664 57777632 222344788988432211 00
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 173 ~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
.++..=+.+|.-.|+. +...+|+|..|+||+-|..|.+||.|-+.
T Consensus 145 --N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 145 --NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred --HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 1111114567778854 34699999999999999999999999763
|
The function of this family is unknown. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0051 Score=51.71 Aligned_cols=131 Identities=15% Similarity=0.180 Sum_probs=84.5
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC-----------------------CHHHHHHHHHHHhcCCCC--
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-----------------------PDEEFLAQVSMVSRLKHE-- 122 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~-----------------------~~~~~~~e~~~l~~l~hp-- 122 (246)
-+.+.+.||-|.-+.||.+-...|+..++|.-+.... .+-...+|+..|+.|.-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567788999999999999988898888884321100 001234677777777531
Q ss_pred CccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 123 ~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
-+.+.++ -+.-++|||++.|-.|.+.-+-. ... .+...+..-+.-|-.+| +||+|..-
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~------------d~~---~ly~~lm~~Iv~la~~G---lIHgDFNE 230 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE------------DPP---TLYDDLMGLIVRLANHG---LIHGDFNE 230 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC------------ChH---HHHHHHHHHHHHHHHcC---ceecccch
Confidence 2333332 34557899999887776543211 111 12222222233444555 99999999
Q ss_pred CCeEecCCCceEEccccC
Q 025893 203 SNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgl 220 (246)
=||++.+++.++++||--
T Consensus 231 FNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 231 FNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred heeEEecCCCEEEeechH
Confidence 999999999999999953
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.009 Score=50.94 Aligned_cols=73 Identities=18% Similarity=0.190 Sum_probs=52.9
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
..+.|++|++. |++|.. +. .-.+.+.+.++.+.+.-+.-+... .++-||++.-.||||+ .|.+
T Consensus 298 ~~y~yl~~kdh-gt~is~-ik------------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~Gnv 360 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-IK------------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNV 360 (488)
T ss_pred ceEEEEEEecC-Cceeee-ee------------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCce
Confidence 34557777875 445532 21 134677788888766655555554 3689999999999999 9999
Q ss_pred EEccccCCCC
Q 025893 214 KIADFDLSNQ 223 (246)
Q Consensus 214 kl~Dfgls~~ 223 (246)
.|+||-+++.
T Consensus 361 tLIDfklsRl 370 (488)
T COG5072 361 TLIDFKLSRL 370 (488)
T ss_pred EEEEeeeeec
Confidence 9999999985
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.14 Score=43.51 Aligned_cols=146 Identities=19% Similarity=0.283 Sum_probs=80.6
Q ss_pred eccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC------ccceEeE----EEeCCeeEEEEecC
Q 025893 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN------FVQLLGY----CVDGTSRVLAYEFA 144 (246)
Q Consensus 75 lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~------iv~~~~~----~~~~~~~~lv~E~~ 144 (246)
|.+ .-..+|+....+|+. ++|..... ....++..|...+..|.-.. +...-|- .....+.+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 455688888776666 88887776 66677777777777664211 2222121 11113667788999
Q ss_pred CCCCHHH------------H---hc-cCCCCC--CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHhhCCC-
Q 025893 145 SNGSLHD------------I---LH-GRKGVK--GAQPGPVLSWQQ-------------RVKIAVGAAKGLEYLHEKAD- 192 (246)
Q Consensus 145 ~~g~L~~------------~---l~-~~~~~~--~~~~~~~l~~~~-------------~~~i~~~i~~~l~~lH~~~~- 192 (246)
+|..+.. + |+ ..++.. .........|.. ......++...+..+.+.-.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 8876652 0 11 011111 001111223320 00122334444444443211
Q ss_pred ---C-C--eeeCCCCCCCeEecCCCc-eEEccccCCCC
Q 025893 193 ---P-H--IIHRDIKSSNVLIFDDDV-AKIADFDLSNQ 223 (246)
Q Consensus 193 ---~-~--ivHrdlkp~Nil~~~~~~-~kl~Dfgls~~ 223 (246)
. + +||.|+.|.||+++.+.. +.+.||+-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1 2 899999999999998774 88999998754
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.55 Score=46.13 Aligned_cols=96 Identities=15% Similarity=0.236 Sum_probs=52.8
Q ss_pred ccccCHHHHHH-HHhcCCCC---ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-------CCC
Q 025893 54 VPAISVDELKE-ITENFGTN---ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-------KHE 122 (246)
Q Consensus 54 ~~~~~~~~~~~-~~~~~~~~---~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-------~hp 122 (246)
.|.++.+++.. +.+.|.+. +.|+ |....+|+....++..+++|...... .......|...|..| .-|
T Consensus 8 ~p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP 85 (1013)
T PRK06148 8 APEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVP 85 (1013)
T ss_pred CCCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcC
Confidence 34566665543 34566553 3454 45677898887778789999886543 223333444455433 223
Q ss_pred CccceE-----eEEEe-CC--eeEEEEecCCCCCHHH
Q 025893 123 NFVQLL-----GYCVD-GT--SRVLAYEFASNGSLHD 151 (246)
Q Consensus 123 ~iv~~~-----~~~~~-~~--~~~lv~E~~~~g~L~~ 151 (246)
.++... ..... .+ ..+.+++|++|..+.+
T Consensus 86 ~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 86 RLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE 122 (1013)
T ss_pred eeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence 333221 11111 12 4566799999876654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.0078 Score=54.82 Aligned_cols=44 Identities=27% Similarity=0.540 Sum_probs=38.5
Q ss_pred HHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 179 ~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+++.|+.|+|..- .+||+.|.|++|.++..+..||+.|+++...
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~ 150 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNA 150 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhcc
Confidence 4458999999764 6999999999999999999999999987654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.21 Score=43.46 Aligned_cols=73 Identities=14% Similarity=0.115 Sum_probs=48.4
Q ss_pred CceeccCCceEEEEEEECC-CCEEEEEEc----CCC---CCCHHHHHHHHHHHhcCC--CC-CccceEeEEEeCCeeEEE
Q 025893 72 NALIGEGSYGRVYYGILKS-GHAAAIKKL----DAS---KQPDEEFLAQVSMVSRLK--HE-NFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~-~~~vaik~~----~~~---~~~~~~~~~e~~~l~~l~--hp-~iv~~~~~~~~~~~~~lv 140 (246)
.+.||.|.-..||++...+ ++.++||.- +.. ..+.++..-|...|+.+. .| .+++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3578999999999998753 567888863 211 234566667777777654 33 56666544 45556788
Q ss_pred EecCCC
Q 025893 141 YEFASN 146 (246)
Q Consensus 141 ~E~~~~ 146 (246)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.23 Score=43.13 Aligned_cols=29 Identities=28% Similarity=0.412 Sum_probs=23.8
Q ss_pred CeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 194 ~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
-+.|.|+-+.|||.++ ..+.++||..|..
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 3789999999998754 5589999987754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.0046 Score=54.41 Aligned_cols=72 Identities=17% Similarity=0.341 Sum_probs=58.4
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeC
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 134 (246)
.+..++|.....+|.|+||+|+.+..+ ++..+|||+|..... ......+|+.-+.++.|++|++++..|...
T Consensus 45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 445678999999999999999999876 455899999865543 345677888889999999999998887654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.33 Score=40.77 Aligned_cols=32 Identities=16% Similarity=0.233 Sum_probs=28.1
Q ss_pred CeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 194 ~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
.++|+|+.+.|+|++.++.+-++||..+....
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~ 228 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFAS 228 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccCC
Confidence 48999999999999998889999998876543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.051 Score=52.70 Aligned_cols=105 Identities=23% Similarity=0.334 Sum_probs=75.4
Q ss_pred HHHHHHHhcCCCCCccceEeEEEeCCee----EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 025893 110 LAQVSMVSRLKHENFVQLLGYCVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185 (246)
Q Consensus 110 ~~e~~~l~~l~hp~iv~~~~~~~~~~~~----~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 185 (246)
.-|...+.++.|+|+++++.+-...... .+..|+|.+-++...+.... .++....+.+..++..||.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---------~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---------SIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---------ccCHHHHHHHHHHHhhhHH
Confidence 3466778889999999999987654332 23458888888888876654 3677788888999999999
Q ss_pred HHhhCCCCCeeeCCCCCC---CeEecCCCceEEc--cccCCCCCCc
Q 025893 186 YLHEKADPHIIHRDIKSS---NVLIFDDDVAKIA--DFDLSNQAPD 226 (246)
Q Consensus 186 ~lH~~~~~~ivHrdlkp~---Nil~~~~~~~kl~--Dfgls~~~~~ 226 (246)
|+|+.. ..|.-+..+ +--.+..+...++ ||+.++....
T Consensus 301 ~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 301 YLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred HHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCC
Confidence 999974 555555444 3344455666666 8888776544
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.29 Score=39.43 Aligned_cols=57 Identities=14% Similarity=0.154 Sum_probs=37.6
Q ss_pred CCEEEEEEcCCCCCCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 91 GHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 91 ~~~vaik~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
...+-+|.-. ......|..|+.-|..|. --.+.+++.+-....+.|+|+||++-+.+
T Consensus 39 ~~~~FvK~n~--~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 39 TDPFFVKCNQ--REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred CcceEEEecc--hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 3456777532 222345667776555553 34567777787888999999999986544
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.18 Score=44.02 Aligned_cols=59 Identities=20% Similarity=0.172 Sum_probs=38.6
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 208 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~ 208 (246)
.++-+|..|-++..+++... .++....+++.--+.|+.-+---. +++|.|+.|.||++-
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 46668888989988887543 344444455544445553322211 399999999999995
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.67 Score=41.14 Aligned_cols=29 Identities=21% Similarity=0.430 Sum_probs=24.0
Q ss_pred CeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 194 ~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
-+.|.|+.+.|||.+.++ ++++||..|..
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccccc
Confidence 478999999999876544 99999988764
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.17 E-value=1.1 Score=36.54 Aligned_cols=77 Identities=18% Similarity=0.091 Sum_probs=52.3
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC-CCCCHHHH
Q 025893 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA-SNGSLHDI 152 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~-~~g~L~~~ 152 (246)
.+-.|..+.|+.++..+|...++|..........+...+ ..|+..+-...|++++.-. ..-.+++|.+ ++.+|.+.
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~L~~~ 85 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAADP--ERGALLLERLDPGRSLASL 85 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeecccc--ccchhhhhhccCCCchhhc
Confidence 455688999999998899999999875443322222222 4488888888899987653 3445678888 44566544
Q ss_pred h
Q 025893 153 L 153 (246)
Q Consensus 153 l 153 (246)
.
T Consensus 86 ~ 86 (253)
T PF04655_consen 86 P 86 (253)
T ss_pred c
Confidence 3
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 246 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-30 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 6e-81
Identities = 71/192 (36%), Positives = 111/192 (57%), Gaps = 10/192 (5%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQ-PDEEFLAQVSM 115
S+ EL+ ++NF ++G G +G+VY G L G A+K+L Q + +F +V M
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+S H N ++L G+C+ T R+L Y + +NGS+ L R + P L W +R +
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQR 135
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-ST 234
IA+G+A+GL YLH+ DP IIHRD+K++N+L+ ++ A + DF L+ H +T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTT 193
Query: 235 RVLGTFGYHAPE 246
V GT G+ APE
Sbjct: 194 AVRGTIGHIAPE 205
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-80
Identities = 78/213 (36%), Positives = 122/213 (57%), Gaps = 11/213 (5%)
Query: 36 ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAA 95
A+ + + + P E + + +L+E T NF LIG G +G+VY G+L+ G A
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 96 IKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
+K+ S Q EEF ++ +S +H + V L+G+C + +L Y++ NG+L L+
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214
G P +SW+QR++I +GAA+GL YLH +A IIHRD+KS N+L+ ++ V K
Sbjct: 128 GSDL-----PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 215 IADFDLSNQAPDMAARLH-STRVLGTFGYHAPE 246
I DF +S + ++ + H ST V GT GY PE
Sbjct: 180 ITDFGISKKGTEL-DQTHLSTVVKGTLGYIDPE 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-77
Identities = 78/213 (36%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 45 QAVKVQPIEVPAISVDELKEITENF------GTNALIGEGSYGRVYYGILKSGHAAAIKK 98
++++V + S ELK +T NF +GEG +G VY G + A+KK
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61
Query: 99 LDA-----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
L A +++ ++F ++ ++++ +HEN V+LLG+ DG L Y + NGSL D L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
G P LSW R KIA GAA G+ +LHE H IHRDIKS+N+L+ + A
Sbjct: 122 SCLDG------TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTA 172
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
KI+DF L+ + A + ++R++GT Y APE
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-56
Identities = 57/201 (28%), Positives = 82/201 (40%), Gaps = 22/201 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
+ + L + + G +G V+ L A+K + + +V +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 117 SRLKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
+KHEN +Q +G G L F GSL D L V+SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122
Query: 173 RVKIAVGAAKGLEYLHEKAD-------PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
IA A+GL YLHE P I HRDIKS NVL+ ++ A IADF L+ +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 226 DMAARLHSTRVLGTFGYHAPE 246
+ + +GT Y APE
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPE 203
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-51
Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
I E++ +G G++G V + AIK++++ + + F+ ++ +
Sbjct: 5 IDYKEIEVEEV-------VGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 55
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SR+ H N V+L G C++ V+ E+A GSL+++LHG + P P + +
Sbjct: 56 SRVNHPNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAE------PLPYYTAAHAMSW 107
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTR 235
+ ++G+ YLH +IHRD+K N+L+ V KI DF + H T
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTN 162
Query: 236 VLGTFGYHAPE 246
G+ + APE
Sbjct: 163 NKGSAAWMAPE 173
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-51
Identities = 44/195 (22%), Positives = 79/195 (40%), Gaps = 28/195 (14%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
I +L +T+ + E G ++ G + G+ +K L D S + +F +
Sbjct: 7 IDFKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+ H N + +LG C + + GSL+++LH V+
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
Q VK A+ A+G+ +LH +P I + S +V+I +D A+I+ D+
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------F 163
Query: 232 HSTRVLGTFGYHAPE 246
S + + APE
Sbjct: 164 QSPGRMYAPAWVAPE 178
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-50
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPD----- 106
+P ++ +E++ + IG+G +G V+ G L AIK L
Sbjct: 12 RLPTLADNEIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 107 ---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
+EF +V ++S L H N V+L G + V+ EF G L+ L +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP---- 118
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADF 218
+ W ++++ + A G+EY+ + +P I+HRD++S N+ + D AK+ADF
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LS Q+ + +LG F + APE
Sbjct: 174 GLSQQSVHS-----VSGLLGNFQWMAPE 196
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-49
Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 28/185 (15%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-----EEFLAQVSMVSRLKHENFVQLLG 129
IG G +G+VY G A+K D E + + + LKH N + L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C+ + L EFA G L+ +L G++ + V AV A+G+ YLH+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHD 123
Query: 190 KADPHIIHRDIKSSNVLI--------FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
+A IIHRD+KSSN+LI + + KI DF L+ R G +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYA 179
Query: 242 YHAPE 246
+ APE
Sbjct: 180 WMAPE 184
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-49
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 20/193 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
I +L + IG GS+G V+ G A+K L D + EFL +V
Sbjct: 34 IPWCDLNIKEK-------IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREV 85
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
+++ RL+H N V +G + + E+ S GSL+ +LH L ++R
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG------AREQLDERRR 139
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
+ +A AKG+ YLH + +P I+HR++KS N+L+ K+ DF LS S
Sbjct: 140 LSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 234 TRVLGTFGYHAPE 246
GT + APE
Sbjct: 199 AA--GTPEWMAPE 209
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-47
Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 24/185 (12%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G+G YG V+ G + G A+K + + ++ L+HEN + + +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 134 GTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ GSL+D L L ++I + A GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHI 123
Query: 190 -----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
+ P I HRD+KS N+L+ + IAD L+ +Q+ + ++ RV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKR 182
Query: 242 YHAPE 246
Y APE
Sbjct: 183 YMAPE 187
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-47
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 29/207 (14%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL 110
P+ V +++ + + IG+G YG V+ G + G A+K +++
Sbjct: 28 PLLVQRTIAKQIQMVKQ-------IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE 79
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGP 166
++ ++HEN + + + GT ++ NGSL+D L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------- 130
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L + +K+A + GL +LH + P I HRD+KS N+L+ + IAD L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 222 --NQAPDMAARLHSTRVLGTFGYHAPE 246
+ + +GT Y PE
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPE 216
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-45
Identities = 57/215 (26%), Positives = 81/215 (37%), Gaps = 39/215 (18%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL 110
P++ +D LK + LIG G YG VY G L A+K S + F+
Sbjct: 4 AASEPSLDLDNLKLLE-------LIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFI 53
Query: 111 A--QVSMVSRLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQ 163
+ V ++H+N + + T+ L E+ NGSL L
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------ 107
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHE------KADPHIIHRDIKSSNVLIFDDDVAKIAD 217
W ++A +GL YLH P I HRD+ S NVL+ +D I+D
Sbjct: 108 ----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 218 FDLS------NQAPDMAARLHSTRVLGTFGYHAPE 246
F LS + +GT Y APE
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-45
Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 25/186 (13%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
+G+G +G+ + +G +K+L + FL +V ++ L+H N ++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
E+ G+L I+ W QRV A A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ--------YPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQAPDMAARLHSTRVLGTF 240
+IIHRD+ S N L+ ++ +ADF L+ ++ R V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 241 GYHAPE 246
+ APE
Sbjct: 187 YWMAPE 192
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-44
Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 20/178 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
IG+G +G+VY+G AI+ +D + + + F +V + +HEN V +G C
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ + +L+ ++ K VL + +IA KG+ YLH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAK- 149
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPE 246
I+H+D+KS NV D+ I DF L G + APE
Sbjct: 150 --GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-44
Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 24/185 (12%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
IG+G +G V+ G + G A+K + ++ A++ L+HEN + +
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 134 GTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
++ +GSL D L+ ++ + +K+A+ A GL +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHM 157
Query: 190 KAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
+ P I HRD+KS N+L+ + IAD L+ + A D + RV GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216
Query: 242 YHAPE 246
Y APE
Sbjct: 217 YMAPE 221
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-43
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 28/195 (14%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
I ++ IG GS+G VY G G A +K L + Q + F +V
Sbjct: 21 IPDGQITVGQR-------IGSGSFGTVYKGKWH-GDVA-VKMLNVTAPTPQQLQAFKNEV 71
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++ + +H N + +GY T+ LA ++ SL+ LH + +
Sbjct: 72 GVLRKTRHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHASE--------TKFEMK 120
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ + IA A+G++YLH K IIHRD+KS+N+ + +D+ KI DF L+ + +
Sbjct: 121 KLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 232 HSTRVLGTFGYHAPE 246
++ G+ + APE
Sbjct: 178 QFEQLSGSILWMAPE 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 14/150 (9%)
Query: 75 IGEGSYGRVYYGILKSGHAA-AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
IG G++G V+ G L++ + A+K +FL + ++ + H N V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ E G L G L + +++ AA G+EYL K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD+ + N L+ + +V KI+DF +S
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-34
Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG G +G V+ G + AIK + +E+F+ + ++ +L H VQL G C++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
L EF +G L D L ++G + + + + + + +G+ YL E
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
+IHRD+ + N L+ ++ V K++DF ++
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 57 ISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSG------HAAAIKKL--DASKQPDE 107
+ V + E+ E + +G+GS+G VY G+ K AIK + AS +
Sbjct: 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GP 166
EFL + S++ + V+LLG G ++ E + G L L + P
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
S + +++A A G+ YL+ +HRD+ + N ++ +D KI DF ++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-33
Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V G K + A+K + ++EF + + +L H V+ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ SNG L + L G L Q +++ +G+ +L
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD+ + N L+ D K++DF ++
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-33
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ + A+K L D + ++F + +++ L+HE+ V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIAVGA 180
G C DG ++ +E+ +G L+ L + Q L Q + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A G+ YL + H +HRD+ + N L+ + + KI DF +S
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-32
Identities = 47/162 (29%), Positives = 69/162 (42%), Gaps = 18/162 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
+GE +G+VY G L AIK L A EEF + + +RL+H N V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIAVG 179
LLG + + + S+G LH+ L R L V +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A G+EYL H++H+D+ + NVL++D KI+D L
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-32
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V YG + + AIK + ++EF+ + ++ L HE VQL G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ +NG L + L + QQ +++ + +EYL K
Sbjct: 92 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
+HRD+ + N L+ D V K++DF LS
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ + A+K L +AS+ ++F + +++ L+H++ V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV------LSWQQRVKIAVGAA 181
G C +G ++ +E+ +G L+ L G L Q + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
G+ YL H +HRD+ + N L+ V KI DF +S
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-32
Identities = 48/148 (32%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G YG VY G+ K A+K L EEFL + +++ +KH N VQLLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ EF + G+L D L +S + +A + +EYL +K
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ IHRD+ + N L+ ++ + K+ADF LS
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 26/199 (13%)
Query: 33 AYHASEAAPKGAQAVKVQPIEVPAISVDELK----EIT-ENFGTNALIGEGSYGRVYYGI 87
++ ++A + +K + +E + DE + + IG+G +G V G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213
Query: 88 LKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY---E 142
+ G+ A+K K DA+ + FLA+ S++++L+H N VQLLG V+ + Y E
Sbjct: 214 YR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL--YIVTE 267
Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
+ + GSL D L R VL +K ++ + +EYL + +HRD+ +
Sbjct: 268 YMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 317
Query: 203 SNVLIFDDDVAKIADFDLS 221
NVL+ +D+VAK++DF L+
Sbjct: 318 RNVLVSEDNVAKVSDFGLT 336
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-32
Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 58 SVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEE 108
S+ +LKE+ +N +G G++G VY G + A+K L S+Q + +
Sbjct: 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
FL + ++S+ H+N V+ +G + R + E + G L L R+ L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSL 137
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLS 221
+ + +A A G +YL E H IHRDI + N L+ VAKI DF ++
Sbjct: 138 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-32
Identities = 55/161 (34%), Positives = 84/161 (52%), Gaps = 16/161 (9%)
Query: 74 LIGEGSYGRVYYGILKSGHA---AAIKKL--DASKQPDEEFLAQVSMVSRL-KHENFVQL 127
+IGEG++G+V +K AAIK++ ASK +F ++ ++ +L H N + L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKIAVGA 180
LG C LA E+A +G+L D L + LS QQ + A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS
Sbjct: 152 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 26/170 (15%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
IGEG++GRV+ A+K L +AS +F + ++++ + N V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRK---------------GVKGAQPGPVLSWQ 171
LLG C G L +E+ + G L++ L + P LS
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+++ IA A G+ YL E+ +HRD+ + N L+ ++ V KIADF LS
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 13/148 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG+G +G V G + G+ A+K + + FLA+ S++++L+H N VQLLG V+
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ + E+ + GSL D L R VL +K ++ + +EYL
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ +HRD+ + NVL+ +D+VAK++DF L+
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+G G++G VY G+ AIK+L S + ++E L + +++ + + + +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C+ T +++ + G L D + K + Q + V AKG+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
++ ++HRD+ + NVL+ KI DF L+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 55 PAISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL--DASKQP 105
S+ +LKE+ +N +G G++G VY G + A+K L S+Q
Sbjct: 58 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 106 DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
+ +FL + ++S+ H+N V+ +G + R + E + G L L R+
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQP 175
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLS 221
L+ + +A A G +YL E H IHRDI + N L+ VAKI DF ++
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 43/188 (22%), Positives = 75/188 (39%), Gaps = 28/188 (14%)
Query: 41 PKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AI 96
P+ QAV+ I ++ V + I G G +G VY+G L A+
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVI----------GRGHFGCVYHGTLLDNDGKKIHCAV 58
Query: 97 KKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA-YEFASNGSLHDIL 153
K L +FL + ++ H N + LLG C+ L + +G L + +
Sbjct: 59 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
+ + + + AKG++YL K +HRD+ + N ++ +
Sbjct: 119 RNET--------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV 167
Query: 214 KIADFDLS 221
K+ADF L+
Sbjct: 168 KVADFGLA 175
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 59/235 (25%), Positives = 90/235 (38%), Gaps = 23/235 (9%)
Query: 19 GNAYMVKSSAGT--DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIG 76
G A+ + S A T G+ P+ V E E +E +G
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67
Query: 77 EGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135
GS+G V+ ++G A+KK+ EE + + L V L G +G
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVREGP 123
Query: 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195
+ E GSL ++ ++ G P A +GLEYLH + I
Sbjct: 124 WVNIFMELLEGGSLGQLI--KQM--GCLPEDRAL-----YYLGQALEGLEYLHTR---RI 171
Query: 196 IHRDIKSSNVLIFDD-DVAKIADFDLSNQ-APDMAARLHSTR--VLGTFGYHAPE 246
+H D+K+ NVL+ D A + DF + PD + T + GT + APE
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G YG VY G+ K A+K L EEFL + +++ +KH N VQLLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ EF + G+L D L +S + +A + +EYL +K
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK--- 337
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ IHR++ + N L+ ++ + K+ADF LS
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-31
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 17/152 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ + AIK L K EE + + ++ +L + V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + +L E A G LH L G++ + ++ + G++YL E
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K + +HRD+ + NVL+ + AKI+DF LS
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-31
Identities = 53/176 (30%), Positives = 79/176 (44%), Gaps = 14/176 (7%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYC 131
++G+G+YG VY G L + AIK++ + L + +++ LKH+N VQ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ + E GSL +L + G + +GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIG-----FYTKQILEGLKYLHDN- 141
Query: 192 DPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRDIK NVLI V KI+DF S + + + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-31
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 21/186 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYC 131
+GEG + V L GH A+K++ +Q D E + M H N ++L+ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 132 VDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+ F G+L + + K G L+ Q + + +G +GLE +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEAI 150
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-------GTF 240
H HRD+K +N+L+ D+ + D NQA L T
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 241 GYHAPE 246
Y APE
Sbjct: 208 SYRAPE 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-31
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG +G V G LK A+K + ++S++ EEFL++ + + H N ++L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 128 LGYCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
LG C++ +S+ + F G LH L + + Q +K V A
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL---ETGPKHIPLQTLLKFMVDIAL 158
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
G+EYL + + +HRD+ + N ++ DD +ADF LS
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-31
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 27 SAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDEL-KEIT-ENFGTNALIGEGSYGRVY 84
S+G + Y + P+ + E P + +EI +IG G G V
Sbjct: 8 SSGRENLYFQGKL-PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVC 66
Query: 85 YGILKSGHAA----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138
YG L+ AIK L +++ +FL++ S++ + H N ++L G G +
Sbjct: 67 YGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
+ E+ NGSL L G + Q V + G G+ YL + +HR
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLSDL---GYVHR 175
Query: 199 DIKSSNVLIFDDDVAKIADFDLS 221
D+ + NVL+ + V K++DF LS
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLS 198
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-31
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
IG+G+ G VY + + +G AI++++ +QP +E + + ++ K+ N V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ + Q + + LE+LH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+IHRDIKS N+L+ D K+ DF Q ++ + ++GT + APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 186
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 14/192 (7%)
Query: 33 AYHASEAAPKGAQAVKVQPIEVPAIS--VDELKEIT-ENFGTNALIGEGSYGRVYYGILK 89
AY++ A + V P P + EI E+ +G+G +G V+ G
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 90 SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149
AIK L E FL + ++ +L+HE VQL + ++ E+ S GSL
Sbjct: 207 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSL 265
Query: 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209
D L G G L Q V +A A G+ Y+ + +HRD++++N+L+ +
Sbjct: 266 LDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 315
Query: 210 DDVAKIADFDLS 221
+ V K+ADF L+
Sbjct: 316 NLVCKVADFGLA 327
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 42/188 (22%), Positives = 75/188 (39%), Gaps = 28/188 (14%)
Query: 41 PKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AI 96
P+ QAV+ I ++ V + I G G +G VY+G L A+
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVI----------GRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 97 KKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL-AYEFASNGSLHDIL 153
K L +FL + ++ H N + LLG C+ L + +G L + +
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
+ + + + AKG+++L K +HRD+ + N ++ +
Sbjct: 183 RNET--------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTV 231
Query: 214 KIADFDLS 221
K+ADF L+
Sbjct: 232 KVADFGLA 239
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 42/150 (28%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G A+K L + FLA+ +++ +L+H+ V+L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--- 77
Query: 135 TSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
++ Y E+ NGSL D L G L+ + + +A A+G+ ++ E+
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ IHRD++++N+L+ D KIADF L+
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 31/198 (15%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK---- 89
+H + + P + LK+I + +GEG +G+V
Sbjct: 5 HHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRD-------LGEGHFGKVSLYCYDPTND 57
Query: 90 -SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY---EF 143
+G A+K L DA Q + ++ ++ L HE+ ++ G C D + L E+
Sbjct: 58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL-QLVMEY 116
Query: 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203
GSL D L + Q + A +G+ YLH + H IHRD+ +
Sbjct: 117 VPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAAR 163
Query: 204 NVLIFDDDVAKIADFDLS 221
NVL+ +D + KI DF L+
Sbjct: 164 NVLLDNDRLVKIGDFGLA 181
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 19/183 (10%)
Query: 47 VKVQPIEVPAISVDEL-KEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKL- 99
V E P +V E KE+ N + ++G G +G V G LK AIK L
Sbjct: 23 VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 100 -DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG 158
+++ +FL + S++ + H N ++L G ++ E+ NGSL L
Sbjct: 83 VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 159 VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
+ Q V + G A G++YL + +HRD+ + N+LI + V K++DF
Sbjct: 143 Q--------FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF 191
Query: 219 DLS 221
L
Sbjct: 192 GLG 194
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 75 IGEGSYGRVYYGILK----SGHAAAIK--KLDASKQPD-EEFLAQVSMVSRLKHENFVQL 127
+G+G +G V LK S A+K K D D EEFL + + + H + +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 128 LGYCVDGTSRVLAY------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
+G + ++ F +G LH L + + L Q V+ V A
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI---GENPFNLPLQTLVRFMVDIA 147
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
G+EYL + + IHRD+ + N ++ +D +ADF LS
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 18/154 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
IG+G +G VY+G AIK Q E FL + ++ L H N + L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 129 GYCVDGTSRVLA-YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + + +G L + P + + + + A+G+EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
E+ +HRD+ + N ++ + K+ADF L+
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-30
Identities = 48/186 (25%), Positives = 72/186 (38%), Gaps = 27/186 (14%)
Query: 72 NALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQL 127
+ IG GS+ VY G+ ++ A +L K E F + M+ L+H N V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 128 LGYCVDGTSR----VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
VL E ++G+L L + +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----------MKIKVLRSWCRQIL 139
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
KGL++LH + P IIHRD+K N+ I KI D L+ A+ V+GT
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTP 194
Query: 241 GYHAPE 246
+ APE
Sbjct: 195 EFMAPE 200
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-30
Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 75 IGEGSYGRVYYGILK-----SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG +G+V +G A+K L ++ + ++ ++ L HEN V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 128 LGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
G C + + EF +GSL + L K ++ +Q++K AV KG+
Sbjct: 89 KGICTEDGGNGI-KLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGM 139
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+YL + +HRD+ + NVL+ + KI DF L+
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-30
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G+G +G V+ G AIK L E FL + ++ +L+HE VQL +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
++ E+ S GSL D L G G L Q V +A A G+ Y+ +
Sbjct: 335 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
+HRD++++N+L+ ++ V K+ADF L+
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-30
Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+G G++G VY G+ AIK+L S + ++E L + +++ + + + +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C+ T +++ + G L D + K + Q + V AKG+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
++ ++HRD+ + NVL+ KI DF L+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-30
Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQL 127
+G G +G V+ G+ + IK + + +Q + + + L H + V+L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C + +++ ++ GSL D + +G L Q + V AKG+ YL
Sbjct: 81 LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYL 131
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
E ++HR++ + NVL+ ++ADF ++
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-30
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
IG G +G VY G+LK+ AIK L +++ +FL + ++ + H N ++L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ E+ NG+L L + G S Q V + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYL 163
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ +HRD+ + N+L+ + V K++DF LS
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-30
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 21/156 (13%)
Query: 75 IGEGSYGRVYYGILK-----SGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G+G++G V +G A+KKL ++++ +F ++ ++ L+H+N V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C R L E+ GSL D L K + + ++ KG+E
Sbjct: 78 GVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL K IHRD+ + N+L+ +++ KI DF L+
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-30
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 21/156 (13%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G+G++G V +G A+KKL ++++ +F ++ ++ L+H+N V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C R L E+ GSL D L K + + ++ KG+E
Sbjct: 109 GVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL K IHRD+ + N+L+ +++ KI DF L+
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-30
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G++G V G + A+K L +E LA+ +++ +L + V+++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C + S +L E A G L+ L + + + +++ + G++YL
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
E + +HRD+ + NVL+ AKI+DF LS
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 37/164 (22%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 75 IGEGSYGRVYYGILKSGHAA--------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFV 125
+G+G++ +++ G+ + +K L A + E F SM+S+L H++ V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G CV G +L EF GSL L K ++ ++++A A +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMH 127
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDD--------VAKIADFDLS 221
+L E +IH ++ + N+L+ ++ K++D +S
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
IGEG +G V+ GI S AIK K S E+FL + + + H + V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G + ++ E + G L L RK L + A + L YL
Sbjct: 83 GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 133
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K +HRDI + NVL+ +D K+ DF LS
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-29
Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 27/225 (12%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDE----LKEI------TENFGTNALIGEGSYGRV 83
+H + + + ++ ++ L+ + + IGEGS G V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIV 61
Query: 84 YYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAY 141
SG A+K +D KQ E L V ++ +H N V++ + G +
Sbjct: 62 CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
EF G+L DI+ + L+ +Q + + L YLH + +IHRDIK
Sbjct: 122 EFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
S ++L+ D K++DF Q + S ++GT + APE
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPE 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-29
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 48 KVQPIEVPAISVDELKEI------TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD 100
VQ P + +L E E F +GEGSYG VY I ++G AIK++
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 101 ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK 160
+E + ++S++ + + V+ G T + E+ GS+ DI+ R
Sbjct: 64 VESDL-QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT- 121
Query: 161 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
L+ + I KGLEYLH IHRDIK+ N+L+ + AK+ADF +
Sbjct: 122 -------LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246
+ Q D A+ ++ V+GT + APE
Sbjct: 172 AGQLTDTMAKRNT--VIGTPFWMAPE 195
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 15/174 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
+G+G++G+VY ++G AA K ++ + + E + +++ H V+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ EF G++ I+ L+ Q + + L +LH K
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+K+ NVL+ + ++ADF +S + + S +GT + APE
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPE 187
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 18/153 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+GEG +G VY G+ + A+K K D + E+F+++ ++ L H + V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G + + E G L L K L V ++ K + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAMAYLE 130
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ +HRDI N+L+ + K+ DF LS
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 20/155 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
+G+GS+G V G + A+K K D QP+ ++F+ +V+ + L H N ++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L G + + E A GSL D L +G + AV A+G+ Y
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 136
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L K IHRD+ + N+L+ D+ KI DF L
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 75 IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG++G+V K A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P ++++ V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G+EYL + IHRD+ + NVL+ +++V KIADF L+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ A+K + E FLA+ +++ L+H+ V+L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
++ EF + GSL D L + G + + + A+G+ ++ ++ +
Sbjct: 256 PIYIIT-EFMAKGSLLDFLKSDE-------GSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLS 221
IHRD++++N+L+ V KIADF L+
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLA 331
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
IGEG +G V+ GI S AIK K S E+FL + + + H + V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G + ++ E + G L L RK L + A + L YL
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE 508
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K +HRDI + NVL+ +D K+ DF LS
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
IGEGS+G+ + G IK+++ S+ +E +V++++ +KH N VQ
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ S + ++ G L ++ +KGV Q + V L+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHD 143
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPE 246
+ I+HRDIKS N+ + D ++ DF ++ N ++A + GT Y +PE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----RACI-GTPYYLSPE 195
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 75 IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V K A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P ++++ V
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G+EYL + IHRD+ + NVL+ +++V KIADF L+
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-29
Identities = 35/156 (22%), Positives = 66/156 (42%), Gaps = 21/156 (13%)
Query: 75 IGEGSYGRVYYGILK-----SGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G+G++G V +G A+K+L + +F ++ ++ L + V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G + L E+ +G L D L + L + + + KG+E
Sbjct: 91 GVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHR--------ARLDASRLLLYSSQICKGME 141
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
YL + +HRD+ + N+L+ + KIADF L+
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-29
Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 15/178 (8%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ----VSMVSRLKHENFVQLL 128
IG G + VY L G A+KK+ D + A + ++ +L H N ++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
++ + E A G L ++ K + ++ + K V LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ ++HRDIK +NV I V K+ D L HS ++GT Y +PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-29
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 75 IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V +G+ K A+K L A E ++++ ++S L +HEN V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-----GPVLSWQQRVKIAVGA 180
LLG C G ++ E+ G L + L + V P S + + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A+G+ +L K + IHRD+ + NVL+ + VAKI DF L+
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-29
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 26/201 (12%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSM 115
I + L++ F L+G G+YG+VY G +K+G AAIK +D + +EE +++M
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 116 VSRL-KHENFVQLLG-YCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVL 168
+ + H N G + + EF GS+ D++ KG L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------L 126
Query: 169 SWQQRVKIAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
+ IA +GL +LH+ +IHRDIK NVL+ ++ K+ DF +S Q
Sbjct: 127 KEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 226 DMAARLHSTRVLGTFGYHAPE 246
R ++ +GT + APE
Sbjct: 181 RTVGRRNT--FIGTPYWMAPE 199
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-29
Identities = 34/178 (19%), Positives = 73/178 (41%), Gaps = 19/178 (10%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
IG G +V+ + + AIK ++ + ++ + +++ +++L+ + ++L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
Y + + E N L+ L +K + +R + + +H
Sbjct: 76 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ I+H D+K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 126 QH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAA--------AIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG++G+V A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P LS + V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 17/152 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ + AIK L K EE + + ++ +L + V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + +L E A G LH L G++ + ++ + G++YL E
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
K + +HR++ + NVL+ + AKI+DF LS
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 42/198 (21%), Positives = 78/198 (39%), Gaps = 34/198 (17%)
Query: 74 LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGY 130
+G G +G V+ K AIK++ + + + +V +++L+H V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 131 CVDGTSRVLAY------------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
++ + + +L D ++GR ++ + L +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI------FL 125
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------DLSNQAPDMA 228
A+ +E+LH K ++HRD+K SN+ DDV K+ DF + M
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 229 ARLHSTRVLGTFGYHAPE 246
A T +GT Y +PE
Sbjct: 183 AYARHTGQVGTKLYMSPE 200
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 34/178 (19%), Positives = 73/178 (41%), Gaps = 19/178 (10%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
IG G +V+ + + AIK ++ + ++ + +++ +++L+ + ++L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
Y + + E N L+ L +K + +R + + +H
Sbjct: 95 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ I+H D+K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 145 QH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
+GEG +G+V A+K L +AS + L++ +++ ++ H + ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ---------------PGPVLSWQ 171
L G C +L E+A GSL L + V L+
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ A ++G++YL E ++HRD+ + N+L+ + KI+DF LS
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-28
Identities = 49/190 (25%), Positives = 76/190 (40%), Gaps = 33/190 (17%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
LIG G +G+V+ G IK++ + E+ +V +++L H N V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 133 DGTSRVLAY----------------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
EF G+L + R+G K L +++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALEL 127
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
KG++Y+H K +I+RD+K SN+ + D KI DF L + R TR
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRS 181
Query: 237 LGTFGYHAPE 246
GT Y +PE
Sbjct: 182 KGTLRYMSPE 191
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 33/178 (18%), Positives = 72/178 (40%), Gaps = 19/178 (10%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
IG G +V+ + + AIK ++ + ++ + +++ +++L+ + ++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
Y + + E N L+ L +K + +R + + +H
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 172
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ I+H D+K +N L D + K+ DF ++NQ + +G Y PE
Sbjct: 173 QH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 75 IGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V + A+K L A+ ++++ ++ + H N V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLSWQQRVKIA 177
LLG C G ++ EF G+L L ++ L+ + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 18/175 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G V+ GI ++ AIK +D + D E+ +++++S+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ T + E+ GS D+L +PGP L Q I KGL+YLH +
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSE- 138
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IHRDIK++NVL+ + K+ADF ++ Q D + ++ +GT + APE
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPE 189
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 34/190 (17%), Positives = 69/190 (36%), Gaps = 26/190 (13%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLD--------------ASKQPDEEFLAQV----SMV 116
+ +G + ++ K A+KK + K + ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
+ +K+E + G + + YE+ N S+ + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CI 156
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
Y+H + +I HRD+K SN+L+ + K++DF S D ++ +R
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR- 211
Query: 237 LGTFGYHAPE 246
GT+ + PE
Sbjct: 212 -GTYEFMPPE 220
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-27
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 75 IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V YG++KS A A+K L A E ++++ ++S L H N V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ---------PGPVLSWQQRVKI 176
LLG C G ++ E+ G L + L ++ L + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ AKG+ +L K + IHRD+ + N+L+ + KI DF L+
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-27
Identities = 51/180 (28%), Positives = 74/180 (41%), Gaps = 25/180 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G+G +G VY +S A+K L ++ Q+ + S L+H N ++L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 129 GYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
GY D T L E+A G+++ L + Q+ A L Y
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSK-----------FDEQRTATYITELANALSY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H K +IHRDIK N+L+ KIADF S AP + + GT Y PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD-LCGTLDYLPPE 177
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 48/221 (21%), Positives = 77/221 (34%), Gaps = 23/221 (10%)
Query: 32 GAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKS 90
G A GA A E+P + VD + +G+G + + + +
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADT 65
Query: 91 GHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146
A K + S ++ S+ L H++ V G+ D + E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 147 GSLHDILHGRKGVKGAQPGPVLSWQQRV-KIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205
SL ++ RK + + G +YLH +IHRD+K N+
Sbjct: 126 RSLLELHKRRKALT----------EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNL 172
Query: 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ +D KI DF L+ + R GT Y APE
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPE 211
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 13 HKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTN 72
H + + GA + P G +A ++ +V + + + + F
Sbjct: 5 HHHHHHDYDIPTTENLYFQGA---MDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDL 59
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ----VSMVSRLKHENFVQL 127
IG GS+G VY+ +++ AIKK+ S + E V + +L+H N +Q
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + + L E+ GS D+L K L + + GA +GL YL
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYL 170
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
H ++IHRD+K+ N+L+ + + K+ DF ++
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-27
Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 47 VKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP 105
+K+ P + + ++LK++ E IG G+YG V + K SG A+K++ ++
Sbjct: 9 LKISPEQHWDFTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 106 DE--EFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
E + L + +V R VQ G + E + S V
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120
Query: 163 Q-PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
P +L KI + K L +L E IIHRDIK SN+L+ K+ DF +S
Sbjct: 121 VIPEEILG-----KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS 173
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPE 246
Q D A+ TR G Y APE
Sbjct: 174 GQLVDSIAK---TRDAGCRPYMAPE 195
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-27
Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 18/178 (10%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
L+G+GS+ VY + +G AIK +D + +V + +LKH + ++L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
Y D L E NG ++ L R S + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSENEARHFMHQIITGMLYLH 129
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRD+ SN+L+ + KIADF L+ Q + ++ GT Y +PE
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPE 182
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 55/194 (28%), Positives = 75/194 (38%), Gaps = 22/194 (11%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE--EFLAQV 113
+ D+L+ I E +G G+YG V SG A+K++ A+ E L +
Sbjct: 4 VKADDLEPIME-------LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL 56
Query: 114 SMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
+ R V G + E + SL P +L
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--- 112
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
KIAV K LE+LH K +IHRD+K SNVLI K+ DF +S D A+
Sbjct: 113 --KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-- 166
Query: 233 STRVLGTFGYHAPE 246
G Y APE
Sbjct: 167 -DIDAGCKPYMAPE 179
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-26
Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 23/185 (12%)
Query: 74 LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
IG GSYGR KS G K+LD + E +++V+++ LKH N V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 130 YCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
+D T+ L Y E+ G L ++ KG + L + +++ L+
Sbjct: 73 RIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 187 LHEKADP--HIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
H ++D ++HRD+K +NV + K+ DF L+ N A T V GT
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTFV-GTPY 181
Query: 242 YHAPE 246
Y +PE
Sbjct: 182 YMSPE 186
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 10/178 (5%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG G+ V AIK+++ K +E L ++ +S+ H N V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
V L + S GS+ DI+ + G L I +GLEYLH+
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEGLEYLHKN- 140
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR--VLGTFGYHAPE 246
IHRD+K+ N+L+ +D +IADF +S A + R +GT + APE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 75 IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V YGI K+G + A+K L A E ++++ M+++L HEN V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDIL--------------HGRKGVKGAQPGPVLSWQ 171
LLG C L +E+ G L + L +K ++ + VL+++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ A AKG+E+L K +HRD+ + NVL+ V KI DF L+
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 43/200 (21%), Positives = 72/200 (36%), Gaps = 23/200 (11%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA 111
E+P + VD + +G+G + + + + A K + S
Sbjct: 3 EIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 112 QV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
++ S+ L H++ V G+ D + E SL ++ RK +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT------- 113
Query: 168 LSWQQRV-KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
+ G +YLH +IHRD+K N+ + +D KI DF L+ +
Sbjct: 114 ---EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167
Query: 227 MAARLHSTRVLGTFGYHAPE 246
R GT Y APE
Sbjct: 168 DGERKKVL--CGTPNYIAPE 185
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-26
Identities = 55/180 (30%), Positives = 75/180 (41%), Gaps = 25/180 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G+G +G VY ++ A+K L S+ E Q+ + S L+H N +++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 129 GYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
Y D L EFA G L+ L HGR Q+ A L Y
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDEQRSATFMEELADALHY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
HE+ +IHRDIK N+L+ KIADF S AP R + GT Y PE
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM--CGTLDYLPPE 182
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-26
Identities = 45/208 (21%), Positives = 82/208 (39%), Gaps = 37/208 (17%)
Query: 65 ITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN 123
+F A++G+G++G+V AIKK+ +++ L++V +++ L H+
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQY 63
Query: 124 FVQLLGYCVDGTSRVLAY-------------EFASNGSLHDILHGRKGVKGAQPGPVLSW 170
V+ ++ + V E+ NG+L+D++H
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--------QQR 115
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
+ ++ + L Y+H + IIHRD+K N+ I + KI DF L+
Sbjct: 116 DEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 231 LHS------------TRVLGTFGYHAPE 246
L T +GT Y A E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 29/215 (13%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAA 95
E K +A Q +V + D+ ++I+E +G G+ G V+ K SG A
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVMA 62
Query: 96 IKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151
K + Q+ ++ V G + E GSL
Sbjct: 63 RKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
+L + P +L K+++ KGL YL EK I+HRD+K SN+L+
Sbjct: 121 VLKKAGRI----PEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRG 169
Query: 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
K+ DF +S Q D A + V GT Y +PE
Sbjct: 170 EIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPE 200
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 9e-25
Identities = 29/183 (15%), Positives = 59/183 (32%), Gaps = 21/183 (11%)
Query: 75 IGEG--SYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF---LAQVSMVSRLKHENFVQLL 128
IG+G V +G +++++ +E ++ + H N V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + F + GS D++ ++ I G K L+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIAYILQGVLKALDYIH 145
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-----GTFGYH 243
+HR +K+S++LI D ++ + R +
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 244 APE 246
+PE
Sbjct: 203 SPE 205
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 3e-24
Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 30/221 (13%)
Query: 47 VKVQPIEVPAISVD-ELKEITENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL 99
++PAI E + ++ + L+GEG++ +VY + A +K
Sbjct: 44 TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103
Query: 100 DASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR 156
EF ++ RLK F++ + VL E S G+L + ++
Sbjct: 104 K--PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161
Query: 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--- 213
K P V+ + A+ +E +H+ IIH DIK N ++ + +
Sbjct: 162 K----NTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214
Query: 214 --------KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ D S T T G+ E
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-24
Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 29/196 (14%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM 115
+++L+ + E +G G+ G+V+ + +GH A+K++ S ++E ++ M
Sbjct: 22 AEINDLENLGE-------MGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILM 72
Query: 116 -----VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
+ VQ G + T +A E + + + P +L
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG- 127
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
K+ V K L YL EK +IHRD+K SN+L+ + K+ DF +S + D A+
Sbjct: 128 ----KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181
Query: 231 LHSTRVLGTFGYHAPE 246
R G Y APE
Sbjct: 182 ---DRSAGCAAYMAPE 194
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-24
Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 32/208 (15%)
Query: 55 PAISVDELKEITE-------NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQP 105
P++ D+ E T +F ++G G+ G + Y + A+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 106 DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
D E V ++ +H N ++ D + +A E + +L + + Q
Sbjct: 65 DRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQK 111
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFD 219
+ + + GL +LH +I+HRD+K N+LI + A I+DF
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 220 LSNQ-APDMAARLHSTRVLGTFGYHAPE 246
L + A + + V GT G+ APE
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-23
Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGY 130
++G+G+ V+ G K +G AIK + +P + + + ++ +L H+N V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 131 CVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ T+R VL EF GSL+ +L G L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHLR 129
Query: 189 EKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
E I+HR+IK N++ V K+ DF + + D + S + GT Y
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LYGTEEYLH 183
Query: 245 PE 246
P+
Sbjct: 184 PD 185
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-23
Identities = 46/193 (23%), Positives = 73/193 (37%), Gaps = 27/193 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK-HENFVQLLGY 130
++ EG + VY + SG A+K+L ++++ + Q V + +L H N VQ
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 131 CVDGTSR-------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
G L G L + L + LS +KI +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------LSCDTVLKIFYQTCRA 148
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------DLSNQAPDMAARLHS 233
++++H + P IIHRD+K N+L+ + K+ DF D S A A
Sbjct: 149 VQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 234 TRVLGTFGYHAPE 246
T Y PE
Sbjct: 208 ITRNTTPMYRTPE 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-23
Identities = 38/191 (19%), Positives = 67/191 (35%), Gaps = 26/191 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRL-KHENFVQLL 128
IG G +G V+ + G AIK+ + L +V + L +H + V+
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ ++ E+ + GSL D + + L + + +GL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLLQVGRGLRYIH 132
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------------MAARLHSTRV 236
++H DIK SN+ I + A + R+ S +V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 237 L-GTFGYHAPE 246
G + A E
Sbjct: 190 EEGDSRFLANE 200
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-23
Identities = 42/185 (22%), Positives = 70/185 (37%), Gaps = 20/185 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRL-KH 121
++F + +G GSYG V+ K G A+K+ + + ++ LA+V ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
V+L +G L E SL G L Q
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTL 167
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
L +LH + ++H D+K +N+ + K+ DF L + A + G
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPR 221
Query: 242 YHAPE 246
Y APE
Sbjct: 222 YMAPE 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-23
Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGY 130
++G+G+ V+ G K +G AIK + +P + + + ++ +L H+N V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 131 CVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ T+R VL EF GSL+ +L G L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHLR 129
Query: 189 EKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
E I+HR+IK N++ V K+ DF + + D + S + GT Y
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LYGTEEYLH 183
Query: 245 PE 246
P+
Sbjct: 184 PD 185
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 8e-23
Identities = 46/184 (25%), Positives = 69/184 (37%), Gaps = 24/184 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP-DEEFLAQ-VSMVSRLKHENFVQLL--- 128
+G G +G V I +G AIK+ P + E + ++ +L H N V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 129 ---GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+LA E+ G L L+ + G L + + L
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG------LKEGPIRTLLSDISSALR 135
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
YLHE IIHRD+K N+++ + KI D + + L + V GT Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV-GTLQY 189
Query: 243 HAPE 246
APE
Sbjct: 190 LAPE 193
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 39/200 (19%), Positives = 78/200 (39%), Gaps = 24/200 (12%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H 121
+ + + ++G GS G V + G A+K++ + L ++ +++ H
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 68
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
N ++ +A E N +L D++ + + + + + A
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN--VSDENLKLQKEYNPISLLRQIA 125
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLI-------------FDDDVAKIADFDLSNQ--APD 226
G+ +LH IIHRD+K N+L+ ++ I+DF L + +
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 227 MAARLHSTRVLGTFGYHAPE 246
+ R + GT G+ APE
Sbjct: 183 SSFRTNLNNPSGTSGWRAPE 202
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 6e-22
Identities = 27/241 (11%), Positives = 50/241 (20%), Gaps = 43/241 (17%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAA 95
AA A V P L + + G V+ ++ A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 96 IKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYC-------------------- 131
+K + L ++ +RL E+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 132 ------VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ +L AS L + + +
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAA 208
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
L K ++H N+ I D + D + +AP
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAP 259
Query: 246 E 246
Sbjct: 260 R 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-21
Identities = 45/181 (24%), Positives = 71/181 (39%), Gaps = 22/181 (12%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
+G G VY AIK + + EE L S+L H+N V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQNIV 74
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
++ + L E+ +L + + GP LS + G++
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIK 125
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+ H+ I+HRDIK N+LI + KI DF ++ +A + + VLGT Y +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181
Query: 246 E 246
E
Sbjct: 182 E 182
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 5e-21
Identities = 46/193 (23%), Positives = 76/193 (39%), Gaps = 37/193 (19%)
Query: 75 IGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+YG VY K A+K+++ + +++++ LKH N + L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87
Query: 132 VDGTSR--VLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
+ R L +++A HD I+ + K + L + G+ Y
Sbjct: 88 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARL---------HS 233
LH ++HRD+K +N+L+ + KIAD ARL
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADL 192
Query: 234 TRVLGTFGYHAPE 246
V+ TF Y APE
Sbjct: 193 DPVVVTFWYRAPE 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 56/206 (27%), Positives = 76/206 (36%), Gaps = 51/206 (24%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-----------------QPDEEFLAQVSM 115
IG+GSYG V A+K L K +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 116 VSR----------LKHENFVQLLGYCV-DGTSRVLAY---EFASNGSLHDIL-HGRKGVK 160
+ + L H N V+L V D + Y E + G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 161 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
LS Q KG+EYLH + IIHRDIK SN+L+ +D KIADF +
Sbjct: 134 -------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246
SN+ A L +T GT + APE
Sbjct: 184 SNEFKGSDALLSNTV--GTPAFMAPE 207
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 26/186 (13%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
++G G V+ L+ A+K L A D F AQ + L H V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIV 75
Query: 126 QLLGY-CVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
+ + + L Y E+ +L DI+H GP ++ ++ +++ A
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADAC 126
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST-RVLGTF 240
+ L + H+ IIHRD+K +N++I + K+ DF ++ D + T V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 241 GYHAPE 246
Y +PE
Sbjct: 184 QYLSPE 189
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 26/244 (10%), Positives = 68/244 (27%), Gaps = 44/244 (18%)
Query: 35 HASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHA 93
++A + + P EL E ++G+ ++G +
Sbjct: 41 EYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 100
Query: 94 AAIKKLDASKQPDEE-----------------------------FLAQVSMVSRLKHENF 124
+ +++P F+ +V + +
Sbjct: 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160
Query: 125 VQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+++ D SR Y +L G + + L R+++ + +
Sbjct: 161 IRVRLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L LH ++H ++ ++++ + F+ + + G+
Sbjct: 218 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGF 268
Query: 243 HAPE 246
PE
Sbjct: 269 EPPE 272
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-19
Identities = 41/181 (22%), Positives = 64/181 (35%), Gaps = 22/181 (12%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
L+G G G VY A+K + + D F A+ RL+ + V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEPHVV 97
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ + + + L +L + GP L+ + V I L+
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--------GP-LAPPRAVAIVRQIGSALD 148
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
H HRD+K N+L+ DD A + DF ++ A +GT Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204
Query: 246 E 246
E
Sbjct: 205 E 205
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-18
Identities = 53/179 (29%), Positives = 78/179 (43%), Gaps = 21/179 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
+GEG+YG V + + A A+K +D + D + + + L HEN V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 131 CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+G + L E+ S G L D + AQ + Q + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA-------GVVYLH 122
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGYHAPE 246
I HRDIK N+L+ + D KI+DF L+ RL + GT Y APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 44/226 (19%), Positives = 88/226 (38%), Gaps = 18/226 (7%)
Query: 25 KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY 84
G + ++ + P + + +++ + +G G++G V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 85 YGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142
++ G+ A K + + D+E + + + +S L+H V L D V+ YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
F S G L + + +S + V+ KGL ++HE + +H D+K
Sbjct: 235 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKP 283
Query: 203 SNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
N++ + K+ DF L+ + + GT + APE
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPE 326
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-18
Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 23/154 (14%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQLL 128
+GEG+YG VY G A+K+ LD DE + ++S++ L H N V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLD---AEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEYL 187
L +EF L +L K G Q + + Q ++ G+ +
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLR-------GVAHC 135
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
H+ I+HRD+K N+LI D K+ADF L+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 29/186 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPDEEFLAQV----SMVSRLKHENFVQL 127
L+GEGSYG+V + ++ A+K L K + A V ++ RL+H+N +QL
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 128 LGYCVDGTSR--VLAYEFASNGS--LHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+ + + + E+ G + D + R V A + Q +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH----GYFCQLID------- 120
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTF 240
GLEYLH + I+H+DIK N+L+ KI+ ++ AA +++ G+
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSP 175
Query: 241 GYHAPE 246
+ PE
Sbjct: 176 AFQPPE 181
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.2 bits (199), Expect = 4e-18
Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 23/154 (14%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQLL 128
IGEG+YG VY G A+KK L+ E + ++S++ LKH N V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLY 66
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYL 187
VL +E D+ K + G + S K + G+ Y
Sbjct: 67 DVIHTKKRLVLVFEHLD----QDL----KKLLDVCEGGLESVT--AKSFLLQLLNGIAYC 116
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
H++ ++HRD+K N+LI + KIADF L+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-18
Identities = 35/185 (18%), Positives = 69/185 (37%), Gaps = 34/185 (18%)
Query: 73 ALIGEGSYGRVYYG---ILKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
I G G +Y + +G +K L S + +A+ ++ + H + VQ+
Sbjct: 86 GCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 128 L--GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
D + Y E+ SL + L + + +
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEILP 193
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST-RVLGTFG 241
L YLH +++ D+K N+++ ++ + K+ D +R++S + GT G
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEEQL-KLIDLGA-------VSRINSFGYLYGTPG 242
Query: 242 YHAPE 246
+ APE
Sbjct: 243 FQAPE 247
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-18
Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 28/182 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G G++G+V G +GH A+K L+ K + + ++ + +H + ++L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
Y V T + E+ S G L D + HGR A +QQ + +
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----RRLFQQILS-------AV 124
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+Y H ++HRD+K NVL+ AKIADF LSN D L ++ G+ Y A
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNYAA 178
Query: 245 PE 246
PE
Sbjct: 179 PE 180
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-18
Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 24/157 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+G G+Y VY G+ +G A+K+ LD+ +E + ++S++ LKHEN V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLMKELKHENIVRL 68
Query: 128 LGYCVDGTSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGL 184
L +EF N D +G + V + Q +GL
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-------LLQGL 121
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+ HE I+HRD+K N+LI K+ DF L+
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 51/181 (28%), Positives = 75/181 (41%), Gaps = 28/181 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG G++G + A+K ++ DE ++ L+H N V+ V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84
Query: 133 DGTSRVLAY--EFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
T LA E+AS G L++ + GR A+ +QQ + G+ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR----FFFQQLL-------SGVSYCH 133
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
I HRD+K N L+ D A KI DF S + ++ ST +GT Y AP
Sbjct: 134 SM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL-HSQPKST--VGTPAYIAP 186
Query: 246 E 246
E
Sbjct: 187 E 187
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 53/179 (29%), Positives = 78/179 (43%), Gaps = 21/179 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
+GEG+YG V + + A A+K +D + D + + + L HEN V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 131 CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+G + L E+ S G L D + AQ + Q + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA-------GVVYLH 122
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGYHAPE 246
I HRDIK N+L+ + D KI+DF L+ RL + GT Y APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 1e-17
Identities = 43/154 (27%), Positives = 64/154 (41%), Gaps = 21/154 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IGEG+YG VY +G A+KK LD E + ++S++ L H N V+L
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L L +EF D+ K A + +GL +
Sbjct: 68 LDVIHTENKLYLVFEFLH----QDL----KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
H ++HRD+K N+LI + K+ADF L+
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 49/227 (21%), Positives = 80/227 (35%), Gaps = 33/227 (14%)
Query: 35 HASEAAPKGAQAVKVQPIEVPAISVDELKEITE-NFGTNALIGEGSYGRVYYGI-LKSGH 92
H+S P+G+ + ++ + KE E + L+G G +G VY GI +
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 93 AAAIKKLDASKQPDEEFLAQVSMVSR-------LKHE--NFVQLLGYCVDGTSRVLAYEF 143
AIK ++ + D L + V + ++LL + S VL E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 144 ASN-GSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200
L D G L + + + + H ++HRDI
Sbjct: 130 PEPVQDLFDFITERGA-----------LQEELARSFFWQVLEAVRHCHNC---GVLHRDI 175
Query: 201 KSSNVLIFDDDV-AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
K N+LI + K+ DF D +++ GT Y PE
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRVYSPPE 218
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 28/182 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G G++G+V G +GH A+K L+ K + + ++ + +H + ++L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
Y V T + E+ S G L D + +GR K + +QQ + G+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----RRLFQQILS-------GV 129
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+Y H ++HRD+K NVL+ AKIADF LSN D L ++ G+ Y A
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNYAA 183
Query: 245 PE 246
PE
Sbjct: 184 PE 185
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 23/247 (9%), Positives = 67/247 (27%), Gaps = 43/247 (17%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGH 92
++A + + P EL E ++G+ ++G
Sbjct: 45 SEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 104
Query: 93 AAAIKKLDASKQPDEEFLAQ--------------------------VSMVSRLKHENFVQ 126
+ + +++P + Q + +K +
Sbjct: 105 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 127 LLGYCVDGTSRVLAYEF-------ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
++ +D + F ++ + ++L + L R+++ +
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQ 219
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
+ L LH ++H ++ ++++ + F+ +A R
Sbjct: 220 VIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAP 275
Query: 240 FGYHAPE 246
A
Sbjct: 276 PETTAER 282
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 27/180 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASK--QPDEEFLAQ-VSMVSRLKHENFVQLLGY 130
IG+G++ +V + +G AIK +D ++ + L + V ++ L H N V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 131 CVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
V T + L E+AS G + D L HGR K A+ ++Q V ++Y
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQIVS-------AVQY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H+K I+HRD+K+ N+L+ D KIADF SN+ G Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPE 183
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-17
Identities = 52/232 (22%), Positives = 72/232 (31%), Gaps = 45/232 (19%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK-----KLDASKQPDEEFL 110
L E+ + + IG+GSYG V I + AIK K+ D E +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 111 AQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
V ++ +L H N +L D L E G L D L+ + +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 170 WQQRVKIAVG------------------------AAK-------GLEYLHEKADPHIIHR 198
Q + L YLH + I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192
Query: 199 DIKSSNVLIFDDDVA--KIADFDLSN--QAPDMAARLHSTRVLGTFGYHAPE 246
DIK N L + K+ DF LS + T GT + APE
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-17
Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKH 121
E + L+GEGSYG V +G AIKK S D+ + ++ ++ +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRH 83
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGA 180
EN V LL C L +EF + ++ D L G V + Q +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQII------ 134
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
G+ + H +IIHRDIK N+L+ V K+ DF +
Sbjct: 135 -NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-17
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 30/182 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IGEG+YG V+ ++ A+K+ LD E L ++ ++ LKH+N V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEY 186
L +EF L G P V S+ Q +K GL +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLK-------GLGF 116
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTRVLGTFGYHA 244
H + +++HRD+K N+LI + K+A+F L+ P R +S V+ T Y
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVV-TLWYRP 169
Query: 245 PE 246
P+
Sbjct: 170 PD 171
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-17
Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 38/192 (19%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IG+G++G V+ K+G A+KK ++ K E F L ++ ++ LKHEN V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNL 81
Query: 128 LGYCVDGTSRV--------LAYEFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIA 177
+ C S L ++F HD+ G + + + ++
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE----HDL-------AGLLSNVLVKFTLSEIKRVM 130
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHST 234
GL Y+H I+HRD+K++NVLI D V K+ADF L+ + A + ++
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 235 RVLGTFGYHAPE 246
RV+ T Y PE
Sbjct: 188 RVV-TLWYRPPE 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-17
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 27/157 (17%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+GEG + VY + AIKK L + + L ++ ++ L H N + L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 128 LGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKG 183
L ++ L ++F D I+ V P + ++ +G
Sbjct: 78 LDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLT--PSHIKAYMLM-------TLQG 124
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
LEYLH+ I+HRD+K +N+L+ ++ V K+ADF L
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-17
Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 39/192 (20%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLK---HENF 124
IG G+YG VY SGH A+K + + +V+++ RL+ H N
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 125 VQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
V+L+ C + L +E D+ + P P L + +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----T 234
+GL++LH I+HRD+K N+L+ K+ADF L AR++S T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177
Query: 235 RVLGTFGYHAPE 246
V+ T Y APE
Sbjct: 178 PVVVTLWYRAPE 189
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-17
Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 17/190 (8%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD--ASKQPDEEFLAQVSMVSRL 119
I + F +G G++G V+ + SG IK ++ S+ P E+ A++ ++ L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H N +++ D + + E G L + + + LS ++
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQ 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRV 236
L Y H + H++H+D+K N+L D KI DF L+ +
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA 187
Query: 237 LGTFGYHAPE 246
GT Y APE
Sbjct: 188 -GTALYMAPE 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 6e-17
Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 20/152 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
IGEGSYG V+ +G AIKK S+ D L ++ M+ +LKH N V LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
L +E+ H +LH + +G V S + + + + H
Sbjct: 70 VFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT------LQAVNFCH 119
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
+ + IHRD+K N+LI V K+ DF
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-17
Identities = 47/203 (23%), Positives = 77/203 (37%), Gaps = 33/203 (16%)
Query: 32 GAYHASEAAPKGAQAVKVQP----IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI 87
G++ S A G + + I+V A ++ + +IG GS+G V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 88 LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV------LAY 141
L AIKK+ Q ++ ++ +KH N V L + + L
Sbjct: 61 LVESDEVAIKKV---LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVL-----SWQQRVKIAVGAAKGLEYLHEKADPHII 196
E+ +++ R K Q P+L +Q + L Y+H I
Sbjct: 118 EYVPE-TVYRAS--RHYAKLKQTMPMLLIKLYMYQ--------LLRSLAYIHSI---GIC 163
Query: 197 HRDIKSSNVLIF-DDDVAKIADF 218
HRDIK N+L+ V K+ DF
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDF 186
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-16
Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 21/116 (18%)
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200
+ +L D ++ R ++ + G L Q IA + +E+LH K ++HRD+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ---IA----EAVEFLHSK---GLMHRDL 190
Query: 201 KSSNVLIFDDDVAKIADF----------DLSNQAPDMAARLHSTRVLGTFGYHAPE 246
K SN+ DDV K+ DF + M A T +GT Y +PE
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 8e-04
Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
+F +G G +G V+ K AIK++ + E+ + +V +++L+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 124 FVQ 126
V+
Sbjct: 66 IVR 68
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 44/189 (23%), Positives = 80/189 (42%), Gaps = 20/189 (10%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK 120
+ + + +G G++G V+ + K+ G K ++ D+ + +S++++L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H + L D VL EF S G L D + +S + + A
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQA 158
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQA-PDMAARLHSTRVL 237
+GL+++HE I+H DIK N++ + KI DF L+ + PD ++
Sbjct: 159 CEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TT 211
Query: 238 GTFGYHAPE 246
T + APE
Sbjct: 212 ATAEFAAPE 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 31/190 (16%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK 120
E + +GEG+Y VY G K + + A+K++ + EE + +VS++ LK
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQRVKI 176
H N V L S L +E+ D L V + Q ++
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGN--IINMHNVKLFLFQLLR- 111
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
GL Y H + ++HRD+K N+LI + K+ADF L+ +A + + + V
Sbjct: 112 ------GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEV 161
Query: 237 LGTFGYHAPE 246
+ T Y P+
Sbjct: 162 V-TLWYRPPD 170
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 39/189 (20%), Positives = 72/189 (38%), Gaps = 21/189 (11%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
KE+ E + +G G +G V+ + S K + ++S+++ +H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
N + L V+ +EF S + + I L+ ++ V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQV 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQ-APDMAARLHSTRVL 237
+ L++LH +I H DI+ N++ + KI +F + Q P RL +
Sbjct: 112 CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LF 164
Query: 238 GTFGYHAPE 246
Y+APE
Sbjct: 165 TAPEYYAPE 173
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-16
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 31/210 (14%)
Query: 50 QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIK-----KLDASK 103
+ +E+ ++ E E ++ + T + +G G++G V+ + + +K K+
Sbjct: 8 KAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 104 QPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS-LHD--ILHGR 156
++ L +V +++SR++H N +++L + L E +G L H R
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR 126
Query: 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216
L I + YL K IIHRDIK N++I +D K+
Sbjct: 127 -----------LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172
Query: 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
DF + +L T GT Y APE
Sbjct: 173 DFGSAAYLER--GKLFYTFC-GTIEYCAPE 199
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-16
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 23/189 (12%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKH 121
I + F ++G G++ V+ + G A+K + S + L ++++ ++KH
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
EN V L T L + S G L D IL +GV + + +
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGV--------YTEKDASLVIQQV 115
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVL 237
++YLHE I+HRD+K N+L ++ I DF LS + + +
Sbjct: 116 LSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMST--AC 168
Query: 238 GTFGYHAPE 246
GT GY APE
Sbjct: 169 GTPGYVAPE 177
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-16
Identities = 39/189 (20%), Positives = 59/189 (31%), Gaps = 34/189 (17%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSR-----------LKH 121
L+G+G +G V+ G L AIK + ++ L+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGS-LHD--ILHGRKGVKGAQPGPVLSWQQRVKIAV 178
++LL + +L E L D G L
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----------LGEGPSRCFFG 146
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVL 237
+++ H + ++HRDIK N+LI AK+ DF D
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDF--D 199
Query: 238 GTFGYHAPE 246
GT Y PE
Sbjct: 200 GTRVYSPPE 208
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 24/222 (10%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDELKE--ITENFGTNALIGEGSYGRVYYGILK-S 90
+H + ++ K+ ++E + +G G+YG V K +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 91 GHAAAIK---KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147
AIK K S + + L +V+++ L H N ++L + D + L E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
L D + R + I G+ YLH+ +I+HRD+K N+L+
Sbjct: 122 ELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLL 169
Query: 208 FDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ + KI DF LS + LGT Y APE
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 29/182 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+GEGS+G+V K+ A+K + + +V S + L+H + ++L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
Y V T V+ E+A G L D + R +QQ + +
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEG----RRFFQQIIC-------AI 121
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
EY H I+HRD+K N+L+ D+ KIADF LSN D L ++ G+ Y A
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNYAA 175
Query: 245 PE 246
PE
Sbjct: 176 PE 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 43/170 (25%), Positives = 70/170 (41%), Gaps = 32/170 (18%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
+ ++ +IG GS+G VY L SG AIKK+ Q ++ ++ +L H
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDH 106
Query: 122 ENFVQLLGYCVDGTSRV-------LAYEFASNGSLHDILHGRKGVKGAQPGPVL-----S 169
N V+L Y + L ++ +++ + R + Q PV+
Sbjct: 107 CNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTLPVIYVKLYM 162
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADF 218
+Q + L Y+H I HRDIK N+L+ D V K+ DF
Sbjct: 163 YQ--------LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 24/190 (12%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKH 121
+I + + IG GS+G V + K + A KK+ D + Q + ++ L H
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
N ++L D T L E + G L + + A + +K +
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLS 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRV 236
A + Y H+ ++ HRD+K N L D K+ DF L+ + ++ T+V
Sbjct: 118 A---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV 169
Query: 237 LGTFGYHAPE 246
GT Y +P+
Sbjct: 170 -GTPYYVSPQ 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 48/197 (24%), Positives = 77/197 (39%), Gaps = 20/197 (10%)
Query: 60 DELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIK-----KLDASKQPDEEFLAQ- 112
D+ + + +IG+G + V I + G A+K K +S E L +
Sbjct: 17 DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
S+ LKH + V+LL + +EF L + VK A G V S
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAV 131
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAA 229
+ L Y H+ +IIHRD+K VL+ + + K+ F ++ Q +
Sbjct: 132 ASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 230 RLHSTRVLGTFGYHAPE 246
+GT + APE
Sbjct: 189 VAGG--RVGTPHFMAPE 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 48/192 (25%), Positives = 77/192 (40%), Gaps = 23/192 (11%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQPDEEFLAQVSMVS 117
++ + ++G+GS+G V K +G A+K + K E L +V ++
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+L H N ++L + D L E + G L D + RK S +I
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARII 132
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHST 234
G+ Y+H+ I+HRD+K N+L+ +I DF LS
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---K 186
Query: 235 RVLGTFGYHAPE 246
+GT Y APE
Sbjct: 187 DKIGTAYYIAPE 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-15
Identities = 56/242 (23%), Positives = 86/242 (35%), Gaps = 29/242 (11%)
Query: 12 MHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGT 71
MH + + + + + + A + I +++ F
Sbjct: 1 MHH---HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEV 57
Query: 72 NALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLG 129
+ +G G+ VY K A+K L K D++ + + ++ RL H N ++L
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 130 YCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
T L E + G L D + G S + + + YL
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGY-----------YSERDAADAVKQILEAVAYL 164
Query: 188 HEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
HE I+HRD+K N+L D KIADF LS L T GT GY A
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCA 218
Query: 245 PE 246
PE
Sbjct: 219 PE 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-15
Identities = 48/198 (24%), Positives = 73/198 (36%), Gaps = 31/198 (15%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK---------QPDEEFLAQ 112
EN+ ++G G V I K A+K +D + Q E +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 113 -VSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVL 168
V ++ ++ H N +QL T L ++ G L D L
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----------L 121
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
S ++ KI + + LH+ +I+HRD+K N+L+ DD K+ DF S Q
Sbjct: 122 SEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176
Query: 229 ARLHSTRVLGTFGYHAPE 246
GT Y APE
Sbjct: 177 GEKLREVC-GTPSYLAPE 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-15
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 28/188 (14%)
Query: 68 NFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFV 125
++G G +G+V+ + G A K + D+E + +S++++L H N +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
QL VL E+ G L D I+ L+ + +G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---------DESYNLTELDTILFMKQICEGI 200
Query: 185 EYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVL----G 238
++H+ +I+H D+K N+L D KI DF L+ R L G
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA-------RRYKPREKLKVNFG 250
Query: 239 TFGYHAPE 246
T + APE
Sbjct: 251 TPEFLAPE 258
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-15
Identities = 44/185 (23%), Positives = 78/185 (42%), Gaps = 25/185 (13%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK-HENFVQLLGY 130
++GEG++ RV I + A+K ++ + + V M+ + + H N ++L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ L +E GS+ +H R+ + + + A L++LH K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNK 130
Query: 191 ADPHIIHRDIKSSNVLIFD-DDVA--KIADFDLS------NQAPDMAARLHSTRVLGTFG 241
I HRD+K N+L + V+ KI DFDL ++ T G+
Sbjct: 131 ---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186
Query: 242 YHAPE 246
Y APE
Sbjct: 187 YMAPE 191
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-15
Identities = 42/199 (21%), Positives = 71/199 (35%), Gaps = 33/199 (16%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ--------- 112
K + + + + +G G+ G V + AI+ + K
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSW 170
+ ++ +L H +++ + D + E G L D + + R +
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------- 242
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDM 227
++YLHE IIHRD+K NVL+ + + KI DF S +
Sbjct: 243 ----LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 228 AARLHSTRVLGTFGYHAPE 246
+ L T GT Y APE
Sbjct: 296 S--LMRTLC-GTPTYLAPE 311
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-15
Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 43/193 (22%)
Query: 75 IGEGSYGRVYYG--ILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLK---HEN 123
IGEG+YG+V+ + G A+K+ + + E + +V+++ L+ H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPN 75
Query: 124 FVQLL----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
V+L D +++ L +E D+ P P + + +
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMF 127
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS----- 233
+GL++LH ++HRD+K N+L+ K+ADF L AR++S
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMAL 176
Query: 234 TRVLGTFGYHAPE 246
T V+ T Y APE
Sbjct: 177 TSVVVTLWYRAPE 189
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-15
Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 32/225 (14%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVD--ELKEITENFGTNALIGEGSYGRVYYGILKS-GHA 93
++A PKG + + Q + D KE + + +IG G V + ++ GH
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 94 AAIKKLDASK--QPDEEFLAQVSMVSR----LK----HENFVQLLGYCVDGTSRVLAYEF 143
A+K ++ + E+ R L+ H + + L+ + L ++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 144 ASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
G L D LS ++ I + + +LH +I+HRD+K
Sbjct: 182 MRKGELFDYLTEKVA-----------LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLK 227
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
N+L+ D+ +++DF S GT GY APE
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEP--GEKLRELC-GTPGYLAPE 269
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-15
Identities = 19/151 (12%), Positives = 42/151 (27%), Gaps = 19/151 (12%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKHENFVQL 127
G + + + A+ +D ++ L + +SR+ ++
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L ++ E+ GSL ++ P P ++ A +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIRAMQSLAAAADAA 145
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
H + S V + D +A
Sbjct: 146 HRA---GVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 34/186 (18%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+GEG+YG VY I + AIK+ L+ + E + +VS++ L+H N ++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE---EGVPGTAIREVSLLKELQHRNIIEL 98
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L +E+A N L + V + S+ ++ G+ +
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV---SMRVIKSFLYQL------INGVNFC 148
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVA-----KIADFDL--SNQAPDMAARLHSTRVLGTF 240
H + +HRD+K N+L+ D + KI DF L + P R + ++ T
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHEII-TL 201
Query: 241 GYHAPE 246
Y PE
Sbjct: 202 WYRPPE 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-14
Identities = 41/191 (21%), Positives = 79/191 (41%), Gaps = 22/191 (11%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
+ ++N+ +G+G++ V + K+ G A K ++ K D + L + + +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
L+H N V+L + + L ++ + G L + + R+ S
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQ 112
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTR 235
+ + Y H I+HR++K N+L+ K+ADF L+ + D +
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGF 167
Query: 236 VLGTFGYHAPE 246
GT GY +PE
Sbjct: 168 A-GTPGYLSPE 177
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 26/193 (13%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
E + ++G+GS+G V + A+K ++ + D + + V ++ +
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKI 176
L H N ++L D +S + E + G L D I R S +I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----------FSEHDAARI 126
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHS 233
G+ Y+H+ +I+HRD+K N+L+ + KI DF LS
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMK 181
Query: 234 TRVLGTFGYHAPE 246
R+ GT Y APE
Sbjct: 182 DRI-GTAYYIAPE 193
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 56/230 (24%), Positives = 86/230 (37%), Gaps = 36/230 (15%)
Query: 35 HASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHA 93
H+S Q + + P + +I E++ +G G+YG V K
Sbjct: 7 HSSGRENLYFQGIAINP---GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 94 AAIKKLD--------------ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139
AIK + ++ EE ++S++ L H N ++L D L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 199
EF G L + + R I G+ YLH+ +I+HRD
Sbjct: 124 VTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKH---NIVHRD 171
Query: 200 IKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IK N+L+ + + KI DF LS+ +L LGT Y APE
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRD--RLGTAYYIAPE 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 22/191 (11%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEEFLAQVSMVSR 118
E + ++G+GS+G V + + A+K K A + L +V ++ +
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
L H N ++L D +S + E + G L D + RK S +I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIK 128
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTR 235
G+ Y+H+ +I+HRD+K N+L+ + KI DF LS ++
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD-- 182
Query: 236 VLGTFGYHAPE 246
+GT Y APE
Sbjct: 183 RIGTAYYIAPE 193
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-14
Identities = 43/199 (21%), Positives = 72/199 (36%), Gaps = 33/199 (16%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
+++ + + +G G + V KS G A K + + + R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+ H N + L + T VL E S G L D L ++ LS ++
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDM 227
G+ YLH K I H D+K N+++ D ++ K+ DF L+ +
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 228 AARLHSTRVLGTFGYHAPE 246
+ GT + APE
Sbjct: 176 ------KNIFGTPEFVAPE 188
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-14
Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 23/215 (10%)
Query: 40 APKGAQAVKVQPIEVPA-ISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIK 97
P A Q + + ++ + ++N+ +G+G++ V + K+ G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 98 KLDASK--QPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
++ K D + L + + +L+H N V+L + + L ++ + G L + +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDD 211
R+ S + + Y H I+HR++K N+L+
Sbjct: 121 ARE---------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168
Query: 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
K+ADF L+ + D + GT GY +PE
Sbjct: 169 AVKLADFGLAIEVND--SEAWHGFA-GTPGYLSPE 200
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-14
Identities = 38/192 (19%), Positives = 71/192 (36%), Gaps = 23/192 (11%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
TE + +G+G++ V + G A ++ K D + L + +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIA 177
LKH N V+L + L ++ + G L + I+ + S
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREY--------YSEADASHCI 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHST 234
+ + + H+ ++HR++K N+L+ K+ADF L+ +
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172
Query: 235 RVLGTFGYHAPE 246
GT GY +PE
Sbjct: 173 -FAGTPGYLSPE 183
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-14
Identities = 43/196 (21%), Positives = 75/196 (38%), Gaps = 27/196 (13%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
+++ + + +G G + V KS G A K + + + R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+ H N + L + T VL E S G L D L ++ LS ++
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAAR 230
G+ YLH K I H D+K N+++ D ++ K+ DF L+++ +
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDG 172
Query: 231 LHSTRVLGTFGYHAPE 246
+ + GT + APE
Sbjct: 173 VEFKNIFGTPEFVAPE 188
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-14
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 23/190 (12%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRL-K 120
+ T+ + IG GSY I K+ A+K +D SK+ E ++ ++ R +
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQ 74
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H N + L DG + E G L D + +K S ++ +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---------FFSEREASAVLFTI 125
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRV 236
K +EYLH + ++HRD+K SN+L D+ +I DF + Q L T
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-TPC 181
Query: 237 LGTFGYHAPE 246
T + APE
Sbjct: 182 -YTANFVAPE 190
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-13
Identities = 44/199 (22%), Positives = 70/199 (35%), Gaps = 33/199 (16%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ--------- 112
K + + + + +G G+ G V + AIK + K
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSW 170
+ ++ +L H +++ + D + E G L D + + R L
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-----------LKE 113
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDM 227
++YLHE IIHRD+K NVL+ + + KI DF S +
Sbjct: 114 ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 228 AARLHSTRVLGTFGYHAPE 246
L T GT Y APE
Sbjct: 171 --SLMRTLC-GTPTYLAPE 186
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 41/172 (23%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEFLAQVSMVSRL 119
++ + F + G+G++G V G K +G + AIKK D + E L + ++ L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVL 76
Query: 120 KHENFVQLLGYCVDGTSR--------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
H N VQL + E+ + +LH R + P + +
Sbjct: 77 HHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC--RNYYRRQVAPPPILIK 132
Query: 172 ----QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADF 218
Q + + LH + ++ HRDIK NVL+ + D K+ DF
Sbjct: 133 VFLFQ-------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 42/199 (21%), Positives = 74/199 (37%), Gaps = 33/199 (16%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
+ + + + T +G G + V KS G A K + + + R
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
++H N + L + T +L E + G L D L ++ L+ ++
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------SLTEEEAT 117
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDM 227
+ G+ YLH I H D+K N+++ D +V KI DF L+ + +
Sbjct: 118 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 228 AARLHSTRVLGTFGYHAPE 246
+ GT + APE
Sbjct: 175 ------KNIFGTPEFVAPE 187
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 5e-13
Identities = 41/197 (20%), Positives = 71/197 (36%), Gaps = 33/197 (16%)
Query: 65 ITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR----- 118
+ +++ +G G + V K G A K + + + R
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 119 --LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
++H N + L + T VL E S G L D L ++ L+ + +
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQF 113
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDMAA 229
G+ YLH K I H D+K N+++ D +V K+ DF ++ +
Sbjct: 114 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168
Query: 230 RLHSTRVLGTFGYHAPE 246
+ GT + APE
Sbjct: 169 ----KNIFGTPEFVAPE 181
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-13
Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 21/177 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV 132
+GEGS+ + K S A A+K + + + + +++ + + H N V+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
D L E + G L + + +K S + I + ++H+
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 193 PHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
++HRD+K N+L D++ KI DF + P L + T Y APE
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPE 179
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-13
Identities = 48/224 (21%), Positives = 78/224 (34%), Gaps = 40/224 (17%)
Query: 36 ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAA 94
A G+ P + + +F ++GEGS+ V +
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELATSREY 58
Query: 95 AIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150
AIK L+ + + ++SRL H FV+L D +A NG L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKS 202
+ ++ + LEYLH K IIHRD+K
Sbjct: 119 KYI-----------------RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKP 158
Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
N+L+ +D +I DF + + + + +GT Y +PE
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 43/211 (20%), Positives = 79/211 (37%), Gaps = 29/211 (13%)
Query: 25 KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELK---EITENFGTNALIGEGSYG 81
+ G H + + Q K P S+ +I + + LIG GSYG
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67
Query: 82 RVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVSRLKHENFVQLLGYCVDGT 135
V AIKK+ + ++ + +++++RL H++ V++L +
Sbjct: 68 HVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125
Query: 136 SRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ E A + + L+ + G++Y+H
Sbjct: 126 VEKFDELYVVLEIADS-DFKKLFRTP------VY---LTELHIKTLLYNLLVGVKYVHS- 174
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A I+HRD+K +N L+ D K+ DF L+
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 32/190 (16%), Positives = 59/190 (31%), Gaps = 44/190 (23%)
Query: 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEFLAQVSMVSRLKH 121
++ + +G GS+G V SG A+KK D + E + ++ L H
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE-----LDIMKVLDH 59
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW----------- 170
N ++L+ Y + + V
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 171 -----QQRVKIAVGAA----------------KGLEYLHEKADPHIIHRDIKSSNVLIF- 208
+ +K + + + + ++H I HRDIK N+L+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 209 DDDVAKIADF 218
D+ K+ DF
Sbjct: 177 KDNTLKLCDF 186
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 38/183 (20%), Positives = 65/183 (35%), Gaps = 29/183 (15%)
Query: 74 LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYC 131
++G G G+V + G A+K L S + +E V + + V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCILDVY 91
Query: 132 VDGTSRVLAY----EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
+ E G L I +G + + ++ +I +++
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQA------FTEREAAEIMRDIGTAIQF 143
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
LH +I HRD+K N+L + V K+ DF + + T T Y
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPC-YTPYYV 196
Query: 244 APE 246
APE
Sbjct: 197 APE 199
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 46/208 (22%), Positives = 76/208 (36%), Gaps = 48/208 (23%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------DEEFLAQ---- 112
+ + I GSYG V G+ G AIK++ + + FL +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 113 -VSMVSRLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKG 158
+ +++ H N + L Y V E L ++H ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLV--------TELMRT-DLAQVIHDQR- 128
Query: 159 VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
V+S Q GL LHE A ++HRD+ N+L+ D++ I DF
Sbjct: 129 -------IVISPQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDF 178
Query: 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+L+ + A + T + Y APE
Sbjct: 179 NLARED---TADANKTHYVTHRWYRAPE 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 9e-12
Identities = 46/194 (23%), Positives = 84/194 (43%), Gaps = 20/194 (10%)
Query: 61 ELKEIT-ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV--S 114
E + + + F ++G G +G V+ +K +G A KKL K+ A V
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
+++++ F+ L Y + + + L + G + ++ + P + R
Sbjct: 238 ILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-----NVDEDNPGFQ-EPR 290
Query: 174 VKI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
GLE+LH++ +II+RD+K NVL+ DD +I+D L+ + +
Sbjct: 291 AIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 233 STRVLGTFGYHAPE 246
GT G+ APE
Sbjct: 348 -GYA-GTPGFMAPE 359
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 1e-11
Identities = 37/195 (18%), Positives = 62/195 (31%), Gaps = 41/195 (21%)
Query: 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---------DASKQPDEEFLAQVSMV 116
TE IGEG +G V+ I AIK + + ++ EE L ++ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 117 SRL---------KHENFVQLLG-YCVDGT---SRVLAYEF--ASNGSLHDILHGRKGVKG 161
L + E F+ L +CV G+ + A++ ++ GS +D K +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 162 --------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
+ S I L HRD+ NVL+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195
Query: 208 FDDDVAKIADFDLSN 222
+ K+
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-11
Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 27/196 (13%)
Query: 61 ELKEIT-ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV--S 114
E + +T F ++G+G +G V ++ +G A KKL K+ E +A
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSL--HDILHGRKGVKGAQPGPVLSWQ 171
++ ++ FV L Y + + L + G L H G+ G +
Sbjct: 237 ILEKVNSR-FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP----------E 285
Query: 172 QRVKI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
R A GLE LH + I++RD+K N+L+ D +I+D L+ P+ +
Sbjct: 286 ARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQ 340
Query: 231 LHSTRVLGTFGYHAPE 246
RV GT GY APE
Sbjct: 341 TIKGRV-GTVGYMAPE 355
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
E+ E + + +G G+YG V K+G A+KKL S+ A+ + ++
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLK 83
Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+KHEN + LL ++ + V L L++I+ +K L+
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDD 132
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ +GL+Y+H IIHRD+K SN+ + +D KI DF L+ D
Sbjct: 133 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 232 HSTRVLGTFGYHAPE 246
+TR Y APE
Sbjct: 190 VATRW-----YRAPE 199
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 41/184 (22%), Positives = 75/184 (40%), Gaps = 29/184 (15%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSRLKH-ENFVQLLG 129
+G G + V I KS G A K L + Q + ++++ K + L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 130 YCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + +L E+A+ G + L + ++S +++ +G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCL--------PELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLS---NQAPDMAARLHSTRVLGTFGY 242
+ +I+H D+K N+L+ KI DF +S A ++ ++GT Y
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL------REIMGTPEY 199
Query: 243 HAPE 246
APE
Sbjct: 200 LAPE 203
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-11
Identities = 42/232 (18%), Positives = 77/232 (33%), Gaps = 28/232 (12%)
Query: 25 KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY 84
T H P Q + + + I + T+ ++G G G+V
Sbjct: 20 PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79
Query: 85 YGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY- 141
K + A+K L + E V + R + + V+++ + +
Sbjct: 80 QIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLL 135
Query: 142 ---EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 197
E G L I + + ++ +I + ++YLH +I H
Sbjct: 136 IVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 184
Query: 198 RDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
RD+K N+L + K+ DF + + +T T Y APE
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC-YTPYYVAPE 233
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 32/201 (15%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
++ + +G G G V+ + AIKK+ + + + ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS----VKHALREIKIIR 63
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGPV 167
RL H+N V++ + + L + S L+ + L V P
Sbjct: 64 RLDHDNIVKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN---VLEQGP--- 116
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLS-NQAP 225
L + +GL+Y+H +++HRD+K +N+ I +D V KI DF L+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 226 DMAARLHSTRVLGTFGYHAPE 246
+ + H + L T Y +P
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPR 194
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 28/190 (14%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV-----SMVSR 118
+F + +IG G +G VY +G A+K L K E LA S+VS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI- 176
F+ + Y ++ + + G LH L + ++
Sbjct: 249 GDCP-FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----------EADMRFY 297
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A GLE++H + +++RD+K +N+L+ + +I+D L+ V
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 351
Query: 237 LGTFGYHAPE 246
GT GY APE
Sbjct: 352 -GTHGYMAPE 360
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 29/195 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
++ + + IGEG+YG V + AIKK+ + + Q + ++
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILL 80
Query: 118 RLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
R +HEN + + T + + L+ +L Q LS
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-------TQH---LSNDH 129
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARL 231
+GL+Y+H A+ ++HRD+K SN+L+ KI DF L+ PD
Sbjct: 130 ICYFLYQILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 232 HSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 187 FLTEYVATRWYRAPE 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 35/196 (17%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
E+ + +G G+YG V + ++G AIKKL + E A+ + ++
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLK 79
Query: 118 RLKHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++HEN + LL + L F L ++ + L
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-------HEK---LGED 128
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAAR 230
+ + KGL Y+H IIHRD+K N+ + +D KI DF L+ +M
Sbjct: 129 RIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--- 182
Query: 231 LHSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 183 ---TGYVVTRWYRAPE 195
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-11
Identities = 44/195 (22%), Positives = 74/195 (37%), Gaps = 32/195 (16%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ + + IG G+ G V AIKKL S+ + A+ + ++
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMK 116
Query: 118 RLKHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+ H+N + LL + L E + +L ++ L +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ--------ME---LDHE 164
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ + G+++LH IIHRD+K SN+++ D KI DF L+ A
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SF 218
Query: 232 HSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 219 MMTPYVVTRYYRAPE 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-11
Identities = 36/191 (18%), Positives = 70/191 (36%), Gaps = 31/191 (16%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H 121
+++ +G G Y V+ I + + +K L K ++ ++ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90
Query: 122 ENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
N + L D SR A E +N + L+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYE 138
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLS---NQAPDMAARLHSTR 235
K L+Y H I+HRD+K NV+I + ++ D+ L+ + + R+ ++R
Sbjct: 139 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASR 194
Query: 236 VLGTFGYHAPE 246
+ PE
Sbjct: 195 Y-----FKGPE 200
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-11
Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 36/196 (18%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
E+ + + + +G G+YG V I +SG AIKKL S+ E A+ + ++
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLK 78
Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++HEN + LL + L F L I+ + S +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-----------FSEE 126
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAAR 230
+ + KGL+Y+H ++HRD+K N+ + +D KI DF L+ + +M
Sbjct: 127 KIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180
Query: 231 LHSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 181 ---TGYVVTRWYRAPE 193
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 41/211 (19%), Positives = 75/211 (35%), Gaps = 35/211 (16%)
Query: 49 VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASK 103
+ + + +L+ E++ +IG G++G V K + A+K L +
Sbjct: 51 LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
F + +++ VQL Y F + L+ ++ G
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLF------------YAFQDDRYLYMVMEYMPG----- 153
Query: 164 PGPVLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215
G +++ + A+ L+ +H IHRD+K N+L+ K+
Sbjct: 154 -GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL 209
Query: 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
ADF + T V GT Y +PE
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 44/195 (22%), Positives = 74/195 (37%), Gaps = 32/195 (16%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ + + IG G+ G V AIKKL S+ + A+ + ++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMK 79
Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+ H+N + LL ++ V + E +L ++ L +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--------ME---LDHE 127
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ + G+++LH IIHRD+K SN+++ D KI DF L A
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSF 181
Query: 232 HSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 182 MMTPYVVTRYYRAPE 196
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 52/210 (24%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
I+ +F +L+GEG+YG V +G AIKK++ D+ A + ++
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILK 64
Query: 118 RLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
KHEN + + Y + E LH ++ Q
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYII--------QELMQT-DLHRVIS-------TQM 108
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
LS + ++ LH ++ +IHRD+K SN+LI + K+ DF L+
Sbjct: 109 ---LSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 225 PDMAARLHSTRVLGTFG--------YHAPE 246
+ AA + Y APE
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPE 192
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 41/177 (23%), Positives = 71/177 (40%), Gaps = 42/177 (23%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ +N+ LIG GSYG VY + AIKK+ ++ ++ + +++++
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILN 80
Query: 118 RLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
RLK + ++L Y V E A + L +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIV--------LEIADS-DLKKLFKTP------IF 125
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L+ + I G ++HE + IIHRD+K +N L+ D K+ DF L+
Sbjct: 126 ---LTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 22/64 (34%), Positives = 33/64 (51%), Gaps = 6/64 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L+YL + IIHRD+K N+L+ + I DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 243 HAPE 246
APE
Sbjct: 181 MAPE 184
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 8e-09
Identities = 18/58 (31%), Positives = 32/58 (55%), Gaps = 3/58 (5%)
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L+ + + + AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 23/94 (24%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 75 IGEGSYGRVY----YGILKSG--HAAAIKKL--DASKQPDEEFLAQVS-MVSRLKHENFV 125
+G G++G+V +GI K+ A+K L A+ ++++ ++ H N V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 126 QLLGYCVDGTSRVLA-YEFASNGSLHDILHGRKG 158
LLG C ++ EF G+L L ++
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 31/172 (18%), Positives = 59/172 (34%), Gaps = 28/172 (16%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
+G G G+V K + A+K L + E V + R + + V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYE 81
Query: 133 DGTSRVLAY----EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+ + E G L I + + ++ +I + ++YL
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 188 HEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRV 236
H +I HRD+K N+L + K+ DF A + +
Sbjct: 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKETTGEKYDKSC 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 39/167 (23%), Positives = 60/167 (35%), Gaps = 24/167 (14%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IGEGS+G ++ G L + AIK S P + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFGQ 76
Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+G VL + SL D+L GRK S + A ++ +HEK
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIHEK 125
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAK-----IADFDLSNQAPDMAARLH 232
+++RDIK N LI + + DF + D + H
Sbjct: 126 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 34/138 (24%), Positives = 54/138 (39%), Gaps = 21/138 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG G++G + G L + AIK S+ P + + Q+ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFGP 75
Query: 133 DGTSRVLAYEFASNG-SLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
G + E G SL D+ L R S + + IA+ +EY+H
Sbjct: 76 CGKYNAMVLELL--GPSLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVHS 123
Query: 190 KADPHIIHRDIKSSNVLI 207
K ++I+RD+K N LI
Sbjct: 124 K---NLIYRDVKPENFLI 138
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-08
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 22/165 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCV 132
IG GS+G +Y G + +G AIK + K + + + ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+G V+ E SL D+ RK S + + +A +EY+H K
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK----------FSLKTVLLLADQMISRIEYIHSK 124
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAK---IADFDLSNQAPDMAARLH 232
+ IHRD+K N L+ I DF L+ + D H
Sbjct: 125 ---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-08
Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 41/175 (23%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ + +G+G+YG V+ I ++G A+KK+ AQ + +++
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILT 63
Query: 118 RLK-HENFVQLLG----------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
L HEN V LL Y V +++ LH ++ A
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLV--------FDYMET-DLHAVIR-------ANI-- 105
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L + + K ++YLH ++HRD+K SN+L+ + K+ADF LS
Sbjct: 106 -LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-08
Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
F L+G+G++G+V K +G A+K L K E + V+ EN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KK----EVIVAKDEVAHTLTENRV 201
Query: 124 -------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
F+ L Y R+ E+A+ G L H + ++ R +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED--------RAR 251
Query: 176 I-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
L+YLH + + +++RD+K N+++ D KI DF L + A + +
Sbjct: 252 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308
Query: 235 RVLGTFGYHAPE 246
GT Y APE
Sbjct: 309 -FCGTPEYLAPE 319
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 30/175 (17%), Positives = 56/175 (32%), Gaps = 42/175 (24%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIK-----KLDASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
IG+G +G +Y + S + K++ S L E F Q
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------------PLFTELKFYQR 89
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--------GP----VLSWQQR-- 173
+ + G G G G + +
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 174 -----VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLS 221
+++++ LEY+HE +H DIK+SN+L+ + ++ D+ L+
Sbjct: 150 SRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-08
Identities = 39/215 (18%), Positives = 71/215 (33%), Gaps = 40/215 (18%)
Query: 31 DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LK 89
+H S G + + Q + P V + + IG G +G +Y
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDM-EGNQWVLGKKIGSGGFGLIYLAFPTN 60
Query: 90 SGHAAAIK--KLDASKQP--DEEF-----LAQVSMVSRLKHENFVQLLG-----YC---- 131
A K++ + E +A+ + + + LG
Sbjct: 61 KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120
Query: 132 -VDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ R + E L I +G VL ++ + LEY+H
Sbjct: 121 FKGRSYRFMVMERLGI-DLQKISGQNGTFKKST-----VL------QLGIRMLDVLEYIH 168
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLS 221
E +H DIK++N+L+ + ++ AD+ LS
Sbjct: 169 EN---EYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 42/204 (20%), Positives = 82/204 (40%), Gaps = 37/204 (18%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEE-FLAQ 112
V +++ E+F +IG G++G V LK + A+K L+ K+ + F +
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
++ + L Y F + +L+ ++ G G +L+
Sbjct: 125 RDVLVNGDSKWITTLH------------YAFQDDNNLYLVMDYYVG------GDLLTLLS 166
Query: 173 RV--KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
+ ++ A+ ++ +H+ H +HRDIK N+L+ + ++ADF
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 223 QAPDMAARLHSTRVLGTFGYHAPE 246
+ + S V GT Y +PE
Sbjct: 224 KLMEDGTVQSSVAV-GTPDYISPE 246
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 45/195 (23%), Positives = 74/195 (37%), Gaps = 42/195 (21%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
+ F +G GS+GRV K SG+ A+K LD KQ E L + ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQAVN 99
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
V+L D ++ + E+ + G + L ++ + +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------------RRIGRFSEPH 142
Query: 181 AK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
A+ EYLH +I+RD+K N+LI ++ DF + +
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194
Query: 233 STRVL-GTFGYHAPE 246
T L GT APE
Sbjct: 195 -TWTLCGTPEALAPE 208
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 31/219 (14%), Positives = 67/219 (30%), Gaps = 42/219 (19%)
Query: 32 GAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTN----ALIGEGSYGRVYYGI 87
+H S G + + Q + ++ +T+ G + + G +Y
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62
Query: 88 -LKSGHAAAIK-------KLDASKQP------------DEEFLAQVSMVSRLKHENFVQL 127
+ + KLDA + + +
Sbjct: 63 PTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122
Query: 128 LGY-CVDGTSRVLAYEFASNGSLHDILH--GRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
+G+ R L SL L + VLS + +++A L
Sbjct: 123 MGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKH---------VLSERSVLQVACRLLDAL 172
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLS 221
E+LHE +H ++ + N+ + +D +++ A + +
Sbjct: 173 EFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 39/213 (18%), Positives = 79/213 (37%), Gaps = 37/213 (17%)
Query: 49 VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASK 103
+Q E + + E++ ++F +IG G++ V +K +G A+K ++ +
Sbjct: 43 LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
F + ++ QL + F L+ ++ G
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQL------------HFAFQDENYLYLVMEYYVG----- 145
Query: 164 PGPVLSWQQRV--KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
G +L+ + +I A+ ++ +H +HRDIK N+L+
Sbjct: 146 -GDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHI 201
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
++ADF + + S +GT Y +PE
Sbjct: 202 RLADFGSCLKL-RADGTVRSLVAVGTPDYLSPE 233
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 35/137 (25%), Positives = 58/137 (42%), Gaps = 19/137 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV 132
IG GS+G +Y G +++ AIK + K + L + + L+ + + V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+G VL + SL D+ RK LS + + +A +E++H K
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK----------LSLKTVLMLADQMINRVEFVHSK 122
Query: 191 ADPHIIHRDIKSSNVLI 207
+HRDIK N L+
Sbjct: 123 ---SFLHRDIKPDNFLM 136
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 23/64 (35%), Positives = 36/64 (56%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L++LH II+RD+K N+L+ ++ K+ DF LS ++ D + +S GT Y
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 243 HAPE 246
APE
Sbjct: 193 MAPE 196
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 21/64 (32%), Positives = 32/64 (50%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L +LH+K II+RD+K N+++ K+ DF L ++ H+ GT Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 243 HAPE 246
APE
Sbjct: 188 MAPE 191
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 4e-06
Identities = 49/193 (25%), Positives = 78/193 (40%), Gaps = 34/193 (17%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDE--------EFLAQVSM 115
+F ++G+GS+G+V K + A+K L D Q D+ LA
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 399
Query: 116 VSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
K QL C R+ E+ + G L + H ++ + +P
Sbjct: 400 ----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP--------HA 444
Query: 175 KI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
A A GL +L K II+RD+K NV++ + KIADF + + ++ + +
Sbjct: 445 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTT 499
Query: 234 TRVLGTFGYHAPE 246
GT Y APE
Sbjct: 500 KTFCGTPDYIAPE 512
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
LEYLH + +++RDIK N+++ D KI DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 243 HAPE 246
APE
Sbjct: 172 LAPE 175
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 5e-06
Identities = 54/195 (27%), Positives = 79/195 (40%), Gaps = 42/195 (21%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
++F +G GS+GRV+ + +G A+K L KQ E + M+S +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIVT 64
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL--HDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
H +++ G D + ++ G L L QR V
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-----------------LRKSQRFPNPV 107
Query: 179 G---AAK---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
AA+ LEYLH K II+RD+K N+L+ + KI DF + PD+
Sbjct: 108 AKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 159
Query: 233 STRVL-GTFGYHAPE 246
T L GT Y APE
Sbjct: 160 -TYTLCGTPDYIAPE 173
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-06
Identities = 47/200 (23%), Positives = 76/200 (38%), Gaps = 48/200 (24%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
++F +IG GSY +V LK + A+K + K E + + ++ E
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV--KK----ELVNDDEDIDWVQTEKHV 62
Query: 124 --------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
F+ L C SR+ E+ + G L H Q++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FH---------------MQRQR 105
Query: 175 KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
K+ A+ L YLHE+ II+RD+K NVL+ + K+ D+ + +
Sbjct: 106 KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162
Query: 227 MAARLHSTRVLGTFGYHAPE 246
+ GT Y APE
Sbjct: 163 PGDTTST--FCGTPNYIAPE 180
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 22/65 (33%), Positives = 32/65 (49%), Gaps = 6/65 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-GTFG 241
LE+LH+ II+RDIK N+L+ + + DF LS + +A GT
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIE 225
Query: 242 YHAPE 246
Y AP+
Sbjct: 226 YMAPD 230
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 48/200 (24%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
++F +IG GSY +V LK + A++ + K E + + ++ E
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV--KK----ELVNDDEDIDWVQTEKHV 105
Query: 124 --------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
F+ L C SR+ E+ + G L H Q++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FH---------------MQRQR 148
Query: 175 KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
K+ A+ L YLHE+ II+RD+K NVL+ + K+ D+ + +
Sbjct: 149 KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205
Query: 227 MAARLHSTRVLGTFGYHAPE 246
+ GT Y APE
Sbjct: 206 PGDTTST--FCGTPNYIAPE 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L YLH +I++RD+K N+L+ + DF L + ++ ++ GT Y
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEY 205
Query: 243 HAPE 246
APE
Sbjct: 206 LAPE 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L +LH+K II+RD+K NVL+ + K+ADF + + + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDY 190
Query: 243 HAPE 246
APE
Sbjct: 191 IAPE 194
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 24/64 (37%), Positives = 36/64 (56%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL++LH K I++RD+K N+L+ D KIADF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 243 HAPE 246
APE
Sbjct: 185 IAPE 188
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 22/64 (34%), Positives = 31/64 (48%), Gaps = 5/64 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL +L K II+RD+K NV++ + KIADF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 243 HAPE 246
APE
Sbjct: 188 IAPE 191
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 2e-04
Identities = 41/241 (17%), Positives = 81/241 (33%), Gaps = 81/241 (33%)
Query: 49 VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE 108
VQ + +S +E+ I + +A+ G+ R+++ +L K ++ + + +
Sbjct: 38 VQDMPKSILSKEEIDHIIMS--KDAV--SGTL-RLFWTLLSKQEEMVQKFVEEVLRINYK 92
Query: 109 FLA--------QVSMVSRL------KHENFVQLLG-YCVDGTSRVLA-----YEFASNGS 148
FL Q SM++R+ + N Q+ Y V L E +
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 149 LHDILHGRKG---------------VKGAQPGPVLSWQQRVKIAVGAA-------KGLEY 186
+ ++ G G V+ + W + + + L+
Sbjct: 153 V--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W-----LNLKNCNSPETVLEMLQK 204
Query: 187 LHEKADP----------HIIHR--DIKSS-----------NVLIFDDDV--AKIAD-FDL 220
L + DP +I R I++ N L+ +V AK + F+L
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL 264
Query: 221 S 221
S
Sbjct: 265 S 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 23/71 (32%), Positives = 30/71 (42%), Gaps = 13/71 (18%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA------KIADFDLSNQAPDMAARLHSTR 235
GL+Y+H + IIH DIK NVL+ D KIAD + + TR
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 236 VLGTFGYHAPE 246
Y +PE
Sbjct: 200 E-----YRSPE 205
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 8e-04
Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
+GL+YLH K IIH DIK N+L+ ++ + + A S + T
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 242 YHAP 245
A
Sbjct: 215 ATAG 218
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.98 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.98 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.98 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.98 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.98 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.98 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.99 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.8 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.44 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.12 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.54 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.54 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.81 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=309.83 Aligned_cols=168 Identities=27% Similarity=0.379 Sum_probs=150.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||+||+|+.+ +++.||+|.+.+. ....+.+.+|+.+|++|+|||||++++++.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 7999999998643 344578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|||+||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 112 Ey~~gG~L~~~i~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 9999999999997653 3899999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.+..........+++||+.|||||
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPE 204 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPE 204 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHH
T ss_pred eecCCCCCcccccCcccCcccCCHH
Confidence 8764333333346789999999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=309.76 Aligned_cols=168 Identities=26% Similarity=0.428 Sum_probs=142.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|++.+.||+|+||+||+|+++ +++.||||.+...... .+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999976 7999999999765443 3578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
||+||+|.++|..... ..+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 104 y~~gg~L~~~i~~~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-------VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp CCTTCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred CCCCCcHHHHHHHcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccce
Confidence 9999999999975432 23788999999999999999999997 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ...+.+||+.|||||
T Consensus 174 ~~~~~~~--~~~~~~GT~~YmAPE 195 (350)
T 4b9d_A 174 VLNSTVE--LARACIGTPYYLSPE 195 (350)
T ss_dssp CCCHHHH--HHHHHHSCCTTCCHH
T ss_pred eecCCcc--cccccCCCccccCHH
Confidence 7654322 224578999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=309.19 Aligned_cols=165 Identities=30% Similarity=0.483 Sum_probs=147.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+.|++.+.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+.+|++|+|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46889999999999999999986 79999999986443 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+||+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 154 ~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 154 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 9999999997532 889999999999999999999997 999999999999999999999999999865
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ...+.+||+.|||||
T Consensus 221 ~~~~~--~~~~~~GTp~YmAPE 240 (346)
T 4fih_A 221 SKEVP--RRKSLVGTPYWMAPE 240 (346)
T ss_dssp CSSSC--CBCCCCSCGGGCCHH
T ss_pred CCCCC--cccccccCcCcCCHH
Confidence 43222 235679999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=310.37 Aligned_cols=165 Identities=30% Similarity=0.483 Sum_probs=147.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+.|++.+.||+|+||.||+|+++ +|+.||||++.... ...+.+.+|+.+|++|+|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46899999999999999999986 79999999996543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
+||+|.+++.... +++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 231 ~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 231 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999999997543 889999999999999999999997 999999999999999999999999999865
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ...+.+||+.|||||
T Consensus 298 ~~~~~--~~~~~~GTp~YmAPE 317 (423)
T 4fie_A 298 SKEVP--RRKSLVGTPYWMAPE 317 (423)
T ss_dssp CSSCC--CBCCCEECTTTCCHH
T ss_pred CCCCc--cccccccCcCcCCHH
Confidence 43222 235679999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=295.30 Aligned_cols=166 Identities=28% Similarity=0.469 Sum_probs=137.3
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+++.+.+.||+|+||+||+|+++ ..||||.++..... .+.|.+|+.++++|+|||||++++++. ++.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEc
Confidence 57778899999999999999875 36899998754433 357899999999999999999999875 4668999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
|++|+|.++|..... .+++.+++.++.||+.||.|||+++ ||||||||+|||+++++.+||+|||+|+.
T Consensus 113 ~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 113 CEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp CSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred CCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 999999999975432 3899999999999999999999996 99999999999999999999999999987
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.............+||+.|||||
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE 204 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPE 204 (307)
T ss_dssp ------------CCCCTTSCCHH
T ss_pred cccCCcceeecccccCCCccCHH
Confidence 65433333345678999999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=293.14 Aligned_cols=165 Identities=27% Similarity=0.418 Sum_probs=133.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||+||+|+.+ +++.||+|.+.+.. ...+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999976 79999999986543 2346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||| +|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 92 mEy~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp EECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred EeCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 9999 689999997653 3899999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+...... ...+.+||+.|||||
T Consensus 159 a~~~~~~~---~~~~~~GT~~Y~APE 181 (275)
T 3hyh_A 159 SNIMTDGN---FLKTSCGSPNYAAPE 181 (275)
T ss_dssp C------------------CTTSCHH
T ss_pred CeecCCCC---ccCCeeECcccCChh
Confidence 98654322 224678999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=299.64 Aligned_cols=177 Identities=23% Similarity=0.414 Sum_probs=139.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|.+.+.||+|+||+||+|+++ ++..||||.+..... ..++|.+|+.+|++|+|||||+++++|.+....+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56777889999999999999864 467899999975432 24679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 140 AYEFASNGSLHDILHGRKGVKG------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
|||||++|+|.++++....... ......++|.+++.++.||+.||.|||+++ ||||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976542110 111235899999999999999999999986 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||+|+..............+||+.|||||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 230 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 230 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChh
Confidence 999999998764433333334568999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=299.30 Aligned_cols=177 Identities=24% Similarity=0.460 Sum_probs=144.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|.+.+.||+|+||+||+|++. ++..||||.+..... ..++|.+|+.+|++|+|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999864 467899999975432 24679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 140 AYEFASNGSLHDILHGRKGV----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
|||||++|+|.++|+..... ........++|.+++.++.||+.||.|||+++ ||||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999754210 00111235899999999999999999999996 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+|+...............||+.|||||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 200 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 200 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHH
Confidence 9999997644333222234457999999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=295.44 Aligned_cols=177 Identities=28% Similarity=0.406 Sum_probs=146.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
.++++.+.||+|+||+||+|.+. +++.||||.+.... ...++|.+|+.++++|+|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667788999999999999863 46789999996543 33578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 139 LAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
||||||++|+|.++|........ ......++|..++.++.||+.||.|||+++ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975432110 011235899999999999999999999996 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+|+..............+||+.|||||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE 217 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE 217 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHH
Confidence 99999999998764433333345568999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=293.36 Aligned_cols=163 Identities=29% Similarity=0.437 Sum_probs=139.2
Q ss_pred CCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEE
Q 025893 70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAY 141 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~ 141 (246)
.+.+.||+|+||+||+|.++ ++..||+|.+...... .+.|.+|+.+|++|+|||||++++++.+ +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55667999999999999976 7889999998654333 3578899999999999999999999875 35579999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgl 220 (246)
|||++|+|.+++.... .+++..+..++.||+.||.|||+++ ++|+||||||+|||++. ++.+||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcC
Confidence 9999999999997643 3889999999999999999999983 45999999999999985 78999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+..... ...+.+|||.|||||
T Consensus 179 a~~~~~~----~~~~~~GTp~YmAPE 200 (290)
T 3fpq_A 179 ATLKRAS----FAKAVIGTPEFMAPE 200 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGG
T ss_pred CEeCCCC----ccCCcccCccccCHH
Confidence 9754322 235678999999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=294.45 Aligned_cols=172 Identities=25% Similarity=0.425 Sum_probs=135.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCC-------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------- 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------- 135 (246)
.++|++.+.||+|+||+||+|+++ +++.||||++...... .+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 467999999999999999999976 7999999998654332 357889999999999999999999987644
Q ss_pred -----eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 136 -----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 136 -----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
.+|+|||||++|+|.+++....... ...+..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence 3689999999999999997654211 2456678889999999999999997 9999999999999999
Q ss_pred CceEEccccCCCCCCccccc----------cccccccccccccCCC
Q 025893 211 DVAKIADFDLSNQAPDMAAR----------LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~~~~~~----------~~~~~~~gt~~y~aPE 246 (246)
+.+||+|||+|+........ ....+.+||+.|||||
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE 200 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence 99999999999876432211 1123468999999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=298.54 Aligned_cols=164 Identities=27% Similarity=0.339 Sum_probs=140.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+.|...+.||+|+||+||+|+++ +|+.||||++...... .+|+.++++|+|||||++++++.+++.+|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 46778889999999999999986 7999999999755432 368999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEccccCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQA 224 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Dfgls~~~ 224 (246)
||+|.++|+... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++ .+||+|||+|+..
T Consensus 134 gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 134 GGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp TCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999999997643 3899999999999999999999997 99999999999999887 6999999999865
Q ss_pred Ccccc---ccccccccccccccCCC
Q 025893 225 PDMAA---RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~---~~~~~~~~gt~~y~aPE 246 (246)
..... ......++||+.|||||
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE 226 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPE 226 (336)
T ss_dssp ------------CCCCCCGGGCCHH
T ss_pred cCCCcccceecCCccccCccccCHH
Confidence 43221 11224568999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=297.31 Aligned_cols=166 Identities=24% Similarity=0.320 Sum_probs=138.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|++.+.||+|+||+||+|+.. +++.||+|.+.+... ....+.+|+.+|++|+|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999863 467899999865321 23467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
|||||+||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 vmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEcCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999999999997643 3899999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|+....... ...+.+||+.|||||
T Consensus 172 la~~~~~~~~--~~~~~~GT~~YmAPE 196 (304)
T 3ubd_A 172 LSKESIDHEK--KAYSFCGTVEYMAPE 196 (304)
T ss_dssp EEEC-----C--CCCSCCCCGGGCCHH
T ss_pred cceeccCCCc--cccccccCcccCCHH
Confidence 9986533222 235678999999998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=290.84 Aligned_cols=169 Identities=27% Similarity=0.423 Sum_probs=135.0
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCC----eeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~lv~E 142 (246)
++|.+.+.||+|+||+||+|+++ |+.||||++.........+..|+..+.+++|||||++++++.+++ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 46778889999999999999884 889999998644322223345666677899999999999998654 5799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-----DPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
||++|+|.++++... ++|..++.++.|++.||.|||++. .++||||||||+|||++.++.+||+|
T Consensus 82 y~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999997643 889999999999999999999861 33599999999999999999999999
Q ss_pred ccCCCCCCcccc--ccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAA--RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~--~~~~~~~~gt~~y~aPE 246 (246)
||+|+....... .......+||+.|||||
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE 182 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHH
T ss_pred CCCCccccCCCCceeeecccccccccccCHH
Confidence 999975432221 11123468999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=287.38 Aligned_cols=187 Identities=21% Similarity=0.357 Sum_probs=151.6
Q ss_pred cCHHHHHHHHhcCCCCceeccCCceEEEEEEECC------CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCC-CCccce
Q 025893 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKH-ENFVQL 127 (246)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~h-p~iv~~ 127 (246)
++.++++...++|++.+.||+|+||+||+|.+.. ++.||||.+...... .+.|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445555556899999999999999999998642 357999999755433 3578999999999976 899999
Q ss_pred EeEEEeC-CeeEEEEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCC
Q 025893 128 LGYCVDG-TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 199 (246)
Q Consensus 128 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrd 199 (246)
+++|.++ +.++||||||++|+|.++|+...... .......+++..++.++.||+.||.|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 56899999999999999997543210 0112345899999999999999999999997 99999
Q ss_pred CCCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 200 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 200 lkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+|||+++++.+||+|||+|+..............+||+.|||||
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE 257 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 257 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHH
Confidence 99999999999999999999998765443333345678999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=285.04 Aligned_cols=167 Identities=26% Similarity=0.432 Sum_probs=142.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC------Ce
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG------TS 136 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~ 136 (246)
++|++.+.||+|+||+||+|+++ +|+.||||++...... .+.+.+|+.+|++|+|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999976 8999999999765443 34678999999999999999999987643 57
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
+|||||||. |+|.+++.... .+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEe
Confidence 899999996 68999997543 4899999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccc--cccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMA--ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~--~~~~~~~~~gt~~y~aPE 246 (246)
|||+|+.+.... ......+.+||+.|||||
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APE 232 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHH
Confidence 999998764321 112235679999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=298.32 Aligned_cols=165 Identities=27% Similarity=0.365 Sum_probs=142.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHH---HHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFL---AQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~---~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|++.++||+|+||+||+|+.+ +|+.||+|.+.+. ........ .++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999977 7999999998643 22233333 346777888999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
|||||||+||+|.++|.... .+++..+..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---------~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecc
Confidence 99999999999999997643 3899999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|+...... ..+.+||+.|||||
T Consensus 336 FGlA~~~~~~~----~~t~~GTp~YmAPE 360 (689)
T 3v5w_A 336 LGLACDFSKKK----PHASVGTHGYMAPE 360 (689)
T ss_dssp CTTCEECSSCC----CCSCCSCGGGCCHH
T ss_pred cceeeecCCCC----CCCccCCcCccCHH
Confidence 99998654322 35679999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=278.63 Aligned_cols=167 Identities=26% Similarity=0.384 Sum_probs=140.4
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeE
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 138 (246)
.+.+.|++.+.||+|+||+||+|+.+ +++.||+|.+.... ....+.+|+.+|+.+ .|||||++++++.+.+.+|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 34678999999999999999999853 46789999986543 456788999999998 5999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CceEEcc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIAD 217 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-~~~kl~D 217 (246)
+|||||++|+|.+++. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 97 lvmE~~~g~~L~~~~~------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EEEECCCCCCHHHHHT------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEeCCCcccHHHHHc------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence 9999999999999984 2788999999999999999999997 9999999999999876 7999999
Q ss_pred ccCCCCCCcccc--------------------------ccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAA--------------------------RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE 246 (246)
||+|+....... .....+.+||+.|||||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 216 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE 216 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 999975432110 01123468999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=289.56 Aligned_cols=167 Identities=25% Similarity=0.384 Sum_probs=146.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|++.+.||+|+||.||+|..+ +|+.||+|.+..... ..+.+.+|+.+|+.|+|||||++++++.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999986 799999999865442 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC--CceEEccccCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--DVAKIADFDLS 221 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~--~~~kl~Dfgls 221 (246)
|+||+|.++|.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 236 ~~gg~L~~~i~~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 236 MSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp CCCCBHHHHHTCTT--------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred cCCCcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence 99999999986443 13889999999999999999999997 9999999999999854 89999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.+..... ..+.+||+.|||||
T Consensus 305 ~~~~~~~~---~~~~~GT~~y~APE 326 (573)
T 3uto_A 305 AHLDPKQS---VKVTTGTAEFAAPE 326 (573)
T ss_dssp EECCTTSE---EEEECSSGGGCCHH
T ss_pred eEccCCCc---eeeeEECccccCHH
Confidence 87643322 24568999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.10 Aligned_cols=167 Identities=26% Similarity=0.356 Sum_probs=146.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||+||+++.+ +++.||+|.+.+. ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999976 7899999998642 34456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 99999999999987543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... .....+||+.|+|||
T Consensus 152 a~~~~~~~~--~~~~~~gt~~y~aPE 175 (337)
T 1o6l_A 152 CKEGISDGA--TMKTFCGTPEYLAPE 175 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGG
T ss_pred hhhcccCCC--cccccccChhhCChh
Confidence 976432211 234678999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=261.36 Aligned_cols=167 Identities=22% Similarity=0.309 Sum_probs=145.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||+||+|+.+ +++.+|+|.+.+. ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999987 6889999998542 22334578899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 148 ~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp ECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999997542 788999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... ....+.+||+.|+|||
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE 239 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPE 239 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHH
T ss_pred eEeeccCCc-ccccCCcCCccccCHH
Confidence 976543221 1234678999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=250.66 Aligned_cols=166 Identities=28% Similarity=0.391 Sum_probs=146.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468999999999999999999975 8999999998654433 356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 94 e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp CCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred ECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999986543 3889999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....+||+.|+|||
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE 183 (328)
T 3fe3_A 162 NEFTVGG---KLDAFCGAPPYAAPE 183 (328)
T ss_dssp GGGSSSC---GGGTTSSSGGGCCHH
T ss_pred eecCCCC---ccccccCCcceeCcc
Confidence 7543322 224568999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=261.39 Aligned_cols=170 Identities=22% Similarity=0.268 Sum_probs=145.7
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
..++|.+.++||+|+||+||+|+.+ +++.+|+|.+.+. ......+.+|+.++..++||||+++++++.+....|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 3578999999999999999999987 6788999998532 1223347889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 152 V~Ey~~gg~L~~~l~~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFE--------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp EECCCTTCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999997632 13889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++........ .....+||+.|+|||
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE 246 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPE 246 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChH
Confidence 99765432221 224568999999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=242.66 Aligned_cols=166 Identities=27% Similarity=0.437 Sum_probs=146.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999965 78999999986433 3467788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++|+|.+++.... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp CTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999997642 788999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....+||+.|+|||
T Consensus 166 ~~~~~~--~~~~~~gt~~y~aPE 186 (297)
T 3fxz_A 166 ITPEQS--KRSTMVGTPYWMAPE 186 (297)
T ss_dssp CCSTTC--CBCCCCSCGGGCCHH
T ss_pred cCCccc--ccCCccCCcCccChh
Confidence 543222 224567999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.22 Aligned_cols=167 Identities=26% Similarity=0.373 Sum_probs=141.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|++.+.||+|+||+||+|+.+ +++.||+|.+.+. ....+.+..|..+++.+ +||||+++++++.+....|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 578999999999999999999976 7899999998643 23446678899999988 69999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG 169 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG 169 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccc
Confidence 999999999999997643 3889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...... ......+||+.|+|||
T Consensus 170 ~a~~~~~~~--~~~~~~~gt~~y~aPE 194 (353)
T 3txo_A 170 MCKEGICNG--VTTATFCGTPDYIAPE 194 (353)
T ss_dssp TCBCSCC-----------CCGGGCCHH
T ss_pred ceeecccCC--ccccccCCCcCeEChh
Confidence 997643222 1235678999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=249.97 Aligned_cols=167 Identities=28% Similarity=0.421 Sum_probs=145.7
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
+.+.|.+.+.||+|+||.||+|..+ ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999976 789999999864332 24678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----c
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~----~ 212 (246)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 999999999999999996543 3889999999999999999999997 99999999999998776 7
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++...... .....+||+.|+|||
T Consensus 158 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 188 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE 188 (361)
T ss_dssp EEECCCSSCEECCTTC---CCCCCCSCGGGCCHH
T ss_pred EEEEecCCceEcCCCC---ccccCCCCccEECch
Confidence 9999999997654322 124568999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=252.80 Aligned_cols=166 Identities=23% Similarity=0.364 Sum_probs=146.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||++..+ +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 368999999999999999999976 7889999998532 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence 99999999999997543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++...... .....+||+.|+|||
T Consensus 162 a~~~~~~~---~~~~~~gt~~Y~aPE 184 (384)
T 4fr4_A 162 AAMLPRET---QITTMAGTKPYMAPE 184 (384)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCGG
T ss_pred eeeccCCC---ceeccCCCccccCCe
Confidence 97654322 235678999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=253.79 Aligned_cols=167 Identities=23% Similarity=0.323 Sum_probs=143.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||+||+|+.+ +++.+|+|.+.+... ....+..|..++.++ +||||+++++++.+....|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999977 688899999864322 234577889998876 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 131 V~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEcCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecc
Confidence 999999999999987543 3889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...... ......+||+.|+|||
T Consensus 199 la~~~~~~~--~~~~~~~gt~~Y~aPE 223 (396)
T 4dc2_A 199 MCKEGLRPG--DTTSTFCGTPNYIAPE 223 (396)
T ss_dssp TCBCCCCTT--CCBCCCCBCGGGCCHH
T ss_pred eeeecccCC--CccccccCCcccCCch
Confidence 997632221 1235678999999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=245.59 Aligned_cols=167 Identities=20% Similarity=0.246 Sum_probs=146.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||.||+|..+ ++..+|+|.+.........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468999999999999999999976 6889999998765555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCceEEccccCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLSN 222 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~--~~~~kl~Dfgls~ 222 (246)
++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 84 ~g~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 84 SGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp CCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred CCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 9999999996542 13889999999999999999999997 999999999999987 7899999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....||+.|+|||
T Consensus 153 ~~~~~~~---~~~~~gt~~y~aPE 173 (321)
T 1tki_A 153 QLKPGDN---FRLLFTAPEYYAPE 173 (321)
T ss_dssp ECCTTCE---EEEEESCGGGSCHH
T ss_pred ECCCCCc---cccccCChhhcCcH
Confidence 6543221 23457999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=245.71 Aligned_cols=164 Identities=28% Similarity=0.408 Sum_probs=145.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||.||+++.+ +++.+|+|.+.+. ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 368999999999999999999976 7899999998543 23456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 99999999999997643 3888999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++..... ....+||+.|+|||
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE 173 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPE 173 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHH
T ss_pred ceecCCc-----cccccCCccccCHh
Confidence 9764321 24568999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=249.32 Aligned_cols=169 Identities=25% Similarity=0.369 Sum_probs=145.6
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCee
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 137 (246)
...++|.+.+.||+|+||.||+|+.+ +++.||+|.+.+. ....+.+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34579999999999999999999986 7889999998643 33456778899998876 899999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~D 161 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIAD 161 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeE
Confidence 99999999999999997543 3889999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+++....... .....+||+.|+|||
T Consensus 162 FG~a~~~~~~~~--~~~~~~gt~~y~aPE 188 (345)
T 1xjd_A 162 FGMCKENMLGDA--KTNTFCGTPDYIAPE 188 (345)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHH
T ss_pred ChhhhhcccCCC--cccCCCCCcccCChh
Confidence 999976432211 235678999999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=247.34 Aligned_cols=176 Identities=40% Similarity=0.726 Sum_probs=149.9
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
....++|...+.||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 345679999999999999999999988899999999875543 3567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 115 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDL-----PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp ECCTTCBTGGGSSSSCC-----CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EcCCCCcHHHHHhccCC-----CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999865431 1224889999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+...............||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE 211 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPE 211 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHH
T ss_pred cccccccccccccccCCCccccCHH
Confidence 7543322222224456999999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=247.21 Aligned_cols=169 Identities=29% Similarity=0.431 Sum_probs=144.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|++.+.||+|+||.||+|..+ +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 789999999854432 24568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 153 (323)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccc
Confidence 999999999986543 3889999999999999999999997 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..............+||+.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE 177 (323)
T 3tki_A 154 VFRYNNRERLLNKMCGTLPYVAPE 177 (323)
T ss_dssp ECEETTEECCBCSCCSCGGGSCHH
T ss_pred eeccCCcccccCCCccCcCccCcH
Confidence 654322222234568999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.67 Aligned_cols=170 Identities=21% Similarity=0.241 Sum_probs=145.6
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
..++|.+.+.||+|+||+||+++.+ +++.||+|.+.+.. ...+.+.+|..++..++||||+++++++.+.+..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3578999999999999999999986 79999999985421 122347789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 139 VmE~~~gg~L~~~l~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFG--------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp EECCCCSCBHHHHHHHHS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEcCCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 999999999999997532 13889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++....... ......+||+.|+|||
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE 233 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPE 233 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHH
T ss_pred hheeccCCCc-cccceeccccCcCCHH
Confidence 9976543221 1223568999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=240.96 Aligned_cols=169 Identities=27% Similarity=0.473 Sum_probs=143.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
++|.+.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888999999999999999976 78899999885433 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 90 KGGTLRGIIKSMD--------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTCBHHHHHHHCC--------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999997643 13889999999999999999999997 999999999999999999999999998764
Q ss_pred Ccccccc------------ccccccccccccCCC
Q 025893 225 PDMAARL------------HSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~------------~~~~~~gt~~y~aPE 246 (246)
....... .....+||+.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192 (310)
T ss_dssp C--------------------CCCCSCGGGCCHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHH
Confidence 3322110 112567999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.34 Aligned_cols=173 Identities=24% Similarity=0.402 Sum_probs=141.9
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
+.++|++.+.||+|+||.||+|+.+ +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999987 899999999864432 3467899999999999999999999986654
Q ss_pred ---------------------------------------------------eeEEEEecCCCCCHHHHhccCCCCCCCCC
Q 025893 136 ---------------------------------------------------SRVLAYEFASNGSLHDILHGRKGVKGAQP 164 (246)
Q Consensus 136 ---------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~ 164 (246)
..++||||+++++|.+++......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----- 158 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----- 158 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-----
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-----
Confidence 379999999999999999765421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccc----------cccc
Q 025893 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR----------LHST 234 (246)
Q Consensus 165 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~----------~~~~ 234 (246)
....+..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ....
T Consensus 159 -~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 -EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp -GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred -cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 23566778899999999999999997 999999999999999999999999998765432211 1123
Q ss_pred cccccccccCCC
Q 025893 235 RVLGTFGYHAPE 246 (246)
Q Consensus 235 ~~~gt~~y~aPE 246 (246)
..+||+.|+|||
T Consensus 235 ~~~gt~~y~aPE 246 (332)
T 3qd2_B 235 GQVGTKLYMSPE 246 (332)
T ss_dssp SCC-CGGGSCHH
T ss_pred ccCCCcCccChH
Confidence 457999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=240.79 Aligned_cols=177 Identities=29% Similarity=0.425 Sum_probs=150.6
Q ss_pred cccCHHHHHHHHhc----------CCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCC
Q 025893 55 PAISVDELKEITEN----------FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHE 122 (246)
Q Consensus 55 ~~~~~~~~~~~~~~----------~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp 122 (246)
+.++.++++..++. |...+.||+|+||.||+|..+ +|+.||||.+.... ...+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45667777666543 666778999999999999987 79999999986544 3457788999999999999
Q ss_pred CccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 123 ~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 169 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS 169 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 9999999999999999999999999999998643 3889999999999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++.++.+||+|||++........ ......||+.|+|||
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE 211 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPE 211 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHh
Confidence 999999999999999999876543221 124567999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=243.90 Aligned_cols=187 Identities=37% Similarity=0.689 Sum_probs=157.3
Q ss_pred ccccCHHHHHHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEE
Q 025893 54 VPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYC 131 (246)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~ 131 (246)
...++..++....++|.+.+.||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788888888999999999999999999999987899999999875432 234688999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 132 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
......++||||+++|+|.+++...... ...+++..+..++.|++.||.|||++..+.|+||||||+|||++.++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 9999999999999999999999765421 23488999999999999999999998222399999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||++......... ......||+.|+|||
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE 205 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPE 205 (326)
T ss_dssp CEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHH
T ss_pred CEEeccCccccccCccccc-ccccccCCcCccCHH
Confidence 9999999999765332221 223456999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=247.57 Aligned_cols=167 Identities=34% Similarity=0.442 Sum_probs=142.4
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe----eEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----RVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----~~lv~ 141 (246)
.++|++.+.||+|+||.||+|.+. ++.||+|.+............|+.++++++||||+++++++..... .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 358999999999999999999876 7899999996554444556678999999999999999999987543 69999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeeeCCCCCCCeEecCCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK----------ADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------~~~~ivHrdlkp~Nil~~~~~ 211 (246)
||+++|+|.+++.... +++..+..++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 102 e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 102 AFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred ecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence 9999999999997642 88999999999999999999998 6 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+++...............||+.|+|||
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE 203 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHH
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHh
Confidence 99999999996544332222234467999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=245.74 Aligned_cols=168 Identities=24% Similarity=0.412 Sum_probs=145.8
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+.++|.+.+.||+|+||.||+|..+ ++..+|+|.+...... .+.+.+|+.++++++||||+++++++.+....|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678999999999999999999976 7899999999755443 3567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CceEEc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIA 216 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~---~~~kl~ 216 (246)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 106 v~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence 999999999999986543 3889999999999999999999997 9999999999999864 459999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++........ ....+||+.|+|||
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE 200 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPE 200 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHH
T ss_pred ecCcceEecCCcc---cccCCCCccccCHH
Confidence 9999976543221 24568999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=246.43 Aligned_cols=167 Identities=23% Similarity=0.331 Sum_probs=144.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||.||+++.+ +++.+|+|.+.+.... .+.+..|..++.++ +||||+++++++.+....|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 358999999999999999999986 7889999998654322 24577899999887 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 v~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999987543 3889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++....... .....+||+.|+|||
T Consensus 156 ~a~~~~~~~~--~~~~~~gt~~y~aPE 180 (345)
T 3a8x_A 156 MCKEGLRPGD--TTSTFCGTPNYIAPE 180 (345)
T ss_dssp GCBCSCCTTC--CBCCCCSCGGGCCHH
T ss_pred ccccccCCCC--cccccCCCccccCcc
Confidence 9976332211 235678999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=247.54 Aligned_cols=164 Identities=26% Similarity=0.326 Sum_probs=145.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+++.+ +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999976 7899999998543 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccc
Confidence 99999999999997543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++..... ....+||+.|+|||
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE 208 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPE 208 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHH
T ss_pred ceeccCC-----cccccCCccccCHH
Confidence 9764321 24568999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=247.92 Aligned_cols=166 Identities=25% Similarity=0.322 Sum_probs=138.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||.||+++.+ +++.||+|.+.......+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 358999999999999999999987 7899999999776666688999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--eEEccccCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIADFDLSN 222 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~--~kl~Dfgls~ 222 (246)
++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 99 ~~~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 99 SGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp CSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 9999999986543 3889999999999999999999997 999999999999987665 9999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .....+||+.|+|||
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE 187 (361)
T 3uc3_A 167 SSVLHS---QPKSTVGTPAYIAPE 187 (361)
T ss_dssp -----------------CTTSCHH
T ss_pred cccccC---CCCCCcCCCCcCChh
Confidence 533222 124567999999998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=241.67 Aligned_cols=167 Identities=25% Similarity=0.405 Sum_probs=145.3
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
+.+.|.+.+.||+|+||.||+|..+ ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4568999999999999999999976 789999998854321 35778999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----c
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~----~ 212 (246)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence 999999999999999996543 3889999999999999999999997 99999999999999877 8
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++...... .....+||+.|+|||
T Consensus 157 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 187 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPE 187 (326)
T ss_dssp EEECCCTTCEECCTTS---CCCCCCSCTTTCCHH
T ss_pred EEEEECCCCeECCCCC---ccccccCCcCcCCce
Confidence 9999999987653222 124567999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=246.84 Aligned_cols=167 Identities=25% Similarity=0.297 Sum_probs=145.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||+||+|+.+ +++.||+|.+.+. ....+.+..|..++..+ +||||+++++++.+....|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 568999999999999999999987 5788999998643 23456788899999988 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCC
Confidence 999999999999997543 3889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++....... .....+||+.|+|||
T Consensus 167 ~a~~~~~~~~--~~~~~~gt~~y~aPE 191 (353)
T 2i0e_A 167 MCKENIWDGV--TTKTFCGTPDYIAPE 191 (353)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHH
T ss_pred cccccccCCc--ccccccCCccccChh
Confidence 9976432211 235678999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=238.62 Aligned_cols=168 Identities=25% Similarity=0.388 Sum_probs=140.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|... ++..+|+|.+...... .+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999976 7889999998543322 25678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999997543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... .......||+.|+|||
T Consensus 158 ~~~~~~~~~-~~~~~~~gt~~y~aPE 182 (294)
T 4eqm_A 158 AKALSETSL-TQTNHVLGTVQYFSPE 182 (294)
T ss_dssp STTC--------------CCSSCCHH
T ss_pred ccccccccc-cccCccccCccccCHh
Confidence 987543221 1224467999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=250.47 Aligned_cols=169 Identities=21% Similarity=0.329 Sum_probs=144.8
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+.++|.+.+.||+|+||.||+|..+ +++.+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45689999999999999999999976 7889999998655432 3467899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCceEEc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIA 216 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~---~~~~~kl~ 216 (246)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 88 v~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 999999999999987653 3889999999999999999999997 99999999999998 45789999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++........ .....+||+.|+|||
T Consensus 156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE 183 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPE 183 (444)
T ss_dssp CCSSCBCCCTTCC--BCCCSCSCGGGCCHH
T ss_pred cCceeEEecCCCc--eeecccCCcccCCHH
Confidence 9999976543221 124568999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=235.36 Aligned_cols=168 Identities=27% Similarity=0.509 Sum_probs=148.0
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 57888999999999999999988888999999987777788899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 90 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp CBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999965432 3889999999999999999999997 99999999999999999999999999876443
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......||+.|+|||
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE 177 (269)
T 4hcu_A 159 DQYT-SSTGTKFPVKWASPE 177 (269)
T ss_dssp HHHH-STTSTTCCGGGCCHH
T ss_pred cccc-cccCcccccccCCHH
Confidence 2211 223445788999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=242.00 Aligned_cols=167 Identities=26% Similarity=0.370 Sum_probs=136.2
Q ss_pred HhcCCCCceeccCCceEEEEEEE----CCCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+++. .+++.+|+|.+.... .....+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 378899999987542 223457789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 999999999999999987543 3788899999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++....... .....+||+.|+|||
T Consensus 164 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE 191 (327)
T 3a62_A 164 DFGLCKESIHDGT--VTHTFCGTIEYMAPE 191 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHH
T ss_pred eCCcccccccCCc--cccccCCCcCccCHh
Confidence 9999875432221 224568999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=245.43 Aligned_cols=178 Identities=27% Similarity=0.471 Sum_probs=144.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468889999999999999999852 3456999998755332 35788999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
+..|+||||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997653210 0011234789999999999999999999997 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............||+.|+|||
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 275 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 275 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence 999999999999997554332222223456789999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=246.36 Aligned_cols=172 Identities=23% Similarity=0.276 Sum_probs=142.7
Q ss_pred HhcCCCCceeccCCceEEEEEE------ECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGI------LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~------~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+|. ..+++.||+|.+... ...++..|+.++++++ |+||+++++++...+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 4678889999999999999994 346889999998643 4567888888888887 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-------
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD------- 209 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~------- 209 (246)
.++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 99999999999999999743211 1124899999999999999999999997 999999999999998
Q ss_pred ----CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 ----DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ----~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||+++..............+||+.|+|||
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 255 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHH
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChH
Confidence 8999999999996543222222235568999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=243.04 Aligned_cols=165 Identities=27% Similarity=0.401 Sum_probs=143.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+... ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 358999999999999999999975 7899999998532 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+ +|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 88 ~E~~-~g~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred EECC-CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecc
Confidence 9999 789999886543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .....+||+.|+|||
T Consensus 155 s~~~~~~~---~~~~~~gt~~y~aPE 177 (336)
T 3h4j_B 155 SNIMTDGN---FLKTSCGSPNYAAPE 177 (336)
T ss_dssp TBTTTTSB---TTCCCTTSTTTSCGG
T ss_pred ceeccCCc---ccccccCCcCcCCHH
Confidence 98654322 224568999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=238.86 Aligned_cols=166 Identities=33% Similarity=0.457 Sum_probs=137.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------------------------CHHHHHHHHHHHh
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------------------------PDEEFLAQVSMVS 117 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---------------------------~~~~~~~e~~~l~ 117 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999976 788999999854321 1245789999999
Q ss_pred cCCCCCccceEeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 025893 118 RLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195 (246)
Q Consensus 118 ~l~hp~iv~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 195 (246)
+++||||+++++++.+ ....++||||+++++|.+++... .+++..+..++.|++.||.|||+++ |
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQK---I 158 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 9999999999999987 56889999999999997765322 3889999999999999999999997 9
Q ss_pred eeCCCCCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 196 vHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||||||+|||++.++.+||+|||+++....... ......||+.|+|||
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE 207 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPE 207 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGG
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChh
Confidence 9999999999999999999999999876543221 123467999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=242.19 Aligned_cols=172 Identities=25% Similarity=0.355 Sum_probs=144.4
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC------CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS------KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
+.+.|.+.+.||+|+||.||+|..+ +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4568999999999999999999976 7899999988421 23467899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---ceE
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAK 214 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~---~~k 214 (246)
|+||||+++++|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD-----AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEE
T ss_pred EEEEeCCCCCCHHHHHHHhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEE
Confidence 999999999999888754321 0123789999999999999999999997 99999999999998655 499
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||++........ .....+||+.|+|||
T Consensus 174 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE 203 (351)
T 3c0i_A 174 LGGFGVAIQLGESGL--VAGGRVGTPHFMAPE 203 (351)
T ss_dssp ECCCTTCEECCTTSC--BCCCCCSCGGGCCHH
T ss_pred EecCcceeEecCCCe--eecCCcCCcCccCHH
Confidence 999999976543221 124567999999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=256.53 Aligned_cols=168 Identities=24% Similarity=0.359 Sum_probs=146.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+.+. ......+.+|+.++++++||||+++++++.+....|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 357888999999999999999986 7999999998542 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||++||+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 263 mEy~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-------AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEcCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence 999999999999875431 23889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... ....+||+.|+|||
T Consensus 333 a~~~~~~~~---~~~~~GT~~Y~APE 355 (576)
T 2acx_A 333 AVHVPEGQT---IKGRVGTVGYMAPE 355 (576)
T ss_dssp CEECCTTCC---EECCCSCGGGCCHH
T ss_pred ceecccCcc---ccccCCCccccCHH
Confidence 976543221 23468999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=247.27 Aligned_cols=167 Identities=23% Similarity=0.340 Sum_probs=136.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHHHHHH-HhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|++.+.||+|+||+||+++.+ ++..+|+|.+.+.. .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999987 68899999986442 223455667666 577899999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 117 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence 999999999999987543 3788899999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++..... .......+||+.|+|||
T Consensus 185 ~a~~~~~~--~~~~~~~~gt~~y~aPE 209 (373)
T 2r5t_A 185 LCKENIEH--NSTTSTFCGTPEYLAPE 209 (373)
T ss_dssp BCGGGBCC--CCCCCSBSCCCCCCCHH
T ss_pred cccccccC--CCccccccCCccccCHH
Confidence 98753221 11235678999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=233.98 Aligned_cols=184 Identities=41% Similarity=0.694 Sum_probs=155.6
Q ss_pred cccccCHHHHHHHHhcCCCC------ceeccCCceEEEEEEECCCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcCCC
Q 025893 53 EVPAISVDELKEITENFGTN------ALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKH 121 (246)
Q Consensus 53 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l~h 121 (246)
..+.++..++..++++|... +.||+|+||.||+|.. ++..+|+|.+.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678899999999998877 8999999999999986 47899999986432 124678899999999999
Q ss_pred CCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC
Q 025893 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (246)
Q Consensus 122 p~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk 201 (246)
|||+++++++.+....++||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+|||||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk 160 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK 160 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG------CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 9999999999999999999999999999999864321 124889999999999999999999997 9999999
Q ss_pred CCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 202 p~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+||+++.++.+||+|||++................||+.|+|||
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE 205 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHH
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChH
Confidence 999999999999999999987544322222234567999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=251.65 Aligned_cols=167 Identities=26% Similarity=0.352 Sum_probs=136.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999976 7899999998632 23345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 227 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EeeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCC
Confidence 99999999999986543 38899999999999999999998 76 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++....... .....+||+.|+|||
T Consensus 295 ~a~~~~~~~~--~~~~~~gt~~y~aPE 319 (446)
T 4ejn_A 295 LCKEGIKDGA--TMKTFCGTPEYLAPE 319 (446)
T ss_dssp CCCTTCC-------CCSSSCGGGCCHH
T ss_pred CceeccCCCc--ccccccCCccccCHh
Confidence 9986433222 234578999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=238.04 Aligned_cols=168 Identities=27% Similarity=0.414 Sum_probs=141.5
Q ss_pred HHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.++|++.+.||+|+||.||+|...+++.||+|.+...... ...+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999999988999999998654332 357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 99 e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp ECCSE-EHHHHHHTCT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCCCC-CHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCc
Confidence 99975 8888876543 23889999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ......||+.|+|||
T Consensus 167 ~~~~~~~~--~~~~~~~t~~y~aPE 189 (311)
T 3niz_A 167 RAFGIPVR--SYTHEVVTLWYRAPD 189 (311)
T ss_dssp EETTSCCC-----CCCCCCTTCCHH
T ss_pred eecCCCcc--cccCCcccCCcCCHH
Confidence 76432211 123457899999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=234.17 Aligned_cols=166 Identities=23% Similarity=0.384 Sum_probs=140.8
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|++.+.||+|+||.||+|..+ +++.||+|.+...... ...+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999976 7889999998654332 3678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+.+ ++.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~-~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSE-EHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCC-CHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9975 6666664432 13889999999999999999999997 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......||+.|+|||
T Consensus 150 ~~~~~~~--~~~~~~~t~~y~aPE 171 (292)
T 3o0g_A 150 AFGIPVR--CYSAEVVTLWYRPPD 171 (292)
T ss_dssp ECCSCCS--CCCSCCSCGGGCCHH
T ss_pred ecCCccc--cccCCccccCCcChH
Confidence 6432211 123457899999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=232.15 Aligned_cols=169 Identities=24% Similarity=0.397 Sum_probs=147.7
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|.+.+.||+|+||.||+|..+++..||+|.+.......+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 46888999999999999999998888889999998777777889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 87 NGCLLNYLRSHG--------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp TCBHHHHHHHHG--------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecc
Confidence 999999997543 13889999999999999999999997 9999999999999999999999999987544
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......+|+.|+|||
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE 175 (268)
T 3sxs_A 156 DDQYV-SSVGTKFPVKWSAPE 175 (268)
T ss_dssp TTCEE-ECCSCCCCGGGCCHH
T ss_pred hhhhh-cccCCCcCcccCCHH
Confidence 32221 123345778899998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=249.71 Aligned_cols=168 Identities=26% Similarity=0.390 Sum_probs=130.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC-----Ce
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 136 (246)
.++|.+.+.||+|+||.||+|..+ +++.||||++...... .+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999976 7899999998654433 35688999999999999999999998543 56
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecc-ccchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence 89999998 579999987543 3889999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccc-------------------------cccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAAR-------------------------LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE 246 (246)
|||+++........ ......+||+.|+|||
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 99999865422110 1124467899999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=250.87 Aligned_cols=166 Identities=26% Similarity=0.412 Sum_probs=145.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+... ......+.+|+.+++.++||||+++++++......++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 358899999999999999999986 8999999998543 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp EECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccc
Confidence 99999999999996543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .....+||+.|+|||
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE 185 (476)
T 2y94_A 163 SNMMSDGE---FLRTSCGSPNYAAPE 185 (476)
T ss_dssp CEECCTTC---CBCCCCSCSTTCCHH
T ss_pred hhhccccc---cccccCCCcCeEChh
Confidence 87654322 124568999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=233.47 Aligned_cols=169 Identities=27% Similarity=0.460 Sum_probs=145.2
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|.+.+.||+|+||.||++.++++..||+|.+.......+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 46888999999999999999999888899999998777778889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 103 ~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 103 NGCLLNYLREMR--------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp TCBHHHHHHCGG--------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999997532 13889999999999999999999997 9999999999999999999999999987543
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......+|+.|+|||
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE 191 (283)
T 3gen_A 172 DDEYT-SSVGSKFPVRWSPPE 191 (283)
T ss_dssp CHHHH-STTSTTSCGGGCCHH
T ss_pred ccccc-cccCCccCcccCCHH
Confidence 32211 123345788999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=252.76 Aligned_cols=170 Identities=24% Similarity=0.351 Sum_probs=146.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|...+.||+|+||.||+|+.+ +++.||+|.+.+. ......+..|+.++++++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999986 7999999998543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||++||+|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 265 E~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence 999999999998754311 124889999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .....+||+.|+|||
T Consensus 337 ~~~~~~~~--~~~~~~GT~~Y~APE 359 (543)
T 3c4z_A 337 VELKAGQT--KTKGYAGTPGFMAPE 359 (543)
T ss_dssp EECCTTCC--CBCCCCSCTTTSCHH
T ss_pred eeccCCCc--ccccccCCccccChh
Confidence 76543221 124468999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=236.11 Aligned_cols=169 Identities=25% Similarity=0.400 Sum_probs=144.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC--eeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 140 (246)
.+.|.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357899999999999999999976 68999999986433 34577889999999999999999999998765 77999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCceEEc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIA 216 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~----~~~~~~kl~ 216 (246)
|||+++++|.+++...... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +..+.+||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEc
Confidence 9999999999999764321 13889999999999999999999997 9999999999999 777889999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++....... .....||+.|+|||
T Consensus 159 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 185 (319)
T 4euu_A 159 DFGAARELEDDEQ---FVSLYGTEEYLHPD 185 (319)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred cCCCceecCCCCc---eeecccCCCccCHH
Confidence 9999976543222 23467999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=245.54 Aligned_cols=170 Identities=27% Similarity=0.478 Sum_probs=142.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||+|.++ ++..||+|.+...... .+.+.+|+.++++++||||+++++++......++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999987 7899999998654322 2457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 193 ~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999975421 3788999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...............+|+.|+|||
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE 285 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPE 285 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHH
T ss_pred ecCCCceeecCCCCCCCcCcCCHh
Confidence 543222111112234678899998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=251.39 Aligned_cols=170 Identities=29% Similarity=0.458 Sum_probs=147.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||.||+|.++ ++..||+|.+.......+.+.+|+.+|++++||||+++++++......++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 467888899999999999999987 5889999999877777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 299 ~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 299 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp TTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999975432 23889999999999999999999997 999999999999999999999999999865
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+|+.|+|||
T Consensus 369 ~~~~~~-~~~~~~~~~~y~aPE 389 (495)
T 1opk_A 369 TGDTYT-AHAGAKFPIKWTAPE 389 (495)
T ss_dssp TTCCEE-CCTTCCCCGGGCCHH
T ss_pred cCCcee-ecCCCcCCcceeCHh
Confidence 432211 122345678999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.06 Aligned_cols=160 Identities=23% Similarity=0.267 Sum_probs=133.2
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCC---------CCHHHHHHHHHHHhcCC---------CCCccce
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---------QPDEEFLAQVSMVSRLK---------HENFVQL 127 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~---------~~~~~~~~e~~~l~~l~---------hp~iv~~ 127 (246)
.++|.+.+.||+|+||+||+|+. +++.||+|.+.... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 68999999986432 12377889999988885 7888877
Q ss_pred EeEEE------------------------------eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHH
Q 025893 128 LGYCV------------------------------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177 (246)
Q Consensus 128 ~~~~~------------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~ 177 (246)
.+.+. .....|+||||+++|++.+.+... .+++..+..++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHH
Confidence 77643 267899999999999776666432 37899999999
Q ss_pred HHHHHHHHHHh-hCCCCCeeeCCCCCCCeEecCCC--------------------ceEEccccCCCCCCccccccccccc
Q 025893 178 VGAAKGLEYLH-EKADPHIIHRDIKSSNVLIFDDD--------------------VAKIADFDLSNQAPDMAARLHSTRV 236 (246)
Q Consensus 178 ~~i~~~l~~lH-~~~~~~ivHrdlkp~Nil~~~~~--------------------~~kl~Dfgls~~~~~~~~~~~~~~~ 236 (246)
.||+.||.||| +++ |+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 168 ~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~ 237 (336)
T 2vuw_A 168 HQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred HHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence 99999999999 886 99999999999999887 899999999975432 235
Q ss_pred cccccccCCC
Q 025893 237 LGTFGYHAPE 246 (246)
Q Consensus 237 ~gt~~y~aPE 246 (246)
+||+.|+|||
T Consensus 238 ~gt~~y~aPE 247 (336)
T 2vuw_A 238 VFCDVSMDED 247 (336)
T ss_dssp ECCCCTTCSG
T ss_pred EEeecccChh
Confidence 7999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=242.72 Aligned_cols=186 Identities=22% Similarity=0.360 Sum_probs=148.1
Q ss_pred CHHHHHHHHhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceE
Q 025893 58 SVDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLL 128 (246)
Q Consensus 58 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~ 128 (246)
+..++....++|.+.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34444555789999999999999999999832 4578999999754432 35688999999999 689999999
Q ss_pred eEEEeCCe-eEEEEecCCCCCHHHHhccCCCCCC----------------------------------------------
Q 025893 129 GYCVDGTS-RVLAYEFASNGSLHDILHGRKGVKG---------------------------------------------- 161 (246)
Q Consensus 129 ~~~~~~~~-~~lv~E~~~~g~L~~~l~~~~~~~~---------------------------------------------- 161 (246)
+++...+. .++||||+++|+|.+++........
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 8999999999999999976532100
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccc
Q 025893 162 -----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (246)
Q Consensus 162 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~ 230 (246)
......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 000123889999999999999999999997 999999999999999999999999999865433332
Q ss_pred cccccccccccccCCC
Q 025893 231 LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 231 ~~~~~~~gt~~y~aPE 246 (246)
.......||+.|+|||
T Consensus 250 ~~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPE 265 (359)
T ss_dssp EEC--CEECGGGCCHH
T ss_pred hhccccCCCceeEChh
Confidence 2334567899999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=243.61 Aligned_cols=174 Identities=21% Similarity=0.287 Sum_probs=147.5
Q ss_pred cCHHHHHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-----CCCccceEeE
Q 025893 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENFVQLLGY 130 (246)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-----hp~iv~~~~~ 130 (246)
+++.+...+.++|.+.+.||+|+||.||+|... +++.||+|.+.........+..|+.+++.++ ||||++++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 344444455679999999999999999999975 7889999999755444567788999999987 9999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-
Q 025893 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD- 209 (246)
Q Consensus 131 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~- 209 (246)
+...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNY-------NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 99999999999999 8999999976432 13888999999999999999999997 999999999999975
Q ss_pred ------------------------CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 ------------------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ------------------------~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||+++..... .....||+.|+|||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE 229 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPE 229 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcH
Confidence 788999999998754321 24567999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.01 Aligned_cols=170 Identities=29% Similarity=0.477 Sum_probs=140.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-C---CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~---~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||.||+|.+. + +..||+|.+...... .+.+.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999975 3 345999999754332 3578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 128 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EeeCCCCCcHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999996543 13889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccc-cccccccccccccCCC
Q 025893 220 LSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
+++........ .......+|+.|+|||
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE 224 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPE 224 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHH
T ss_pred cccccccCccceeeccCCCCcccccCHh
Confidence 99765432211 1112335688999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=242.23 Aligned_cols=167 Identities=25% Similarity=0.351 Sum_probs=143.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.+.|.+.+.||+|+||.||+|..+ +++.+|+|.+..... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 568999999999999999999976 788999999865432 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCceEEccccCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLS 221 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~--~~~~kl~Dfgls 221 (246)
+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++
T Consensus 130 ~~gg~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 130 LSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp CCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccc
Confidence 99999999986532 13889999999999999999999997 999999999999984 468999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ....+||+.|+|||
T Consensus 199 ~~~~~~~~---~~~~~gt~~y~aPE 220 (387)
T 1kob_A 199 TKLNPDEI---VKVTTATAEFAAPE 220 (387)
T ss_dssp EECCTTSC---EEEECSSGGGCCHH
T ss_pred eecCCCcc---eeeeccCCCccCch
Confidence 76543221 23457999999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=240.20 Aligned_cols=166 Identities=29% Similarity=0.406 Sum_probs=129.6
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+.+.|.+.+.||+|+||.||+|..+ +++.||+|.+.... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4578999999999999999999987 68899999986443 345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEEccccC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDL 220 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl~Dfgl 220 (246)
+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 130 ~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 130 VTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp CCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred CCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999986543 3789999999999999999999997 999999999999975 78999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++...... .....+||+.|+|||
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE 220 (349)
T 2w4o_A 198 SKIVEHQV---LMKTVCGTPGYCAPE 220 (349)
T ss_dssp ------------------CGGGSCHH
T ss_pred ccccCccc---ccccccCCCCccCHH
Confidence 98654321 124567999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=240.09 Aligned_cols=168 Identities=25% Similarity=0.350 Sum_probs=145.0
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------CHHHHHHHHHHHhcCCCCCccceEeEEEe
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCVD 133 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 133 (246)
.+.++|.+.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45679999999999999999999975 788999999865432 22356789999999999999999999999
Q ss_pred CCeeEEEEecCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 134 GTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 134 ~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
.+..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 99999999999766 9999997543 3889999999999999999999997 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||++........ ....+||+.|+|||
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 199 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPE 199 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHH
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChh
Confidence 99999999876543221 23467999999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=249.30 Aligned_cols=170 Identities=25% Similarity=0.436 Sum_probs=145.7
Q ss_pred HHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
..++|.+.+.||+|+||.||+|.++.+..||||.+.......+.+.+|+.++++++||||+++++++. ....++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35688889999999999999999988889999999877677889999999999999999999999986 66789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 265 ~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp TTCBHHHHHHSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999975321 12778889999999999999999997 999999999999999999999999999765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+|+.|+|||
T Consensus 335 ~~~~~~-~~~~~~~~~~y~aPE 355 (454)
T 1qcf_A 335 EDNEYT-AREGAKFPIKWTAPE 355 (454)
T ss_dssp CCHHHH-TTCSSSSCGGGSCHH
T ss_pred CCCcee-ccCCCcccccccCHH
Confidence 432211 112345788999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=233.80 Aligned_cols=167 Identities=24% Similarity=0.277 Sum_probs=138.0
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
+.++|++.+.||+|+||+||+|..+ +++.||||++....... ..+..|+..+.++ +||||+++++++.+....++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4578999999999999999999987 79999999986554433 3344555555444 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 135 v~e~~-~~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG--------ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEECC-CCBHHHHHHHHC--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEecc-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence 99999 679998886543 23899999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... ......||+.|+|||
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE 226 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPE 226 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGG
T ss_pred eeeecccCC---CCcccCCCccccCHh
Confidence 987653322 224457999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=239.67 Aligned_cols=178 Identities=30% Similarity=0.471 Sum_probs=146.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
.++|.+.+.||+|+||.||+|... .+..||+|.+...... ...+.+|+.+++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999853 2346999998755332 35688999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
+..++||||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999997654211 0112235899999999999999999999997 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............||+.|+|||
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 263 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHH
Confidence 999999999999998765433222334456889999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=234.24 Aligned_cols=166 Identities=29% Similarity=0.421 Sum_probs=139.1
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|.+.+.||+|+||.||+|...+++.+|+|++..... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999998899999999865432 246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTST--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 975 9999886542 13788999999999999999999997 99999999999999999999999999864
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 150 ~~~~~~--~~~~~~~t~~y~aPE 170 (288)
T 1ob3_A 150 FGIPVR--KYTHEIVTLWYRAPD 170 (288)
T ss_dssp HCC-----------CCCTTCCHH
T ss_pred cCcccc--ccccccccccccCch
Confidence 321111 123457899999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=233.91 Aligned_cols=171 Identities=33% Similarity=0.500 Sum_probs=136.3
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||+|.. ++..||+|.+....... +.+.+|+.++++++||||+++++++......++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46899999999999999999987 47889999987655443 468899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++|+|.+++...... ..+++..++.++.|++.||.|||+++ ++|+||||||+|||++.++.+||+|||+++
T Consensus 115 ~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred cCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999754310 12788999999999999999999983 349999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... .......||+.|+|||
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aPE 209 (309)
T 3p86_A 188 LKASTF--LSSKSAAGTPEWMAPE 209 (309)
T ss_dssp ----------------CCTTSCHH
T ss_pred cccccc--cccccCCCCccccChh
Confidence 543221 1124567999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=248.27 Aligned_cols=167 Identities=31% Similarity=0.427 Sum_probs=142.5
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--------------CCHHHHHHHHHHHhcCCCCCccceEe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--------------QPDEEFLAQVSMVSRLKHENFVQLLG 129 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--------------~~~~~~~~e~~~l~~l~hp~iv~~~~ 129 (246)
+.+.|.+.+.||+|+||.||+|..+ ++..+|+|.+.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999976 68899999986432 23467889999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 025893 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 130 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~ 209 (246)
++.+....++|||||++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLEN 181 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEec
Confidence 9999999999999999999999886543 3889999999999999999999997 999999999999987
Q ss_pred CC---ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 DD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ~~---~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++ .+||+|||++....... .....+||+.|+|||
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 218 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE 218 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHH
T ss_pred CCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHH
Confidence 65 69999999997654322 124567999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=240.11 Aligned_cols=170 Identities=27% Similarity=0.466 Sum_probs=133.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||.||+|+.+ ++..||+|.+..... ..+.+.+|+.++++++||||+++++++......++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999865 467799999875433 23578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 124 v~e~~~~~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCc
Confidence 999999999999997543 23889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCcccccc-ccccccccccccCCC
Q 025893 220 LSNQAPDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
+++......... ......+|+.|+|||
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE 220 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPE 220 (373)
T ss_dssp ---------------------CTTSCHH
T ss_pred cccccccCCccceeccCCCcCCCccChh
Confidence 998754322111 112234578899998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=240.70 Aligned_cols=169 Identities=27% Similarity=0.450 Sum_probs=132.5
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCC-CCCccceEeEEEeCC--e
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGT--S 136 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~--~ 136 (246)
.+.++|.+.+.||+|+||.||+|..+ +++.||+|++...... ...+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45689999999999999999999976 7899999998654333 346778999999998 999999999998654 6
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.|+||||+. ++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEecccC-cCHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence 899999997 5999998753 2888999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccc-------------------cccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMA-------------------ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~-------------------~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...... ........+||+.|+|||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE 200 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHH
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHH
Confidence 999997542210 011123468999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=237.19 Aligned_cols=169 Identities=22% Similarity=0.385 Sum_probs=135.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCe----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS---- 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~---- 136 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999975 7889999999765432 2467889999999999999999999876544
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 158 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 158 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEEC
T ss_pred cEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEe
Confidence 399999999999999997543 3889999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccc-cccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
|||++......... .......||+.|+|||
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 189 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189 (311)
T ss_dssp CCSCC------------------CCTTCCHH
T ss_pred eccCcccccccccccccccccCcCcccCCHH
Confidence 99999765432211 1223457999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=233.64 Aligned_cols=172 Identities=26% Similarity=0.396 Sum_probs=130.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+.... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999976 78999999986443 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|++ ++|.+++....... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~-~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp CCC-CBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred ecC-CCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccce
Confidence 998 59999886542111 1124888999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......||+.|+|||
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE 178 (317)
T 2pmi_A 157 AFGIPVN--TFSSEVVTLWYRAPD 178 (317)
T ss_dssp ETTSCCC--CCCCCCSCCTTCCHH
T ss_pred ecCCCcc--cCCCCcccccccCch
Confidence 6432211 123457999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=247.58 Aligned_cols=167 Identities=29% Similarity=0.435 Sum_probs=141.2
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
+.+.|.+.+.||+|+||.||+|+.+ ++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4678999999999999999999986 78899999986542 3357789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEEcc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIAD 217 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl~D 217 (246)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 115 ~e~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 99999999999886543 3889999999999999999999997 999999999999976 45699999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++....... .....+||+.|+|||
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE 208 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPE 208 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHH
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHH
Confidence 99987654322 224567999999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=239.94 Aligned_cols=171 Identities=16% Similarity=0.232 Sum_probs=144.9
Q ss_pred HhcCCCCceeccC--CceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G--~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|++.+.||+| +||.||+|+.+ +++.||+|.+...... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999987 7999999998654433 2567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-------DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEccCCCCHHHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccc
Confidence 9999999999999976421 13889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCcccc-----ccccccccccccccCCC
Q 025893 220 LSNQAPDMAA-----RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~-----~~~~~~~~gt~~y~aPE 246 (246)
++........ .......+||+.|+|||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred cceeeccccccccccccccccccccccccCHH
Confidence 8754322111 11123347999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=228.41 Aligned_cols=168 Identities=24% Similarity=0.386 Sum_probs=146.2
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC-CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.+.++|.+.+.||+|+||.||+|..+ ++..+|+|++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 35678999999999999999999976 6778999998654 345678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCceEEccc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF 218 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~---~~~~~~kl~Df 218 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+||
T Consensus 86 e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp ECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 9999999999886543 3789999999999999999999997 9999999999999 77889999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|++....... ......||+.|+|||
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE 178 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQ 178 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHH
T ss_pred ccceeccCcc---chhccCCCCCccChH
Confidence 9987543322 124567999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=233.45 Aligned_cols=167 Identities=28% Similarity=0.428 Sum_probs=145.3
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
+.+.|.+.+.||+|+||.||+|..+ ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4578999999999999999999976 789999998854321 35778999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----c
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~----~ 212 (246)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999997543 3889999999999999999999997 99999999999999877 7
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||++....... ......||+.|+|||
T Consensus 158 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE 188 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE 188 (321)
T ss_dssp EEECCCTTCEECCTTC---CCCCCCSCGGGCCHH
T ss_pred EEEccCccceecCccc---cccccCCCCCccCcc
Confidence 9999999987654322 123457999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=243.59 Aligned_cols=168 Identities=25% Similarity=0.390 Sum_probs=135.1
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------CHHHHHHHHHHHhcCCCCCccceEeEEE
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCV 132 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 132 (246)
..+.++|.+.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456789999999999999999999976 789999999854321 1124788999999999999999999975
Q ss_pred eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC--
Q 025893 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-- 210 (246)
Q Consensus 133 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-- 210 (246)
....++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++..
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred -cCceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 456799999999999998886543 3889999999999999999999997 9999999999999754
Q ss_pred -CceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 211 -DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 -~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..+||+|||+++...... .....+||+.|+|||
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 311 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPE 311 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTT
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCce
Confidence 459999999998764322 224568999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=238.37 Aligned_cols=179 Identities=27% Similarity=0.424 Sum_probs=144.2
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
..++|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+.++++++||||+++++++.....
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3578999999999999999999974 3478999998754332 3568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk 201 (246)
.++||||+++|+|.+++........ ......+++..++.++.||+.||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999976431100 000135889999999999999999999997 9999999
Q ss_pred CCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 202 p~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||++.++.+||+|||+++...............||+.|+|||
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 246 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence 999999999999999999986543222212223456899999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=244.40 Aligned_cols=168 Identities=28% Similarity=0.424 Sum_probs=140.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC-----Ce
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 136 (246)
.++|.+.+.||+|+||.||+|..+ +++.||||++...... .+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 7889999999754433 35788999999999999999999999776 56
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEc
Confidence 899999996 59999997543 3889999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccc--------------------cccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAAR--------------------LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~--------------------~~~~~~~gt~~y~aPE 246 (246)
|||+++........ ......+||+.|+|||
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 221 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence 99999765432111 1124568999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=257.71 Aligned_cols=167 Identities=25% Similarity=0.297 Sum_probs=144.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||+||+|+.+ +++.||+|.+.+. ....+.+..|..++..+ +||+|+++++++.+...+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467899999999999999999976 7889999998642 23456788899999988 69999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 420 V~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecc
Confidence 999999999999997643 3889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++....... .....+||+.|+|||
T Consensus 488 la~~~~~~~~--~~~~~~GT~~Y~APE 512 (674)
T 3pfq_A 488 MCKENIWDGV--TTKTFCGTPDYIAPE 512 (674)
T ss_dssp TCEECCCTTC--CBCCCCSCSSSCCHH
T ss_pred eeeccccCCc--ccccccCCCcccCHh
Confidence 9975332221 235678999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=246.46 Aligned_cols=168 Identities=28% Similarity=0.443 Sum_probs=144.8
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCC---CCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~---~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+.++|.+.+.||+|+||.||+|..+ +++.||+|.+.. .......+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 35678999999999999999999976 789999999853 23456788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCceEEc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIA 216 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~---~~~~~kl~ 216 (246)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 99 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEE
Confidence 999999999999886543 3889999999999999999999997 99999999999996 45679999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...... .....+||+.|+|||
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 193 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPE 193 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGG
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHH
Confidence 999998654322 124567999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=243.35 Aligned_cols=176 Identities=26% Similarity=0.404 Sum_probs=143.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+...... ...+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468899999999999999999843 4668999998654332 34688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---ceE
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAK 214 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~---~~k 214 (246)
++||||+++|+|.+++....... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999997644211 11234889999999999999999999997 99999999999999554 599
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++...............||+.|+|||
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 256 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHH
Confidence 99999986432222222223456899999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=236.72 Aligned_cols=166 Identities=21% Similarity=0.380 Sum_probs=138.2
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCC--CCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~ 141 (246)
+.|.+.+.||+|+||.||++...+++.||+|.+....... +.+.+|+.++++++| |||+++++++......++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 5788999999999999999998889999999986554432 567899999999987 99999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|+ .+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 89 e~-~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp CC-CSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred eC-CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccc
Confidence 94 5789999997643 3788999999999999999999997 99999999999997 678999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..............+||+.|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE 179 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPE 179 (343)
T ss_dssp CCC------------CCCCSSCCHH
T ss_pred cccCcccccccCCCCcCCcCcCCHH
Confidence 8765433322234567999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=234.23 Aligned_cols=164 Identities=24% Similarity=0.352 Sum_probs=126.7
Q ss_pred hcCCC---CceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGT---NALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~---~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++ .+.||+|+||.||+|..+ +++.||+|.+... ....+.+|+.+++.+. ||||+++++++.+....++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 34544 378999999999999976 7899999998532 3467788999999997 999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---ceEEccc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADF 218 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~---~~kl~Df 218 (246)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 86 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 86 ELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp CCCCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCC
T ss_pred EccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecc
Confidence 9999999999997643 3889999999999999999999997 99999999999998665 8999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++....... .....+||+.|+|||
T Consensus 154 g~a~~~~~~~~--~~~~~~~t~~y~aPE 179 (325)
T 3kn6_A 154 GFARLKPPDNQ--PLKTPCFTLHYAAPE 179 (325)
T ss_dssp TTCEECCC--------------------
T ss_pred ccceecCCCCC--cccccCCCcCccCHH
Confidence 99975433221 124567899999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=232.65 Aligned_cols=178 Identities=24% Similarity=0.404 Sum_probs=144.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+.++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 468889999999999999999862 3478999998754332 35788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
++||||+++++|.+++........ ......+++..+..++.|++.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976532100 001123789999999999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+++.++.+||+|||++................+|+.|+|||
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 222 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence 99999999999999999987654332222233456789999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=235.97 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=140.3
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEE
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.+.++|.+.+.||+|+||.||+|..+ +++.+|+|.+...... ..+|+.++.++ +||||+++++++.+....|+||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 35678999999999999999999976 7889999999655433 34577888777 7999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC----CceEEcc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVAKIAD 217 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~----~~~kl~D 217 (246)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+... +.+||+|
T Consensus 96 E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp CCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999987543 3889999999999999999999997 9999999999998543 3599999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+++....... .....+||+.|+|||
T Consensus 164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE 190 (342)
T 2qr7_A 164 FGFAKQLRAENG--LLMTPCYTANFVAPE 190 (342)
T ss_dssp CTTCEECBCTTC--CBCCSSCCSSCCCHH
T ss_pred CCCcccCcCCCC--ceeccCCCccccCHH
Confidence 999976533221 224568999999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=240.07 Aligned_cols=166 Identities=20% Similarity=0.363 Sum_probs=139.0
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.|.+.+.||+|+||.||++...+++.||||.+...... .+.+.+|+.++++|+ ||||+++++++......|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999999888999999998655433 356889999999997 599999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
| +.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 136 E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp E-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred e-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9 56889999997643 3788889999999999999999997 99999999999995 588999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..............+||+.|+|||
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE 226 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPE 226 (390)
T ss_dssp CCC---------CCSCCCGGGCCHH
T ss_pred ccccCCCccccCCCCCcCCCccChH
Confidence 8765433222234568999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=240.23 Aligned_cols=161 Identities=25% Similarity=0.372 Sum_probs=133.4
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999975 78999999986543 2346788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe--cCCCceEEccccCCCCCCcc
Q 025893 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLSNQAPDM 227 (246)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~--~~~~~~kl~Dfgls~~~~~~ 227 (246)
.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 174 ~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 174 FDRIIDES--------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp HHHHHHTG--------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99886432 13788999999999999999999997 9999999999999 46779999999999765432
Q ss_pred ccccccccccccccccCCC
Q 025893 228 AARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE 246 (246)
.. ....+||+.|+|||
T Consensus 243 ~~---~~~~~gt~~y~aPE 258 (373)
T 2x4f_A 243 EK---LKVNFGTPEFLAPE 258 (373)
T ss_dssp CB---CCCCCSSCTTCCHH
T ss_pred cc---cccccCCCcEeChh
Confidence 21 23457999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=245.84 Aligned_cols=169 Identities=30% Similarity=0.503 Sum_probs=140.4
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|.+.+.||+|+||.||+|.++.+..||+|.+.......+.+.+|+.++++++||||+++++++.+ ...++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 46788889999999999999999877889999998776677889999999999999999999999865 77899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 262 ~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 262 KGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp TCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999974321 13788999999999999999999997 9999999999999999999999999998654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......+|+.|+|||
T Consensus 332 ~~~~~-~~~~~~~~~~y~aPE 351 (452)
T 1fmk_A 332 DNEYT-ARQGAKFPIKWTAPE 351 (452)
T ss_dssp ------------CCGGGSCHH
T ss_pred CCcee-cccCCcccccccCHh
Confidence 32211 112345788999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=230.83 Aligned_cols=167 Identities=28% Similarity=0.410 Sum_probs=138.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.++|.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++......++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367899999999999999999976 6899999998665543 356778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp ECCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 9999999998886543 3889999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......||+.|+|||
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE 172 (311)
T 4agu_A 150 RLLTGPSD--YYDDEVATRWYRSPE 172 (311)
T ss_dssp EECC--------------GGGCCHH
T ss_pred hhccCccc--ccCCCcCCccccChH
Confidence 76542221 123457999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=235.81 Aligned_cols=171 Identities=24% Similarity=0.415 Sum_probs=147.4
Q ss_pred HHHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---------HHHHHHHHHHHhcC-CCCCccceEe
Q 025893 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---------DEEFLAQVSMVSRL-KHENFVQLLG 129 (246)
Q Consensus 61 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---------~~~~~~e~~~l~~l-~hp~iv~~~~ 129 (246)
....+.++|.+.+.||+|+||.||+|..+ +|+.||||.+...... .+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34556788999999999999999999986 7999999998654321 24567899999999 7999999999
Q ss_pred EEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 025893 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 130 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~ 209 (246)
++......++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999987542 3889999999999999999999997 999999999999999
Q ss_pred CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||++........ ....+||+.|+|||
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE 269 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE 269 (365)
T ss_dssp TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred CCCEEEEecCcccccCCCcc---cccCCCCCCccChh
Confidence 99999999999876543221 24568999999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=227.34 Aligned_cols=170 Identities=29% Similarity=0.432 Sum_probs=146.5
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.++|++.+.||+|+||.||+|..+ +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999976 78999999985433 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999886532 3789999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
................||+.|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE 177 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPE 177 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGG
T ss_pred cccCCCcchhcccCCccccCccChH
Confidence 7653322222234567999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=247.71 Aligned_cols=167 Identities=29% Similarity=0.472 Sum_probs=145.1
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
+.+.|.+.+.||+|+||.||+|..+ +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4578999999999999999999976 8899999998543 2346789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCceEEc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIA 216 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~---~~~~~kl~ 216 (246)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 104 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999987543 3889999999999999999999997 99999999999994 57899999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...... .....+||+.|+|||
T Consensus 172 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 198 (484)
T 3nyv_A 172 DFGLSTHFEASK---KMKDKIGTAYYIAPE 198 (484)
T ss_dssp CTTHHHHBCCCC---SHHHHTTGGGTCCHH
T ss_pred eeeeeEEccccc---ccccCCCCccccCce
Confidence 999986543222 123457999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=227.70 Aligned_cols=171 Identities=26% Similarity=0.388 Sum_probs=141.2
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC--CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.+.|.+.+.||+|+||.||++..+ ++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4578999999999999999999976 7889999998643 334678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCceEEccc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADF 218 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~---~~~~~kl~Df 218 (246)
||+++++|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+||
T Consensus 100 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 100 ETCEGGELLERIVSAQA-----RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp CCCSCCBHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EeCCCCcHHHHHHhhhh-----cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEee
Confidence 99999999998854210 0124889999999999999999999997 99999999999994 4578999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|++........ .....||+.|+|||
T Consensus 172 g~a~~~~~~~~---~~~~~~t~~y~aPE 196 (285)
T 3is5_A 172 GLAELFKSDEH---STNAAGTALYMAPE 196 (285)
T ss_dssp CCCCC-------------CTTGGGCCHH
T ss_pred ecceecCCccc---CcCcccccCcCChH
Confidence 99976543221 24567999999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=240.88 Aligned_cols=164 Identities=21% Similarity=0.320 Sum_probs=131.1
Q ss_pred HhcCCCC-ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHH-hcCCCCCccceEeEEEe----CCeeE
Q 025893 66 TENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMV-SRLKHENFVQLLGYCVD----GTSRV 138 (246)
Q Consensus 66 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~----~~~~~ 138 (246)
.++|.+. +.||+|+||+||++..+ +++.||+|.+.. ...+.+|+.++ +.++||||+++++++.. ....|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 4567665 68999999999999976 788999999853 35677888876 45589999999999875 56789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEE
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKI 215 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl 215 (246)
+||||+++|+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 136 lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEE
Confidence 99999999999999976431 23889999999999999999999997 999999999999997 788999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++...... .....+||+.|+|||
T Consensus 206 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 233 (400)
T 1nxk_A 206 TDFGFAKETTSHN---SLTTPCYTPYYVAPE 233 (400)
T ss_dssp CCCTTCEECC--------------CTTCCGG
T ss_pred EecccccccCCCC---ccccCCCCCCccCHh
Confidence 9999997643222 224568999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=226.86 Aligned_cols=168 Identities=27% Similarity=0.493 Sum_probs=147.2
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|.+.+.||+|+||.||++...++..+|+|.+.......+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 57888999999999999999988888999999987777778899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 88 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999976431 3789999999999999999999997 99999999999999999999999999875433
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
... .......||+.|+|||
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE 175 (267)
T 3t9t_A 157 DQY-TSSTGTKFPVKWASPE 175 (267)
T ss_dssp HHH-HSTTSTTCCGGGCCHH
T ss_pred ccc-cccccccccccccChh
Confidence 221 1123346788999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=231.47 Aligned_cols=165 Identities=28% Similarity=0.445 Sum_probs=135.9
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhc--CCCCCccceEeEEEeC----CeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVDG----TSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~----~~~~l 139 (246)
.++|.+.+.||+|+||.||+|.+ +++.||+|.+... ....+..|.+++.. ++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 56899999999999999999987 5889999998543 34556666666665 8899999999987653 45789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeCCCCCCCeEecCCC
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--------EKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
||||+++|+|.++++.. .+++..+..++.|++.||.||| +++ |+||||||+|||++.++
T Consensus 84 v~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EECCCTTCBHHHHHTTC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTS
T ss_pred ehhhccCCCHHHHHhhc----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCC
Confidence 99999999999999643 3889999999999999999999 775 99999999999999999
Q ss_pred ceEEccccCCCCCCccccc--cccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+++........ .......||+.|+|||
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 187 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHH
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChh
Confidence 9999999998653322111 1123457999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=235.97 Aligned_cols=168 Identities=23% Similarity=0.307 Sum_probs=142.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ..+.+..|+.++++| +||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 357999999999999999999975 78899999885443 234688899999999 899999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-----eEEccc
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-----AKIADF 218 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~-----~kl~Df 218 (246)
+ +++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 87 ~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 87 L-GPSLEDLFDLCD--------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred C-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9 999999997542 14899999999999999999999997 999999999999998876 999999
Q ss_pred cCCCCCCcccccc-----ccccccccccccCCC
Q 025893 219 DLSNQAPDMAARL-----HSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~-----~~~~~~gt~~y~aPE 246 (246)
|+++......... ......||+.|+|||
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 187 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSIN 187 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChH
Confidence 9997643322111 124568999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=239.86 Aligned_cols=169 Identities=25% Similarity=0.400 Sum_probs=144.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCC--eeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 140 (246)
.+.|.+.+.||+|+||.||+|..+ +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357899999999999999999976 68999999986432 34577889999999999999999999998765 77999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCceEEc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIA 216 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~----~~~~~~kl~ 216 (246)
|||+++|+|.+++...... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEe
Confidence 9999999999999754321 13889999999999999999999997 9999999999999 677889999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++....... .....||+.|+|||
T Consensus 159 DFG~a~~~~~~~~---~~~~~gt~~y~aPE 185 (396)
T 4eut_A 159 DFGAARELEDDEQ---FVSLYGTEEYLHPD 185 (396)
T ss_dssp CGGGCEECCCGGG---SSCSSSCCTTCCHH
T ss_pred cCCCceEccCCCc---cccccCCccccCHH
Confidence 9999976543322 24567999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=229.33 Aligned_cols=168 Identities=31% Similarity=0.473 Sum_probs=138.4
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC------CCHHHHHHHHHHHhcCC---CCCccceEeEEEeC
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDG 134 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~------~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~ 134 (246)
..++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999975 78999999985322 22356777887777665 99999999999876
Q ss_pred C-----eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 025893 135 T-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 135 ~-----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~ 209 (246)
. ..++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 5 5789999997 599999976432 23889999999999999999999997 999999999999999
Q ss_pred CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||+++....... ....+||+.|+|||
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 189 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPE 189 (308)
T ss_dssp TSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHH
T ss_pred CCCEEEeeCccccccCCCcc---cCCccccccccCch
Confidence 99999999999986543222 24567999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=242.38 Aligned_cols=164 Identities=32% Similarity=0.542 Sum_probs=139.8
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCC-eeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-SRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||.||+|.+. ++.||||.+.... ..+.+.+|+.++++++||||+++++++.... ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 357888899999999999999886 7799999997544 5678999999999999999999999988765 789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 270 ~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp TTCBHHHHHHHHCT-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999999976431 13688999999999999999999997 999999999999999999999999998753
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
... .....+|+.|+|||
T Consensus 340 ~~~-----~~~~~~~~~y~aPE 356 (450)
T 1k9a_A 340 SST-----QDTGKLPVKWTAPE 356 (450)
T ss_dssp C-----------CCCTTTSCHH
T ss_pred ccc-----ccCCCCCcceeCHH
Confidence 321 12336789999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=234.54 Aligned_cols=163 Identities=30% Similarity=0.489 Sum_probs=141.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.+.|...+.||+|+||.||+|... +++.||+|.+...... .+.+.+|+.++++++||||+++++++......++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 456888999999999999999975 7889999998654333 24678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+. |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~e~~~-g~l~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp EECCS-EEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred EecCC-CCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 99997 68888875432 13889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... .....||+.|+|||
T Consensus 201 a~~~~~------~~~~~gt~~y~aPE 220 (348)
T 1u5q_A 201 ASIMAP------ANSFVGTPYWMAPE 220 (348)
T ss_dssp CBSSSS------BCCCCSCGGGCCHH
T ss_pred ceecCC------CCcccCCcceeCHh
Confidence 876532 13467999999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=234.48 Aligned_cols=178 Identities=28% Similarity=0.449 Sum_probs=143.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 468999999999999999999862 35579999986442 2346789999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
.++||||+++|+|.+++......- .......+++..++.++.||+.||.|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 999999999999999997653210 0001134789999999999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++.++.+||+|||++................||+.|+|||
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 244 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence 99999999999999999998654332222233456889999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=234.25 Aligned_cols=169 Identities=28% Similarity=0.474 Sum_probs=138.4
Q ss_pred HHHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhc--CCCCCccceEeEEEeC----C
Q 025893 62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVDG----T 135 (246)
Q Consensus 62 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~----~ 135 (246)
...+.++|.+.+.||+|+||.||+|..+ ++.||+|.+... ....+..|.+++.. ++||||+++++++... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3456789999999999999999999876 889999998533 23445556666555 4899999999999887 7
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCCeeeCCCCCCCeEe
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK--------ADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~~~~ivHrdlkp~Nil~ 207 (246)
..++||||+++|+|.++++... +++..+..++.|++.||.|||++ + |+||||||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill 175 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILV 175 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEE
T ss_pred ceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEE
Confidence 8899999999999999997542 88999999999999999999987 6 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccc--cccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||++......... .......||+.|+|||
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 216 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHH
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChh
Confidence 99999999999998654332211 1123457999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=236.77 Aligned_cols=181 Identities=28% Similarity=0.333 Sum_probs=141.7
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC------CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCC
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS------KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 135 (246)
..+.++|.+.+.||+|+||.||+|... ++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 556789999999999999999999976 7889999988532 233567889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHHHH
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKG-------------------------------AQPGPVLSWQQRVKIAVGAAKGL 184 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~~i~~~l 184 (246)
..++||||+++|+|.+++........ ......+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999999853111000 00011235677788999999999
Q ss_pred HHHhhCCCCCeeeCCCCCCCeEecCCC--ceEEccccCCCCCCcccc--ccccccccccccccCCC
Q 025893 185 EYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 185 ~~lH~~~~~~ivHrdlkp~Nil~~~~~--~~kl~Dfgls~~~~~~~~--~~~~~~~~gt~~y~aPE 246 (246)
.|||+++ |+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 9999997 99999999999998766 899999999875432111 11124567999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=239.32 Aligned_cols=168 Identities=25% Similarity=0.338 Sum_probs=143.9
Q ss_pred HhcCCCCceeccCCceEEEEEEE----CCCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGT 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 135 (246)
.++|.+.+.||+|+||.||+++. .+++.||+|.+.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 368899999986432 2345677899999999 6999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence 9999999999999999997543 3789999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++........ .....+||+.|+|||
T Consensus 201 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE 230 (355)
T 1vzo_A 201 TDFGLSKEFVADETE-RAYDFCGTIEYMAPD 230 (355)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHH
T ss_pred eeCCCCeecccCCCC-cccCcccCcCccChh
Confidence 999998765432221 224567999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=229.11 Aligned_cols=169 Identities=25% Similarity=0.380 Sum_probs=137.8
Q ss_pred HhcCCCC-ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.+.|.+. +.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4577774 78999999999999965 78999999986543 3467889999999885 6999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---eEEccc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIADF 218 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~---~kl~Df 218 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 91 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 9999999999997643 3788999999999999999999997 999999999999997765 999999
Q ss_pred cCCCCCCcccc-----ccccccccccccccCCC
Q 025893 219 DLSNQAPDMAA-----RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~-----~~~~~~~~gt~~y~aPE 246 (246)
|++........ .......+||+.|+|||
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 191 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191 (316)
T ss_dssp TCCC-------------------CCSGGGCCHH
T ss_pred cCccccccCCccccccccccccccCCcCccChH
Confidence 99876532211 11123456999999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=225.60 Aligned_cols=165 Identities=33% Similarity=0.567 Sum_probs=131.9
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC-----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~-----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|.+.+.||+|+||.||+|.+. +..+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888999999999999999976 78899999865422 2467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--------CCce
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--------DDVA 213 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~--------~~~~ 213 (246)
||+++++|.+++... .+++..+..++.|++.||.|||+++..+|+||||||+||+++. ++.+
T Consensus 86 e~~~~~~L~~~~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp ECCTTEEHHHHHTSS----------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EcCCCCCHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999998643 3889999999999999999999986445899999999999986 6789
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++....... .....||+.|+|||
T Consensus 156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE 184 (271)
T 3dtc_A 156 KITDFGLAREWHRTT----KMSAAGAYAWMAPE 184 (271)
T ss_dssp EECCCCC-----------------CCGGGSCHH
T ss_pred EEccCCccccccccc----ccCCCCccceeCHH
Confidence 999999997654322 13457999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=235.68 Aligned_cols=171 Identities=32% Similarity=0.515 Sum_probs=142.2
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEe------CC
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD------GT 135 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~------~~ 135 (246)
...++|.+.+.||+|+||.||+|... +++.||+|.+.......+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 34678999999999999999999975 789999999976666678899999999998 79999999999987 46
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred eEEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 78999999999999999976431 13788999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++........ ......||+.|+|||
T Consensus 171 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 199 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPE 199 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHH
T ss_pred eeCcCceecCcCcc--ccccccCCccccChh
Confidence 99999876543211 123457999999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=248.95 Aligned_cols=169 Identities=30% Similarity=0.503 Sum_probs=145.4
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|.+.+.||+|+||.||+|.+..+..||||.+.......+.+.+|+.+|++|+||||+++++++.+ ...+|||||++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 56788889999999999999999877889999998776677899999999999999999999999865 77899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 345 ~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 345 KGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp TEEHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred CCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999974321 13788999999999999999999997 9999999999999999999999999998764
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......+|+.|+|||
T Consensus 415 ~~~~~-~~~~~~~~~~y~aPE 434 (535)
T 2h8h_A 415 DNEYT-ARQGAKFPIKWTAPE 434 (535)
T ss_dssp CHHHH-TTCSTTSCGGGSCHH
T ss_pred CCcee-cccCCcCcccccCHH
Confidence 32211 122345788999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=233.75 Aligned_cols=180 Identities=24% Similarity=0.399 Sum_probs=145.6
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCC
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 135 (246)
...++|.+.+.||+|+||.||+|..+ ++..||+|.+...... ...+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999854 3678999998754432 346889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
..++||||+++|+|.+++....... .......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999986532100 0000123688999999999999999999997 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++...............||+.|+|||
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChh
Confidence 99999997654332222233456789999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=230.07 Aligned_cols=170 Identities=30% Similarity=0.463 Sum_probs=147.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||.||+|.++ ++..+|+|.+.......+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 568899999999999999999977 6888999999877666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 92 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp TTEEHHHHHHHCCT-------TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCCcHHHHHHhccc-------CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999975432 23889999999999999999999997 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......+|+.|+|||
T Consensus 162 ~~~~~~-~~~~~~~~~~y~aPE 182 (288)
T 3kfa_A 162 TGDTYT-AHAGAKFPIKWTAPE 182 (288)
T ss_dssp CSSSSE-EETTEEECGGGCCHH
T ss_pred cCCccc-cccCCccccCcCChh
Confidence 432211 123345788999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=230.70 Aligned_cols=170 Identities=27% Similarity=0.438 Sum_probs=138.1
Q ss_pred HhcCCCCceeccCCceEEEEEEE-----CCCCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeC--Cee
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 137 (246)
.++|++.+.||+|+||.||+|++ .+++.||+|.+...... .+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 26788999998754322 35788999999999999999999998653 568
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+++++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 999999999999999976431 3788999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025893 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
||++......... .......||+.|+|||
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 187 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcH
Confidence 9999875433211 1123345788899998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=234.83 Aligned_cols=169 Identities=27% Similarity=0.457 Sum_probs=134.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCE----EEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
.++|.+.+.||+|+||.||+|.+. +++. ||+|.+.... .....+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357999999999999999999965 4443 5888875432 34578999999999999999999999998755 77
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+++||+.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence 89999999999999976432 3889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++...............||+.|+|||
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHH
T ss_pred cceeEccCCcccccccCCCccccccChH
Confidence 9986543322222223445788999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=245.91 Aligned_cols=163 Identities=26% Similarity=0.327 Sum_probs=133.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999976 788999999865432 2356789999999999999999999997653
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeCCCC-CHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEE
Confidence 56999999975 57777643 2788999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++...... .....+||+.|+|||
T Consensus 206 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 233 (464)
T 3ttj_A 206 LDFGLARTAGTSF---MMTPYVVTRYYRAPE 233 (464)
T ss_dssp CCCCCC-----CC---CC----CCCTTCCHH
T ss_pred EEEEeeeecCCCc---ccCCCcccccccCHH
Confidence 9999998654321 224568999999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=225.14 Aligned_cols=166 Identities=25% Similarity=0.429 Sum_probs=141.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------CHHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||++..+ +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999987 789999998854321 357889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----ce
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VA 213 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~----~~ 213 (246)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCE
T ss_pred EEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCce
Confidence 99999999999999996543 3889999999999999999999997 99999999999998776 89
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++........ .....||+.|+|||
T Consensus 152 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 181 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE---FKNIFGTPEFVAPE 181 (283)
T ss_dssp EECCCTTCEECC-----------CCCGGGCCHH
T ss_pred EEEecccceeccCCCc---ccccCCCcCccCcc
Confidence 9999999876533221 23457999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=226.10 Aligned_cols=167 Identities=24% Similarity=0.409 Sum_probs=143.3
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
+.++|.+.+.||+|+||.||+|..+ ++..+|+|.+...... .+.+.+|+.++++++||||+++++++......++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999976 6889999998654433 35677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---eEEcc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIAD 217 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~---~kl~D 217 (246)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|
T Consensus 84 ~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence 99999999998886543 3889999999999999999999997 999999999999986554 99999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++........ .....||+.|+|||
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE 177 (284)
T 3kk8_A 152 FGLAIEVNDSEA---WHGFAGTPGYLSPE 177 (284)
T ss_dssp CTTCEECCSSCB---CCCSCSCGGGCCHH
T ss_pred ceeeEEcccCcc---ccCCCCCcCCcCch
Confidence 999865443221 23467999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=226.17 Aligned_cols=169 Identities=27% Similarity=0.467 Sum_probs=144.6
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|.+.+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4688899999999999999999888889999999877667788999999999999999999999876 556899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 91 NGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp TCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999864321 13788999999999999999999997 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......+|+.|+|||
T Consensus 161 ~~~~~-~~~~~~~~~~y~aPE 180 (279)
T 1qpc_A 161 DNEYT-AREGAKFPIKWTAPE 180 (279)
T ss_dssp SSCEE-CCTTCCCCTTTSCHH
T ss_pred Ccccc-cccCCCCccCccChh
Confidence 32211 123345788999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=231.28 Aligned_cols=178 Identities=27% Similarity=0.466 Sum_probs=143.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... ...+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999863 4668999998754432 35688999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
+..++||||+++|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999976542110 001224889999999999999999999997 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............+|+.|+|||
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 229 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence 999999999999987654332222223446789999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=229.52 Aligned_cols=171 Identities=25% Similarity=0.416 Sum_probs=138.6
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEe----------
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD---------- 133 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~---------- 133 (246)
+.++|.+.+.||+|+||.||+|... +++.||+|.+.......+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4678999999999999999999976 78999999986543345678899999999999999999999865
Q ss_pred ---CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 134 ---GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 134 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence 356789999999999999997532 13678888999999999999999997 9999999999999999
Q ss_pred CceEEccccCCCCCCcccc------------ccccccccccccccCCC
Q 025893 211 DVAKIADFDLSNQAPDMAA------------RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~~~~~------------~~~~~~~~gt~~y~aPE 246 (246)
+.+||+|||++........ ........||+.|+|||
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHH
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence 9999999999976542210 11123457999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=234.48 Aligned_cols=168 Identities=27% Similarity=0.450 Sum_probs=136.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCE----EEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|.+.+.||+|+||.||+|.+. ++.. +|+|.+.... .....+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999975 4554 7888775432 22356778999999999999999999885 566889
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCS
T ss_pred EEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCC
Confidence 9999999999999976431 3778889999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...............||+.|+|||
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE 187 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALE 187 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHH
T ss_pred cccccCcccccccccCCCCcccccChH
Confidence 998654433322234556888999997
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=226.67 Aligned_cols=168 Identities=29% Similarity=0.508 Sum_probs=143.0
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEe--------
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-------- 133 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-------- 133 (246)
..+.++|.+.+.||+|+||.||+|... +++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 345678999999999999999999986 78999999986443 457789999999999999999998864
Q ss_pred --------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 025893 134 --------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (246)
Q Consensus 134 --------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Ni 205 (246)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Ni 153 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-------EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNI 153 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHE
Confidence 3457899999999999999975431 13889999999999999999999997 99999999999
Q ss_pred EecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 206 l~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++.++.+||+|||++........ .....||+.|+|||
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE 191 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPE 191 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHH
T ss_pred EEcCCCCEEECcchhheecccccc---ccccCCcccccChh
Confidence 999999999999999876543221 23457999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=229.89 Aligned_cols=178 Identities=24% Similarity=0.424 Sum_probs=146.3
Q ss_pred HhcCCCCceeccCCceEEEEEEE------CCCCEEEEEEcCCCCC--CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46889999999999999999985 2467899999975543 236788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVK---------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
.++||||+++|+|.+++....... .......+++..+..++.|++.||.|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 999999999999999997653210 0001124889999999999999999999997 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||++................||+.|+|||
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 217 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence 999999999999998765433322233456889999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=235.18 Aligned_cols=162 Identities=29% Similarity=0.403 Sum_probs=134.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
.+.|.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 458999999999999999999975 7999999998654433 356789999999999999999999998663
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..|+||||+ +++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence 459999999 78999998753 2889999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++..... ....+||+.|+|||
T Consensus 170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE 195 (367)
T 1cm8_A 170 LDFGLARQADSE-----MTGYVVTRWYRAPE 195 (367)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTH
T ss_pred Eeeecccccccc-----cCcCcCCCCcCCHH
Confidence 999998764321 24567999999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=231.71 Aligned_cols=175 Identities=26% Similarity=0.381 Sum_probs=127.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCC---EEEEEEcCCCC---CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCee-
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR- 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~---~vaik~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~- 137 (246)
.++|.+.+.||+|+||.||+|... ++. .||+|.+.... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 458999999999999999999965 333 79999986543 2246788999999999999999999999877655
Q ss_pred -----EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 138 -----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 138 -----~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
++||||+++|+|.+++....... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 89999999999999986433111 1123889999999999999999999997 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++...............+|+.|+|||
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHH
T ss_pred EEEeeccccccccccccccccccccCcccccCch
Confidence 9999999998654333222223445788999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-32 Score=223.10 Aligned_cols=168 Identities=23% Similarity=0.354 Sum_probs=141.8
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 139 (246)
+.++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4678999999999999999999986 799999999865432 245678899999998 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---------
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--------- 210 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~--------- 210 (246)
||||+++++|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred EEEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccc
Confidence 99999999999999753210 013789999999999999999999997 9999999999999843
Q ss_pred ----------CceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 211 ----------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 ----------~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..+||+|||++...... ....||+.|+|||
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE 200 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANE 200 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHH
T ss_pred cccccccCCceEEEEcccccccccCCc------cccCCCccccChh
Confidence 47999999998764322 2346999999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=226.19 Aligned_cols=165 Identities=33% Similarity=0.480 Sum_probs=140.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|... ++..+|+|.+... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999976 6778999988532 12346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 88 ~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCE
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccc
Confidence 99999999999987543 3788999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .....||+.|+|||
T Consensus 156 ~~~~~~~~----~~~~~~~~~y~aPE 177 (279)
T 3fdn_A 156 SVHAPSSR----RTDLCGTLDYLPPE 177 (279)
T ss_dssp ESCC------------CCCCTTCCHH
T ss_pred cccCCccc----ccccCCCCCccCHh
Confidence 86543322 23457999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=227.96 Aligned_cols=164 Identities=26% Similarity=0.470 Sum_probs=141.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CC-------CEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SG-------HAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-------~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+|..+ ++ ..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 368889999999999999999865 34 469999986543 345778999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc----
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---- 212 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~---- 212 (246)
.++||||+++++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred CEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence 9999999999999999976431 3788999999999999999999997 999999999999998876
Q ss_pred ----eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 ----AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ----~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||++...... ....||+.|+|||
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE 187 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK------DILQERIPWVPPE 187 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHH
T ss_pred ccceeeeccCcccccccCc------cccCCcCcccCHH
Confidence 999999998765322 2346899999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=233.19 Aligned_cols=169 Identities=28% Similarity=0.435 Sum_probs=137.2
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC------HHHHHHHHHHHhcCCCCCccceEeEEEeCCe
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 136 (246)
...++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999976 7899999998643221 2467899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEcCCC-CHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence 9999999986 8988886543 13777888999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++....... .....+||+.|+|||
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE 182 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPE 182 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHH
T ss_pred ecccceeccCCcc--cCCcccccccccCch
Confidence 9999986543221 123467999999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=223.80 Aligned_cols=168 Identities=30% Similarity=0.435 Sum_probs=132.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 468999999999999999999975 7899999998532 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--------KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp EECCTTEEHHHHHHTCS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 99999999999997542 13889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......||+.|+|||
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~y~aPE 182 (278)
T 3cok_A 159 ATQLKMPHE--KHYTLCGTPNYISPE 182 (278)
T ss_dssp CEECC---------------------
T ss_pred eeeccCCCC--cceeccCCCCcCCcc
Confidence 876432221 123457999999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=226.70 Aligned_cols=169 Identities=27% Similarity=0.436 Sum_probs=140.8
Q ss_pred hcCCCCceeccCCceEEEEEEE-----CCCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeC--Cee
Q 025893 67 ENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 137 (246)
+.|++.+.||+|+||.||+|.+ .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4688899999999999999984 268889999986443 3457889999999999999999999999876 668
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+++++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECc
Confidence 999999999999999954331 3889999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025893 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
||++......... .......||+.|+|||
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 199 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCe
Confidence 9998765432211 1223456889999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=226.15 Aligned_cols=166 Identities=28% Similarity=0.444 Sum_probs=142.6
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
+.++|.+.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4678999999999999999999976 789999999865432 34568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCceEEcccc
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFD 219 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~---~~~~~~kl~Dfg 219 (246)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||
T Consensus 87 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 87 LVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp CCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred cCCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 999999999986543 3788999999999999999999997 9999999999999 678899999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... .....||+.|+|||
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE 177 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPE 177 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTT
T ss_pred cceecCCCc----cccccCCCCccChH
Confidence 987643221 23456999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-33 Score=233.56 Aligned_cols=167 Identities=25% Similarity=0.401 Sum_probs=134.4
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
..++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++.+....++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3568999999999999999999976 7889999999654332 34677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-----CCCceEE
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-----DDDVAKI 215 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~-----~~~~~kl 215 (246)
|||++ |+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||
T Consensus 112 ~e~~~-~~L~~~~~~~~---------~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP---------DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp EECCS-EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred EecCC-CCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence 99997 59999997653 3889999999999999999999997 99999999999994 4556999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++........ .....+||+.|+|||
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE 207 (329)
T 3gbz_A 179 GDFGLARAFGIPIR--QFTHEIITLWYRPPE 207 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHH
T ss_pred CcCCCccccCCccc--ccCCCcCCccccCHH
Confidence 99999864322111 123457899999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=229.75 Aligned_cols=167 Identities=25% Similarity=0.396 Sum_probs=138.8
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------CHHHHHHHHHHHhcCCCCCccceEeEEEe
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCVD 133 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 133 (246)
.+.++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45678999999999999999999976 688999999865421 12357889999999999999999999876
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC--
Q 025893 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-- 211 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-- 211 (246)
.. .++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 55 899999999999999986533 3889999999999999999999997 99999999999998755
Q ss_pred -ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 -VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 -~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+++....... .....||+.|+|||
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE 186 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPE 186 (322)
T ss_dssp CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHH
T ss_pred CeEEEccCccceecccccc---cccccCCcCccCch
Confidence 499999999876543221 13457999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=233.22 Aligned_cols=173 Identities=27% Similarity=0.415 Sum_probs=138.3
Q ss_pred HHHHHHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC------------HHHHHHHHHHHhcCCCCCccc
Q 025893 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFVQ 126 (246)
Q Consensus 59 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~------------~~~~~~e~~~l~~l~hp~iv~ 126 (246)
..++..+.++|.+.+.||+|+||.||+|...++..||+|++...... .+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45667778999999999999999999999888999999998543221 267889999999999999999
Q ss_pred eEeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC
Q 025893 127 LLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (246)
Q Consensus 127 ~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk 201 (246)
+++++... ...++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+++ |+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--------IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence 99998643 35799999997 68888886432 24889999999999999999999997 9999999
Q ss_pred CCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 202 p~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||++.++.+||+|||++........ .....||+.|+|||
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE 203 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPE 203 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHH
T ss_pred hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcH
Confidence 9999999999999999999975433222 24467999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=224.45 Aligned_cols=168 Identities=30% Similarity=0.431 Sum_probs=130.4
Q ss_pred HhcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||.||+|.... +..+|+|.+...... .+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4688899999999999999998752 446999998654332 35688999999999999999999997 4567899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 93 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence 999999999999997543 13889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++........ ......+|+.|+|||
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE 187 (281)
T 1mp8_A 162 LSRYMEDSTYY-KASKGKLPIKWMAPE 187 (281)
T ss_dssp ------------------CCGGGCCHH
T ss_pred cccccCccccc-ccccCCCcccccChh
Confidence 99875432211 123345788999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=230.85 Aligned_cols=167 Identities=24% Similarity=0.344 Sum_probs=144.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999976 688899999864322 235688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 120 ~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 187 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 187 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccC
Confidence 99999999999886543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......||+.|+|||
T Consensus 188 ~~~~~~~~~--~~~~~~gt~~y~aPE 211 (335)
T 2owb_A 188 ATKVEYDGE--RKKVLCGTPNYIAPE 211 (335)
T ss_dssp CEECCSTTC--CBCCCCSCCSSCCHH
T ss_pred ceecccCcc--cccccCCCccccCHH
Confidence 876432221 124467999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-32 Score=224.11 Aligned_cols=166 Identities=31% Similarity=0.456 Sum_probs=144.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.+.|...+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357888999999999999999975 78899999986443 345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 101 ~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp CCTTEEHHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 99999999998643 3889999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......||+.|+|||
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE 189 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPE 189 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHH
T ss_pred ecCcccc--ccCccCCCcCccCHH
Confidence 6533221 224567999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=224.29 Aligned_cols=165 Identities=31% Similarity=0.481 Sum_probs=143.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|... ++..+|+|.+... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999976 6788999988532 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccc
Confidence 99999999999987543 3788999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .....||+.|+|||
T Consensus 161 ~~~~~~~~----~~~~~~~~~y~aPE 182 (284)
T 2vgo_A 161 SVHAPSLR----RRTMCGTLDYLPPE 182 (284)
T ss_dssp CEECSSSC----BCCCCSCGGGCCHH
T ss_pred cccCcccc----cccccCCCCcCCHH
Confidence 86543221 24567999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.5e-33 Score=232.01 Aligned_cols=166 Identities=26% Similarity=0.411 Sum_probs=134.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH--HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~--~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|.+.+.||+|+||.||+|... +++.||+|.+....... ..+.+|+.++++++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47888999999999999999976 78999999986543221 2445799999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+. |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp CS-EEHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred cc-cCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 97 59999887543 23888999999999999999999997 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 150 ~~~~~~--~~~~~~~t~~y~aPE 170 (324)
T 3mtl_A 150 KSIPTK--TYDNEVVTLWYRPPD 170 (324)
T ss_dssp C--------------CGGGCCHH
T ss_pred ccCCcc--ccccccCcccccChh
Confidence 432221 123457899999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8.1e-32 Score=226.39 Aligned_cols=161 Identities=19% Similarity=0.330 Sum_probs=140.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEe--CCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVD--GTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~ 141 (246)
.++|++.+.||+|+||.||+|... +++.||+|.+.. ...+.+.+|+.++++++ ||||+++++++.. ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 368999999999999999999975 789999999863 34678899999999997 9999999999987 66789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Dfgl 220 (246)
||+.+++|.+++.. +++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 113 e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 99999999998853 778889999999999999999997 99999999999999766 899999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... .....||+.|+|||
T Consensus 178 a~~~~~~~~---~~~~~~~~~y~aPE 200 (330)
T 3nsz_A 178 AEFYHPGQE---YNVRVASRYFKGPE 200 (330)
T ss_dssp CEECCTTCC---CCSCCSCGGGCCHH
T ss_pred ceEcCCCCc---cccccccccccChh
Confidence 975433221 24457999999997
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=228.73 Aligned_cols=167 Identities=31% Similarity=0.467 Sum_probs=139.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 358999999999999999999976 6899999998655443 245778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 104 e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp ECCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence 9999998888765432 3889999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ ......||+.|+|||
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE 194 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPE 194 (331)
T ss_dssp --------------CCCCCTTCCHH
T ss_pred eeecCCcc--ccCCCcCCccccCcc
Confidence 76543221 123457999999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.9e-32 Score=221.61 Aligned_cols=164 Identities=32% Similarity=0.553 Sum_probs=138.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--H------HHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--D------EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~------~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
++|.+.+.||+|+||.||+|... +++.||+|.+...... . +.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 58889999999999999999975 7899999998654322 1 57889999999999999999999986544
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-----
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----- 212 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~----- 212 (246)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||||+||+++.++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA--------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eEEEEecCCCCHHHHHhccc--------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCcee
Confidence 79999999999998886543 24889999999999999999999984 34999999999999987776
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++..... .....||+.|+|||
T Consensus 168 ~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE 196 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS-----VSGLLGNFQWMAPE 196 (287)
T ss_dssp EEECCCTTCBCCSSC-----EECCCCCCTTSCGG
T ss_pred EEeCCCCcccccccc-----ccccCCCccccCch
Confidence 999999998754332 24467999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=224.81 Aligned_cols=167 Identities=28% Similarity=0.531 Sum_probs=130.7
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||+|... ..+|+|.+...... .+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999865 35999998755443 35688999999999999999999965 5667899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ecCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 999999999996443 23889999999999999999999997 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...............||+.|+|||
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE 192 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPE 192 (289)
T ss_dssp ---------------CCCTTCCHH
T ss_pred ccccccccccccccCCCccccCch
Confidence 654322222234467999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=230.78 Aligned_cols=165 Identities=32% Similarity=0.515 Sum_probs=132.0
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHH--HhcCCCCCccceEeEEEe-----CCeeE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSM--VSRLKHENFVQLLGYCVD-----GTSRV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~--l~~l~hp~iv~~~~~~~~-----~~~~~ 138 (246)
.++|.+.+.||+|+||.||+|.. +++.||+|.+.... ...+..|.++ +..++||||+++++.+.. ....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46899999999999999999976 57899999985432 3344444444 556899999999986543 23568
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeeeCCCCCCCeEecC
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK---------ADPHIIHRDIKSSNVLIFD 209 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------~~~~ivHrdlkp~Nil~~~ 209 (246)
+||||+++|+|.+++.... .++..+..++.||+.||.|||++ + |+||||||+|||++.
T Consensus 89 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECT
T ss_pred EEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcC
Confidence 9999999999999997643 67888999999999999999998 6 999999999999999
Q ss_pred CCceEEccccCCCCCCccc------cccccccccccccccCCC
Q 025893 210 DDVAKIADFDLSNQAPDMA------ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ~~~~kl~Dfgls~~~~~~~------~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||+++...... ........+||+.|+|||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHH
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCch
Confidence 9999999999997543221 111123457999999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-32 Score=220.75 Aligned_cols=165 Identities=24% Similarity=0.359 Sum_probs=141.9
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|.++ +..+|+|.+...... .+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 358889999999999999999986 788999999765443 35688999999999999999999999887 788999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ +.|+||||||+||+++.++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccc
Confidence 999999999999976432 23889999999999999999999973 3499999999999999999999999988
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... ....||+.|+|||
T Consensus 160 ~~~~~~-------~~~~~t~~y~aPE 178 (271)
T 3kmu_A 160 KFSFQS-------PGRMYAPAWVAPE 178 (271)
T ss_dssp CCTTSC-------TTCBSCGGGSCHH
T ss_pred eeeecc-------cCccCCccccChh
Confidence 754321 3457899999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=234.04 Aligned_cols=165 Identities=28% Similarity=0.425 Sum_probs=141.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||++... ++..+|+|.+...... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999976 7889999998654322 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|+++++|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||++
T Consensus 112 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp CCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999999999997643 378899999999999999999985 6 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 180 ~~~~~~----~~~~~~gt~~y~aPE 200 (360)
T 3eqc_A 180 GQLIDS----MANSFVGTRSYMSPE 200 (360)
T ss_dssp HHHHHH----C----CCCCTTCCHH
T ss_pred cccccc----cccCCCCCCCeECHH
Confidence 643211 124567999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-32 Score=224.86 Aligned_cols=171 Identities=24% Similarity=0.395 Sum_probs=139.6
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC-----CCCHHHHHHHHHHHhcCCCCCccceEeEEE--eCCe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKHENFVQLLGYCV--DGTS 136 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~-----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~ 136 (246)
+.++|.+.+.||+|+||.||++... ++..+|+|.+... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999975 7889999998643 223467889999999999999999999985 4457
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.++||||+.++ |.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-------KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEehhccCC-HHHHHHhCcc-------cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEee
Confidence 89999999876 7777765331 23889999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++................||+.|+|||
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 181 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPE 181 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHH
T ss_pred ccccccccCccccccccccCCCCCCCcChh
Confidence 999987654322222234567999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-32 Score=223.76 Aligned_cols=167 Identities=24% Similarity=0.344 Sum_probs=143.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999976 688899998854422 235678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp EECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccC
Confidence 99999999999886543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......||+.|+|||
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE 185 (294)
T 2rku_A 162 ATKVEYDGE--RKKVLCGTPNYIAPE 185 (294)
T ss_dssp CEECCSTTC--CBCCCCSCCSSCCHH
T ss_pred ceecccCcc--ccccccCCCCcCCcc
Confidence 876432221 123457999999997
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=228.53 Aligned_cols=169 Identities=27% Similarity=0.455 Sum_probs=133.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCE----EEEEEcCCC--CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vaik~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
.++|.+.+.||+|+||.||+|.+. +++. +++|.+... ......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 358999999999999999999965 4544 577777543 335678999999999999999999999998765 78
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+++||+.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccC
Confidence 89999999999999976432 3889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++...............||+.|+|||
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp TC----------------CCCGGGSCHH
T ss_pred cceeEccCccccccccCCCccccccCHH
Confidence 9998754333322233445788999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-32 Score=228.68 Aligned_cols=169 Identities=29% Similarity=0.452 Sum_probs=140.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeC-------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG------- 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------- 134 (246)
.++|.+.+.||+|+||.||+|+.+ +++.||+|++..... ....+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999975 789999999865432 246788999999999999999999999873
Q ss_pred -CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 135 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
+..++||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 468999999975 7877776432 13889999999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCcccc--ccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~--~~~~~~~~gt~~y~aPE 246 (246)
||+|||+++....... ........||+.|+|||
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCch
Confidence 9999999875432111 11123457899999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=226.85 Aligned_cols=169 Identities=21% Similarity=0.313 Sum_probs=137.9
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
..++|.+.+.||+|+||.||++... +++.||+|.+...... .+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999976 7889999998654322 2568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 112 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 999999999999997543 3889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++......... ......||+.|+|||
T Consensus 180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE 205 (309)
T 2h34_A 180 IASATTDEKLT-QLGNTVGTLYYMAPE 205 (309)
T ss_dssp C-----------------CCGGGCCGG
T ss_pred cCccccccccc-cccccCCCcCccCHH
Confidence 98765432211 123457999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=224.63 Aligned_cols=165 Identities=29% Similarity=0.467 Sum_probs=138.7
Q ss_pred CCCCceeccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEE
Q 025893 69 FGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL 139 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~~-----~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 139 (246)
|.+.+.||+|+||.||++.++ +++.||+|.+...... .+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998653 5788999999765432 35688999999999999999999999874 67899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++++|.+++.... +++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 113 v~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcc
Confidence 999999999999997643 889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccc-cccccccccccccCCC
Q 025893 220 LSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
++......... .......||+.|+|||
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPE 207 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHH
T ss_pred ccccccccccccccccCCCCCceeeChH
Confidence 99765432211 1123456889999997
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=232.97 Aligned_cols=169 Identities=20% Similarity=0.307 Sum_probs=135.6
Q ss_pred HhcCCCCceeccCCceEEEEEEECC------CCEEEEEEcCCCCCC------------HHHHHHHHHHHhcCCCCCccce
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFVQL 127 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vaik~~~~~~~~------------~~~~~~e~~~l~~l~hp~iv~~ 127 (246)
.++|.+.+.||+|+||.||+|.++. ++.||+|.+...... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998764 467999998654321 1223456667788899999999
Q ss_pred EeEEEeC----CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 025893 128 LGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (246)
Q Consensus 128 ~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~ 203 (246)
++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~ 181 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--------KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKAS 181 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHH
Confidence 9998765 4579999999 999999997642 13899999999999999999999997 999999999
Q ss_pred CeEec--CCCceEEccccCCCCCCcccccc-----ccccccccccccCCC
Q 025893 204 NVLIF--DDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPE 246 (246)
Q Consensus 204 Nil~~--~~~~~kl~Dfgls~~~~~~~~~~-----~~~~~~gt~~y~aPE 246 (246)
|||++ .++.+||+|||+++......... ......||+.|+|||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 231 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID 231 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH
Confidence 99999 88999999999997654322111 113456999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=224.34 Aligned_cols=167 Identities=30% Similarity=0.398 Sum_probs=144.2
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---C-------HHHHHHHHHHHhcCC-CCCccceEeEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---P-------DEEFLAQVSMVSRLK-HENFVQLLGYCV 132 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~-------~~~~~~e~~~l~~l~-hp~iv~~~~~~~ 132 (246)
+.++|.+.+.||+|+||.||+|..+ +++.||+|.+..... . .+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999986 788999999865431 1 245778999999996 999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 133 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
.....++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 9999999999999999999997543 3889999999999999999999997 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||++....... ......||+.|+|||
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE 193 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 193 (298)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHH
T ss_pred EEEecccchhhcCCCc---ccccccCCccccCHH
Confidence 9999999987643322 124467999999997
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=229.36 Aligned_cols=178 Identities=28% Similarity=0.453 Sum_probs=143.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CC-----CEEEEEEcCCCCC--CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SG-----HAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-----~~vaik~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|.+.+.||+|+||.||+|... ++ ..||+|.+..... ..+.+.+|+.+++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 468899999999999999999965 33 3799999865543 235688999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 025893 137 RVLAYEFASNGSLHDILHGRKGV-----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
.++||||+++|+|.+++...... ........+++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 99999999999999998643210 00001224789999999999999999999997 99999999999999999
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||++................||+.|+|||
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 236 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 236 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHH
Confidence 99999999998654332222223456788999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=221.39 Aligned_cols=166 Identities=25% Similarity=0.389 Sum_probs=137.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368899999999999999999986 7899999998532 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 90 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred EeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccc
Confidence 99999999999997543 3788999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ .....||+.|+|||
T Consensus 158 ~~~~~~~~~---~~~~~~~~~y~aPE 180 (276)
T 2h6d_A 158 SNMMSDGEF---LRTSCGSPNYAAPE 180 (276)
T ss_dssp GGCCCC----------------CCTG
T ss_pred ccccCCCcc---eecccCCccccCHH
Confidence 876543221 23457999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=230.42 Aligned_cols=167 Identities=26% Similarity=0.369 Sum_probs=141.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeC-----Cee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~ 137 (246)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... ...+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999976 7888999998754332 35788999999999999999999999765 367
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+. ++|.+++.... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEcccC-cCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence 99999997 59999987542 889999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~-~~~~~~gt~~y~aPE 246 (246)
||++.......... .....+||+.|+|||
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 201 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPE 201 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred CcceEecCCCCCccccccccccccCCCCCH
Confidence 99997654332211 124458999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=228.66 Aligned_cols=173 Identities=23% Similarity=0.364 Sum_probs=143.2
Q ss_pred HHHHHHhcCCCC-ceeccCCceEEEEEEEC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcCC-CCCccceEeEEEeC
Q 025893 61 ELKEITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDG 134 (246)
Q Consensus 61 ~~~~~~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~ 134 (246)
..+.+.+.|.+. +.||+|+||.||+|..+ +++.||+|.+.... .....+.+|+.+++++. ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345667788877 89999999999999976 78999999986433 23578889999999996 69999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CC
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DD 211 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~ 211 (246)
...++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence 999999999999999998854321 24889999999999999999999997 999999999999987 78
Q ss_pred ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+||+|||+++....... .....||+.|+|||
T Consensus 172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 203 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPE 203 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHH
T ss_pred cEEEeeCccccccCCccc---cccccCCcCccCCe
Confidence 999999999976543221 23467999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=226.57 Aligned_cols=169 Identities=27% Similarity=0.471 Sum_probs=142.5
Q ss_pred HHHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhc--CCCCCccceEeEEEeCC----
Q 025893 62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVDGT---- 135 (246)
Q Consensus 62 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~~---- 135 (246)
...+.++|.+.+.||+|+||.||+|... ++.||+|.+... ....+..|++++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3556789999999999999999999884 889999998533 34667788888877 78999999999998876
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeCCCCCCCeEe
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--------EKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivHrdlkp~Nil~ 207 (246)
..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+ |+||||||+|||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred eeEEEEeecCCCcHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 789999999999999999754 2889999999999999999999 665 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccc--cccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||++......... .......||+.|+|||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 221 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHH
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHh
Confidence 99999999999998654322111 0124457999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=227.94 Aligned_cols=184 Identities=22% Similarity=0.368 Sum_probs=146.4
Q ss_pred HHHHHHHhcCCCCceeccCCceEEEEEEE------CCCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeE
Q 025893 60 DELKEITENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGY 130 (246)
Q Consensus 60 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~ 130 (246)
.++....++|.+.+.||+|+||.||+|.+ .+++.||+|.+...... .+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33344467899999999999999999984 24678999998755432 34688999999999 69999999999
Q ss_pred EEeCC-eeEEEEecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 131 CVDGT-SRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 131 ~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
+...+ ..++||||+++++|.+++........ ......+++..+..++.|++.||.|||+++ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 88754 48999999999999999976542100 001123788999999999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+++.++.+||+|||+++...............||+.|+|||
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence 99999999999999999998654333222234456899999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=223.86 Aligned_cols=169 Identities=34% Similarity=0.514 Sum_probs=140.1
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
...++|.+.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34578999999999999999999976 68999999986543 45678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 105 ~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 105 YCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp CCTTEEHHHHHHHHT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 999999999986322 13889999999999999999999997 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......||+.|+|||
T Consensus 174 ~~~~~~~--~~~~~~~~~~y~aPE 195 (314)
T 3com_A 174 QLTDTMA--KRNTVIGTPFWMAPE 195 (314)
T ss_dssp ECBTTBS--CBCCCCSCGGGCCHH
T ss_pred hhhhhcc--ccCccCCCCCccChh
Confidence 5433211 123457999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=230.41 Aligned_cols=163 Identities=26% Similarity=0.321 Sum_probs=130.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999976 7889999998654333 356789999999999999999999998665
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++||||+.+ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEcCCC-CHHHHHhh-----------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEE
Confidence 67999999974 78888853 2788899999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++...... .....+||+.|+|||
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 196 (371)
T 2xrw_A 169 LDFGLARTAGTSF---MMTPYVVTRYYRAPE 196 (371)
T ss_dssp CCCCC-------------------CTTCCHH
T ss_pred EEeeccccccccc---ccCCceecCCccCHH
Confidence 9999997654321 123467999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=232.16 Aligned_cols=168 Identities=23% Similarity=0.331 Sum_probs=134.5
Q ss_pred HHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeC--------
Q 025893 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-------- 134 (246)
Q Consensus 64 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-------- 134 (246)
...++|.+.+.||+|+||.||+|... +++.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 44578999999999999999999975 7999999998644322 23689999999999999999998543
Q ss_pred ------------------------------CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 025893 135 ------------------------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184 (246)
Q Consensus 135 ------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 184 (246)
...++||||++ ++|.+.+..... ....+++..+..++.||+.||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-----SGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHH
Confidence 34789999998 588777653210 012488999999999999999
Q ss_pred HHHhhCCCCCeeeCCCCCCCeEec-CCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 185 EYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 185 ~~lH~~~~~~ivHrdlkp~Nil~~-~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.|||+++ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||
T Consensus 155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE 211 (383)
T 3eb0_A 155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPE 211 (383)
T ss_dssp HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHH
T ss_pred HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHH
Confidence 9999997 99999999999998 688999999999976533222 24557899999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=222.12 Aligned_cols=168 Identities=21% Similarity=0.265 Sum_probs=141.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.+++++ +|+||+++++++......++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 457999999999999999999974 78899999885432 334577899999999 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-----eEEccc
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-----AKIADF 218 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~-----~kl~Df 218 (246)
+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+||
T Consensus 88 ~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 88 L-GPSLEDLLDLCG--------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9 999999997543 13889999999999999999999997 999999999999987765 999999
Q ss_pred cCCCCCCccccc-----cccccccccccccCCC
Q 025893 219 DLSNQAPDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
|+++........ .......||+.|+|||
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 188 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCch
Confidence 999765432211 1124567999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=228.09 Aligned_cols=174 Identities=24% Similarity=0.314 Sum_probs=130.6
Q ss_pred HHHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe---
Q 025893 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS--- 136 (246)
Q Consensus 61 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--- 136 (246)
......++|.+.+.||+|+||.||+|..+ ++..||+|++.........+..++..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 34556789999999999999999999976 78999999986665555667788888999999999999999976443
Q ss_pred ----eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeeeCCCCCCCeEecC-
Q 025893 137 ----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--EKADPHIIHRDIKSSNVLIFD- 209 (246)
Q Consensus 137 ----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~~~~ivHrdlkp~Nil~~~- 209 (246)
.++||||+.+ +|.+.+..... ....+++..+..++.|++.||.||| +++ |+||||||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYR-----RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEA 167 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETT
T ss_pred cceeEEEEeecccc-cHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCC
Confidence 7899999986 55544432110 0124788889999999999999999 776 999999999999996
Q ss_pred CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 ~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||+++....... .....||+.|+|||
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 201 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPE 201 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHH
T ss_pred CCcEEEeeCCCceecCCCCC---cccccCCcceeCHH
Confidence 89999999999987543322 23567999999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=222.20 Aligned_cols=169 Identities=25% Similarity=0.405 Sum_probs=137.6
Q ss_pred hcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEE-eCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~l 139 (246)
..|.+.+.||+|+||.||+|.... ...+|+|.+...... .+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999998642 235899988654332 356889999999999999999999865 4567899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 105 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp EEECCTTCBHHHHHHCTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred EEeCCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence 999999999999997533 23788999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccc--cccccccccccccCCC
Q 025893 220 LSNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
+++........ .......||+.|+|||
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALE 202 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHH
T ss_pred ccccccccchhccccccCCCCCccccChH
Confidence 99876433211 1123456889999997
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=223.51 Aligned_cols=175 Identities=26% Similarity=0.408 Sum_probs=131.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeCC---
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGT--- 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--- 135 (246)
.++|.+.+.||+|+||.||+|... ++..||+|.+....... +.+.+|+.++++++||||+++++++....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 468888999999999999999854 34479999987554432 56889999999999999999999998755
Q ss_pred --eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 136 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
..++||||+++++|.+++....... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3499999999999999985432111 1134889999999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++................+|+.|+|||
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 219 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCch
Confidence 999999997654332222223456788999997
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=218.87 Aligned_cols=168 Identities=32% Similarity=0.450 Sum_probs=139.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+|....+||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4455568999999999999975 78899999986543 335678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCceEEccccCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQA 224 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~kl~Dfgls~~~ 224 (246)
+++|.+++...... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||++...
T Consensus 103 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 103 GGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred CCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999764321 13678888899999999999999997 999999999999997 899999999998764
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......||+.|+|||
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE 193 (295)
T 2clq_A 174 AGINP--CTETFTGTLQYMAPE 193 (295)
T ss_dssp CC-------CCCCCCGGGCCHH
T ss_pred CCCCC--cccccCCCccccChh
Confidence 32211 123557999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=225.77 Aligned_cols=174 Identities=32% Similarity=0.504 Sum_probs=138.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCE--EEEEEcCCCC--CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHA--AAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~--vaik~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|.+.+.||+|+||.||+|..+ ++.. +|+|.+.... ...+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 58899999999999999999975 5664 4899885432 2345788999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 141 YEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
|||+++++|.+++........ ......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 999999999999975430000 001124889999999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||+++...... ......+|+.|+|||
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE 211 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIE 211 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHH
T ss_pred EEcccCcCccccccc---cccCCCCCccccChh
Confidence 999999987533221 123345788999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=246.54 Aligned_cols=155 Identities=17% Similarity=0.127 Sum_probs=120.8
Q ss_pred eccCCceEEEEEEE-CCCCEEEEEEcCCCCC-----------CHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEE
Q 025893 75 IGEGSYGRVYYGIL-KSGHAAAIKKLDASKQ-----------PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 75 lG~G~fg~V~~~~~-~~~~~vaik~~~~~~~-----------~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.+.|++|.+..++. ..|+.+++|.+.+... ..++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45666666666553 3688999999864321 124688999999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||++|++|.++|.... .++.. .|+.||+.||.|+|+++ ||||||||+|||++.++.+||+|||+|
T Consensus 322 Eyv~G~~L~d~i~~~~---------~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---------EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp ECCCSEEHHHHHHTTC---------CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred ecCCCCcHHHHHHhCC---------CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccC
Confidence 9999999999997653 25543 58899999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ...+.+||+.|||||
T Consensus 387 r~~~~~~~--~~~t~vGTp~YmAPE 409 (569)
T 4azs_A 387 VTTPQDCS--WPTNLVQSFFVFVNE 409 (569)
T ss_dssp ESCC---C--CSHHHHHHHHHHHHH
T ss_pred eeCCCCCc--cccCceechhhccHH
Confidence 87643322 234578999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=226.12 Aligned_cols=169 Identities=24% Similarity=0.385 Sum_probs=141.6
Q ss_pred hcCCCCceeccCCceEEEEEEE-----CCCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEE--eCCeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCV--DGTSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~ 138 (246)
++|++.+.||+|+||.||+|++ .++..||+|.+..... ..+.+.+|+.++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5889999999999999999984 2678899999875532 2356889999999999999999999987 456689
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCG
T ss_pred EEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccc
Confidence 99999999999999975321 3889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025893 219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
|++......... .......||+.|+|||
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPE 200 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHH
T ss_pred ccceecccCCccceeeccCCccccccCHH
Confidence 999765432211 1123456889999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=233.23 Aligned_cols=177 Identities=24% Similarity=0.381 Sum_probs=127.1
Q ss_pred HHhcCCC-CceeccCCceEEEEEEEC---CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeE
Q 025893 65 ITENFGT-NALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRV 138 (246)
Q Consensus 65 ~~~~~~~-~~~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 138 (246)
+.+.|.. .++||+|+||.||+|.++ ++..||+|.+.... ....+.+|+.++++|+||||+++++++.. ....+
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3456666 458999999999999965 57889999986543 34578899999999999999999999965 67889
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCceE
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAK 214 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~----~~~~~~k 214 (246)
+||||+. ++|.+++..............+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 588887753221110111123889999999999999999999997 9999999999999 6778999
Q ss_pred EccccCCCCCCcccc-ccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++....... .......+||+.|+|||
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCch
Confidence 999999987543211 11224567999999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=220.62 Aligned_cols=168 Identities=27% Similarity=0.475 Sum_probs=138.9
Q ss_pred hcCCCCc-eeccCCceEEEEEEEC---CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNA-LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|.+.. .||+|+||.||+|.++ ++..||+|.+..... ..+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999854 577899999976533 246788999999999999999999999 55678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp EECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCCHHHHHHhCC--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence 99999999999996432 23889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccc-cccccccccccccCCC
Q 025893 221 SNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
+......... .......||+.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 183 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPE 183 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHH
T ss_pred eeeeccCcceeeccccccccccccCHH
Confidence 8765322211 1123345789999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=242.02 Aligned_cols=161 Identities=27% Similarity=0.476 Sum_probs=131.6
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCC
Q 025893 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 74 ~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
.||+|+||.||+|.++ ++..||||.+.... ...+.+.+|+.+|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999997543 346789999999999999999999999976 56899999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccc
Q 025893 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (246)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~ 228 (246)
|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 422 L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 422 LHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp HHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred HHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999996543 23889999999999999999999997 9999999999999999999999999998764322
Q ss_pred ccc-ccccccccccccCCC
Q 025893 229 ARL-HSTRVLGTFGYHAPE 246 (246)
Q Consensus 229 ~~~-~~~~~~gt~~y~aPE 246 (246)
... ......+|+.|+|||
T Consensus 491 ~~~~~~~~~~~~~~y~APE 509 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPE 509 (613)
T ss_dssp -----------CCTTSCHH
T ss_pred ceeeeccCCCCccceeCHh
Confidence 111 112234678999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=231.72 Aligned_cols=162 Identities=29% Similarity=0.441 Sum_probs=123.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeC------C
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG------T 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~ 135 (246)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368999999999999999999965 7889999998654333 35678999999999999999999998754 5
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..++|+|++ +++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCEEEEECC-CEECC-----C----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccc-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEE
Confidence 679999999 68998888642 3889999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++..... ....+||+.|+|||
T Consensus 174 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE 199 (367)
T 2fst_X 174 LDFGLARHTADE-----MTGYVATRWYRAPE 199 (367)
T ss_dssp CC--------------------CCCTTCCHH
T ss_pred eecccccccccc-----CCCcCcCcCccChH
Confidence 999999764322 23467999999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=223.96 Aligned_cols=171 Identities=24% Similarity=0.398 Sum_probs=133.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-C---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-P---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||+|... ++..+|+|.+..... . ...+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 468999999999999999999975 789999999875332 2 35688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++...... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred EecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 9999999999998642110 124788999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ ......||+.|+|||
T Consensus 183 ~~~~~~~~~--~~~~~~~~~~y~aPE 206 (310)
T 2wqm_A 183 GRFFSSKTT--AAHSLVGTPYYMSPE 206 (310)
T ss_dssp ------------------CCSSCCHH
T ss_pred eeeecCCCc--cccccCCCeeEeChH
Confidence 876543221 123457999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=220.00 Aligned_cols=168 Identities=23% Similarity=0.375 Sum_probs=138.5
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCC---EEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee-EEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR-VLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~---~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~lv 140 (246)
.|...+.||+|+||.||+|.+. ++. .+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556688999999999999854 333 6999998654432 35788999999999999999999999876655 899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+.+++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 102 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--------RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EecccCCCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCC
Confidence 99999999999997633 23788999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCcccc--ccccccccccccccCCC
Q 025893 221 SNQAPDMAA--RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~--~~~~~~~~gt~~y~aPE 246 (246)
++....... ........||+.|+|||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE 198 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALE 198 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHH
T ss_pred cccccCCcccccccCcCCCCCccccChh
Confidence 986543221 11223456899999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=230.35 Aligned_cols=168 Identities=25% Similarity=0.424 Sum_probs=128.7
Q ss_pred cCCCCceeccCCceEEEEEEEC--CC--CEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK--SG--HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~--~~--~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 140 (246)
.|.+.+.||+|+||.||+|.+. ++ ..+|+|.+...... .+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999864 22 35899988654332 4678899999999999999999998764 4678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 170 ~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp EECCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EECCCCCCHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccc
Confidence 99999999999997543 23788899999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccc--cccccccccccccCCC
Q 025893 221 SNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
++........ .......+|+.|+|||
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE 266 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALE 266 (373)
T ss_dssp -------------------CCGGGSCHH
T ss_pred cccccccccccccccCCCCCcccccChH
Confidence 9765332211 1113345788999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=233.81 Aligned_cols=165 Identities=22% Similarity=0.298 Sum_probs=140.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcC------CCCCccceEeEEEeCCeeE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL------KHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~~~~~~~~~~~ 138 (246)
..+|.+.+.||+|+||.||+|... +++.||+|.+.........+..|+.+++.+ .|+||+++++++......+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 457999999999999999999976 688999999976544456677788887766 5789999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--eEEc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIA 216 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~--~kl~ 216 (246)
+||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 176 lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF-------QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred EEEeccC-CCHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence 9999996 699999876432 13889999999999999999999997 999999999999998876 9999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||++..... .....+||+.|+|||
T Consensus 245 DFG~a~~~~~-----~~~~~~gt~~y~aPE 269 (429)
T 3kvw_A 245 DFGSSCYEHQ-----RVYTYIQSRFYRAPE 269 (429)
T ss_dssp CCTTCEETTC-----CCCSSCSCGGGCCHH
T ss_pred ecccceecCC-----cccccCCCCCccChH
Confidence 9999864322 124568999999998
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=222.02 Aligned_cols=167 Identities=29% Similarity=0.429 Sum_probs=139.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|.+.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57888999999999999999976 789999999865432 23678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+. ++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~-~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 151 (299)
T 2r3i_A 83 FLH-QDLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151 (299)
T ss_dssp CCS-EEHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ccc-CCHHHHHHhhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhh
Confidence 997 699999875431 13788899999999999999999997 9999999999999999999999999875
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......||+.|+|||
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE 173 (299)
T 2r3i_A 152 AFGVPVR--TYTHEVVTLWYRAPE 173 (299)
T ss_dssp HHCCCSB--CTTSCBCCCTTCCHH
T ss_pred hccCCcc--ccCcccccccccCcH
Confidence 4321111 123456899999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=236.03 Aligned_cols=168 Identities=11% Similarity=0.174 Sum_probs=132.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHH---HHHhcCCCCCccceE-------eEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQV---SMVSRLKHENFVQLL-------GYC 131 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~---~~l~~l~hp~iv~~~-------~~~ 131 (246)
++|.+.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+ .++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 56788899999999999999964 7999999998633 22346788999 556666899999998 666
Q ss_pred EeCCe-----------------eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025893 132 VDGTS-----------------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194 (246)
Q Consensus 132 ~~~~~-----------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 194 (246)
...+. .|+||||+ +|+|.+++........ ....+++..+..++.||+.||.|||+++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT--TTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc--ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 65532 78999999 6899999975431110 0112446788889999999999999997
Q ss_pred eeeCCCCCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 195 ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE 272 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPE 272 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChh
Confidence 99999999999999999999999999875332 1245678 9999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=228.32 Aligned_cols=168 Identities=18% Similarity=0.248 Sum_probs=133.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCCCC------------HHHHHHHHHHHhcCCCCCccceEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFVQLLG 129 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~~~------------~~~~~~e~~~l~~l~hp~iv~~~~ 129 (246)
.++|.+.+.||+|+||.||+|... ++..+|+|.+...... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 358999999999999999999975 5678999988654321 124667888899999999999999
Q ss_pred EEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 025893 130 YCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (246)
Q Consensus 130 ~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Ni 205 (246)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 182 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANL 182 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHE
Confidence 9988 78899999999 999999997543 3889999999999999999999997 99999999999
Q ss_pred EecCCC--ceEEccccCCCCCCccccc-----cccccccccccccCCC
Q 025893 206 LIFDDD--VAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 206 l~~~~~--~~kl~Dfgls~~~~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
|++.++ .+||+|||+++........ .......||+.|+|||
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 230 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD 230 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHH
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHH
Confidence 999877 9999999999765432211 1113457999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-32 Score=224.06 Aligned_cols=168 Identities=27% Similarity=0.427 Sum_probs=139.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.+.|++.+.||+|+||.||+|... ++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999986 68899999986543 4467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--------RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CTTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred CCCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999886532 13889999999999999999999997 99999999999999999999999998643
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ........||+.|+|||
T Consensus 167 ~~~~--~~~~~~~~~~~~y~aPE 187 (302)
T 2j7t_A 167 NLKT--LQKRDSFIGTPYWMAPE 187 (302)
T ss_dssp HHHH--HHC-----CCGGGCCHH
T ss_pred cccc--ccccccccCChhhcCCe
Confidence 2111 11123457999999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=223.93 Aligned_cols=165 Identities=28% Similarity=0.532 Sum_probs=131.5
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|.+.+.||+|+||.||++.+. ++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 57888999999999999999876 678999998533 34567899999999999999999999876 458999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-eEEccccCCCCCC
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADFDLSNQAP 225 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~-~kl~Dfgls~~~~ 225 (246)
++|.+++..... .+.+++..++.++.|++.||.|||+.+...|+||||||+||+++.++. +||+|||++....
T Consensus 84 ~~L~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 84 GSLYNVLHGAEP------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CBHHHHHHCSSS------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCHHHHHhccCC------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999976432 123678889999999999999999932124999999999999998876 7999999987543
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.. .....||+.|+|||
T Consensus 158 ~~-----~~~~~gt~~y~aPE 173 (307)
T 2eva_A 158 TH-----MTNNKGSAAWMAPE 173 (307)
T ss_dssp ------------CCTTSSCHH
T ss_pred cc-----cccCCCCCceEChh
Confidence 22 13346999999998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=224.76 Aligned_cols=169 Identities=28% Similarity=0.464 Sum_probs=134.4
Q ss_pred hcCCCCceeccCCceEEEEEEECC-----CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
++|.+.+.||+|+||.||+|..+. +..||+|.+...... ...+.+|+.++++++||||+++++++......++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778899999999999998652 235999998754332 3468899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 124 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999997542 13889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccc-cccccccccccccCCC
Q 025893 220 LSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
+++........ .......+|+.|+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE 220 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPE 220 (333)
T ss_dssp C-----------------CCCGGGSCHH
T ss_pred cchhhccccccccccCCCCccccccCch
Confidence 99865432211 1112234688999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=218.96 Aligned_cols=165 Identities=29% Similarity=0.424 Sum_probs=138.6
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVL 139 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~l 139 (246)
.|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677788999999999999976 7888999998644333 3568899999999999999999999875 356899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCceEEccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADF 218 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~-~~~~~kl~Df 218 (246)
||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||||+||+++ .++.+||+||
T Consensus 107 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEecCCCCHHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 999999999999997543 3788999999999999999999983 3499999999999998 7889999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|++....... .....||+.|+|||
T Consensus 177 g~~~~~~~~~----~~~~~~t~~y~aPE 200 (290)
T 1t4h_A 177 GLATLKRASF----AKAVIGTPEFMAPE 200 (290)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGG
T ss_pred CCcccccccc----cccccCCcCcCCHH
Confidence 9986533221 23457999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=228.93 Aligned_cols=166 Identities=22% Similarity=0.348 Sum_probs=142.8
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC------------------HHHHHHHHHHHhcCCCCCccce
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP------------------DEEFLAQVSMVSRLKHENFVQL 127 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~------------------~~~~~~e~~~l~~l~hp~iv~~ 127 (246)
.++|.+.+.||+|+||.||+|.. +++.||+|.+...... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998532111 1789999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCCHHHH------hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCC
Q 025893 128 LGYCVDGTSRVLAYEFASNGSLHDI------LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDI 200 (246)
Q Consensus 128 ~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdl 200 (246)
++++.+.+..++||||+++++|.++ +.... ...+++..+..++.|++.||.|||+ ++ |+||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl 178 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-------TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV 178 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-------CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence 9999999999999999999999988 43311 2348999999999999999999998 86 999999
Q ss_pred CCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 201 kp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+||+++.++.+||+|||++...... ......||+.|+|||
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE 220 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPE 220 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGG
T ss_pred ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCch
Confidence 999999999999999999998764332 224567999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=221.60 Aligned_cols=169 Identities=28% Similarity=0.318 Sum_probs=128.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.++|++.+.||+|+||.||+|... +++.||+|.+....... +.+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999975 78899999987553322 22334555588899999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||++ |+|.+++..... ....+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+
T Consensus 86 e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID-----KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp ECCS-EEHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred ehhc-cchHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCC
Confidence 9997 588777653210 012488999999999999999999997 7 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ .....||+.|+|||
T Consensus 157 ~~~~~~~~~---~~~~~~t~~y~aPE 179 (290)
T 3fme_A 157 SGYLVDDVA---KDIDAGCKPYMAPE 179 (290)
T ss_dssp ----------------CCCCCCSCHH
T ss_pred ccccccccc---ccccCCCccccChh
Confidence 976543222 23447999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=226.41 Aligned_cols=176 Identities=26% Similarity=0.404 Sum_probs=138.4
Q ss_pred HhcCCCCceeccCCceEEEEEEE------CCCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|.+ .++..||+|.+..... ....+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999983 2567899999864432 235688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceE
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK 214 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~k 214 (246)
++||||+++++|.+++....... .....+++..++.++.|++.||.|||+++ |+||||||+|||++. ...+|
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999997654211 11134889999999999999999999997 999999999999984 44699
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||++................||+.|+|||
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 215 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHh
Confidence 99999875432211111223456899999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=221.97 Aligned_cols=168 Identities=26% Similarity=0.430 Sum_probs=136.3
Q ss_pred HhcCCCCc-eeccCCceEEEEEEEC---CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 66 TENFGTNA-LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 66 ~~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
.++|.+.. .||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45777777 9999999999999642 4678999998754322 46788999999999999999999999 567789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 9999999999999997643 3889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025893 219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
|++......... .......||+.|+|||
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 190 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPE 190 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHH
T ss_pred CcceeeccCCCcccccccCCCCceeeChH
Confidence 998765332211 1112335678999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=225.65 Aligned_cols=167 Identities=28% Similarity=0.440 Sum_probs=139.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeC-----Cee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~ 137 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999976 7889999999654332 35678999999999999999999988754 678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+. ++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 155 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCD 155 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred EEEEeccC-ccHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEe
Confidence 99999997 5999998753 2889999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCcccccc--------ccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARL--------HSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~--------~~~~~~gt~~y~aPE 246 (246)
||++.......... .....+||+.|+|||
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCe
Confidence 99987654221110 123457999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=224.99 Aligned_cols=177 Identities=27% Similarity=0.370 Sum_probs=127.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468999999999999999999965 78899999886443 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++....... ......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp CCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999986421000 011124889999999999999999999997 9999999999999999999999999876
Q ss_pred CCCcccc---ccccccccccccccCCC
Q 025893 223 QAPDMAA---RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~---~~~~~~~~gt~~y~aPE 246 (246)
....... ........||+.|+|||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPE 196 (303)
T ss_dssp HCC---------------CCCTTCCHH
T ss_pred eeccCCCccchhhhcccCCCccccCHH
Confidence 4432111 11123457999999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=222.13 Aligned_cols=170 Identities=27% Similarity=0.439 Sum_probs=140.9
Q ss_pred HhcCCCCceeccCCceEEEEEEE-----CCCCEEEEEEcCCCCCC-HHHHHHHHHHHhcCCCCCccceEeEEEeCC--ee
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vaik~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~ 137 (246)
.++|.+.+.||+|+||.||++++ .+++.||+|.+...... .+.+.+|+.++++++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35788999999999999999984 26888999998754332 457889999999999999999999987654 78
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 999999999999999976431 3889999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025893 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
||++......... .......+|+.|+|||
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 218 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHH
T ss_pred CcchhhccccccccccccCCCCceeEECch
Confidence 9998765432211 1122345788899998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=244.58 Aligned_cols=160 Identities=19% Similarity=0.377 Sum_probs=136.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCe-----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----- 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----- 136 (246)
.++|.+.+.||+|+||.||++.+. +++.||||.+...... ...+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 6889999998654322 3567899999999999999999999987665
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.||||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred eEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 6999999999999887643 2889999999999999999999997 9999999999999875 89999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++..... ....||+.|+|||
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE 247 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPE 247 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTT
T ss_pred ecccchhcccC------CccCCCccccCHH
Confidence 99998764322 3467999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=226.95 Aligned_cols=161 Identities=30% Similarity=0.440 Sum_probs=136.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCee----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR---- 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~---- 137 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999976 7889999999765433 35678999999999999999999999877655
Q ss_pred --EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 138 --VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 138 --~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
++||||+. ++|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEcccc-ccHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEE
Confidence 99999997 689888742 2789999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++..... .....||+.|+|||
T Consensus 186 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE 211 (371)
T 4exu_A 186 LDFGLARHADAE-----MTGYVVTRWYRAPE 211 (371)
T ss_dssp CSTTCC-------------CTTCCCTTSCHH
T ss_pred EecCcccccccC-----cCCcccCccccCHH
Confidence 999999764322 24567999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=226.25 Aligned_cols=169 Identities=22% Similarity=0.314 Sum_probs=134.2
Q ss_pred HHHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC-------HHHHHHHHHHHhcC----CCCCccceEe
Q 025893 62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-------DEEFLAQVSMVSRL----KHENFVQLLG 129 (246)
Q Consensus 62 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~-------~~~~~~e~~~l~~l----~hp~iv~~~~ 129 (246)
...+.++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+..|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3456789999999999999999999975 7889999998654321 12345688888888 8999999999
Q ss_pred EEEeCCeeEEEEec-CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 025893 130 YCVDGTSRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 208 (246)
Q Consensus 130 ~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~ 208 (246)
++...+..++|+|+ +.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILID 173 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEe
Confidence 99999999999999 78999999997643 3889999999999999999999997 99999999999999
Q ss_pred -CCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 209 -DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 209 -~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.++.+||+|||++....... .....||+.|+|||
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE 208 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPE 208 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHH
T ss_pred CCCCeEEEEEcchhhhcccCc----ccccCCcccccCce
Confidence 78999999999987654322 23457999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=232.58 Aligned_cols=165 Identities=26% Similarity=0.343 Sum_probs=131.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~~~l 139 (246)
.+|.+.+.||+|+||.||+|.+. +++.||||++..... ...+|+.++++++||||+++++++... ...++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 47888999999999999999986 789999999864432 233689999999999999999998642 23678
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CceEEccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADF 218 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-~~~kl~Df 218 (246)
||||+++ +|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 131 v~e~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSR-----AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEECCCE-EHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ehhcccc-cHHHHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccc
Confidence 9999975 67666542110 0124889999999999999999999997 9999999999999955 67899999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++....... ....+||+.|+|||
T Consensus 202 G~a~~~~~~~~---~~~~~~t~~y~aPE 226 (420)
T 1j1b_A 202 GSAKQLVRGEP---NVSYICSRYYRAPE 226 (420)
T ss_dssp TTCEECCTTCC---CCSCCSCTTSCCHH
T ss_pred hhhhhcccCCC---ceeeeeCCCcCCHH
Confidence 99976533221 23467999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=217.75 Aligned_cols=169 Identities=27% Similarity=0.430 Sum_probs=144.7
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC---CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
..+.++|.+.+.||+|+||.||+|..+ +++.||+|.+... ....+.+.+|+.++++++||||+++++++......+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 456789999999999999999999976 7899999998533 334678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CceEE
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKI 215 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~---~~~kl 215 (246)
+|+||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.. +.+||
T Consensus 98 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEE
Confidence 9999999999998886543 3789999999999999999999997 9999999999999754 47999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++........ .....||+.|+|||
T Consensus 166 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE 193 (287)
T 2wei_A 166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193 (287)
T ss_dssp CSTTGGGTBCCCSS---CSCHHHHHTTCCHH
T ss_pred eccCcceeecCCCc---cccccCcccccChH
Confidence 99999876432221 23446899999997
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=219.88 Aligned_cols=164 Identities=32% Similarity=0.539 Sum_probs=132.8
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeC-CeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-TSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||.||++... ++.+|+|.+.... ..+.+.+|+.++++++||||+++++++... +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468899999999999999999875 7899999986443 457789999999999999999999997654 4789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp TTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 99999999865321 12678889999999999999999997 999999999999999999999999998764
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ....+|+.|+|||
T Consensus 168 ~~~~-----~~~~~~~~y~aPE 184 (278)
T 1byg_A 168 SSTQ-----DTGKLPVKWTAPE 184 (278)
T ss_dssp -------------CCTTTSCHH
T ss_pred cccc-----cCCCccccccCHH
Confidence 3221 2346789999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=229.55 Aligned_cols=166 Identities=23% Similarity=0.285 Sum_probs=131.6
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCe------eEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS------RVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~------~~l 139 (246)
..+|.+.+.||+|+||.||+|+...+..+|+|++...... ..+|+.+++.++||||+++++++..... .++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 3579999999999999999999876667999987543322 2368999999999999999999965443 789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCceEEccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADF 218 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~-~~~~~kl~Df 218 (246)
||||++++ +.+.+..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 116 v~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAK-----LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp EEECCSEE-HHHHHHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EeeccCcc-HHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 99999864 4433321100 0124889999999999999999999997 99999999999999 7899999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+++....... .....||+.|+|||
T Consensus 187 G~a~~~~~~~~---~~~~~~t~~y~aPE 211 (394)
T 4e7w_A 187 GSAKILIAGEP---NVSYICSRYYRAPE 211 (394)
T ss_dssp TTCEECCTTCC---CCSSCSCGGGCCHH
T ss_pred CCcccccCCCC---CcccccCcCccCHH
Confidence 99976533222 23567899999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=223.31 Aligned_cols=173 Identities=27% Similarity=0.373 Sum_probs=139.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~l 139 (246)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 358999999999999999999975 78999999885432 234678899999999999999999999873 347789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++...... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 99999999999998753211 124889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccc-------cccccccccccccCCC
Q 025893 220 LSNQAPDMAAR-------LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~-------~~~~~~~gt~~y~aPE 246 (246)
++......... .......||+.|+|||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 213 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred cchhcccccccccccccccccccccCCcccCCHh
Confidence 98754321110 0012345799999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=229.96 Aligned_cols=165 Identities=25% Similarity=0.311 Sum_probs=137.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC--------CCCccceEeEEE----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK--------HENFVQLLGYCV---- 132 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~--------hp~iv~~~~~~~---- 132 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.......+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 468999999999999999999975 7889999999755444567889999999886 788999999988
Q ss_pred eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCC
Q 025893 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 133 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~ 211 (246)
.....++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY-------QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 456789999999 5677766654321 1388999999999999999999998 7 99999999999998765
Q ss_pred -------------------------------------------------ceEEccccCCCCCCccccccccccccccccc
Q 025893 212 -------------------------------------------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242 (246)
Q Consensus 212 -------------------------------------------------~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y 242 (246)
.+||+|||++...... ....+||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999998764322 2445799999
Q ss_pred cCCC
Q 025893 243 HAPE 246 (246)
Q Consensus 243 ~aPE 246 (246)
+|||
T Consensus 260 ~aPE 263 (397)
T 1wak_A 260 RSLE 263 (397)
T ss_dssp CCHH
T ss_pred cCCh
Confidence 9998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=219.98 Aligned_cols=167 Identities=21% Similarity=0.363 Sum_probs=136.6
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|.+.+.||+|+||.||++...+++.+|+|.+...... .+.+.+|+.++++++ ||||+++++++......++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4679999999999999999999888999999998654433 356889999999998 59999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|| +.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||+++ +.+||+|||+
T Consensus 107 ~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred Ee-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99 55789999997643 3788899999999999999999997 999999999999964 8999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++...............||+.|+|||
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPE 198 (313)
T ss_dssp SCC--------------CCGGGCCHH
T ss_pred cccccCccccccccCCCCCCCcCCHH
Confidence 98764433222223457999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=242.12 Aligned_cols=161 Identities=27% Similarity=0.437 Sum_probs=130.5
Q ss_pred ceeccCCceEEEEEEEC---CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||.||+|.+. ++..||||.+..... ..+.+.+|+.++++++|||||++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 467899999875432 24789999999999999999999999964 557899999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 454 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 99999997543 3889999999999999999999997 99999999999999999999999999875533
Q ss_pred cccc-cccccccccccccCCC
Q 025893 227 MAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~-~~~~~~~gt~~y~aPE 246 (246)
.... .......||+.|+|||
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE 542 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPE 542 (635)
T ss_dssp -------------CGGGSCHH
T ss_pred CccccccccCCCCceeeeChh
Confidence 2211 1123345788999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=222.57 Aligned_cols=165 Identities=22% Similarity=0.355 Sum_probs=140.1
Q ss_pred HhcCCCCceeccCCceEEEEEEE-C-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC------ccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGIL-K-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN------FVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~-~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~------iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|.. + +++.||+|.+.......+.+.+|+.+++.++|++ |+++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999986 3 6788999998755444567888999998887654 99999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--------
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-------- 209 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-------- 209 (246)
++||||+ +++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF-------LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEcCC-CCCHHHHHHhcCC-------CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence 9999999 8899999976432 13788999999999999999999997 999999999999987
Q ss_pred -----------CCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 210 -----------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 210 -----------~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++.+||+|||+++..... .....||+.|+|||
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE 204 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPE 204 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHH
T ss_pred CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChH
Confidence 567999999998753321 24567999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=216.40 Aligned_cols=168 Identities=25% Similarity=0.404 Sum_probs=136.8
Q ss_pred HhcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4688999999999999999998542 23599999875532 24678899999999999999999999764 55789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 90 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEecCCCCCHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence 999999999999997543 13788999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++......... ......+|+.|+|||
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE 184 (281)
T 3cc6_A 159 LSRYIEDEDYY-KASVTRLPIKWMSPE 184 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHH
T ss_pred CCccccccccc-ccccCCCCcceeCch
Confidence 98765432211 123345788999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=227.50 Aligned_cols=165 Identities=16% Similarity=0.248 Sum_probs=137.4
Q ss_pred hcCCCCceeccCCceEEEEEEECC---------CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccc-----------
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS---------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ----------- 126 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~---------~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~----------- 126 (246)
++|.+.+.||+|+||.||+|.... ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 589999999999999999999763 788999998644 46788999999999999988
Q ss_pred ----eEeEEEe-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC
Q 025893 127 ----LLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (246)
Q Consensus 127 ----~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk 201 (246)
+++++.. ....++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik 186 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLHENE---YVHGNVT 186 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence 6777776 67889999999 9999999976421 13899999999999999999999997 9999999
Q ss_pred CCCeEecCCC--ceEEccccCCCCCCcccccc-----ccccccccccccCCC
Q 025893 202 SSNVLIFDDD--VAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPE 246 (246)
Q Consensus 202 p~Nil~~~~~--~~kl~Dfgls~~~~~~~~~~-----~~~~~~gt~~y~aPE 246 (246)
|+|||++.++ .+||+|||+++......... ......||+.|+|||
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 238 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD 238 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHH
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHH
Confidence 9999999988 89999999997764332111 113457999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=222.81 Aligned_cols=161 Identities=30% Similarity=0.436 Sum_probs=134.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCe-----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----- 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----- 136 (246)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+...... ...+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357889999999999999999976 7899999998755433 3567899999999999999999999987654
Q ss_pred -eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 137 -RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 137 -~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
.++||||+. ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 499999997 588777632 2789999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++..... .....||+.|+|||
T Consensus 168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE 193 (353)
T 3coi_A 168 LDFGLARHADAE-----MTGYVVTRWYRAPE 193 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHH
T ss_pred eecccccCCCCC-----ccccccCcCcCCHH
Confidence 999999764322 23457899999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=218.33 Aligned_cols=174 Identities=24% Similarity=0.390 Sum_probs=140.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 139 (246)
.++|.+.+.||+|+||.||++..+ +++.+|+|.+...... .+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999976 7899999998755433 3568899999999999999999998864 568899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
||||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ..+|+||||||+||+++.++.+||+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEeCCCCCCHHHHHHhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 9999999999999865321 1123889999999999999999999974 12399999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++........ ......||+.|+|||
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~~~y~aPE 186 (279)
T 2w5a_A 160 FGLARILNHDTS--FAKTFVGTPYYMSPE 186 (279)
T ss_dssp CCHHHHC---CH--HHHHHHSCCTTCCHH
T ss_pred Cchheeeccccc--cccccCCCccccChH
Confidence 999865432211 113456899999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=218.72 Aligned_cols=167 Identities=25% Similarity=0.364 Sum_probs=131.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEE-----------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCV----------- 132 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~----------- 132 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468899999999999999999987 688999998864432 2467889999999999999999999874
Q ss_pred ---eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-
Q 025893 133 ---DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF- 208 (246)
Q Consensus 133 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~- 208 (246)
.....++||||+. |+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----------PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINT 155 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEET
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----------CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 3467899999997 6999998643 2788999999999999999999997 99999999999998
Q ss_pred CCCceEEccccCCCCCCcccc-ccccccccccccccCCC
Q 025893 209 DDDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 209 ~~~~~kl~Dfgls~~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
.++.+||+|||+++....... ........||+.|+|||
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcH
Confidence 567999999999986532211 11123446899999997
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=237.94 Aligned_cols=168 Identities=30% Similarity=0.430 Sum_probs=137.2
Q ss_pred HhcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|.+.+.||+|+||.||+|.+.. +..+|+|.+...... .+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEE
Confidence 4678888999999999999998752 456999988654332 36788999999999999999999998 4567899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 468 v~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp EEECCTTCBHHHHHHHTT--------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCCCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 999999999999997543 13789999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++........ ......||+.|+|||
T Consensus 537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE 562 (656)
T 2j0j_A 537 LSRYMEDSTYY-KASKGKLPIKWMAPE 562 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHH
T ss_pred CCeecCCCcce-eccCCCCCcceeCHH
Confidence 99876433221 123345788999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=218.17 Aligned_cols=167 Identities=28% Similarity=0.446 Sum_probs=137.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--CCCEEEEEEcCCCC---CCHHHHHHHHHHHhcC---CCCCccceEeEEE-----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASK---QPDEEFLAQVSMVSRL---KHENFVQLLGYCV----- 132 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vaik~~~~~~---~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~----- 132 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999973 67889999885322 2233566677766655 8999999999987
Q ss_pred eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 133 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
.....++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCT-------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCC
Confidence 4567899999997 699999876432 23889999999999999999999997 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++...... ......||+.|+|||
T Consensus 159 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE 189 (326)
T 1blx_A 159 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 189 (326)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHH
T ss_pred EEEecCcccccccCCC---CccccccccceeCHH
Confidence 9999999998764322 224567999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=217.88 Aligned_cols=169 Identities=30% Similarity=0.395 Sum_probs=124.4
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|...+.||+|+||.||+|..+ +++.||+|.+...... ...+..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 58888999999999999999986 7889999998654332 234555665 7788899999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|+.+ +|.+++...... ....+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp CCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 9975 887777531100 012488999999999999999999997 7 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... .....||+.|+|||
T Consensus 174 ~~~~~~~~---~~~~~gt~~y~aPE 195 (327)
T 3aln_A 174 GQLVDSIA---KTRDAGCRPYMAPE 195 (327)
T ss_dssp CC-----------------------
T ss_pred eecccccc---cccCCCCccccCce
Confidence 87543221 23347999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=224.50 Aligned_cols=168 Identities=24% Similarity=0.366 Sum_probs=141.9
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------CHHHHHHHHHHHhcCC--CCCccceEeEEE
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLK--HENFVQLLGYCV 132 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-------~~~~~~~e~~~l~~l~--hp~iv~~~~~~~ 132 (246)
..+.++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+..|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344678999999999999999999975 788999999854322 2245667899999996 599999999999
Q ss_pred eCCeeEEEEecCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CC
Q 025893 133 DGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DD 210 (246)
Q Consensus 133 ~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~-~~ 210 (246)
..+..++|+|++.+ ++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++ .+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 99999999999976 89999987543 3788999999999999999999997 99999999999999 78
Q ss_pred CceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.+||+|||+++...... .....||+.|+|||
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE 218 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 218 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHH
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChH
Confidence 999999999987654321 23457999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=219.06 Aligned_cols=165 Identities=22% Similarity=0.322 Sum_probs=120.8
Q ss_pred HHhcCCCC-ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeE
Q 025893 65 ITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRV 138 (246)
Q Consensus 65 ~~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~ 138 (246)
+.++|.+. ++||+|+||.||+|..+ +++.||+|.+.... .........++.++||||+++++++.. ....+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 35688885 46999999999999987 78999999985432 222223334677789999999999876 45589
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEE
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKI 215 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl 215 (246)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 103 lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEE
Confidence 99999999999999976432 24889999999999999999999997 999999999999986 456999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++...... .....||+.|+|||
T Consensus 173 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 173 TDFGFAKETTQNA----LQTPCYTPYYVAPE 199 (336)
T ss_dssp CCCTTCEEC----------------------
T ss_pred eccccceeccccc----cccCCCCcCccChh
Confidence 9999987543221 23467899999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=214.51 Aligned_cols=169 Identities=23% Similarity=0.387 Sum_probs=134.9
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEE-EeCCeeEEEEe
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC-VDGTSRVLAYE 142 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~E 142 (246)
+.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+..|+.+++.++|++++..+..+ ......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4578999999999999999999975 78899999864332 223577899999999988877766655 66788899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCceEEcccc
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFD 219 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~---~~~~~~kl~Dfg 219 (246)
|+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 86 ~~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp CC-CCBHHHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred cc-CCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 99 999999987432 13889999999999999999999997 9999999999999 788999999999
Q ss_pred CCCCCCccccc-----cccccccccccccCCC
Q 025893 220 LSNQAPDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
+++........ .......||+.|+|||
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchH
Confidence 99765432211 1123567999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=228.02 Aligned_cols=162 Identities=12% Similarity=0.044 Sum_probs=119.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHH---HHHhcCCCCCccceE-------eEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQV---SMVSRLKHENFVQLL-------GYC 131 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~---~~l~~l~hp~iv~~~-------~~~ 131 (246)
.+|.+.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+ .+++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 35888899999999999999976 7889999999765532 24566774 45555 799988755 455
Q ss_pred EeC-----------------CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHh
Q 025893 132 VDG-----------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR------VKIAVGAAKGLEYLH 188 (246)
Q Consensus 132 ~~~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~lH 188 (246)
... ...++||||++ |+|.+++..... .+.+..+ ..++.||+.||.|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--------VYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--------SCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--------ccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 433 23799999998 899999975421 1333344 567799999999999
Q ss_pred hCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 189 ~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++ |+||||||+|||++.++.+||+|||+++...... ....||+.|+|||
T Consensus 212 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE 261 (371)
T 3q60_A 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPRE 261 (371)
T ss_dssp HTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHH
T ss_pred HCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChh
Confidence 997 9999999999999999999999999987643221 1345779999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=226.53 Aligned_cols=168 Identities=24% Similarity=0.384 Sum_probs=138.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC-CCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ...+..|+.+++.|+| ++|..+..++......+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 468999999999999999999975 789999998754332 2357889999999987 5666677777788899999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCceEEccccC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDL 220 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~---~~~~~~kl~Dfgl 220 (246)
+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~-g~sL~~ll~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred C-CCCHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9 999999997432 13899999999999999999999997 9999999999999 5789999999999
Q ss_pred CCCCCccccc-----cccccccccccccCCC
Q 025893 221 SNQAPDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
++........ .......||+.|+|||
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 183 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVN 183 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ceeccCCccccccccccccccCCCccccCHH
Confidence 9765432221 1123567999999997
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=212.31 Aligned_cols=168 Identities=23% Similarity=0.383 Sum_probs=138.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEE-EeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC-VDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~E~ 143 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.+++.++|++++..+..+ ......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 468999999999999999999974 78999999875443 234688999999999988876666555 567788999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCceEEccccC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDL 220 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~---~~~~~~kl~Dfgl 220 (246)
+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred c-CCCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 9 899999997432 13889999999999999999999997 9999999999999 4788999999999
Q ss_pred CCCCCccccc-----cccccccccccccCCC
Q 025893 221 SNQAPDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
+......... .......||+.|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHH
T ss_pred cccccccccccccccccccccccccccCChh
Confidence 8765432211 1124567999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=214.74 Aligned_cols=169 Identities=30% Similarity=0.476 Sum_probs=129.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC--CCC--EEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK--SGH--AAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~--~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|.+. ++. .||+|.+..... ..+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 358999999999999999999853 333 589998865422 2357889999999999999999999997655 8
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++|+||+++++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcc
Confidence 899999999999999875421 3788999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025893 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
||++......... .......+|+.|+|||
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHH
T ss_pred ccccccccccccchhhhccCCCCceeeCch
Confidence 9998765432211 1123346788999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=219.60 Aligned_cols=165 Identities=20% Similarity=0.351 Sum_probs=138.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CC-CEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC------ccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SG-HAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN------FVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~------iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|... ++ ..||+|.+.......+.+.+|+.++++++|++ ++.+.+++......
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999975 44 68999999755444567888999999887766 89999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----------
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---------- 207 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~---------- 207 (246)
++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF-------QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEecc-CCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence 9999999 6677777765431 13889999999999999999999997 9999999999999
Q ss_pred ---------cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 ---------FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ---------~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++..... .....||+.|+|||
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE 209 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPE 209 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHH
T ss_pred ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCe
Confidence 56789999999998753321 24567999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=219.27 Aligned_cols=172 Identities=24% Similarity=0.358 Sum_probs=127.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCC-CCCccceEeEEEe--------CC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLK-HENFVQLLGYCVD--------GT 135 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--------~~ 135 (246)
.+|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47899999999999999999976 789999998854332 2456889999999996 9999999999853 34
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..+++|||+. |+|.+++..... ...+++..+..++.||+.||.|||+++ ++|+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMES------RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHT------TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred eEEEEEEecC-CCHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 4789999996 799988864221 113889999999999999999999973 34999999999999999999999
Q ss_pred ccccCCCCCCcccccc----------ccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARL----------HSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~----------~~~~~~gt~~y~aPE 246 (246)
+|||++.......... ......||+.|+|||
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220 (337)
T ss_dssp CCCTTCBCCSSCC----------------------------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence 9999997754322110 112456999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=223.71 Aligned_cols=164 Identities=22% Similarity=0.286 Sum_probs=138.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-----------CCCccceEeEEEeC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----------HENFVQLLGYCVDG 134 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-----------hp~iv~~~~~~~~~ 134 (246)
++|.+.+.||+|+||.||+|... +++.||+|.+.......+.+.+|+.++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 58999999999999999999975 7889999999765445567888999988876 89999999998865
Q ss_pred C----eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEec-
Q 025893 135 T----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIF- 208 (246)
Q Consensus 135 ~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~- 208 (246)
. ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEI 167 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhc-------cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEec
Confidence 4 789999999 8899999976432 1388899999999999999999997 7 99999999999995
Q ss_pred -----CCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 209 -----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 209 -----~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..+.+||+|||++...... .....||+.|+|||
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE 205 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPE 205 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHH
T ss_pred cCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcH
Confidence 3348999999998764321 23457999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=221.46 Aligned_cols=168 Identities=25% Similarity=0.312 Sum_probs=138.4
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CC-----CccceEeEEEeCCee
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HE-----NFVQLLGYCVDGTSR 137 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp-----~iv~~~~~~~~~~~~ 137 (246)
+.++|.+.+.||+|+||.||+|... +++.||+|.+.........+..|+.+++.++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4578999999999999999999976 7888999999755434456777888888775 44 499999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCCceEE
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDDVAKI 215 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~--~~~~~kl 215 (246)
++||||+. ++|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNF-------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred EEEEecCC-CCHHHHHhhcCc-------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999996 599999976431 1388999999999999999999953 12499999999999995 4778999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++..... ....+||+.|+|||
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE 228 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPE 228 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHH
T ss_pred EeccCceecccc-----cccccCCccccChH
Confidence 999998764321 23567999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=217.95 Aligned_cols=167 Identities=29% Similarity=0.430 Sum_probs=135.5
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||.||+|..+. .+|+|.+..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4688999999999999999998763 589999864432 23567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ ++.+||+|||++.
T Consensus 110 ~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CCCSEEHHHHTTSSC--------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred cccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999996543 13788899999999999999999997 99999999999998 6799999999987
Q ss_pred CCCcccc---ccccccccccccccCCC
Q 025893 223 QAPDMAA---RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~---~~~~~~~~gt~~y~aPE 246 (246)
....... ........||+.|+|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE 204 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPE 204 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHH
T ss_pred ccccccccccccccccCCCcccccChH
Confidence 5432111 11123446999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=225.73 Aligned_cols=166 Identities=23% Similarity=0.305 Sum_probs=129.1
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.+|...+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....|+||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46888899999999997755566789999999864332 2356799999999 79999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-----CCceEEccccC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-----DDVAKIADFDL 220 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-----~~~~kl~Dfgl 220 (246)
|+|.+++..... .+.+..+..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+
T Consensus 102 -g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 102 -ATLQEYVEQKDF--------AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp -EEHHHHHHSSSC--------CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred -CCHHHHHHhcCC--------CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 599999976542 1333345689999999999999997 999999999999953 23688999999
Q ss_pred CCCCCccccc-cccccccccccccCCC
Q 025893 221 SNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
++........ ......+||+.|+|||
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE 196 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPE 196 (432)
T ss_dssp EECC------------CCSCTTSCCGG
T ss_pred eeeccCCCcceeeccccCCCcCccChh
Confidence 9775432211 1224567999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=226.38 Aligned_cols=172 Identities=22% Similarity=0.290 Sum_probs=126.7
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345556889999999998776668999999988543 245678899999876 89999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-------------Cc
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-------------DV 212 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~-------------~~ 212 (246)
|+|.+++......... .....+..++.++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 93 -gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 93 -LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp -EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred -CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 6999999765421100 011123345679999999999999997 9999999999999754 48
Q ss_pred eEEccccCCCCCCcccccc--ccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~--~~~~~~gt~~y~aPE 246 (246)
+||+|||+++......... .....+||+.|+|||
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 202 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence 9999999997654322111 123457999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=212.96 Aligned_cols=166 Identities=26% Similarity=0.394 Sum_probs=122.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+....... +.+..+..+++.++||||+++++++......++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468888999999999999999986 78999999986554322 22334455788889999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||+ ++.+..+..... ..+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+
T Consensus 104 e~~-~~~~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--------GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp CCC-SEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCC
Confidence 999 556655554321 1388999999999999999999985 6 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+........ .....||+.|+|||
T Consensus 172 ~~~~~~~~~---~~~~~~~~~y~aPE 194 (318)
T 2dyl_A 172 SGRLVDDKA---KDRSAGCAAYMAPE 194 (318)
T ss_dssp C-----------------CCTTCCHH
T ss_pred chhccCCcc---ccccCCCccccChh
Confidence 876543221 23457999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=232.34 Aligned_cols=169 Identities=26% Similarity=0.392 Sum_probs=139.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEe------CCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD------GTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~------~~~ 136 (246)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|+.++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999975 7899999998654322 3568899999999999999999998765 677
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---e
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---A 213 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~---~ 213 (246)
.++||||+++|+|.+++...... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEE
T ss_pred EEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeE
Confidence 89999999999999999764321 23777888999999999999999997 999999999999996654 9
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||++........ .....||+.|+|||
T Consensus 164 KL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE 193 (676)
T 3qa8_A 164 KIIDLGYAKELDQGEL---CTEFVGTLQYLAPE 193 (676)
T ss_dssp EECSCCCCCBTTSCCC---CCCCCSCCTTCSSC
T ss_pred EEcccccccccccccc---cccccCCcccCChH
Confidence 9999999987543221 24567999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=206.21 Aligned_cols=144 Identities=13% Similarity=0.090 Sum_probs=127.6
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH----HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~----~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.+.|.+.+.||+|+||.||+|... +++.||+|.+....... +.+.+|+.++.+++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999976 68999999997654432 6788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.++++.. ....++..++.|++.||.|||+++ |+||||||+|||++.++.+||++++.
T Consensus 110 ~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~ 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT 175 (286)
T ss_dssp EECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC
T ss_pred EEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc
Confidence 9999999999998532 344567889999999999999997 99999999999999999999998876
Q ss_pred CCC
Q 025893 221 SNQ 223 (246)
Q Consensus 221 s~~ 223 (246)
...
T Consensus 176 ~~~ 178 (286)
T 3uqc_A 176 MPD 178 (286)
T ss_dssp CTT
T ss_pred cCC
Confidence 543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=228.17 Aligned_cols=154 Identities=18% Similarity=0.178 Sum_probs=119.5
Q ss_pred CCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC---------HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~---------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
...+.||+|+||.||+|.. .+..+++|+....... .+.+.+|+.++++++||||+++..++......|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999944 4778888886543322 13478999999999999999776677788888999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++++|.+++.. ++.++.|++.||.|||+++ |+||||||+|||++. .+||+|||+
T Consensus 418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 999999999999854 2478999999999999997 999999999999999 999999999
Q ss_pred CCCCCcccccc-----ccccccccccccCCC
Q 025893 221 SNQAPDMAARL-----HSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~-----~~~~~~gt~~y~aPE 246 (246)
++......... ....++||+.|||||
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APE 506 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDE 506 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHH
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHH
Confidence 98765432211 124678999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=199.67 Aligned_cols=146 Identities=19% Similarity=0.346 Sum_probs=126.4
Q ss_pred HhcCCCC-ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHH-hcCCCCCccceEeEEEe----CCeeE
Q 025893 66 TENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMV-SRLKHENFVQLLGYCVD----GTSRV 138 (246)
Q Consensus 66 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~----~~~~~ 138 (246)
.++|.+. +.||+|+||.||++... +++.||+|.+.. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 4577776 78999999999999975 789999999853 35677888887 66789999999999987 67789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEE
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKI 215 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl 215 (246)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEE
Confidence 99999999999999976432 23889999999999999999999997 999999999999997 788999
Q ss_pred ccccCCCCCC
Q 025893 216 ADFDLSNQAP 225 (246)
Q Consensus 216 ~Dfgls~~~~ 225 (246)
+|||++....
T Consensus 162 ~Dfg~a~~~~ 171 (299)
T 3m2w_A 162 TDFGFAKETT 171 (299)
T ss_dssp CCCTTCEECT
T ss_pred eccccccccc
Confidence 9999986543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=206.87 Aligned_cols=168 Identities=13% Similarity=0.170 Sum_probs=122.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHhcCCC-CCcc---------c-----
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKH-ENFV---------Q----- 126 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~----~~~~~~~e~~~l~~l~h-p~iv---------~----- 126 (246)
.+|...+.||+|+||.||+|.+. +++.||||.+..... ..+.+.+|+.+++.++| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35667789999999999999965 799999999873322 24678899999999987 2211 1
Q ss_pred -------eEeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025893 127 -------LLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194 (246)
Q Consensus 127 -------~~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 194 (246)
+..++.. ....+++|+++ +++|.+++....... .....+++..++.++.||+.||.|||+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12346667765 679998884211000 00123778888999999999999999997
Q ss_pred eeeCCCCCCCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 195 ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE 277 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPE 277 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCch
Confidence 999999999999999999999999998764332 245678 9999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=189.21 Aligned_cols=133 Identities=14% Similarity=0.144 Sum_probs=108.0
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC-------------------CHHHHHHHHHHHhcCCCCCccceE
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-------------------PDEEFLAQVSMVSRLKHENFVQLL 128 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~-------------------~~~~~~~e~~~l~~l~hp~iv~~~ 128 (246)
.|.+.+.||+|+||.||+|...+++.+|+|.+..... ....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4556689999999999999997789999999864321 1345789999999999 4 5666
Q ss_pred eEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 025893 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 208 (246)
Q Consensus 129 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~ 208 (246)
+++. .+..++||||++|++|.+ +.. .....++.|++.||.|||+++ |+||||||+|||++
T Consensus 168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 168 KVYA-WEGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp CEEE-EETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred eEEe-ccceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 6543 356799999999999987 421 123468999999999999997 99999999999999
Q ss_pred CCCceEEccccCCCCC
Q 025893 209 DDDVAKIADFDLSNQA 224 (246)
Q Consensus 209 ~~~~~kl~Dfgls~~~ 224 (246)
++.+||+|||+++..
T Consensus 228 -~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEV 242 (282)
T ss_dssp -TTEEEECCCTTCEET
T ss_pred -CCcEEEEECCCCeEC
Confidence 999999999998654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=169.44 Aligned_cols=136 Identities=18% Similarity=0.191 Sum_probs=104.7
Q ss_pred CCCCceeccCCceEEEEEEE-CCCCE--EEEEEcCCCCCC-------------------------HHHHHHHHHHHhcCC
Q 025893 69 FGTNALIGEGSYGRVYYGIL-KSGHA--AAIKKLDASKQP-------------------------DEEFLAQVSMVSRLK 120 (246)
Q Consensus 69 ~~~~~~lG~G~fg~V~~~~~-~~~~~--vaik~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 120 (246)
|.+.+.||+|+||.||+|.. .+|+. ||||.+...... ...+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 58888 999987543211 125778999999998
Q ss_pred CCCc--cceEeEEEeCCeeEEEEecCCC-C----CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCC
Q 025893 121 HENF--VQLLGYCVDGTSRVLAYEFASN-G----SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKAD 192 (246)
Q Consensus 121 hp~i--v~~~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~ 192 (246)
|+++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +++
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 8764 334432 356899999942 3 67766532 123345688999999999999 886
Q ss_pred CCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 193 ~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
|+||||||+|||++. .++|+|||+|....
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999999998 99999999987543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-20 Score=160.27 Aligned_cols=135 Identities=13% Similarity=0.188 Sum_probs=97.3
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC---------------CHHHH--------HHHHHHHhcCCCCCc
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---------------PDEEF--------LAQVSMVSRLKHENF 124 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~---------------~~~~~--------~~e~~~l~~l~hp~i 124 (246)
-|.+...||+|+||.||+|...+|+.||||.++.... ..... .+|...|.+|.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999988899999998753210 11111 245666666654443
Q ss_pred cceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 025893 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (246)
Q Consensus 125 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~N 204 (246)
....-+... ..+|||||+.|++|.++.. . .....++.|++.+|.|||.++ ||||||||.|
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N 235 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVSS-------------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFN 235 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCCC-------------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhcc-------------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 322222222 2379999999988865432 1 123467899999999999997 9999999999
Q ss_pred eEecCCC----------ceEEccccCCC
Q 025893 205 VLIFDDD----------VAKIADFDLSN 222 (246)
Q Consensus 205 il~~~~~----------~~kl~Dfgls~ 222 (246)
||+++++ .+.|+||+-+.
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EEEeCCCCcccccccccceEEEEeCCcc
Confidence 9998766 38899998653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-14 Score=117.62 Aligned_cols=146 Identities=17% Similarity=0.126 Sum_probs=112.8
Q ss_pred HHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEE
Q 025893 63 KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 63 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 140 (246)
......|.....++.|+.+.||++... ++.+++|...... .....+.+|+.+++.|. +..+.++++++...+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 445567888888888999999998754 6789999886421 22346888999998885 67888999999998999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA----------------------------- 191 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------- 191 (246)
|||++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EECCSSEEHHHHCCTT--------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred EEecCCeehhhccCCc--------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 9999999998764211 112367788999999999810
Q ss_pred ---------------------------CCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 192 ---------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 192 ---------------------------~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.+.++|+|++|.|||++....+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.6e-12 Score=104.77 Aligned_cols=137 Identities=13% Similarity=0.055 Sum_probs=97.5
Q ss_pred cCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC--ccceEeEEEeCCeeEEEEecCC
Q 025893 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--FVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.+.+..+.+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34333333456679999997767778999987543 2345678888888886433 5678888888888899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA---------------------------------- 191 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------- 191 (246)
|.+|. ... .. ...++.+++..|..||+..
T Consensus 99 G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 99 GQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp SEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 98874 211 11 1245666777777777642
Q ss_pred ---------------------CCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 192 ---------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 192 ---------------------~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.+.++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=8.6e-12 Score=105.62 Aligned_cols=140 Identities=18% Similarity=0.246 Sum_probs=102.6
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcC--CCC--CCHHHHHHHHHHHhcCC--CCCccceEeEEEeC---CeeEEEEe
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLD--ASK--QPDEEFLAQVSMVSRLK--HENFVQLLGYCVDG---TSRVLAYE 142 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~--~~~--~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~---~~~~lv~E 142 (246)
.+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.|. +..+++++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 457899999999998765 4577888765 332 22356778999998887 45688899888766 44799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------------------------------- 191 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------- 191 (246)
|++|..+.+... ..++......++.+++..|..||+..
T Consensus 122 ~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp CCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred ecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 999877643110 12667777888999999999999731
Q ss_pred ------------------------CCCeeeCCCCCCCeEecCCC--ceEEccccCCCC
Q 025893 192 ------------------------DPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQ 223 (246)
Q Consensus 192 ------------------------~~~ivHrdlkp~Nil~~~~~--~~kl~Dfgls~~ 223 (246)
.+.++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 23599999999999999764 368999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=7.9e-09 Score=85.32 Aligned_cols=136 Identities=19% Similarity=0.195 Sum_probs=92.3
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCC--ccceEeEEEeCC---eeEEEEecCC
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HEN--FVQLLGYCVDGT---SRVLAYEFAS 145 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~--iv~~~~~~~~~~---~~~lv~E~~~ 145 (246)
.+.++.|....||+.. ..+++|..... .....+..|+.+++.+. +.. +.+++....... ..|+|||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999763 56788875322 22456888999998874 332 445555443333 3488999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----------------------------------
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK----------------------------------- 190 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------------------------------- 190 (246)
|.+|.+.... .++..+...++.+++..|..||+.
T Consensus 100 G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 100 GVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred CeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 9877643221 145555666677777777777651
Q ss_pred --------------------CCCCeeeCCCCCCCeEecC--CCceEEccccCCCC
Q 025893 191 --------------------ADPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQ 223 (246)
Q Consensus 191 --------------------~~~~ivHrdlkp~Nil~~~--~~~~kl~Dfgls~~ 223 (246)
..+.++|+|++|.||+++. ...+.|+||+.+..
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 1134899999999999997 45678999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.2e-07 Score=78.51 Aligned_cols=74 Identities=15% Similarity=0.117 Sum_probs=53.2
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCC---CccceEeEEE-eCCeeEEEEecCCCCC
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---NFVQLLGYCV-DGTSRVLAYEFASNGS 148 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp---~iv~~~~~~~-~~~~~~lv~E~~~~g~ 148 (246)
..++.|....||+. +..+++|.-. .......+..|+.+|+.|.+. .+.+++.+.. ..+..+++||+++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 46788888899987 5677888742 112235688999999998742 3567777764 3456789999999987
Q ss_pred HHH
Q 025893 149 LHD 151 (246)
Q Consensus 149 L~~ 151 (246)
+..
T Consensus 100 l~~ 102 (306)
T 3tdw_A 100 LGE 102 (306)
T ss_dssp CHH
T ss_pred Cch
Confidence 765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.2e-07 Score=76.55 Aligned_cols=134 Identities=14% Similarity=0.104 Sum_probs=89.4
Q ss_pred eccCCce-EEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCCHHH
Q 025893 75 IGEGSYG-RVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (246)
Q Consensus 75 lG~G~fg-~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 151 (246)
+..|..+ .||+.... .+..+.+|.-... ....+..|..+|+.|. +-.+.+++.++.+.+..++|||+++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445444 68987765 4567888875322 2456778999888775 3347788999999999999999999987765
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----------------------------------------
Q 025893 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK----------------------------------------- 190 (246)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------------------------------------- 190 (246)
...... .....+..+++..|.-||..
T Consensus 110 ~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 110 VLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp HHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 442211 11122333444444444421
Q ss_pred --------------CCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 191 --------------ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 191 --------------~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
..+.++|+|+.+.|||++..+.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999877777999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=2.7e-07 Score=77.70 Aligned_cols=78 Identities=6% Similarity=0.006 Sum_probs=52.8
Q ss_pred cee-ccCCceEEEEEEEC-------CCCEEEEEEcCCCC---C-CHHHHHHHHHHHhcCC-C--CCccceEeEEEeC---
Q 025893 73 ALI-GEGSYGRVYYGILK-------SGHAAAIKKLDASK---Q-PDEEFLAQVSMVSRLK-H--ENFVQLLGYCVDG--- 134 (246)
Q Consensus 73 ~~l-G~G~fg~V~~~~~~-------~~~~vaik~~~~~~---~-~~~~~~~e~~~l~~l~-h--p~iv~~~~~~~~~--- 134 (246)
+.| +.|..+.+|+.... ++..+++|...... . ....+..|+.+++.|. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999987654 25678888764332 1 1245677888887774 2 3577888877655
Q ss_pred CeeEEEEecCCCCCHH
Q 025893 135 TSRVLAYEFASNGSLH 150 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~ 150 (246)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=6.1e-06 Score=70.47 Aligned_cols=74 Identities=18% Similarity=0.040 Sum_probs=49.0
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEcCCCC--------CCHHHHHHHHHHHhcCCC--C-CccceEeEEEeCCeeEE
Q 025893 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--------QPDEEFLAQVSMVSRLKH--E-NFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~--------~~~~~~~~e~~~l~~l~h--p-~iv~~~~~~~~~~~~~l 139 (246)
.+.||.|.++.||++... .++.+++|...... ...+.+..|..+++.+.. | .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 46789999764321 123456778888877642 3 34566644 4556789
Q ss_pred EEecCCCC
Q 025893 140 AYEFASNG 147 (246)
Q Consensus 140 v~E~~~~g 147 (246)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.8e-05 Score=65.70 Aligned_cols=147 Identities=18% Similarity=0.279 Sum_probs=77.8
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-----CCCccceE-e--EEEeCCeeEEEEecC
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENFVQLL-G--YCVDGTSRVLAYEFA 144 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-----hp~iv~~~-~--~~~~~~~~~lv~E~~ 144 (246)
..|+.|..+.||+....++ .+++|.... ....+..|+.+++.|. .|.++... + +....+..++++||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3455567889999876544 588888764 2344444555555443 34443310 1 123466788999999
Q ss_pred CCCCHH-----------H---HhccC-CCC--C-CC-CCCCCCCHHHH-------------------------------H
Q 025893 145 SNGSLH-----------D---ILHGR-KGV--K-GA-QPGPVLSWQQR-------------------------------V 174 (246)
Q Consensus 145 ~~g~L~-----------~---~l~~~-~~~--~-~~-~~~~~l~~~~~-------------------------------~ 174 (246)
+|..+. . .++.. ... . .. .......|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 985431 0 11111 101 0 00 00011123211 0
Q ss_pred HHHHHHHHHHHHHhh----------CCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 175 KIAVGAAKGLEYLHE----------KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 175 ~i~~~i~~~l~~lH~----------~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.+...+..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123345556652 0123599999999999998778899999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.3e-05 Score=65.74 Aligned_cols=72 Identities=14% Similarity=0.164 Sum_probs=43.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCC-----CC---C--CHHHHHHHHHHHh-cCCCCCccceEeEEEeCCeeEEE
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDA-----SK---Q--PDEEFLAQVSMVS-RLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~-----~~---~--~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.+.||.|..+.||++.. ++..+++|.... .. . ....+..|+..+. ......+.+++.+. ....++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45689999999999864 466788994321 11 1 2223333332222 22234567777665 5677999
Q ss_pred EecC-CC
Q 025893 141 YEFA-SN 146 (246)
Q Consensus 141 ~E~~-~~ 146 (246)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.97 E-value=0.0002 Score=59.15 Aligned_cols=94 Identities=9% Similarity=0.063 Sum_probs=59.7
Q ss_pred ccccCHHHHHHHHhcCCC-----CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC--CCccc
Q 025893 54 VPAISVDELKEITENFGT-----NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH--ENFVQ 126 (246)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~ 126 (246)
...++.+.+......|.+ ...|+ |....||+....+|+.+++|.........+.+..|..+++.|.. -.+++
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecc
Confidence 345666667666666643 23466 77788998776667778999886544456677778877776642 12344
Q ss_pred eEeE-----EEeCCeeEEEEecCCCCC
Q 025893 127 LLGY-----CVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 127 ~~~~-----~~~~~~~~lv~E~~~~g~ 148 (246)
++.. ....+..++++|+++|..
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCC
Confidence 4332 223456678999998743
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.95 E-value=5.4e-05 Score=62.63 Aligned_cols=143 Identities=17% Similarity=0.156 Sum_probs=89.9
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
..|+.|....+|+... ++..+++|..... ....+..|+..|+.|. ...+++++.+....+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 5689999999999875 3667888876432 3566788988888774 36788899888888889999999998654
Q ss_pred H--------H---HhccCCC-CCC--C----------CCCCCCCHHHHH---HHHH----------------HHHHHH-H
Q 025893 150 H--------D---ILHGRKG-VKG--A----------QPGPVLSWQQRV---KIAV----------------GAAKGL-E 185 (246)
Q Consensus 150 ~--------~---~l~~~~~-~~~--~----------~~~~~l~~~~~~---~i~~----------------~i~~~l-~ 185 (246)
. . .|+.... ... . .....-.|.... ++.. .++..+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 1 1 1222111 000 0 000112454332 1111 111111 2
Q ss_pred HHhh-CCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 186 YLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 186 ~lH~-~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
.|.. ...+.++|+|+.+.|++++.++ +-|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3422 2245699999999999999877 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.93 E-value=0.0001 Score=60.01 Aligned_cols=75 Identities=23% Similarity=0.225 Sum_probs=53.7
Q ss_pred CCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCC---CCccceEeEEEeCCeeEEEEecCC
Q 025893 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKH---ENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~h---p~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.....+|.|..+.||+....+|+.+.+|.-..... ....+..|+..|+.|.- -.+.+++++. ..++||||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 34567899999999999999999999998654432 23467789988887742 2345555542 3478999987
Q ss_pred CCC
Q 025893 146 NGS 148 (246)
Q Consensus 146 ~g~ 148 (246)
++.
T Consensus 94 ~~~ 96 (288)
T 3f7w_A 94 ERP 96 (288)
T ss_dssp CCC
T ss_pred ccC
Confidence 654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00013 Score=59.85 Aligned_cols=71 Identities=7% Similarity=0.031 Sum_probs=41.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecC-CCCCH
Q 025893 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFA-SNGSL 149 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~E~~-~~g~L 149 (246)
.+.|+.|....+|+. ..+++|..........+...|+.+++.+...++ .+++.+ +...-++++||+ +|.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 567888999999998 457788765432111122356666665542222 455544 344457899999 65433
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00013 Score=60.24 Aligned_cols=166 Identities=15% Similarity=0.204 Sum_probs=86.7
Q ss_pred ccCHHHHHHHHhcCCCC-----ceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-----CCCcc
Q 025893 56 AISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENFV 125 (246)
Q Consensus 56 ~~~~~~~~~~~~~~~~~-----~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-----hp~iv 125 (246)
.++.+++..+...|.+. +.|+.|....+|+....++ .+++|..... ...+.+..|+.+++.|. -|.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 45667777777778662 3456687888999876655 6778887642 12234555666665553 23333
Q ss_pred ceE-e--EEEeCCeeEEEEecCCCCCHH-----------H---HhccC-CCCCCCC--CCCCCCHHHHHH----------
Q 025893 126 QLL-G--YCVDGTSRVLAYEFASNGSLH-----------D---ILHGR-KGVKGAQ--PGPVLSWQQRVK---------- 175 (246)
Q Consensus 126 ~~~-~--~~~~~~~~~lv~E~~~~g~L~-----------~---~l~~~-~~~~~~~--~~~~l~~~~~~~---------- 175 (246)
... | +....+..+++++|++|..+. . .++.. ....... ......|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 210 1 112345678999999875421 0 01111 1111000 000011222100
Q ss_pred --HHHHHHHHHHHHhhC----CCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 176 --IAVGAAKGLEYLHEK----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 176 --i~~~i~~~l~~lH~~----~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+...+...+.++... ....++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344455421 122489999999999998776668999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00023 Score=60.45 Aligned_cols=145 Identities=16% Similarity=0.178 Sum_probs=79.4
Q ss_pred ceeccCCceEEEEEEEC--------CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEec
Q 025893 73 ALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+.|..|-...+|+.... ++..+.+|.............+|..+++.|. +.-..++++.+. + .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 45666777889998864 2467888876433334566778988887775 222356766653 2 288999
Q ss_pred CCCCCHH--------------HHh---ccCCCCCCCCCCCCCCHHHHHHHHHHHH-------------------HHHHH-
Q 025893 144 ASNGSLH--------------DIL---HGRKGVKGAQPGPVLSWQQRVKIAVGAA-------------------KGLEY- 186 (246)
Q Consensus 144 ~~~g~L~--------------~~l---~~~~~~~~~~~~~~l~~~~~~~i~~~i~-------------------~~l~~- 186 (246)
++|..|. +.| +.... . ....+..-+.++.++..++. ..+.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~-~-~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEM-P-FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC-S-SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCC-C-CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9875432 111 11110 0 00001112344444433321 11222
Q ss_pred ---HhhCC-CCCeeeCCCCCCCeEecCC----CceEEccccCCCC
Q 025893 187 ---LHEKA-DPHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQ 223 (246)
Q Consensus 187 ---lH~~~-~~~ivHrdlkp~Nil~~~~----~~~kl~Dfgls~~ 223 (246)
|.... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32221 2258999999999999876 6899999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0012 Score=54.58 Aligned_cols=31 Identities=23% Similarity=0.407 Sum_probs=26.2
Q ss_pred CCeeeCCCCCCCeEecCC----CceEEccccCCCC
Q 025893 193 PHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQ 223 (246)
Q Consensus 193 ~~ivHrdlkp~Nil~~~~----~~~kl~Dfgls~~ 223 (246)
+.++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 359999999999999864 6789999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00024 Score=61.37 Aligned_cols=69 Identities=12% Similarity=0.135 Sum_probs=46.5
Q ss_pred ceeccCCceEEEEEEECC--------CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC-ccceEeEEEeCCeeEEEEec
Q 025893 73 ALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~E~ 143 (246)
+.|+.|-...+|++...+ +..+++|+.... ...+.+..|..+++.|...+ ..++++.+. + .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 467788889999998652 467888877332 22256678888888775333 356776553 2 378999
Q ss_pred CCC
Q 025893 144 ASN 146 (246)
Q Consensus 144 ~~~ 146 (246)
++|
T Consensus 154 l~G 156 (429)
T 1nw1_A 154 IPS 156 (429)
T ss_dssp CCE
T ss_pred eCC
Confidence 976
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0011 Score=57.74 Aligned_cols=72 Identities=11% Similarity=-0.018 Sum_probs=43.6
Q ss_pred ceeccCCceEEEEEEECC-CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecCCCCC
Q 025893 73 ALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGS 148 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~E~~~~g~ 148 (246)
+.|+.|-...+|+....+ +..+++|.........-+-..|..+++.|...++ .++++.+ .+ .+|+||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 357777788899988764 4678888764322111112467788887764444 5677766 23 25899998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00036 Score=58.76 Aligned_cols=72 Identities=11% Similarity=0.014 Sum_probs=40.6
Q ss_pred ceeccCCceEEEEEEECC---------CCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCC-ccceEeEEEeCCeeEEEEe
Q 025893 73 ALIGEGSYGRVYYGILKS---------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~---------~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~E 142 (246)
..|+.|....+|+..... +..+++|..........+...|..+++.|...+ +.++++.. . -++++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457778888899987653 257788876432211112346777776664223 44666544 2 368999
Q ss_pred cCCCCC
Q 025893 143 FASNGS 148 (246)
Q Consensus 143 ~~~~g~ 148 (246)
|++|..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.011 Score=49.25 Aligned_cols=30 Identities=30% Similarity=0.436 Sum_probs=26.3
Q ss_pred CeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 194 ~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 589999999999999878899999987643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0062 Score=52.41 Aligned_cols=72 Identities=7% Similarity=-0.041 Sum_probs=43.6
Q ss_pred ceeccCCceEEEEEEECC--------CCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEec
Q 025893 73 ALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+.|..|--..+|+..... +..++++.........-+..+|..+++.|. +.-..++++.+ . -++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 456667788899988652 567888876433211112345676666664 22245566533 2 3688999
Q ss_pred CCCCC
Q 025893 144 ASNGS 148 (246)
Q Consensus 144 ~~~g~ 148 (246)
++|..
T Consensus 152 I~G~~ 156 (424)
T 3mes_A 152 IDGEP 156 (424)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 98854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.12 E-value=0.94 Score=34.99 Aligned_cols=87 Identities=7% Similarity=-0.020 Sum_probs=61.2
Q ss_pred CCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeeeC
Q 025893 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE-YLHEKADPHIIHR 198 (246)
Q Consensus 120 ~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~lH~~~~~~ivHr 198 (246)
.||++ -...-.+++.+.+.++.-+++.=...++. ++....++++..|+.... +++. -+|-
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~tf 108 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLIF 108 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------------cCHHHHHHHHHHHHHHHHHhhhC-----ceeE
Confidence 57877 34444666777776665544333344432 667788888888776665 5544 4788
Q ss_pred CCCCCCeEecCCCceEEccccCCCCCC
Q 025893 199 DIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 199 dlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
-|.|+||+++.++.+++.-.|+-..++
T Consensus 109 ~l~P~NL~f~~~~~p~i~hRGi~~~lp 135 (219)
T 4ano_A 109 IVCPENLMFNRALEPFFLHVGVKESLP 135 (219)
T ss_dssp CCCGGGEEECTTCCEEESCCEETTTBS
T ss_pred EEeCceEEEeCCCcEEEEEcCCcccCC
Confidence 899999999999999999999865543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.54 E-value=0.035 Score=48.29 Aligned_cols=59 Identities=5% Similarity=0.050 Sum_probs=17.2
Q ss_pred CceeccCCceEEEEEEECC-CCEEEE------EEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEe
Q 025893 72 NALIGEGSYGRVYYGILKS-GHAAAI------KKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD 133 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~-~~~vai------k~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 133 (246)
.+.|| ||.||+|.+.. ...||+ |....... ....+.+|..+++.++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 34565 99999998763 356777 65543222 22467788899999999999999887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.54 E-value=0.95 Score=34.86 Aligned_cols=88 Identities=10% Similarity=0.094 Sum_probs=61.1
Q ss_pred CCCCccceEeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCC
Q 025893 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 199 (246)
Q Consensus 120 ~hp~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrd 199 (246)
.||+++.. ..-.+++.+.+.++.-+.+.=+..++. ++....++++..|+....+++. -+|--
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~------------~~~~eKlr~l~ni~~l~~~~~~-----r~tf~ 104 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS------------FTKNEKLRYLLNIKNLEEVNRT-----RYTFV 104 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG------------SCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh------------cCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence 58888865 455566666665554432211222322 6677888899888877766654 36888
Q ss_pred CCCCCeEecCCCceEEccccCCCCCC
Q 025893 200 IKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 200 lkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
|.|+|++++.++.+++.-.|+-..++
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik~~l~ 130 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQNVVD 130 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEETTTBS
T ss_pred EecceEEEcCCCCEEEEEccCccCCC
Confidence 99999999999999999999865544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.81 E-value=0.29 Score=41.46 Aligned_cols=29 Identities=24% Similarity=0.465 Sum_probs=24.4
Q ss_pred eeeCCCCCCCeEe------cCCCceEEccccCCCC
Q 025893 195 IIHRDIKSSNVLI------FDDDVAKIADFDLSNQ 223 (246)
Q Consensus 195 ivHrdlkp~Nil~------~~~~~~kl~Dfgls~~ 223 (246)
++|+|+.+.|||+ ++...+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456799999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 246 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 7e-47
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
E +G G +G V+ G A+K L + FLA+ +++ +L+H+ V+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L + E+ NGSL D L G+K L+ + + +A A+G+ +
Sbjct: 73 LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAF 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+ E+ + IHRD++++N+L+ D KIADF L+ D + AP
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP 179
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-46
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG GS+G VY G A + + A + Q + F +V ++ + +H N + +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ ++ SL+ LH + + + IA A+G++YLH K
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+KS+N+ + +D KI DF L+ + ++ G+ + APE
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-46
Identities = 49/189 (25%), Positives = 79/189 (41%), Gaps = 20/189 (10%)
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVS 117
ELK+ ++F + +G G+ G V+ K SG A K + +P + + ++ ++
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
V G + E GSL +L + Q K++
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVS 110
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
+ KGL YL EK I+HRD+K SN+L+ K+ DF +S Q D + +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 238 GTFGYHAPE 246
GT Y +PE
Sbjct: 165 GTRSYMSPE 173
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-45
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 12/172 (6%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V YG + + AIK + ++EF+ + ++ L HE VQL G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ +NG L + L + QQ +++ + +EYL K
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+HRD+ + N L+ D V K++DF LS D S + PE
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPE 171
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-43
Identities = 47/221 (21%), Positives = 84/221 (38%), Gaps = 23/221 (10%)
Query: 43 GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAI 96
G V + P ++P E +G G++G+V + A+
Sbjct: 1 GNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAV 58
Query: 97 KKLDASKQPD--EEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
K L S E ++++ ++S L H N V LLG C G ++ E+ G L + L
Sbjct: 59 KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 154 HGRKG---------VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
++ L + + + AKG+ +L K + IHRD+ + N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175
Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+L+ + KI DF L+ + + + + AP
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-43
Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 27/220 (12%)
Query: 51 PIEVPAISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASK 103
++ D E EN ++G G++G+V A+K L
Sbjct: 20 YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 79
Query: 104 QPDE--EFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG-- 158
E ++++ M+++L HEN V LLG C L +E+ G L + L ++
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 159 ------------VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206
++ + VL+++ + A AKG+E+L K +HRD+ + NVL
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL 196
Query: 207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ V KI DF L+ + + + APE
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-43
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 12/172 (6%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG G +G V+ G + AIK + +E+F+ + ++ +L H VQL G C++
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
L +EF +G L D L ++G+ + + + + + +G+ YL E
Sbjct: 73 APICLVFEFMEHGCLSDYLRTQRGLF--------AAETLLGMCLDVCEGMAYLEEA---C 121
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+IHRD+ + N L+ ++ V K++DF ++ D ST + +PE
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPE 172
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-42
Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 15/174 (8%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
+G+G++G+VY K + AA K +D + + E+++ ++ +++ H N V+LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ + EF + G++ ++ + L+ Q + L YLH+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNYLHDN-- 129
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
IIHRD+K+ N+L D K+ADF +S + R S +GT + APE
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 180
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 5e-42
Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG+G +G V+ G + G A+K + ++ A++ L+HEN + +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 135 TSRV----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
L ++ +GSL D L+ ++ + +K+A+ A GL +LH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHME 119
Query: 191 A-----DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYH 243
P I HRD+KS N+L+ + IAD L+ + + +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 244 APE 246
APE
Sbjct: 180 APE 182
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 1e-41
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 25/199 (12%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE--- 108
+V + + + + F IG GS+G VY+ +++ AIKK+ S + E
Sbjct: 3 DVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 109 -FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
+ +V + +L+H N +Q G + + L E+ + + +K
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--------- 111
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
L + + GA +GL YLH ++IHRD+K+ N+L+ + + K+ DF ++
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 228 AARLHSTRVLGTFGYHAPE 246
+GT + APE
Sbjct: 169 ------NSFVGTPYWMAPE 181
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (357), Expect = 2e-41
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 26/203 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPD--EEFLAQVSMVSR 118
N IGEG++GRV+ A+K L D +F + ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQ 163
+ N V+LLG C G L +E+ + G L++ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
P LS +++ IA A G+ YL E +HRD+ + N L+ ++ V KIADF LS
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 224 APDMAARLHSTRVLGTFGYHAPE 246
+ PE
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPE 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-41
Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 15/183 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
E++ +GEG+YG V + + + A A+K +D + D E ++ + L HEN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V+ G+ +G + L E+ S G L D + G + + G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAG 115
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
+ YLH I HRDIK N+L+ + D KI+DF L+ ++ GT Y
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 244 APE 246
APE
Sbjct: 173 APE 175
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-40
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 18/174 (10%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
IG+G +G V G + G+ A+K + + FLA+ S++++L+H N VQLLG V+
Sbjct: 14 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 134 GTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ + E+ + GSL D L R VL +K ++ + +EYL
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ +HRD+ + NVL+ +D+VAK++DF L+ +A + APE
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPE 170
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-40
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGH---AAAIKKLD--ASKQP 105
P P + +++K +IGEG++G+V +K AAIK++ ASK
Sbjct: 1 PTIYPVLDWNDIKFQD-------VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53
Query: 106 DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---- 160
+F ++ ++ +L H N + LLG C LA E+A +G+L D L + ++
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 161 ---GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217
LS QQ + A A+G++YL +K IHRD+ + N+L+ ++ VAKIAD
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170
Query: 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
F LS + T + A E
Sbjct: 171 FGLSRGQEVY---VKKTMGRLPVRWMAIE 196
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-40
Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 15/188 (7%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHE 122
E++ IG GSYGR K G K+LD + E +++V+++ LKH
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 123 NFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
N V+ +D T+ L E+ G L ++ KG + L + +++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMTQL 118
Query: 181 AKGLEYLHEKAD--PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
L+ H ++D ++HRD+K +NV + K+ DF L+ + + +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVG 176
Query: 239 TFGYHAPE 246
T Y +PE
Sbjct: 177 TPYYMSPE 184
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-40
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 12/179 (6%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
E+ +G+G +G V+ G AIK L E FL + ++ +L+HE VQ
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L + + E+ S GSL D L G G L Q V +A A G+ Y
Sbjct: 77 LYAVVSEE-PIYIVTEYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAY 128
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+ + +HRD++++N+L+ ++ V K+ADF L+ D + AP
Sbjct: 129 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAP 183
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (347), Expect = 4e-40
Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 29/206 (14%)
Query: 58 SVDELKEITENFGTNA---------LIGEGSYGRVYYGILKS----GHAAAIKKL--DAS 102
+ ++ E F +IG G +G V G LK AIK L +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 103 KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
++ +FL++ S++ + H N + L G T ++ EF NGSL L G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
+ Q V + G A G++YL D + +HRD+ + N+L+ + V K++DF LS
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 223 QAPDMAARLHSTRVLG---TFGYHAP 245
D + T LG + AP
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAP 202
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-40
Identities = 55/185 (29%), Positives = 77/185 (41%), Gaps = 21/185 (11%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKH 121
E+F +G+G +G VY K S A+K L ++ + +V + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
N ++L GY D T L E+A G+++ L Q+ A
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
L Y H K +IHRDIK N+L+ KIADF S AP T + GT
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169
Query: 242 YHAPE 246
Y PE
Sbjct: 170 YLPPE 174
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 9e-40
Identities = 51/180 (28%), Positives = 79/180 (43%), Gaps = 12/180 (6%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
+ +G G YG VY G+ K A+K L EEFL + +++ +KH N V
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
QLLG C + EF + G+L D L + +S + +A + +E
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAME 129
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YL +K + IHRD+ + N L+ ++ + K+ADF LS H + AP
Sbjct: 130 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAP 185
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-39
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 18/177 (10%)
Query: 75 IGEGSYGRVYYGILK---SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ + AIK L + EE + + ++ +L + V+L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + +L E A G LH L G++ + ++ + G++YL E
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 127
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAP 245
K + +HRD+ + NVL+ + AKI+DF LS D + + ++AP
Sbjct: 128 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-39
Identities = 48/181 (26%), Positives = 72/181 (39%), Gaps = 23/181 (12%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
IG GS+ VY G+ + A +L +K + F + M+ L+H N V+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 131 CVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
VL E ++G+L L K V+ + KGL++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
LH + P IIHRD+K N+ I KI D L+ + V+GT + AP
Sbjct: 128 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 246 E 246
E
Sbjct: 183 E 183
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-38
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 12/189 (6%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPDE--EFLAQVSMVSR 118
E + +G+GS+G VY G+ K AIK ++ + E EFL + S++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GPVLSWQQRVKIA 177
+ V+LLG G ++ E + G L L + P S + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
A G+ YL+ +HRD+ + N ++ +D KI DF ++ + + L
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 238 GTFGYHAPE 246
+ +PE
Sbjct: 197 LPVRWMSPE 205
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-38
Identities = 47/191 (24%), Positives = 87/191 (45%), Gaps = 17/191 (8%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-FLAQVSM 115
S+ + + + + IG+G+ G VY + + +G AI++++ +QP +E + ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+ K+ N V L + G + E+ + GSL D++ Q
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAA 120
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
+ + LE+LH +IHRDIKS N+L+ D K+ DF Q + +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRST 175
Query: 236 VLGTFGYHAPE 246
++GT + APE
Sbjct: 176 MVGTPYWMAPE 186
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-37
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 19/180 (10%)
Query: 74 LIGEGSYGRVYYGILKSGH-----AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
++G G++G VY G+ AIK+L + P +E L + +++ + + + +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C+ T +++ + G L D + K Q + V AKG+ Y
Sbjct: 76 LLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLLNWCVQIAKGMNY 126
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
L ++ ++HRD+ + NVL+ KI DF L+ H+ + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-37
Identities = 49/189 (25%), Positives = 73/189 (38%), Gaps = 17/189 (8%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVS 117
K+ E+F ++GEGS+ V L + AIK L+ E + V ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
RL H FV+L D +A NG L +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYT 114
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
LEYLH IIHRD+K N+L+ +D +I DF + + + + +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 238 GTFGYHAPE 246
GT Y +PE
Sbjct: 172 GTAQYVSPE 180
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 6e-37
Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 75 IGEGSYGRVYYGIL---KSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLL 128
+G G++G V G K A+K L +E LA+ +++ +L + V+++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C S +L E A G L+ L + + + +++ + G++YL
Sbjct: 75 GICEAE-SWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
E + +HRD+ + NVL+ AKI+DF LS D T ++APE
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-36
Identities = 42/214 (19%), Positives = 85/214 (39%), Gaps = 32/214 (14%)
Query: 52 IEVPAISVDELKEITE----------NFGTNALIGEGSYGRVYYGILK----SGHAAAIK 97
I++ A++ + ++ + +F +IG G +G VY+G L A+K
Sbjct: 4 IDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 98 KLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILH 154
L+ E +FL + ++ H N + LLG C+ + + +G L + +
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214
+ + + + AKG+++L +HRD+ + N ++ + K
Sbjct: 122 NETHN--------PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVK 170
Query: 215 IADFDLSNQAPD--MAARLHSTRVLGTFGYHAPE 246
+ADF L+ D + + T + A E
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-36
Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 20/192 (10%)
Query: 64 EI-TENFGTNALIGEGSYGRVYYGILKSGHAA-----AIKKLDASKQPDE--EFLAQVSM 115
EI +IG G +G VY G+LK+ AIK L A + +FL + +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+ + H N ++L G ++ E+ NG+L L + G S Q V
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVG 114
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST- 234
+ G A G++YL + +HRD+ + N+L+ + V K++DF LS D ++T
Sbjct: 115 MLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 235 RVLGTFGYHAPE 246
+ APE
Sbjct: 172 GGKIPIRWTAPE 183
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 129 bits (324), Expect = 3e-36
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 24/201 (11%)
Query: 50 QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE 108
QP+EV SV + +I E +G G++G V+ + +G K ++ D+
Sbjct: 18 QPVEVKQGSVYDYYDILE------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 109 -FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
++S++++L H + L D VL EF S G L D +
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------K 123
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLSNQAP 225
+S + + A +GL+++HE I+H DIK N++ KI DF L+ +
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
Query: 226 DMAARLHSTRVLGTFGYHAPE 246
+T T + APE
Sbjct: 181 PDEIVKVTT---ATAEFAAPE 198
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 128 bits (323), Expect = 5e-36
Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 24/201 (11%)
Query: 50 QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD-E 107
QP+E+ + +++ + +G G++G V+ +G+ A K + + D E
Sbjct: 15 QPVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68
Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
++ +S L+H V L D V+ YEF S G L + +
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------K 120
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAP 225
+S + V+ KGL ++HE + +H D+K N++ K+ DF L+
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
Query: 226 DMAARLHSTRVLGTFGYHAPE 246
+ +T GT + APE
Sbjct: 178 PKQSVKVTT---GTAEFAAPE 195
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-36
Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 21/191 (10%)
Query: 74 LIGEGSYGRVYYGILKS--------GHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHE 122
+GEG++G+V A+K L DA+++ + ++++ M+ + KH+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLSWQQRVK 175
N + LLG C + E+AS G+L + L R+ P LS + V
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+ + +T
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 236 VLGTFGYHAPE 246
+ APE
Sbjct: 197 GRLPVKWMAPE 207
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 9e-36
Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 19/179 (10%)
Query: 74 LIGEGSYGRVYYGILKS----GHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
IGEG +G V+ GI S A AIK E+FL + + + H + V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+G + + E + G L L RK L + A + L YL
Sbjct: 74 IGVITENP-VWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYL 124
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
K +HRDI + NVL+ +D K+ DF LS D +++ + APE
Sbjct: 125 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-34
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 75 IGEGSYGRVYYGILKS----GHAAAIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQ 126
+G+GS+G V G + + A+K L + + ++F+ +V+ + L H N ++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L G + + + E A GSL D L +G + AV A+G+ Y
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 126
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
L K IHRD+ + N+L+ D+ KI DF L P + + F + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-34
Identities = 37/196 (18%), Positives = 73/196 (37%), Gaps = 20/196 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSR 118
+ +G G++G+V + A+K L A+ ++++ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 119 LKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLS 169
+ H V L G ++ EF G+L L ++ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
+ + + AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 230 RLHSTRVLGTFGYHAP 245
+ + AP
Sbjct: 190 YVRKGDARLPLKWMAP 205
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-34
Identities = 35/187 (18%), Positives = 70/187 (37%), Gaps = 17/187 (9%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
KE+ E + +G G +G V+ + S K + ++S+++ +H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
N + L V+ +EF S + + ++ L+ ++ V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVC 112
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAARLHSTRVLGT 239
+ L++LH +I H DI+ N++ KI +F + Q + +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166
Query: 240 FGYHAPE 246
Y+APE
Sbjct: 167 PEYYAPE 173
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 119 bits (299), Expect = 3e-33
Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 27/192 (14%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD----------EEFLAQVSM 115
EN+ ++G G V I + A+K +D + E L +V +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 116 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+ ++ H N +QL T L ++ G L D L + LS ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETR 113
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
KI + + LH+ +I+HRD+K N+L+ DD K+ DF S Q
Sbjct: 114 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 167
Query: 235 RVLGTFGYHAPE 246
V GT Y APE
Sbjct: 168 EVCGTPSYLAPE 179
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-33
Identities = 46/191 (24%), Positives = 78/191 (40%), Gaps = 21/191 (10%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLK 120
++ + + IGEG+YG V + AIKK+ + + L ++ ++ R +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 121 HENFVQLLGYCVDGTSRVLAYEF----ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
HEN + + T + + L+ +L + LS
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYF 114
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTR 235
+GL+Y+H +++HRD+K SN+L+ KI DF L+ A PD T
Sbjct: 115 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 236 VLGTFGYHAPE 246
+ T Y APE
Sbjct: 172 YVATRWYRAPE 182
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-32
Identities = 41/186 (22%), Positives = 72/186 (38%), Gaps = 20/186 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQV-----SMVSRLK 120
E+F + ++G+GS+G+V+ K + AIK L ++ + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H + + E+ + G L + + A
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEI 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
GL++LH K I++RD+K N+L+ D KIADF + + A+ + GT
Sbjct: 113 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 167
Query: 241 GYHAPE 246
Y APE
Sbjct: 168 DYIAPE 173
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 116 bits (292), Expect = 3e-32
Identities = 41/194 (21%), Positives = 78/194 (40%), Gaps = 22/194 (11%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE----FLAQVSMVS 117
+++ + ++G G V+ L+ A+K L A D F + +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 118 RLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
L H V + G + E+ +L DI+H ++ ++
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRA 113
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
+++ A + L + H+ IIHRD+K +N++I + K+ DF ++ D +
Sbjct: 114 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 234 T-RVLGTFGYHAPE 246
T V+GT Y +PE
Sbjct: 171 TAAVIGTAQYLSPE 184
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (292), Expect = 6e-32
Identities = 35/188 (18%), Positives = 71/188 (37%), Gaps = 15/188 (7%)
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE--FLAQVSMVS 117
+ ++I + + ++G G++ V ++ AIK + +E +++++
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
++KH N V L G L + S G L D + + + + ++
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLI 113
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
++YLH+ H + + +D I+DF LS + +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STAC 170
Query: 238 GTFGYHAP 245
GT GY AP
Sbjct: 171 GTPGYVAP 178
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (290), Expect = 3e-31
Identities = 40/188 (21%), Positives = 69/188 (36%), Gaps = 24/188 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-------VSMVSR 118
+F + +IG G +G VY +G A+K LD + ++ +S+VS
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
V + + + G LH L A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAA 114
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
GLE++H + +++RD+K +N+L+ + +I+D L+ +G
Sbjct: 115 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG 167
Query: 239 TFGYHAPE 246
T GY APE
Sbjct: 168 THGYMAPE 175
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 8e-30
Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 21/180 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD------EEFLAQVSMVSRLKHENFVQ 126
+GEG + VY K + AIKK+ + + L ++ ++ L H N +
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LL ++ L ++F I L+ + +GLEY
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH+ I+HRD+K +N+L+ ++ V K+ADF L+ T + T Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPE 170
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (271), Expect = 4e-29
Identities = 45/175 (25%), Positives = 71/175 (40%), Gaps = 17/175 (9%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
IGEG+YG VY G A+KK+ K+ + + ++S++ LKH N V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
VL +E + G L + G+ Y H++
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR- 119
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
++HRD+K N+LI + KIADF L+ + + T Y AP+
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPD 170
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 7e-29
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 22/185 (11%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKH 121
++F +G GS+GRV+ + +G A+K L E + M+S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
+++ G D + ++ G L +L + A
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
LEYLH K II+RD+K N+L+ + KI DF + PD+ + + GT
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPD 166
Query: 242 YHAPE 246
Y APE
Sbjct: 167 YIAPE 171
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 6e-28
Identities = 46/202 (22%), Positives = 75/202 (37%), Gaps = 25/202 (12%)
Query: 52 IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL 110
+ P D +E+ ++ +IG GS+G VY L SG AIKK+ K
Sbjct: 7 VATPGQGPDRPQEV--SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKN 61
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQP 164
++ ++ +L H N V+L + + L ++ H +
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------ 115
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQ 223
L + L Y+H I HRDIK N+L+ D V K+ DF + Q
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 224 APDMAARLHSTRVLGTFGYHAP 245
+ + + + Y AP
Sbjct: 173 LVR--GEPNVSYICSRY-YRAP 191
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 1e-27
Identities = 32/181 (17%), Positives = 65/181 (35%), Gaps = 24/181 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
++G G G+V ++ A+K L + E + + V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL---HWRASQCPHIVRIVDVYE 75
Query: 133 DGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + ++ E G L + R + ++ +I + ++YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQYLH 128
Query: 189 EKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+I HRD+K N+L + + K+ DF + + + T Y AP
Sbjct: 129 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP 182
Query: 246 E 246
E
Sbjct: 183 E 183
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-27
Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 17/184 (9%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
ENF IGEG+YG VY K +G A+KK+ + + + ++S++ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
N V+LL L +EF + + +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQ 113
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL + H ++HRD+K N+LI + K+ADF L+ T + T Y
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWY 168
Query: 243 HAPE 246
APE
Sbjct: 169 RAPE 172
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-27
Identities = 40/184 (21%), Positives = 64/184 (34%), Gaps = 26/184 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD-------EEFLAQVSMVSRLK--HEN 123
L+G G +G VY GI + AIK ++ + D +V ++ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
++LL + S VL E +G L + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--------ALQEELARSFFWQVLEA 122
Query: 184 LEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
+ + H ++HRDIK N+LI + K+ DF D T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175
Query: 243 HAPE 246
PE
Sbjct: 176 SPPE 179
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 4e-27
Identities = 40/180 (22%), Positives = 68/180 (37%), Gaps = 17/180 (9%)
Query: 75 IGEGSYGRVYYGILK--SGHAAAIKKLDASKQPDEEFLAQV------SMVSRLKHENFVQ 126
IGEG+YG+V+ G A+K++ + L+ + + +H N V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L C + + P P + + + +GL++
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH ++HRD+K N+L+ K+ADF L+ T V+ T Y APE
Sbjct: 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 185
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 2e-26
Identities = 36/183 (19%), Positives = 66/183 (36%), Gaps = 23/183 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC- 131
IG GS+G +Y G + +G AIK + + + + ++ + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+G V+ E + S + + +A +EY+H K
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTVLLLADQMISRIEYIHSK- 122
Query: 192 DPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPD-----MAARLHSTRVLGTFGYH 243
+ IHRD+K N L+ + I DF L+ + D + + GT Y
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 244 APE 246
+
Sbjct: 181 SIN 183
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-26
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 26/186 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
IG+G++G V+ K+G A+KK+ + + L ++ ++ LKHEN V L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 131 CVDGTSRV--------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
C S L ++F + + + + + ++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---------FTLSEIKRVMQMLLN 128
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLGTF 240
GL Y+H I+HRD+K++NVLI D V K+ADF L+ + T + T
Sbjct: 129 GLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 241 GYHAPE 246
Y PE
Sbjct: 186 WYRPPE 191
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-26
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 17/187 (9%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
E+ + +G G+YG V + ++G AIKKL Q + + ++ ++ +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+HEN + LL + +F G+ L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQ 129
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
KGL Y+H IIHRD+K N+ + +D KI DF L+ QA T + T
Sbjct: 130 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVT 181
Query: 240 FGYHAPE 246
Y APE
Sbjct: 182 RWYRAPE 188
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 5e-26
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 27/196 (13%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-------EEFLAQVS 114
+ + + + T +G G + V K +G A K + + E+ +VS
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
++ ++H N + L + T +L E + G L D L ++ L+ ++
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEAT 116
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAAR 230
+ G+ YLH I H D+K N+++ D +V KI DF L+++
Sbjct: 117 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-- 171
Query: 231 LHSTRVLGTFGYHAPE 246
+ GT + APE
Sbjct: 172 -EFKNIFGTPEFVAPE 186
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-25
Identities = 40/184 (21%), Positives = 70/184 (38%), Gaps = 19/184 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKH 121
+F L+G+G++G+V K +G A+K L ++ + + ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
L E+A+ G L L + + ++
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIV 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
LEYLH + +++RDIK N+++ D KI DF L + A + GT
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPE 170
Query: 242 YHAP 245
Y AP
Sbjct: 171 YLAP 174
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.5 bits (247), Expect = 3e-25
Identities = 51/224 (22%), Positives = 83/224 (37%), Gaps = 32/224 (14%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVDELKEIT---------ENFGTNALIGEGSYGRVYYGI 87
+ AA KG++ V+ A D LK+ + F +G GS+GRV
Sbjct: 3 AAAAKKGSEQESVKEFLAKA-KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 88 -LKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142
+SG+ A+K LD K E L + ++ + V+L D ++ + E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
+ + G + L S A EYLH +I+RD+K
Sbjct: 122 YVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKP 169
Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
N+LI ++ DF + + + + GT APE
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPE 208
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 97.6 bits (242), Expect = 8e-25
Identities = 35/194 (18%), Positives = 66/194 (34%), Gaps = 25/194 (12%)
Query: 65 ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN 123
+ ++ IGEGS+G ++ G L + AIK + + + L
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCT 61
Query: 124 FV-QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+ + + +G VL + + G S + A
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLA 112
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI-----FDDDVAKIADFDLSNQAPDMAARLH----- 232
++ +HEK +++RDIK N LI + ++ + DF + D + H
Sbjct: 113 RVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 233 STRVLGTFGYHAPE 246
+ GT Y +
Sbjct: 170 KKNLSGTARYMSIN 183
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.9 bits (235), Expect = 1e-23
Identities = 34/178 (19%), Positives = 64/178 (35%), Gaps = 25/178 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYC 131
+G G Y V+ I + + +K L K+ ++ ++ ++ L+ N + L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLADIV 99
Query: 132 VDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
D SR L +E +N + L+ K L+Y H
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHS 147
Query: 190 KADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
I+HRD+K NV+I + ++ D+ L+ + + + PE
Sbjct: 148 M---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPE 199
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (233), Expect = 1e-23
Identities = 38/176 (21%), Positives = 71/176 (40%), Gaps = 17/176 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
IGEG+YG V+ + + A+K++ + L ++ ++ LKH+N V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
L +EF + + KGL + H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+++HRD+K N+LI + K+A+F L+ +A + R +S V+ +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDV 172
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 7e-23
Identities = 51/192 (26%), Positives = 80/192 (41%), Gaps = 27/192 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
E+ E + + +G G+YG V K+G A+KKL Q + ++ ++ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
KHEN + LL S V L++I+ +K L+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQ 124
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
+ +GL+Y+H IIHRD+K SN+ + +D KI DF L+ D +T
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 235 RVLGTFGYHAPE 246
R Y APE
Sbjct: 182 R-----WYRAPE 188
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 1e-21
Identities = 45/190 (23%), Positives = 73/190 (38%), Gaps = 23/190 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPD-----EEFLAQVSMVS 117
ENF ++G G+YG+V+ SGH A+K L + E + ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 118 RLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
++ F V L T L ++ + G L L R+ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIY 134
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
LE+LH+ II+RDIK N+L+ + + DF LS + +
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDF 190
Query: 237 LGTFGYHAPE 246
GT Y AP+
Sbjct: 191 CGTIEYMAPD 200
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 1e-20
Identities = 42/197 (21%), Positives = 67/197 (34%), Gaps = 28/197 (14%)
Query: 60 DELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSM 115
D + + + IG G+ G V AIKKL Q + ++ +
Sbjct: 10 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 116 VSRLKHENFVQLLGYCV------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
+ + H+N + LL + L E I
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------D 117
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
++ + G+++LH IIHRD+K SN+++ D KI DF L+
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGT 171
Query: 230 RLHSTRVLGTFGYHAPE 246
T + T Y APE
Sbjct: 172 SFMMTPYVVTRYYRAPE 188
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (211), Expect = 4e-20
Identities = 33/182 (18%), Positives = 66/182 (36%), Gaps = 11/182 (6%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
+G G + V+ + + A+K + K E ++ ++ R+ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 133 DGTSRVLAY--EFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLE 185
+ ++L + NG ++ G + +I+ GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 186 YLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
Y+H + IIH DIK NVL+ D + +++ H T + T Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 245 PE 246
PE
Sbjct: 198 PE 199
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.3 bits (179), Expect = 1e-16
Identities = 26/173 (15%), Positives = 54/173 (31%), Gaps = 32/173 (18%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------QPDEEFLAQVSMVSRLKHE 122
L+GEG V+ + +K D F +R +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+L G V Y + N L +++ + + + ++ +
Sbjct: 67 ALQKLQGLAV-----PKVYAWEGNAVLMELIDA-------KELYRVRVENPDEVLDMILE 114
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-----NQAPDMAAR 230
+ + + I+H D+ NVL+ ++ + I DF S ++ R
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILER 163
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.85 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.0 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=294.87 Aligned_cols=169 Identities=29% Similarity=0.431 Sum_probs=147.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|++.+.||+|+||+||+|.++ +++.||+|.+..... ..+.+.+|+.++++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999986 789999999865432 24568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
||++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 84 y~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 999999999986543 3889999999999999999999997 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..............+||+.|||||
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE 175 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPE 175 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTH
T ss_pred eeccCCccccccceeeCcCccCHh
Confidence 765433333345678999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=284.56 Aligned_cols=165 Identities=27% Similarity=0.445 Sum_probs=146.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
++|++.+.||+|+||+||+|..+ +|+.||+|.+.... ...+.+.+|+.++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999975 79999999986443 34677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 100 AGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 999999988654 2889999999999999999999997 999999999999999999999999999865
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....+||+.|||||
T Consensus 167 ~~~~~--~~~~~~gt~~Y~aPE 186 (293)
T d1yhwa1 167 TPEQS--KRSTMVGTPYWMAPE 186 (293)
T ss_dssp CSTTC--CBCCCCSCGGGCCHH
T ss_pred ccccc--cccccccCCCccChh
Confidence 43222 234568999999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=281.51 Aligned_cols=165 Identities=33% Similarity=0.480 Sum_probs=146.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||+||+|+.+ +++.||+|.+.+. ....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999986 7889999998532 33457788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||||++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 mEy~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp EECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EeecCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 99999999999997543 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+...... ....+||+.|||||
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE 174 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPE 174 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHH
T ss_pred eeecCCCc----ccccCCCCcccCHH
Confidence 98765332 24568999999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-43 Score=288.22 Aligned_cols=170 Identities=30% Similarity=0.463 Sum_probs=149.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||+||+|.++ +++.||||++..+....+++.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 468888999999999999999986 6889999999887777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 96 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp TTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred cCcchHHHhhhccc-------cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999865432 24899999999999999999999997 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|||||
T Consensus 166 ~~~~~~-~~~~~~g~~~y~aPE 186 (287)
T d1opja_ 166 TGDTYT-AHAGAKFPIKWTAPE 186 (287)
T ss_dssp CSSSSE-EETTEEECGGGCCHH
T ss_pred CCCCce-eeccccccccccChH
Confidence 543222 223346899999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=285.59 Aligned_cols=168 Identities=27% Similarity=0.379 Sum_probs=144.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||+||+|+.+ +++.||||.+.+. ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999976 7899999998532 334577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|||++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 88 Ey~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccc
Confidence 9999999999987654 3889999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+............+.+||+.|||||
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE 180 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPE 180 (288)
T ss_dssp EECC----------CCCCGGGCCHH
T ss_pred eecccCCcccccccccCCccccCce
Confidence 8765433333335678999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=280.25 Aligned_cols=168 Identities=26% Similarity=0.493 Sum_probs=140.1
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|++.+.||+|+||.||+|.+++++.||||++.......+++.+|+.++++++|||||++++++..++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 46888899999999999999998888999999988777788999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 g~L~~~l~~~~--------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 85 GCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CcHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccC
Confidence 99999987543 24889999999999999999999997 99999999999999999999999999987643
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......||+.|+|||
T Consensus 154 ~~~~-~~~~~~gt~~y~aPE 172 (263)
T d1sm2a_ 154 DQYT-SSTGTKFPVKWASPE 172 (263)
T ss_dssp ------------CTTSCCHH
T ss_pred CCce-eecceecCcccCChH
Confidence 3222 223457999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=290.56 Aligned_cols=165 Identities=28% Similarity=0.425 Sum_probs=143.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|++.+.||+|+||+||+|+.+ +++.||+|.+...... ...+.+|+.+|++++|||||+++++|.+.+..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999976 7899999998654322 4678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|+++|+|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|
T Consensus 85 y~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp CCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred cCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999999999997543 388999999999999999999974 5 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... ...+.+||+.|||||
T Consensus 153 ~~~~~~----~~~~~~GT~~Y~APE 173 (322)
T d1s9ja_ 153 GQLIDS----MANSFVGTRSYMSPE 173 (322)
T ss_dssp HHHHHH----TC---CCSSCCCCHH
T ss_pred cccCCC----ccccccCCccccCch
Confidence 754321 234678999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=278.44 Aligned_cols=167 Identities=28% Similarity=0.486 Sum_probs=137.6
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
.++|.+.+.||+|+||+||+|+++ ..||||.+..... ..+.|.+|+.++++++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 358899999999999999999865 3699999865432 3467889999999999999999999875 456899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
||++|+|.+++..... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred cCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999965432 3889999999999999999999996 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...............||+.|||||
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE 176 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPE 176 (276)
T ss_dssp C------------CCCCGGGCCHH
T ss_pred eccccCCcccccccccCcccCCHH
Confidence 765443333345678999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=279.23 Aligned_cols=169 Identities=27% Similarity=0.467 Sum_probs=147.2
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 145 (246)
.++|++.+.||+|+||.||+|.++++..||||++.......+.|.+|+.++++++|||||++++++. ++..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 4688889999999999999999988889999999877777889999999999999999999999875 466799999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 91 ~g~L~~~~~~~~~-------~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp TCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 9999998754332 13889999999999999999999997 9999999999999999999999999998765
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ......||+.|||||
T Consensus 161 ~~~~~-~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 161 DNEYT-AREGAKFPIKWTAPE 180 (272)
T ss_dssp SSCEE-CCTTCCCCTTTSCHH
T ss_pred CCccc-cccccCCcccccChH
Confidence 43222 224457999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=283.15 Aligned_cols=167 Identities=26% Similarity=0.429 Sum_probs=146.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
+.|++.+.||+|+||+||+|+++ ++..||+|.+.... ...+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999976 78999999986543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 92 ~~g~L~~~~~~~~--------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 92 AGGAVDAVMLELE--------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 9999999876432 13899999999999999999999997 999999999999999999999999999765
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... ...+.+||+.|||||
T Consensus 161 ~~~~~--~~~~~~Gt~~y~APE 180 (288)
T d2jfla1 161 TRTIQ--RRDSFIGTPYWMAPE 180 (288)
T ss_dssp HHHHH--HHTCCCSCCTTCCHH
T ss_pred CCCcc--cccccccccccCCHH
Confidence 43221 224578999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=283.26 Aligned_cols=167 Identities=26% Similarity=0.356 Sum_probs=148.3
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||+||+|+.+ +++.||+|++.+. ....+.+.+|+.+|++++||||+++++++.+...+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 368999999999999999999976 8999999998643 33467788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||||++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eeccCCCchhhhhhccc---------CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence 99999999999997654 3889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+....... .....+||+.|||||
T Consensus 152 a~~~~~~~~--~~~~~~GT~~Y~aPE 175 (337)
T d1o6la_ 152 CKEGISDGA--TMKTFCGTPEYLAPE 175 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGG
T ss_pred ccccccCCc--ccccceeCHHHhhhh
Confidence 986543222 235678999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-41 Score=280.53 Aligned_cols=162 Identities=28% Similarity=0.462 Sum_probs=143.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH----HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~----~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.|+..+.||+|+||+||+|+.+ +++.||||.+....... +.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999976 78899999987654432 46789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
|||++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 95 E~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp ECCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred EecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence 9999999977665433 3899999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.... ....+||+.|||||
T Consensus 163 ~~~~~------~~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 163 SIMAP------ANSFVGTPYWMAPE 181 (309)
T ss_dssp BSSSS------BCCCCSCGGGCCHH
T ss_pred cccCC------CCccccCccccCHH
Confidence 86532 24568999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=280.45 Aligned_cols=173 Identities=24% Similarity=0.392 Sum_probs=133.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 140 (246)
++|++.+.||+|+||+||+|+.+ +|+.||+|.+....... +.+.+|+.++++++|||||++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999976 78999999997665443 467899999999999999999999865 4568999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
||||++|+|.+++...... ...+++..+..++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+||
T Consensus 84 mEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 9999999999998642110 124899999999999999999999864 135999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|+....... .....+||+.|||||
T Consensus 159 G~a~~~~~~~~--~~~~~~gt~~Y~APE 184 (269)
T d2java1 159 GLARILNHDTS--FAKAFVGTPYYMSPE 184 (269)
T ss_dssp HHHHHC-------------CCCSCCCHH
T ss_pred cceeecccCCC--ccccCCCCcccCCHH
Confidence 99876543222 234578999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-41 Score=280.98 Aligned_cols=167 Identities=25% Similarity=0.424 Sum_probs=130.8
Q ss_pred HHhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 65 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
+.+.|++.+.||+|+||+||+|+.+ +++.||+|.+..... ....+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999976 789999999865432 3456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCceEEccc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADF 218 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~---~~~~~kl~Df 218 (246)
|||+||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+. .++.+||+||
T Consensus 87 E~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp CCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 9999999999997543 4899999999999999999999997 99999999999995 4689999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|+....... ..+.+||+.|||||
T Consensus 155 G~a~~~~~~~~---~~~~~GT~~y~APE 179 (307)
T d1a06a_ 155 GLSKMEDPGSV---LSTACGTPGYVAPE 179 (307)
T ss_dssp ---------------------CTTSCHH
T ss_pred ceeEEccCCCe---eeeeeeCccccCcH
Confidence 99986543222 24568999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-41 Score=270.43 Aligned_cols=168 Identities=27% Similarity=0.462 Sum_probs=149.8
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|++.+.||+|+||+||+|++++++.||||.+.......++|.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 58999999999999999999998888999999988777888999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 84 GCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred CcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999998765432 3788999999999999999999997 99999999999999999999999999986544
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......||+.|+|||
T Consensus 153 ~~~~-~~~~~~~t~~y~aPE 171 (258)
T d1k2pa_ 153 DEYT-SSVGSKFPVRWSPPE 171 (258)
T ss_dssp SSCC-CCCCSCCCGGGCCHH
T ss_pred CCce-eecccCCCCCcCCcH
Confidence 3222 223467999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-41 Score=273.28 Aligned_cols=163 Identities=29% Similarity=0.435 Sum_probs=138.1
Q ss_pred CCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEE
Q 025893 70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAY 141 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~ 141 (246)
++.+.||+|+||+||+|.++ ++..||+|.+...... .+.+.+|+++|++++|||||++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999976 7889999998654332 3568899999999999999999999875 35679999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCceEEccccC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDL 220 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~-~~~~~kl~Dfgl 220 (246)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++|+||||||+|||++ .++.+||+|||+
T Consensus 92 E~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCcHHHHHhccc---------cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 9999999999997643 3889999999999999999999973 4599999999999997 478999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+..... .....+||+.|||||
T Consensus 162 a~~~~~~----~~~~~~GT~~Y~aPE 183 (270)
T d1t4ha_ 162 ATLKRAS----FAKAVIGTPEFMAPE 183 (270)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGG
T ss_pred ceeccCC----ccCCcccCccccCHH
Confidence 9754322 224578999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-41 Score=278.91 Aligned_cols=164 Identities=28% Similarity=0.408 Sum_probs=146.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+. ....+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 368999999999999999999986 7999999998532 34457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||||+||+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 mE~~~gg~l~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp ECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeecCCccccccccccc---------cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 99999999999887654 3778888899999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+..... ..+.+||+.|||||
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE 171 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPE 171 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHH
T ss_pred ceEeccc-----cccccCcccccCHH
Confidence 9875432 24578999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-41 Score=282.00 Aligned_cols=167 Identities=25% Similarity=0.384 Sum_probs=145.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++..... ..+.+.+|+.+|++|+|||||++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 568999999999999999999976 789999999965542 245688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCceEEccccCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLS 221 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~--~~~~kl~Dfgls 221 (246)
|++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 105 ~~gg~L~~~l~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 105 MSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp CCSCBHHHHHTCTT--------SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CCCCCHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 99999999986432 13899999999999999999999997 999999999999964 578999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+....... ..+..||+.|||||
T Consensus 174 ~~~~~~~~---~~~~~gT~~Y~aPE 195 (350)
T d1koaa2 174 AHLDPKQS---VKVTTGTAEFAAPE 195 (350)
T ss_dssp EECCTTSC---EEEECSCTTTCCHH
T ss_pred eecccccc---cceecCcccccCHH
Confidence 76543222 24568999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=271.37 Aligned_cols=166 Identities=25% Similarity=0.398 Sum_probs=145.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC-------CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-------QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~-------~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.+.|++.+.||+|+||+||+|+.+ +|+.||+|.+.+.. ...+.+.+|+.+|++|+|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999986 79999999985332 1357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----ce
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VA 213 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~----~~ 213 (246)
|||||||++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCE
T ss_pred EEEEEcCCCccccchhcccc---------ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccce
Confidence 99999999999999997643 3899999999999999999999997 99999999999998766 59
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||+++...... ......||+.|+|||
T Consensus 157 kl~DfG~a~~~~~~~---~~~~~~~t~~y~APE 186 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGN---EFKNIFGTPEFVAPE 186 (293)
T ss_dssp EECCCTTCEECTTSC---BCSCCCCCGGGCCHH
T ss_pred EecchhhhhhcCCCc---cccccCCCCcccCHH
Confidence 999999997654322 224568999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-40 Score=274.13 Aligned_cols=169 Identities=30% Similarity=0.466 Sum_probs=131.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC---EEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~---~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|++.+.||+|+||+||+|.++ +++ .||||.+...... .+.|.+|+.+|++++|||||++++++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677789999999999999976 333 5889988654332 35789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||||++|+|.+++.... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 106 ~Ey~~~g~L~~~~~~~~--------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EECCTTEEHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEecCCCcceeeecccc--------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence 99999999999887543 24899999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCcccccc---ccccccccccccCCC
Q 025893 221 SNQAPDMAARL---HSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~---~~~~~~gt~~y~aPE 246 (246)
++......... ......||+.|||||
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE 203 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPE 203 (299)
T ss_dssp ---------------------CGGGSCHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHH
Confidence 98764332211 112245899999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-40 Score=278.85 Aligned_cols=167 Identities=25% Similarity=0.349 Sum_probs=145.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
.+.|++.+.||+|+||.||+|+.+ +|+.||+|.+..... ....+.+|+.+|++|+|||||++++++.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999976 799999999865432 245678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCCceEEccccCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLS 221 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~--~~~~~kl~Dfgls 221 (246)
|++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|
T Consensus 108 ~~gg~L~~~~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 108 LSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp CCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CCCChHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 99999998876543 24899999999999999999999997 99999999999998 5789999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+...... ...+..||+.|||||
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE 198 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPE 198 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHH
T ss_pred eecCCCC---ceeeccCcccccCHH
Confidence 8754322 124567999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=275.13 Aligned_cols=178 Identities=28% Similarity=0.447 Sum_probs=144.1
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CC-----CEEEEEEcCCCC--CCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SG-----HAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-----~~vaik~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|++.+.||+|+||+||+|+++ .+ ..||+|.+.... .....+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 368889999999999999999865 22 258999886432 3346788999999998 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
.++|||||++|+|.++|+...... .......+++..++.++.||+.||.|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 999999999999999997654210 0111235889999999999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++.++.+||+|||+|+............+..||+.|||||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 236 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence 99999999999999999998765443333334567899999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=271.04 Aligned_cols=168 Identities=30% Similarity=0.499 Sum_probs=141.2
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
++|++.+.||+|+||+||+|+++++..||||.+.......+.|.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 589999999999999999999988788999999877777889999999999999999999999984 5668999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|..++..... ..++|..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 96 g~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 96 GSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred Cchhhhhhhccc-------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999988865321 23899999999999999999999997 99999999999999999999999999987543
Q ss_pred cccccccccccccccccCCC
Q 025893 227 MAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE 246 (246)
.... ......||+.|+|||
T Consensus 166 ~~~~-~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 166 NEYT-ARQGAKFPIKWTAPE 184 (285)
T ss_dssp -----------CCGGGSCHH
T ss_pred CCce-eeccccccccccChH
Confidence 3221 223457999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-40 Score=276.65 Aligned_cols=163 Identities=26% Similarity=0.331 Sum_probs=146.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 141 (246)
++|++.+.||+|+||.||+|+++ +|+.||||.+.+. ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999986 7999999998532 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCC
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls 221 (246)
||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 121 e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceee
Confidence 9999999999987643 3889999999999999999999997 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+..... ..+.+||+.|||||
T Consensus 189 ~~~~~~-----~~~~~Gt~~Y~APE 208 (350)
T d1rdqe_ 189 KRVKGR-----TWTLCGTPEALAPE 208 (350)
T ss_dssp EECSSC-----BCCCEECGGGCCHH
T ss_pred eecccc-----cccccCccccCCHH
Confidence 865432 24578999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=274.20 Aligned_cols=167 Identities=20% Similarity=0.243 Sum_probs=146.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.++|.+.+.||+|+||+||+|..+ +++.||+|.+.........+.+|+.+|++++|||||++++++.+.+.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467999999999999999999986 7889999999776655567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCceEEccccCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLSN 222 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~--~~~~kl~Dfgls~ 222 (246)
+||+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++
T Consensus 84 ~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 84 SGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp CCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhh
Confidence 99999999975431 3899999999999999999999997 999999999999985 4589999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... .....||+.|+|||
T Consensus 153 ~~~~~~~---~~~~~~t~~y~ape 173 (321)
T d1tkia_ 153 QLKPGDN---FRLLFTAPEYYAPE 173 (321)
T ss_dssp ECCTTCE---EEEEESCGGGSCHH
T ss_pred ccccCCc---ccccccccccccch
Confidence 6543221 24567999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=266.10 Aligned_cols=168 Identities=27% Similarity=0.479 Sum_probs=139.4
Q ss_pred hcCCCCce-eccCCceEEEEEEEC---CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNAL-IGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~-lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|.+... ||+|+||.||+|.++ ++..||||.+...... .+.|.+|+.+|++++|||||++++++.. +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999865 3457999999754432 4678999999999999999999999865 568999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
||||++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence 999999999999865431 3899999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCcccc-ccccccccccccccCCC
Q 025893 221 SNQAPDMAA-RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~-~~~~~~~~gt~~y~aPE 246 (246)
++....... ........||+.|||||
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPE 182 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHH
T ss_pred hhcccccccccccccccccCccccChH
Confidence 986543322 11223457999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-39 Score=265.34 Aligned_cols=165 Identities=30% Similarity=0.400 Sum_probs=145.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----------HHHHHHHHHHHhcCC-CCCccceEeEEEeC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----------DEEFLAQVSMVSRLK-HENFVQLLGYCVDG 134 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----------~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~ 134 (246)
++|++.+.||+|+||+||+|+.+ +++.+|||++.+.... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999976 7889999998654321 135778999999997 99999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceE
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~k 214 (246)
+..|||||||++|+|.++++... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeE
Confidence 99999999999999999997643 3899999999999999999999997 99999999999999999999
Q ss_pred EccccCCCCCCccccccccccccccccccCCC
Q 025893 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 215 l~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|||+++...... .....+||+.|+|||
T Consensus 151 l~DFG~a~~~~~~~---~~~~~~gt~~y~~PE 179 (277)
T d1phka_ 151 LTDFGFSCQLDPGE---KLREVCGTPSYLAPE 179 (277)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHH
T ss_pred EccchheeEccCCC---ceeeeeccCCCCCHH
Confidence 99999998654322 224568999999997
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=265.49 Aligned_cols=161 Identities=27% Similarity=0.440 Sum_probs=132.3
Q ss_pred ceeccCCceEEEEEEEC---CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC
Q 025893 73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~---~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~~ 146 (246)
+.||+|+||+||+|.++ +++.||||.+...... .+.+.+|+.+|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 3467999998654322 3578999999999999999999999965 457899999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCCc
Q 025893 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (246)
Q Consensus 147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~~ 226 (246)
|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence 99999997643 3899999999999999999999997 99999999999999999999999999976543
Q ss_pred cccc-cccccccccccccCCC
Q 025893 227 MAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 227 ~~~~-~~~~~~~gt~~y~aPE 246 (246)
.... .......||+.|||||
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE 180 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPE 180 (277)
T ss_dssp TCSEEEC----CCCGGGCCHH
T ss_pred cccccccccccCCCceecCch
Confidence 3221 1223457999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=266.31 Aligned_cols=169 Identities=28% Similarity=0.467 Sum_probs=135.7
Q ss_pred hcCCCCceeccCCceEEEEEEECC-C----CEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKS-G----HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~-~----~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
+.|...++||+|+||.||+|.++. + ..||||.+...... ..+|.+|+.++++++|||||++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 467788999999999999998763 2 36999998654433 3468899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+.++++.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecccCcchhhhhccc--------ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 999999999998886543 24889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccc-cccccccccccccCCC
Q 025893 220 LSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
+++........ .......||+.|||||
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE 183 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPE 183 (283)
T ss_dssp C-----------------CCCGGGSCHH
T ss_pred hhhcccCCCccceEeccCCCCccccCHH
Confidence 99876433221 1223456899999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-39 Score=275.36 Aligned_cols=164 Identities=27% Similarity=0.368 Sum_probs=141.2
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCC----CCHHHHHH---HHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLA---QVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~----~~~~~~~~---e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
++|++.++||+|+||.||+|+.+ +|+.||+|.+.+.. .....+.+ ++.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999976 79999999985321 22233333 467788889999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+|||||++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCC
T ss_pred EEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeee
Confidence 9999999999999997643 3788999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025893 219 DLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|+|+...... ....+||+.|||||
T Consensus 152 Gla~~~~~~~----~~~~~GT~~y~APE 175 (364)
T d1omwa3 152 GLACDFSKKK----PHASVGTHGYMAPE 175 (364)
T ss_dssp TTCEECSSSC----CCSCCSCGGGCCHH
T ss_pred ceeeecCCCc----ccccccccccchhH
Confidence 9998654322 24568999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-39 Score=266.16 Aligned_cols=166 Identities=26% Similarity=0.391 Sum_probs=144.0
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCC----CCCHHHHHHHHHHHh-cCCCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVS-RLKHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~----~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|.+.+.||+|+||+||+|..+ +++.||||.+.+. ....+.+..|..++. .++|||||++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 7899999998642 334566777777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccC
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgl 220 (246)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 mEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeecCCCcHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccch
Confidence 99999999999997654 3788999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025893 221 SNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 221 s~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
++....... .....+||+.|+|||
T Consensus 150 a~~~~~~~~--~~~~~~gt~~y~aPE 173 (320)
T d1xjda_ 150 CKENMLGDA--KTNTFCGTPDYIAPE 173 (320)
T ss_dssp CBCCCCTTC--CBCCCCSCGGGCCHH
T ss_pred hhhcccccc--cccccCCCCCcCCHH
Confidence 986543322 234568999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=263.51 Aligned_cols=161 Identities=29% Similarity=0.410 Sum_probs=134.7
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC------HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecC
Q 025893 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
.++||+|+||+||+|+.+ +++.||||++...... .+.+.+|+.++++++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999976 7999999998654321 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
.++++..+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp SEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred cchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccccc
Confidence 9887766654332 3777888999999999999999997 999999999999999999999999999875
Q ss_pred CccccccccccccccccccCCC
Q 025893 225 PDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE 246 (246)
..... .....+||+.|+|||
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE 170 (299)
T d1ua2a_ 151 GSPNR--AYTHQVVTRWYRAPE 170 (299)
T ss_dssp TSCCC--CCCCSCCCCTTCCHH
T ss_pred CCCcc--cccceecChhhccHH
Confidence 43322 224568999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=265.51 Aligned_cols=164 Identities=21% Similarity=0.327 Sum_probs=138.2
Q ss_pred HhcCCCC-ceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhc-CCCCCccceEeEEEe----CCeeE
Q 025893 66 TENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSR-LKHENFVQLLGYCVD----GTSRV 138 (246)
Q Consensus 66 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~----~~~~~ 138 (246)
.++|.+. ++||+|+||+||+|+.+ +++.||||.+.. ...+.+|+.++.+ ++|||||++++++.+ ...+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5688876 46999999999999975 789999999853 3567789988654 589999999999875 46689
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEE
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKI 215 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl 215 (246)
+|||||+||+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccc
Confidence 99999999999999976432 24899999999999999999999997 999999999999985 467999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+|+....... ....+||+.|||||
T Consensus 156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE 183 (335)
T d2ozaa1 156 TDFGFAKETTSHNS---LTTPCYTPYYVAPE 183 (335)
T ss_dssp CCCTTCEECCCCCC---CCCCSCCCSSCCCC
T ss_pred cccceeeeccCCCc---cccccCCcccCCcH
Confidence 99999976543222 24568999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=264.81 Aligned_cols=168 Identities=26% Similarity=0.459 Sum_probs=136.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC----EEEEEEcCCCC--CCHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vaik~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.+|++.+.||+|+||+||+|.+. +|+ .||+|.+.... ...+.+.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999975 444 58999886432 3467899999999999999999999999865 5678
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
++||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccc
Confidence 8899999999998875432 4889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|+...............||+.|||||
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE 183 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALE 183 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHH
T ss_pred cceecccccccccccccccCccccChH
Confidence 987654433333334457999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-38 Score=263.56 Aligned_cols=178 Identities=28% Similarity=0.432 Sum_probs=145.4
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|++.+.||+|+||+||+|+++ ++..||||++...... .+++.+|+.++++++||||+++++++......
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 578999999999999999999864 3467999998755433 35789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
+++|||+++|+|.+++........ ......+++..++.++.|++.||.|||+++ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 999999999999999975432110 011234889999999999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||++.++.+||+|||+|+............+..||+.|+|||
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE 212 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence 99999999999999999987544333333334567999999997
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-38 Score=258.69 Aligned_cols=169 Identities=22% Similarity=0.375 Sum_probs=136.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHhcCCCCCccceEeEEEeCC----e
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGT----S 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~ 136 (246)
.++|++.+.||+|+||+||+|... +++.||||.+...... ...+.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 7999999999765432 246889999999999999999999988654 3
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.|+||||++|++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++..+|+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEECCCCCEehhhhcccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence 789999999999999886543 3889999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccc-cccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMA-ARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~-~~~~~~~~~gt~~y~aPE 246 (246)
|||++....... ........+||+.|||||
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 184 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184 (277)
T ss_dssp CCTTCEECC----------------TTCCHH
T ss_pred hhhhhhhhccccccccccccccCcccccCHH
Confidence 999886543222 112234568999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=260.98 Aligned_cols=167 Identities=29% Similarity=0.432 Sum_probs=139.3
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|++.+.||+|+||+||+|..+ +++.||+|++..... ..+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999975 799999999965432 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
|+.+ ++.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~~-~~~~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp CCSE-EHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ecCC-chhhhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence 9975 44444433221 24899999999999999999999997 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
....... ......||+.|+|||
T Consensus 151 ~~~~~~~--~~~~~~gt~~y~apE 172 (298)
T d1gz8a_ 151 AFGVPVR--TYTHEVVTLWYRAPE 172 (298)
T ss_dssp HHCCCSB--CTTCCBCCCTTCCHH
T ss_pred eccCCcc--cceeecccceeeehh
Confidence 5432221 224557999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=261.00 Aligned_cols=184 Identities=22% Similarity=0.368 Sum_probs=137.3
Q ss_pred HHHHHHHhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeE
Q 025893 60 DELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGY 130 (246)
Q Consensus 60 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~ 130 (246)
++++...++|++.+.||+|+||.||+|.+. +++.||+|.+...... .+.+..|+.++.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 333333578999999999999999999853 2457999998654332 35677788877776 58999999999
Q ss_pred EEeC-CeeEEEEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 025893 131 CVDG-TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (246)
Q Consensus 131 ~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp 202 (246)
+... ...++|||||++|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8765 46899999999999999997543210 0011235889999999999999999999997 99999999
Q ss_pred CCeEecCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 203 ~Nil~~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+++++.+||+|||+|+...............||+.|||||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 206 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchh
Confidence 99999999999999999998765444333345678999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=262.15 Aligned_cols=170 Identities=27% Similarity=0.417 Sum_probs=134.9
Q ss_pred HhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeCC----eeEEEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRVLAY 141 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~lv~ 141 (246)
..+|.+.+.||+|+||.||+|++ +|+.||||.+............|+..+.+++|||||++++++.+.+ ..|+||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 35677788999999999999987 4889999998644322222334555567889999999999998654 578999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeCCCCCCCeEecCCCceEEc
Q 025893 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-----DPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 142 E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
||+++|+|.++++... ++|..++.++.|++.||.|+|+.. .++|+||||||+|||++.++.+||+
T Consensus 81 Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred ecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 9999999999997642 889999999999999999999741 2359999999999999999999999
Q ss_pred cccCCCCCCccccc--cccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
|||+++........ .......||+.|||||
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHH
T ss_pred ecCccccccCCCcceeccccceecccCcCChh
Confidence 99999765332211 1224567999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-38 Score=255.41 Aligned_cols=168 Identities=30% Similarity=0.429 Sum_probs=131.0
Q ss_pred HhcCCCCceeccCCceEEEEEEECC----CCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 139 (246)
.++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.++++++|||||++++++. .+..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3688999999999999999998752 346899988654433 357889999999999999999999985 577899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 025893 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (246)
Q Consensus 140 v~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfg 219 (246)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 85 v~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence 9999999999998765432 3889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|+........ ......||+.|+|||
T Consensus 154 ~a~~~~~~~~~-~~~~~~gt~~y~apE 179 (273)
T d1mp8a_ 154 LSRYMEDSTYY-KASKGKLPIKWMAPE 179 (273)
T ss_dssp ------------------CCGGGCCHH
T ss_pred hheeccCCcce-eccceecCcccchhh
Confidence 99875433221 224457899999997
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=257.69 Aligned_cols=165 Identities=25% Similarity=0.353 Sum_probs=140.0
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------CHHHHHHHHHHHhcCC--CCCccceEeEEEeCC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLK--HENFVQLLGYCVDGT 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~-------~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~ 135 (246)
.++|++.+.||+|+||.||+|+.. +++.||||.+.+... ....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999976 789999999854321 1234668999999987 899999999999999
Q ss_pred eeEEEEecCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCce
Q 025893 136 SRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVA 213 (246)
Q Consensus 136 ~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-~~~~ 213 (246)
..++||||+.+ +++.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred eEEEEEEeccCcchHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence 99999999976 67888876543 3889999999999999999999997 999999999999985 5799
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||+|+...... ..+.+||+.|+|||
T Consensus 151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE 179 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPE 179 (273)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHH
T ss_pred EECccccceeccccc----ccccccCCCcCCHH
Confidence 999999997643321 24578999999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=252.99 Aligned_cols=163 Identities=32% Similarity=0.544 Sum_probs=133.0
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYEFAS 145 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~E~~~ 145 (246)
++|++.+.||+|+||.||+|.++ |..||||.+..+ ...+.+.+|+.++++++||||+++++++.+ .+..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 57888899999999999999985 778999999654 345789999999999999999999999865 466899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCCC
Q 025893 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (246)
Q Consensus 146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~~ 225 (246)
+|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 85 KGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp TEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC
Confidence 9999999865421 12789999999999999999999986 9999999999999999999999999998653
Q ss_pred ccccccccccccccccccCCC
Q 025893 226 DMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE 246 (246)
.. .....+|+.|+|||
T Consensus 155 ~~-----~~~~~~~~~y~aPE 170 (262)
T d1byga_ 155 ST-----QDTGKLPVKWTAPE 170 (262)
T ss_dssp ------------CCTTTSCHH
T ss_pred CC-----CccccccccCCChH
Confidence 32 23457899999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=257.93 Aligned_cols=178 Identities=24% Similarity=0.410 Sum_probs=146.8
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCee
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 137 (246)
.++|.+.+.||+|+||.||+|.++ ++..||||++...... ...+.+|+.++++++|||||++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 468888999999999999999863 2567999999754332 24688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 138 VLAYEFASNGSLHDILHGRKGV-KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
++||||+++|+|.+++...... ........+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988643210 00111224788999999999999999999996 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...............||+.|+|||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred ecccceeccCCcceeeccceecccccCCHH
Confidence 999998765444433345567999999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=254.84 Aligned_cols=174 Identities=33% Similarity=0.513 Sum_probs=139.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCC--EEEEEEcCCC--CCCHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDAS--KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vaik~~~~~--~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 140 (246)
++|++.+.||+|+||.||+|.++ ++. .||||++... ....+.+.+|+.+|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 58888999999999999999976 454 4788887533 23345799999999999 699999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 141 YEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
|||+++|+|.++|....... .......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997542100 0011235899999999999999999999996 9999999999999999999
Q ss_pred EEccccCCCCCCccccccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||+|||+++....... .....||+.|+|||
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE 196 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIE 196 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHH
T ss_pred EEcccccccccccccc---ccceecCCcccchH
Confidence 9999999976543322 23457999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-37 Score=255.28 Aligned_cols=178 Identities=24% Similarity=0.414 Sum_probs=147.9
Q ss_pred HhcCCCCceeccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeCCe
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 136 (246)
.++|++.+.||+|+||.||+|.++ ++..||||++...... ...+.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368888999999999999999852 3567999999765433 34688999999999 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKG---------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
.++|||||++|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999976542110 112235889999999999999999999997 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............||+.|+|||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE 217 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHH
Confidence 999999999999998765544333445578999999997
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-37 Score=254.32 Aligned_cols=166 Identities=28% Similarity=0.380 Sum_probs=139.9
Q ss_pred hcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEec
Q 025893 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
++|++.+.||+|+||+||+|+.++++.||||++..... ..+.+.+|+.+|++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999999999999999965432 347899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCC
Q 025893 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (246)
Q Consensus 144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~ 223 (246)
+.++.+..+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 98877666655432 4899999999999999999999997 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025893 224 APDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
...... ......||+.|+|||
T Consensus 150 ~~~~~~--~~~~~~~~~~y~~pE 170 (286)
T d1ob3a_ 150 FGIPVR--KYTHEIVTLWYRAPD 170 (286)
T ss_dssp HCC-----------CCCTTCCHH
T ss_pred cccCcc--ccceecccchhhhHH
Confidence 432211 123456899999997
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-37 Score=252.71 Aligned_cols=178 Identities=30% Similarity=0.467 Sum_probs=142.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-C-------CCEEEEEEcCCCCCC--HHHHHHHHHHHhcC-CCCCccceEeEEEeC
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-S-------GHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~-------~~~vaik~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 134 (246)
.++|.+.+.||+|+||.||+|+.. + +..||||++...... ...+.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468889999999999999999854 2 236999998765432 36788898888888 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 025893 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (246)
Q Consensus 135 ~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~ 207 (246)
...++||||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997654211 0112345899999999999999999999997 9999999999999
Q ss_pred cCCCceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 208 ~~~~~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+.++.+||+|||+++...............||+.|+|||
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence 999999999999998765544433345567999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=250.94 Aligned_cols=168 Identities=30% Similarity=0.478 Sum_probs=130.1
Q ss_pred hcCCCCceeccCCceEEEEEEEC--CC--CEEEEEEcCCCCC----CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeE
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK--SG--HAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~--~~--~~vaik~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 138 (246)
++|++.+.||+|+||.||+|++. ++ ..||||.+..... ..++|.+|+.++++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57899999999999999999864 23 3689998865432 23578999999999999999999999965 5678
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+||||+++|++.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred eeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccc
Confidence 99999999999988765431 3889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025893 219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
|+++........ .......||+.|+|||
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE 184 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPE 184 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHH
T ss_pred hhhhhcccCCCcceecCccccCcccCCHH
Confidence 999876443222 1223456888999997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-36 Score=254.06 Aligned_cols=160 Identities=19% Similarity=0.332 Sum_probs=137.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeC--CeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDG--TSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~~~lv~E 142 (246)
++|++.+.||+|+||+||+|+.+ +++.||||++... ..+.+.+|+.+|++++ ||||+++++++... ...++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 58999999999999999999975 7899999998643 4677889999999996 99999999999854 56899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEccccCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLS 221 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Dfgls 221 (246)
||.+++|..+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|
T Consensus 113 ~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 113 HVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp CCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred ecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccc
Confidence 999999876542 3889999999999999999999997 99999999999999654 6999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025893 222 NQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+...... .....+||+.|+|||
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE 199 (328)
T d3bqca1 178 EFYHPGQ---EYNVRVASRYFKGPE 199 (328)
T ss_dssp EECCTTC---CCCSCCSCGGGCCHH
T ss_pred eeccCCC---cccccccCccccCcc
Confidence 7654322 224567999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=256.33 Aligned_cols=168 Identities=27% Similarity=0.356 Sum_probs=137.5
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHhcCCCCCccceEeEEEeCCe----eE
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----RV 138 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----~~ 138 (246)
.++|++.+.||+|+||+||+|..+ +++.||||++.+.... .+.+.+|+.+|++|+||||+++++++..... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357899999999999999999975 8999999999765432 3578899999999999999999999876532 34
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccc
Q 025893 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (246)
Q Consensus 139 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Df 218 (246)
+++||+.+|+|.+++.... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 4556677999999997542 889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025893 219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 219 gls~~~~~~~~~-~~~~~~~gt~~y~aPE 246 (246)
|+++........ ......+||+.|+|||
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPE 182 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred CceeeccCCCccceeeccccccceechHH
Confidence 999765433221 1234567999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-36 Score=248.54 Aligned_cols=164 Identities=25% Similarity=0.439 Sum_probs=136.1
Q ss_pred CceeccCCceEEEEEEECCC----CEEEEEEcCCCCC--CHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecC
Q 025893 72 NALIGEGSYGRVYYGILKSG----HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYEFA 144 (246)
Q Consensus 72 ~~~lG~G~fg~V~~~~~~~~----~~vaik~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~E~~ 144 (246)
.++||+|+||+||+|.+... ..||||++..... ..++|.+|+.+|++++||||+++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 2589999865433 23679999999999999999999999876 46789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCCCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~~~ 224 (246)
++|+|.+++..... .+.+..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99999999876542 3678889999999999999999996 999999999999999999999999999876
Q ss_pred Cccccc--cccccccccccccCCC
Q 025893 225 PDMAAR--LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 225 ~~~~~~--~~~~~~~gt~~y~aPE 246 (246)
...... .......||+.|+|||
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE 204 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALE 204 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHH
T ss_pred cccccccceecccccccccccChH
Confidence 433221 1123456999999997
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-36 Score=253.28 Aligned_cols=162 Identities=29% Similarity=0.403 Sum_probs=134.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHhcCCCCCccceEeEEEeCC------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 135 (246)
.+.|++.+.||+|+||+||+|..+ +|+.||||++...... .+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999976 7999999999765443 346789999999999999999999998654
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEE
Q 025893 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (246)
Q Consensus 136 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl 215 (246)
..|+||||+ +.+|..+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-cccHHHHHHhc----------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccc
Confidence 469999999 66888877653 3899999999999999999999997 999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccCCC
Q 025893 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 216 ~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+|||+|+..... .+...||+.|+|||
T Consensus 163 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE 188 (346)
T d1cm8a_ 163 LDFGLARQADSE-----MTGYVVTRWYRAPE 188 (346)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTH
T ss_pred ccccceeccCCc-----cccccccccccCHH
Confidence 999999765322 24568999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=254.41 Aligned_cols=164 Identities=27% Similarity=0.342 Sum_probs=132.0
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEE
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSRVLA 140 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~~~lv 140 (246)
+|...++||+|+||+||+|+++ +++.||||++...... ..+|+.+|++++||||+++++++... .++++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 6888899999999999999986 7999999998654422 23699999999999999999998643 357899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-ceEEcccc
Q 025893 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFD 219 (246)
Q Consensus 141 ~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~-~~kl~Dfg 219 (246)
||||+++.+..+..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 98 ~Ey~~~~~~~~l~~~~~------~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSR------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EECCSEEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EeccCCccHHHHHhhhh------ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence 99998654333322111 1124899999999999999999999997 99999999999999765 89999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025893 220 LSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+++...... ...+.+||+.|+|||
T Consensus 169 ~a~~~~~~~---~~~~~~gt~~y~aPE 192 (350)
T d1q5ka_ 169 SAKQLVRGE---PNVSYICSRYYRAPE 192 (350)
T ss_dssp TCEECCTTS---CCCSCCSCTTSCCHH
T ss_pred chhhccCCc---ccccccccccccChH
Confidence 987654322 224568999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=246.47 Aligned_cols=169 Identities=28% Similarity=0.415 Sum_probs=136.2
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEe--------
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-------- 133 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-------- 133 (246)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ...++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999975 899999999864432 34678899999999999999999998865
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCce
Q 025893 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~ 213 (246)
....|+||||+.++.+..+..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 346799999998776655443322 4788899999999999999999997 9999999999999999999
Q ss_pred EEccccCCCCCCcccc--ccccccccccccccCCC
Q 025893 214 KIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 214 kl~Dfgls~~~~~~~~--~~~~~~~~gt~~y~aPE 246 (246)
||+|||+++....... .......+||+.|+|||
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 191 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHH
Confidence 9999999975543221 11223467999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=245.78 Aligned_cols=167 Identities=26% Similarity=0.418 Sum_probs=134.7
Q ss_pred HhcCCCCceeccCCceEEEEEEEC-C-CCEEEEEEcCCCC---CCHHHHHHHHHHHhcC---CCCCccceEeEEEe----
Q 025893 66 TENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDASK---QPDEEFLAQVSMVSRL---KHENFVQLLGYCVD---- 133 (246)
Q Consensus 66 ~~~~~~~~~lG~G~fg~V~~~~~~-~-~~~vaik~~~~~~---~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~---- 133 (246)
.++|++.+.||+|+||+||+|++. + ++.||||++.... .....+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 5679999985322 2233566777776655 79999999999863
Q ss_pred -CCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 025893 134 -GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (246)
Q Consensus 134 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~ 212 (246)
....+++|||+.++.+........ ..+++..+..++.|++.||.|||+++ |+||||||+|||++..+.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 346789999998877655443322 24889999999999999999999997 999999999999999999
Q ss_pred eEEccccCCCCCCccccccccccccccccccCCC
Q 025893 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 213 ~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
+||+|||+++...... ......||+.|+|||
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE 185 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 185 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHH
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcc
Confidence 9999999998754333 235678999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-35 Score=241.58 Aligned_cols=167 Identities=22% Similarity=0.267 Sum_probs=139.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCC-CCccceEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~E~~ 144 (246)
++|++.+.||+|+||+||+|++. +++.||+|.+.... ..+.+..|+++++.|+| +|++.+++++......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 57999999999999999999976 78899999875432 23456788889999985 89999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-----CCceEEcccc
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-----DDVAKIADFD 219 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~-----~~~~kl~Dfg 219 (246)
+++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 84 -~~~l~~~~~~~~--------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 84 -GPSLEDLLDLCG--------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp -CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred -CCCHHHHHHhhc--------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccc
Confidence 689999886543 23889999999999999999999997 999999999999974 5689999999
Q ss_pred CCCCCCcccc-----ccccccccccccccCCC
Q 025893 220 LSNQAPDMAA-----RLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 220 ls~~~~~~~~-----~~~~~~~~gt~~y~aPE 246 (246)
+|+....... ......++||+.|||||
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE 183 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHH
Confidence 9976543211 11234568999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-35 Score=240.26 Aligned_cols=166 Identities=23% Similarity=0.346 Sum_probs=142.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 142 (246)
++|++.+.||+|+||+||+|+.+ +++.||||++..... ....+.+|+.+++.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47889999999999999999976 788999999864432 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEccccCCC
Q 025893 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (246)
Q Consensus 143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~Dfgls~ 222 (246)
++.+++|..++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhh
Confidence 999999988876543 3788999999999999999999997 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025893 223 QAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
........ .....+++.|+|||
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~pe 171 (292)
T d1unla_ 150 AFGIPVRC--YSAEVVTLWYRPPD 171 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHH
T ss_pred cccCCCcc--ceeeccccchhhhh
Confidence 65433221 23345778888886
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-35 Score=246.59 Aligned_cols=162 Identities=29% Similarity=0.421 Sum_probs=135.9
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeC-----Cee
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSR 137 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~ 137 (246)
++|++.+.||+|+||+||+|+.. +++.||||++....... +.+.+|+.+|++++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 57999999999999999999975 79999999997665443 4678999999999999999999998643 334
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEcc
Q 025893 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (246)
Q Consensus 138 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~D 217 (246)
++++||+.+|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|
T Consensus 98 ~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~d 164 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD 164 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEeecCCchhhhcccc----------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccc
Confidence 6667778899999999643 2899999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025893 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 218 fgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
||++...... .....||+.|+|||
T Consensus 165 fg~a~~~~~~-----~~~~~g~~~y~apE 188 (348)
T d2gfsa1 165 FGLARHTDDE-----MTGYVATRWYRAPE 188 (348)
T ss_dssp C----CCTGG-----GSSSCHHHHTSCHH
T ss_pred cchhcccCcc-----cccccccccccCch
Confidence 9998765332 24567999999997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-35 Score=244.54 Aligned_cols=167 Identities=25% Similarity=0.341 Sum_probs=143.7
Q ss_pred hcCCCCceeccCCceEEEEEEEC----CCCEEEEEEcCCCC-----CCHHHHHHHHHHHhcCCC-CCccceEeEEEeCCe
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTS 136 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vaik~~~~~~-----~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~ 136 (246)
++|++.+.||+|+||+||+|+.. +|+.||+|.+.+.. ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 68999999999999999999852 57899999986432 234667889999999987 899999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
.+++|||+.+|+|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---------~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred eeeeeecccccHHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEe
Confidence 999999999999999987654 3678888899999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++........ ...+..||+.|+|||
T Consensus 172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe 200 (322)
T d1vzoa_ 172 DFGLSKEFVADETE-RAYDFCGTIEYMAPD 200 (322)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHH
T ss_pred eccchhhhcccccc-cccccccccccchhH
Confidence 99999765433222 234567999999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=244.32 Aligned_cols=162 Identities=27% Similarity=0.334 Sum_probs=127.6
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHhcCCCCCccceEeEEEeC------Ce
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDG------TS 136 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~ 136 (246)
++|++.+.||+|+||+||+|+++ +|+.||||++....... ..+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999976 79999999997654433 4578999999999999999999999643 67
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCceEEc
Q 025893 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (246)
Q Consensus 137 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~~~~kl~ 216 (246)
+|+||||+.++ +.+.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~ 161 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEeccchH-HHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeee
Confidence 89999999765 4444432 3789999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025893 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 217 Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
|||+++...... .....+||+.|+|||
T Consensus 162 df~~~~~~~~~~---~~~~~~~t~~y~aPE 188 (355)
T d2b1pa1 162 DFGLARTAGTSF---MMTPYVVTRYYRAPE 188 (355)
T ss_dssp CCCC------------------CCTTCCHH
T ss_pred chhhhhcccccc---ccccccccccccChh
Confidence 999988754432 224567999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-34 Score=234.71 Aligned_cols=167 Identities=23% Similarity=0.331 Sum_probs=133.5
Q ss_pred hcCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCccc-eEeEEEeCCeeEEEEecC
Q 025893 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ-LLGYCVDGTSRVLAYEFA 144 (246)
Q Consensus 67 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~iv~-~~~~~~~~~~~~lv~E~~ 144 (246)
+.|++.+.||+|+||.||+|++. +++.||||.+.... ..+.+..|++++++++|+|++. +..++.+....++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 46999999999999999999975 78899999876443 2345788999999998776554 555567788889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCceEEccccCC
Q 025893 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLS 221 (246)
Q Consensus 145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~---~~~~kl~Dfgls 221 (246)
+++|.+.+.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++. +..+||+|||+|
T Consensus 86 -~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 86 -GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp -CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred -CCchhhhhhhcc--------CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 567766665432 24889999999999999999999997 999999999999864 457999999999
Q ss_pred CCCCccccc-----cccccccccccccCCC
Q 025893 222 NQAPDMAAR-----LHSTRVLGTFGYHAPE 246 (246)
Q Consensus 222 ~~~~~~~~~-----~~~~~~~gt~~y~aPE 246 (246)
+........ .......||+.|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 183 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASIN 183 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred eeccccccccceeccccCCcCCCccccCHH
Confidence 865432211 1234568999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=3e-29 Score=211.69 Aligned_cols=164 Identities=22% Similarity=0.258 Sum_probs=128.1
Q ss_pred cCCCCceeccCCceEEEEEEEC-CCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC-----------CCCccceEeEEEe--
Q 025893 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----------HENFVQLLGYCVD-- 133 (246)
Q Consensus 68 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~-----------hp~iv~~~~~~~~-- 133 (246)
.|++.+.||+|+||+||+|+.+ +|+.||||++.......+.+.+|+.+++++. |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 4999999999999999999975 7999999999765544567788898888775 5789999988764
Q ss_pred CCeeEEEEecCCCCCHH-HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCC
Q 025893 134 GTSRVLAYEFASNGSLH-DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDD 211 (246)
Q Consensus 134 ~~~~~lv~E~~~~g~L~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nil~~~~~ 211 (246)
....+++++++..+... ....... ...+.+..+..++.||+.||.|||+ ++ |+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYE-------HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 163 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred ccceeeeeeeccccccccccccccc-------ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccC
Confidence 45666777766554433 2222221 1247888999999999999999998 65 99999999999998654
Q ss_pred ------ceEEccccCCCCCCccccccccccccccccccCCC
Q 025893 212 ------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246 (246)
Q Consensus 212 ------~~kl~Dfgls~~~~~~~~~~~~~~~~gt~~y~aPE 246 (246)
.+|++|||.+...... ....+||+.|+|||
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE 199 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPE 199 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHH
T ss_pred cccccceeeEeecccccccccc-----cccccccccccChh
Confidence 4899999998754322 24568999999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.3e-25 Score=173.08 Aligned_cols=132 Identities=14% Similarity=0.168 Sum_probs=102.4
Q ss_pred CCCceeccCCceEEEEEEECCCCEEEEEEcCCCCCC-------------------HHHHHHHHHHHhcCCCCCccceEeE
Q 025893 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------------------DEEFLAQVSMVSRLKHENFVQLLGY 130 (246)
Q Consensus 70 ~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~~~-------------------~~~~~~e~~~l~~l~hp~iv~~~~~ 130 (246)
.+.+.||+|+||.||+|...+|+.||||.+...... ......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346789999999999999888999999987532110 0123467888999999999988765
Q ss_pred EEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 025893 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (246)
Q Consensus 131 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil~~~~ 210 (246)
. ..+++|||+++..+.+ +.......++.|++.+|.|||+++ |+||||||+|||++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 3 2378999998765532 222334578999999999999997 9999999999999864
Q ss_pred CceEEccccCCCCCC
Q 025893 211 DVAKIADFDLSNQAP 225 (246)
Q Consensus 211 ~~~kl~Dfgls~~~~ 225 (246)
.++|+|||+|....
T Consensus 140 -~~~liDFG~a~~~~ 153 (191)
T d1zara2 140 -GIWIIDFPQSVEVG 153 (191)
T ss_dssp -EEEECCCTTCEETT
T ss_pred -CEEEEECCCcccCC
Confidence 58999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.85 E-value=1.3e-08 Score=80.11 Aligned_cols=91 Identities=15% Similarity=0.051 Sum_probs=62.2
Q ss_pred HHHHHHhcCCCCceeccCCceEEEEEEECCCCEEEEEEcCCCC-CCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeE
Q 025893 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRV 138 (246)
Q Consensus 61 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vaik~~~~~~-~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~ 138 (246)
+++.....|+..+..+.++.+.||+... +++.+.+|...... .....+.+|...+..|. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 5566667777665544445568998754 45667788765332 23345667777776664 444678888888889999
Q ss_pred EEEecCCCCCHHHH
Q 025893 139 LAYEFASNGSLHDI 152 (246)
Q Consensus 139 lv~E~~~~g~L~~~ 152 (246)
+||++++|.++.+.
T Consensus 87 lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 87 LLMSEADGVLCSEE 100 (263)
T ss_dssp EEEECCSSEEHHHH
T ss_pred EEEEeccccccccc
Confidence 99999998777554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=9.4e-07 Score=68.68 Aligned_cols=73 Identities=12% Similarity=0.013 Sum_probs=50.1
Q ss_pred eccCC-ceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCCCCH
Q 025893 75 IGEGS-YGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (246)
Q Consensus 75 lG~G~-fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~E~~~~g~L 149 (246)
+..|. -..||+.....+..+++|.-.... ...+..|...++.|. .-.+.+++.+..+++..++|||+++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 357898887777778888765433 234556666666554 33467788888888889999999987544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=3.5e-05 Score=63.79 Aligned_cols=74 Identities=18% Similarity=0.055 Sum_probs=47.0
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEcCC------C--CCCHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEE
Q 025893 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDA------S--KQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLA 140 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~-~~~~vaik~~~~------~--~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv 140 (246)
+.||.|....||+.... .++.+++|.-.. . .....+...|...|+.+. ...+++++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999865 467788886432 1 112344556777776553 2346666654 45667899
Q ss_pred EecCCCCC
Q 025893 141 YEFASNGS 148 (246)
Q Consensus 141 ~E~~~~g~ 148 (246)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.00094 Score=53.34 Aligned_cols=68 Identities=9% Similarity=0.042 Sum_probs=47.7
Q ss_pred CceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCCCCCc--cceE-----eEEEeCCeeEEEEecCCC
Q 025893 79 SYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF--VQLL-----GYCVDGTSRVLAYEFASN 146 (246)
Q Consensus 79 ~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~hp~i--v~~~-----~~~~~~~~~~lv~E~~~~ 146 (246)
--..||++...+|..+++|.........+++..|...+..|....| +... ..+......+.+++++.|
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3467999998889999999988776777888888888877642222 1111 123346677888898876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.28 E-value=0.00082 Score=55.19 Aligned_cols=70 Identities=11% Similarity=0.103 Sum_probs=45.8
Q ss_pred ceeccCCceEEEEEEECCC--------CEEEEEEcCCCCCCHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEec
Q 025893 73 ALIGEGSYGRVYYGILKSG--------HAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (246)
Q Consensus 73 ~~lG~G~fg~V~~~~~~~~--------~~vaik~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~E~ 143 (246)
+.|+.|---.+|+....++ ..+.++..- ......+..+|..+++.+. +.-..++++++. + .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEE
Confidence 4677788888999886532 346666554 3334445667888888775 333457777763 2 578999
Q ss_pred CCCC
Q 025893 144 ASNG 147 (246)
Q Consensus 144 ~~~g 147 (246)
++|.
T Consensus 123 i~g~ 126 (395)
T d1nw1a_ 123 IPSR 126 (395)
T ss_dssp CCEE
T ss_pred eccc
Confidence 8864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.00 E-value=0.002 Score=50.87 Aligned_cols=62 Identities=13% Similarity=0.224 Sum_probs=37.3
Q ss_pred cCHHHHHHHHhcCCCCcee-----ccCCceEEEEEEECCCCEEEEEEcCCCCCCHHHHHHHHHHHhcCC
Q 025893 57 ISVDELKEITENFGTNALI-----GEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120 (246)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~l-----G~G~fg~V~~~~~~~~~~vaik~~~~~~~~~~~~~~e~~~l~~l~ 120 (246)
++.++++.+..+|.+.++. ..|--.+.|+....+| .+++|...... ..+++..|+.++..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhh
Confidence 5678888889999886543 3565677898876655 47888875432 2234444555555543
|